Clustering O 0 0.4607812762260437
of O 0 0.02550528198480606
missense O 1 0.988013505935669
mutations O 1 0.994504988193512
in O 0 0.016554487869143486
the O 0 0.025280950590968132
ataxia B-Disease 1 0.9994412064552307
- I-Disease 1 0.9878028035163879
telangiectasia I-Disease 1 0.9987107515335083
gene O 1 0.9943292737007141
in O 0 0.014550874009728432
a O 0 0.02383282221853733
sporadic B-Disease 1 0.9618038535118103
T I-Disease 1 0.996656060218811
- I-Disease 1 0.980250895023346
cell I-Disease 1 0.9937708973884583
leukaemia I-Disease 1 0.9963552951812744
. O 0 0.05570307746529579

Ataxia B-Disease 1 0.9973305463790894
- I-Disease 1 0.9595112800598145
telangiectasia I-Disease 1 0.9956905245780945
( O 0 0.03687206655740738
A B-Disease 0 0.041607603430747986
- I-Disease 1 0.7274139523506165
T I-Disease 1 0.9823691248893738
) O 0 0.012508926913142204
is O 0 0.007604030426591635
a O 0 0.01861491985619068
recessive B-Disease 1 0.9995286464691162
multi I-Disease 1 0.9755335450172424
- I-Disease 1 0.9480801820755005
system I-Disease 1 0.7544924020767212
disorder I-Disease 1 0.999397873878479
caused O 1 0.7574731111526489
by O 0 0.014496670104563236
mutations O 1 0.9965329170227051
in O 0 0.007992167957127094
the O 0 0.009401295334100723
ATM O 1 0.866487443447113
gene O 1 0.9866286516189575
at O 0 0.01724824868142605
11q22 O 1 0.8950868248939514
- O 0 0.422368586063385
q23 O 1 0.8722361922264099
( O 0 0.026927180588245392
ref O 1 0.6293930411338806
. O 0 0.01281250175088644
3 O 0 0.02045259438455105
) O 0 0.019240502268075943
. O 0 0.019504930824041367

The O 0 0.026719698682427406
risk O 1 0.7126768231391907
of O 0 0.017209939658641815
cancer B-Disease 1 0.9988202452659607
, O 0 0.012902707792818546
especially O 0 0.043143946677446365
lymphoid B-Disease 1 0.9964056015014648
neoplasias I-Disease 1 0.8797347545623779
, O 0 0.008332357741892338
is O 0 0.0073177022859454155
substantially O 0 0.08414088934659958
elevated O 0 0.24297483265399933
in O 0 0.009096588008105755
A B-Disease 0 0.1376384198665619
- I-Disease 1 0.975741982460022
T I-Disease 1 0.9988744854927063
patients O 1 0.995521068572998
and O 0 0.0052410513162612915
has O 0 0.005480836611241102
long O 0 0.011428865604102612
been O 0 0.006913214456290007
associated O 0 0.042093679308891296
with O 0 0.022389311343431473
chromosomal O 1 0.9985775947570801
instability O 1 0.9722299575805664
. O 0 0.03712163865566254

By O 0 0.04052279144525528
analysing O 1 0.6830447912216187
tumour B-Disease 1 0.9981116056442261
DNA O 1 0.9751945734024048
from O 0 0.02689451351761818
patients O 1 0.990148663520813
with O 0 0.021351663395762444
sporadic B-Disease 1 0.9552546739578247
T I-Disease 1 0.9952392578125
- I-Disease 1 0.957612931728363
cell I-Disease 1 0.9949486255645752
prolymphocytic I-Disease 1 0.9944943785667419
leukaemia I-Disease 1 0.9990559220314026
( O 0 0.1451459527015686
T B-Disease 1 0.9912436008453369
- I-Disease 1 0.8033342957496643
PLL I-Disease 1 0.9894914627075195
) O 0 0.014566524885594845
, O 0 0.006079529877752066
a O 0 0.01062716729938984
rare O 0 0.3991766571998596
clonal B-Disease 1 0.9964115023612976
malignancy I-Disease 1 0.9971261620521545
with O 0 0.008768599480390549
similarities O 0 0.020741699263453484
to O 0 0.005279748234897852
a O 0 0.014024866744875908
mature B-Disease 1 0.9828885793685913
T I-Disease 1 0.997154951095581
- I-Disease 1 0.9784983992576599
cell I-Disease 1 0.9972844123840332
leukaemia I-Disease 1 0.9990541338920593
seen O 0 0.01753513514995575
in O 0 0.008984457701444626
A B-Disease 0 0.032957229763269424
- I-Disease 1 0.6402701139450073
T I-Disease 1 0.9756198525428772
, O 0 0.00577915832400322
we O 0 0.003927495796233416
demonstrate O 0 0.009476743638515472
a O 0 0.007563616614788771
high O 0 0.009017731063067913
frequency O 0 0.027608992531895638
of O 0 0.008835111744701862
ATM O 1 0.8879870772361755
mutations O 1 0.997365415096283
in O 0 0.028591664507985115
T B-Disease 1 0.9893061518669128
- I-Disease 1 0.772819459438324
PLL I-Disease 1 0.970744252204895
. O 0 0.045373547822237015

In O 0 0.017386682331562042
marked O 0 0.020853200927376747
contrast O 0 0.014446317218244076
to O 0 0.006057220511138439
the O 0 0.00868475902825594
ATM O 1 0.9424275755882263
mutation O 1 0.9984354376792908
pattern O 0 0.4988976716995239
in O 0 0.009084912948310375
A B-Disease 0 0.03819247707724571
- I-Disease 1 0.6918640732765198
T I-Disease 1 0.9785526990890503
, O 0 0.0053651765920221806
the O 0 0.004630113486200571
most O 0 0.006808008532971144
frequent O 0 0.06601627916097641
nucleotide O 1 0.8350858092308044
changes O 0 0.019095059484243393
in O 0 0.008972792886197567
this O 0 0.012461970560252666
leukaemia B-Disease 1 0.9980560541152954
were O 0 0.02014540508389473
missense O 1 0.9930078983306885
mutations O 1 0.9952402114868164
. O 0 0.03814762830734253

These O 0 0.01642475463449955
clustered O 0 0.030770093202590942
in O 0 0.006548818666487932
the O 0 0.004851202946156263
region O 0 0.008623241446912289
corresponding O 0 0.010192959569394588
to O 0 0.004160014446824789
the O 0 0.006275654304772615
kinase O 1 0.9924457669258118
domain O 0 0.03264140337705612
, O 0 0.004058676306158304
which O 0 0.0033098733983933926
is O 0 0.003964148461818695
highly O 0 0.013146387413144112
conserved O 0 0.19102691113948822
in O 0 0.007726444397121668
ATM O 1 0.8671512603759766
- O 0 0.45903488993644714
related O 0 0.28863608837127686
proteins O 1 0.9242292642593384
in O 0 0.010928494855761528
mouse O 1 0.9871525168418884
, O 0 0.012472627684473991
yeast O 1 0.9872277975082397
and O 0 0.01510513387620449
Drosophila O 1 0.943004846572876
. O 0 0.031091464683413506

The O 0 0.025632333010435104
resulting O 0 0.1763099730014801
amino O 1 0.8434686064720154
- O 1 0.5113235116004944
acid O 1 0.9541277289390564
substitutions O 0 0.03551642224192619
are O 0 0.0057554361410439014
predicted O 0 0.014297557063400745
to O 0 0.005406589712947607
interfere O 0 0.033257294446229935
with O 0 0.011504721827805042
ATP O 1 0.6868401765823364
binding O 0 0.133974090218544
or O 0 0.017564883455634117
substrate O 1 0.5963082909584045
recognition O 0 0.04950042814016342
. O 0 0.02433820441365242

Two O 0 0.020201530307531357
of O 0 0.013102840632200241
seventeen O 0 0.04968489333987236
mutated O 1 0.9958118200302124
T B-Disease 1 0.993134617805481
- I-Disease 1 0.7873055934906006
PLL I-Disease 1 0.983905017375946
samples O 0 0.030260398983955383
had O 0 0.008013153448700905
a O 0 0.0093861548230052
previously O 0 0.013033892028033733
reported O 0 0.01916276104748249
A B-Disease 0 0.04928476735949516
- I-Disease 1 0.8890711665153503
T I-Disease 1 0.9936560392379761
allele O 1 0.9897540211677551
. O 0 0.036650534719228745

In O 0 0.020779037848114967
contrast O 0 0.02448626421391964
, O 0 0.008611403405666351
no O 0 0.009804658591747284
mutations O 1 0.9934800863265991
were O 0 0.005342328455299139
detected O 0 0.12539635598659515
in O 0 0.006733199115842581
the O 0 0.010292808525264263
p53 O 1 0.9988945126533508
gene O 1 0.995807409286499
, O 0 0.00834173709154129
suggesting O 0 0.016275811940431595
that O 0 0.005319476593285799
this O 0 0.011607455089688301
tumour B-Disease 1 0.9997654557228088
suppressor O 1 0.9983335137367249
is O 0 0.008284566923975945
not O 0 0.005648905411362648
frequently O 0 0.013211782090365887
altered O 0 0.12875325977802277
in O 0 0.011655433103442192
this O 0 0.016602104529738426
leukaemia B-Disease 1 0.9973675608634949
. O 0 0.036667462438344955

Occasional O 0 0.39953872561454773
missense O 1 0.9869067668914795
mutations O 1 0.991452693939209
in O 0 0.012966979295015335
ATM O 0 0.04911963269114494
were O 0 0.004515130538493395
also O 0 0.004325398709625006
found O 0 0.0091513367369771
in O 0 0.011637955904006958
tumour B-Disease 1 0.9995805621147156
DNA O 1 0.9899442195892334
from O 0 0.018745671957731247
patients O 1 0.9937469959259033
with O 0 0.01635141484439373
B B-Disease 1 0.9518681168556213
- I-Disease 1 0.9218313097953796
cell I-Disease 1 0.990766167640686
non I-Disease 1 0.7253049612045288
- I-Disease 1 0.9928336143493652
Hodgkins I-Disease 1 0.9995935559272766
lymphomas I-Disease 1 0.9989513158798218
( O 0 0.0803399533033371
B B-Disease 1 0.7698958516120911
- I-Disease 0 0.15107570588588715
NHL I-Disease 0 0.0437956377863884
) O 0 0.009956662543118
and O 0 0.0050999876111745834
a O 0 0.012530947104096413
B B-Disease 0 0.4651804268360138
- I-Disease 0 0.16954155266284943
NHL I-Disease 0 0.20233945548534393
cell O 1 0.7754706740379333
line O 0 0.02989758551120758
. O 0 0.023986170068383217

The O 0 0.01225808821618557
evidence O 0 0.008583545684814453
of O 0 0.004303830210119486
a O 0 0.006216011941432953
significant O 0 0.008371320553123951
proportion O 0 0.01325150765478611
of O 0 0.005306166596710682
loss O 0 0.129128560423851
- O 0 0.10347612202167511
of O 0 0.006686716340482235
- O 0 0.4817614257335663
function O 1 0.7758051156997681
mutations O 1 0.9977725148200989
and O 0 0.004461762495338917
a O 0 0.0060442411340773106
complete O 0 0.0077482592314481735
absence O 0 0.010238347575068474
of O 0 0.0029101434629410505
the O 0 0.003820891724899411
normal O 0 0.026343505829572678
copy O 0 0.014278900809586048
of O 0 0.004309295676648617
ATM O 0 0.06193624436855316
in O 0 0.004359144251793623
the O 0 0.0039868042804300785
majority O 0 0.010188414715230465
of O 0 0.009994694963097572
mutated O 1 0.9982489347457886
tumours B-Disease 1 0.9992509484291077
establishes O 1 0.9576392769813538
somatic O 1 0.992641270160675
inactivation O 1 0.8752983212471008
of O 0 0.007234702352434397
this O 0 0.006780735217034817
gene O 1 0.9808506965637207
in O 0 0.007175675593316555
the O 0 0.008943693712353706
pathogenesis O 1 0.9951441287994385
of O 0 0.011664026416838169
sporadic B-Disease 1 0.9593014717102051
T I-Disease 1 0.9958702921867371
- I-Disease 1 0.8236575126647949
PLL I-Disease 1 0.9868277311325073
and O 0 0.00823886413127184
suggests O 0 0.02076014317572117
that O 0 0.006282086484134197
ATM O 0 0.11763419210910797
acts O 0 0.014324987307190895
as O 0 0.008817682974040508
a O 0 0.05580891668796539
tumour B-Disease 1 0.9992388486862183
suppressor O 1 0.9951738715171814
. O 0 0.04346693307161331

As O 0 0.016960090026259422
constitutional O 0 0.022190652787685394
DNA O 0 0.28016015887260437
was O 0 0.005889130290597677
not O 0 0.003575956914573908
available O 0 0.004947255365550518
, O 0 0.004292680881917477
a O 0 0.011313753202557564
putative O 1 0.9849943518638611
hereditary O 1 0.9951314926147461
predisposition O 1 0.9953138828277588
to O 0 0.01802702248096466
T B-Disease 1 0.9909245371818542
- I-Disease 1 0.6341736316680908
PLL I-Disease 1 0.9719576835632324
will O 0 0.00814447645097971
require O 0 0.01807447522878647
further O 0 0.011647075414657593
investigation O 0 0.021495215594768524
. O 0 0.011019805446267128
. O 0 0.018282728269696236

Myotonic B-Disease 1 0.996852457523346
dystrophy I-Disease 1 0.9989136457443237
protein O 1 0.9894968271255493
kinase O 1 0.9862939715385437
is O 0 0.01345677487552166
involved O 0 0.011985941790044308
in O 0 0.005185217130929232
the O 0 0.005570156965404749
modulation O 0 0.30051007866859436
of O 0 0.006779662799090147
the O 0 0.014359823428094387
Ca2 O 1 0.9967198967933655
+ O 1 0.9819715619087219
homeostasis O 1 0.9944376945495605
in O 0 0.04560641199350357
skeletal O 1 0.9974417686462402
muscle O 1 0.9978164434432983
cells O 1 0.9913908243179321
. O 0 0.042021073400974274

Myotonic B-Disease 1 0.9977241158485413
dystrophy I-Disease 1 0.9991612434387207
( O 0 0.4131383001804352
DM B-Disease 1 0.9957000017166138
) O 0 0.01966714859008789
, O 0 0.006612108554691076
the O 0 0.0053554438054561615
most O 0 0.009641215205192566
prevalent O 1 0.9948531985282898
muscular B-Disease 1 0.999652624130249
disorder I-Disease 1 0.999626874923706
in O 0 0.01536677684634924
adults O 1 0.6120750308036804
, O 0 0.007041109260171652
is O 0 0.006955122109502554
caused O 0 0.13501682877540588
by O 0 0.009813115932047367
( O 0 0.01853509433567524
CTG O 1 0.9483591914176941
) O 0 0.017373912036418915
n O 0 0.05163547396659851
- O 0 0.04810192435979843
repeat O 0 0.045024771243333817
expansion O 0 0.01734883524477482
in O 0 0.006666798610240221
a O 0 0.014447499997913837
gene O 1 0.9859400987625122
encoding O 1 0.6673147082328796
a O 0 0.032042521983385086
protein O 1 0.9918954968452454
kinase O 1 0.9930874705314636
( O 0 0.16339996457099915
DM B-Disease 1 0.9979332685470581
protein O 1 0.9949022531509399
kinase O 1 0.9945751428604126
; O 0 0.02244463749229908
DMPK O 1 0.7161586284637451
) O 0 0.010860812850296497
and O 0 0.0052102599292993546
involves O 0 0.025340566411614418
changes O 0 0.014676762744784355
in O 0 0.008563147857785225
cytoarchitecture O 1 0.6146898865699768
and O 0 0.016136974096298218
ion O 1 0.93576580286026
homeostasis O 1 0.984706461429596
. O 0 0.036519844084978104

To O 0 0.013289316557347775
obtain O 0 0.01977841928601265
clues O 0 0.01884128339588642
to O 0 0.004756346344947815
the O 0 0.00523148849606514
normal O 0 0.03108316846191883
biological O 0 0.02994406409561634
role O 0 0.012586808763444424
of O 0 0.006112700793892145
DMPK O 1 0.8048075437545776
in O 0 0.011868758127093315
cellular O 1 0.9905084371566772
ion O 1 0.9794512391090393
homeostasis O 1 0.9929487705230713
, O 0 0.005850471090525389
we O 0 0.003195839701220393
have O 0 0.003032577456906438
compared O 0 0.008347654715180397
the O 0 0.006133065093308687
resting O 0 0.3812721371650696
[ O 0 0.4230964183807373
Ca2 O 1 0.9971389770507812
+ O 1 0.8806583285331726
] O 0 0.030989065766334534
i O 0 0.005323108751326799
, O 0 0.003364522010087967
the O 0 0.004168583545833826
amplitude O 0 0.06749069690704346
and O 0 0.005086891353130341
shape O 0 0.0273103266954422
of O 0 0.010304482653737068
depolarization O 1 0.9971045851707458
- O 1 0.9816878437995911
induced O 1 0.999065101146698
Ca2 O 1 0.9984960556030273
+ O 1 0.9783843755722046
transients O 1 0.8328572511672974
, O 0 0.00582561269402504
and O 0 0.0035124877467751503
the O 0 0.0035919176880270243
content O 0 0.009357618167996407
of O 0 0.0058265491388738155
ATP O 1 0.6004550457000732
- O 0 0.10097134858369827
driven O 0 0.04943763464689255
ion O 1 0.7378087043762207
pumps O 0 0.3766971528530121
in O 0 0.018466388806700706
cultured O 1 0.990051805973053
skeletal O 1 0.9986763596534729
muscle O 1 0.9988932013511658
cells O 1 0.9887816309928894
of O 0 0.011649057269096375
wild O 0 0.10415585339069366
- O 0 0.25194376707077026
type O 0 0.20317894220352173
and O 0 0.010623112320899963
DMPK O 1 0.9277750253677368
[ O 0 0.2782454788684845
- O 1 0.6548861265182495
/ O 1 0.7989223003387451
- O 1 0.5021117925643921
] O 0 0.4118971824645996
knockout O 1 0.969154953956604
mice O 1 0.99058997631073
. O 0 0.04317822307348251

In O 0 0.04342922195792198
vitro O 1 0.9567102789878845
- O 1 0.5655952095985413
differentiated O 1 0.9660534262657166
DMPK O 1 0.9709010124206543
[ O 0 0.3285766541957855
- O 1 0.6651250720024109
/ O 1 0.7697898149490356
- O 0 0.30327165126800537
] O 0 0.08323615789413452
myotubes O 0 0.42002901434898376
exhibit O 0 0.0203094445168972
a O 0 0.010974555276334286
higher O 0 0.016099905595183372
resting O 0 0.21687625348567963
[ O 0 0.3566913306713104
Ca2 O 1 0.9959068298339844
+ O 1 0.7971612215042114
] O 0 0.0297368336468935
i O 0 0.006505702622234821
than O 0 0.005041401367634535
do O 0 0.007050613407045603
wild O 0 0.05564773455262184
- O 0 0.393986314535141
type O 0 0.4604920446872711
myotubes O 0 0.48969781398773193
because O 0 0.0069118947722017765
of O 0 0.0037732133641839027
an O 0 0.005152916070073843
altered O 0 0.060722194612026215
open O 0 0.014120654202997684
probability O 0 0.02534552291035652
of O 0 0.008442385122179985
voltage O 1 0.5120351314544678
- O 0 0.3955768644809723
dependent O 0 0.45191138982772827
l O 1 0.9543216824531555
- O 1 0.8112077116966248
type O 1 0.9346484541893005
Ca2 O 1 0.9953727126121521
+ O 1 0.7095606923103333
and O 0 0.016203168779611588
Na O 1 0.8596453666687012
+ O 1 0.5055633783340454
channels O 0 0.06361518800258636
. O 0 0.026441538706421852

The O 0 0.03137049823999405
mutant O 1 0.9310415387153625
myotubes O 1 0.5555450320243835
exhibit O 0 0.033644676208496094
smaller O 0 0.024599798023700714
and O 0 0.010851104743778706
slower O 0 0.42907479405403137
Ca2 O 1 0.9943106174468994
+ O 1 0.6905087828636169
responses O 0 0.06589169800281525
upon O 0 0.012362038716673851
triggering O 0 0.38800129294395447
by O 0 0.013527922332286835
acetylcholine O 1 0.9595205187797546
or O 0 0.01461564190685749
high O 0 0.018804706633090973
external O 0 0.046193499118089676
K O 0 0.49311527609825134
+ O 1 0.5302872657775879
. O 0 0.02732377126812935

In O 0 0.01668047159910202
addition O 0 0.01204616017639637
, O 0 0.004494825843721628
we O 0 0.0037153807934373617
observed O 0 0.00939568318426609
that O 0 0.004061958286911249
these O 0 0.008298722095787525
Ca2 O 1 0.9961283206939697
+ O 1 0.9382829666137695
transients O 1 0.9472643136978149
partially O 0 0.07432566583156586
result O 0 0.012964685447514057
from O 0 0.005704695358872414
an O 0 0.004829881712794304
influx O 0 0.03346212953329086
of O 0 0.0090825529769063
extracellular O 1 0.9832502007484436
Ca2 O 1 0.9948843121528625
+ O 0 0.30880141258239746
through O 0 0.013816425576806068
the O 0 0.012839077971875668
l O 1 0.8625043630599976
- O 1 0.774307131767273
type O 1 0.9193219542503357
Ca2 O 1 0.9926096796989441
+ O 1 0.6778637170791626
channel O 0 0.056324418634176254
. O 0 0.030586078763008118

Neither O 0 0.029073165729641914
the O 0 0.008871765807271004
content O 0 0.01561511866748333
nor O 0 0.011339614167809486
the O 0 0.005247600842267275
activity O 0 0.013851202093064785
of O 0 0.009947773069143295
Na O 1 0.9801023602485657
+ O 1 0.9457961916923523
/ O 1 0.7248194217681885
K O 1 0.6398728489875793
+ O 1 0.8890753984451294
ATPase O 1 0.9638149738311768
and O 0 0.02500475011765957
sarcoplasmic O 1 0.9945306181907654
reticulum O 1 0.9947538375854492
Ca2 O 1 0.9952346682548523
+ O 1 0.950372576713562
- O 1 0.552044153213501
ATPase O 1 0.9627148509025574
are O 0 0.011010305024683475
affected O 0 0.04944158345460892
by O 0 0.01822461560368538
DMPK O 1 0.8473535776138306
absence O 0 0.10622701048851013
. O 0 0.031009823083877563

In O 0 0.0138765349984169
conclusion O 0 0.013074660673737526
, O 0 0.004582993686199188
our O 0 0.004182637203484774
data O 0 0.00649438938125968
suggest O 0 0.008753162808716297
that O 0 0.003964092116802931
DMPK O 0 0.4659956097602844
is O 0 0.004572032485157251
involved O 0 0.00921501126140356
in O 0 0.00583880627527833
modulating O 1 0.8827419877052307
the O 0 0.0066917468793690205
initial O 0 0.013149506412446499
events O 0 0.01046007964760065
of O 0 0.00833510048687458
excitation O 1 0.9810391664505005
- O 1 0.7282200455665588
contraction O 1 0.9812642335891724
coupling O 1 0.968749463558197
in O 0 0.0314759835600853
skeletal O 1 0.9973874688148499
muscle O 1 0.9949280023574829
. O 0 0.020810531452298164
. O 0 0.023510316386818886

Constitutional O 0 0.16228510439395905
RB1 O 1 0.9900341629981995
- O 1 0.9565415382385254
gene O 1 0.9969978332519531
mutations O 1 0.9975384473800659
in O 0 0.02949146181344986
patients O 1 0.9824891090393066
with O 0 0.021902121603488922
isolated O 1 0.6252447962760925
unilateral B-Disease 1 0.8550770878791809
retinoblastoma I-Disease 1 0.989424467086792
. O 0 0.04051978513598442

In O 0 0.019183078780770302
most O 0 0.014309239573776722
patients O 1 0.9752007722854614
with O 0 0.013575667515397072
isolated O 1 0.7252355217933655
unilateral B-Disease 1 0.9515891671180725
retinoblastoma I-Disease 1 0.9984036087989807
, O 0 0.0263814777135849
tumor B-Disease 1 0.9990234375
development O 0 0.017424598336219788
is O 0 0.0067983041517436504
initiated O 0 0.021901320666074753
by O 0 0.01087737176567316
somatic O 1 0.9892532229423523
inactivation O 1 0.8843956589698792
of O 0 0.007461159490048885
both O 0 0.009875965304672718
alleles O 1 0.9802659153938293
of O 0 0.012593411840498447
the O 0 0.023357514292001724
RB1 O 1 0.9960407018661499
gene O 1 0.9894139766693115
. O 0 0.037113070487976074

However O 0 0.01462923176586628
, O 0 0.0057164509780704975
some O 0 0.003927719313651323
of O 0 0.0041785696521401405
these O 0 0.007825960405170918
patients O 1 0.9924283623695374
can O 0 0.032500263303518295
transmit O 1 0.9834932088851929
retinoblastoma B-Disease 1 0.9986661672592163
predisposition O 1 0.9901661276817322
to O 0 0.01073120255023241
their O 0 0.013648629188537598
offspring O 1 0.9012701511383057
. O 0 0.02970743365585804

To O 0 0.012384985573589802
determine O 0 0.014329834841191769
the O 0 0.007786966860294342
frequency O 0 0.01969216763973236
and O 0 0.004194092936813831
nature O 0 0.008836129680275917
of O 0 0.0061577907763421535
constitutional O 0 0.06839360296726227
RB1 O 1 0.9982445240020752
- O 1 0.9839978218078613
gene O 1 0.9989687204360962
mutations O 1 0.9988090991973877
in O 0 0.017974650487303734
patients O 1 0.9929437041282654
with O 0 0.013495280407369137
isolated O 1 0.7747834324836731
unilateral B-Disease 1 0.875527560710907
retinoblastoma I-Disease 1 0.9961608648300171
, O 0 0.007469716481864452
we O 0 0.005934607237577438
analyzed O 0 0.04536709561944008
DNA O 1 0.84591144323349
from O 0 0.017196079716086388
peripheral O 1 0.9945183396339417
blood O 1 0.9924311637878418
and O 0 0.01614515110850334
from O 0 0.08613680303096771
tumor B-Disease 1 0.9996356964111328
tissue O 1 0.9973760843276978
. O 0 0.03892650082707405

The O 0 0.018657924607396126
analysis O 0 0.02498931810259819
of O 0 0.011533492244780064
tumors B-Disease 1 0.9971843361854553
from O 0 0.012438606470823288
54 O 0 0.023869534954428673
( O 0 0.01112348772585392
71 O 0 0.019499730318784714
% O 0 0.010177983902394772
) O 0 0.0071442630141973495
of O 0 0.004863432142883539
76 O 0 0.028061922639608383
informative O 0 0.3330387771129608
patients O 1 0.9826439023017883
showed O 0 0.014708863571286201
loss O 0 0.022601954638957977
of O 0 0.007488657720386982
constitutional O 0 0.030112257227301598
heterozygosity O 1 0.9871354699134827
( O 0 0.05186518654227257
LOH O 1 0.9885777235031128
) O 0 0.020427044481039047
at O 0 0.02097170799970627
intragenic O 1 0.8726806640625
loci O 1 0.9721144437789917
. O 0 0.03850407525897026

Three O 0 0.020684830844402313
of O 0 0.012135611847043037
13 O 0 0.03127776458859444
uninformative O 1 0.9653039574623108
patients O 1 0.9693970084190369
had O 0 0.020617559552192688
constitutional O 0 0.0383404903113842
deletions O 1 0.8357499837875366
. O 0 0.03244524449110031

For O 0 0.0224191602319479
39 O 0 0.032726407051086426
randomly O 0 0.033925097435712814
selected O 0 0.02247599884867668
tumors B-Disease 1 0.9975332021713257
, O 0 0.014374815858900547
SSCP O 1 0.8074214458465576
, O 0 0.016401631757616997
hetero O 1 0.9954054355621338
- O 1 0.8012640476226807
duplex O 1 0.9802520871162415
analysis O 0 0.031622014939785004
, O 0 0.007428938988596201
sequencing O 0 0.2019069343805313
, O 0 0.004924907349050045
and O 0 0.0044380612671375275
Southern O 0 0.011346796527504921
blot O 0 0.3652395009994507
analysis O 0 0.016770796850323677
were O 0 0.003929357510060072
used O 0 0.0069747744128108025
to O 0 0.007471233140677214
identify O 0 0.15310688316822052
mutations O 1 0.9953559637069702
. O 0 0.028168633580207825

Mutations O 1 0.9833635091781616
were O 0 0.01593462936580181
detected O 0 0.11594464629888535
in O 0 0.008983884006738663
21 O 0 0.01477257814258337
( O 0 0.011240966618061066
91 O 0 0.018493743613362312
% O 0 0.012396242469549179
) O 0 0.009365533478558064
of O 0 0.007726678159087896
23 O 0 0.036611612886190414
tumors B-Disease 1 0.9983738660812378
with O 0 0.04752378165721893
LOH O 1 0.9814224243164062
. O 0 0.04116537421941757

In O 0 0.018869677558541298
6 O 0 0.019002366811037064
( O 0 0.011813109740614891
38 O 0 0.0125568937510252
% O 0 0.009991061873733997
) O 0 0.007261058781296015
of O 0 0.0049293567426502705
16 O 0 0.018474156036973
tumors B-Disease 1 0.9993440508842468
without O 0 0.02413480170071125
LOH O 1 0.9894962906837463
, O 0 0.007388374302536249
one O 0 0.00876330491155386
mutation O 1 0.9976964592933655
was O 0 0.007361907511949539
detected O 0 0.200697660446167
, O 0 0.0038987635634839535
and O 0 0.0027485601603984833
in O 0 0.003777605714276433
9 O 0 0.007922962307929993
( O 0 0.006594136822968721
56 O 0 0.009657916612923145
% O 0 0.007390907034277916
) O 0 0.005250304937362671
of O 0 0.003798291552811861
the O 0 0.008389588445425034
tumors B-Disease 1 0.9994513392448425
without O 0 0.041775234043598175
LOH O 1 0.9893686175346375
, O 0 0.008315260522067547
both O 0 0.01081074494868517
mutations O 1 0.9942591190338135
were O 0 0.008213270455598831
found O 0 0.019687041640281677
. O 0 0.02113444358110428

Thus O 0 0.02322518639266491
, O 0 0.0071838912554085255
a O 0 0.006569195073097944
total O 0 0.005582831334322691
of O 0 0.005014179740101099
45 O 0 0.01409993227571249
mutations O 1 0.9929741621017456
were O 0 0.005506988149136305
identified O 0 0.022280648350715637
in O 0 0.013037547469139099
tumors B-Disease 1 0.9980999827384949
of O 0 0.015624144114553928
36 O 0 0.12337282299995422
patients O 1 0.985410213470459
. O 0 0.03152085840702057

Thirty O 0 0.04475945979356766
- O 0 0.03351624682545662
nine O 0 0.00989021547138691
of O 0 0.004952484276145697
the O 0 0.008148351684212685
mutations O 1 0.9988221526145935
- O 0 0.09837121516466141
including O 0 0.008920999243855476
34 O 0 0.014241057448089123
small O 0 0.016783664003014565
mutations O 1 0.996496856212616
, O 0 0.006647986359894276
2 O 0 0.00969766266644001
large O 0 0.010020134039223194
structural O 0 0.285934180021286
alterations O 0 0.18432192504405975
, O 0 0.007483113091439009
and O 0 0.008029453456401825
hypermethylation O 1 0.963911771774292
in O 0 0.012219062075018883
3 O 0 0.08574340492486954
tumors O 1 0.9994903802871704
- O 0 0.062420804053545
were O 0 0.004921922460198402
not O 0 0.005305351223796606
detected O 0 0.09401098638772964
in O 0 0.005664729978889227
the O 0 0.007125981617718935
corresponding O 0 0.15149782598018646
peripheral O 1 0.9945993423461914
blood O 1 0.9918056726455688
DNA O 1 0.9680564403533936
. O 0 0.032737743109464645

In O 0 0.017829440534114838
6 O 0 0.017550330609083176
( O 0 0.010909100994467735
17 O 0 0.009777475148439407
% O 0 0.007757842540740967
) O 0 0.005053561646491289
of O 0 0.0027708904817700386
the O 0 0.004115630406886339
36 O 0 0.020103134214878082
patients O 1 0.9886050224304199
, O 0 0.006385530810803175
a O 0 0.011097684502601624
mutation O 1 0.9978569149971008
was O 0 0.006213496904820204
detected O 0 0.1628236174583435
in O 0 0.005065827630460262
constitutional O 0 0.011100150644779205
DNA O 1 0.7176414728164673
, O 0 0.0037498269230127335
and O 0 0.002544565126299858
1 O 0 0.004339842591434717
of O 0 0.0029789984691888094
these O 0 0.005853766575455666
mutations O 1 0.9986801743507385
is O 0 0.005613053683191538
known O 0 0.0064408606849610806
to O 0 0.0034355490934103727
be O 0 0.00392528809607029
associated O 0 0.013894027099013329
with O 0 0.010420825332403183
reduced O 0 0.19369354844093323
expressivity O 1 0.9789117574691772
. O 0 0.03247267007827759

The O 0 0.012628273107111454
presence O 0 0.01581776887178421
of O 0 0.004919157829135656
a O 0 0.008757633157074451
constitutional O 0 0.019260214641690254
mutation O 1 0.9979825019836426
was O 0 0.005786535330116749
not O 0 0.0034477566368877888
associated O 0 0.009786834008991718
with O 0 0.004114395007491112
an O 0 0.004576252773404121
early O 0 0.008991027250885963
age O 0 0.019287312403321266
at O 0 0.014952002093195915
treatment O 1 0.8893417119979858
. O 0 0.02603350393474102

In O 0 0.025768805295228958
1 O 0 0.02911924198269844
patient O 1 0.865393877029419
, O 0 0.015377553179860115
somatic O 1 0.9884157180786133
mosaicism O 1 0.9872982501983643
was O 0 0.009624829515814781
demonstrated O 0 0.01861664280295372
by O 0 0.008935007266700268
molecular O 1 0.7307950258255005
analysis O 0 0.017203213647007942
of O 0 0.007474829908460379
DNA O 1 0.7770107984542847
and O 0 0.01108160987496376
RNA O 1 0.9639455676078796
from O 0 0.023945624008774757
peripheral O 1 0.9928053021430969
blood O 1 0.9849512577056885
. O 0 0.034186217933893204

In O 0 0.024510206654667854
2 O 0 0.027789270505309105
patients O 1 0.9365307688713074
without O 0 0.014598154462873936
a O 0 0.019940165802836418
detectable O 1 0.9912105798721313
mutation O 1 0.9985393285751343
in O 0 0.02093452587723732
peripheral O 1 0.9975782036781311
blood O 1 0.9930395483970642
, O 0 0.011088283732533455
mosaicism O 1 0.9913589954376221
was O 0 0.007511000148952007
suggested O 0 0.010347940027713776
because O 0 0.006407344713807106
1 O 0 0.006091663613915443
of O 0 0.0037717351224273443
the O 0 0.008509122766554356
patients O 1 0.9966827034950256
showed O 1 0.6456947326660156
multifocal O 1 0.9996494054794312
tumors B-Disease 1 0.9992424249649048
and O 0 0.007117046508938074
the O 0 0.006119100376963615
other O 0 0.006075212266296148
later O 0 0.010663743130862713
developed O 0 0.15164583921432495
bilateral B-Disease 0 0.23074690997600555
retinoblastoma I-Disease 1 0.993858277797699
. O 0 0.03210488706827164

In O 0 0.015194385312497616
conclusion O 0 0.014982892200350761
, O 0 0.005250000860542059
our O 0 0.005890738684684038
results O 0 0.010411241091787815
emphasize O 0 0.015091143548488617
that O 0 0.0038856465835124254
the O 0 0.005082109477370977
manifestation O 0 0.2663576304912567
and O 0 0.006700317841023207
transmissibility O 1 0.9849509000778198
of O 0 0.008963079191744328
retinoblastoma B-Disease 1 0.9966223239898682
depend O 0 0.011753026396036148
on O 0 0.0029638204723596573
the O 0 0.0029704223852604628
nature O 0 0.005422913935035467
of O 0 0.0025076272431761026
the O 0 0.0032663890160620213
first O 0 0.0054901596158742905
mutation O 1 0.9975261092185974
, O 0 0.003590967273339629
its O 0 0.00273282453417778
time O 0 0.002672995673492551
in O 0 0.002544037764891982
development O 0 0.0052203829400241375
, O 0 0.0022397181019186974
and O 0 0.0016104417154565454
the O 0 0.0019574372563511133
number O 0 0.002759765600785613
and O 0 0.0025345059111714363
types O 0 0.015615682117640972
of O 0 0.0047836825251579285
cells O 1 0.9751173853874207
that O 0 0.0053247069008648396
are O 0 0.005417192354798317
affected O 0 0.03995203226804733
. O 0 0.010225922800600529
. O 0 0.016460346058011055

Hereditary B-Disease 1 0.9922401905059814
deficiency I-Disease 1 0.9976807832717896
of I-Disease 0 0.010640284977853298
the I-Disease 0 0.007954992353916168
fifth I-Disease 0 0.013764990493655205
component I-Disease 0 0.024761689826846123
of I-Disease 0 0.006291499827057123
complement I-Disease 0 0.03947289660573006
in O 0 0.009189890697598457
man O 0 0.02188173495233059
. O 0 0.019804634153842926

I O 0 0.053473684936761856
. O 0 0.041212670505046844

Clinical O 1 0.9262779951095581
, O 0 0.021398622542619705
immunochemical O 0 0.3990094065666199
, O 0 0.00962289422750473
and O 0 0.00793878361582756
family O 0 0.025321664288640022
studies O 0 0.043391719460487366
. O 0 0.021770063787698746

The O 0 0.015515699982643127
first O 0 0.011947086080908775
recognized O 0 0.022608811035752296
human O 0 0.05695587024092674
kindred O 1 0.9529688358306885
with O 0 0.03002304583787918
hereditary B-Disease 1 0.9984651803970337
deficiency I-Disease 1 0.9994227886199951
of I-Disease 0 0.005679198075085878
the I-Disease 0 0.004930842202156782
fifth I-Disease 0 0.010556384921073914
component I-Disease 0 0.022191941738128662
of I-Disease 0 0.006669376511126757
complement I-Disease 0 0.17460326850414276
( O 0 0.025500215590000153
C5 O 1 0.9760832786560059
) O 0 0.013575999066233635
is O 0 0.00971282459795475
described O 0 0.02297508530318737
. O 0 0.01651335507631302

The O 0 0.019573181867599487
proband O 0 0.09208446741104126
, O 0 0.008701631799340248
a O 0 0.010153676383197308
20 O 0 0.012757613323628902
- O 0 0.056020379066467285
year O 0 0.010745305567979813
- O 0 0.06767327338457108
old O 0 0.024246184155344963
black O 0 0.11742720752954483
female O 1 0.7191394567489624
with O 1 0.7894033193588257
systemic B-Disease 1 0.9999443292617798
lupus I-Disease 1 0.9999526739120483
erythematosus I-Disease 1 0.9997392296791077
since O 0 0.03062290884554386
age O 0 0.021186117082834244
11 O 0 0.01452355645596981
, O 0 0.010720738209784031
lacked O 0 0.37080615758895874
serum O 1 0.9982693195343018
hemolytic O 1 0.9997140765190125
complement O 1 0.6192888617515564
activity O 0 0.04063824191689491
, O 0 0.009066703729331493
even O 0 0.011284785345196724
during O 0 0.021068120375275612
remission O 1 0.988494336605072
. O 0 0.030056681483983994

C5 O 1 0.8418267369270325
was O 0 0.02516377717256546
undetectable O 1 0.8491518497467041
in O 0 0.01261973101645708
her O 0 0.02034141682088375
serum O 1 0.9601477384567261
by O 0 0.013229294680058956
both O 0 0.014248955994844437
immunodiffusion O 1 0.9094273447990417
and O 0 0.029843928292393684
hemolytic O 1 0.9993695616722107
assays O 1 0.9611598253250122
. O 0 0.038466766476631165

Other O 0 0.01790017820894718
complement O 0 0.03373558819293976
components O 0 0.018034229055047035
were O 0 0.006058851256966591
normal O 0 0.039908088743686676
during O 0 0.01730508916079998
remission O 1 0.993293285369873
of O 0 0.019546452909708023
lupus O 1 0.9996691942214966
, O 0 0.010454433970153332
but O 0 0.010078176856040955
C1 O 1 0.9856311082839966
, O 0 0.01173066720366478
C4 O 1 0.8775894641876221
, O 0 0.01180164236575365
C2 O 1 0.9838293194770813
, O 0 0.008970778435468674
and O 0 0.009239640086889267
C3 O 1 0.9746973514556885
levels O 0 0.07303490489721298
fell O 0 0.03181207552552223
during O 0 0.03201491758227348
exacerbations O 1 0.9897454977035522
. O 0 0.034646324813365936

A O 0 0.033308692276477814
younger O 0 0.04845382645726204
half O 0 0.01966106705367565
- O 0 0.1302357167005539
sister O 0 0.03655518218874931
, O 0 0.00563081493601203
who O 0 0.004809515085071325
had O 0 0.004672096110880375
no O 0 0.008294147439301014
underlying O 1 0.9693580865859985
disease O 1 0.9994899034500122
, O 0 0.0054253581911325455
was O 0 0.0037551105488091707
also O 0 0.003777808276936412
found O 0 0.006968310568481684
to O 0 0.006810691673308611
lack O 0 0.05132222920656204
immunochemically O 1 0.9625805020332336
detectable O 1 0.9839261770248413
C5 O 1 0.9678636789321899
. O 0 0.03920995071530342

By O 0 0.07393614202737808
hemolytic O 1 0.9989615678787231
assay O 1 0.7796925902366638
, O 0 0.010568229481577873
she O 0 0.008362608961760998
exhibited O 0 0.01564151793718338
1 O 0 0.009955886751413345
- O 0 0.020983433350920677
2 O 0 0.00760413846001029
% O 0 0.0061425706371665
of O 0 0.0036259896587580442
the O 0 0.006180863827466965
normal O 0 0.38556012511253357
serum O 1 0.9941353797912598
C5 O 1 0.9791800379753113
level O 0 0.011680066585540771
and O 0 0.00486610596999526
normal O 0 0.04045834392309189
concentrations O 0 0.06965698301792145
of O 0 0.004880345426499844
other O 0 0.00751819834113121
complement O 0 0.04339931905269623
components O 0 0.037803784012794495
. O 0 0.020993635058403015

C5 O 1 0.8417003750801086
levels O 0 0.028215009719133377
of O 0 0.006731471046805382
other O 0 0.004961614031344652
family O 0 0.008208917453885078
members O 0 0.004433061927556992
were O 0 0.0028458014130592346
either O 0 0.005789711140096188
normal O 0 0.02150695025920868
or O 0 0.0060865385457873344
approximately O 0 0.007882850244641304
half O 0 0.009429633617401123
- O 0 0.09248626232147217
normal O 0 0.0639861598610878
, O 0 0.006836323533207178
consistent O 0 0.01947486214339733
with O 0 0.02015330269932747
autosomal O 1 0.99965500831604
codominant O 1 0.9723613262176514
inheritance O 1 0.6740046739578247
of O 0 0.010744971223175526
the O 0 0.017897536978125572
gene O 1 0.9962665438652039
determining O 1 0.9230879545211792
C5 B-Disease 1 0.996575653553009
deficiency I-Disease 1 0.9990398287773132
. O 0 0.06208024173974991

Normal O 1 0.9229888319969177
hemolytic O 1 0.9977769255638123
titers O 1 0.8443774580955505
were O 0 0.013754993677139282
restored O 0 0.02043892815709114
to O 0 0.008560212329030037
both O 0 0.013548720628023148
homozygous O 1 0.9935808181762695
C5 B-Disease 1 0.9954185485839844
- I-Disease 1 0.9381669163703918
deficient I-Disease 1 0.9953786134719849
( O 0 0.03719180077314377
C5D B-Disease 1 0.9604439735412598
) O 0 0.017071574926376343
sera O 0 0.05097438022494316
by O 0 0.008712307550013065
addition O 0 0.008933194912970066
of O 0 0.006514257751405239
highly O 0 0.02823888137936592
purified O 1 0.8911860585212708
human O 0 0.32906800508499146
C5 O 1 0.9668146371841431
. O 0 0.03368678689002991

In O 0 0.028282539919018745
specific O 0 0.03957981988787651
C5 O 1 0.9802752137184143
titrations O 1 0.9680553078651428
, O 0 0.007744866423308849
however O 0 0.005487267859280109
, O 0 0.0032977291848510504
it O 0 0.002354307798668742
was O 0 0.002378924982622266
noted O 0 0.004053729586303234
that O 0 0.002449664054438472
when O 0 0.004279364366084337
limited O 0 0.006494912784546614
amounts O 0 0.011295952834188938
of O 0 0.005296661984175444
C5 O 1 0.8152745962142944
were O 0 0.005213609896600246
assayed O 0 0.05884857475757599
in O 0 0.004655927419662476
the O 0 0.004251033067703247
presence O 0 0.010788637213408947
of O 0 0.005436412524431944
low O 0 0.04541689157485962
dilutions O 1 0.9234446287155151
of O 0 0.00921813677996397
either O 0 0.019367454573512077
C5D B-Disease 1 0.9819784760475159
serum O 1 0.9859060049057007
, O 0 0.011040491983294487
curving O 0 0.1306825429201126
rather O 0 0.011190681718289852
than O 0 0.009561005979776382
linear O 1 0.9354410767555237
dose O 1 0.9908590912818909
- O 0 0.26941749453544617
response O 0 0.024833953008055687
plots O 0 0.018108677119016647
were O 0 0.003844192251563072
consistently O 0 0.008736290968954563
obtained O 0 0.00887333881109953
, O 0 0.005425275769084692
suggesting O 0 0.01905759982764721
some O 0 0.011578825302422047
inhibitory O 1 0.9238077998161316
effect O 0 0.08686523884534836
. O 0 0.029046883806586266

Further O 0 0.026993216946721077
studies O 0 0.025514259934425354
suggested O 0 0.0158466175198555
that O 0 0.007240561302751303
low O 0 0.029972970485687256
dilutions O 1 0.8924176096916199
of O 0 0.014226844534277916
C5D B-Disease 1 0.9864482283592224
serum O 1 0.987739622592926
contain O 0 0.04315876215696335
a O 0 0.014703351072967052
factor O 0 0.3616200387477875
( O 0 0.010477901436388493
or O 0 0.008600832894444466
factors O 0 0.10955477505922318
) O 0 0.007887513376772404
interfering O 0 0.019429726526141167
at O 0 0.004598635248839855
some O 0 0.003664098447188735
step O 0 0.008299766108393669
in O 0 0.005323297809809446
the O 0 0.012045127339661121
hemolytic O 1 0.9996992349624634
assay O 1 0.9202185869216919
of O 0 0.009571022354066372
C5 O 1 0.9689764976501465
, O 0 0.006842633243650198
rather O 0 0.008439943194389343
than O 0 0.0061241076327860355
a O 0 0.010646160691976547
true O 0 0.03215770795941353
C5 O 1 0.986404299736023
inhibitor O 1 0.9930611252784729
or O 0 0.03532111272215843
inactivator O 1 0.7817161679267883
. O 0 0.03469978645443916

Of O 0 0.01954568363726139
clinical O 1 0.7667052745819092
interest O 0 0.01040018443018198
are O 0 0.004482554737478495
( O 0 0.007555484771728516
a O 0 0.005780188832432032
) O 0 0.005517527926713228
the O 0 0.003788497531786561
documentation O 0 0.013700053095817566
of O 0 0.011192206293344498
membranous O 1 0.9951878786087036
glomerulonephritis B-Disease 1 0.9984831213951111
, O 0 0.03709486126899719
vasculitis B-Disease 1 0.9987850785255432
, O 0 0.011866816319525242
and O 0 0.012826766818761826
arthritis B-Disease 1 0.9994847774505615
in O 0 0.006802916061133146
an O 0 0.005981027614325285
individual O 0 0.019915999844670296
lacking O 0 0.45689141750335693
C5 O 1 0.9831984639167786
( O 0 0.009437961503863335
and O 0 0.003813881427049637
its O 0 0.006649498362094164
biologic O 1 0.9857909679412842
functions O 0 0.016824549064040184
) O 0 0.00698321545496583
, O 0 0.0033628290984779596
and O 0 0.003313518362119794
( O 0 0.00825047492980957
b O 0 0.068745456635952
) O 0 0.00710901478305459
a O 0 0.008041881956160069
remarkable O 0 0.021423740312457085
propensity O 1 0.9414670467376709
to O 0 0.030830025672912598
bacterial B-Disease 1 0.9998441934585571
infections I-Disease 1 0.9995307922363281
in O 0 0.009424908086657524
the O 0 0.006897413171827793
proband O 1 0.6544296145439148
, O 0 0.005943807773292065
even O 0 0.006526581943035126
during O 0 0.006864762399345636
periods O 0 0.012765471823513508
of O 0 0.005467682145535946
low O 0 0.08942598849534988
- O 1 0.6133685111999512
dose O 1 0.9752933382987976
or O 0 0.016303028911352158
alternate O 0 0.03867218643426895
- O 0 0.26908040046691895
day O 0 0.037025582045316696
corticosteroid O 1 0.9933183193206787
therapy O 1 0.9874841570854187
. O 0 0.03681109473109245

Other O 0 0.017670532688498497
observations O 0 0.02258196845650673
indicate O 0 0.015548770315945148
that O 0 0.005768176633864641
the O 0 0.006250741891562939
C5D B-Disease 0 0.4526233673095703
state O 0 0.006834698375314474
is O 0 0.006500988733023405
compatible O 0 0.03634704276919365
with O 0 0.009497889317572117
normal O 1 0.7970219254493713
coagulation O 1 0.9984090924263
function O 0 0.05553474277257919
and O 0 0.0033121721353381872
the O 0 0.0036075308453291655
capacity O 0 0.006372359581291676
to O 0 0.005126825999468565
mount O 0 0.018665650859475136
a O 0 0.0352468378841877
neutrophilic O 1 0.9968067407608032
leukocytosis O 1 0.9947863817214966
during O 1 0.5689364075660706
pyogenic B-Disease 1 0.9980315566062927
infection I-Disease 1 0.9986856579780579
. O 0 0.02661973237991333
. O 0 0.026749100536108017

Susceptibility O 1 0.983160674571991
to O 0 0.06002103164792061
ankylosing B-Disease 1 0.9980409741401672
spondylitis I-Disease 1 0.9975230097770691
in O 0 0.01995047554373741
twins O 1 0.6592022180557251
: O 0 0.009893560782074928
the O 0 0.0053963628597557545
role O 0 0.01175633817911148
of O 0 0.007575584575533867
genes O 1 0.9956119060516357
, O 0 0.013111469335854053
HLA O 1 0.9940155744552612
, O 0 0.006946597248315811
and O 0 0.005178499035537243
the O 0 0.007599177770316601
environment O 0 0.026928337290883064
. O 0 0.020041784271597862

OBJECTIVE O 0 0.03324113041162491
To O 0 0.00817605759948492
determine O 0 0.010969282127916813
the O 0 0.005298420786857605
relative O 0 0.016087807714939117
effects O 0 0.2004106491804123
of O 0 0.007505826652050018
genetic O 1 0.9905036091804504
and O 0 0.007704113144427538
environmental O 0 0.026679744943976402
factors O 0 0.2128027379512787
in O 0 0.01625560224056244
susceptibility O 1 0.9979879856109619
to O 0 0.1021566390991211
ankylosing B-Disease 1 0.9994874000549316
spondylitis I-Disease 1 0.9988142251968384
( O 0 0.033955179154872894
AS B-Disease 0 0.020333824679255486
) O 0 0.0206876453012228
. O 0 0.021199358627200127

METHODS O 0 0.06830769777297974
Twins O 0 0.27607306838035583
with O 0 0.009113709442317486
AS B-Disease 0 0.006259355694055557
were O 0 0.0033131861127913
identified O 0 0.009247317910194397
from O 0 0.004714565817266703
the O 0 0.004970973823219538
Royal O 0 0.01419919915497303
National O 0 0.026056738570332527
Hospital O 1 0.9805650115013123
for O 0 0.22100098431110382
Rheumatic B-Disease 1 0.9998301267623901
Diseases I-Disease 1 0.9994034767150879
database O 1 0.6171891689300537
. O 0 0.034789618104696274

Clinical O 1 0.9208545088768005
and O 0 0.017663368955254555
radiographic O 1 0.8609107136726379
examinations O 0 0.0362362377345562
were O 0 0.0055036647245287895
performed O 0 0.00848196167498827
to O 0 0.0055542499758303165
establish O 0 0.03986410051584244
diagnoses O 1 0.9964441657066345
, O 0 0.011141428723931313
and O 0 0.017745032906532288
disease O 1 0.9996820688247681
severity O 1 0.9786490797996521
was O 0 0.008368447422981262
assessed O 0 0.016510605812072754
using O 0 0.009875098243355751
a O 0 0.009107046760618687
combination O 0 0.06378777325153351
of O 0 0.00655351672321558
validated O 0 0.037437018007040024
scoring O 0 0.020787030458450317
systems O 0 0.05364394560456276
. O 0 0.022851159796118736

HLA O 1 0.9773361086845398
typing O 1 0.7740039229393005
for O 0 0.03885875269770622
HLA O 1 0.9930468201637268
- O 1 0.6550598740577698
B27 O 1 0.894327700138092
, O 0 0.026323551312088966
HLA O 1 0.9957764744758606
- O 1 0.6194403767585754
B60 O 1 0.6924741268157959
, O 0 0.011969001032412052
and O 0 0.011862915009260178
HLA O 1 0.9943483471870422
- O 1 0.5950279831886292
DR1 O 1 0.967930257320404
was O 0 0.013035089708864689
performed O 0 0.017785552889108658
by O 0 0.013666344806551933
polymerase O 1 0.9690640568733215
chain O 0 0.4044179618358612
reaction O 0 0.04895608127117157
with O 0 0.008119545876979828
sequence O 0 0.13410906493663788
- O 0 0.07077959924936295
specific O 0 0.019157275557518005
primers O 1 0.5453156232833862
, O 0 0.007552121765911579
and O 0 0.006859875284135342
zygosity O 0 0.3433413803577423
was O 0 0.010118826292455196
assessed O 0 0.028851421549916267
using O 0 0.028120674192905426
microsatellite O 1 0.977644145488739
markers O 1 0.5947829484939575
. O 0 0.034998245537281036

Genetic O 1 0.9045337438583374
and O 0 0.014244618825614452
environmental O 0 0.027538839727640152
variance O 0 0.043909553438425064
components O 0 0.01484251394867897
were O 0 0.004305184818804264
assessed O 0 0.012063776142895222
with O 0 0.004635225981473923
the O 0 0.004729121457785368
program O 0 0.01655568554997444
Mx O 1 0.8589167594909668
, O 0 0.004869027528911829
using O 0 0.006468302104622126
data O 0 0.004818378947675228
from O 0 0.003123902715742588
this O 0 0.0025476349983364344
and O 0 0.002547498093917966
previous O 0 0.006220909301191568
studies O 0 0.014736081473529339
of O 0 0.006206905003637075
twins O 1 0.6192269325256348
with O 0 0.011280849575996399
AS B-Disease 0 0.015301517210900784
. O 0 0.019026415422558784

RESULTS O 0 0.04030269384384155
Six O 0 0.016348086297512054
of O 0 0.009996991604566574
8 O 0 0.027070462703704834
monozygotic O 1 0.9886886477470398
( O 0 0.0394180491566658
MZ O 1 0.9924429059028625
) O 0 0.02394767664372921
twin O 0 0.38815373182296753
pairs O 0 0.23428960144519806
were O 0 0.010738271288573742
disease O 1 0.9991748929023743
concordant O 1 0.9590821266174316
, O 0 0.0072448356077075005
compared O 0 0.010888992808759212
with O 0 0.005433319602161646
4 O 0 0.007713787257671356
of O 0 0.005160401575267315
15 O 0 0.013975159265100956
B27 O 1 0.8782579302787781
- O 0 0.2980307340621948
positive O 0 0.2800988256931305
dizygotic O 1 0.9888074398040771
( O 0 0.030920008197426796
DZ O 1 0.9847028851509094
) O 0 0.019133511930704117
twin O 0 0.3270280361175537
pairs O 0 0.15746459364891052
( O 0 0.010822603479027748
27 O 0 0.01126175094395876
% O 0 0.008865528739988804
) O 0 0.005926112178713083
and O 0 0.003097397508099675
4 O 0 0.007223614025861025
of O 0 0.004723715130239725
32 O 0 0.021612029522657394
DZ O 1 0.9859326481819153
twin O 1 0.6565157771110535
pairs O 0 0.13278324902057648
overall O 0 0.022800985723733902
( O 0 0.01128394529223442
12 O 0 0.008976303972303867
. O 0 0.0064139170572161674
5 O 0 0.011168216355144978
% O 0 0.013644469901919365
) O 0 0.015053174458444118
. O 0 0.017479419708251953

Nonsignificant O 1 0.6492283344268799
increases O 0 0.04886457696557045
in O 0 0.01011226698756218
similarity O 0 0.031833305954933167
with O 0 0.007142782211303711
regard O 0 0.009172054007649422
to O 0 0.004708750173449516
age O 0 0.02111375704407692
at O 0 0.06626126170158386
disease O 1 0.9998441934585571
onset O 1 0.9985259175300598
and O 0 0.003941095434129238
all O 0 0.002703879028558731
of O 0 0.003650892525911331
the O 0 0.017576949670910835
disease O 1 0.9997759461402893
severity O 1 0.9883038997650146
scores O 0 0.034467048943042755
assessed O 0 0.022063735872507095
were O 0 0.004937632009387016
noted O 0 0.013263442553579807
in O 0 0.025815609842538834
disease O 1 0.9995469450950623
- O 1 0.9482668042182922
concordant O 1 0.9889677166938782
MZ O 1 0.9969431757926941
twins O 1 0.9336104989051819
compared O 0 0.04678482189774513
with O 0 0.028698239475488663
concordant O 1 0.9662962555885315
DZ O 1 0.9803300499916077
twins O 1 0.8593457937240601
. O 0 0.04572027176618576

HLA O 1 0.9857450723648071
- O 0 0.3745691478252411
B27 O 0 0.45544692873954773
and O 0 0.013056717813014984
B60 O 0 0.18147850036621094
were O 0 0.006038675084710121
associated O 0 0.013613404706120491
with O 0 0.006253829225897789
the O 0 0.00898295734077692
disease O 1 0.999272882938385
in O 0 0.0078097982332110405
probands O 1 0.7851938009262085
, O 0 0.004954744596034288
and O 0 0.003292720764875412
the O 0 0.0039998008869588375
rate O 0 0.02577662467956543
of O 0 0.010171914473176003
disease O 1 0.999482274055481
concordance O 1 0.8833979368209839
was O 0 0.009521798230707645
significantly O 0 0.07156568020582199
increased O 0 0.019494295120239258
among O 0 0.015218363143503666
DZ O 1 0.9831323027610779
twin O 0 0.3730277717113495
pairs O 0 0.08387437462806702
in O 0 0.005893637426197529
which O 0 0.003965336829423904
the O 0 0.005616139154881239
co O 0 0.2106873095035553
- O 0 0.23074255883693695
twin O 0 0.4108804762363434
was O 0 0.006421476136893034
positive O 0 0.015049228444695473
for O 0 0.005991678684949875
both O 0 0.008134436793625355
B27 O 1 0.534127414226532
and O 0 0.015998492017388344
DR1 O 1 0.9605767130851746
. O 0 0.0374278724193573

Additive O 1 0.9523540735244751
genetic O 1 0.9842650890350342
effects O 0 0.10180795192718506
were O 0 0.006341796834021807
estimated O 0 0.009310095570981503
to O 0 0.0049261185340583324
contribute O 0 0.017167646437883377
97 O 0 0.01645258069038391
% O 0 0.007630675099790096
of O 0 0.004243962466716766
the O 0 0.005733241327106953
population O 0 0.01633058302104473
variance O 0 0.12165649235248566
. O 0 0.02115333266556263

CONCLUSION O 0 0.07680998742580414
Susceptibility O 1 0.9656306505203247
to O 0 0.008731096982955933
AS B-Disease 0 0.007651719264686108
is O 0 0.0060018147341907024
largely O 0 0.011073815636336803
genetically O 1 0.9030343890190125
determined O 0 0.010972097516059875
, O 0 0.0038616920355707407
and O 0 0.002837744075804949
the O 0 0.004113164730370045
environmental O 0 0.023470744490623474
trigger O 1 0.8018133640289307
for O 0 0.00758148031309247
the O 0 0.010378250852227211
disease O 1 0.9991428852081299
is O 0 0.01228856947273016
probably O 0 0.02273702248930931
ubiquitous O 0 0.4489528238773346
. O 0 0.02420950122177601

HLA O 1 0.9861283302307129
- O 0 0.3364986777305603
B27 O 0 0.44064050912857056
accounts O 0 0.013846234418451786
for O 0 0.005415147636085749
a O 0 0.006828641518950462
minority O 0 0.011725709773600101
of O 0 0.004234694875776768
the O 0 0.006703780498355627
overall O 0 0.14816336333751678
genetic O 1 0.9984983205795288
susceptibility O 1 0.9962772727012634
to O 0 0.012459969148039818
AS B-Disease 0 0.018239375203847885
. O 0 0.02033938467502594

Cell O 1 0.9543159604072571
cycle O 1 0.7233209609985352
- O 0 0.1716001331806183
dependent O 0 0.07819391787052155
colocalization O 0 0.3480992913246155
of O 0 0.014581919647753239
BARD1 O 1 0.9101028442382812
and O 0 0.021250633522868156
BRCA1 O 1 0.9989393353462219
proteins O 1 0.9513910412788391
in O 0 0.015487747266888618
discrete O 0 0.12928007543087006
nuclear O 0 0.040318407118320465
domains O 0 0.2118302285671234
. O 0 0.025303052738308907

Germ O 1 0.9456184506416321
- O 0 0.11153411865234375
line O 0 0.03574659675359726
mutations O 1 0.9790842533111572
of O 0 0.011577242985367775
the O 0 0.019272951409220695
BRCA1 O 1 0.9995737671852112
gene O 1 0.9978522062301636
predispose O 1 0.9931201934814453
women O 0 0.025065908208489418
to O 0 0.010991753078997135
early O 0 0.05106430873274803
- O 1 0.9885922074317932
onset O 1 0.9996887445449829
breast B-Disease 1 0.9998080134391785
and I-Disease 1 0.696635901927948
ovarian I-Disease 1 0.9999222755432129
cancer I-Disease 1 0.9996125102043152
by O 0 0.01918993890285492
compromising O 0 0.4021506905555725
the O 0 0.014780018478631973
genes O 1 0.992359459400177
presumptive O 1 0.9807844161987305
function O 0 0.31721651554107666
as O 0 0.015682974830269814
a O 0 0.10850657522678375
tumor B-Disease 1 0.999118983745575
suppressor O 1 0.9953816533088684
. O 0 0.0513572134077549

Although O 0 0.02168947644531727
the O 0 0.012206809595227242
biochemical O 1 0.7223601937294006
properties O 0 0.02850654534995556
of O 0 0.012432518415153027
BRCA1 O 1 0.9993537068367004
polypeptides O 1 0.9057893753051758
are O 0 0.005533104762434959
not O 0 0.0043134079314768314
understood O 0 0.008953461423516273
, O 0 0.0037873624823987484
their O 0 0.005032554268836975
expression O 0 0.06463193893432617
pattern O 0 0.194478377699852
and O 0 0.009463239461183548
subcellular O 1 0.7737396955490112
localization O 0 0.3894646167755127
suggest O 0 0.01687375269830227
a O 0 0.010860905051231384
role O 0 0.01407448761165142
in O 0 0.010943081229925156
cell O 1 0.9833554625511169
- O 1 0.5853059887886047
cycle O 1 0.8509261012077332
regulation O 0 0.2514718770980835
. O 0 0.028341617435216904

When O 0 0.03706789389252663
resting O 0 0.302489697933197
cells O 1 0.968686580657959
are O 0 0.010807269252836704
induced O 1 0.9830958247184753
to O 0 0.007648938335478306
proliferate O 0 0.34062454104423523
, O 0 0.0050286403857171535
the O 0 0.004562532063573599
steady O 0 0.016152212396264076
- O 0 0.020394135266542435
state O 0 0.00765596330165863
levels O 0 0.01925041154026985
of O 0 0.008888301439583302
BRCA1 O 1 0.9991693496704102
increase O 0 0.021095696836709976
in O 0 0.007552089169621468
late O 0 0.01463967002928257
G1 O 1 0.9617404341697693
and O 0 0.006031620781868696
reach O 0 0.010104658082127571
a O 0 0.00941771175712347
maximum O 0 0.015469804406166077
during O 0 0.016162490472197533
S O 0 0.19360429048538208
phase O 0 0.13574527204036713
. O 0 0.02454703114926815

Moreover O 0 0.04470372945070267
, O 0 0.010609648190438747
in O 0 0.010557929053902626
S O 0 0.35632774233818054
phase O 1 0.6895329356193542
cells O 1 0.9939337372779846
, O 0 0.023347707465291023
BRCA1 O 1 0.9986817240715027
polypeptides O 1 0.8737584352493286
are O 0 0.010199792683124542
hyperphosphorylated O 0 0.39600932598114014
and O 0 0.010553097352385521
accumulate O 0 0.4887726604938507
into O 0 0.01593826524913311
discrete O 0 0.4643177092075348
subnuclear O 1 0.9077662229537964
foci O 1 0.9562212824821472
termed O 0 0.4973881244659424
" O 0 0.03866047412157059
BRCA1 O 1 0.9955793023109436
nuclear O 0 0.08356069773435593
dots O 1 0.6082781553268433
. O 0 0.04041590914130211

" O 0 0.06087307631969452
BRCA1 O 1 0.9957736134529114
associates O 0 0.13044483959674835
in O 0 0.016102729365229607
vivo O 1 0.807844340801239
with O 0 0.011653725989162922
a O 0 0.017100024968385696
structurally O 1 0.9090250134468079
related O 0 0.4310014843940735
protein O 1 0.9843447804450989
termed O 1 0.8030385971069336
BARD1 O 1 0.8918558359146118
. O 0 0.03573828190565109

Here O 0 0.013506634160876274
we O 0 0.005903967656195164
show O 0 0.006453942507505417
that O 0 0.003361616749316454
the O 0 0.00461204070597887
steady O 0 0.017867764458060265
- O 0 0.022919250652194023
state O 0 0.006739184260368347
levels O 0 0.015919743105769157
of O 0 0.006248550955206156
BARD1 O 1 0.6735159158706665
, O 0 0.006673269439488649
unlike O 0 0.0134945809841156
those O 0 0.0053644971922039986
of O 0 0.008224899880588055
BRCA1 O 1 0.9992056488990784
, O 0 0.009114761836826801
remain O 0 0.009893480688333511
relatively O 0 0.01706741377711296
constant O 0 0.02392689511179924
during O 0 0.01910094916820526
cell O 1 0.9787371158599854
cycle O 1 0.9678540825843811
progression O 1 0.9907138347625732
. O 0 0.035455793142318726

However O 0 0.021093172952532768
, O 0 0.013115922920405865
immunostaining O 0 0.23034805059432983
revealed O 0 0.023723872378468513
that O 0 0.009741070680320263
BARD1 O 1 0.7593867182731628
resides O 0 0.06213530898094177
within O 0 0.01966104470193386
BRCA1 O 1 0.9985311031341553
nuclear O 0 0.04112118110060692
dots O 0 0.44908443093299866
during O 0 0.012749342247843742
S O 0 0.07560934871435165
phase O 0 0.022402318194508553
of O 0 0.004855637904256582
the O 0 0.006544163916260004
cell O 1 0.9326128363609314
cycle O 0 0.4725521504878998
, O 0 0.005476323422044516
but O 0 0.003976836334913969
not O 0 0.003815432544797659
during O 0 0.00809570960700512
the O 0 0.00991219561547041
G1 O 1 0.9861948490142822
phase O 0 0.3054392337799072
. O 0 0.029226012527942657

Nevertheless O 0 0.04329612851142883
, O 0 0.01676664501428604
BARD1 O 1 0.515533983707428
polypeptides O 0 0.35154688358306885
are O 0 0.0062576173804700375
found O 0 0.00759486760944128
exclusively O 0 0.008187676779925823
in O 0 0.0038501040544360876
the O 0 0.003721734741702676
nuclear O 0 0.009800567291676998
fractions O 0 0.017338350415229797
of O 0 0.00504309544339776
both O 0 0.009003712795674801
G1 O 1 0.9948428273200989
- O 0 0.23947633802890778
and O 0 0.010993762873113155
S O 0 0.44147294759750366
- O 1 0.6430701017379761
phase O 1 0.7885137796401978
cells O 1 0.9854516386985779
. O 0 0.032900404185056686

Therefore O 0 0.02643580175936222
, O 0 0.0147244893014431
progression O 1 0.8732110261917114
to O 0 0.009239397011697292
S O 0 0.1486230343580246
phase O 0 0.05091989040374756
is O 0 0.0050790272653102875
accompanied O 0 0.008194969035685062
by O 0 0.004627573769539595
the O 0 0.00588436983525753
aggregation O 0 0.36244943737983704
of O 0 0.008268074132502079
nuclear O 0 0.03142925351858139
BARD1 O 1 0.8825302720069885
polypeptides O 1 0.855522871017456
into O 0 0.040524695068597794
BRCA1 O 1 0.9972401857376099
nuclear O 0 0.08638378232717514
dots O 1 0.6684563159942627
. O 0 0.034849006682634354

This O 0 0.02906581200659275
cell O 1 0.8595559597015381
cycle O 1 0.5862897634506226
- O 0 0.1447724848985672
dependent O 0 0.06281470507383347
colocalization O 0 0.40120670199394226
of O 0 0.012197660282254219
BARD1 O 1 0.7796095609664917
and O 0 0.013528672978281975
BRCA1 O 1 0.9988823533058167
indicates O 0 0.04312596097588539
a O 0 0.013951273635029793
role O 0 0.015265945345163345
for O 0 0.01051211915910244
BARD1 O 1 0.920511782169342
in O 0 0.03830293193459511
BRCA1 O 1 0.9995512366294861
- O 1 0.9841334819793701
mediated O 1 0.9950018525123596
tumor B-Disease 1 0.9986145496368408
suppression O 1 0.8586418628692627
. O 0 0.045031480491161346

Ethnic O 0 0.03955341875553131
differences O 0 0.03254186362028122
in O 0 0.012312917970120907
the O 0 0.01664993353188038
HFE O 1 0.9876178503036499
codon O 1 0.9451937675476074
282 O 1 0.6558067798614502
( O 0 0.05528775602579117
Cys O 1 0.9846320152282715
/ O 1 0.8413960933685303
Tyr O 1 0.9722588062286377
) O 0 0.03996322304010391
polymorphism O 1 0.8889099955558777
. O 0 0.03265509009361267

Recent O 0 0.03821295127272606
studies O 0 0.027167001739144325
have O 0 0.00826715212315321
shown O 0 0.017595188692212105
that O 0 0.014599252492189407
hereditary B-Disease 1 0.999040424823761
hemochromatosis I-Disease 1 0.9997926354408264
( O 0 0.26189517974853516
HH B-Disease 1 0.996132493019104
) O 0 0.01134302094578743
is O 0 0.0044802101328969
likely O 0 0.005645895842462778
to O 0 0.0031117715407162905
be O 0 0.003932206891477108
caused O 0 0.047908052802085876
by O 0 0.0068876734003424644
homozygosity O 0 0.4312712848186493
for O 0 0.006348588038235903
a O 0 0.014405856840312481
Cys282Tyr O 1 0.9718045592308044
mutation O 1 0.9958388805389404
in O 0 0.011642761528491974
the O 0 0.015637636184692383
HFE O 1 0.9953463673591614
gene O 1 0.9893043041229248
located O 0 0.022548692300915718
4 O 0 0.028576575219631195
. O 0 0.020747870206832886

5 O 0 0.08272559195756912
Mb O 1 0.6638352274894714
telomeric O 1 0.9407752752304077
to O 0 0.032993149012327194
HLA O 1 0.9892024397850037
- O 0 0.19490160048007965
A O 0 0.03761503845453262
. O 0 0.03359127417206764

Population O 0 0.028578734025359154
studies O 0 0.019693350419402122
of O 0 0.0049549187533557415
this O 0 0.00536691676825285
polymorphism O 1 0.686352014541626
are O 0 0.004460178781300783
facilitated O 0 0.024126676842570305
by O 0 0.004161518532782793
the O 0 0.0031805161852389574
fact O 0 0.0049920701421797276
that O 0 0.004024079069495201
the O 0 0.007331958971917629
Cys282Tyr O 1 0.9554148316383362
mutation O 1 0.9970786571502686
creates O 0 0.21482151746749878
a O 0 0.02352251671254635
Rsal O 1 0.7710203528404236
restriction O 0 0.06582312285900116
site O 0 0.024976935237646103
. O 0 0.022001443430781364

We O 0 0.0137723907828331
have O 0 0.010322319343686104
studied O 0 0.01646720990538597
the O 0 0.012052655220031738
codon O 1 0.723101019859314
282 O 0 0.4423942565917969
( O 0 0.05171502009034157
Cys O 1 0.9917425513267517
/ O 1 0.8710347414016724
Tyr O 1 0.9722251892089844
) O 0 0.022960472851991653
polymorphism O 1 0.7206457853317261
in O 0 0.007812912575900555
different O 0 0.008454419672489166
ethnic O 0 0.0158213023096323
groups O 0 0.01686452515423298
. O 0 0.016863537952303886

In O 0 0.017109829932451248
agreement O 0 0.013509816490113735
with O 0 0.008696253411471844
previous O 0 0.010928375646471977
observations O 0 0.015996869653463364
the O 0 0.010883980430662632
Tyr O 1 0.9877979159355164
allele O 1 0.9890296459197998
appeared O 0 0.012549374252557755
to O 0 0.004515044391155243
be O 0 0.004358205012977123
rare O 0 0.02119782753288746
or O 0 0.0076513937674462795
absent O 0 0.0348655991256237
in O 0 0.008492639288306236
Asiatic O 1 0.7584931254386902
( O 0 0.013119109906256199
Indian O 0 0.011979100294411182
, O 0 0.007126547861844301
Chinese O 0 0.013605045154690742
) O 0 0.017550576478242874
populations O 0 0.3056473731994629
. O 0 0.02386036328971386

The O 0 0.019511690363287926
highest O 0 0.028828881680965424
allele O 1 0.9828447103500366
frequency O 0 0.06951530277729034
( O 0 0.012186702340841293
7 O 0 0.010000428184866905
. O 0 0.004918915219604969
5 O 0 0.008250265382230282
% O 0 0.008436878211796284
) O 0 0.006530695129185915
was O 0 0.0042691524140536785
found O 0 0.007094002328813076
in O 0 0.007812377065420151
Swedes O 0 0.03833264485001564
. O 0 0.022058730944991112

Saamis O 1 0.6660722494125366
( O 0 0.024925587698817253
2 O 0 0.014916393905878067
% O 0 0.012342771515250206
) O 0 0.008615442551672459
and O 0 0.004961087368428707
Mordvinians O 1 0.5140810608863831
( O 0 0.00998949259519577
1 O 0 0.0069268858060240746
. O 0 0.004887462593615055
8 O 0 0.007251742761582136
% O 0 0.007178825791925192
) O 0 0.006022126413881779
had O 0 0.00541333481669426
significantly O 0 0.024281632155179977
lower O 0 0.012523774988949299
frequencies O 0 0.021570216864347458
of O 0 0.007601602002978325
the O 0 0.013681741431355476
Tyr O 1 0.9801934361457825
allele O 1 0.9842729568481445
. O 0 0.044960685074329376

Comparisons O 0 0.06166192889213562
with O 0 0.024434171617031097
allele O 1 0.9410990476608276
frequencies O 0 0.039913296699523926
based O 0 0.012947245500981808
on O 0 0.00902903825044632
prevalence O 1 0.9742368459701538
estimates O 0 0.01722872257232666
of O 0 0.008022809401154518
HH B-Disease 1 0.9764724373817444
showed O 0 0.012634259648621082
some O 0 0.005915282294154167
disagreements O 0 0.015263807959854603
with O 0 0.005944813136011362
the O 0 0.006629587151110172
RFLP O 1 0.9799096584320068
data O 0 0.012526310048997402
, O 0 0.006473204120993614
particularly O 0 0.01224108412861824
in O 0 0.010042161680758
Finns O 0 0.06352810561656952
. O 0 0.02728882245719433

The O 0 0.02219954878091812
newly O 0 0.029436109587550163
described O 0 0.042017173022031784
HFE O 1 0.9866967797279358
marker O 0 0.1620480865240097
provides O 0 0.013600560836493969
a O 0 0.0068985954858362675
new O 0 0.005870375782251358
approach O 0 0.009045607410371304
to O 0 0.003416504478082061
the O 0 0.004674302879720926
screening O 0 0.18726004660129547
of O 0 0.006413400638848543
HH B-Disease 1 0.9876202940940857
as O 0 0.005180378910154104
well O 0 0.004395525902509689
as O 0 0.0032635366078466177
studies O 0 0.008549114689230919
of O 0 0.002595070982351899
the O 0 0.0036937477998435497
relationship O 0 0.019250771030783653
between O 0 0.008317021653056145
the O 0 0.011601089499890804
HFE O 1 0.9982315897941589
Tyr O 1 0.9948705434799194
allele O 1 0.9930961728096008
and O 0 0.014815220609307289
different O 0 0.052443813532590866
disorders O 1 0.9992133378982544
including O 0 0.24775581061840057
cancer B-Disease 1 0.9986679553985596

Autosomal B-Disease 1 0.9979458451271057
dominant I-Disease 1 0.9716640710830688
neurohypophyseal I-Disease 1 0.9950333833694458
diabetes I-Disease 1 0.9997010231018066
insipidus I-Disease 1 0.9967772364616394
associated O 0 0.06347016990184784
with O 0 0.015147961676120758
a O 0 0.027601631358265877
missense O 1 0.9912111163139343
mutation O 1 0.9972363710403442
encoding O 1 0.9689120650291443
Gly23 O 1 0.9805850386619568
- O 1 0.7869415283203125
- O 1 0.7936906814575195
> O 1 0.9547172784805298
Val O 1 0.9393607378005981
in O 0 0.02837550826370716
neurophysin O 1 0.8548216819763184
II O 0 0.09922807663679123
. O 0 0.036708731204271317

Autosomal B-Disease 1 0.9961490631103516
dominant I-Disease 1 0.9600314497947693
neurohypophyseal I-Disease 1 0.9919725656509399
diabetes I-Disease 1 0.9995269775390625
insipidus I-Disease 1 0.9965155124664307
( O 0 0.07271116226911545
ADNDI B-Disease 1 0.902888298034668
) O 0 0.015661325305700302
is O 0 0.009743747301399708
an O 0 0.015353167429566383
inherited B-Disease 1 0.9987439513206482
disease I-Disease 1 0.99981290102005
caused O 1 0.9063255190849304
by O 0 0.01753547228872776
progressive O 1 0.8956685066223145
degeneration O 1 0.9979409575462341
of O 0 0.008637389168143272
the O 0 0.011005601845681667
magnocellular O 1 0.9873535633087158
neurons O 1 0.8063758611679077
of O 0 0.0068080793134868145
the O 0 0.0075460937805473804
hypothalamus O 1 0.9653369188308716
leading O 0 0.013974764384329319
to O 0 0.005876902490854263
decreased O 0 0.12821587920188904
ability O 0 0.014653419144451618
to O 0 0.005454797763377428
produce O 0 0.01801527477800846
the O 0 0.013895836658775806
hormone O 1 0.9956406354904175
arginine O 1 0.9846289157867432
vasopressin O 1 0.984832227230072
( O 0 0.04475630074739456
AVP O 1 0.9225724339485168
) O 0 0.0321958027780056
. O 0 0.026690147817134857

Affected O 0 0.0863448902964592
individuals O 0 0.020555177703499794
are O 0 0.006443442776799202
not O 0 0.0073384386487305164
symptomatic O 1 0.9825122356414795
at O 0 0.011369467712938786
birth O 0 0.3764973282814026
, O 0 0.006174399983137846
but O 0 0.007078892085701227
usually O 0 0.05798095092177391
develop O 1 0.9896529316902161
diabetes B-Disease 1 0.9998575448989868
insipidus I-Disease 1 0.9982390403747559
at O 0 0.018641043454408646
1 O 0 0.018207352608442307
- O 0 0.10814239829778671
6 O 0 0.024471299722790718
yr O 1 0.9260737895965576
of O 0 0.014323909766972065
age O 0 0.03294486179947853
. O 0 0.02647784911096096

The O 0 0.025726977735757828
genetic O 1 0.9903504252433777
locus O 1 0.9510655403137207
of O 0 0.008338412269949913
the O 0 0.011910609900951385
disease O 1 0.9987648725509644
is O 0 0.009653270244598389
the O 0 0.01014502439647913
AVP O 1 0.9820500612258911
- O 1 0.6993935704231262
neurophysin O 1 0.9229112267494202
II O 0 0.1683748960494995
( O 0 0.026171909645199776
NPII O 1 0.9607568383216858
) O 0 0.0245557501912117
gene O 1 0.9876307845115662
, O 0 0.006134652066975832
and O 0 0.006723836529999971
mutations O 1 0.9977522492408752
that O 0 0.007962092757225037
cause O 1 0.8928881883621216
ADNDI B-Disease 1 0.7730404734611511
have O 0 0.004418397322297096
been O 0 0.0034885064233094454
found O 0 0.004501511808484793
in O 0 0.00309382495470345
both O 0 0.00339723052456975
the O 0 0.0042525711469352245
signal O 0 0.04138711094856262
peptide O 1 0.876470148563385
of O 0 0.006025081500411034
the O 0 0.00893245730549097
prepro O 1 0.973446249961853
- O 1 0.8128535747528076
AVP O 1 0.9889543056488037
- O 1 0.78920578956604
NPII O 1 0.9698484539985657
precursor O 1 0.7444387078285217
and O 0 0.01040030736476183
within O 0 0.016515731811523438
NPII O 1 0.7623974680900574
itself O 0 0.035243161022663116
. O 0 0.023971518501639366

An O 0 0.022571686655282974
affected O 0 0.040824003517627716
girl O 0 0.03466508537530899
who O 0 0.007761204615235329
presented O 0 0.008963486179709435
at O 0 0.005730001721531153
9 O 0 0.00875790510326624
months O 0 0.007029326166957617
of O 0 0.0031950955744832754
age O 0 0.007683327421545982
and O 0 0.0039044911973178387
her O 0 0.009941119700670242
similarly O 0 0.1450628638267517
affected O 0 0.3655214309692383
younger O 0 0.17608657479286194
brother O 0 0.020986437797546387
and O 0 0.004555946681648493
father O 0 0.006751180160790682
were O 0 0.002411317080259323
all O 0 0.0022383525501936674
found O 0 0.004196120426058769
to O 0 0.002914182376116514
have O 0 0.00394574785605073
a O 0 0.009262463077902794
novel O 0 0.23854754865169525
missense O 1 0.9961918592453003
mutation O 1 0.9985155463218689
( O 0 0.05388351157307625
G1758 O 1 0.9663139581680298
- O 1 0.7935392260551453
- O 1 0.8452118039131165
> O 1 0.9787459969520569
T O 1 0.9534278512001038
) O 0 0.01777038350701332
encoding O 0 0.10908330231904984
the O 0 0.012833870016038418
amino O 1 0.8588623404502869
acid O 1 0.9830946326255798
substitution O 1 0.8635332584381104
Gly23 O 1 0.9730854630470276
- O 1 0.713194727897644
- O 1 0.7084182500839233
> O 1 0.9566150307655334
Val O 1 0.9389722347259521
within O 0 0.03655917942523956
NPII O 1 0.8762486577033997
. O 0 0.033513911068439484

The O 0 0.032060734927654266
mutation O 1 0.9892409443855286
was O 0 0.014841999858617783
confirmed O 0 0.02393726445734501
by O 0 0.01757829077541828
restriction O 0 0.22607815265655518
endonuclease O 1 0.9580404758453369
analysis O 0 0.0522124208509922
. O 0 0.027508322149515152

A O 0 0.060217540711164474
T1 O 1 0.9272444248199463
- O 0 0.08971913903951645
weighted O 0 0.046241823583841324
magnetic O 0 0.05920591577887535
resonance O 0 0.289847731590271
imaging O 0 0.34137165546417236
of O 0 0.009446109645068645
the O 0 0.011732385493814945
fathers O 1 0.6371328234672546
pituitary O 1 0.9981250166893005
gland O 1 0.9960487484931946
demonstrates O 0 0.3705110549926758
an O 0 0.030236396938562393
attenuated O 1 0.9953130483627319
posterior O 1 0.9961804151535034
pituitary O 1 0.9959656000137329
bright O 0 0.35675370693206787
spot O 0 0.052096497267484665
. O 0 0.032483670860528946

This O 0 0.02535673975944519
mutation O 1 0.9941596984863281
may O 0 0.011391205713152885
be O 0 0.003948366269469261
valuable O 0 0.007859718054533005
for O 0 0.004902394488453865
developing O 0 0.021602893248200417
models O 0 0.014396028593182564
of O 0 0.00814591720700264
dominantly B-Disease 1 0.9904745221138
inherited I-Disease 1 0.9976913928985596
neurodegeneration I-Disease 1 0.9987621307373047
, O 0 0.0062726568430662155
as O 0 0.003277059178799391
the O 0 0.003226763103157282
early O 0 0.0057401820085942745
age O 0 0.010360761545598507
of O 0 0.006934584118425846
onset O 1 0.9991875290870667
of O 0 0.014703585766255856
symptoms O 1 0.9993873834609985
suggests O 0 0.16007792949676514
that O 0 0.004891580902040005
this O 0 0.006119935307651758
mutation O 1 0.9984259605407715
may O 0 0.011317307129502296
be O 0 0.004890682175755501
particularly O 0 0.013596588745713234
deleterious O 1 0.9424808025360107
to O 0 0.007540175691246986
the O 0 0.01313374936580658
magnocellular O 1 0.9924147725105286
neuron O 1 0.9877437949180603
. O 0 0.02081310749053955
. O 0 0.023721756413578987

Frequent O 0 0.16393417119979858
inactivation O 1 0.7886649370193481
of O 0 0.02656739577651024
PTEN O 1 0.9933575987815857
/ O 1 0.8395451307296753
MMAC1 O 1 0.9311992526054382
in O 0 0.027899881824851036
primary O 1 0.9671520590782166
prostate B-Disease 1 0.9998353719711304
cancer I-Disease 1 0.9992474317550659
. O 0 0.05153996869921684

Sporadic B-Disease 1 0.9836397767066956
prostate I-Disease 1 0.9996910095214844
carcinoma I-Disease 1 0.999504804611206
is O 0 0.009465770795941353
the O 0 0.005582387093454599
most O 0 0.0068565295077860355
common O 0 0.49480345845222473
male B-Disease 1 0.9819506406784058
cancer I-Disease 1 0.9996470212936401
in O 0 0.004898878745734692
the O 0 0.003091934137046337
Western O 0 0.005387124605476856
world O 0 0.0043111699633300304
, O 0 0.0027482989244163036
yet O 0 0.002957344288006425
many O 0 0.0021828690078109503
of O 0 0.0021641808561980724
the O 0 0.0030155556742101908
major O 0 0.014438160695135593
genetic O 1 0.9943547248840332
events O 0 0.011026994325220585
involved O 0 0.0099854851141572
in O 0 0.004163921810686588
the O 0 0.005442072171717882
progression O 1 0.9806069731712341
of O 0 0.005293546710163355
this O 0 0.006352412514388561
often O 0 0.09570111334323883
fatal O 1 0.9991090893745422
cancer B-Disease 1 0.9992639422416687
remain O 0 0.012053290382027626
to O 0 0.007275802083313465
be O 0 0.009584669955074787
elucidated O 1 0.6766327619552612
. O 0 0.023640261963009834

Numerous O 0 0.061040543019771576
cytogenetic O 1 0.939973771572113
and O 0 0.017240246757864952
allelotype O 1 0.6273050308227539
studies O 0 0.029765889048576355
have O 0 0.006988917011767626
reported O 0 0.015131957828998566
frequent O 0 0.03300689533352852
loss O 0 0.02729017660021782
of O 0 0.010391529649496078
heterozygosity O 1 0.9694394469261169
on O 0 0.014819599688053131
chromosomal O 1 0.9967851638793945
arm O 1 0.8851423263549805
10q O 1 0.9528914093971252
in O 0 0.06253674626350403
sporadic B-Disease 1 0.9954745173454285
prostate I-Disease 1 0.9999055862426758
cancer I-Disease 1 0.9995155334472656
. O 0 0.06372502446174622

Deletion O 1 0.923801600933075
mapping O 0 0.07913870364427567
studies O 0 0.030660521239042282
have O 0 0.008659636601805687
unambiguously O 0 0.034343820065259933
identified O 0 0.013690494932234287
a O 0 0.00777006708085537
region O 0 0.010004300624132156
of O 0 0.006893753539770842
chromosome O 1 0.9973535537719727
10q23 O 1 0.5104329586029053
to O 0 0.004544337745755911
be O 0 0.0031168197747319937
the O 0 0.003879505442455411
minimal O 0 0.01823444478213787
area O 0 0.007700942922383547
of O 0 0.007193726021796465
loss O 0 0.07439509779214859
. O 0 0.02159048803150654

A O 0 0.0506293848156929
new O 0 0.06112780421972275
tumor B-Disease 1 0.9992870688438416
suppressor O 1 0.9977715611457825
gene O 1 0.9954128861427307
, O 0 0.03527827188372612
PTEN O 1 0.9971213936805725
/ O 1 0.7967774271965027
MMAC1 O 1 0.803019642829895
, O 0 0.0072804600931704044
was O 0 0.005795576609671116
isolated O 0 0.04049166291952133
recently O 0 0.009536734782159328
at O 0 0.004563602153211832
this O 0 0.0035488952416926622
region O 0 0.007644263561815023
of O 0 0.00716404989361763
chromosome O 1 0.9981605410575867
10q23 O 1 0.5730636119842529
and O 0 0.005115928128361702
found O 0 0.005402906332165003
to O 0 0.0038705416955053806
be O 0 0.004513261839747429
inactivated O 0 0.48960772156715393
by O 0 0.013377433642745018
mutation O 1 0.9980000853538513
in O 0 0.017451034858822823
three O 0 0.29755231738090515
prostate B-Disease 1 0.9999446868896484
cancer I-Disease 1 0.9998629093170166
cell O 1 0.9898563623428345
lines O 0 0.10209343582391739
. O 0 0.03106050007045269

We O 0 0.025359995663166046
screened O 0 0.08841538429260254
80 O 0 0.20302821695804596
prostate B-Disease 1 0.9995642304420471
tumors I-Disease 1 0.9988638162612915
by O 0 0.023748600855469704
microsatellite O 1 0.9892483353614807
analysis O 0 0.028233496472239494
and O 0 0.008150403387844563
found O 0 0.018139071762561798
chromosome O 1 0.9949670433998108
10q23 O 1 0.5161782503128052
to O 0 0.005543641280382872
be O 0 0.004610860720276833
deleted O 0 0.024938233196735382
in O 0 0.007313834503293037
23 O 0 0.01866718754172325
cases O 0 0.05055324360728264
. O 0 0.0204353965818882

We O 0 0.01206578966230154
then O 0 0.008659228682518005
proceeded O 0 0.012683232314884663
with O 0 0.006375953089445829
sequence O 0 0.019457928836345673
analysis O 0 0.01100411731749773
of O 0 0.00413478072732687
the O 0 0.005969197489321232
entire O 0 0.03706273064017296
PTEN O 1 0.9968463778495789
/ O 1 0.8790958523750305
MMAC1 O 1 0.9671196341514587
coding O 1 0.9231711626052856
region O 0 0.017051104456186295
and O 0 0.006806099787354469
tested O 0 0.0539434514939785
for O 0 0.009467799216508865
homozygous O 1 0.9913710355758667
deletion O 1 0.9806296229362488
with O 0 0.009664143435657024
new O 0 0.010250449180603027
intragenic O 1 0.8714714646339417
markers O 0 0.26175111532211304
in O 0 0.006249432452023029
these O 0 0.0050390721298754215
23 O 0 0.011843234300613403
cases O 0 0.02036953903734684
with O 0 0.009718631394207478
10q23 O 1 0.7713922262191772
loss O 0 0.06500470638275146
of O 0 0.014951481483876705
heterozygosity O 1 0.9685436487197876
. O 0 0.03019697219133377

The O 0 0.013405519537627697
identification O 0 0.015092943795025349
of O 0 0.004850355442613363
the O 0 0.004939845763146877
second O 0 0.01028203871101141
mutational O 1 0.9785526394844055
event O 0 0.01587856002151966
in O 0 0.007019409444183111
10 O 0 0.010427899658679962
( O 0 0.010868781246244907
43 O 0 0.018384264782071114
% O 0 0.020602568984031677
) O 0 0.06063587963581085
tumors B-Disease 1 0.9995067119598389
establishes O 1 0.9733675122261047
PTEN O 1 0.9971311092376709
/ O 1 0.6578119993209839
MMAC1 O 0 0.48460158705711365
as O 0 0.007172058802098036
a O 0 0.008166491985321045
main O 0 0.010522262193262577
inactivation O 1 0.6983693242073059
target O 0 0.014984671957790852
of O 0 0.007599933538585901
10q O 1 0.8238243460655212
loss O 0 0.24632245302200317
in O 0 0.032721199095249176
sporadic B-Disease 1 0.9964770674705505
prostate I-Disease 1 0.9999169111251831
cancer I-Disease 1 0.9996421337127686
. O 0 0.028819140046834946
. O 0 0.029299907386302948

Risk O 1 0.9005013704299927
reversals O 0 0.36143210530281067
in O 0 0.026639478281140327
predictive O 1 0.9659801125526428
testing O 1 0.607024073600769
for O 0 0.05887976661324501
Huntington B-Disease 1 0.9979677796363831
disease I-Disease 1 0.9991826415061951
. O 0 0.045320551842451096

The O 0 0.017519377171993256
first O 0 0.01760631985962391
predictive O 1 0.8432439565658569
testing O 0 0.4041653275489807
for O 0 0.04018447920680046
Huntington B-Disease 1 0.999106228351593
disease I-Disease 1 0.9996592998504639
( O 0 0.05131500959396362
HD B-Disease 1 0.8371473550796509
) O 0 0.008480935357511044
was O 0 0.003956343047320843
based O 0 0.004403333179652691
on O 0 0.0031831928063184023
analysis O 0 0.01025437843054533
of O 0 0.005845037288963795
linked O 1 0.7858313918113708
polymorphic O 1 0.9968620538711548
DNA O 1 0.9785570502281189
markers O 0 0.22017209231853485
to O 0 0.005059969611465931
estimate O 0 0.010489526204764843
the O 0 0.0049667963758111
likelihood O 0 0.027570895850658417
of O 0 0.006139840930700302
inheriting O 1 0.8338308930397034
the O 0 0.012400252744555473
mutation O 1 0.9977154731750488
for O 0 0.017763858661055565
HD B-Disease 1 0.7597832679748535
. O 0 0.024034209549427032

Limits O 0 0.029904918745160103
to O 0 0.008817825466394424
accuracy O 0 0.01926312781870365
included O 0 0.010854826308786869
recombination O 1 0.8467053771018982
between O 0 0.007701610215008259
the O 0 0.006235784385353327
DNA O 1 0.8887989521026611
markers O 0 0.19956238567829132
and O 0 0.004590702708810568
the O 0 0.006225607357919216
mutation O 1 0.9972586631774902
, O 0 0.008537260815501213
pedigree O 1 0.7275862097740173
structure O 0 0.01512790098786354
, O 0 0.004347959998995066
and O 0 0.0035033002495765686
whether O 0 0.008672934956848621
DNA O 1 0.8243723511695862
samples O 0 0.018140478059649467
were O 0 0.004036972764879465
available O 0 0.0062639364041388035
from O 0 0.007112687919288874
family O 0 0.01780642382800579
members O 0 0.013439378701150417
. O 0 0.02009677141904831

With O 0 0.01785753294825554
direct O 0 0.017195740714669228
tests O 0 0.01630569063127041
for O 0 0.005459331441670656
the O 0 0.006518079433590174
HD B-Disease 1 0.9573665261268616
mutation O 1 0.9968382120132446
, O 0 0.005252058617770672
we O 0 0.0025885377544909716
have O 0 0.002864815993234515
assessed O 0 0.007250781636685133
the O 0 0.002564934780821204
accuracy O 0 0.007650445215404034
of O 0 0.003189641982316971
results O 0 0.00915432907640934
obtained O 0 0.00802116934210062
by O 0 0.007739745080471039
linkage O 1 0.6554936170578003
approaches O 0 0.021991552785038948
when O 0 0.006530373822897673
requested O 0 0.005873172543942928
to O 0 0.0030028775800019503
do O 0 0.003859441727399826
so O 0 0.0032646674662828445
by O 0 0.0042054918594658375
the O 0 0.004489718936383724
test O 0 0.01994236558675766
individuals O 0 0.021668722853064537
. O 0 0.01715962588787079

For O 0 0.013119703158736229
six O 0 0.009662355296313763
such O 0 0.006939314771443605
individuals O 0 0.007987145334482193
, O 0 0.0036096705589443445
there O 0 0.0032287670765072107
was O 0 0.004108504392206669
significant O 0 0.009239505976438522
disparity O 0 0.15521229803562164
between O 0 0.008620526641607285
the O 0 0.008625181391835213
tests O 0 0.05962974950671196
. O 0 0.0194205641746521

Three O 0 0.014189365319907665
went O 0 0.011377762071788311
from O 0 0.007169078104197979
a O 0 0.010293458588421345
decreased O 1 0.506512463092804
risk O 1 0.7015413045883179
to O 0 0.0041169715113937855
an O 0 0.005174172576516867
increased O 0 0.07505705952644348
risk O 1 0.8899478912353516
, O 0 0.003751141717657447
while O 0 0.0033124948386102915
in O 0 0.0030316878110170364
another O 0 0.004755186848342419
three O 0 0.0043860855512320995
the O 0 0.006228365935385227
risk O 1 0.8356931209564209
was O 0 0.010788006708025932
decreased O 0 0.3340970277786255
. O 0 0.02674615941941738

Knowledge O 0 0.022400882095098495
of O 0 0.0061543476767838
the O 0 0.0053131673485040665
potential O 0 0.014783046208322048
reasons O 0 0.008514723740518093
for O 0 0.003991841804236174
these O 0 0.0035683498717844486
changes O 0 0.0073430174961686134
in O 0 0.00355429551564157
results O 0 0.0070975711569190025
and O 0 0.00291249668225646
impact O 0 0.008112006820738316
of O 0 0.0031933768186718225
these O 0 0.0058361440896987915
risk O 1 0.9406777024269104
reversals O 1 0.5390715003013611
on O 0 0.005071007180958986
both O 0 0.006102887447923422
patients O 1 0.9858076572418213
and O 0 0.0038322738837450743
the O 0 0.004598274827003479
counseling O 1 0.604180634021759
team O 0 0.005716294515877962
can O 0 0.004861730150878429
assist O 0 0.007802928797900677
in O 0 0.0024179525207728148
the O 0 0.00265560788102448
development O 0 0.00558066600933671
of O 0 0.0032067603897303343
strategies O 0 0.054014381021261215
for O 0 0.00397386634722352
the O 0 0.004686788655817509
prevention O 1 0.8866516947746277
and O 0 0.0034333381336182356
, O 0 0.0030170725658535957
where O 0 0.0033292558509856462
necessary O 0 0.005227301735430956
, O 0 0.0036621056497097015
management O 0 0.009601187892258167
of O 0 0.004393560811877251
a O 0 0.010200277902185917
risk O 1 0.8590443730354309
reversal O 0 0.19671006500720978
in O 0 0.007880746386945248
any O 0 0.009652312844991684
predictive O 1 0.9473562836647034
testing O 0 0.26541250944137573
program O 0 0.02833983488380909
. O 0 0.013433347456157207
. O 0 0.018289726227521896

A O 0 0.045807186514139175
novel O 0 0.05586899816989899
common O 0 0.11707381904125214
missense O 1 0.9895519614219666
mutation O 1 0.9975422620773315
G301C O 1 0.5768400430679321
in O 0 0.010084562934935093
the O 0 0.0087810093536973
N O 0 0.24988022446632385
- O 0 0.4481181800365448
acetylgalactosamine O 1 0.9503111839294434
- O 0 0.3246188163757324
6 O 0 0.04236479103565216
- O 1 0.861362099647522
sulfate O 1 0.9954224228858948
sulfatase O 1 0.9969319105148315
gene O 1 0.9910982251167297
in O 0 0.030424192547798157
mucopolysaccharidosis B-Disease 1 0.9266480207443237
IVA I-Disease 1 0.9659044742584229
. O 0 0.046591248363256454

Mucopolysaccharidosis B-Disease 1 0.9244972467422485
IVA I-Disease 1 0.9648206233978271
( O 0 0.040229860693216324
MPS B-Disease 0 0.1347649246454239
IVA I-Disease 1 0.9801063537597656
) O 0 0.018533561378717422
is O 0 0.012194122187793255
an O 0 0.055308133363723755
autosomal B-Disease 1 0.9998830556869507
recessive I-Disease 1 0.9998552799224854
lysosomal I-Disease 1 0.9988068342208862
storage I-Disease 1 0.9224672317504883
disorder I-Disease 1 0.9989838004112244
caused O 1 0.6239698529243469
by O 0 0.014079457148909569
a O 0 0.04193529486656189
genetic B-Disease 1 0.9990630745887756
defect I-Disease 1 0.9956963062286377
in O 0 0.01645403914153576
N O 1 0.5299612283706665
- O 0 0.39823663234710693
acetylgalactosamine O 1 0.9262135028839111
- O 0 0.3107912242412567
6 O 0 0.03855254501104355
- O 1 0.8462187647819519
sulfate O 1 0.9958477020263672
sulfatase O 1 0.9921974539756775
( O 0 0.05229683592915535
GALNS O 1 0.8671810030937195
) O 0 0.034390706568956375
. O 0 0.025496656075119972

In O 0 0.016209857538342476
previous O 0 0.013780385255813599
studies O 0 0.01666966639459133
, O 0 0.0035850857384502888
we O 0 0.0025291629135608673
have O 0 0.0026106166187673807
found O 0 0.005037690978497267
two O 0 0.005190685391426086
common O 0 0.1896458864212036
mutations O 1 0.9985044002532959
in O 0 0.01042882539331913
Caucasians O 1 0.8069543242454529
and O 0 0.007601451128721237
Japanese O 0 0.012759930454194546
, O 0 0.008940818719565868
respectively O 0 0.019064616411924362
. O 0 0.019099939614534378

To O 0 0.020301779732108116
characterize O 0 0.06704006344079971
the O 0 0.01628733053803444
mutational O 1 0.9720981121063232
spectrum O 0 0.04585684463381767
in O 0 0.007105949334800243
various O 0 0.005826275330036879
ethnic O 0 0.010065198875963688
groups O 0 0.009863216429948807
, O 0 0.007814350537955761
mutations O 1 0.9966424703598022
in O 0 0.008640533313155174
the O 0 0.010469861328601837
GALNS O 1 0.9850698113441467
gene O 1 0.9911770820617676
in O 0 0.011838145554065704
Colombian O 0 0.14448122680187225
MPS B-Disease 1 0.5377400517463684
IVA I-Disease 1 0.9974551796913147
patients O 1 0.9889560341835022
were O 0 0.0065162573009729385
investigated O 0 0.018515130504965782
, O 0 0.0050657219253480434
and O 0 0.00516544422134757
genetic O 1 0.9781791567802429
backgrounds O 0 0.01519990898668766
were O 0 0.0038262896705418825
extensively O 0 0.012055743485689163
analyzed O 0 0.015367303974926472
to O 0 0.004537427797913551
identify O 0 0.013037524186074734
racial O 0 0.01646972820162773
origin O 0 0.009965111501514912
, O 0 0.00490583386272192
based O 0 0.006480890791863203
on O 0 0.0070400116965174675
mitochondrial O 1 0.9950990080833435
DNA O 1 0.9849892854690552
( O 0 0.03417997062206268
mtDNA O 1 0.9840032458305359
) O 0 0.02837236598134041
lineages O 1 0.8893546462059021
. O 0 0.026182174682617188

Three O 0 0.030307035893201828
novel O 0 0.33756524324417114
missense O 1 0.9935144186019897
mutations O 1 0.9968668818473816
never O 0 0.013240117579698563
identified O 0 0.012384116649627686
previously O 0 0.005957029294222593
in O 0 0.003809872316196561
other O 0 0.0037550104316323996
populations O 0 0.07119879871606827
and O 0 0.0032277789432555437
found O 0 0.005747043993324041
in O 0 0.0036727269180119038
16 O 0 0.006196042988449335
out O 0 0.004081149119883776
of O 0 0.005012158304452896
19 O 0 0.014641856774687767
Colombian O 0 0.05176222324371338
MPS B-Disease 0 0.35634803771972656
IVA I-Disease 1 0.9956896901130676
unrelated O 1 0.9457600712776184
alleles O 1 0.9902594685554504
account O 0 0.023967811837792397
for O 0 0.013132870197296143
84 O 0 0.0427195280790329
. O 0 0.02605265937745571

2 O 0 0.023024680092930794
% O 0 0.012967784889042377
of O 0 0.0066459896042943
the O 0 0.009739772416651249
alleles O 1 0.9740221500396729
in O 0 0.009260101243853569
this O 0 0.009199194610118866
study O 0 0.029214290902018547
. O 0 0.02154465578496456

The O 0 0.029799481853842735
G301C O 0 0.31042614579200745
and O 0 0.018530454486608505
S162F O 1 0.9298150539398193
mutations O 1 0.9906846284866333
account O 0 0.024269185960292816
for O 0 0.013390266336500645
68 O 0 0.03718658536672592
. O 0 0.022051649168133736

4 O 0 0.037845779210329056
% O 0 0.023216335102915764
and O 0 0.011086768470704556
10 O 0 0.020421413704752922
. O 0 0.022679759189486504

5 O 0 0.03142101690173149
% O 0 0.016634585335850716
of O 0 0.010700974613428116
mutations O 1 0.9944831728935242
, O 0 0.007852844893932343
respectively O 0 0.007420884445309639
, O 0 0.0039995997212827206
whereas O 0 0.009531322866678238
the O 0 0.003933658357709646
remaining O 0 0.008742132224142551
F69V O 1 0.5767953991889954
is O 0 0.005642101168632507
limited O 0 0.007273167837411165
to O 0 0.004930930677801371
a O 0 0.010215223766863346
single O 0 0.029337497428059578
allele O 1 0.9845900535583496
. O 0 0.030604636296629906

The O 0 0.026720602065324783
skewed O 1 0.5583370923995972
prevalence O 1 0.9488534331321716
of O 0 0.010142755694687366
G301C O 0 0.29859164357185364
in O 0 0.007694984320551157
only O 0 0.007691544480621815
Colombian O 0 0.23360934853553772
patients O 1 0.9890516400337219
and O 0 0.010869729332625866
haplotype O 1 0.994125485420227
analysis O 0 0.022672638297080994
by O 0 0.00939378421753645
restriction O 0 0.1068689376115799
fragment O 0 0.49474969506263733
length O 0 0.05630410462617874
polymorphisms O 1 0.9854429960250854
in O 0 0.008094752207398415
the O 0 0.009754694998264313
GALNS O 1 0.9855307340621948
gene O 1 0.9943830966949463
suggest O 0 0.02638888731598854
that O 0 0.00904018059372902
G301C O 0 0.3881293833255768
originated O 0 0.025921223685145378
from O 0 0.008467021398246288
a O 0 0.014341121539473534
common O 0 0.04342353716492653
ancestor O 1 0.5318718552589417
. O 0 0.027542144060134888

Investigation O 0 0.029072823002934456
of O 0 0.008475159294903278
the O 0 0.008617918007075787
genetic O 1 0.9728747606277466
background O 0 0.018612492829561234
by O 0 0.006071970798075199
means O 0 0.009536519646644592
of O 0 0.006199837662279606
mtDNA O 1 0.9864739179611206
lineages O 1 0.9403817653656006
indicate O 0 0.013581945560872555
that O 0 0.00375865469686687
all O 0 0.0032854366581887007
our O 0 0.007330217398703098
patients O 1 0.9578976631164551
are O 0 0.0048500606790184975
probably O 0 0.008017294108867645
of O 0 0.005506437737494707
native O 0 0.014933807775378227
American O 0 0.02643980085849762
descent O 0 0.1849045604467392

Low O 0 0.08278390765190125
frequency O 0 0.07667231559753418
of O 0 0.03505593165755272
BRCA1 O 1 0.9985234141349792
germline O 1 0.9971197843551636
mutations O 1 0.9954641461372375
in O 0 0.020548831671476364
45 O 0 0.03235507011413574
German O 1 0.7589371204376221
breast B-Disease 1 0.9998025298118591
/ I-Disease 1 0.9976351261138916
ovarian I-Disease 1 0.9998900890350342
cancer I-Disease 1 0.9995317459106445
families O 0 0.10947661101818085
. O 0 0.03680400550365448

In O 0 0.012802132405340672
this O 0 0.007559958845376968
study O 0 0.011636470444500446
we O 0 0.0053855483420193195
investigated O 0 0.021710561588406563
45 O 0 0.02126546949148178
German O 1 0.6911143660545349
breast B-Disease 1 0.999864935874939
/ I-Disease 1 0.9986684322357178
ovarian I-Disease 1 0.9999508857727051
cancer I-Disease 1 0.9996886253356934
families O 0 0.06845296919345856
for O 0 0.01936117559671402
germline O 1 0.9985551238059998
mutations O 1 0.9975147247314453
in O 0 0.018268343061208725
the O 0 0.028819845989346504
BRCA1 O 1 0.9992252588272095
gene O 1 0.9946415424346924
. O 0 0.041809339076280594

We O 0 0.017030000686645508
identified O 0 0.027246147394180298
four O 0 0.018387362360954285
germline O 1 0.99839848279953
mutations O 1 0.9979992508888245
in O 0 0.014706598594784737
three O 0 0.10316944867372513
breast B-Disease 1 0.999885082244873
cancer I-Disease 1 0.9995912909507751
families O 0 0.020338762551546097
and O 0 0.006040038075298071
in O 0 0.00905601680278778
one O 0 0.19621798396110535
breast B-Disease 1 0.99992835521698
- I-Disease 1 0.9992647767066956
ovarian I-Disease 1 0.9999803304672241
cancer I-Disease 1 0.9999076128005981
family O 0 0.11731857806444168
. O 0 0.005563502665609121
among O 0 0.00511138653382659
these O 0 0.0033107700292021036
were O 0 0.003066880162805319
one O 0 0.008401768282055855
frameshift O 1 0.9986371397972107
mutation O 1 0.9985929131507874
, O 0 0.006833404302597046
one O 0 0.006447834428399801
nonsense O 0 0.3714008033275604
mutation O 1 0.99783855676651
, O 0 0.006157399620860815
one O 0 0.006364312022924423
novel O 0 0.08248938620090485
splice O 1 0.9889689683914185
site O 0 0.03945997357368469
mutation O 1 0.9967271089553833
, O 0 0.007974651642143726
and O 0 0.0064054811373353004
one O 0 0.013589581474661827
missense O 1 0.9900762438774109
mutation O 1 0.995087206363678
. O 0 0.040922861546278

The O 0 0.03420225903391838
missense O 1 0.9891613125801086
mutation O 1 0.9938236474990845
was O 0 0.011517450213432312
also O 0 0.007792689837515354
found O 0 0.01159494649618864
in O 0 0.009314811788499355
2 O 0 0.01993236504495144
. O 0 0.02043965272605419

8 O 0 0.023619331419467926
% O 0 0.012780793011188507
of O 0 0.004015177488327026
the O 0 0.004052439704537392
general O 0 0.005817087832838297
population O 0 0.006345106288790703
, O 0 0.003858598880469799
suggesting O 0 0.010619083419442177
that O 0 0.003150949254631996
it O 0 0.0035199043340981007
is O 0 0.006140946876257658
not O 0 0.010490981861948967
disease O 1 0.9990856647491455
associated O 0 0.13739748299121857
. O 0 0.024980103597044945

The O 0 0.01640520989894867
average O 0 0.02378109097480774
age O 0 0.025804849341511726
of O 0 0.020475078374147415
disease O 1 0.9996620416641235
onset O 1 0.9973852038383484
in O 0 0.009217639453709126
those O 0 0.01051284372806549
families O 0 0.05439300835132599
harbouring O 1 0.9892175197601318
causative O 1 0.9974592328071594
mutations O 1 0.9966639876365662
was O 0 0.013942577876150608
between O 0 0.015161911956965923
32 O 0 0.028992600739002228
. O 0 0.023730143904685974

3 O 0 0.03824219852685928
and O 0 0.015913303941488266
37 O 0 0.034004271030426025
. O 0 0.02692144550383091

4 O 0 0.028421981260180473
years O 0 0.012132885865867138
, O 0 0.006509765516966581
whereas O 0 0.013305137865245342
the O 0 0.005591446999460459
family O 0 0.019826075062155724
harbouring O 1 0.5094570517539978
the O 0 0.01120504830032587
missense O 1 0.9979984164237976
mutation O 1 0.9986249208450317
had O 0 0.007391491439193487
an O 0 0.0051109883934259415
average O 0 0.011184177361428738
age O 0 0.012987312860786915
of O 0 0.008934009820222855
onset O 1 0.9895995855331421
of O 0 0.012210880406200886
51 O 0 0.04085365682840347
. O 0 0.023873621597886086

2 O 0 0.054721176624298096
years O 0 0.03754971921443939
. O 0 0.03160031512379646

These O 0 0.016933931037783623
findings O 0 0.024240227416157722
show O 0 0.01489141397178173
that O 0 0.012113828212022781
BRCA1 O 1 0.9982998967170715
is O 0 0.0128333680331707
implicated O 0 0.21533705294132233
in O 0 0.006986389867961407
a O 0 0.008706494234502316
small O 0 0.010816887021064758
fraction O 0 0.06151437759399414
of O 0 0.042208101600408554
breast B-Disease 1 0.9998602867126465
/ I-Disease 1 0.9991292357444763
ovarian I-Disease 1 0.9999666213989258
cancer I-Disease 1 0.9997528195381165
families O 0 0.04580893740057945
suggesting O 0 0.03186504915356636
the O 0 0.008573560975492
involvement O 0 0.02372637949883938
of O 0 0.00822607520967722
another O 0 0.047249048948287964
susceptibility O 1 0.9984813332557678
gene O 1 0.9948480129241943
( O 0 0.037138573825359344
s O 0 0.17023533582687378
) O 0 0.04066202789545059

Paternal O 1 0.9497737884521484
transmission O 1 0.9684779047966003
of O 0 0.3084077537059784
congenital B-Disease 1 0.9997732043266296
myotonic I-Disease 1 0.9990783929824829
dystrophy I-Disease 1 0.9988052845001221
. O 0 0.08264096826314926

We O 0 0.01554952934384346
report O 0 0.013743573799729347
a O 0 0.012190733104944229
rare O 0 0.03878757730126381
case O 0 0.02075723558664322
of O 0 0.021116742864251137
paternally O 1 0.9966534972190857
transmitted O 1 0.9987826943397522
congenital B-Disease 1 0.9999287128448486
myotonic I-Disease 1 0.9995571970939636
dystrophy I-Disease 1 0.9995728135108948
( O 1 0.5230362415313721
DM B-Disease 1 0.9924072623252869
) O 0 0.04756583645939827
. O 0 0.03283187374472618

The O 0 0.021605927497148514
proband O 0 0.16710923612117767
is O 0 0.009936957620084286
a O 0 0.009222066029906273
23 O 0 0.011321852914988995
year O 0 0.008705411106348038
old O 0 0.01606798730790615
, O 0 0.012583047151565552
mentally B-Disease 1 0.9792411923408508
retarded I-Disease 1 0.9887043833732605
male O 1 0.9043560028076172
who O 0 0.10044298321008682
suffers O 1 0.997195839881897
severe O 1 0.9956430196762085
muscular B-Disease 1 0.9971994161605835
weakness I-Disease 1 0.955293595790863
. O 0 0.05031178519129753

He O 0 0.01869083009660244
presented O 0 0.022622281685471535
with O 0 0.022395100444555283
respiratory O 1 0.9985865354537964
and O 0 0.014279208146035671
feeding O 1 0.6865990161895752
difficulties O 0 0.14172935485839844
at O 0 0.01799936033785343
birth O 1 0.5709559917449951
. O 0 0.026097187772393227

His O 0 0.03783145546913147
two O 0 0.03124767169356346
sibs O 1 0.9873550534248352
suffer O 1 0.9323996901512146
from O 0 0.04122402146458626
childhood O 1 0.9897667765617371
onset O 1 0.9986779093742371
DM B-Disease 1 0.9948158860206604
. O 0 0.0543648861348629

Their O 0 0.015667472034692764
late O 0 0.014798512682318687
father O 0 0.012394297868013382
had O 0 0.006042731925845146
the O 0 0.005976255517452955
adult O 0 0.27106165885925293
type O 0 0.14894607663154602
of O 0 0.011274254880845547
DM B-Disease 1 0.9971423745155334
, O 0 0.011055955663323402
with O 0 0.012419340200722218
onset O 1 0.9923819899559021
around O 0 0.014013822190463543
30 O 0 0.017576880753040314
years O 0 0.0192255899310112
. O 0 0.021309223026037216

Only O 0 0.012582342140376568
six O 0 0.010449754074215889
other O 0 0.006654835306107998
cases O 0 0.014183181338012218
of O 0 0.008258359506726265
paternal O 1 0.9620581269264221
transmission O 1 0.9886882901191711
of O 0 0.08346918970346451
congenital B-Disease 1 0.999901533126831
DM I-Disease 1 0.9979528188705444
have O 0 0.010982135310769081
been O 0 0.009103836491703987
reported O 0 0.021013500168919563
recently O 0 0.023354792967438698
. O 0 0.01884743571281433

We O 0 0.0124836266040802
review O 0 0.01246431190520525
the O 0 0.007537949364632368
sex O 0 0.09614907205104828
related O 0 0.0627693459391594
effects O 0 0.4811806380748749
on O 0 0.012701103463768959
transmission O 1 0.9700508713722229
of O 0 0.08706626296043396
congenital B-Disease 1 0.999794065952301
DM I-Disease 1 0.9956517815589905
. O 0 0.054418668150901794

Decreased O 0 0.34310024976730347
fertility O 1 0.7917765378952026
of O 0 0.015976421535015106
males O 0 0.16490507125854492
with O 0 0.01782255992293358
adult O 1 0.9793689846992493
onset O 1 0.9992942810058594
DM B-Disease 1 0.9976048469543457
and O 0 0.008977535180747509
contraction O 0 0.35481923818588257
of O 0 0.005661158822476864
the O 0 0.005636828485876322
repeat O 0 0.07000187039375305
upon O 0 0.00882149301469326
male O 0 0.38184279203414917
transmission O 1 0.9168092012405396
contribute O 0 0.016696371138095856
to O 0 0.0038227431941777468
the O 0 0.00388943194411695
almost O 0 0.008764419704675674
absent O 0 0.06703093647956848
occurrence O 0 0.2677299678325653
of O 0 0.01182397361844778
paternal O 1 0.965954065322876
transmission O 1 0.9878893494606018
of O 0 0.12350404262542725
congenital B-Disease 1 0.9998329877853394
DM I-Disease 1 0.9963375329971313
. O 0 0.05125797912478447

Also O 0 0.011892979964613914
the O 0 0.0075181592255830765
fathers O 0 0.016805630177259445
of O 0 0.004755445756018162
the O 0 0.005713758058845997
reported O 0 0.026904799044132233
congenitally O 1 0.9856061339378357
affected O 0 0.22239796817302704
children O 0 0.022480880841612816
showed O 0 0.011013014242053032
, O 0 0.004396377131342888
on O 0 0.003988317679613829
average O 0 0.011839495040476322
, O 0 0.008084781467914581
shorter O 0 0.25826624035835266
CTG O 1 0.9669510722160339
repeat O 0 0.19545842707157135
lengths O 0 0.040311381220817566
and O 0 0.006838642060756683
hence O 0 0.0460548959672451
less O 0 0.09053970128297806
severe O 1 0.9986599683761597
clinical O 1 0.998613715171814
symptoms O 1 0.9980006814002991
than O 0 0.008251676335930824
the O 0 0.008034217171370983
mothers O 0 0.445194274187088
of O 0 0.00998709537088871
children O 0 0.28115853667259216
with O 0 0.38927698135375977
congenital B-Disease 1 0.9998698234558105
DM I-Disease 1 0.9974851608276367
. O 0 0.0506739541888237

We O 0 0.01840374618768692
conclude O 0 0.02790134958922863
that O 0 0.011484435759484768
paternal O 1 0.8197776079177856
transmission O 1 0.9690984487533569
of O 0 0.049402255564928055
congenital B-Disease 1 0.9999141693115234
DM I-Disease 1 0.9984861016273499
is O 0 0.014715430326759815
rare O 0 0.06307048350572586
and O 0 0.007779240608215332
preferentially O 1 0.7744512557983398
occurs O 1 0.5728483200073242
with O 0 0.015788724645972252
onset O 1 0.9972921013832092
of O 0 0.01282621268182993
DM B-Disease 1 0.9944674968719482
past O 0 0.012258225120604038
30 O 0 0.009940190240740776
years O 0 0.005365049000829458
in O 0 0.004339898470789194
the O 0 0.005478368140757084
father O 0 0.016302403062582016
. O 0 0.010518890805542469
. O 0 0.01565481163561344

The O 0 0.05841910094022751
RB1 O 1 0.9945360422134399
gene O 1 0.99578458070755
mutation O 1 0.9937574863433838
in O 0 0.013162446208298206
a O 0 0.015855448320508003
child O 0 0.3976805806159973
with O 0 0.08981870859861374
ectopic B-Disease 1 0.9992177486419678
intracranial I-Disease 1 0.9984581470489502
retinoblastoma I-Disease 1 0.9947190284729004
. O 0 0.053080763667821884

The O 0 0.04983029514551163
RB1 O 1 0.9947890043258667
gene O 1 0.9955652356147766
mutation O 1 0.9953399896621704
was O 0 0.01147743221372366
investigated O 0 0.018776684999465942
in O 0 0.006250498816370964
a O 0 0.011310734786093235
child O 0 0.2629736363887787
with O 0 0.06881193071603775
ectopic B-Disease 1 0.9995429515838623
intracranial I-Disease 1 0.9991414546966553
retinoblastoma I-Disease 1 0.9978153705596924
using O 0 0.02876182459294796
DNA O 1 0.8775062561035156
obtained O 0 0.012243708595633507
from O 0 0.005886170081794262
both O 0 0.005142728332430124
the O 0 0.007959811016917229
pineal B-Disease 1 0.9904980063438416
and I-Disease 0 0.020761538296937943
retinal I-Disease 1 0.9991462230682373
tumours I-Disease 1 0.9980732202529907
of O 0 0.013497988693416119
the O 0 0.016955574974417686
patient O 1 0.974758505821228
. O 0 0.031942788511514664

A O 0 0.04166541248559952
nonsense O 0 0.23211437463760376
mutation O 1 0.9883530735969543
in O 0 0.016530107706785202
exon O 0 0.4557485580444336
17 O 0 0.027239341288805008
( O 0 0.018922753632068634
codon O 1 0.7483084201812744
556 O 0 0.13468311727046967
) O 0 0.009446216747164726
of O 0 0.005312913563102484
the O 0 0.009846579283475876
RB1 O 1 0.9983687996864319
gene O 1 0.990889847278595
was O 0 0.005307986866682768
found O 0 0.0054292501881718636
to O 0 0.003131269011646509
be O 0 0.0030190444085747004
present O 0 0.006766574457287788
homozygously O 0 0.33844590187072754
in O 0 0.005088146310299635
both O 0 0.005540051963180304
the O 0 0.008853286504745483
retinal B-Disease 1 0.9948791265487671
and I-Disease 0 0.011384247802197933
the I-Disease 0 0.0208366010338068
pineal I-Disease 1 0.9956299066543579
tumours I-Disease 1 0.9973681569099426
. O 0 0.05169757083058357

The O 0 0.016345219686627388
same O 0 0.01892523653805256
mutation O 1 0.9891379475593567
was O 0 0.0078306058421731
present O 0 0.00857619196176529
heterozygously O 0 0.22080977261066437
in O 0 0.004711823537945747
the O 0 0.0048483582213521
DNA O 0 0.41850563883781433
from O 0 0.0043872869573533535
the O 0 0.00354609708301723
constitutional O 0 0.011761713773012161
cells O 1 0.9050990343093872
of O 0 0.0044446708634495735
the O 0 0.005707498174160719
patient O 1 0.9482027888298035
, O 0 0.005840957630425692
proving O 0 0.013876836746931076
it O 0 0.003047082806006074
to O 0 0.0031323139555752277
be O 0 0.003449845826253295
of O 0 0.0075770653784275055
germline O 1 0.9932577610015869
origin O 0 0.0411439910531044
. O 0 0.025166213512420654

The O 0 0.02068089134991169
initial O 0 0.07105834037065506
mutation O 1 0.9933180809020996
was O 0 0.008673976175487041
shown O 0 0.00965143833309412
to O 0 0.003763292683288455
have O 0 0.004585319198668003
occurred O 0 0.011519763618707657
in O 0 0.005965461488813162
the O 0 0.01016443595290184
paternally O 1 0.9766591191291809
derived O 1 0.8740189075469971
RB1 O 1 0.9949949979782104
allele O 1 0.9845818877220154
. O 0 0.039911575615406036

The O 0 0.02767426148056984
mutation O 1 0.9901037812232971
is O 0 0.006697448901832104
in O 0 0.0041063809767365456
an O 0 0.003436719998717308
area O 0 0.0039012362249195576
of O 0 0.003029773011803627
the O 0 0.005477289669215679
gene O 1 0.9781576991081238
that O 0 0.0068052071146667
encodes O 0 0.4992072284221649
the O 0 0.009611743502318859
protein O 1 0.9860593676567078
- O 0 0.23450784385204315
binding O 0 0.1331748515367508
region O 0 0.009718484245240688
known O 0 0.007209163159132004
as O 0 0.003106743795797229
the O 0 0.003500893944874406
pocket O 0 0.0772978737950325
region O 0 0.006861506495624781
and O 0 0.0030927015468478203
has O 0 0.00379379210062325
been O 0 0.004354239907115698
detected O 0 0.20349615812301636
in O 0 0.0040086484514176846
other O 0 0.004499075468629599
cases O 0 0.02194982022047043
of O 0 0.009672855958342552
retinoblastoma B-Disease 1 0.9961901903152466
. O 0 0.015579814091324806
. O 0 0.02145567163825035

Low O 0 0.058437615633010864
levels O 0 0.03446570783853531
of O 0 0.01137319765985012
beta O 0 0.4755876064300537
hexosaminidase O 0 0.43472233414649963
A O 0 0.013839853927493095
in O 0 0.009648812934756279
healthy O 1 0.7542912364006042
individuals O 0 0.017997262999415398
with O 0 0.012154679745435715
apparent O 1 0.952147364616394
deficiency O 1 0.9994211196899414
of O 0 0.010107018053531647
this O 0 0.013780788518488407
enzyme O 1 0.9753289222717285
. O 0 0.02863355167210102

Appreciable O 1 0.6874284148216248
beta O 1 0.5183848142623901
hexosaminidase O 0 0.4338633716106415
A O 0 0.02167164534330368
( O 0 0.01560510229319334
hex O 0 0.043677471578121185
A O 0 0.014292845502495766
) O 0 0.00962412916123867
activity O 0 0.009724617004394531
has O 0 0.004780423827469349
been O 0 0.005910884123295546
detected O 0 0.369893878698349
in O 0 0.01257124450057745
cultured O 1 0.9948425889015198
skin O 1 0.9995148181915283
fibroblasts O 1 0.9981460571289062
and O 0 0.24266766011714935
melanoma B-Disease 1 0.9998729228973389
tissue O 1 0.9982889294624329
from O 0 0.018239768221974373
healthy O 1 0.9648306369781494
individuals O 0 0.01586778834462166
previously O 0 0.008258262649178505
reported O 0 0.009420364163815975
as O 0 0.0053531331941485405
having O 0 0.019509563222527504
deficiency B-Disease 1 0.9993983507156372
of I-Disease 0 0.007204134948551655
hex I-Disease 0 0.12715721130371094
A I-Disease 0 0.014505814760923386
activity O 0 0.019084757193922997
indistinguishable O 0 0.05239620804786682
from O 0 0.0063597033731639385
that O 0 0.005122732371091843
of O 0 0.008727334439754486
patients O 1 0.9965798258781433
with O 0 0.2938733398914337
Tay B-Disease 1 0.9994916915893555
- I-Disease 1 0.9956718683242798
Sachs I-Disease 1 0.9984620809555054
disease I-Disease 1 0.9996504783630371
( O 0 0.2566215395927429
TSD B-Disease 1 0.9879712462425232
) O 0 0.03354040905833244
. O 0 0.022022118791937828

Identification O 0 0.046006765216588974
and O 0 0.01466370839625597
quantitation O 0 0.31480103731155396
of O 0 0.010957003571093082
hex O 0 0.043252915143966675
A O 0 0.014151794835925102
, O 0 0.006632115226238966
amounting O 0 0.017811594530940056
to O 0 0.007608292158693075
3 O 0 0.019577747210860252
. O 0 0.018627282232046127

5 O 0 0.04731638729572296
% O 0 0.037169039249420166
- O 0 0.05585499480366707
6 O 0 0.03716794773936272
. O 0 0.03130219504237175

9 O 0 0.02825034223496914
% O 0 0.01355058141052723
of O 0 0.0062827058136463165
total O 0 0.01101504173129797
beta O 1 0.6444206833839417
hexosaminidase O 1 0.7217360138893127
activity O 0 0.020555773749947548
, O 0 0.005168721079826355
has O 0 0.0043424577452242374
been O 0 0.004890990909188986
obtained O 0 0.010614454746246338
by O 0 0.012453833594918251
cellulose O 1 0.9734116792678833
acetate O 1 0.9841533303260803
gel O 1 0.9894970655441284
electrophoresis O 1 0.9790177941322327
, O 0 0.024778427556157112
DEAE O 1 0.9371780157089233
- O 1 0.6918903589248657
cellulose O 1 0.983465313911438
ion O 1 0.8254400491714478
- O 0 0.13996849954128265
exchange O 0 0.029691651463508606
chromatography O 1 0.7830001711845398
, O 0 0.018267955631017685
radial O 1 0.9702028036117554
immunodiffusion O 1 0.7706338167190552
, O 0 0.01434874627739191
and O 0 0.012701068073511124
radioimmunoassay O 1 0.5220284461975098
. O 0 0.026029283180832863

Previous O 0 0.03310134634375572
family O 0 0.03061353601515293
studies O 0 0.021958904340863228
suggested O 0 0.010103563778102398
that O 0 0.003431560005992651
these O 0 0.0037380754947662354
individuals O 0 0.007945101708173752
may O 0 0.006277391221374273
be O 0 0.003746401285752654
compound O 0 0.039911892265081406
heterozygotes O 1 0.9133015275001526
for O 0 0.00614917604252696
the O 0 0.0069132172502577305
common O 0 0.18500261008739471
mutant O 1 0.9956568479537964
TSD B-Disease 1 0.9980923533439636
gene O 1 0.9919154047966003
and O 0 0.008563968352973461
a O 0 0.014425748027861118
rare O 0 0.15129975974559784
( O 0 0.02361237443983555
allelic O 1 0.9837032556533813
) O 0 0.044942282140254974
mutant O 1 0.9899492263793945
gene O 1 0.9907767176628113
. O 0 0.03844383731484413

Thus O 0 0.02823040448129177
, O 0 0.008829726837575436
the O 0 0.008093872107565403
postulated O 0 0.39426857233047485
rate O 0 0.1891467422246933
mutant O 1 0.9941701889038086
gene O 1 0.9914702773094177
appears O 0 0.019941257312893867
to O 0 0.0044497353956103325
code O 0 0.009791973978281021
for O 0 0.0036909254267811775
the O 0 0.0035916087217628956
expression O 0 0.01774950511753559
of O 0 0.004525025840848684
low O 0 0.015377097763121128
amounts O 0 0.014611274935305119
of O 0 0.007135788910090923
hex O 0 0.09132348001003265
A O 0 0.023031797260046005
. O 0 0.02259202115237713

Heterozygotes O 1 0.7071832418441772
for O 0 0.015666501596570015
the O 0 0.011433672159910202
rare O 0 0.1125352680683136
mutant O 1 0.9377676248550415
may O 0 0.014050673693418503
be O 0 0.006318081170320511
indistinguishable O 0 0.11286351084709167
from O 0 0.010683747939765453
heterozygotes O 1 0.826992928981781
for O 0 0.0086476756259799
the O 0 0.01181202381849289
common O 0 0.3003064692020416
TSD B-Disease 1 0.9929632544517517
mutant O 1 0.9684887528419495
. O 0 0.04886739328503609

However O 0 0.019984526559710503
, O 0 0.009679144248366356
direct O 0 0.016872478649020195
visualization O 0 0.0670376792550087
and O 0 0.007295677904039621
quantitation O 1 0.5362800359725952
of O 0 0.00711749168112874
hex O 0 0.0379970408976078
A O 0 0.009216203354299068
by O 0 0.005346338730305433
the O 0 0.004781921859830618
methods O 0 0.014997015707194805
described O 0 0.01437463704496622
may O 0 0.013800464570522308
prevent O 0 0.29245543479919434
false O 0 0.05453305318951607
- O 1 0.5914126634597778
positive O 1 0.9013087749481201
prenatal O 1 0.9994267225265503
diagnosis O 1 0.9981624484062195
of O 0 0.014729279093444347
TSD B-Disease 1 0.9943601489067078
in O 0 0.01316774170845747
fetuses O 1 0.9729984402656555
having O 0 0.011314629577100277
the O 0 0.006550022400915623
incomplete O 0 0.024332983419299126
hex B-Disease 0 0.28541526198387146
A I-Disease 0 0.06713081151247025
deficiency I-Disease 1 0.9992634654045105
of O 0 0.005409162025898695
the O 0 0.0056556155905127525
type O 0 0.17521509528160095
described O 0 0.010282311588525772
in O 0 0.005000568460673094
the O 0 0.005859174765646458
four O 0 0.012584853917360306
healthy O 1 0.9084540009498596
individuals O 0 0.10262424498796463

The O 0 0.0790732130408287
tumor B-Disease 1 0.9986887574195862
suppressor O 1 0.9968042373657227
gene O 1 0.9955573678016663
Smad4 O 1 0.9765609502792358
/ O 1 0.5278610587120056
Dpc4 O 0 0.40758830308914185
is O 0 0.009063559584319592
required O 0 0.00916366744786501
for O 0 0.00678664306178689
gastrulation O 1 0.7625440359115601
and O 0 0.005300698336213827
later O 0 0.006585122086107731
for O 0 0.007052636705338955
anterior O 1 0.972647488117218
development O 0 0.013942311517894268
of O 0 0.006598689127713442
the O 0 0.013153886422514915
mouse O 1 0.9918644428253174
embryo O 1 0.986335277557373
. O 0 0.03760441020131111

Mutations O 1 0.9742133021354675
in O 0 0.020712032914161682
the O 0 0.019636275246739388
SMAD4 O 1 0.9730322957038879
/ O 1 0.9690002202987671
DPC4 O 1 0.9938510656356812
tumor B-Disease 1 0.999502420425415
suppressor O 1 0.9981940388679504
gene O 1 0.9903509020805359
, O 0 0.009087436832487583
a O 0 0.008288074284791946
key O 0 0.012016105465590954
signal O 0 0.0252407006919384
transducer O 0 0.26883721351623535
in O 0 0.006593974772840738
most O 0 0.00860048271715641
TGFbeta O 1 0.9778289794921875
- O 1 0.5878411531448364
related O 0 0.4820460081100464
pathways O 1 0.9789053201675415
, O 0 0.005172127857804298
are O 0 0.003429408185184002
involved O 0 0.0069590783677995205
in O 0 0.0043079061433672905
50 O 0 0.008328953757882118
% O 0 0.013136988505721092
of O 0 0.018570153042674065
pancreatic B-Disease 1 0.9997040629386902
cancers I-Disease 1 0.9992576241493225
. O 0 0.04566006362438202

Homozygous O 1 0.970027506351471
Smad4 O 1 0.972276508808136
mutant O 1 0.991908848285675
mice O 1 0.9937571287155151
die O 0 0.45614728331565857
before O 0 0.01842799223959446
day O 0 0.0180202629417181
7 O 0 0.028289688751101494
. O 0 0.02187321148812771

5 O 0 0.05513453483581543
of O 0 0.028598785400390625
embryogenesis O 1 0.7622696161270142
. O 0 0.043774913996458054

Mutant O 1 0.9419118762016296
embryos O 0 0.46233031153678894
have O 0 0.01213716622442007
reduced O 0 0.025240583345294
size O 0 0.014705698005855083
, O 0 0.007320715580135584
fail O 0 0.026597056537866592
to O 0 0.006817798130214214
gastrulate O 0 0.3033672869205475
or O 0 0.01095090713351965
express O 0 0.01535383053123951
a O 0 0.013130536302924156
mesodermal O 1 0.9874103665351868
marker O 0 0.25141099095344543
, O 0 0.0063506849110126495
and O 0 0.006268937140703201
show O 0 0.01887296698987484
abnormal O 1 0.9941664934158325
visceral O 1 0.9795624017715454
endoderm O 1 0.980927586555481
development O 0 0.05125385895371437
. O 0 0.03348691016435623

Growth B-Disease 1 0.6149277687072754
retardation I-Disease 1 0.962451159954071
of O 0 0.012459664605557919
the O 0 0.01404421404004097
Smad4 O 1 0.9691165685653687
- O 1 0.8376708030700684
deficient O 1 0.9899595975875854
embryos O 1 0.8706983923912048
results O 0 0.0269329696893692
from O 0 0.0124539565294981
reduced O 0 0.2443789392709732
cell O 1 0.9830668568611145
proliferation O 1 0.7245873212814331
rather O 0 0.01750434935092926
than O 0 0.013567043468356133
increased O 0 0.06932825595140457
apoptosis O 1 0.9887564778327942
. O 0 0.03376292437314987

Aggregation O 0 0.24913838505744934
of O 0 0.027325443923473358
mutant O 1 0.9791488647460938
Smad4 O 1 0.9765368700027466
ES O 1 0.9586743712425232
cells O 1 0.9758467674255371
with O 0 0.016947580501437187
wild O 0 0.25977087020874023
- O 1 0.5779072642326355
type O 1 0.7779028415679932
tetraploid O 1 0.9791325926780701
morulae O 1 0.9050962924957275
rescues O 1 0.658413290977478
the O 0 0.030557673424482346
gastrulation B-Disease 1 0.9864744544029236
defect I-Disease 1 0.9798675775527954
. O 0 0.04330013692378998

These O 0 0.015388472937047482
results O 0 0.016808215528726578
indicate O 0 0.014425314031541348
that O 0 0.005798269994556904
Smad4 O 0 0.4054063558578491
is O 0 0.004888745490461588
initially O 0 0.00546319829300046
required O 0 0.00474139116704464
for O 0 0.002616182202473283
the O 0 0.003509156173095107
differentiation O 1 0.6946041584014893
of O 0 0.0042816163040697575
the O 0 0.006630997639149427
visceral O 1 0.967810869216919
endoderm O 1 0.9586789011955261
and O 0 0.005835350137203932
that O 0 0.004349376540631056
the O 0 0.007442861795425415
gastrulation B-Disease 1 0.9935073852539062
defect I-Disease 1 0.9873368144035339
in O 0 0.007401623297482729
the O 0 0.007482539396733046
epiblast O 1 0.9817078113555908
is O 0 0.008862998336553574
secondary O 0 0.021464725956320763
and O 0 0.0066413735039532185
non O 0 0.04154208302497864
- O 1 0.5723574161529541
cell O 1 0.9471079707145691
autonomous O 0 0.041896890848875046
. O 0 0.02277432568371296

Rescued O 0 0.12406560033559799
embryos O 1 0.6021304130554199
show O 0 0.049451012164354324
severe O 1 0.9805095195770264
anterior O 1 0.9896283149719238
truncations O 1 0.8845252990722656
, O 0 0.009517243131995201
indicating O 0 0.01805104874074459
a O 0 0.008110415190458298
second O 0 0.007250761613249779
important O 0 0.006659426260739565
role O 0 0.013073933310806751
for O 0 0.008723003789782524
Smad4 O 1 0.7685382962226868
in O 0 0.01806948520243168
anterior O 1 0.9947185516357422
patterning O 1 0.9875883460044861
during O 0 0.0522720143198967
embryogenesis O 1 0.9663065671920776
. O 0 0.0423257015645504

Prevalence O 1 0.9478256702423096
of O 0 0.032614901661872864
p16 O 1 0.953072726726532
and O 0 0.030679689720273018
CDK4 O 1 0.9794753789901733
germline O 1 0.9970490336418152
mutations O 1 0.9953924417495728
in O 0 0.024745823815464973
48 O 1 0.5694341063499451
melanoma B-Disease 1 0.9996399879455566
- O 1 0.861375093460083
prone O 1 0.8206841349601746
families O 0 0.02498149313032627
in O 0 0.011811567470431328
France O 0 0.02452109009027481
. O 0 0.019999928772449493

The O 0 0.0403725691139698
French O 1 0.6010154485702515
Familial B-Disease 1 0.9989078044891357
Melanoma I-Disease 1 0.999480664730072
Study O 0 0.19499406218528748
Group O 0 0.04516191408038139
. O 0 0.0345182940363884

Germline O 1 0.9893675446510315
mutations O 1 0.9804401993751526
in O 0 0.016100246459245682
the O 0 0.01365660410374403
p16 O 1 0.9750366806983948
and O 0 0.01223936676979065
CDK4 O 1 0.9636604189872742
genes O 1 0.9734922647476196
have O 0 0.0054921964183449745
been O 0 0.004278226755559444
reported O 0 0.006491887848824263
in O 0 0.0040133036673069
a O 0 0.007459125481545925
subset O 0 0.3852391242980957
of O 0 0.015182957984507084
melanoma B-Disease 1 0.9997772574424744
pedigrees O 1 0.9432491660118103
, O 0 0.005815387703478336
but O 0 0.004272457677870989
their O 0 0.006374068092554808
prevalence O 1 0.9945672750473022
is O 0 0.005513690412044525
not O 0 0.004277585074305534
well O 0 0.00641124090179801
known O 0 0.015794506296515465
. O 0 0.01849895901978016

We O 0 0.013369204476475716
searched O 0 0.020401794463396072
for O 0 0.009653636254370213
such O 0 0.014127355068922043
germline O 1 0.9976946711540222
mutations O 1 0.9971576929092407
in O 0 0.012752474285662174
48 O 0 0.03644350543618202
French O 1 0.6694240570068359
melanoma B-Disease 1 0.9997690320014954
- O 1 0.8611754775047302
prone O 1 0.817720890045166
families O 0 0.011595229618251324
selected O 0 0.006000429391860962
according O 0 0.004644239321351051
to O 0 0.002797449007630348
two O 0 0.003371218917891383
major O 0 0.00618526479229331
criteria O 0 0.009713593870401382
families O 0 0.007197609171271324
with O 0 0.0036452976055443287
at O 0 0.0036611733958125114
least O 0 0.0056258006952703
three O 0 0.004206059034913778
affected O 0 0.019458986818790436
members O 0 0.0070281620137393475
( O 0 0.01066342182457447
n O 0 0.040423180907964706
= O 0 0.0412711575627327
20 O 0 0.0069893538020551205
) O 0 0.005319446790963411
or O 0 0.004468486178666353
families O 0 0.005113869905471802
with O 0 0.003293644404038787
two O 0 0.0031284247525036335
affected O 0 0.013687861151993275
members O 0 0.003222101368010044
, O 0 0.002303511369973421
one O 0 0.0019285714952275157
of O 0 0.0020016618072986603
them O 0 0.0029251386877149343
affected O 0 0.014419300481677055
before O 0 0.003654025960713625
the O 0 0.0028901633340865374
age O 0 0.006715656258165836
of O 0 0.0038848454132676125
50 O 0 0.009195813909173012
( O 0 0.010975921526551247
n O 0 0.06891144812107086
= O 0 0.058871328830718994
28 O 0 0.009363518096506596
) O 0 0.005494824144989252
, O 0 0.0028395215049386024
and O 0 0.0026774879079312086
one O 0 0.004748592618852854
additional O 0 0.011944035068154335
minor O 0 0.10315294563770294
criterion O 0 0.15980589389801025
. O 0 0.02175929956138134

Sixteen O 0 0.06479637324810028
different O 0 0.04404383897781372
p16 O 1 0.9918934106826782
germline O 1 0.9975109100341797
mutations O 1 0.9914095997810364
were O 0 0.007566283922642469
found O 0 0.010351241566240788
in O 0 0.005649066064506769
21 O 0 0.009644768200814724
families O 0 0.009880946949124336
, O 0 0.004845248535275459
while O 0 0.006236711982637644
one O 0 0.009838203899562359
germline O 1 0.9988157749176025
mutation O 1 0.9988825917243958
, O 0 0.013253841549158096
Arg24His O 1 0.7992935180664062
, O 0 0.0067980787716805935
was O 0 0.007511618547141552
detected O 0 0.11157343536615372
in O 0 0.008618571795523167
the O 0 0.013677147217094898
CDK4 O 1 0.9654721617698669
gene O 1 0.9886577725410461
. O 0 0.037972163408994675

The O 0 0.020292527973651886
frequency O 0 0.04476838931441307
of O 0 0.01696423999965191
p16 O 1 0.9954688549041748
gene O 1 0.9972448348999023
mutation O 1 0.9924673438072205
in O 0 0.007831567898392677
our O 0 0.007135785184800625
sample O 0 0.016805026680231094
( O 0 0.008644957095384598
44 O 0 0.009950388222932816
% O 0 0.008911888115108013
) O 0 0.005262978374958038
is O 0 0.002861528657376766
among O 0 0.00354019645601511
the O 0 0.0030726753175258636
highest O 0 0.006711942609399557
rates O 0 0.016706645488739014
yet O 0 0.006881518755108118
reported O 0 0.008183984085917473
and O 0 0.004033431876450777
the O 0 0.0064583937637507915
CDK4 O 1 0.9831748604774475
mutation O 1 0.9975905418395996
is O 0 0.007805247325450182
the O 0 0.005994104780256748
second O 0 0.01785212941467762
mutation O 1 0.9990049004554749
detected O 1 0.778948187828064
in O 0 0.01039342861622572
this O 0 0.012070565484464169
gene O 1 0.9898555278778076
worldwide O 0 0.09645691514015198
. O 0 0.03129689767956734

In O 0 0.019304674118757248
summary O 0 0.026643050834536552
, O 0 0.006013249512761831
our O 0 0.00591162359341979
results O 0 0.012311282567679882
show O 0 0.008719953708350658
frequent O 0 0.023375211283564568
involvement O 0 0.017740759998559952
of O 0 0.005685235373675823
the O 0 0.012606730684638023
p16 O 1 0.9976671934127808
gene O 1 0.9978103041648865
in O 0 0.11012417823076248
familial B-Disease 1 0.9996405839920044
melanoma I-Disease 1 0.9996999502182007
and O 0 0.007590103894472122
confirm O 0 0.011349579319357872
the O 0 0.00439127953723073
role O 0 0.00858338363468647
of O 0 0.004315114114433527
the O 0 0.008302439004182816
CDK4 O 1 0.9771971106529236
gene O 1 0.992608368396759
as O 0 0.015242993831634521
a O 0 0.19677555561065674
melanoma B-Disease 1 0.9997838139533997
- O 1 0.9882705211639404
predisposing O 1 0.9984109401702881
gene O 1 0.9938806295394897
. O 0 0.02077852375805378
. O 0 0.024939313530921936

Progression O 1 0.927359938621521
of O 0 0.02961132861673832
somatic O 1 0.9790552258491516
CTG O 1 0.9384186863899231
repeat O 0 0.29022911190986633
length O 0 0.04608907178044319
heterogeneity O 1 0.5784991383552551
in O 0 0.010497241280972958
the O 0 0.01321821752935648
blood O 1 0.9950998425483704
cells O 1 0.9967373013496399
of O 0 0.3061380684375763
myotonic B-Disease 1 0.9996908903121948
dystrophy I-Disease 1 0.9997815489768982
patients O 1 0.9964743256568909
. O 0 0.05252217873930931

The O 0 0.02762187458574772
genetic O 1 0.9527592658996582
basis O 0 0.027051376178860664
of O 0 0.027693530544638634
myotonic B-Disease 1 0.9995846152305603
dystrophy I-Disease 1 0.9997643828392029
( O 0 0.33395543694496155
DM B-Disease 1 0.9969642758369446
) O 0 0.013130893930792809
is O 0 0.004658593330532312
the O 0 0.0038696001283824444
expansion O 0 0.008829285390675068
of O 0 0.004078893922269344
an O 0 0.007467701565474272
unstable O 1 0.9462596774101257
CTG O 1 0.9746310114860535
repeat O 0 0.11839322000741959
in O 0 0.006178225390613079
the O 0 0.006195080000907183
34 O 0 0.017394106835126877
UTR O 0 0.3965362310409546
of O 0 0.009758813306689262
the O 0 0.017172837629914284
DM B-Disease 1 0.9981289505958557
protein O 1 0.9967959523200989
kinase O 1 0.9955075979232788
gene O 1 0.9876576662063599
on O 0 0.024920836091041565
chromosome O 1 0.9875555634498596
19 O 0 0.040751971304416656
. O 0 0.025176383554935455

One O 0 0.010626109316945076
of O 0 0.004819007124751806
the O 0 0.005139060318470001
principal O 0 0.008867239579558372
features O 0 0.008377252146601677
of O 0 0.005132296588271856
the O 0 0.01061142049729824
DM B-Disease 1 0.9990063309669495
mutation O 1 0.9986924529075623
is O 0 0.007593052927404642
an O 0 0.006206975318491459
extraordinarily O 0 0.030416127294301987
high O 0 0.009301682002842426
level O 0 0.009709040634334087
of O 0 0.00752695556730032
somatic O 1 0.9954758286476135
mosaicism O 1 0.9947262406349182
, O 0 0.007346431724727154
due O 0 0.007148147094994783
to O 0 0.002770362189039588
an O 0 0.003779978957027197
extremely O 0 0.009809507057070732
high O 0 0.008157877251505852
degree O 0 0.01085506659001112
of O 0 0.005532899871468544
somatic O 1 0.9941731095314026
instability O 1 0.7691690325737
both O 0 0.005812600255012512
within O 0 0.005882161669433117
and O 0 0.004285386763513088
between O 0 0.00886883120983839
different O 0 0.01495512668043375
tissues O 1 0.9845861196517944
. O 0 0.027931472286581993

This O 0 0.020916884765028954
instability O 0 0.409161239862442
appears O 0 0.016616662964224815
to O 0 0.004502503201365471
be O 0 0.0032930823508650064
biased O 0 0.013301094062626362
towards O 0 0.006687298882752657
further O 0 0.00504148518666625
expansion O 0 0.008838454261422157
and O 0 0.0030017958488315344
continuous O 0 0.010587982833385468
throughout O 0 0.00405815988779068
the O 0 0.0026648903731256723
life O 0 0.0053481897339224815
of O 0 0.002593991346657276
an O 0 0.003289226908236742
individual O 0 0.006897401064634323
, O 0 0.0030576596036553383
features O 0 0.004758053459227085
that O 0 0.002320264233276248
could O 0 0.0033479086123406887
be O 0 0.0027201673947274685
associated O 0 0.007577979937195778
with O 0 0.003639406757429242
the O 0 0.004280238412320614
progressive O 0 0.10941235721111298
nature O 0 0.014748888090252876
of O 0 0.006618946325033903
the O 0 0.016447465866804123
disease O 1 0.9988964796066284
. O 0 0.03642063960433006

Although O 0 0.030850011855363846
increasing O 0 0.035622257739305496
measured O 0 0.043078258633613586
allele O 1 0.9830371737480164
size O 0 0.02401631698012352
between O 0 0.016969870775938034
patients O 1 0.9862877130508423
clearly O 0 0.017029136419296265
correlates O 0 0.4593956470489502
with O 0 0.008077159523963928
an O 0 0.006708846893161535
increased O 0 0.04028959199786186
severity O 1 0.9605869650840759
of O 0 0.008799023926258087
symptoms O 1 0.998145341873169
and O 0 0.004442677367478609
an O 0 0.004104933701455593
earlier O 0 0.006494303233921528
age O 0 0.010636703111231327
of O 0 0.006054894998669624
onset O 1 0.9977200627326965
, O 0 0.005736944265663624
this O 0 0.00455778744071722
correlation O 1 0.529979407787323
is O 0 0.004030663054436445
not O 0 0.0028192298486828804
precise O 0 0.010836957022547722
and O 0 0.004036553204059601
measured O 0 0.02377469092607498
allele O 1 0.9876155257225037
length O 0 0.016986630856990814
cannot O 0 0.006181830074638128
be O 0 0.0028045172803103924
used O 0 0.0038086671847850084
as O 0 0.0034247017465531826
an O 0 0.004454988054931164
accurate O 0 0.01639149710536003
predictor O 1 0.8528382182121277
of O 0 0.0068841781467199326
age O 0 0.017904946580529213
of O 0 0.013457939960062504
onset O 1 0.9969727993011475
. O 0 0.03083021007478237

In O 0 0.013879969716072083
order O 0 0.009967436082661152
to O 0 0.005133080296218395
further O 0 0.008144168183207512
characterize O 0 0.03381102532148361
the O 0 0.00788415502756834
dynamics O 0 0.15663419663906097
of O 0 0.01334052812308073
DM B-Disease 1 0.9972807168960571
CTG O 1 0.9890796542167664
repeat O 1 0.9595304727554321
somatic O 1 0.9951240420341492
instability O 1 0.7935900092124939
, O 0 0.005399421788752079
we O 0 0.0032782461494207382
have O 0 0.003727189963683486
studied O 0 0.009740307927131653
repeat O 0 0.10489095002412796
length O 0 0.016439978033304214
changes O 0 0.011218094266951084
over O 0 0.0057158819399774075
time O 0 0.007998824119567871
in O 0 0.012997427023947239
111 O 1 0.9220608472824097
myotonic B-Disease 1 0.999796450138092
dystrophy I-Disease 1 0.999897837638855
patients O 1 0.997153639793396
with O 0 0.022800186648964882
varying O 0 0.43945974111557007
clinical O 1 0.9963610768318176
severity O 1 0.9801038503646851
and O 0 0.011636793613433838
CTG O 1 0.9718114137649536
repeat O 0 0.1818154752254486
size O 0 0.013716441579163074
over O 0 0.006423953454941511
time O 0 0.006287035532295704
intervals O 0 0.017804672941565514
of O 0 0.005508751142770052
1 O 0 0.012282625772058964
- O 0 0.047087084501981735
7 O 0 0.017275873571634293
years O 0 0.015488059259951115
. O 0 0.019461987540125847

We O 0 0.011651165783405304
have O 0 0.005876035895198584
found O 0 0.008448697626590729
a O 0 0.00809277780354023
direct O 0 0.016653886064887047
progression O 1 0.927901566028595
of O 0 0.0049950843676924706
the O 0 0.005114859435707331
size O 0 0.013975566253066063
heterogeneity O 1 0.6308834552764893
over O 0 0.005782189778983593
time O 0 0.005850004963576794
related O 0 0.012698257341980934
to O 0 0.005399575922638178
initial O 0 0.02585768699645996
CTG O 1 0.9448416233062744
repeat O 0 0.11129455268383026
size O 0 0.011821601539850235
and O 0 0.003414151258766651
the O 0 0.003410400589928031
time O 0 0.004841277375817299
interval O 0 0.01847510226070881
and O 0 0.0036601386964321136
always O 0 0.005823569372296333
biased O 0 0.016039853915572166
towards O 0 0.010186942294239998
further O 0 0.013296088203787804
expansion O 0 0.030304089188575745
. O 0 0.020528942346572876

Attempts O 0 0.03952733799815178
to O 0 0.010632835328578949
mathematically O 0 0.027949823066592216
model O 0 0.015441492199897766
the O 0 0.005582015961408615
dynamics O 0 0.04031642898917198
have O 0 0.00450084637850523
proved O 0 0.009674674831330776
only O 0 0.004023846238851547
partially O 0 0.025139791890978813
successful O 0 0.013431653380393982
suggesting O 0 0.01519935205578804
that O 0 0.005162335466593504
individual O 0 0.011413952335715294
specific O 0 0.028676442801952362
genetic O 1 0.9937025308609009
and O 0 0.0078095607459545135
/ O 0 0.49649593234062195
or O 0 0.010364535264670849
environmental O 0 0.019508294761180878
factors O 0 0.02673831768333912
also O 0 0.004162139259278774
play O 0 0.005466261878609657
a O 0 0.007449656259268522
role O 0 0.014700103551149368
in O 0 0.011665687896311283
somatic O 1 0.9952738881111145
mosaicism O 1 0.9941514134407043
. O 0 0.020489128306508064
. O 0 0.024518854916095734

Aspartylglucosaminuria B-Disease 1 0.5531905293464661
among O 0 0.03710300102829933
Palestinian O 0 0.04440358281135559
Arabs O 0 0.04777056723833084
. O 0 0.02997441403567791

Aspartylglucosaminuria B-Disease 1 0.9499658346176147
( O 0 0.06485982984304428
AGU B-Disease 1 0.9893214702606201
) O 0 0.017822744324803352
is O 0 0.007886601611971855
a O 0 0.013836321420967579
rare O 1 0.6309342384338379
disorder B-Disease 1 0.998364269733429
of I-Disease 0 0.016509894281625748
glycoprotein I-Disease 1 0.9974507689476013
metabolism I-Disease 1 0.9978014826774597
caused O 0 0.3938468098640442
by O 0 0.009205063804984093
the O 0 0.01135653629899025
deficiency B-Disease 1 0.999152660369873
of I-Disease 0 0.009216038510203362
the I-Disease 0 0.016189394518733025
lysosomal I-Disease 1 0.997399091720581
enzyme I-Disease 1 0.9947814345359802
aspartylglucosaminidase I-Disease 1 0.9593881368637085
( O 0 0.03816305845975876
AGA O 1 0.8211244344711304
) O 0 0.026866445317864418
. O 0 0.022364569827914238

AGU B-Disease 1 0.9676299095153809
is O 0 0.031301625072956085
inherited O 1 0.7817557454109192
as O 0 0.015617317520081997
an O 0 0.06945138424634933
autosomal O 1 0.9998865127563477
recessive O 1 0.9997186064720154
trait O 1 0.9910829067230225
and O 0 0.009420573711395264
occurs O 0 0.13050659000873566
with O 0 0.006107030902057886
a O 0 0.006332713179290295
high O 0 0.008561604656279087
frequency O 0 0.02139565721154213
in O 0 0.005316803231835365
Finland O 0 0.010529260151088238
because O 0 0.007293799426406622
of O 0 0.005077299661934376
a O 0 0.013365392573177814
founder O 0 0.042728740721940994
effect O 0 0.0513409785926342
. O 0 0.022673791274428368

While O 0 0.021430479362607002
very O 0 0.015015085227787495
few O 0 0.014181667938828468
patients O 1 0.981157124042511
with O 0 0.015838878229260445
AGU B-Disease 1 0.9927565455436707
have O 0 0.006173351779580116
been O 0 0.0050561921671032906
reported O 0 0.00930423941463232
from O 0 0.005753681994974613
non O 0 0.016066892072558403
- O 0 0.039487048983573914
Finnish O 0 0.025502486154437065
origin O 0 0.01369568519294262
, O 0 0.005312860012054443
we O 0 0.006412133574485779
diagnosed O 1 0.9987698197364807
the O 0 0.01800401695072651
disorder O 1 0.999476969242096
in O 0 0.008998353965580463
8 O 0 0.03689324110746384
patients O 1 0.9935769438743591
originating O 0 0.14397720992565155
from O 0 0.006946863606572151
3 O 0 0.010365348309278488
unrelated O 0 0.32414573431015015
families O 0 0.009437978267669678
, O 0 0.0035404807422310114
all O 0 0.0027839969843626022
Palestinian O 0 0.008198224939405918
Arabs O 0 0.009930987842381
from O 0 0.0044887252151966095
the O 0 0.004344522021710873
region O 0 0.008491688407957554
of O 0 0.006000284105539322
Jerusalem O 0 0.019361576065421104
. O 0 0.020850511267781258

The O 0 0.031518589705228806
clinical O 1 0.9922775030136108
diagnosis O 1 0.9963207244873047
of O 0 0.015487667173147202
AGU B-Disease 1 0.9958721995353699
is O 0 0.008435658179223537
often O 0 0.0069406949914991856
difficult O 0 0.0078544020652771
, O 0 0.0030327418353408575
in O 0 0.0031181492377072573
particular O 0 0.005088367965072393
early O 0 0.003925850614905357
in O 0 0.002426926512271166
the O 0 0.002390106674283743
course O 0 0.005881079472601414
of O 0 0.002997708972543478
the O 0 0.007079917471855879
disease O 1 0.9995419979095459
, O 0 0.003663217881694436
and O 0 0.002257231855764985
most O 0 0.002864482579752803
of O 0 0.0033653953578323126
the O 0 0.006560592912137508
patients O 1 0.9958310723304749
are O 0 0.01054038479924202
diagnosed O 1 0.9985207915306091
after O 0 0.01042715273797512
the O 0 0.0051771183498203754
age O 0 0.010386898182332516
of O 0 0.005833516363054514
5 O 0 0.013345802202820778
years O 0 0.014385836198925972
. O 0 0.017274891957640648

However O 0 0.018145719543099403
, O 0 0.00832667388021946
since O 0 0.009614690206944942
these O 0 0.008669517002999783
patients O 1 0.9862706661224365
excrete O 1 0.9077330231666565
early O 0 0.01089445874094963
large O 0 0.008813440799713135
amounts O 0 0.0120737599208951
of O 0 0.0056476895697414875
aspartylglucosamine O 1 0.6764469146728516
in O 0 0.009267093613743782
urine O 1 0.9469855427742004
, O 0 0.012223005294799805
biochemical O 1 0.9709294438362122
screening O 0 0.29437747597694397
is O 0 0.007742217276245356
easy O 0 0.014663529582321644
by O 0 0.011541795916855335
urine O 1 0.9446582794189453
chromatography O 1 0.8898767232894897
. O 0 0.01895180344581604
. O 0 0.023491714149713516

Detection O 0 0.21717238426208496
of O 0 0.020059721544384956
heterozygous O 1 0.9419397115707397
carriers O 0 0.13722264766693115
of O 0 0.012821492739021778
the O 0 0.023875057697296143
ataxia B-Disease 1 0.9992189407348633
- I-Disease 1 0.9809650778770447
telangiectasia I-Disease 1 0.9977422952651978
( O 0 0.04258100688457489
ATM O 1 0.6138079166412354
) O 0 0.02872675471007824
gene O 1 0.9773306846618652
by O 0 0.022860608994960785
G2 O 1 0.9910978078842163
phase O 1 0.8379523158073425
chromosomal O 1 0.9973883032798767
radiosensitivity O 1 0.9181786775588989
of O 0 0.023395046591758728
peripheral O 1 0.9961079955101013
blood O 1 0.9968216419219971
lymphocytes O 1 0.9949250221252441
. O 0 0.05091679468750954

In O 0 0.07361568510532379
ataxia B-Disease 1 0.9978906512260437
- I-Disease 1 0.9614073634147644
telangiectasia I-Disease 1 0.9961257576942444
( O 0 0.03621111437678337
A B-Disease 0 0.08175510168075562
- I-Disease 1 0.9435031414031982
T I-Disease 1 0.9973996877670288
) O 0 0.06714630126953125
patients O 1 0.9930981993675232
, O 0 0.009774806909263134
mutations O 1 0.9944814443588257
in O 0 0.006533393636345863
a O 0 0.008570456877350807
single O 0 0.02976807951927185
gene O 1 0.9947763681411743
, O 0 0.007438336033374071
ATM O 0 0.17767804861068726
, O 0 0.006449834909290075
result O 0 0.014368790201842785
in O 0 0.010516752488911152
an O 0 0.2561625838279724
autosomal B-Disease 1 0.9999721050262451
recessive I-Disease 1 0.9999510049819946
syndrome I-Disease 1 0.9998433589935303
that O 0 0.0094480374827981
embraces O 0 0.07197684794664383
a O 0 0.009021284990012646
variety O 0 0.011864391155540943
of O 0 0.006075465586036444
clinical O 1 0.9686711430549622
features O 0 0.012102152220904827
and O 0 0.006957789417356253
manifests O 1 0.5382311344146729
extreme O 0 0.09163739532232285
radiosensitivity O 1 0.5238722562789917
and O 0 0.0065584611147642136
a O 0 0.009107735939323902
strong O 0 0.013328119181096554
pre O 0 0.1878550946712494
- O 0 0.3118937015533447
disposition O 0 0.2877674996852875
to O 0 0.01788337714970112
malignancy B-Disease 1 0.9919191598892212
. O 0 0.033080317080020905

Heterozygotes O 1 0.6887698769569397
for O 0 0.016443924978375435
the O 0 0.013609269633889198
ATM O 1 0.7694609761238098
gene O 1 0.9828544855117798
have O 0 0.007050763349980116
no O 0 0.007990390062332153
clinical O 1 0.8522019982337952
expression O 0 0.041299883276224136
of O 0 0.005213840398937464
A B-Disease 0 0.03563906252384186
- I-Disease 1 0.8254796266555786
T I-Disease 1 0.992633044719696
but O 0 0.009015156887471676
may O 0 0.015250161290168762
be O 0 0.010515374131500721
cancer B-Disease 1 0.9992708563804626
prone O 1 0.8449456691741943
with O 0 0.00846612174063921
a O 0 0.008996637538075447
moderate O 0 0.03022358939051628
increase O 0 0.013015949167311192
in O 0 0.008188962936401367
in O 0 0.013917375355958939
vitro O 1 0.9849165081977844
radiosensitivity O 1 0.9366774559020996
. O 0 0.03419940173625946

We O 0 0.01745540089905262
performed O 0 0.020976802334189415
a O 0 0.01768338494002819
blind O 1 0.5617882609367371
chromosomal O 1 0.9958551526069641
analysis O 0 0.042045723646879196
on O 0 0.014164307154715061
G2 O 1 0.9928635954856873
- O 1 0.5378841757774353
phase O 1 0.7892900705337524
lymphocytes O 1 0.9942177534103394
from O 0 0.014153298921883106
7 O 0 0.020441774278879166
unrelated O 1 0.6008480787277222
A B-Disease 0 0.12658604979515076
- I-Disease 1 0.9474431872367859
T I-Disease 1 0.9965330362319946
patients O 1 0.9905095100402832
, O 0 0.010297195054590702
13 O 0 0.017268847674131393
obligate O 1 0.7947514653205872
A B-Disease 0 0.06596297025680542
- I-Disease 1 0.9077112674713135
T I-Disease 1 0.9958908557891846
heterozygotes O 1 0.9836887121200562
( O 0 0.013651362620294094
parents O 0 0.011293012648820877
of O 0 0.003957539796829224
the O 0 0.005972828716039658
patients O 1 0.9937993884086609
) O 0 0.006672384217381477
, O 0 0.0033910367637872696
and O 0 0.0030509629286825657
14 O 0 0.007176701445132494
normal O 0 0.028358671814203262
controls O 0 0.023225216194987297
following O 0 0.012952866032719612
X O 0 0.42595595121383667
- O 0 0.2119651585817337
irradiation O 1 0.5812351107597351
with O 0 0.010300902649760246
1 O 0 0.012935039587318897
Gy O 1 0.8733706474304199
in O 0 0.007338903844356537
order O 0 0.006644000764936209
to O 0 0.0049424972385168076
evaluate O 0 0.01849042810499668
this O 0 0.006494339555501938
cytogenetic O 1 0.9731989502906799
method O 0 0.016790378838777542
as O 0 0.004771149717271328
a O 0 0.007465779315680265
tool O 0 0.01715848408639431
for O 0 0.0071248579770326614
detection O 0 0.3763088881969452
of O 0 0.01328292116522789
ATM O 1 0.8113553524017334
carriers O 1 0.5217794179916382
. O 0 0.029418881982564926

Both O 0 0.03126748651266098
A B-Disease 0 0.04652890935540199
- I-Disease 1 0.6229029893875122
T I-Disease 1 0.9814016222953796
homozygotes O 1 0.9680206179618835
and O 0 0.01577126979827881
heterozygotes O 1 0.9131998419761658
showed O 0 0.018430355936288834
significantly O 0 0.06992466002702713
increased O 0 0.018257277086377144
levels O 0 0.03007657080888748
of O 0 0.011370453983545303
radiation O 1 0.9959282279014587
- O 1 0.9721199870109558
induced O 1 0.9985899329185486
chromatid O 1 0.9964845180511475
damage O 1 0.6220381855964661
relative O 0 0.016741491854190826
to O 0 0.004810046870261431
that O 0 0.004299079533666372
of O 0 0.005999442655593157
normal O 0 0.08394207060337067
controls O 0 0.04779714345932007
. O 0 0.022858375683426857

These O 0 0.013968891464173794
results O 0 0.015872204676270485
show O 0 0.010434683412313461
that O 0 0.00601736968383193
the O 0 0.009464853443205357
G2 O 1 0.9904841184616089
- O 1 0.650056004524231
phase O 1 0.8221268057823181
chromosomal O 1 0.9984617233276367
radiosensitivity O 1 0.9663211703300476
assay O 1 0.5761157274246216
can O 0 0.00777345011010766
be O 0 0.0031377533450722694
used O 0 0.004660743288695812
for O 0 0.003679487621411681
the O 0 0.005656600464135408
detection O 0 0.22137989103794098
of O 0 0.008257688954472542
A B-Disease 0 0.059595879167318344
- I-Disease 1 0.862175464630127
T I-Disease 1 0.992362380027771
heterozygotes O 1 0.9776495099067688
. O 0 0.03831919655203819

In O 0 0.02179080620408058
combination O 0 0.08574482053518295
with O 0 0.015451543964445591
molecular O 1 0.9918909072875977
genetic O 1 0.995891809463501
analyses O 0 0.07303722947835922
, O 0 0.004730934277176857
this O 0 0.0034114737063646317
test O 0 0.009065101854503155
may O 0 0.004757443908601999
be O 0 0.0018577236915007234
of O 0 0.0018996339058503509
value O 0 0.0034640359226614237
in O 0 0.0033283887896686792
studies O 0 0.01323782466351986
of O 0 0.0059211645275354385
familial B-Disease 1 0.9984220266342163
and I-Disease 0 0.010422050952911377
sporadic I-Disease 1 0.9515905976295471
cancers I-Disease 1 0.9992573857307434
aimed O 0 0.02513701468706131
at O 0 0.006001653149724007
determination O 0 0.007038918789476156
of O 0 0.0028185865376144648
the O 0 0.003924657590687275
potential O 0 0.019582059234380722
involvement O 0 0.02839384227991104
of O 0 0.008832388557493687
ATM O 1 0.980654776096344
mutations O 1 0.9991480112075806
in O 0 0.12268609553575516
tumor B-Disease 1 0.9997327923774719
risk O 1 0.9818296432495117
or O 0 0.014177457429468632
development O 0 0.01708224043250084
. O 0 0.013178260065615177
. O 0 0.01722189597785473

Ataxia B-Disease 1 0.9972314238548279
- I-Disease 1 0.9449379444122314
telangiectasia I-Disease 1 0.9948496222496033
: O 0 0.02179807983338833
identification O 0 0.022010227665305138
and O 0 0.006968795787543058
detection O 0 0.08194060623645782
of O 0 0.006878383923321962
founder O 0 0.0629725232720375
- O 0 0.2765143811702728
effect O 0 0.3694242238998413
mutations O 1 0.9964702129364014
in O 0 0.010028584860265255
the O 0 0.010831335559487343
ATM O 1 0.9137569069862366
gene O 1 0.9874043464660645
in O 0 0.014860179275274277
ethnic O 0 0.031748753041028976
populations O 0 0.41909259557724
. O 0 0.027692506089806557

To O 0 0.013804268091917038
facilitate O 0 0.023335754871368408
the O 0 0.007441839203238487
evaluation O 0 0.01977483555674553
of O 0 0.007781331893056631
ATM O 1 0.6078172922134399
heterozygotes O 1 0.974185049533844
for O 0 0.010371943935751915
susceptibility O 1 0.9939820170402527
to O 0 0.006123997271060944
other O 0 0.009886831045150757
diseases O 1 0.9991903901100159
, O 0 0.006339131388813257
such O 0 0.008719970472157001
as O 0 0.06703519821166992
breast B-Disease 1 0.9999414682388306
cancer I-Disease 1 0.9997459053993225
, O 0 0.005418892949819565
we O 0 0.002953032497316599
have O 0 0.0028306390158832073
attempted O 0 0.008259719237685204
to O 0 0.003240365069359541
define O 0 0.0096915103495121
the O 0 0.0038427296094596386
most O 0 0.005179152823984623
common O 0 0.09248242527246475
mutations O 1 0.9946311712265015
and O 0 0.004983173217624426
their O 0 0.006428915075957775
frequencies O 0 0.07260022312402725
in O 0 0.02495310828089714
ataxia B-Disease 1 0.9996009469032288
- I-Disease 1 0.9889445304870605
telangiectasia I-Disease 1 0.9986698627471924
( O 0 0.03700721263885498
A B-Disease 0 0.08702322840690613
- I-Disease 1 0.8625779747962952
T I-Disease 1 0.9933273792266846
) O 0 0.024655524641275406
homozygotes O 1 0.9152899980545044
from O 0 0.012172623537480831
10 O 0 0.01410746481269598
ethnic O 0 0.025589920580387115
populations O 0 0.22787968814373016
. O 0 0.02626620978116989

Both O 0 0.042719293385744095
genomic O 1 0.9847352504730225
mutations O 1 0.98834627866745
and O 0 0.009305207058787346
their O 0 0.009658541530370712
effects O 0 0.1989871710538864
on O 0 0.010218054056167603
cDNA O 1 0.5471736192703247
were O 0 0.014081224799156189
characterized O 0 0.3961988091468811
. O 0 0.02946876734495163

Protein O 1 0.9558721780776978
- O 0 0.1865464448928833
truncation O 1 0.6319639086723328
testing O 0 0.03299802914261818
of O 0 0.006885045673698187
the O 0 0.007633051369339228
entire O 0 0.026092037558555603
ATM O 0 0.49046263098716736
cDNA O 1 0.8989732265472412
detected O 1 0.55836421251297
92 O 0 0.04016614705324173
( O 0 0.017557699233293533
66 O 0 0.02709040232002735
% O 0 0.01902090385556221
) O 0 0.019796600565314293
truncating O 1 0.9717851877212524
mutations O 1 0.9919493198394775
in O 0 0.015846090391278267
140 O 0 0.04993598535656929
mutant O 1 0.9818068742752075
alleles O 1 0.9892123937606812
screened O 0 0.19428971409797668
. O 0 0.03851555287837982

The O 0 0.02156517095863819
haplotyping O 0 0.3753032684326172
of O 0 0.01213569100946188
patients O 1 0.9749046564102173
with O 0 0.011765927076339722
identical O 1 0.7144817113876343
mutations O 1 0.998881995677948
indicates O 0 0.03612181171774864
that O 0 0.0034097651951014996
almost O 0 0.0037996952887624502
all O 0 0.002008699346333742
of O 0 0.0020183452870696783
these O 0 0.0028351221699267626
represent O 0 0.00581344636157155
common O 0 0.015620463527739048
ancestry O 0 0.04228844493627548
and O 0 0.0036411951296031475
that O 0 0.00396659504622221
very O 0 0.007760411594063044
few O 0 0.011462279595434666
spontaneously O 1 0.8642621636390686
recurring O 1 0.9733889102935791
ATM O 1 0.9728087782859802
mutations O 1 0.9956914782524109
exist O 0 0.03984645754098892
. O 0 0.02401164546608925

Assays O 1 0.502345860004425
requiring O 0 0.05321447178721428
minimal O 0 0.03984658047556877
amounts O 0 0.024319158867001534
of O 0 0.010479873977601528
genomic O 1 0.9777634143829346
DNA O 0 0.4748605191707611
were O 0 0.004329059273004532
designed O 0 0.00834559090435505
to O 0 0.004013258032500744
allow O 0 0.009910128079354763
rapid O 0 0.19365212321281433
screening O 0 0.2557062804698944
for O 0 0.008176405914127827
common O 0 0.05459693819284439
ethnic O 0 0.07849463075399399
mutations O 1 0.9953762292861938
. O 0 0.03587869182229042

These O 0 0.028265245258808136
rapid O 0 0.2338189333677292
assays O 1 0.9440557956695557
detected O 1 0.9502199292182922
mutations O 1 0.9942992925643921
in O 0 0.008925503119826317
76 O 0 0.01752381958067417
% O 0 0.009329124353826046
of O 0 0.0058024004101753235
Costa O 0 0.06970973312854767
Rican O 0 0.4670978784561157
patients O 1 0.9931718111038208
( O 0 0.012788098305463791
3 O 0 0.009280595928430557
) O 0 0.006138456054031849
, O 0 0.0033223817590624094
50 O 0 0.004617426544427872
% O 0 0.005364143289625645
of O 0 0.004369568545371294
Norwegian O 0 0.03580112382769585
patients O 1 0.9909607768058777
( O 0 0.010244115255773067
1 O 0 0.008059444837272167
) O 0 0.00557114789262414
, O 0 0.0030938393902033567
25 O 0 0.004384954459965229
% O 0 0.005644672084599733
of O 0 0.004333552438765764
Polish O 0 0.09196586161851883
patients O 1 0.9937764406204224
( O 0 0.011116272769868374
4 O 0 0.008303839713335037
) O 0 0.005335003137588501
, O 0 0.0026509910821914673
and O 0 0.0021410516928881407
14 O 0 0.005131109151989222
% O 0 0.006078002974390984
of O 0 0.004621787928044796
Italian O 0 0.17598550021648407
patients O 1 0.9964994192123413
( O 0 0.009446622803807259
1 O 0 0.008017202839255333
) O 0 0.005374938249588013
, O 0 0.0025691885966807604
as O 0 0.0027148122899234295
well O 0 0.003160992870107293
as O 0 0.0035259220749139786
in O 0 0.00576662877574563
patients O 1 0.9680091142654419
of O 0 0.008012817241251469
Amish O 1 0.605087161064148
/ O 0 0.4386453628540039
Mennonite O 0 0.10167988389730453
and O 0 0.009132573381066322
Irish O 0 0.029547955840826035
English O 0 0.019300736486911774
backgrounds O 0 0.04117140918970108
. O 0 0.023800702765583992

Additional O 0 0.04489899426698685
mutations O 1 0.98263019323349
were O 0 0.008117197081446648
observed O 0 0.016371840611100197
in O 0 0.005817990284413099
Japanese O 0 0.009316897951066494
, O 0 0.005426763091236353
Utah O 0 0.015552040189504623
Mormon O 0 0.025212980806827545
, O 0 0.006998859345912933
and O 0 0.007090168539434671
African O 0 0.033314477652311325
American O 0 0.0572386272251606
patients O 1 0.9890885353088379
. O 0 0.032562512904405594

These O 0 0.01941065676510334
assays O 0 0.09483328461647034
should O 0 0.012739621102809906
facilitate O 0 0.026410307735204697
screening O 0 0.06949116289615631
for O 0 0.009343836456537247
A B-Disease 0 0.02667347714304924
- I-Disease 1 0.8125551342964172
T I-Disease 1 0.9928621649742126
heterozygotes O 1 0.9525899291038513
in O 0 0.009283437393605709
the O 0 0.007729293312877417
populations O 0 0.2123091220855713
studied O 0 0.022076597437262535
. O 0 0.01203967072069645
. O 0 0.018330685794353485

The O 0 0.04977897182106972
von B-Disease 1 0.8978673815727234
Hippel I-Disease 1 0.9915211200714111
- I-Disease 1 0.981536328792572
Lindau I-Disease 1 0.9986509680747986
tumor I-Disease 1 0.9996886253356934
suppressor O 1 0.9984997510910034
gene O 1 0.9931769371032715
is O 0 0.010217209346592426
required O 0 0.011440503410995007
for O 0 0.008063294924795628
cell O 1 0.9190141558647156
cycle O 0 0.4841044247150421
exit O 0 0.045509934425354004
upon O 0 0.021365098655223846
serum O 1 0.9738374948501587
withdrawal O 0 0.2476292848587036
. O 0 0.029074013233184814

The O 0 0.02747318707406521
inactivation O 0 0.3573773205280304
of O 0 0.011582799255847931
the O 0 0.018548481166362762
von B-Disease 1 0.864870011806488
Hippel I-Disease 1 0.9935004115104675
- I-Disease 1 0.9596127271652222
Lindau I-Disease 1 0.9953896999359131
( I-Disease 0 0.35275107622146606
VHL I-Disease 1 0.9978481531143188
) I-Disease 1 0.7491982579231262
tumor I-Disease 1 0.9996699094772339
suppressor O 1 0.9990378618240356
gene O 1 0.9976166486740112
predisposes O 1 0.9927002787590027
affected O 0 0.1524132490158081
individuals O 0 0.01459414791315794
to O 0 0.006648175418376923
the O 0 0.010982073843479156
human O 1 0.9808856844902039
VHL B-Disease 1 0.9998365640640259
cancer I-Disease 1 0.9999477863311768
syndrome I-Disease 1 0.9998136162757874
and O 0 0.009750311262905598
is O 0 0.008603313937783241
associated O 0 0.047318585216999054
with O 0 0.018879421055316925
sporadic B-Disease 1 0.9935352802276611
renal I-Disease 1 0.9999148845672607
cell I-Disease 1 0.9989138841629028
carcinomas I-Disease 1 0.9993488192558289
( O 0 0.16689109802246094
RCC B-Disease 1 0.9799428582191467
) O 0 0.0229940302670002
and O 0 0.01635725237429142
brain B-Disease 1 0.9923760294914246
hemangioblastomas I-Disease 1 0.8789488673210144
. O 0 0.036839500069618225

VHL O 1 0.9824292659759521
- O 0 0.4174170196056366
negative O 0 0.35402265191078186
786 O 1 0.9408233761787415
- O 0 0.4226670563220978
0 O 0 0.11472287774085999
RCC B-Disease 1 0.985261857509613
cells O 1 0.9601525664329529
are O 0 0.00902171153575182
tumorigenic O 0 0.41234514117240906
in O 0 0.010453013703227043
nude O 1 0.8231667280197144
mice O 1 0.9954748749732971
which O 0 0.008024411275982857
is O 0 0.007428576238453388
suppressed O 0 0.03703553229570389
by O 0 0.007275874260812998
the O 0 0.008563663810491562
reintroduction O 1 0.6860642433166504
of O 0 0.02295924350619316
VHL B-Disease 1 0.990269660949707
. O 0 0.03711099177598953

Remarkably O 0 0.07770185172557831
, O 0 0.010897192172706127
this O 0 0.00704480754211545
occurs O 0 0.09474261850118637
without O 0 0.007838977500796318
affecting O 0 0.13004827499389648
the O 0 0.005037750583142042
growth O 0 0.0489710234105587
rate O 0 0.019147038459777832
and O 0 0.006673737894743681
cell O 1 0.9685444235801697
cycle O 1 0.7309333086013794
profile O 0 0.08402075618505478
of O 0 0.006468660663813353
these O 0 0.00958691630512476
cells O 1 0.9546008110046387
in O 0 0.01073542982339859
culture O 0 0.026027102023363113
. O 0 0.022847143933176994

The O 0 0.03306869789958
786 O 1 0.7608757615089417
- O 0 0.1519424468278885
0 O 0 0.04265019670128822
cell O 0 0.4984118342399597
line O 0 0.011423737742006779
, O 0 0.005436273291707039
like O 0 0.009283472783863544
many O 0 0.015967030078172684
cancer B-Disease 1 0.9998276233673096
cells O 1 0.9965734481811523
, O 0 0.007832220755517483
fails O 0 0.03227747976779938
to O 0 0.005147628951817751
exit O 0 0.017743799835443497
the O 0 0.007897522300481796
cell O 1 0.8917506337165833
cycle O 0 0.4066663980484009
upon O 0 0.024941585958003998
serum O 1 0.9799047708511353
withdrawal O 0 0.1980801820755005
. O 0 0.02986743114888668

Here O 0 0.014642615802586079
, O 0 0.006494761444628239
it O 0 0.00403015548363328
is O 0 0.004442381672561169
shown O 0 0.006674603559076786
that O 0 0.004700256511569023
reintroduction O 0 0.1632380187511444
of O 0 0.005036467220634222
the O 0 0.007115813437849283
wild O 0 0.23140953481197357
- O 1 0.7673425078392029
type O 1 0.975561797618866
VHL B-Disease 1 0.9989866614341736
gene O 1 0.9954634308815002
restores O 0 0.3659042418003082
the O 0 0.009362703189253807
ability O 0 0.02190115675330162
of O 0 0.013337485492229462
VHL O 1 0.9984186887741089
- O 1 0.9510983824729919
negative O 1 0.9803196787834167
RCC B-Disease 1 0.9988168478012085
cancer I-Disease 1 0.9997410178184509
cells O 1 0.9895431995391846
to O 0 0.008211255073547363
exit O 0 0.02153048664331436
the O 0 0.008237500675022602
cell O 1 0.9133930206298828
cycle O 0 0.3493400514125824
and O 0 0.009594026021659374
enter O 0 0.04166045039892197
G0 O 1 0.9928112626075745
/ O 1 0.80457603931427
quiescence O 1 0.9474825859069824
in O 0 0.023036427795886993
low O 0 0.16058547794818878
serum O 1 0.9777892827987671
. O 0 0.03510921075940132

Both O 0 0.04757075756788254
VHL O 1 0.9902865886688232
- O 0 0.19229768216609955
positive O 0 0.06488002091646194
and O 0 0.01604563370347023
VHL O 1 0.9977335929870605
- O 1 0.7794349789619446
negative O 1 0.7725709676742554
RCC B-Disease 1 0.9917876124382019
cells O 1 0.9888601899147034
exit O 0 0.03781455382704735
the O 0 0.010702387429773808
cell O 1 0.9357852339744568
cycle O 1 0.562366247177124
by O 0 0.01827630214393139
contact O 0 0.3670903444290161
inhibition O 1 0.980859100818634
. O 0 0.028518492355942726

The O 0 0.04524938389658928
cyclin O 1 0.9828023314476013
- O 1 0.5441566109657288
dependent O 1 0.7293599247932434
kinase O 1 0.9932510256767273
inhibitor O 1 0.9918237328529358
, O 0 0.02051011472940445
p27 O 1 0.9822797179222107
, O 0 0.012372533790767193
accumulates O 0 0.4488328993320465
upon O 0 0.016168193891644478
serum O 1 0.9875079989433289
withdrawal O 0 0.07538961619138718
, O 0 0.004203822463750839
only O 0 0.002643754007294774
in O 0 0.0025364691391587257
the O 0 0.003503306768834591
presence O 0 0.010498162358999252
of O 0 0.005806013010442257
VHL B-Disease 1 0.9953393936157227
, O 0 0.005900805816054344
as O 0 0.003613229375332594
a O 0 0.005522844381630421
result O 0 0.007466026581823826
of O 0 0.0036802534013986588
the O 0 0.004822935443371534
stabilization O 0 0.028717895969748497
of O 0 0.0061538550071418285
the O 0 0.012372161261737347
protein O 1 0.9451370239257812
. O 0 0.025742219761013985

We O 0 0.013683491386473179
propose O 0 0.0251290425658226
that O 0 0.0052720229141414165
the O 0 0.005636415909975767
loss O 0 0.015843166038393974
of O 0 0.00742760905995965
wild O 0 0.21836455166339874
- O 1 0.7974615693092346
type O 1 0.9839524626731873
VHL B-Disease 1 0.9993601441383362
gene O 1 0.9967361092567444
results O 0 0.019662626087665558
in O 0 0.0061442069709300995
a O 0 0.008781537413597107
specific O 0 0.027422485873103142
cellular O 1 0.9892156720161438
defect O 1 0.9926837086677551
in O 0 0.015621151775121689
serum O 1 0.9960008263587952
- O 1 0.6130702495574951
dependent O 0 0.25431814789772034
growth O 0 0.1915304958820343
control O 0 0.021612498909235
, O 0 0.005041683558374643
which O 0 0.0063303071074187756
may O 0 0.02366769313812256
initiate O 1 0.9197454452514648
tumor B-Disease 1 0.9984921216964722
formation O 1 0.5093093514442444
. O 0 0.029580555856227875

This O 0 0.01487378403544426
is O 0 0.009782157838344574
corrected O 0 0.037970174103975296
by O 0 0.006651765666902065
the O 0 0.006462626159191132
reintroduction O 0 0.25584957003593445
of O 0 0.009046275168657303
wild O 0 0.17353831231594086
- O 1 0.6593282222747803
type O 1 0.8772783875465393
VHL B-Disease 1 0.9970355033874512
, O 0 0.016228148713707924
implicating O 1 0.9111176133155823
VHL B-Disease 1 0.9920356869697571
as O 0 0.008539718575775623
the O 0 0.007187619339674711
first O 0 0.01939408667385578
tumor B-Disease 1 0.9997264742851257
suppressor O 1 0.997306227684021
involved O 0 0.01416459959000349
in O 0 0.0045578572899103165
the O 0 0.004572639707475901
regulation O 0 0.027118396013975143
of O 0 0.006219435483217239
cell O 1 0.9585123658180237
cycle O 1 0.5159809589385986
exit O 0 0.033366430550813675
, O 0 0.004502289462834597
which O 0 0.0030949516221880913
is O 0 0.00370564847253263
consistent O 0 0.00887248758226633
with O 0 0.0051184287294745445
its O 0 0.00864352472126484
gatekeeper O 1 0.9634288549423218
function O 0 0.11147609353065491
in O 0 0.009825567714869976
the O 0 0.015565832145512104
kidney O 1 0.9988679885864258
. O 0 0.01859654299914837
. O 0 0.02347838319838047

Piebaldism B-Disease 1 0.9286000728607178
with O 0 0.05253104865550995
deafness B-Disease 1 0.9976608753204346
: O 0 0.027634216472506523
molecular O 1 0.8737953305244446
evidence O 0 0.013827838934957981
for O 0 0.008260836824774742
an O 0 0.012016257271170616
expanded O 0 0.10361573100090027
syndrome O 1 0.9991831183433533
. O 0 0.04035032540559769

In O 0 0.015758616849780083
a O 0 0.013361325487494469
South O 0 0.01163847278803587
African O 0 0.02405860275030136
girl O 0 0.04638266563415527
of O 0 0.009484278969466686
Xhosa O 1 0.9535664319992065
stock O 0 0.0579366534948349
with O 0 0.017079737037420273
severe O 1 0.986443042755127
piebaldism B-Disease 1 0.9479007720947266
and O 0 0.022992467507719994
profound O 1 0.9911770820617676
congenital O 1 0.9999105930328369
sensorineural B-Disease 1 0.9991602897644043
deafness I-Disease 1 0.9988105297088623
we O 0 0.012788363732397556
identified O 0 0.02007124572992325
a O 0 0.012428699061274529
novel O 0 0.058919887989759445
missense O 1 0.9737802147865295
substitution O 0 0.1140156015753746
at O 0 0.007443579379469156
a O 0 0.00919396337121725
highly O 0 0.017719030380249023
conserved O 0 0.15225213766098022
residue O 0 0.08426077663898468
in O 0 0.006812768988311291
the O 0 0.009573929943144321
intracellular O 1 0.9913601279258728
kinase O 1 0.9893502593040466
domain O 0 0.03500819578766823
of O 0 0.007128087338060141
the O 0 0.010207603685557842
KIT O 1 0.8506942391395569
proto O 1 0.9788646697998047
- O 1 0.92329341173172
oncogene O 1 0.9941231608390808
, O 0 0.028886403888463974
R796G O 1 0.5271794199943542
. O 0 0.03766993433237076

Though O 0 0.049303747713565826
auditory B-Disease 1 0.9431977272033691
anomalies I-Disease 1 0.5261116027832031
have O 0 0.009340102784335613
been O 0 0.007892297580838203
observed O 0 0.018624402582645416
in O 0 0.010045717470347881
mice O 1 0.9900006055831909
with O 0 0.013676118105649948
dominant O 0 0.3716541826725006
white O 0 0.27024754881858826
spotting O 1 0.977831244468689
( O 0 0.031723618507385254
W O 1 0.9103279113769531
) O 0 0.012571706436574459
due O 0 0.011426926590502262
to O 0 0.008814957924187183
KIT O 1 0.9629295468330383
mutations O 1 0.9987792372703552
, O 0 0.017864268273115158
deafness B-Disease 1 0.9989894032478333
is O 0 0.009480319917201996
not O 0 0.006074227392673492
typical O 0 0.022297566756606102
in O 0 0.011009671725332737
human O 0 0.104422926902771
piebaldism B-Disease 1 0.8338330984115601
. O 0 0.02956925891339779

Thus O 0 0.028794309124350548
, O 0 0.00971288327127695
the O 0 0.008045291528105736
occurrence O 0 0.4971092641353607
of O 0 0.01679151877760887
sensorineural B-Disease 1 0.9987657070159912
deafness I-Disease 1 0.9991421699523926
in O 0 0.01373230665922165
this O 0 0.010545353405177593
patient O 1 0.9560885429382324
extends O 0 0.03223920986056328
considerably O 0 0.026259811595082283
the O 0 0.0067909350618720055
phenotypic O 1 0.8281252980232239
range O 0 0.014263351447880268
of O 0 0.006996174808591604
piebaldism B-Disease 1 0.544453501701355
due O 0 0.016134483739733696
to O 0 0.009706545621156693
KIT O 1 0.9738808870315552
gene O 1 0.9983964562416077
mutation O 1 0.9979520440101624
in O 0 0.011428790166974068
humans O 1 0.6105209589004517
and O 0 0.007593630813062191
tightens O 1 0.9211458563804626
the O 0 0.011090663261711597
clinical O 1 0.9838472008705139
similarity O 0 0.23704540729522705
between O 0 0.01026215311139822
piebaldism B-Disease 0 0.4104536473751068
and O 0 0.0038166216108947992
the O 0 0.0039762696251273155
various O 0 0.006821796763688326
forms O 0 0.04142842814326286
of O 0 0.03164111077785492
Waardenburg B-Disease 1 0.9995288848876953
syndrome I-Disease 1 0.9997550845146179
. O 0 0.024698413908481598
. O 0 0.025019675493240356

Cycloheximide O 1 0.5867531299591064
facilitates O 0 0.08523033559322357
the O 0 0.010150747373700142
identification O 0 0.020676666870713234
of O 0 0.010579719208180904
aberrant O 1 0.8929079174995422
transcripts O 0 0.04811595380306244
resulting O 0 0.05257611721754074
from O 0 0.00979532115161419
a O 0 0.014493605121970177
novel O 0 0.1021537184715271
splice O 1 0.9756991863250732
- O 0 0.2777513265609741
site O 0 0.026862939819693565
mutation O 1 0.9946611523628235
in O 0 0.012762696482241154
COL17A1 O 1 0.7616857886314392
in O 0 0.011424422264099121
a O 0 0.019311144948005676
patient O 1 0.9507227540016174
with O 0 0.047202564775943756
generalized O 1 0.9948809146881104
atrophic B-Disease 1 0.9980257749557495
benign I-Disease 1 0.9972690939903259
epidermolysis I-Disease 1 0.9972668886184692
bullosa I-Disease 1 0.9910876154899597
. O 0 0.07176053524017334

Patients O 1 0.9755844473838806
with O 0 0.06576260179281235
generalized O 1 0.9883042573928833
atrophic B-Disease 1 0.9974141120910645
benign I-Disease 1 0.997470498085022
epidermolysis I-Disease 1 0.9976065158843994
bullosa I-Disease 1 0.9922266006469727
often O 0 0.031842637807130814
show O 0 0.022311534732580185
decreased O 0 0.11400862038135529
expression O 0 0.04973872750997543
of O 0 0.009823179803788662
type O 1 0.746660053730011
XVII O 1 0.9869013428688049
collagen O 1 0.9956896901130676
, O 0 0.01288569625467062
a O 0 0.018318530172109604
transmembrane O 1 0.9501381516456604
hemidesmosomal O 1 0.9425451159477234
protein O 1 0.9704237580299377
encoded O 0 0.18090148270130157
by O 0 0.023393571376800537
COL17A1 O 1 0.5747339129447937
. O 0 0.03841407597064972

This O 0 0.013656534254550934
report O 0 0.012194016948342323
documents O 0 0.0110167870298028
a O 0 0.012942980974912643
novel O 0 0.05114777386188507
splice O 1 0.9818965196609497
- O 0 0.2898111045360565
site O 0 0.027654506266117096
mutation O 1 0.9972096085548401
in O 0 0.010823552496731281
COL17A1 O 1 0.7892336845397949
in O 0 0.00972690898925066
a O 0 0.018137916922569275
patient O 1 0.9733187556266785
with O 0 0.04029146209359169
generalized O 1 0.9965031147003174
atrophic B-Disease 1 0.9991742968559265
benign I-Disease 1 0.9988604784011841
epidermolysis I-Disease 1 0.9991859793663025
bullosa I-Disease 1 0.9970526695251465
, O 0 0.011161977425217628
and O 0 0.005869788583368063
applies O 0 0.012982391752302647
a O 0 0.006626789923757315
new O 0 0.005367135629057884
methodology O 0 0.013128163293004036
to O 0 0.004077896010130644
define O 0 0.013817607425153255
and O 0 0.005766043905168772
characterize O 0 0.08043724298477173
the O 0 0.011809896677732468
resulting O 0 0.4443705677986145
mRNA O 1 0.933800995349884
splice O 1 0.9731243252754211
variants O 1 0.7708376049995422
. O 0 0.03848254680633545

Mutational O 1 0.9179713129997253
analysis O 0 0.052114278078079224
of O 0 0.01656690612435341
COL17A1 O 1 0.5285350680351257
identified O 0 0.0332433320581913
a O 0 0.027777409180998802
maternally O 1 0.9819262623786926
inherited O 1 0.9842696189880371
G O 1 0.9017313122749329
- O 0 0.13678036630153656
to O 0 0.011641270481050014
- O 1 0.6249832510948181
T O 1 0.9807555079460144
transversion O 1 0.5555627346038818
at O 0 0.00869853887706995
the O 0 0.006914523895829916
- O 0 0.02317224256694317
1 O 0 0.009703874588012695
position O 0 0.007992182858288288
of O 0 0.009393393062055111
exon O 1 0.7204859256744385
32 O 0 0.04147413745522499
. O 0 0.02663232758641243

This O 0 0.033572662621736526
acceptor O 1 0.9009760022163391
splice O 1 0.958549976348877
- O 0 0.19732773303985596
site O 0 0.0248433668166399
mutation O 1 0.9852100014686584
led O 0 0.012593993917107582
to O 0 0.00505469786003232
the O 0 0.005385362543165684
formation O 0 0.022834070026874542
of O 0 0.007776400074362755
aberrant O 1 0.9408081769943237
transcripts O 0 0.03612099215388298
present O 0 0.0092889703810215
at O 0 0.00813390128314495
extremely O 0 0.02363237924873829
low O 0 0.031330931931734085
levels O 0 0.04912733659148216
. O 0 0.025051115080714226

Based O 0 0.02167695015668869
on O 0 0.007674018386751413
our O 0 0.008655065670609474
recent O 0 0.012875244952738285
finding O 0 0.017432140186429024
that O 0 0.010649897158145905
cycloheximide O 1 0.7979711890220642
stabilized O 1 0.890285074710846
mutant O 1 0.9745433330535889
COL17A1 O 1 0.9058189392089844
transcripts O 0 0.05567948520183563
in O 0 0.017408952116966248
keratinocytes O 1 0.9765439033508301
homozygous O 1 0.9621297121047974
for O 0 0.01434256974607706
a O 0 0.02626558393239975
frameshift O 1 0.9970753192901611
mutation O 1 0.9971675276756287
, O 0 0.007026917301118374
the O 0 0.0049734837375581264
effects O 0 0.06141382455825806
of O 0 0.005274349357932806
the O 0 0.007762698922306299
splice O 1 0.9756295084953308
- O 0 0.18214432895183563
site O 0 0.019214972853660583
mutation O 1 0.9928959012031555
on O 0 0.008775228634476662
splicing O 1 0.8508723378181458
of O 0 0.010225980542600155
COL17A1 O 1 0.5939653515815735
transcripts O 0 0.024807443842291832
were O 0 0.006003669463098049
determined O 0 0.013564319349825382
using O 0 0.016194794327020645
reverse O 1 0.6702383756637573
transcriptase O 1 0.9955006241798401
polymerase O 1 0.985587477684021
chain O 0 0.4732321500778198
reaction O 0 0.03410785272717476
of O 0 0.006378733087331057
total O 0 0.012415982782840729
RNA O 1 0.9468631148338318
from O 0 0.01719818264245987
keratinocytes O 1 0.9700212478637695
incubated O 0 0.48513591289520264
for O 0 0.014782795682549477
2 O 0 0.02396419644355774
. O 0 0.022786306217312813

5 O 0 0.037023186683654785
h O 0 0.04514853283762932
in O 0 0.0074430229142308235
the O 0 0.0060739112086594105
presence O 0 0.01521750632673502
or O 0 0.00841452181339264
absence O 0 0.016279278323054314
of O 0 0.0071268086321651936
10 O 0 0.015778953209519386
microg O 1 0.8205552697181702
cycloheximide O 1 0.7636354565620422
per O 0 0.03174997866153717
ml O 1 0.8167122006416321
. O 0 0.03042149916291237

Using O 0 0.026829112321138382
this O 0 0.009714493528008461
approach O 0 0.01587756723165512
, O 0 0.0069808936677873135
an O 0 0.010691829957067966
abnormally O 1 0.9876999855041504
spliced O 1 0.9854433536529541
transcript O 0 0.21885693073272705
was O 0 0.007401871960610151
identified O 0 0.01030501164495945
that O 0 0.003439618507400155
contains O 0 0.006341114174574614
an O 0 0.004381075967103243
extra O 0 0.012017356231808662
264 O 0 0.027945855632424355
bases O 0 0.015613769181072712
upstream O 0 0.029407821595668793
from O 0 0.011716154403984547
exon O 1 0.5843871831893921
32 O 0 0.018361369147896767
, O 0 0.007113475818186998
resulting O 0 0.031225183978676796
in O 0 0.007728655822575092
a O 0 0.015601190738379955
premature O 1 0.9820979237556458
termination O 1 0.9386515617370605
codon O 1 0.774739146232605
27 O 0 0.031172223389148712
bp O 0 0.05193588137626648
downstream O 0 0.04571515694260597
from O 0 0.011955712921917439
the O 0 0.013931669294834137
cryptic O 1 0.8019474148750305
splice O 1 0.9251354336738586
site O 0 0.03957532346248627
. O 0 0.027157429605722427

Three O 0 0.01802823692560196
other O 0 0.01229813788086176
splice O 1 0.9012062549591064
variants O 0 0.24037449061870575
, O 0 0.005689296871423721
including O 0 0.00523953465744853
one O 0 0.003973585087805986
derived O 0 0.011277977377176285
from O 0 0.004394365940243006
the O 0 0.004644433036446571
skipping O 0 0.052015021443367004
of O 0 0.0072374725714325905
exon O 1 0.7326166033744812
32 O 0 0.013957219198346138
, O 0 0.0054271589033305645
were O 0 0.0040537104941904545
also O 0 0.00661200936883688
identified O 0 0.02063390426337719
. O 0 0.019005510956048965

These O 0 0.014659754931926727
results O 0 0.015834687277674675
indicate O 0 0.013386625796556473
the O 0 0.006180161144584417
usefulness O 0 0.0457538440823555
of O 0 0.007600454147905111
cycloheximide O 1 0.9487624168395996
treatment O 1 0.7846845388412476
in O 0 0.007018072996288538
evaluating O 0 0.026660820469260216
the O 0 0.0071156080812215805
abnormal O 1 0.9786148071289062
processing O 0 0.02030358649790287
of O 0 0.0076416670344769955
mRNA O 0 0.3951825201511383
due O 0 0.013514554128050804
to O 0 0.008718281053006649
splice O 1 0.9827277064323425
- O 0 0.3617072105407715
site O 0 0.02488734759390354
mutations O 1 0.9972875118255615
, O 0 0.008003005757927895
because O 0 0.009159891866147518
( O 0 0.009267251007258892
i O 0 0.007303410209715366
) O 0 0.011908270418643951
aberrant O 1 0.9473141431808472
splicing O 1 0.9646185040473938
often O 0 0.013621604070067406
generates O 0 0.041866060346364975
a O 0 0.021336382254958153
premature O 1 0.9797986745834351
termination O 1 0.9218974113464355
codon O 1 0.8390527963638306
, O 0 0.009735148400068283
( O 0 0.011858869343996048
ii O 0 0.02009911648929119
) O 0 0.01043395884335041
transcripts O 0 0.027447612956166267
with O 0 0.013192301616072655
premature O 1 0.9776124358177185
termination O 1 0.9703571796417236
codons O 1 0.8697717189788818
can O 0 0.012141699902713299
occur O 0 0.03310079500079155
at O 0 0.006272675469517708
low O 0 0.022074760869145393
or O 0 0.015053937211632729
undetectable O 1 0.9861332774162292
levels O 0 0.027444584295153618
due O 0 0.013009526766836643
to O 0 0.007305250037461519
nonsense O 0 0.14262449741363525
- O 0 0.3889603614807129
mediated O 1 0.9780126214027405
mRNA O 1 0.9173160791397095
decay O 1 0.5259803533554077
, O 0 0.006267627235502005
and O 0 0.004884534049779177
( O 0 0.009690448641777039
iii O 0 0.058598801493644714
) O 0 0.004950837232172489
the O 0 0.003058029105886817
levels O 0 0.008151242509484291
of O 0 0.0031328201293945312
these O 0 0.003956312779337168
transcripts O 0 0.01639793999493122
can O 0 0.006439853459596634
be O 0 0.004826427437365055
increased O 0 0.013177765533328056
by O 0 0.015492452308535576
cycloheximide O 1 0.5732117891311646
. O 0 0.02693161554634571

A O 0 0.06964914500713348
deletion O 1 0.9835509657859802
mutation O 1 0.9924271702766418
in O 0 0.01811254769563675
COL17A1 O 1 0.5046565532684326
in O 0 0.011100987903773785
five O 0 0.01366626750677824
Austrian O 0 0.04556536674499512
families O 0 0.02915239706635475
with O 0 0.025336172431707382
generalized O 1 0.9919084906578064
atrophic B-Disease 1 0.997884213924408
benign I-Disease 1 0.9974052309989929
epidermolysis I-Disease 1 0.9984771609306335
bullosa I-Disease 1 0.9954654574394226
represents O 0 0.05879597365856171
propagation O 0 0.1603059321641922
of O 0 0.010581765323877335
an O 0 0.015615945681929588
ancestral O 1 0.5639114379882812
allele O 1 0.9852820038795471
. O 0 0.037535421550273895

Patients O 1 0.979828417301178
with O 0 0.06324374675750732
generalized O 1 0.9925454258918762
atrophic B-Disease 1 0.9982262253761292
benign I-Disease 1 0.9972963929176331
epidermolysis I-Disease 1 0.9978532195091248
bullosa I-Disease 1 0.9946681261062622
, O 0 0.01662302203476429
a O 0 0.01467915065586567
usually O 0 0.0175430066883564
nonlethal O 0 0.2949346899986267
form O 0 0.02384018711745739
of O 0 0.019350918009877205
junctional B-Disease 1 0.9959554672241211
epidermolysis I-Disease 1 0.9985554814338684
bullosa I-Disease 1 0.9951044321060181
, O 0 0.020118670538067818
have O 0 0.014983166009187698
generalized O 1 0.9513540267944336
blistering B-Disease 1 0.8803235292434692
, O 0 0.034836579114198685
nail B-Disease 1 0.9953041076660156
dystrophy I-Disease 1 0.9993502497673035
, O 0 0.05820876732468605
patchy B-Disease 1 0.9930342435836792
alopecia I-Disease 1 0.9986973404884338
, O 0 0.022136522457003593
and O 0 0.021270429715514183
dental B-Disease 1 0.9947742819786072
abnormalities I-Disease 1 0.9976325035095215
. O 0 0.04231974855065346

Skin B-Disease 1 0.9932482242584229
fragility I-Disease 1 0.9000968337059021
in O 0 0.010720283724367619
most O 0 0.00792660191655159
cases O 0 0.01789836585521698
is O 0 0.005127264652401209
due O 0 0.00787044782191515
to O 0 0.006079374812543392
mutations O 1 0.9963339567184448
in O 0 0.0075278570875525475
the O 0 0.01052703894674778
gene O 1 0.9962461590766907
encoding O 1 0.9773253202438354
type O 1 0.9573757648468018
XVII O 1 0.9914296269416809
collagen O 1 0.9975927472114563
( O 0 0.06757060438394547
COL17A1 O 1 0.9198371171951294
) O 0 0.028547033667564392
. O 0 0.022920262068510056

Recently O 0 0.036280225962400436
, O 0 0.009242338128387928
we O 0 0.005358478054404259
reported O 0 0.01013329066336155
five O 0 0.008734780363738537
Austrian O 0 0.03423820063471794
families O 0 0.0236126109957695
with O 0 0.021417075768113136
generalized O 1 0.9940958023071289
atrophic B-Disease 1 0.9982143640518188
benign I-Disease 1 0.9979098439216614
epidermolysis I-Disease 1 0.9984756112098694
bullosa I-Disease 1 0.9940780401229858
who O 0 0.018063973635435104
share O 0 0.01843070797622204
the O 0 0.010465756990015507
same O 0 0.022112859413027763
COL17A1 O 1 0.9775427579879761
mutation O 1 0.9962331652641296
. O 0 0.03626875579357147

Affected O 0 0.07131913304328918
individuals O 0 0.01751433126628399
in O 0 0.006202708464115858
three O 0 0.005714489612728357
families O 0 0.009517665952444077
are O 0 0.005109791643917561
homozygous O 1 0.970313549041748
for O 0 0.008682895451784134
4003delTC O 1 0.7457860112190247
, O 0 0.0058456831611692905
whereas O 0 0.012363413348793983
those O 0 0.004026028793305159
in O 0 0.004012693651020527
two O 0 0.004653926473110914
others O 0 0.007291859015822411
are O 0 0.006428236607462168
compound O 0 0.23411087691783905
heterozygotes O 1 0.9710208177566528
. O 0 0.02761547826230526

To O 0 0.01168090384453535
determine O 0 0.014406547881662846
if O 0 0.005760459695011377
the O 0 0.00493088411167264
occurrence O 0 0.08111502230167389
of O 0 0.005168672185391188
4003delTC O 1 0.5809574127197266
in O 0 0.005804755259305239
these O 0 0.005771311931312084
unrelated O 0 0.16062811017036438
families O 0 0.017947103828191757
signifies O 0 0.15426872670650482
propagation O 0 0.08899790048599243
of O 0 0.005974550731480122
an O 0 0.008233468979597092
ancestral O 1 0.5850696563720703
allele O 1 0.9932035207748413
or O 0 0.014750086702406406
a O 0 0.016500482335686684
mutational O 1 0.9852051138877869
hot O 0 0.03559455648064613
spot O 0 0.018332794308662415
, O 0 0.008942543528974056
haplotypes O 1 0.9597840905189514
were O 0 0.0051406812854111195
determined O 0 0.01144256442785263
for O 0 0.0072815739549696445
polymorphisms O 1 0.9551942944526672
both O 0 0.007394399493932724
within O 0 0.010334694758057594
and O 0 0.009086287580430508
flanking O 0 0.4954758882522583
COL17A1 O 1 0.9081639647483826
. O 0 0.03217945620417595

Five O 0 0.04604785889387131
intragenic O 1 0.6958392858505249
polymorphisms O 1 0.9074044227600098
were O 0 0.0064260829240083694
chosen O 0 0.008528856560587883
based O 0 0.00706788944080472
on O 0 0.0051475949585437775
their O 0 0.010533845983445644
informativeness O 1 0.7086262106895447
. O 0 0.02486421726644039

One O 0 0.010563060641288757
of O 0 0.004995021969079971
these O 0 0.004458231385797262
, O 0 0.003287713974714279
not O 0 0.003301232820376754
previously O 0 0.0059060947969555855
reported O 0 0.008483032695949078
, O 0 0.003773679258301854
was O 0 0.004609747789800167
2988 O 0 0.38932061195373535
A O 0 0.009935148060321808
or O 0 0.008039935491979122
C O 0 0.0305790938436985
that O 0 0.004310453776270151
introduces O 0 0.021554820239543915
a O 0 0.007444622926414013
new O 0 0.006870929151773453
restriction O 0 0.022870535030961037
site O 0 0.011289521120488644
for O 0 0.009924416430294514
Eco0109 O 0 0.26596125960350037
I O 0 0.02172648161649704
. O 0 0.023082561790943146

All O 0 0.013875960372388363
the O 0 0.013198044151067734
4003delTC O 1 0.8057400584220886
alleles O 1 0.9796386957168579
showed O 0 0.015417390502989292
the O 0 0.007391152437776327
same O 0 0.010997841134667397
haplotype O 1 0.9794990420341492
for O 0 0.007700546644628048
these O 0 0.008635404519736767
five O 0 0.015240116976201534
polymorphic O 1 0.9832245111465454
markers O 1 0.6842160820960999
. O 0 0.029746118932962418

Fourteen O 0 0.0826953575015068
microsatellite O 1 0.9726647734642029
polymorphisms O 1 0.905427098274231
were O 0 0.0065945712849497795
selected O 0 0.00739038223400712
based O 0 0.0062509081326425076
on O 0 0.003204640932381153
their O 0 0.004400221630930901
high O 0 0.010527883656322956
heterozygosity O 1 0.8443203568458557
and O 0 0.005240228492766619
their O 0 0.005902422592043877
location O 0 0.010625968687236309
within O 0 0.012327609583735466
10q23 O 1 0.8157125115394592
- O 0 0.2873076796531677
q25 O 1 0.7634729146957397
near O 0 0.04231730103492737
COL17A1 O 1 0.8261520862579346
. O 0 0.037600524723529816

Three O 0 0.027014201506972313
families O 0 0.0333140604197979
shared O 0 0.03364347666501999
microsatellite O 1 0.9897080659866333
polymorphisms O 1 0.9849932193756104
covering O 0 0.021864723414182663
at O 0 0.007948147132992744
most O 0 0.006045531015843153
19 O 0 0.011878362856805325
cM O 0 0.08563446998596191
, O 0 0.00440934905782342
whereas O 0 0.009076463989913464
the O 0 0.0033601003233343363
others O 0 0.004960074555128813
shared O 0 0.007496820297092199
smaller O 0 0.009863575920462608
regions O 0 0.013309859670698643
consistent O 0 0.012617746368050575
with O 0 0.005675510503351688
cross O 0 0.01722790114581585
- O 0 0.01991996541619301
over O 0 0.004544639959931374
events O 0 0.006640580482780933
during O 0 0.0052446722984313965
passage O 0 0.008323482237756252
of O 0 0.004042880143970251
this O 0 0.006520215887576342
mutation O 1 0.9957928657531738
through O 0 0.012266241945326328
several O 0 0.011881877668201923
generations O 0 0.047408901154994965
. O 0 0.019938211888074875

These O 0 0.015643728896975517
results O 0 0.020077548921108246
indicate O 0 0.018503811210393906
that O 0 0.007572850212454796
4003delTC O 1 0.5478806495666504
occurs O 0 0.05369492247700691
on O 0 0.005201872903853655
a O 0 0.010883210226893425
single O 0 0.019316619262099266
ancestral O 1 0.6621010303497314
allele O 1 0.9840326905250549
. O 0 0.02158096805214882
. O 0 0.02459700219333172

The O 0 0.04308604076504707
haptoglobin O 1 0.9639529585838318
- O 1 0.8644319772720337
gene O 1 0.9926521182060242
deletion O 1 0.9681558609008789
responsible O 0 0.0410815104842186
for O 0 0.018949225544929504
anhaptoglobinemia B-Disease 1 0.529812216758728
. O 0 0.03603966906666756

We O 0 0.011509396135807037
have O 0 0.006024164147675037
found O 0 0.008777582086622715
an O 0 0.00950020831078291
allelic O 1 0.9725874662399292
deletion O 1 0.854368269443512
of O 0 0.007906263694167137
the O 0 0.009769076481461525
haptoglobin O 1 0.9733067750930786
( O 0 0.022229555994272232
Hp O 1 0.5382879376411438
) O 0 0.018360834568738937
gene O 1 0.9542160630226135
from O 0 0.008248087018728256
an O 0 0.007513218093663454
individual O 0 0.01665225438773632
with O 0 0.014836910180747509
anhaptoglobinemia B-Disease 1 0.6460232734680176
. O 0 0.02701450139284134

The O 0 0.030091335996985435
Hp O 1 0.6875482201576233
gene O 1 0.9855390787124634
cluster O 0 0.23999127745628357
consists O 0 0.014127269387245178
of O 0 0.006778275594115257
coding O 1 0.7514058947563171
regions O 0 0.013859190046787262
of O 0 0.004410967230796814
the O 0 0.005929090548306704
alpha O 0 0.07171826809644699
chain O 0 0.08098234236240387
and O 0 0.0068192738108336926
beta O 0 0.3660484850406647
chain O 0 0.042940519750118256
of O 0 0.005809643771499395
the O 0 0.009535023011267185
haptoglobin O 1 0.9944745898246765
gene O 1 0.9971626400947571
( O 0 0.021113315597176552
Hp O 0 0.24303658306598663
) O 0 0.005810336209833622
and O 0 0.0024279046338051558
of O 0 0.002904697088524699
the O 0 0.004353867378085852
alpha O 0 0.053468771278858185
chain O 0 0.10363561660051346
and O 0 0.006990538910031319
beta O 0 0.4293658435344696
chain O 0 0.0406540110707283
of O 0 0.006104869302362204
the O 0 0.01024874672293663
haptoglobin O 1 0.988778829574585
- O 1 0.8634822368621826
related O 1 0.7814130187034607
gene O 1 0.9965846538543701
( O 0 0.03945139795541763
Hpr O 1 0.9864802956581116
) O 0 0.013421131297945976
, O 0 0.005572193767875433
in O 0 0.005947922356426716
tandem O 0 0.069221630692482
from O 0 0.007275605574250221
the O 0 0.007599900476634502
5 O 0 0.016207411885261536
side O 0 0.01725051924586296
. O 0 0.021479468792676926

Southern O 0 0.044541556388139725
blot O 0 0.24451039731502533
and O 0 0.016827115789055824
PCR O 1 0.8132600784301758
analyses O 0 0.024403158575296402
have O 0 0.00496141891926527
indicated O 0 0.007669713813811541
that O 0 0.002743879798799753
the O 0 0.0029127737507224083
individual O 0 0.007136684376746416
with O 0 0.006390015594661236
anhaptoglobinemia B-Disease 1 0.5879143476486206
was O 0 0.007443360984325409
homozygous O 1 0.8739945292472839
for O 0 0.007404976058751345
the O 0 0.009131926111876965
gene O 1 0.9961242079734802
deletion O 1 0.947298526763916
and O 0 0.005623859353363514
that O 0 0.004498102702200413
the O 0 0.007424319628626108
gene O 1 0.9963656663894653
deletion O 1 0.9751293659210205
was O 0 0.005180312320590019
included O 0 0.004284870345145464
at O 0 0.0034842754248529673
least O 0 0.004506831057369709
from O 0 0.004278486594557762
the O 0 0.005217383150011301
promoter O 0 0.2572709918022156
region O 0 0.01079001184552908
of O 0 0.00604126276448369
Hp O 0 0.13654306530952454
to O 0 0.009819451719522476
Hpr O 1 0.9742246270179749
alpha O 0 0.06443169713020325
but O 0 0.006475433707237244
not O 0 0.00542360357940197
to O 0 0.008133982308208942
Hpr O 1 0.9840420484542847
beta O 1 0.9078422784805298
( O 0 0.02677929773926735
Hpdel O 1 0.7142277956008911
) O 0 0.02372899278998375
. O 0 0.019137641414999962

In O 0 0.013670407235622406
addition O 0 0.010572373867034912
, O 0 0.004629746079444885
we O 0 0.0028046772349625826
found O 0 0.00484026363119483
seven O 0 0.0049277921207249165
individuals O 0 0.007113843224942684
with O 0 0.005815210286527872
hypohaptoglobinemia B-Disease 0 0.4220242202281952
in O 0 0.0043104044161736965
three O 0 0.004670348018407822
families O 0 0.005893252789974213
, O 0 0.0028671722393482924
and O 0 0.0020116139203310013
the O 0 0.0033335909247398376
genotypes O 1 0.9506730437278748
of O 0 0.0028313712682574987
six O 0 0.0037709304597228765
of O 0 0.0022092382423579693
the O 0 0.0026725521311163902
seven O 0 0.004002666566520929
individuals O 0 0.006149054039269686
were O 0 0.0023099202662706375
found O 0 0.004567307885736227
to O 0 0.0038552936166524887
be O 0 0.006693262606859207
Hp2 O 1 0.932149350643158
/ O 1 0.7077316045761108
Hpdel O 1 0.8348846435546875
. O 0 0.026638727635145187

The O 0 0.02639288827776909
phenotypes O 1 0.973552942276001
and O 0 0.01167520135641098
genotypes O 1 0.9572715759277344
in O 0 0.005527904257178307
one O 0 0.0035064213443547487
of O 0 0.002843386959284544
these O 0 0.002974458271637559
three O 0 0.0033080566208809614
families O 0 0.006207192782312632
showed O 0 0.006403551436960697
the O 0 0.003521006554365158
father O 0 0.007394582033157349
to O 0 0.003921892028301954
be O 0 0.0047709327191114426
hypohaptoglobinemic B-Disease 1 0.6527276635169983
( O 0 0.01819981262087822
Hp2 O 1 0.8282396793365479
) O 0 0.012295590713620186
and O 0 0.007723341695964336
Hp2 O 1 0.8813135027885437
/ O 1 0.6077605485916138
Hpdel O 1 0.6576117277145386
, O 0 0.0056008934043347836
the O 0 0.004338639788329601
mother O 0 0.01127623300999403
to O 0 0.004052856005728245
be O 0 0.005501523148268461
Hp2 O 1 0.751794695854187
- O 0 0.05621179938316345
1 O 0 0.00982997752726078
and O 0 0.006795355584472418
Hp1 O 1 0.9703994393348694
/ O 1 0.6396703124046326
Hp2 O 1 0.5212060213088989
, O 0 0.004364853259176016
one O 0 0.0028487779200077057
of O 0 0.002183231757953763
the O 0 0.0026572872884571552
two O 0 0.003438470885157585
children O 0 0.008851993829011917
to O 0 0.004001474939286709
be O 0 0.005557406693696976
hypohaptoglobinemic B-Disease 1 0.6932893395423889
( O 0 0.01810346730053425
Hp2 O 1 0.7350247502326965
) O 0 0.012091051787137985
and O 0 0.007515817880630493
Hp2 O 1 0.9088354706764221
/ O 1 0.6092789769172668
Hpdel O 1 0.5726445913314819
, O 0 0.004971941001713276
and O 0 0.0025924472138285637
the O 0 0.0027801687829196453
other O 0 0.0036105713807046413
child O 0 0.01637391746044159
to O 0 0.004290725104510784
be O 0 0.00512081291526556
Hp1 O 1 0.5887939929962158
and O 0 0.009070689789950848
Hp1 O 1 0.9593271613121033
/ O 1 0.7347249984741211
Hpdel O 1 0.6636554002761841
, O 0 0.007291876245290041
showing O 0 0.011681266129016876
an O 0 0.008373326621949673
anomalous O 1 0.824114978313446
inheritance O 1 0.7150793671607971
of O 0 0.009357565082609653
Hp O 1 0.6911060214042664
phenotypes O 1 0.9848563075065613
in O 0 0.0086147990077734
the O 0 0.008646040223538876
child O 0 0.15048718452453613
with O 0 0.018052980303764343
Hp1 O 1 0.8105533719062805
. O 0 0.03195835277438164

The O 0 0.03425087407231331
Hp2 O 1 0.9080529808998108
/ O 0 0.49961158633232117
Hpdel O 1 0.681734025478363
individuals O 0 0.016317006200551987
had O 0 0.006742849946022034
an O 0 0.00510024931281805
extremely O 0 0.014272311702370644
low O 0 0.013835590332746506
level O 0 0.00829655583947897
of O 0 0.006447949912399054
Hp O 0 0.397093266248703
( O 0 0.01574365422129631
mean O 0 0.03703959658741951
+ O 1 0.8141904473304749
/ O 1 0.5377048254013062
- O 0 0.3188978135585785
SD O 1 0.7935311198234558
= O 0 0.11118092387914658
0 O 0 0.03263281658291817
. O 0 0.01705482043325901
049 O 1 0.9819329380989075
+ O 1 0.8528949022293091
/ O 0 0.28939083218574524
- O 0 0.055540621280670166
0 O 0 0.02835697866976261
. O 0 0.015664750710129738
043 O 1 0.9740532636642456
mg O 1 0.9819507598876953
/ O 1 0.7927348017692566
ml O 1 0.922346830368042
; O 0 0.019456233829259872
n O 0 0.04359155148267746
= O 0 0.05316099151968956
6 O 0 0.010213131085038185
) O 0 0.005739324726164341
, O 0 0.0036632767878472805
compared O 0 0.006722963880747557
with O 0 0.0038921707309782505
the O 0 0.003230930073186755
level O 0 0.006259008310735226
( O 0 0.006450400222092867
1 O 0 0.00712710153311491
. O 0 0.00550326332449913
64 O 0 0.019060775637626648
+ O 1 0.7858977317810059
/ O 0 0.22128701210021973
- O 0 0.034379132091999054
1 O 0 0.013274562545120716
. O 0 0.009365348145365715
07 O 0 0.37198519706726074
mg O 1 0.9760000109672546
/ O 1 0.807275652885437
ml O 1 0.9126296639442444
) O 0 0.011835925281047821
obtained O 0 0.009016801603138447
from O 0 0.006984491366893053
52 O 0 0.01625780388712883
healthy O 1 0.645064651966095
volunteers O 0 0.02797776833176613
having O 0 0.02553234063088894
phenotype O 1 0.9987161159515381
Hp2 O 1 0.8876044750213623
, O 0 0.00835330504924059
whereas O 0 0.01746997982263565
the O 0 0.007233174983412027
serum O 1 0.9879463315010071
Hp O 0 0.1382981836795807
level O 0 0.008714744821190834
of O 0 0.004362603183835745
an O 0 0.005072792526334524
individual O 0 0.01194064226001501
with O 0 0.0122761195525527
Hp1 O 1 0.9715112447738647
/ O 1 0.7357309460639954
Hpdel O 1 0.7151728272438049
was O 0 0.014213048852980137
0 O 0 0.037329383194446564
. O 0 0.022832782939076424

50 O 0 0.05285564064979553
mg O 1 0.9536995887756348
/ O 1 0.6957738995552063
ml O 1 0.8022332191467285
, O 0 0.006611676886677742
which O 0 0.0037261720281094313
was O 0 0.003385497722774744
approximately O 0 0.005094036925584078
half O 0 0.004180798772722483
the O 0 0.0028328096959739923
level O 0 0.005701174959540367
of O 0 0.004243413917720318
Hp O 0 0.10768212378025055
in O 0 0.006663648411631584
control O 0 0.0234295055270195
sera O 0 0.059613220393657684
from O 0 0.007484585512429476
the O 0 0.009526155889034271
Hp1 O 1 0.9861657619476318
phenotype O 1 0.9983173608779907
( O 0 0.016787301748991013
1 O 0 0.01090687420219183
. O 0 0.006554082501679659
26 O 0 0.015923747792840004
+ O 1 0.7129030823707581
/ O 0 0.2639225125312805
- O 0 0.04061942547559738
0 O 0 0.01880330964922905
. O 0 0.00861052330583334
33 O 0 0.02496693655848503
mg O 1 0.9511114358901978
/ O 1 0.7135074734687805
ml O 1 0.9240696430206299
; O 0 0.01738753914833069
n O 0 0.04068060964345932
= O 0 0.04449307546019554
9 O 0 0.011432789266109467
) O 0 0.008196387439966202
, O 0 0.00469382805749774
showing O 0 0.013263248838484287
a O 0 0.021948495879769325
gene O 1 0.9973770380020142
- O 1 0.8102452754974365
dosage O 1 0.9788894653320312
effect O 0 0.13407287001609802
. O 0 0.027397235855460167

The O 0 0.020185871049761772
other O 0 0.017786486074328423
allele O 1 0.9839696884155273
( O 0 0.02251565270125866
Hp2 O 1 0.5578227639198303
) O 0 0.00909640733152628
of O 0 0.004493196029216051
individuals O 0 0.010277518071234226
with O 0 0.008875863626599312
Hp2 O 1 0.9837348461151123
/ O 1 0.7525626420974731
Hpdel O 1 0.7032692432403564
was O 0 0.00601536501199007
found O 0 0.00573553005233407
to O 0 0.0027649598196148872
have O 0 0.002557129133492708
, O 0 0.002737035509198904
in O 0 0.003499566577374935
all O 0 0.00402562553063035
exons O 1 0.6612479090690613
, O 0 0.007035073358565569
no O 0 0.009874007664620876
mutation O 1 0.9955315589904785
, O 0 0.007987907156348228
by O 0 0.013915400952100754
DNA O 1 0.938696026802063
sequencing O 1 0.8469597697257996
. O 0 0.028917379677295685

On O 0 0.009990010410547256
the O 0 0.005021035671234131
basis O 0 0.004629774950444698
of O 0 0.0026430601719766855
the O 0 0.0031782493460923433
present O 0 0.005095353815704584
study O 0 0.008357192389667034
, O 0 0.0031562242656946182
the O 0 0.0034871501848101616
mechanism O 0 0.04389212280511856
of O 0 0.004707016050815582
anhaptoglobinemia B-Disease 0 0.3650076687335968
and O 0 0.004383707419037819
the O 0 0.005290956702083349
mechanism O 0 0.07439517229795456
of O 0 0.006981594022363424
anomalous O 1 0.9123449921607971
inheritance O 1 0.8528370261192322
of O 0 0.011393729597330093
Hp O 1 0.8055693507194519
phenotypes O 1 0.9835087656974792
were O 0 0.007959870621562004
well O 0 0.011218004859983921
explained O 0 0.024578148499131203
. O 0 0.02100113220512867

However O 0 0.02068200148642063
, O 0 0.009821578860282898
the O 0 0.008599747903645039
mechanism O 0 0.039393551647663116
of O 0 0.011149391531944275
hypohaptoglobinemia B-Disease 1 0.6446657776832581
remains O 0 0.03589814156293869
unknown O 0 0.06659012287855148

ATM O 1 0.871685266494751
mutations O 1 0.9880232810974121
and O 0 0.02328469790518284
phenotypes O 1 0.9897547364234924
in O 0 0.06075913459062576
ataxia B-Disease 1 0.9995853304862976
- I-Disease 1 0.9829584956169128
telangiectasia I-Disease 1 0.9977219700813293
families O 0 0.020991483703255653
in O 0 0.006756563670933247
the O 0 0.005992213264107704
British O 0 0.011497283354401588
Isles O 0 0.03132697939872742
: O 0 0.009966710582375526
expression O 0 0.024848083034157753
of O 0 0.007751787547022104
mutant O 1 0.9736477136611938
ATM O 0 0.2575755715370178
and O 0 0.0060708774253726006
the O 0 0.007168769370764494
risk O 1 0.9643841981887817
of O 0 0.053966838866472244
leukemia B-Disease 1 0.9998959302902222
, O 0 0.4130363464355469
lymphoma B-Disease 1 0.9998718500137329
, O 0 0.027118589729070663
and O 0 0.11252512782812119
breast B-Disease 1 0.9997939467430115
cancer I-Disease 1 0.9994456171989441
. O 0 0.04821489378809929

We O 0 0.012592405080795288
report O 0 0.01011096965521574
the O 0 0.007084350101649761
spectrum O 0 0.02578624151647091
of O 0 0.009710383601486683
59 O 0 0.050900399684906006
ATM O 1 0.9407476186752319
mutations O 1 0.9973998069763184
observed O 0 0.1651860773563385
in O 0 0.0335521437227726
ataxia B-Disease 1 0.9995487332344055
- I-Disease 1 0.984655499458313
telangiectasia I-Disease 1 0.9979321956634521
( O 0 0.04267168417572975
A B-Disease 0 0.12086686491966248
- I-Disease 1 0.9579708576202393
T I-Disease 1 0.9964219331741333
) O 0 0.033917136490345
patients O 1 0.9559356570243835
in O 0 0.006931268610060215
the O 0 0.007978531531989574
British O 0 0.020049626007676125
Isles O 0 0.1432148814201355
. O 0 0.028991030529141426

Of O 0 0.02363116480410099
51 O 0 0.056830789893865585
ATM O 1 0.8619092702865601
mutations O 1 0.994953453540802
identified O 0 0.021341748535633087
in O 0 0.005590009968727827
families O 0 0.008816582150757313
native O 0 0.006737390533089638
to O 0 0.0035750768147408962
the O 0 0.003910942934453487
British O 0 0.009402014315128326
Isles O 0 0.026777325198054314
, O 0 0.00510807940736413
11 O 0 0.007591906003654003
were O 0 0.004987276624888182
founder O 0 0.1573573648929596
mutations O 1 0.9968295693397522
, O 0 0.005002071149647236
and O 0 0.0030624454375356436
2 O 0 0.005317287519574165
of O 0 0.003408660413697362
these O 0 0.00412137433886528
11 O 0 0.008821109309792519
conferred O 0 0.024037137627601624
a O 0 0.01753692887723446
milder O 1 0.9951423406600952
clinical O 1 0.9981180429458618
phenotype O 1 0.9978150129318237
with O 0 0.00859519187361002
respect O 0 0.007883721962571144
to O 0 0.0054784901440143585
both O 0 0.012437237426638603
cerebellar B-Disease 1 0.9988428354263306
degeneration I-Disease 1 0.999017596244812
and O 0 0.018146079033613205
cellular O 1 0.9456984400749207
features O 0 0.0320897251367569
. O 0 0.023389721289277077

We O 0 0.011971439234912395
report O 0 0.009399261325597763
, O 0 0.004674739670008421
in O 0 0.004203526768833399
two O 0 0.005585455801337957
A B-Disease 0 0.03464408963918686
- I-Disease 1 0.6485117077827454
T I-Disease 1 0.9868130683898926
families O 0 0.015462907031178474
, O 0 0.006204070057719946
an O 0 0.008740884251892567
ATM O 1 0.9491284489631653
mutation O 1 0.9984099864959717
( O 0 0.0347735732793808
7271T O 1 0.9637150764465332
- O 1 0.8257938623428345
- O 1 0.8145848512649536
> O 1 0.9750989079475403
G O 1 0.7614686489105225
) O 0 0.008571458049118519
that O 0 0.00375050725415349
may O 0 0.0051404694095253944
be O 0 0.0023921430110931396
associated O 0 0.006834180559962988
with O 0 0.0036716368049383163
an O 0 0.0042558517307043076
increased O 0 0.07282642275094986
risk O 1 0.9757761359214783
of O 0 0.04935615882277489
breast B-Disease 1 0.999904990196228
cancer I-Disease 1 0.9994668364524841
in O 0 0.010147974826395512
both O 0 0.012003414332866669
homozygotes O 1 0.9897438883781433
and O 0 0.011857930570840836
heterozygotes O 1 0.9901463389396667
( O 0 0.016804559156298637
relative O 0 0.03797155246138573
risk O 1 0.5698492527008057
12 O 0 0.010770495049655437
. O 0 0.006074290722608566
7 O 0 0.011947980150580406
; O 0 0.012647676281630993
P O 0 0.4661940634250641
= O 0 0.17562679946422577
. O 0 0.008692881092429161
0025 O 1 0.9771538972854614
) O 0 0.007821658626198769
, O 0 0.003639394650235772
although O 0 0.003353258827701211
there O 0 0.002563315210863948
is O 0 0.003064150922000408
a O 0 0.005813016556203365
less O 0 0.011698344722390175
severe O 1 0.9833407998085022
A B-Disease 0 0.35578081011772156
- I-Disease 1 0.9723281860351562
T I-Disease 1 0.9984279870986938
phenotype O 1 0.9975183010101318
in O 0 0.007848859764635563
terms O 0 0.006564401555806398
of O 0 0.0036737758200615644
the O 0 0.005517713725566864
degree O 0 0.01893031969666481
of O 0 0.015724655240774155
cerebellar B-Disease 1 0.9983738660812378
degeneration I-Disease 1 0.9985670447349548
. O 0 0.04721817374229431

This O 0 0.03492073714733124
mutation O 1 0.9875341653823853
( O 0 0.03800026699900627
7271T O 1 0.9436070322990417
- O 1 0.6540301442146301
- O 1 0.8074228763580322
> O 1 0.9647680521011353
G O 1 0.6655076146125793
) O 0 0.010751206427812576
also O 0 0.005271023139357567
allows O 0 0.011520251631736755
expression O 0 0.016346720978617668
of O 0 0.00451858201995492
full O 0 0.008653858676552773
- O 0 0.04772360250353813
length O 0 0.030612166970968246
ATM O 1 0.7354424595832825
protein O 1 0.7696834206581116
at O 0 0.007770945783704519
a O 0 0.007666280958801508
level O 0 0.008745082654058933
comparable O 0 0.01341645885258913
with O 0 0.005377903580665588
that O 0 0.0045157140120863914
in O 0 0.008680913597345352
unaffected O 1 0.7542102932929993
individuals O 0 0.03570344299077988
. O 0 0.021408962085843086

In O 0 0.015302530489861965
addition O 0 0.01211228221654892
, O 0 0.00496475538238883
we O 0 0.0033434501383453608
have O 0 0.0039091454818844795
studied O 0 0.010125047527253628
18 O 0 0.011777880601584911
A B-Disease 0 0.05513491481542587
- I-Disease 1 0.9636724591255188
T I-Disease 1 0.9981940388679504
patients O 1 0.9935399889945984
, O 0 0.006282920017838478
in O 0 0.005134079605340958
15 O 0 0.008238996379077435
families O 0 0.009791945107281208
, O 0 0.00577934505417943
who O 0 0.010821603238582611
developed O 1 0.9623881578445435
leukemia B-Disease 1 0.9998818635940552
, O 0 0.19245296716690063
lymphoma B-Disease 1 0.999835729598999
, O 0 0.026473600417375565
preleukemic O 1 0.9900834560394287
T O 1 0.9963816404342651
- O 1 0.9640120267868042
cell O 1 0.9924772381782532
proliferation O 1 0.9599844217300415
, O 0 0.018289389088749886
or O 1 0.5376846790313721
Hodgkin B-Disease 1 0.9998756647109985
lymphoma I-Disease 1 0.9998237490653992
, O 0 0.015183044597506523
mostly O 0 0.015230037271976471
in O 0 0.01664252020418644
childhood O 1 0.7533049583435059
. O 0 0.03214377164840698

A O 0 0.028873199597001076
wide O 0 0.025876307860016823
variety O 0 0.02098308876156807
of O 0 0.010104442946612835
ATM O 1 0.9268128275871277
mutation O 1 0.9974276423454285
types O 0 0.058190420269966125
, O 0 0.007926387712359428
including O 0 0.010863938368856907
missense O 1 0.9950351715087891
mutations O 1 0.9975123405456543
and O 0 0.006256924010813236
in O 0 0.006352120079100132
- O 0 0.1158364787697792
frame O 0 0.10176116228103638
deletions O 1 0.8916667103767395
, O 0 0.0053679863922297955
were O 0 0.0034072871785610914
seen O 0 0.00862571969628334
in O 0 0.007537414785474539
these O 0 0.011757424101233482
patients O 1 0.9911912083625793
. O 0 0.026064781472086906

We O 0 0.010367211885750294
also O 0 0.005585688631981611
show O 0 0.005768592935055494
that O 0 0.0033544828183948994
25 O 0 0.00487185874953866
% O 0 0.005819490645080805
of O 0 0.0032597731333225965
all O 0 0.004222719930112362
A B-Disease 0 0.05219090357422829
- I-Disease 1 0.9428303837776184
T I-Disease 1 0.997850775718689
patients O 1 0.9890011548995972
carried O 0 0.014092582277953625
in O 0 0.008999545127153397
- O 0 0.12581203877925873
frame O 0 0.1662687063217163
deletions O 1 0.9548547267913818
or O 0 0.03291381895542145
missense O 1 0.996889054775238
mutations O 1 0.997622549533844
, O 0 0.005130836274474859
many O 0 0.002943305065855384
of O 0 0.002289897296577692
which O 0 0.0021691240835934877
were O 0 0.0019367996137589216
also O 0 0.003310134168714285
associated O 0 0.0094539113342762
with O 0 0.00542648509144783
expression O 0 0.04865489900112152
of O 0 0.009978152811527252
mutant O 1 0.9866761565208435
ATM O 1 0.9481740593910217
protein O 1 0.9649904370307922
. O 0 0.03342645242810249

The O 0 0.03890471160411835
DMPK O 1 0.9233821034431458
gene O 1 0.9801771640777588
of O 0 0.02786966972053051
severely O 1 0.975739598274231
affected O 1 0.9912741780281067
myotonic B-Disease 1 0.9997089505195618
dystrophy I-Disease 1 0.9997922778129578
patients O 1 0.9960604310035706
is O 0 0.027773721143603325
hypermethylated O 1 0.9324577450752258
proximal O 1 0.9666962027549744
to O 0 0.00847198348492384
the O 0 0.008040405809879303
largely O 0 0.017859743908047676
expanded O 0 0.029991956427693367
CTG O 1 0.9183582067489624
repeat O 0 0.3042556941509247
. O 0 0.02847873978316784

Using O 0 0.05865192040801048
methylation O 1 0.8525769114494324
- O 0 0.11919330805540085
sensitive O 0 0.04185846075415611
restriction O 0 0.11862069368362427
enzymes O 1 0.8343093991279602
, O 0 0.007023302372545004
we O 0 0.005031098611652851
characterized O 0 0.03398856893181801
the O 0 0.006380350328981876
methylation O 1 0.9212440848350525
pattern O 0 0.05790901929140091
on O 0 0.00356662436388433
the O 0 0.0034448872320353985
5 O 0 0.005081437062472105
side O 0 0.004295678343623877
of O 0 0.003265451407060027
the O 0 0.005481161177158356
CTG O 1 0.9299994707107544
repeat O 0 0.07094608247280121
in O 0 0.005929174367338419
the O 0 0.0080385971814394
DMPK O 1 0.9834670424461365
gene O 1 0.9929678440093994
of O 0 0.007386513985693455
normal O 0 0.0938374325633049
individuals O 0 0.011543700471520424
and O 0 0.005038025323301554
of O 0 0.008104302920401096
patients O 1 0.9978247880935669
affected O 1 0.8324301242828369
with O 0 0.3063484728336334
myotonic B-Disease 1 0.9997116923332214
dystrophy I-Disease 1 0.9995008707046509
, O 0 0.015401959419250488
showing O 0 0.01940276473760605
expansions O 0 0.03818266838788986
of O 0 0.008034647442400455
the O 0 0.011505642905831337
repetitive O 1 0.9645327925682068
sequence O 0 0.3934954106807709
. O 0 0.031197892501950264

The O 0 0.03653139993548393
gene O 1 0.9555123448371887
segment O 0 0.052186429500579834
analyzed O 0 0.034614887088537216
corresponds O 0 0.023371482267975807
to O 0 0.0068375058472156525
the O 0 0.011426964774727821
genomic O 1 0.988041877746582
SacI O 1 0.9673335552215576
- O 0 0.3482019007205963
HindIII O 1 0.7676070332527161
fragment O 0 0.1912098079919815
carrying O 0 0.0381169468164444
exons O 1 0.6329830884933472
11 O 0 0.032503414899110794
- O 0 0.06170693784952164
15 O 0 0.027745578438043594
. O 0 0.024929527193307877

There O 0 0.01891404204070568
is O 0 0.014380327425897121
constitutive O 1 0.6041920185089111
methylation O 1 0.8185898065567017
in O 0 0.01648268662393093
intron O 1 0.960669994354248
12 O 0 0.015835966914892197
at O 0 0.008759896270930767
restriction O 0 0.019372841343283653
sites O 0 0.008951075375080109
of O 0 0.006027654744684696
SacII O 0 0.35174885392189026
and O 0 0.008842124603688717
HhaI O 1 0.5273271799087524
, O 0 0.010779659263789654
localized O 1 0.8519617319107056
1 O 0 0.013994674198329449
, O 0 0.008058822713792324
159 O 0 0.034312035888433456
- O 0 0.03235745057463646
1 O 0 0.011410004459321499
, O 0 0.007241383660584688
232 O 0 0.025289999321103096
bp O 0 0.03318587318062782
upstream O 0 0.023019568994641304
of O 0 0.005723029840737581
the O 0 0.007201832253485918
CTG O 1 0.9299565553665161
repeat O 0 0.2749825716018677
, O 0 0.0053008561953902245
whereas O 0 0.012633155100047588
most O 0 0.0036286194808781147
, O 0 0.0027036089450120926
if O 0 0.002579409396275878
not O 0 0.0015762225957587361
all O 0 0.0014440747909247875
, O 0 0.0017050998285412788
of O 0 0.0015399158000946045
the O 0 0.001976500963792205
other O 0 0.0025728957261890173
sites O 0 0.005124322138726711
of O 0 0.004590162076056004
SacII O 1 0.8537574410438538
, O 0 0.007918532006442547
HhaI O 1 0.6296818256378174
, O 0 0.004653568379580975
and O 0 0.004086206201463938
HpaII O 0 0.42455020546913147
in O 0 0.004001465626060963
this O 0 0.0034145989920943975
region O 0 0.006898792460560799
are O 0 0.004602664150297642
unmethylated O 1 0.8523260354995728
, O 0 0.005028680898249149
in O 0 0.004839393775910139
normal O 0 0.04347921907901764
individuals O 0 0.00833778828382492
and O 0 0.003375633619725704
most O 0 0.004017419181764126
of O 0 0.0046090297400951385
the O 0 0.011043158359825611
patients O 1 0.9883314967155457
. O 0 0.024486493319272995

In O 0 0.013824867084622383
a O 0 0.009333478286862373
number O 0 0.005274779628962278
of O 0 0.004746086895465851
young O 0 0.017281655222177505
and O 0 0.007274290546774864
severely O 1 0.9535015225410461
affected O 1 0.9177214503288269
patients O 1 0.9950022101402283
, O 0 0.005032215733081102
however O 0 0.004524424206465483
, O 0 0.003355456981807947
complete O 0 0.007375530898571014
methylation O 1 0.5129428505897522
of O 0 0.003501642495393753
these O 0 0.004285028669983149
restriction O 0 0.020752718672156334
sites O 0 0.007236866746097803
was O 0 0.004164530895650387
found O 0 0.007161069195717573
in O 0 0.007112229708582163
the O 0 0.012422538362443447
mutated O 1 0.9960712194442749
allele O 1 0.9913593530654907
. O 0 0.035962022840976715

In O 0 0.014481527730822563
most O 0 0.007749198470264673
of O 0 0.005795433651655912
these O 0 0.009048462845385075
patients O 1 0.9590343236923218
, O 0 0.006969432812184095
the O 0 0.008171971887350082
onset O 1 0.9953393936157227
of O 0 0.010900420136749744
the O 0 0.02268330752849579
disease O 1 0.9994174242019653
was O 0 0.0794086679816246
congenital O 1 0.9991517066955566
. O 0 0.04831381142139435

Preliminary O 0 0.04399457573890686
in O 0 0.024133695289492607
vivo O 1 0.9627781510353088
footprinting O 1 0.9626789093017578
data O 0 0.01576787233352661
gave O 0 0.009838082827627659
evidence O 0 0.009018882177770138
for O 0 0.00848205853253603
protein O 1 0.9876043796539307
- O 1 0.6816030740737915
DNA O 1 0.9838497638702393
contact O 0 0.05100216343998909
in O 0 0.007785883266478777
normal O 0 0.26366233825683594
genes O 1 0.973131000995636
at O 0 0.00836916733533144
an O 0 0.007616267539560795
Sp1 O 1 0.9786834716796875
consensus O 0 0.01542166993021965
binding O 0 0.024289969354867935
site O 0 0.008442800492048264
upstream O 0 0.01744668558239937
of O 0 0.004045619163662195
the O 0 0.006117795128375292
CTG O 1 0.9103755354881287
repeat O 0 0.08747950196266174
and O 0 0.0036184536293148994
for O 0 0.003512434661388397
a O 0 0.0048221442848443985
significant O 0 0.007254909258335829
reduction O 0 0.017950130626559258
of O 0 0.0036100635770708323
this O 0 0.004127614665776491
interaction O 0 0.045758072286844254
in O 0 0.0075318594463169575
cells O 1 0.9721077084541321
with O 0 0.009619314223527908
a O 0 0.019636891782283783
hypermethylated O 1 0.9679567217826843
DMPK O 1 0.9842600226402283
gene O 1 0.9901920557022095
. O 0 0.02262725867331028
. O 0 0.025500956922769547

The O 0 0.0564449168741703
hemochromatosis B-Disease 1 0.9974350333213806
gene O 1 0.9877605438232422
product O 0 0.05341138318181038
complexes O 0 0.12906178832054138
with O 0 0.010646551847457886
the O 0 0.011324997060000896
transferrin O 1 0.9806802272796631
receptor O 1 0.9757335782051086
and O 0 0.010996740311384201
lowers O 1 0.7546659111976624
its O 0 0.014549206010997295
affinity O 0 0.2540586292743683
for O 0 0.014076022431254387
ligand O 1 0.802928626537323
binding O 0 0.1252952516078949
. O 0 0.02529132552444935

We O 0 0.014506020583212376
recently O 0 0.016995815560221672
reported O 0 0.0114771518856287
the O 0 0.006830187980085611
positional O 0 0.3233351409435272
cloning O 0 0.49608269333839417
of O 0 0.006403557024896145
a O 0 0.010983233340084553
candidate O 0 0.04078160226345062
gene O 1 0.9929070472717285
for O 0 0.03174906224012375
hereditary B-Disease 1 0.9974506497383118
hemochromatosis I-Disease 1 0.998896598815918
called O 0 0.2983112931251526
HFE O 1 0.9829995036125183
. O 0 0.054889556020498276

The O 0 0.025354867801070213
gene O 1 0.9811907410621643
product O 0 0.02421281300485134
, O 0 0.005896896589547396
a O 0 0.006000153720378876
member O 0 0.004197822418063879
of O 0 0.002666235202923417
the O 0 0.004270016215741634
major O 0 0.016425156965851784
histocompatibility O 1 0.9968069791793823
complex O 0 0.04949655756354332
class O 0 0.019974656403064728
I O 0 0.009691867977380753
- O 0 0.053744763135910034
like O 0 0.009702462702989578
family O 0 0.01173145230859518
, O 0 0.0036323796957731247
was O 0 0.0028463327325880527
found O 0 0.004817955195903778
to O 0 0.003057396737858653
have O 0 0.004192650783807039
a O 0 0.011247259564697742
mutation O 1 0.997938334941864
, O 0 0.016927991062402725
Cys O 1 0.9919983744621277
- O 1 0.6567803025245667
282 O 1 0.837447464466095
- O 1 0.8513953685760498
- O 1 0.839492678642273
> O 1 0.9713504910469055
Tyr O 1 0.9778414964675903
( O 0 0.02840138040482998
C282Y O 1 0.6161214113235474
) O 0 0.010159986093640327
, O 0 0.00468151131644845
in O 0 0.004734544083476067
85 O 0 0.013799639418721199
% O 0 0.011251428164541721
of O 0 0.012066937983036041
patient O 1 0.9867466688156128
chromosomes O 1 0.9664321541786194
. O 0 0.03069746494293213

This O 0 0.02661486528813839
mutation O 1 0.9918870329856873
eliminates O 0 0.16802066564559937
the O 0 0.009320925921201706
ability O 0 0.01633199118077755
of O 0 0.008594037964940071
HFE O 1 0.975093424320221
to O 0 0.009384900331497192
associate O 0 0.02016136422753334
with O 0 0.012346561998128891
beta2 O 1 0.9703364372253418
- O 1 0.6595380902290344
microglobulin O 1 0.9353434443473816
( O 0 0.023458587005734444
beta2m O 1 0.6366760730743408
) O 0 0.014549423940479755
and O 0 0.009005777537822723
prevents O 1 0.9668398499488831
cell O 1 0.9738761782646179
- O 0 0.29390156269073486
surface O 0 0.04541974514722824
expression O 0 0.18176774680614471
. O 0 0.026143649592995644

A O 0 0.028432698920369148
second O 0 0.019404377788305283
mutation O 1 0.993597149848938
that O 0 0.005916759371757507
has O 0 0.004919496364891529
no O 0 0.005746678914874792
effect O 0 0.014585752040147781
on O 0 0.005849561188369989
beta2m O 1 0.8016374111175537
association O 0 0.01738755591213703
, O 0 0.0063810148276388645
H63D O 1 0.6666371822357178
, O 0 0.004128704313188791
was O 0 0.0034104441292583942
found O 0 0.004560431931167841
in O 0 0.003561249701306224
eight O 0 0.004882448352873325
out O 0 0.004578942898660898
of O 0 0.004401965998113155
nine O 0 0.014813649468123913
patients O 1 0.9950653910636902
heterozygous O 1 0.9803336262702942
for O 0 0.01159951463341713
the O 0 0.014642009511590004
C282Y O 1 0.8793825507164001
mutant O 1 0.9621294140815735
. O 0 0.03955904394388199

In O 0 0.014742070809006691
this O 0 0.006298556923866272
report O 0 0.0071457624435424805
, O 0 0.004319933708757162
we O 0 0.0036228999961167574
demonstrate O 0 0.010230613872408867
in O 0 0.008096185512840748
cultured O 1 0.9272195100784302
293 O 1 0.9576900005340576
cells O 1 0.996321439743042
overexpressing O 1 0.9948444366455078
wild O 0 0.38591474294662476
- O 0 0.3727310299873352
type O 0 0.364637166261673
or O 0 0.02393433265388012
mutant O 1 0.9936562180519104
HFE O 1 0.9970735311508179
proteins O 1 0.8180599808692932
that O 0 0.005671319086104631
both O 0 0.004408499225974083
the O 0 0.005005326122045517
wild O 0 0.09671758115291595
- O 0 0.2689712643623352
type O 0 0.20831529796123505
and O 0 0.009595232084393501
H63D O 1 0.9823371171951294
HFE O 1 0.9960092306137085
proteins O 1 0.9475629329681396
form O 0 0.052062902599573135
stable O 0 0.3114306926727295
complexes O 0 0.18247637152671814
with O 0 0.008868479169905186
the O 0 0.01187741756439209
transferrin O 1 0.989046037197113
receptor O 1 0.9909020066261292
( O 0 0.05235931649804115
TfR O 1 0.9786802530288696
) O 0 0.03241386637091637
. O 0 0.025185443460941315

The O 0 0.033956319093704224
C282Y O 1 0.8585683107376099
mutation O 1 0.9867634177207947
nearly O 0 0.024731090292334557
completely O 0 0.02208913117647171
prevents O 0 0.2902071177959442
the O 0 0.006153309717774391
association O 0 0.009284981526434422
of O 0 0.0048210592940449715
the O 0 0.009475531056523323
mutant O 1 0.9935330152511597
HFE O 1 0.9954238533973694
protein O 1 0.9664731621742249
with O 0 0.01682131551206112
the O 0 0.01696632243692875
TfR O 1 0.9510427713394165
. O 0 0.034762486815452576

Studies O 0 0.053401388227939606
on O 0 0.01503776852041483
cell O 1 0.9185565114021301
- O 0 0.1885116696357727
associated O 0 0.05727589502930641
transferrin O 1 0.8654091358184814
at O 0 0.011062630452215672
37 O 0 0.017685696482658386
degrees O 0 0.01702834665775299
C O 0 0.06939297169446945
suggest O 0 0.012592594139277935
that O 0 0.004633410833775997
the O 0 0.007507926784455776
overexpressed O 1 0.983110785484314
wild O 0 0.240976482629776
- O 1 0.7409548759460449
type O 1 0.9340667724609375
HFE O 1 0.9958571791648865
protein O 1 0.9848699569702148
decreases O 0 0.27255305647850037
the O 0 0.009700273163616657
affinity O 0 0.05063551664352417
of O 0 0.007847735658288002
the O 0 0.011060785502195358
TfR O 1 0.9690222144126892
for O 0 0.01992526836693287
transferrin O 1 0.9566201567649841
. O 0 0.03482743352651596

The O 0 0.04118522256612778
overexpressed O 1 0.9783510565757751
H63D O 1 0.9611532092094421
protein O 1 0.9485819339752197
does O 0 0.01271874364465475
not O 0 0.003818623721599579
have O 0 0.0029314346611499786
this O 0 0.0027079577557742596
effect O 0 0.009613691829144955
, O 0 0.0034135833848267794
providing O 0 0.006221961695700884
the O 0 0.0025134473107755184
first O 0 0.003624253673478961
direct O 0 0.00700946431607008
evidence O 0 0.005635770037770271
for O 0 0.003933336120098829
a O 0 0.007832728326320648
functional O 0 0.22209784388542175
consequence O 0 0.030124295502901077
of O 0 0.006606805603951216
the O 0 0.01305381115525961
H63D O 1 0.9763175249099731
mutation O 1 0.9958173632621765
. O 0 0.04264083877205849

Addition O 0 0.033716872334480286
of O 0 0.016987180337309837
soluble O 1 0.958092212677002
wild O 0 0.27735793590545654
- O 1 0.7296222448348999
type O 1 0.9203386306762695
HFE O 1 0.9951098561286926
/ O 1 0.7997589111328125
beta2m O 1 0.8839598894119263
heterodimers O 1 0.9682037234306335
to O 0 0.013432714156806469
cultured O 1 0.9692503809928894
cells O 1 0.9844138622283936
also O 0 0.007875341922044754
decreased O 0 0.06149934232234955
the O 0 0.006851524580270052
apparent O 0 0.0835425928235054
affinity O 0 0.10604546964168549
of O 0 0.0051776147447526455
the O 0 0.006368749774992466
TfR O 1 0.946733832359314
for O 0 0.005336820147931576
its O 0 0.006563014350831509
ligand O 1 0.5129066705703735
under O 0 0.007254661526530981
steady O 0 0.01886560395359993
- O 0 0.024433668702840805
state O 0 0.006213482469320297
conditions O 0 0.013252443633973598
, O 0 0.004282923880964518
both O 0 0.004617613274604082
in O 0 0.006542874965816736
293 O 1 0.8371137380599976
cells O 1 0.9880163073539734
and O 0 0.009672500193119049
in O 0 0.016479989513754845
HeLa O 1 0.9943403005599976
cells O 1 0.9890496730804443
. O 0 0.03739151731133461

Furthermore O 0 0.041017383337020874
, O 0 0.010909050703048706
at O 0 0.009722552262246609
4 O 0 0.013388527557253838
degrees O 0 0.01593930646777153
C O 0 0.03357655555009842
, O 0 0.004453334957361221
the O 0 0.004583792295306921
added O 0 0.009513868018984795
soluble O 1 0.8803208470344543
complex O 0 0.025908976793289185
of O 0 0.013568620197474957
HFE O 1 0.9941707253456116
/ O 1 0.8090799450874329
beta2m O 1 0.8357222676277161
inhibited O 1 0.8244144916534424
binding O 0 0.03991216421127319
of O 0 0.012091883458197117
transferrin O 1 0.896851122379303
to O 0 0.019153008237481117
HeLa O 1 0.9965094923973083
cell O 1 0.9868768453598022
TfR O 1 0.9697690606117249
in O 0 0.011832445859909058
a O 0 0.016027795150876045
concentration O 0 0.36153969168663025
- O 0 0.3662487864494324
dependent O 0 0.13051873445510864
manner O 0 0.04010468348860741
. O 0 0.02522803470492363

Scatchard O 0 0.2190070003271103
plots O 0 0.03015349805355072
of O 0 0.0061723110266029835
these O 0 0.0044677481055259705
data O 0 0.006491132080554962
indicate O 0 0.008247346617281437
that O 0 0.003263285383582115
the O 0 0.003973429556936026
added O 0 0.010811323300004005
heterodimer O 1 0.9492271542549133
substantially O 0 0.12010794878005981
reduced O 0 0.019927628338336945
the O 0 0.007824983447790146
affinity O 0 0.22211183607578278
of O 0 0.012161975726485252
TfR O 1 0.960197925567627
for O 0 0.021495221182703972
transferrin O 1 0.9550267457962036
. O 0 0.034638628363609314

These O 0 0.015774251893162727
results O 0 0.01970575749874115
establish O 0 0.01928975246846676
a O 0 0.013348112814128399
molecular O 1 0.8972979784011841
link O 0 0.0816449522972107
between O 0 0.013061868958175182
HFE O 1 0.9809957146644592
and O 0 0.005404895171523094
a O 0 0.007347648497670889
key O 0 0.012679566629230976
protein O 1 0.9392877817153931
involved O 0 0.010975436307489872
in O 0 0.004840863402932882
iron O 0 0.024783391505479813
transport O 0 0.011542928405106068
, O 0 0.004813033621758223
the O 0 0.005177590064704418
TfR O 1 0.9786918759346008
, O 0 0.004362562205642462
and O 0 0.003227545879781246
raise O 0 0.007140909321606159
the O 0 0.0034102466888725758
possibility O 0 0.009893765673041344
that O 0 0.0038379288744181395
alterations O 0 0.05521540343761444
in O 0 0.0044426522217690945
this O 0 0.004282488487660885
regulatory O 0 0.4331263601779938
mechanism O 0 0.42655399441719055
may O 0 0.009671964682638645
play O 0 0.0048767877742648125
a O 0 0.005535839591175318
role O 0 0.008654983714222908
in O 0 0.005814769770950079
the O 0 0.009681995958089828
pathogenesis O 1 0.9971404075622559
of O 0 0.03168352320790291
hereditary B-Disease 1 0.9988341927528381
hemochromatosis I-Disease 1 0.9993095397949219
. O 0 0.0322624035179615
. O 0 0.031301286071538925

Genomic O 1 0.9037153720855713
organization O 0 0.028381656855344772
of O 0 0.011079059913754463
the O 0 0.015143202617764473
UBE3A O 1 0.9882593154907227
/ O 1 0.8619773983955383
E6 O 1 0.9553458094596863
- O 1 0.5781770944595337
AP O 0 0.29422909021377563
gene O 1 0.9766759276390076
and O 0 0.015587055124342442
related O 0 0.14293840527534485
pseudogenes O 1 0.9562734961509705
. O 0 0.03565588593482971

The O 0 0.04831762611865997
UBE3A O 1 0.9621878862380981
gene O 1 0.9731404781341553
encodes O 0 0.3306562304496765
the O 0 0.02349434792995453
E6 O 1 0.8264710903167725
- O 0 0.31434395909309387
AP O 0 0.1721409410238266
ubiquitin O 1 0.9580478072166443
- O 1 0.6039503812789917
protein O 1 0.9823105335235596
ligase O 0 0.28177064657211304
and O 0 0.005858161486685276
has O 0 0.005875863134860992
recently O 0 0.008636017329990864
been O 0 0.004087862093001604
shown O 0 0.007939481176435947
to O 0 0.00485448632389307
be O 0 0.008253393694758415
mutated O 1 0.9973980188369751
in O 1 0.5996102690696716
Angelman B-Disease 1 0.999893307685852
syndrome I-Disease 1 0.9999501705169678
patients O 1 0.9966285824775696
who O 0 0.019134532660245895
lack O 0 0.12813876569271088
15q11 O 1 0.9646263718605042
- O 1 0.7368136048316956
q13 O 1 0.9506991505622864
deletions O 1 0.9669516086578369
or O 0 0.049993857741355896
chromosome O 1 0.9928604960441589
15 O 0 0.05044592544436455
paternal O 1 0.960965633392334
uniparental B-Disease 1 0.9879157543182373
disomy I-Disease 1 0.8941289782524109
. O 0 0.0533720962703228

Previous O 0 0.07320722192525864
UBE3A O 1 0.9434803128242493
cDNA O 1 0.5589340329170227
analysis O 0 0.03339255601167679
has O 0 0.009438651613891125
shown O 0 0.012940982356667519
a O 0 0.011996783316135406
coding O 1 0.7565023303031921
region O 0 0.012533643282949924
of O 0 0.006028805859386921
approximately O 0 0.012274605222046375
2 O 0 0.01608257181942463
. O 0 0.017752090469002724

6 O 0 0.04192747920751572
kb O 0 0.0635756179690361
and O 0 0.008178552612662315
a O 0 0.012253868393599987
3 O 0 0.01988832838833332
- O 0 0.1282743513584137
untranslated O 1 0.7320919036865234
region O 0 0.022981544956564903
( O 0 0.01877814717590809
UTR O 1 0.7816327810287476
) O 0 0.011661839671432972
of O 0 0.006523250136524439
< O 0 0.3311648964881897
50 O 0 0.011661411263048649
bp O 0 0.02839355729520321
, O 0 0.0066529628820717335
whereas O 0 0.013149334117770195
Northern O 0 0.008993151597678661
analysis O 0 0.012838134542107582
has O 0 0.005800221581012011
indicated O 0 0.01284815277904272
mRNA O 0 0.23198091983795166
sizes O 0 0.01737389713525772
of O 0 0.006447730120271444
5 O 0 0.015570185147225857
- O 0 0.07499726116657257
8 O 0 0.0259842611849308
kb O 0 0.27841565012931824
. O 0 0.02335355430841446

We O 0 0.011587303131818771
have O 0 0.0075554028153419495
analyzed O 0 0.0199307631701231
additional O 0 0.01435219869017601
cDNA O 1 0.801275372505188
clones O 1 0.8188551664352417
and O 0 0.005516787525266409
provide O 0 0.00693600345402956
evidence O 0 0.00716088991612196
for O 0 0.004522225819528103
an O 0 0.005805629771202803
additional O 0 0.013119189999997616
0 O 0 0.023804951459169388
. O 0 0.018818989396095276

5 O 0 0.04048958048224449
kb O 0 0.06701203435659409
of O 0 0.012502120807766914
5 O 0 0.02179977297782898
- O 0 0.10240603983402252
UTR O 1 0.6991168260574341
and O 0 0.010898527689278126
> O 0 0.4491426944732666
2 O 0 0.015076905488967896
kb O 0 0.05092473328113556
of O 0 0.00907951034605503
3 O 0 0.021636629477143288
- O 0 0.148463636636734
UTR O 1 0.8501201272010803
. O 0 0.032973386347293854

We O 0 0.011340710334479809
have O 0 0.005979038309305906
established O 0 0.008522722870111465
the O 0 0.006989798508584499
genomic O 1 0.9346213340759277
organization O 0 0.013651722110807896
of O 0 0.006595699116587639
UBE3A O 1 0.9324741363525391
and O 0 0.005574821028858423
the O 0 0.005856539122760296
sequence O 0 0.03542020544409752
of O 0 0.011774284765124321
intron O 1 0.9947906732559204
- O 1 0.7275502681732178
exon O 1 0.9511412978172302
borders O 0 0.06618988513946533
. O 0 0.03382456675171852

We O 0 0.010737542062997818
have O 0 0.006033456418663263
also O 0 0.005706225987523794
mapped O 0 0.01557962317019701
two O 0 0.00718720443546772
highly O 0 0.02760908007621765
homologous O 1 0.9846842885017395
processed O 0 0.10865745693445206
pseudogenes O 1 0.9554068446159363
, O 0 0.012133055366575718
UBE3AP1 O 0 0.48659008741378784
and O 0 0.009006394073367119
UBE3AP2 O 0 0.46678778529167175
, O 0 0.00612197769805789
to O 0 0.005143389105796814
chromosomes O 1 0.7425205707550049
2 O 0 0.009054831229150295
and O 0 0.0037768250331282616
21 O 0 0.007279622368514538
, O 0 0.0038242691662162542
respectively O 0 0.005645842291414738
, O 0 0.0032894518226385117
and O 0 0.0035207257606089115
determined O 0 0.009784375317394733
their O 0 0.009608626365661621
genomic O 1 0.9847770929336548
organization O 0 0.03116476535797119
. O 0 0.02400527149438858

These O 0 0.01373439934104681
results O 0 0.013594210147857666
will O 0 0.0038314368575811386
form O 0 0.006854224484413862
the O 0 0.003442061133682728
basis O 0 0.005351000931113958
for O 0 0.004547905642539263
studies O 0 0.015057380311191082
of O 0 0.007119965739548206
mutation O 1 0.9972566962242126
and O 0 0.012804212048649788
imprinting O 1 0.982418954372406
of O 0 0.026452593505382538
UBE3A O 1 0.9804453253746033
. O 0 0.04334831237792969

Mutation O 1 0.9926548004150391
spectrum O 0 0.21995727717876434
and O 0 0.024135077372193336
genotype O 1 0.9958322644233704
- O 1 0.9469467997550964
phenotype O 1 0.9975634813308716
analyses O 0 0.48390454053878784
in O 0 0.037743572145700455
Cowden B-Disease 1 0.9975479245185852
disease I-Disease 1 0.9991883635520935
and O 0 0.029555777087807655
Bannayan B-Disease 1 0.9914492964744568
- I-Disease 1 0.9911158084869385
Zonana I-Disease 1 0.997829020023346
syndrome I-Disease 1 0.9994907379150391
, O 0 0.025024473667144775
two O 0 0.035777315497398376
hamartoma B-Disease 1 0.9979413151741028
syndromes I-Disease 1 0.9991495609283447
with O 0 0.3236568868160248
germline O 1 0.9984676241874695
PTEN O 1 0.997395396232605
mutation O 1 0.99625164270401
. O 0 0.0501260943710804

The O 0 0.07125066965818405
tumour B-Disease 1 0.9984253644943237
suppressor O 1 0.9979118704795837
gene O 1 0.9964607357978821
PTEN O 1 0.9863870143890381
, O 0 0.013152970932424068
which O 0 0.008023477159440517
maps O 0 0.01883217692375183
to O 0 0.01377186831086874
10q23 O 0 0.38613179326057434
. O 0 0.032628584653139114

3 O 0 0.03131118044257164
and O 0 0.012422135099768639
encodes O 0 0.08534283190965652
a O 0 0.019711246713995934
403 O 0 0.10015816986560822
amino O 1 0.779338538646698
acid O 1 0.9537220001220703
dual O 0 0.2678826153278351
specificity O 1 0.910944402217865
phosphatase O 1 0.9878150224685669
( O 0 0.04818759486079216
protein O 1 0.98594069480896
tyrosine O 1 0.9893648624420166
phosphatase O 1 0.9954094290733337
; O 0 0.026646550744771957
PTPase O 1 0.7276046872138977
) O 0 0.01010728906840086
, O 0 0.004187231417745352
was O 0 0.004246376920491457
shown O 0 0.007466563954949379
recently O 0 0.007206154055893421
to O 0 0.0032601107377558947
play O 0 0.00523414509370923
a O 0 0.006825725547969341
broad O 0 0.01845156028866768
role O 0 0.01495963055640459
in O 0 0.011456720530986786
human O 1 0.6054983735084534
malignancy B-Disease 1 0.9974996447563171
. O 0 0.03541770204901695

Somatic O 1 0.9782776832580566
PTEN O 1 0.9843218326568604
deletions O 1 0.8647512793540955
and O 0 0.019709045067429543
mutations O 1 0.989395797252655
were O 0 0.008951270021498203
observed O 0 0.02335987240076065
in O 0 0.012802951037883759
sporadic B-Disease 1 0.968100905418396
breast I-Disease 1 0.9994656443595886
, I-Disease 0 0.05881711468100548
brain I-Disease 1 0.9989020824432373
, I-Disease 0 0.16257593035697937
prostate I-Disease 1 0.9998672008514404
and I-Disease 1 0.6189122796058655
kidney I-Disease 1 0.9999485015869141
cancer I-Disease 1 0.999854326248169
cell O 1 0.9904630780220032
lines O 0 0.0244120042771101
and O 0 0.005165258422493935
in O 0 0.005221049301326275
several O 0 0.00775417173281312
primary O 0 0.19913460314273834
tumours B-Disease 1 0.9981877207756042
such O 0 0.024507680907845497
as O 0 0.141719251871109
endometrial B-Disease 1 0.9997997879981995
carcinomas I-Disease 1 0.9996681213378906
, O 1 0.8944010734558105
malignant B-Disease 1 0.9999067783355713
melanoma I-Disease 1 0.999860405921936
and O 1 0.628883421421051
thyroid B-Disease 1 0.9995966553688049
tumours I-Disease 1 0.9983966946601868
. O 0 0.058293599635362625

In O 0 0.01965026557445526
addition O 0 0.02022235281765461
, O 0 0.013323417864739895
PTEN O 1 0.9769830703735352
was O 0 0.008710199035704136
identified O 0 0.014942564070224762
as O 0 0.006646997760981321
the O 0 0.010163563303649426
susceptibility O 1 0.997530996799469
gene O 1 0.9923707246780396
for O 0 0.0159810408949852
two O 0 0.0664597600698471
hamartoma B-Disease 1 0.99947589635849
syndromes I-Disease 1 0.999862790107727
Cowden B-Disease 1 0.9995195865631104
disease I-Disease 1 0.9994587302207947
( O 0 0.04416526108980179
CD B-Disease 0 0.07223213464021683
; O 0 0.027538280934095383
MIM O 1 0.9794030785560608
158350 O 1 0.6962918043136597
) O 0 0.019223565235733986
and O 0 0.012462975457310677
Bannayan B-Disease 1 0.9479687809944153
- I-Disease 1 0.774126410484314
Zonana I-Disease 1 0.9877570867538452
( I-Disease 0 0.03950027748942375
BZS I-Disease 1 0.9519352912902832
) I-Disease 0 0.022404512390494347
or I-Disease 0 0.024403205141425133
Ruvalcaba I-Disease 1 0.9880548119544983
- I-Disease 1 0.7923516631126404
Riley I-Disease 1 0.8670076727867126
- I-Disease 1 0.9284244179725647
Smith I-Disease 1 0.9379847645759583
syndrome I-Disease 1 0.9997395873069763
( O 0 0.1239895224571228
MIM O 1 0.9832997918128967
153480 O 1 0.8888039588928223
) O 0 0.03223839029669762
. O 0 0.027654577046632767

Constitutive O 1 0.7133962512016296
DNA O 0 0.4465790390968323
from O 0 0.016782954335212708
37 O 0 0.021964270621538162
CD B-Disease 0 0.020272668451070786
families O 0 0.013375552371144295
and O 0 0.00621141167357564
seven O 0 0.0122832041233778
BZS B-Disease 1 0.8500692844390869
families O 0 0.01816886104643345
was O 0 0.010334938764572144
screened O 0 0.04738536477088928
for O 0 0.022068213671445847
germline O 1 0.9982091188430786
PTEN O 1 0.9970656037330627
mutations O 1 0.9948157668113708
. O 0 0.04421262815594673

PTEN O 1 0.9828646183013916
mutations O 1 0.9786170125007629
were O 0 0.011666446924209595
identified O 0 0.014652152545750141
in O 0 0.0051928129978477955
30 O 0 0.006665495689958334
of O 0 0.004437942989170551
37 O 0 0.012112287804484367
( O 0 0.00929210800677538
81 O 0 0.015427478589117527
% O 0 0.010247188620269299
) O 0 0.007418994791805744
CD B-Disease 0 0.012959031388163567
families O 0 0.007863895036280155
, O 0 0.004755931440740824
including O 0 0.007524626329541206
missense O 1 0.9108895659446716
and O 0 0.006929440889507532
nonsense O 0 0.060287605971097946
point O 0 0.016147183254361153
mutations O 1 0.9972507357597351
, O 0 0.010473625734448433
deletions O 1 0.6653915643692017
, O 0 0.00902233924716711
insertions O 1 0.7040826082229614
, O 0 0.007776068989187479
a O 0 0.015586674213409424
deletion O 1 0.9855852723121643
/ O 1 0.529747724533081
insertion O 1 0.6993329524993896
and O 0 0.014668208546936512
splice O 1 0.957709789276123
site O 0 0.053959496319293976
mutations O 1 0.9915425777435303
. O 0 0.03620534390211105

These O 0 0.02504953369498253
mutations O 1 0.9244409203529358
were O 0 0.006203094031661749
scattered O 0 0.010017958469688892
over O 0 0.004801276605576277
the O 0 0.004241811111569405
entire O 0 0.010592514649033546
length O 0 0.014563022181391716
of O 0 0.0071566225960850716
PTEN O 1 0.9955541491508484
, O 0 0.005211516283452511
with O 0 0.003851944347843528
the O 0 0.002975745126605034
exception O 0 0.006263972260057926
of O 0 0.0025576597545295954
the O 0 0.002938763704150915
first O 0 0.004195674322545528
, O 0 0.004104929976165295
fourth O 0 0.008628280833363533
and O 0 0.005951277446001768
last O 0 0.013208655640482903
exons O 1 0.8386805653572083
. O 0 0.028092389926314354

A O 0 0.03516653925180435
hot O 0 0.03719337284564972
spot O 0 0.026755420491099358
for O 0 0.016678648069500923
PTEN O 1 0.9971444010734558
mutation O 1 0.9956594109535217
in O 0 0.010717332363128662
CD B-Disease 0 0.015953991562128067
was O 0 0.0052476306445896626
identified O 0 0.012350761331617832
in O 0 0.006748804356902838
exon O 0 0.40705275535583496
5 O 0 0.008451675064861774
that O 0 0.0035923223476856947
contains O 0 0.006359667517244816
the O 0 0.004885897506028414
PTPase O 1 0.7174060940742493
core O 0 0.020899226889014244
motif O 0 0.3145351707935333
, O 0 0.003595788264647126
with O 0 0.00348452664911747
13 O 0 0.005354037042707205
of O 0 0.003062252188101411
30 O 0 0.007170225027948618
( O 0 0.006778066046535969
43 O 0 0.01118477899581194
% O 0 0.010344921611249447
) O 0 0.010124742053449154
CD B-Disease 0 0.0865791067481041
mutations O 1 0.9965265393257141
identified O 0 0.0207989439368248
in O 0 0.008533746004104614
this O 0 0.010992048308253288
exon O 1 0.7061375379562378
. O 0 0.03063143789768219

Seven O 0 0.01909448206424713
of O 0 0.007412255741655827
30 O 0 0.010039645247161388
( O 0 0.008405602537095547
23 O 0 0.00771113857626915
% O 0 0.006315238308161497
) O 0 0.0038345465436577797
were O 0 0.0015629937406629324
within O 0 0.002712432760745287
the O 0 0.002485421719029546
core O 0 0.010217471048235893
motif O 0 0.24998193979263306
, O 0 0.003191583324223757
the O 0 0.002912369091063738
majority O 0 0.005998600739985704
( O 0 0.004826422780752182
five O 0 0.0030876770615577698
of O 0 0.002334402874112129
seven O 0 0.003930574748665094
) O 0 0.0039058232214301825
of O 0 0.0022687518503516912
which O 0 0.0026940603274852037
were O 0 0.004536734893918037
missense O 1 0.9979026317596436
mutations O 1 0.9992013573646545
, O 0 0.006302695255726576
possibly O 0 0.012605074793100357
pointing O 0 0.009789078496396542
to O 0 0.003333552973344922
the O 0 0.003968107979744673
functional O 0 0.03701198846101761
significance O 0 0.009408587589859962
of O 0 0.004241573624312878
this O 0 0.005749071482568979
region O 0 0.016610506922006607
. O 0 0.01700757071375847

Germline O 1 0.9934214949607849
PTEN O 1 0.9939985275268555
mutations O 1 0.9870100021362305
were O 0 0.008687936700880527
identified O 0 0.011855707503855228
in O 0 0.004020041320472956
four O 0 0.004064096603542566
of O 0 0.0036597142461687326
seven O 0 0.006700214929878712
( O 0 0.009334572590887547
57 O 0 0.017488833516836166
% O 0 0.014650514349341393
) O 0 0.016029981896281242
BZS B-Disease 1 0.842596709728241
families O 0 0.026468772441148758
studied O 0 0.026727814227342606
. O 0 0.020600182935595512

Interestingly O 0 0.07800670713186264
, O 0 0.0102969566360116
none O 0 0.010345869697630405
of O 0 0.004518093075603247
these O 0 0.008064662106335163
mutations O 1 0.9940441250801086
was O 0 0.006526898127049208
observed O 0 0.013570737093687057
in O 0 0.00589166022837162
the O 0 0.007410804275423288
PTPase O 1 0.7532098293304443
core O 0 0.05205569788813591
motif O 1 0.7063691020011902
. O 0 0.029824625700712204

It O 0 0.01100908499211073
is O 0 0.006646751891821623
also O 0 0.004517055116593838
worthy O 0 0.01296029333025217
of O 0 0.004007331095635891
note O 0 0.009959026239812374
that O 0 0.0032200622372329235
a O 0 0.0062351045198738575
single O 0 0.010208014398813248
nonsense O 0 0.054517172276973724
point O 0 0.01418623048812151
mutation O 1 0.9978200197219849
, O 0 0.008911472745239735
R233X O 0 0.4785032272338867
, O 0 0.004880178719758987
was O 0 0.004151054657995701
observed O 0 0.009891106747090816
in O 0 0.004813728388398886
the O 0 0.007658623158931732
germline O 1 0.9967920184135437
DNA O 1 0.8392074704170227
from O 0 0.008800454437732697
two O 0 0.00811870489269495
unrelated O 0 0.25194108486175537
CD B-Disease 0 0.028766339644789696
families O 0 0.014265536330640316
and O 0 0.007512084674090147
one O 0 0.013738146983087063
BZS B-Disease 1 0.9213485717773438
family O 0 0.05507773160934448
. O 0 0.028308117762207985

Genotype O 1 0.9906188249588013
- O 1 0.9255842566490173
phenotype O 1 0.9959779977798462
studies O 0 0.025873852893710136
were O 0 0.0036494319792836905
not O 0 0.0033326689153909683
performed O 0 0.005888047628104687
on O 0 0.0029257608111947775
this O 0 0.0037752212956547737
small O 0 0.0075060962699353695
group O 0 0.010040019638836384
of O 0 0.009362136013805866
BZS B-Disease 1 0.9375131726264954
families O 0 0.03440668806433678
. O 0 0.023996910080313683

However O 0 0.031310707330703735
, O 0 0.025293631479144096
genotype O 1 0.9900561571121216
- O 1 0.855873703956604
phenotype O 1 0.9965343475341797
analysis O 0 0.06725449860095978
inthe O 1 0.7533731460571289
group O 0 0.012677531689405441
of O 0 0.005406456533819437
CD B-Disease 0 0.017299681901931763
families O 0 0.010634585283696651
revealed O 0 0.011678371578454971
two O 0 0.0047136289067566395
possible O 0 0.008616793900728226
associations O 0 0.013104388490319252
worthy O 0 0.01735573820769787
of O 0 0.004633195698261261
follow O 0 0.010681909509003162
- O 0 0.021449197083711624
up O 0 0.007709547411650419
in O 0 0.006916258949786425
independent O 0 0.013949641026556492
analyses O 0 0.04807135462760925
. O 0 0.021235385909676552

The O 0 0.011926782317459583
first O 0 0.0072712404653429985
was O 0 0.005485383793711662
an O 0 0.00507174339145422
association O 0 0.011073925532400608
noted O 0 0.006446391809731722
in O 0 0.003152197226881981
the O 0 0.0031272261403501034
group O 0 0.00589675921946764
of O 0 0.004667835775762796
CD B-Disease 0 0.03952069208025932
families O 0 0.05333811789751053
with O 0 0.3125717341899872
breast B-Disease 1 0.9997604489326477
disease I-Disease 1 0.9992656111717224
. O 0 0.04282296076416969

A O 0 0.032468944787979126
correlation O 0 0.11396326124668121
was O 0 0.007945485413074493
observed O 0 0.013981928117573261
between O 0 0.006848365068435669
the O 0 0.005552385933697224
presence O 0 0.02169741876423359
/ O 0 0.18835490942001343
absence O 0 0.017848478630185127
of O 0 0.005759312771260738
a O 0 0.01961902715265751
PTEN O 1 0.9978830218315125
mutation O 1 0.9962835907936096
and O 0 0.007092454470694065
the O 0 0.006527818739414215
type O 0 0.21047751605510712
of O 0 0.014516917057335377
breast O 1 0.9994231462478638
involvement O 1 0.631199061870575
( O 0 0.03475258871912956
unaffected O 1 0.9434985518455505
versus O 1 0.8932271599769592
benign O 1 0.9968053102493286
versus O 1 0.9784704446792603
malignant O 1 0.9992815852165222
) O 0 0.03835728392004967
. O 0 0.024787137284874916

Specifically O 0 0.028451133519411087
and O 0 0.006999654229730368
more O 0 0.004678688477724791
directly O 0 0.006872145924717188
, O 0 0.0031247446313500404
an O 0 0.003515416756272316
association O 0 0.006792804226279259
was O 0 0.0032731052488088608
also O 0 0.0030829960014671087
observed O 0 0.008968994952738285
between O 0 0.004238689783960581
the O 0 0.0038087526336312294
presence O 0 0.011465613730251789
of O 0 0.006543286144733429
a O 0 0.05916168540716171
PTEN O 1 0.9991222023963928
mutation O 1 0.9994800686836243
and O 1 0.6016832590103149
malignant B-Disease 1 0.9999023675918579
breast I-Disease 1 0.9998999834060669
disease I-Disease 1 0.9994294047355652
. O 0 0.052640896290540695

Secondly O 0 0.0625264048576355
, O 0 0.009108802303671837
there O 0 0.004651907365769148
appeared O 0 0.0061873020604252815
to O 0 0.0031967666000127792
be O 0 0.0028064141515642405
an O 0 0.004588947165757418
interdependent O 1 0.5809392333030701
association O 0 0.01858280412852764
between O 0 0.016983525827527046
mutations O 1 0.9976418018341064
upstream O 0 0.0514494888484478
and O 0 0.005351955536752939
within O 0 0.0056228032335639
the O 0 0.004989338107407093
PTPase O 1 0.6254547834396362
core O 0 0.028173405677080154
motif O 0 0.3096058964729309
, O 0 0.004782050382345915
the O 0 0.004669502377510071
core O 0 0.015375358052551746
motif O 0 0.15146927535533905
containing O 0 0.011670471169054508
the O 0 0.0046896906569600105
majority O 0 0.008019265718758106
of O 0 0.006860628258436918
missense O 1 0.9973057508468628
mutations O 1 0.9983685612678528
, O 0 0.004686820320785046
and O 0 0.002616838552057743
the O 0 0.0029900853987783194
involvement O 0 0.009259400889277458
of O 0 0.00326317991130054
all O 0 0.0034641032107174397
major O 0 0.014272874221205711
organ O 1 0.8905407786369324
systems O 0 0.11383393406867981
( O 0 0.010675632394850254
central O 0 0.01240930799394846
nervous O 1 0.9801479578018188
system O 0 0.16667532920837402
, O 0 0.029275771230459213
thyroid O 1 0.9997523427009583
, O 0 0.16506308317184448
breast O 1 0.9998007416725159
, O 0 0.11014795303344727
skin O 1 0.9992930889129639
and O 0 0.22554370760917664
gastrointestinal O 1 0.9997503161430359
tract O 1 0.9979192614555359
) O 0 0.040758006274700165
. O 0 0.026747608557343483

However O 0 0.013661639764904976
, O 0 0.0050854189321398735
these O 0 0.004165987484157085
observations O 0 0.008169800043106079
would O 0 0.0028285225853323936
need O 0 0.0036585249472409487
to O 0 0.001967833610251546
be O 0 0.002319681691005826
confirmed O 0 0.004643683787435293
by O 0 0.0031421442981809378
studying O 0 0.006588104646652937
a O 0 0.005404695402830839
larger O 0 0.008630091324448586
number O 0 0.004846301861107349
of O 0 0.005382098723202944
CD B-Disease 0 0.025835447013378143
families O 0 0.0206267349421978
. O 0 0.020111024379730225

Molecular O 1 0.9789365530014038
defects O 1 0.986009418964386
leading O 0 0.024673331528902054
to O 0 0.009302232414484024
human O 0 0.04181213676929474
complement B-Disease 1 0.5279455780982971
component I-Disease 1 0.9544070363044739
C6 I-Disease 1 0.9990924596786499
deficiency I-Disease 1 0.9996294975280762
in O 0 0.011599455960094929
an O 0 0.010618886910378933
African O 0 0.0525544136762619
- O 0 0.1784636676311493
American O 0 0.023975510150194168
family O 0 0.036053769290447235
. O 0 0.024468598887324333

Complement B-Disease 0 0.4845829904079437
component I-Disease 1 0.9200037717819214
C6 I-Disease 1 0.9972694516181946
deficiency I-Disease 1 0.999550998210907
( O 0 0.06995566934347153
C6D B-Disease 1 0.9368845224380493
) O 0 0.016702258959412575
was O 0 0.010171908885240555
diagnosed O 1 0.9943645000457764
in O 0 0.006931676063686609
a O 0 0.00906463898718357
16 O 0 0.012128952890634537
- O 0 0.05717281252145767
year O 0 0.010922362096607685
- O 0 0.06521757692098618
old O 0 0.021749241277575493
African O 0 0.07278839498758316
- O 0 0.18297691643238068
American O 0 0.024807699024677277
male O 1 0.8239526748657227
with O 0 0.36644119024276733
meningococcal B-Disease 1 0.9997439980506897
meningitis I-Disease 1 0.9994897842407227
. O 0 0.05644970014691353

The O 0 0.02759290672838688
patients O 1 0.9574984908103943
father O 0 0.017345517873764038
and O 0 0.005472860764712095
two O 0 0.005764677654951811
brothers O 0 0.018515992909669876
also O 0 0.004630254581570625
had O 0 0.005751879885792732
C6D B-Disease 1 0.6124517321586609
, O 0 0.004507104400545359
but O 0 0.0033346936106681824
gave O 0 0.005160029511898756
no O 0 0.004130218643695116
history O 0 0.006750224158167839
of O 0 0.0096231484785676
meningitis B-Disease 1 0.9995946288108826
or O 0 0.024395620450377464
other O 0 0.021184910088777542
neisserial B-Disease 1 0.9914398193359375
infection I-Disease 1 0.9989245533943176
. O 0 0.04543110355734825

By O 0 0.024780457839369774
using O 0 0.03002336621284485
exon O 1 0.725121796131134
- O 0 0.11084382236003876
specific O 0 0.03925955295562744
polymerase O 1 0.9701191782951355
chain O 1 0.6706706285476685
reaction O 0 0.2460552453994751
( O 0 0.02291252464056015
PCR O 1 0.9421448707580566
) O 0 0.017173634842038155
/ O 0 0.10134051740169525
single O 0 0.019701549783349037
- O 0 0.3359205722808838
strand O 1 0.9189521670341492
conformation O 1 0.8739914894104004
polymorphism O 1 0.7178162932395935
as O 0 0.007923985831439495
a O 0 0.011623024940490723
screening O 0 0.09745677560567856
step O 0 0.01756042242050171
and O 0 0.007295957300812006
nucleotide O 1 0.6151714324951172
sequencing O 0 0.17962515354156494
of O 0 0.0076831309124827385
target O 0 0.0165390782058239
exons O 1 0.5713908672332764
, O 0 0.004834899678826332
we O 0 0.0029524625279009342
determined O 0 0.005503356922417879
that O 0 0.002828227123245597
the O 0 0.004053483251482248
proband O 0 0.2543058395385742
was O 0 0.006162718404084444
a O 0 0.010460356250405312
compound O 0 0.05330010876059532
heterozygote O 1 0.9131399989128113
for O 0 0.011825240217149258
two O 0 0.01969495601952076
C6 O 1 0.9960106611251831
gene O 1 0.9977006316184998
mutations O 1 0.9944010376930237
. O 0 0.041753802448511124

The O 0 0.012710663489997387
first O 0 0.009863216429948807
, O 0 0.008133644238114357
1195delC O 0 0.2077292948961258
located O 0 0.009437083266675472
in O 0 0.00710385013371706
exon O 1 0.5886289477348328
7 O 0 0.010898754000663757
, O 0 0.004044837784022093
is O 0 0.0037184020038694143
a O 0 0.007414978928864002
novel O 0 0.3160898983478546
mutation O 1 0.9977648258209229
, O 0 0.004348992370069027
while O 0 0.0033559068106114864
the O 0 0.0030346016865223646
second O 0 0.005947939120233059
, O 0 0.005032727029174566
1936delG O 0 0.30256664752960205
in O 0 0.006639759987592697
exon O 1 0.6749499440193176
12 O 0 0.009103729389607906
, O 0 0.003934844397008419
has O 0 0.0034402688033878803
been O 0 0.003753635799512267
described O 0 0.007205017376691103
before O 0 0.004821987822651863
to O 0 0.005417505279183388
cause O 1 0.7199143171310425
C6D B-Disease 1 0.7798743844032288
in O 0 0.007399062626063824
an O 0 0.008024858310818672
unrelated O 1 0.5364910364151001
African O 0 0.09016474336385727
- O 0 0.11995935440063477
American O 0 0.018471214920282364
individual O 0 0.02725946344435215
. O 0 0.026369886472821236

Both O 0 0.04109247401356697
mutations O 1 0.9902366995811462
result O 0 0.0455353707075119
in O 0 0.020048728212714195
premature O 1 0.9786085486412048
termination O 1 0.9620029330253601
codons O 1 0.9303444623947144
and O 0 0.024486737325787544
C6 O 1 0.9836472868919373
null O 1 0.8406780958175659
alleles O 1 0.9827936887741089
. O 0 0.04398651793599129

Allele O 1 0.9710573554039001
- O 0 0.13111631572246552
specific O 0 0.03318604826927185
PCR O 1 0.8693626523017883
indicated O 0 0.01399356871843338
that O 0 0.004512379877269268
the O 0 0.005995536223053932
probands O 0 0.2800666391849518
two O 0 0.008405796252191067
brothers O 0 0.026297220960259438
also O 0 0.007297725882381201
inherited O 1 0.7857059240341187
the O 0 0.009128444828093052
1195delC O 1 0.968778669834137
mutation O 1 0.9956402778625488
from O 0 0.010095775127410889
their O 0 0.008713394403457642
heterozygous O 1 0.9757964611053467
mother O 0 0.023912327364087105
and O 0 0.0064138383604586124
the O 0 0.007455077487975359
1936delG O 1 0.9657223224639893
mutation O 1 0.9958630800247192
from O 0 0.013781384564936161
their O 0 0.013759780675172806
homozygous O 1 0.9828835129737854
father O 0 0.03201894089579582
. O 0 0.015068905428051949
. O 0 0.019489826634526253

PAX6 O 1 0.9682427048683167
mutations O 1 0.9786531925201416
reviewed O 0 0.09406233578920364
. O 0 0.04942011460661888

Mutations O 1 0.989153265953064
in O 0 0.022962335497140884
PAX6 O 1 0.9744930863380432
are O 0 0.008439503610134125
responsible O 0 0.014425110071897507
for O 0 0.006087485235184431
human O 0 0.048797186464071274
aniridia B-Disease 1 0.7699184417724609
and O 0 0.004663721192628145
have O 0 0.0032867344561964273
also O 0 0.003041511168703437
been O 0 0.0037311650812625885
found O 0 0.006821169517934322
in O 0 0.007002180442214012
patients O 1 0.9927581548690796
with O 0 0.015108787454664707
Peters B-Disease 1 0.9023791551589966
anomaly I-Disease 1 0.9872870445251465
, O 0 0.013209277763962746
with O 0 0.2093788981437683
congenital B-Disease 1 0.9999376535415649
cataracts I-Disease 1 0.9995710253715515
, O 0 0.02165655419230461
with O 0 0.10946891456842422
autosomal B-Disease 1 0.999806821346283
dominant I-Disease 1 0.988303005695343
keratitis I-Disease 1 0.998633086681366
, O 0 0.009860795922577381
and O 0 0.006962822284549475
with O 0 0.013544349931180477
isolated B-Disease 1 0.8757807612419128
foveal I-Disease 1 0.9870775938034058
hypoplasia I-Disease 1 0.9940100908279419
. O 0 0.043346334248781204

No O 0 0.02566199004650116
locus O 1 0.6522495746612549
other O 0 0.012461155652999878
than O 0 0.015132292173802853
chromosome O 1 0.9967221617698669
11p13 O 1 0.6158739328384399
has O 0 0.00789940170943737
been O 0 0.007264337968081236
implicated O 0 0.29671937227249146
in O 0 0.008671623654663563
aniridia B-Disease 1 0.8219075798988342
, O 0 0.008183163590729237
and O 0 0.007521799299865961
PAX6 O 1 0.9909961223602295
is O 0 0.006331741344183683
clearly O 0 0.006526804994791746
the O 0 0.003310634521767497
major O 0 0.0065590799786150455
, O 0 0.0031888021621853113
if O 0 0.0038038725033402443
not O 0 0.0031111242715269327
only O 0 0.003985992167145014
, O 0 0.008733740076422691
gene O 1 0.986443042755127
responsible O 0 0.03576124459505081
. O 0 0.021958457306027412

Twenty O 0 0.046672362834215164
- O 0 0.03494981676340103
eight O 0 0.013847645372152328
percent O 0 0.012945490889251232
of O 0 0.009735900908708572
identified O 0 0.1359034925699234
PAX6 O 1 0.9954038858413696
mutations O 1 0.9965883493423462
are O 0 0.014244657009840012
C O 1 0.6720941066741943
- O 0 0.44173550605773926
T O 1 0.9404500722885132
changes O 0 0.021605130285024643
at O 0 0.01235127355903387
CpG O 1 0.963763952255249
dinucleotides O 1 0.6795305013656616
, O 0 0.005721950437873602
20 O 0 0.007248894777148962
% O 0 0.008337142877280712
are O 0 0.005490099545568228
splicing O 1 0.9393025040626526
errors O 0 0.033067647367715836
, O 0 0.0036761676892638206
and O 0 0.002676806878298521
more O 0 0.0028994984459131956
than O 0 0.004085711669176817
30 O 0 0.006994340103119612
% O 0 0.008259976282715797
are O 0 0.0059262970462441444
deletion O 1 0.9658080339431763
or O 0 0.017170270904898643
insertion O 1 0.7740683555603027
events O 0 0.026453761383891106
. O 0 0.023201536387205124

There O 0 0.01582012139260769
is O 0 0.009677442722022533
a O 0 0.0115896575152874
noticeably O 0 0.1121421530842781
elevated O 0 0.1813693344593048
level O 0 0.011042553000152111
of O 0 0.0073927477933466434
mutation O 1 0.9963489770889282
in O 0 0.006267137359827757
the O 0 0.005859246477484703
paired O 0 0.35747095942497253
domain O 0 0.03723778575658798
compared O 0 0.010146714746952057
with O 0 0.004775195848196745
the O 0 0.003566829254850745
rest O 0 0.0057704937644302845
of O 0 0.004708223044872284
the O 0 0.010384702123701572
gene O 1 0.9888006448745728
. O 0 0.028027961030602455

Increased O 0 0.07993193715810776
mutation O 1 0.9801843762397766
in O 0 0.009534397162497044
the O 0 0.008765945211052895
homeodomain O 1 0.9151219129562378
is O 0 0.008439606986939907
accounted O 0 0.01528856996446848
for O 0 0.005993258208036423
by O 0 0.007102458272129297
the O 0 0.010097947902977467
hypermutable O 1 0.8714221119880676
CpG O 1 0.9724490642547607
dinucleotide O 1 0.8585858941078186
in O 0 0.028268979862332344
codon O 1 0.5387623310089111
240 O 0 0.0625527948141098
. O 0 0.029334938153624535

Very O 0 0.021073803305625916
nearly O 0 0.017969952896237373
all O 0 0.008918162435293198
mutations O 1 0.9937718510627747
appear O 0 0.014307774603366852
to O 0 0.006038016639649868
cause O 0 0.3997286856174469
loss O 0 0.018325449898838997
of O 0 0.004377258941531181
function O 0 0.014998121187090874
of O 0 0.003888034960255027
the O 0 0.006899909116327763
mutant O 1 0.9936193823814392
allele O 1 0.9935517311096191
, O 0 0.005901337135583162
and O 0 0.0033471970818936825
more O 0 0.00346203101798892
than O 0 0.004395200405269861
80 O 0 0.008766122162342072
% O 0 0.00950548704713583
of O 0 0.006717533804476261
exonic O 1 0.6009284853935242
substitutions O 0 0.06566403061151505
result O 0 0.022178824990987778
in O 0 0.012425573542714119
nonsense O 0 0.19383345544338226
codons O 1 0.8331083655357361
. O 0 0.034513358026742935

In O 0 0.018904482945799828
a O 0 0.02227923646569252
gene O 1 0.9711484313011169
with O 0 0.00967183243483305
such O 0 0.008646327070891857
extraordinarily O 0 0.05635463073849678
high O 0 0.013791238889098167
sequence O 0 0.05607536435127258
conservation O 0 0.017595138400793076
throughout O 0 0.008503814227879047
evolution O 0 0.017490316182374954
, O 0 0.004262921866029501
there O 0 0.0033031946513801813
are O 0 0.003944166470319033
presumed O 0 0.06603150069713593
undiscovered O 1 0.9415157437324524
missense O 1 0.9974502921104431
mutations O 1 0.9976863861083984
, O 0 0.006358860060572624
these O 0 0.004050715826451778
are O 0 0.0033203884959220886
hypothesized O 0 0.20208847522735596
to O 0 0.003575972281396389
exist O 0 0.00670855725184083
in O 0 0.004287934862077236
as O 0 0.005388595629483461
- O 0 0.058349963277578354
yet O 0 0.01646856777369976
unidentified O 0 0.29756683111190796
phenotypes O 1 0.9896152019500732
. O 0 0.019173547625541687
. O 0 0.020689334720373154

Genetic O 1 0.9795433878898621
heterogeneity O 1 0.7652922868728638
and O 0 0.01818150281906128
penetrance O 1 0.9517514705657959
analysis O 0 0.024600744247436523
of O 0 0.007682978641241789
the O 0 0.012862887233495712
BRCA1 O 1 0.9992820620536804
and O 0 0.0575295127928257
BRCA2 O 1 0.999661922454834
genes O 1 0.9986187219619751
in O 1 0.670890748500824
breast B-Disease 1 0.9998471736907959
cancer I-Disease 1 0.9993736147880554
families O 0 0.09460724145174026
. O 0 0.02834433875977993

The O 0 0.21114791929721832
Breast B-Disease 1 0.9993242025375366
Cancer I-Disease 1 0.999129593372345
Linkage O 1 0.9681411385536194
Consortium O 0 0.4093223810195923
. O 0 0.041972506791353226

The O 0 0.01715739071369171
contribution O 0 0.024991605430841446
of O 0 0.01573912613093853
BRCA1 O 1 0.9977890253067017
and O 0 0.026199840009212494
BRCA2 O 1 0.9988908171653748
to O 0 0.10917392373085022
inherited B-Disease 1 0.9993295669555664
breast I-Disease 1 0.9998742341995239
cancer I-Disease 1 0.9995806813240051
was O 0 0.011532748118042946
assessed O 0 0.023080365732312202
by O 0 0.009562632068991661
linkage O 1 0.895740807056427
and O 0 0.008543163537979126
mutation O 1 0.9973526000976562
analysis O 0 0.020059406757354736
in O 0 0.0055875456891953945
237 O 0 0.027768999338150024
families O 0 0.008381210267543793
, O 0 0.0033653019927442074
each O 0 0.0032590923365205526
with O 0 0.003258171258494258
at O 0 0.003164597786962986
least O 0 0.004913572687655687
four O 0 0.005258915945887566
cases O 0 0.14352750778198242
of O 0 0.04334089159965515
breast B-Disease 1 0.9999196529388428
cancer I-Disease 1 0.9996819496154785
, O 0 0.007691198028624058
collected O 0 0.009543701075017452
by O 0 0.010689157992601395
the O 0 0.11021875590085983
Breast B-Disease 1 0.9999232292175293
Cancer I-Disease 1 0.999893069267273
Linkage O 1 0.9930201172828674
Consortium O 1 0.7246090769767761
. O 0 0.029598385095596313

Families O 0 0.024770475924015045
were O 0 0.005523475352674723
included O 0 0.006917235441505909
without O 0 0.006877393927425146
regard O 0 0.006546300370246172
to O 0 0.003405321855098009
the O 0 0.005302179139107466
occurrence O 1 0.6660099029541016
of O 0 0.013381249271333218
ovarian B-Disease 1 0.9995824694633484
or I-Disease 0 0.03756735473871231
other I-Disease 0 0.02893492765724659
cancers I-Disease 1 0.9986692667007446
. O 0 0.03821118175983429

Overall O 0 0.0590728335082531
, O 0 0.02263512648642063
disease O 1 0.9983087778091431
was O 0 0.010150647722184658
linked O 0 0.2703371047973633
to O 0 0.008698998019099236
BRCA1 O 1 0.9987816214561462
in O 0 0.00572184706106782
an O 0 0.004565599840134382
estimated O 0 0.0090560894459486
52 O 0 0.01029304601252079
% O 0 0.005996008403599262
of O 0 0.002931713592261076
families O 0 0.007361433934420347
, O 0 0.004143838305026293
to O 0 0.005470727104693651
BRCA2 O 1 0.9986176490783691
in O 0 0.006168521475046873
32 O 0 0.008738277480006218
% O 0 0.006579983048141003
of O 0 0.0031942573841661215
families O 0 0.007116447202861309
, O 0 0.0032614264637231827
and O 0 0.002735971240326762
to O 0 0.0036904746666550636
neither O 0 0.0123134171590209
gene O 1 0.9739179015159607
in O 0 0.006002458278089762
16 O 0 0.008863166905939579
% O 0 0.009769140742719173
( O 0 0.00868973508477211
95 O 0 0.011841347441077232
% O 0 0.010393972508609295
confidence O 0 0.014774174429476261
interval O 0 0.1601812243461609
[ O 0 0.09657218307256699
CI O 1 0.9078525304794312
] O 0 0.03626207634806633
6 O 0 0.012898361310362816
% O 0 0.012097900733351707
- O 0 0.025591133162379265
28 O 0 0.012489869259297848
% O 0 0.011147062294185162
) O 0 0.00907469354569912
, O 0 0.006576755084097385
suggesting O 0 0.024213247001171112
other O 0 0.01573045551776886
predisposition O 1 0.9960436820983887
genes O 1 0.9878702759742737
. O 0 0.03655435889959335

The O 0 0.016539186239242554
majority O 0 0.017432808876037598
( O 0 0.012610239908099174
81 O 0 0.018403418362140656
% O 0 0.010536421090364456
) O 0 0.007071066182106733
of O 0 0.005105700343847275
the O 0 0.026242893189191818
breast B-Disease 1 0.999909520149231
- I-Disease 1 0.999171257019043
ovarian I-Disease 1 0.999984622001648
cancer I-Disease 1 0.9998499155044556
families O 0 0.02172161266207695
were O 0 0.0048578279092907906
due O 0 0.01151097472757101
to O 0 0.007937738671898842
BRCA1 O 1 0.9993082284927368
, O 0 0.005978943780064583
with O 0 0.004091225564479828
most O 0 0.004047543276101351
others O 0 0.006083458662033081
( O 0 0.00708007114008069
14 O 0 0.007575072813779116
% O 0 0.009754831902682781
) O 0 0.0096126152202487
due O 0 0.011485659517347813
to O 0 0.013654110953211784
BRCA2 O 1 0.9966508746147156
. O 0 0.03565891832113266

Conversely O 0 0.06429842114448547
, O 0 0.007849350571632385
the O 0 0.004477724898606539
majority O 0 0.006424647755920887
of O 0 0.0035602885764092207
families O 0 0.007821719162166119
with O 0 0.00582104129716754
male B-Disease 0 0.30828550457954407
and I-Disease 0 0.009548714384436607
female I-Disease 1 0.9845708012580872
breast I-Disease 1 0.9999088048934937
cancer I-Disease 1 0.9996423721313477
were O 0 0.00644858181476593
due O 0 0.014905279502272606
to O 0 0.01055468525737524
BRCA2 O 1 0.9994555115699768
( O 0 0.024682514369487762
76 O 0 0.04254600405693054
% O 0 0.018010135740041733
) O 0 0.016993504017591476
. O 0 0.017590096220374107

The O 0 0.017176887020468712
largest O 0 0.019369008019566536
proportion O 0 0.025786133483052254
( O 0 0.013195548206567764
67 O 0 0.016551118344068527
% O 0 0.009780417196452618
) O 0 0.005570371635258198
of O 0 0.003224005689844489
families O 0 0.006131600122898817
due O 0 0.005664302967488766
to O 0 0.003097438719123602
other O 0 0.004658407531678677
genes O 1 0.9786849021911621
was O 0 0.004317177925258875
found O 0 0.004927974659949541
in O 0 0.003073101630434394
families O 0 0.006155491340905428
with O 0 0.0035904007963836193
four O 0 0.0038785291835665703
or O 0 0.004849547520279884
five O 0 0.005817970726639032
cases O 0 0.02886369824409485
of O 0 0.008920776657760143
female O 1 0.9890284538269043
breast B-Disease 1 0.9999121427536011
cancer I-Disease 1 0.9995883107185364
only O 0 0.019000232219696045
. O 0 0.026145650073885918

These O 0 0.013458572328090668
estimates O 0 0.016332682222127914
were O 0 0.004814838524907827
not O 0 0.0053978064097464085
substantially O 0 0.026489298790693283
affected O 0 0.020229525864124298
either O 0 0.008378020487725735
by O 0 0.00525501137599349
changing O 0 0.012362318113446236
the O 0 0.005793367978185415
assumed O 0 0.021611278876662254
penetrance O 1 0.9868865609169006
model O 0 0.03573314845561981
for O 0 0.013725967146456242
BRCA1 O 1 0.9990216493606567
or O 0 0.01134505309164524
by O 0 0.006649466697126627
including O 0 0.007656427565962076
or O 0 0.011705426499247551
excluding O 0 0.30890846252441406
BRCA1 O 1 0.9996591806411743
mutation O 1 0.9979044198989868
data O 0 0.03740183636546135
. O 0 0.025958767160773277

Among O 0 0.020692696794867516
those O 0 0.011294801719486713
families O 0 0.017305519431829453
with O 0 0.021576493978500366
disease O 1 0.9991583824157715
due O 0 0.026468895375728607
to O 0 0.007654315792024136
BRCA1 O 1 0.9993307590484619
that O 0 0.005045545753091574
were O 0 0.0031154972966760397
tested O 0 0.019530750811100006
by O 0 0.003249516710639
one O 0 0.0025230522733181715
of O 0 0.0021089750807732344
the O 0 0.003317098133265972
standard O 0 0.018020130693912506
screening O 0 0.35798314213752747
methods O 0 0.020902449265122414
, O 0 0.0074638426303863525
mutations O 1 0.9964130520820618
were O 0 0.005001624580472708
detected O 0 0.14245261251926422
in O 0 0.004958672448992729
the O 0 0.005646334495395422
coding O 1 0.9352460503578186
sequence O 0 0.10364321619272232
or O 0 0.012424076907336712
splice O 1 0.8239796161651611
sites O 0 0.01078944094479084
in O 0 0.004558670800179243
an O 0 0.004238564986735582
estimated O 0 0.010212505236268044
63 O 0 0.01668732427060604
% O 0 0.011332736350595951
( O 0 0.009755698963999748
95 O 0 0.013750065118074417
% O 0 0.015659524127840996
CI O 1 0.6694543361663818
51 O 0 0.023802801966667175
% O 0 0.01734408736228943
- O 0 0.04528534412384033
77 O 0 0.027350010350346565
% O 0 0.019959265366196632
) O 0 0.017940819263458252
. O 0 0.019700033590197563

The O 0 0.017798902466893196
estimated O 0 0.02221420779824257
sensitivity O 0 0.06327261030673981
was O 0 0.007380266673862934
identical O 0 0.01812165416777134
for O 0 0.0063301813788712025
direct O 0 0.015152791514992714
sequencing O 0 0.25640010833740234
and O 0 0.006751011125743389
other O 0 0.00821695663034916
techniques O 0 0.03563038259744644
. O 0 0.02110660821199417

The O 0 0.030320296064019203
penetrance O 1 0.9131171107292175
of O 0 0.018265500664711
BRCA2 O 1 0.9968411922454834
was O 0 0.01162929367274046
estimated O 0 0.01177794300019741
by O 0 0.007932273671030998
maximizing O 0 0.037786614149808884
the O 0 0.008639774285256863
LOD O 0 0.25935080647468567
score O 0 0.014398031868040562
in O 0 0.016280081123113632
BRCA2 O 1 0.9995974898338318
- O 1 0.9707878828048706
mutation O 1 0.9981208443641663
families O 0 0.014151623472571373
, O 0 0.00473047187551856
over O 0 0.005025659687817097
all O 0 0.005198493599891663
possible O 0 0.023326758295297623
penetrance O 1 0.9818219542503357
functions O 0 0.03617455065250397
. O 0 0.022932007908821106

The O 0 0.021494872868061066
estimated O 0 0.028213774785399437
cumulative O 1 0.5898686647415161
risk O 1 0.9707806706428528
of O 0 0.04397396370768547
breast B-Disease 1 0.9998227953910828
cancer I-Disease 1 0.9994099140167236
reached O 0 0.01431427150964737
28 O 0 0.01369403675198555
% O 0 0.011302504688501358
( O 0 0.009095598943531513
95 O 0 0.012061156332492828
% O 0 0.013165033422410488
CI O 1 0.7237669825553894
9 O 0 0.013366424478590488
% O 0 0.011114127933979034
- O 0 0.023290125653147697
44 O 0 0.012361329048871994
% O 0 0.010321409441530704
) O 0 0.006148290354758501
by O 0 0.004530760459601879
age O 0 0.007560149300843477
50 O 0 0.006480872165411711
years O 0 0.004738570190966129
and O 0 0.004121008794754744
84 O 0 0.01506451889872551
% O 0 0.010968315415084362
( O 0 0.009144767187535763
95 O 0 0.013515367172658443
% O 0 0.012847221456468105
CI O 1 0.6644729375839233
43 O 0 0.01665469817817211
% O 0 0.013809611089527607
- O 0 0.035229459404945374
95 O 0 0.013453672640025616
% O 0 0.01114096213132143
) O 0 0.008089187555015087
by O 0 0.006322668865323067
age O 0 0.01409628614783287
70 O 0 0.01666768081486225
years O 0 0.01590815931558609
. O 0 0.020647849887609482

The O 0 0.043144479393959045
corresponding O 1 0.9411818385124207
ovarian B-Disease 1 0.9998360872268677
cancer I-Disease 1 0.9996439218521118
risks O 1 0.8620770573616028
were O 0 0.013828332535922527
0 O 0 0.03973778709769249
. O 0 0.026197804138064384

4 O 0 0.03239243105053902
% O 0 0.021035829558968544
( O 0 0.01399720087647438
95 O 0 0.0172552652657032
% O 0 0.017964644357562065
CI O 1 0.6140241026878357
0 O 0 0.021596301347017288
% O 0 0.014979640021920204
- O 0 0.02458137460052967
1 O 0 0.008637418039143085
% O 0 0.008251629769802094
) O 0 0.00596765847876668
by O 0 0.0044534592889249325
age O 0 0.007207159884274006
50 O 0 0.00591267179697752
years O 0 0.004602254834026098
and O 0 0.003216198645532131
27 O 0 0.009084800258278847
% O 0 0.008863115683197975
( O 0 0.008294273167848587
95 O 0 0.011242837645113468
% O 0 0.0129198944196105
CI O 1 0.7547914981842041
0 O 0 0.01765584945678711
% O 0 0.012677650898694992
- O 0 0.03108997829258442
47 O 0 0.01391027681529522
% O 0 0.010439842939376831
) O 0 0.00646729301661253
by O 0 0.005911665502935648
age O 0 0.012429450638592243
70 O 0 0.015732213854789734
years O 0 0.014230898581445217
. O 0 0.019415054470300674

The O 0 0.026034614071249962
lifetime O 0 0.399532288312912
risk O 1 0.9468852281570435
of O 0 0.05435893312096596
breast B-Disease 1 0.9998425245285034
cancer I-Disease 1 0.9996646642684937
appears O 0 0.08488218486309052
similar O 0 0.011614778079092503
to O 0 0.004668734967708588
the O 0 0.005835375282913446
risk O 1 0.9576219320297241
in O 0 0.019013168290257454
BRCA1 O 1 0.9996665716171265
carriers O 1 0.6947746276855469
, O 0 0.00527102779597044
but O 0 0.003248208900913596
there O 0 0.00242885435000062
was O 0 0.002340100472792983
some O 0 0.0027377046644687653
suggestion O 0 0.007441036868840456
of O 0 0.0036307715345174074
a O 0 0.008169660344719887
lower O 0 0.033466264605522156
risk O 1 0.9389639496803284
in O 0 0.026194743812084198
BRCA2 O 1 0.9993261098861694
carriers O 1 0.9515204429626465
< O 1 0.8197664618492126
50 O 0 0.01668553799390793
years O 0 0.011145900934934616
of O 0 0.009206847287714481
age O 0 0.0281388983130455
. O 0 0.0215839222073555

Eye B-Disease 1 0.9119074940681458
movement I-Disease 0 0.20137281715869904
abnormalities I-Disease 1 0.9936314225196838
correlate O 1 0.6882362961769104
with O 0 0.03445654734969139
genotype O 1 0.9893627762794495
in O 0 0.06336822360754013
autosomal O 1 0.9994180202484131
dominant O 1 0.9876402020454407
cerebellar B-Disease 1 0.9989558458328247
ataxia I-Disease 1 0.998964786529541
type I-Disease 1 0.7363858222961426
I I-Disease 0 0.028671354055404663
. O 0 0.026505693793296814

We O 0 0.02281062677502632
compared O 0 0.037923913449048996
horizontal O 0 0.3047647178173065
eye O 1 0.8064820170402527
movements O 0 0.04030610993504524
( O 0 0.021261470392346382
visually O 0 0.13863803446292877
guided O 0 0.0354074202477932
saccades O 1 0.9781111478805542
, O 0 0.011296410113573074
antisaccades O 0 0.2910025715827942
, O 0 0.006507731508463621
and O 0 0.005628943908959627
smooth O 0 0.0909375324845314
pursuit O 0 0.04846164211630821
) O 0 0.00835562776774168
in O 0 0.005480441264808178
control O 0 0.016983095556497574
subjects O 0 0.016409771516919136
( O 0 0.012038842774927616
n O 0 0.06441965699195862
= O 0 0.08230795711278915
14 O 0 0.009870939888060093
) O 0 0.007559290621429682
and O 0 0.004827613942325115
patients O 1 0.8803196549415588
with O 0 0.005015650298446417
three O 0 0.0057171666994690895
forms O 0 0.02164018340408802
of O 0 0.014909626916050911
autosomal O 1 0.9995187520980835
dominant O 1 0.9687744379043579
cerebellar B-Disease 1 0.9984179735183716
ataxias I-Disease 1 0.9833492040634155
type I-Disease 1 0.7788860201835632
I I-Disease 0 0.0320172980427742
spinocerebellar B-Disease 1 0.996526300907135
ataxias I-Disease 1 0.8236306309700012
1 I-Disease 0 0.013997740112245083
and I-Disease 0 0.006111332681030035
2 I-Disease 0 0.01075751706957817
( O 0 0.012471416033804417
SCA1 B-Disease 1 0.5366725325584412
, O 0 0.008410956710577011
n O 0 0.03146529197692871
= O 0 0.0638267919421196
11 O 0 0.014649337157607079
; O 0 0.012671157717704773
SCA2 B-Disease 1 0.5419076681137085
, O 0 0.008973704650998116
n O 0 0.0311785489320755
= O 0 0.03531573712825775
10 O 0 0.010264905169606209
) O 0 0.010037440806627274
and O 0 0.008123809471726418
SCA3 B-Disease 1 0.975250780582428
/ O 1 0.9021090865135193
Machado B-Disease 1 0.9704462289810181
- I-Disease 1 0.9192723035812378
Joseph I-Disease 1 0.8861668705940247
disease I-Disease 1 0.9993500113487244
( O 0 0.06231147423386574
MJD B-Disease 1 0.9826304316520691
) O 0 0.018670156598091125
( O 0 0.016713980585336685
n O 0 0.043558262288570404
= O 0 0.056675802916288376
16 O 0 0.016554053872823715
) O 0 0.015953917056322098
. O 0 0.01651877723634243

In O 0 0.03337213769555092
SCA1 B-Disease 1 0.6752541065216064
, O 0 0.02260635606944561
saccade O 1 0.9335514903068542
amplitude O 0 0.25361698865890503
was O 0 0.010542437434196472
significantly O 0 0.045942582190036774
increased O 0 0.019279904663562775
, O 0 0.010237223468720913
resulting O 0 0.05966045334935188
in O 0 0.015656262636184692
hypermetria B-Disease 1 0.733356773853302
. O 0 0.0317530557513237

The O 0 0.027295950800180435
smooth O 0 0.07419749349355698
pursuit O 0 0.05059610307216644
gain O 0 0.027402034029364586
was O 0 0.017990201711654663
decreased O 0 0.12964609265327454
. O 0 0.02984258159995079

In O 0 0.03508225828409195
SCA2 B-Disease 1 0.562595009803772
, O 0 0.02699303813278675
saccade O 1 0.9124462008476257
velocity O 0 0.06998341530561447
was O 0 0.022920023649930954
markedly O 1 0.6747441291809082
decreased O 0 0.423002690076828
. O 0 0.03364778310060501

The O 0 0.015428775921463966
percentage O 0 0.018934959545731544
of O 0 0.0077756717801094055
errors O 0 0.02823346108198166
in O 0 0.008470091968774796
antisaccades O 0 0.3725913465023041
was O 0 0.008289014920592308
greatly O 0 0.015541034750640392
increased O 0 0.010989409871399403
and O 0 0.004284947644919157
was O 0 0.007121671922504902
significantly O 0 0.21526579558849335
correlated O 1 0.8620225787162781
with O 0 0.013032629154622555
age O 0 0.07993286848068237
at O 0 0.16635775566101074
disease O 1 0.9996315240859985
onset O 1 0.9970042109489441
. O 0 0.045083023607730865

In O 0 0.014884931035339832
addition O 0 0.01301676407456398
, O 0 0.0057900045067071915
a O 0 0.008760347031056881
correlation O 0 0.20561982691287994
between O 0 0.008969294838607311
smooth O 0 0.18061523139476776
pursuit O 0 0.032037705183029175
gain O 0 0.009962067939341068
and O 0 0.0031672315672039986
the O 0 0.003444358706474304
number O 0 0.005257377400994301
of O 0 0.007716455962508917
trinucleotide O 1 0.9810891151428223
repeats O 0 0.2928753197193146
was O 0 0.01136042457073927
found O 0 0.018580887466669083
. O 0 0.019832095131278038

In O 0 0.03835098445415497
SCA3 B-Disease 1 0.7673569917678833
, O 0 0.022860625758767128
gaze B-Disease 0 0.21295545995235443
- I-Disease 0 0.3671926259994507
evoked I-Disease 1 0.8020842671394348
nystagmus I-Disease 1 0.9909664392471313
was O 0 0.009784162975847721
often O 0 0.009753406047821045
present O 0 0.007769213989377022
as O 0 0.006271450314670801
was O 0 0.010501639917492867
saccade O 1 0.9606205224990845
hypometria O 1 0.5768188834190369
and O 0 0.010549324564635754
smooth O 0 0.13569611310958862
pursuit O 0 0.050923462957143784
gain O 0 0.025488443672657013
was O 0 0.015369150787591934
markedly O 1 0.7600991129875183
decreased O 0 0.4708324670791626
. O 0 0.03296946734189987

Three O 0 0.021506721153855324
major O 0 0.016865616664290428
criteria O 0 0.022690005600452423
, O 0 0.013244877569377422
saccade O 1 0.9558680057525635
amplitude O 0 0.48906126618385315
, O 0 0.012673013843595982
saccade O 1 0.9403334259986877
velocity O 0 0.03791355341672897
, O 0 0.004657324403524399
and O 0 0.0036530266515910625
presence O 0 0.009815617464482784
of O 0 0.00572951277717948
gaze B-Disease 1 0.5097421407699585
- I-Disease 1 0.6661341190338135
evoked I-Disease 1 0.8831523060798645
nystagmus I-Disease 1 0.9932268261909485
, O 0 0.006404813379049301
permitted O 0 0.007655927445739508
the O 0 0.00496811093762517
correct O 0 0.020100796595215797
assignment O 0 0.011998003348708153
of O 0 0.003519233549013734
90 O 0 0.00729889702051878
% O 0 0.00590193597599864
of O 0 0.003110351972281933
the O 0 0.004346888978034258
SCA1 B-Disease 1 0.5164898037910461
, O 0 0.004856571089476347
90 O 0 0.0074677723459899426
% O 0 0.005543788429349661
of O 0 0.002716958522796631
the O 0 0.004478101618587971
SCA2 B-Disease 1 0.6319535374641418
, O 0 0.004184599965810776
and O 0 0.003020939417183399
93 O 0 0.009563630446791649
% O 0 0.0052882651798427105
of O 0 0.003174670971930027
the O 0 0.005183191038668156
patients O 1 0.974951982498169
with O 0 0.0064058443531394005
SCA3 B-Disease 1 0.8819055557250977
to O 0 0.004750742577016354
their O 0 0.006159378215670586
genetically O 1 0.9891184568405151
confirmed O 0 0.19429178535938263
patient O 1 0.9775612950325012
group O 0 0.009133504703640938
and O 0 0.0030376561917364597
, O 0 0.0031995440367609262
therefore O 0 0.004843235015869141
, O 0 0.0032244333997368813
may O 0 0.007248084992170334
help O 0 0.012168267741799355
orient O 0 0.07371712476015091
diagnoses O 1 0.9824053645133972
of O 0 0.008915077894926071
SCA1 B-Disease 1 0.8916546702384949
, O 0 0.009289281442761421
SCA2 B-Disease 1 0.7480739951133728
, O 0 0.00717742508277297
and O 0 0.006724358536303043
SCA3 B-Disease 1 0.8314832448959351
at O 0 0.00913727842271328
early O 0 0.014341316185891628
clinical O 1 0.9438771605491638
stages O 0 0.05510891228914261
of O 0 0.007559962570667267
the O 0 0.014987297356128693
diseases O 1 0.9985429048538208
. O 0 0.015429940074682236
. O 0 0.019614245742559433

Genetic O 1 0.9431253671646118
basis O 0 0.024202343076467514
and O 0 0.015030226670205593
molecular O 1 0.9579416513442993
mechanism O 1 0.8531274199485779
for O 0 0.06886908411979675
idiopathic B-Disease 1 0.9994437098503113
ventricular I-Disease 1 0.9986296892166138
fibrillation I-Disease 1 0.9979263544082642
. O 0 0.0627385824918747

Ventricular B-Disease 1 0.9963818788528442
fibrillation I-Disease 1 0.9975554347038269
causes O 1 0.905275821685791
more O 0 0.01150177139788866
than O 0 0.00811546016484499
300 O 0 0.011790391989052296
, O 0 0.006464135833084583
000 O 0 0.028342505916953087
sudden O 1 0.822925329208374
deaths O 0 0.13454636931419373
each O 0 0.006729246117174625
year O 0 0.006820287089794874
in O 0 0.005793346557766199
the O 0 0.00691487081348896
USA O 0 0.02677810750901699
alone O 0 0.022762559354305267
. O 0 0.020451992750167847

In O 0 0.018921922892332077
approximately O 0 0.018790829926729202
5 O 0 0.015405316837131977
- O 0 0.01939939148724079
12 O 0 0.007500922307372093
% O 0 0.006016864906996489
of O 0 0.003079749643802643
these O 0 0.003551722504198551
cases O 0 0.00942143239080906
, O 0 0.0027348706498742104
there O 0 0.0023280668538063765
are O 0 0.0027983791660517454
no O 0 0.007229990791529417
demonstrable O 1 0.9959979057312012
cardiac O 1 0.9995359182357788
or O 0 0.03794384375214577
non O 0 0.4767192304134369
- O 1 0.9871705174446106
cardiac O 1 0.9997280240058899
causes O 1 0.9740506410598755
to O 0 0.004367768298834562
account O 0 0.00552660645917058
for O 0 0.0032454603351652622
the O 0 0.003340203780680895
episode O 0 0.013010713271796703
, O 0 0.0037562702782452106
which O 0 0.0030910582281649113
is O 0 0.004194877576082945
therefore O 0 0.009815404191613197
classified O 0 0.045578163117170334
as O 0 0.03578944876790047
idiopathic B-Disease 1 0.9997124075889587
ventricular I-Disease 1 0.9993651509284973
fibrillation I-Disease 1 0.9995618462562561
( O 0 0.3653883635997772
IVF B-Disease 1 0.9958892464637756
) O 0 0.036954618990421295
. O 0 0.02927352860569954

A O 0 0.02981436811387539
distinct O 0 0.03144381567835808
group O 0 0.01731461100280285
of O 0 0.012524700723588467
IVF B-Disease 1 0.999138593673706
patients O 1 0.9944102168083191
has O 0 0.005821394268423319
been O 0 0.003851688001304865
found O 0 0.0047852648422122
to O 0 0.0027840116526931524
present O 0 0.00487170135602355
with O 0 0.0057206968776881695
a O 0 0.010695579461753368
characteristic O 1 0.5967928171157837
electrocardiographic O 1 0.959013819694519
pattern O 1 0.7750833034515381
. O 0 0.028784219175577164

Because O 0 0.016750050708651543
of O 0 0.005044616758823395
the O 0 0.0038702806923538446
small O 0 0.0057996716350317
size O 0 0.0066394140012562275
of O 0 0.003058670088648796
most O 0 0.004436626564711332
pedigrees O 0 0.2948175072669983
and O 0 0.003497327445074916
the O 0 0.004351912997663021
high O 0 0.017211487516760826
incidence O 1 0.9933379888534546
of O 0 0.006633617915213108
sudden B-Disease 1 0.8990362882614136
death I-Disease 0 0.052975744009017944
, O 0 0.004789470229297876
however O 0 0.005336498375982046
, O 0 0.00581819424405694
molecular O 1 0.9933096170425415
genetic O 1 0.9968043565750122
studies O 0 0.036842457950115204
of O 0 0.006784480530768633
IVF B-Disease 1 0.9952398538589478
have O 0 0.005505414213985205
not O 0 0.00421541603282094
yet O 0 0.006861232686787844
been O 0 0.006535777356475592
done O 0 0.011898641474545002
. O 0 0.016187289729714394

Because O 0 0.30737507343292236
IVF B-Disease 1 0.9963012933731079
causes O 1 0.9967637062072754
cardiac O 1 0.9990777969360352
rhythm O 1 0.9573891162872314
disturbance O 1 0.8563252091407776
, O 0 0.008905371651053429
we O 0 0.005701996851712465
investigated O 0 0.017231015488505363
whether O 0 0.010089443065226078
malfunction O 1 0.6893899440765381
of O 0 0.007368269842118025
ion O 1 0.5576614737510681
channels O 0 0.03707478940486908
could O 0 0.011124294251203537
cause O 1 0.69777911901474
the O 0 0.010685254819691181
disorder O 1 0.9986936450004578
by O 0 0.012294085696339607
studying O 0 0.0635610818862915
mutations O 1 0.9973025321960449
in O 0 0.011382241733372211
the O 0 0.018111318349838257
cardiac O 1 0.9983696341514587
sodium O 1 0.9893530607223511
channel O 0 0.41620931029319763
gene O 1 0.9918319582939148
SCN5A O 1 0.8655818104743958
. O 0 0.041556574404239655

We O 0 0.0133089954033494
have O 0 0.006655129138380289
now O 0 0.006845031399279833
identified O 0 0.014325914904475212
a O 0 0.015448200516402721
missense O 1 0.993477463722229
mutation O 1 0.9955046772956848
, O 0 0.010949399322271347
a O 0 0.018327925354242325
splice O 1 0.9876739382743835
- O 1 0.8989236354827881
donor O 1 0.9901909828186035
mutation O 1 0.9965083003044128
, O 0 0.009516038000583649
and O 0 0.005976906977593899
a O 0 0.015099168755114079
frameshift O 1 0.9963484406471252
mutation O 1 0.9953739047050476
in O 0 0.00832211971282959
the O 0 0.007355116307735443
coding O 1 0.826361358165741
region O 0 0.012271777726709843
of O 0 0.007817722856998444
SCN5A O 1 0.6469518542289734
in O 0 0.010051656514406204
three O 0 0.016271719709038734
IVF B-Disease 1 0.9933005571365356
families O 0 0.04994827136397362
. O 0 0.027308233082294464

We O 0 0.01237147394567728
show O 0 0.013049217872321606
that O 0 0.0077817440032958984
sodium O 0 0.260600745677948
channels O 0 0.023121660575270653
with O 0 0.008456910029053688
the O 0 0.010050716809928417
missense O 1 0.996224045753479
mutation O 1 0.9979738593101501
recover O 0 0.41947269439697266
from O 0 0.012376170605421066
inactivation O 1 0.8358089923858643
more O 0 0.006267179269343615
rapidly O 0 0.020108671858906746
than O 0 0.005012885667383671
normal O 0 0.015349325723946095
and O 0 0.0034450918901711702
that O 0 0.004215255845338106
the O 0 0.008640973828732967
frameshift O 1 0.9984169006347656
mutation O 1 0.9989074468612671
causes O 1 0.9335362911224365
the O 0 0.009111221879720688
sodium O 1 0.7646124362945557
channel O 0 0.020308872684836388
to O 0 0.005390103906393051
be O 0 0.006035756319761276
non O 0 0.020561059936881065
- O 0 0.13013704121112823
functional O 0 0.40319401025772095
. O 0 0.02799556590616703

Our O 0 0.01961790956556797
results O 0 0.022834330797195435
indicate O 0 0.020475391298532486
that O 0 0.010813269764184952
mutations O 1 0.9972187280654907
in O 0 0.025730296969413757
cardiac O 1 0.9992745518684387
ion O 1 0.9658523201942444
- O 0 0.4881298243999481
channel O 0 0.08169101178646088
genes O 1 0.970103919506073
contribute O 0 0.02166895940899849
to O 0 0.006472170352935791
the O 0 0.007430777885019779
risk O 0 0.49949342012405396
of O 0 0.00974548701196909
developing O 1 0.6350098848342896
IVF B-Disease 1 0.9916567802429199
. O 0 0.02086399309337139
. O 0 0.025312846526503563

Molecular O 1 0.9254128336906433
heterogeneity O 1 0.785704493522644
in O 0 0.018592799082398415
mucopolysaccharidosis B-Disease 1 0.8843030333518982
IVA I-Disease 1 0.9516874551773071
in O 0 0.008314472623169422
Australia O 0 0.006593253463506699
and O 0 0.004307137336581945
Northern O 0 0.007924756966531277
Ireland O 0 0.008376887999475002
: O 0 0.0075666592456400394
nine O 0 0.00962129421532154
novel O 0 0.16441702842712402
mutations O 1 0.9943187832832336
including O 0 0.014189762994647026
T312S O 1 0.5490342974662781
, O 0 0.00801793858408928
a O 0 0.011423619464039803
common O 0 0.08115927875041962
allele O 1 0.9889399409294128
that O 0 0.012468468397855759
confers O 1 0.7847809195518494
a O 0 0.04495733231306076
mild O 1 0.9906696081161499
phenotype O 1 0.9964116215705872
. O 0 0.042411163449287415

Mucopolysaccharidosis B-Disease 1 0.910220742225647
IVA I-Disease 1 0.943402111530304
( O 0 0.04498061537742615
MPS B-Disease 0 0.1441342979669571
IVA I-Disease 1 0.9872368574142456
) O 0 0.022613007575273514
is O 0 0.013199684210121632
an O 0 0.03565570339560509
autosomal B-Disease 1 0.9998268485069275
recessive I-Disease 1 0.9998481273651123
lysosomal I-Disease 1 0.9988127946853638
storage I-Disease 1 0.9042888879776001
disorder I-Disease 1 0.9990472197532654
caused O 0 0.44948169589042664
by O 0 0.012623504735529423
a O 0 0.03279170021414757
genetic B-Disease 1 0.9989308714866638
defect I-Disease 1 0.9956411123275757
in O 0 0.013263661414384842
N O 0 0.4385862350463867
- O 1 0.5691426992416382
acetylgalactosamine O 1 0.9651492238044739
- O 0 0.3952731490135193
6 O 0 0.04194445163011551
- O 1 0.8411300182342529
sulfate O 1 0.9935595989227295
sulfatase O 1 0.9935063123703003
( O 0 0.05120867118239403
GALNS O 1 0.8663747906684875
) O 0 0.029492875561118126
. O 0 0.02555806376039982

Previous O 0 0.030516041442751884
studies O 0 0.025974616408348083
of O 0 0.008365638554096222
patients O 1 0.9600065350532532
from O 0 0.008320321328938007
a O 0 0.010171473026275635
British O 0 0.013704944401979446
- O 0 0.07154516130685806
Irish O 0 0.020310480147600174
population O 0 0.008254759944975376
showed O 0 0.008213542401790619
that O 0 0.00472240662202239
the O 0 0.007096260320395231
I113F O 1 0.9557115435600281
mutation O 1 0.9972702860832214
is O 0 0.0068266247399151325
the O 0 0.004214947577565908
most O 0 0.00512293167412281
common O 0 0.028924385085701942
single O 0 0.044219721108675
mutation O 1 0.9984134435653687
among O 0 0.025880731642246246
MPS B-Disease 1 0.7613325715065002
IVA I-Disease 1 0.9983940720558167
patients O 1 0.9950926303863525
and O 0 0.01100916601717472
produces O 0 0.48613911867141724
a O 0 0.1113927885890007
severe O 1 0.9960430860519409
clinical O 1 0.997117280960083
phenotype O 1 0.9971702694892883
. O 0 0.047478966414928436

We O 0 0.019195258617401123
studied O 0 0.030566856265068054
mutations O 1 0.9848297238349915
in O 0 0.009954025037586689
the O 0 0.010581516660749912
GALNS O 1 0.9430603981018066
gene O 1 0.9803593158721924
from O 0 0.01233468297868967
23 O 0 0.017145277932286263
additional O 0 0.017423003911972046
MPS B-Disease 0 0.38704466819763184
IVA I-Disease 1 0.9976369142532349
patients O 1 0.9933006763458252
( O 0 0.012123812921345234
15 O 0 0.008441673591732979
from O 0 0.004900970961898565
Australia O 0 0.004286192823201418
, O 0 0.003064389806240797
8 O 0 0.005615018308162689
from O 0 0.003884210716933012
Northern O 0 0.006414513103663921
Ireland O 0 0.008218970149755478
) O 0 0.004984667059034109
, O 0 0.0030493391677737236
with O 0 0.003959613852202892
various O 0 0.008590503595769405
clinical O 1 0.9981081485748291
phenotypes O 1 0.9991241097450256
( O 0 0.11092695593833923
severe O 1 0.9823358654975891
, O 0 0.007112721912562847
16 O 0 0.010113107040524483
cases O 0 0.06007744371891022
; O 0 0.009203845635056496
intermediate O 0 0.07335494458675385
, O 0 0.00645645335316658
4 O 0 0.012805581092834473
cases O 0 0.1706654280424118
; O 0 0.01710585318505764
mild O 1 0.9287036061286926
, O 0 0.008423947729170322
3 O 0 0.016406264156103134
cases O 0 0.048818569630384445
) O 0 0.015490619465708733
. O 0 0.016530122607946396

We O 0 0.011913910508155823
found O 0 0.011385718360543251
two O 0 0.0073097883723676205
common O 0 0.07465792447328568
mutations O 1 0.9956658482551575
that O 0 0.004543712828308344
together O 0 0.005284947343170643
accounted O 0 0.009204376488924026
for O 0 0.003541385754942894
32 O 0 0.007982607930898666
% O 0 0.0062776850536465645
of O 0 0.003452740842476487
the O 0 0.004918322432786226
44 O 0 0.01992952823638916
unrelated O 1 0.882710874080658
alleles O 1 0.9936521053314209
in O 0 0.011977825313806534
these O 0 0.016037272289395332
patients O 1 0.9898154735565186
. O 0 0.028898440301418304

One O 0 0.01414224412292242
is O 0 0.00889213290065527
the O 0 0.009637346491217613
T312S O 1 0.9232572317123413
mutation O 1 0.9962332844734192
, O 0 0.008664506487548351
a O 0 0.012833229266107082
novel O 0 0.31162214279174805
mutation O 1 0.9979300498962402
found O 0 0.020840976387262344
exclusively O 0 0.02462713234126568
in O 0 0.02025950700044632
milder O 1 0.9875729084014893
patients O 1 0.9921525120735168
. O 0 0.03802284225821495

The O 0 0.01177218183875084
other O 0 0.006596817634999752
is O 0 0.005251806695014238
the O 0 0.004653786774724722
previously O 0 0.008322694338858128
described O 0 0.01703939028084278
I113F O 1 0.5106925964355469
that O 0 0.008495367132127285
produces O 0 0.1947832852602005
a O 0 0.04157067462801933
severe O 1 0.9907530546188354
phenotype O 1 0.9962007403373718
. O 0 0.04611924663186073

The O 0 0.02561432495713234
I113F O 0 0.2327515333890915
and O 0 0.015028526075184345
T312S O 1 0.8845279216766357
mutations O 1 0.9934313893318176
accounted O 0 0.023200949653983116
for O 0 0.0063960738480091095
8 O 0 0.00956710521131754
( O 0 0.007133866660296917
18 O 0 0.006929855328053236
% O 0 0.007193106692284346
) O 0 0.005847415421158075
and O 0 0.003198368474841118
6 O 0 0.007434641011059284
( O 0 0.00622817687690258
14 O 0 0.007067261263728142
% O 0 0.007960006594657898
) O 0 0.005850326735526323
of O 0 0.004622636828571558
44 O 0 0.021232107654213905
unrelated O 1 0.7004109025001526
alleles O 1 0.9905186295509338
, O 0 0.014450459741055965
respectively O 0 0.023966412991285324
. O 0 0.023010466247797012

The O 0 0.01856468990445137
relatively O 0 0.027228616178035736
high O 0 0.02420351468026638
residual O 1 0.7630366086959839
GALNS O 1 0.8469928503036499
activity O 0 0.025444630533456802
seen O 0 0.012496822513639927
when O 0 0.008518380112946033
the O 0 0.00849956925958395
T312S O 1 0.7788283824920654
mutant O 1 0.9746112823486328
cDNA O 1 0.9128707051277161
is O 0 0.016991935670375824
overexpressed O 1 0.9837138652801514
in O 0 0.01523104589432478
mutant O 1 0.9961680769920349
cells O 1 0.992836058139801
provides O 0 0.015942662954330444
an O 0 0.005827079061418772
explanation O 0 0.013533852994441986
for O 0 0.006043806206434965
the O 0 0.010738939978182316
mild O 1 0.9966661334037781
phenotype O 1 0.9992009997367859
in O 0 0.023605089634656906
patients O 1 0.9919601082801819
with O 0 0.014500252902507782
this O 0 0.016034811735153198
mutation O 1 0.996563732624054
. O 0 0.03212205693125725

The O 0 0.016578471288084984
distribution O 0 0.020496798679232597
and O 0 0.006060339044779539
relative O 0 0.014714268036186695
frequencies O 0 0.017821189016103745
of O 0 0.004131495486944914
the O 0 0.005423441529273987
I113F O 0 0.43828728795051575
and O 0 0.008246004581451416
T312S O 1 0.9511945843696594
mutations O 1 0.9973849654197693
in O 0 0.007710108999162912
Australia O 0 0.00696263462305069
corresponded O 0 0.014671538956463337
to O 0 0.0033465942833572626
those O 0 0.004118293058127165
observed O 0 0.010018933564424515
in O 0 0.004044255707412958
Northern O 0 0.005454665515571833
Ireland O 0 0.005706437863409519
and O 0 0.002361931372433901
are O 0 0.00181612279266119
unique O 0 0.004344538785517216
to O 0 0.0021047338377684355
these O 0 0.0027472837828099728
two O 0 0.0030868849717080593
populations O 0 0.17708182334899902
, O 0 0.0037230560556054115
suggesting O 0 0.011257069185376167
that O 0 0.003577394876629114
both O 0 0.006387878675013781
mutations O 1 0.9968505501747131
were O 0 0.003924637101590633
probably O 0 0.006296193692833185
introduced O 0 0.00635541370138526
to O 0 0.0025626644492149353
Australia O 0 0.004627420101314783
by O 0 0.005453832447528839
Irish O 0 0.014693377539515495
migrants O 0 0.013127638027071953
during O 0 0.008756209164857864
the O 0 0.006709259934723377
19th O 0 0.01772579364478588
century O 0 0.019844403490424156
. O 0 0.0219083484262228

Haplotype O 1 0.9523026347160339
analysis O 0 0.04445486143231392
using O 0 0.02302784100174904
6 O 0 0.018391087651252747
RFLPs O 0 0.1907166987657547
provides O 0 0.013860323466360569
additional O 0 0.008196289651095867
data O 0 0.006867506541311741
that O 0 0.003975106403231621
the O 0 0.006714746821671724
I113F O 1 0.9558489918708801
mutation O 1 0.9976627826690674
originated O 0 0.04209708049893379
from O 0 0.01001539546996355
a O 0 0.015013872645795345
common O 0 0.053083017468452454
ancestor O 0 0.4165656566619873
. O 0 0.028852757066488266

The O 0 0.014912519603967667
other O 0 0.009537500329315662
9 O 0 0.01817796193063259
novel O 0 0.20288927853107452
mutations O 1 0.9969261288642883
identified O 0 0.016066327691078186
in O 0 0.005151099991053343
these O 0 0.005223360378295183
23 O 0 0.013122383505105972
patients O 1 0.9558920860290527
were O 0 0.003705449867993593
each O 0 0.0044967313297092915
limited O 0 0.0068524423986673355
to O 0 0.004363886546343565
a O 0 0.009868769906461239
single O 0 0.017879551276564598
family O 0 0.031957946717739105
. O 0 0.022320790216326714

These O 0 0.013398281298577785
data O 0 0.01206574309617281
provide O 0 0.008268934674561024
further O 0 0.006714921444654465
evidence O 0 0.007208818569779396
for O 0 0.0069311936385929585
extensive O 0 0.03007463365793228
allelic O 1 0.9766991138458252
heterogeneity O 1 0.886458694934845
in O 0 0.011715701781213284
MPS B-Disease 0 0.1036376878619194
IVA I-Disease 1 0.987084686756134
in O 0 0.011126697063446045
British O 0 0.023090803995728493
- O 0 0.45888617634773254
Irish O 0 0.3119232952594757
patients O 1 0.9773577451705933
and O 0 0.003916798625141382
provide O 0 0.005673879757523537
evidence O 0 0.004453146364539862
for O 0 0.003266916610300541
their O 0 0.00394442118704319
transmission O 1 0.502328634262085
to O 0 0.003717135637998581
Australia O 0 0.005663540214300156
by O 0 0.005954937543720007
British O 0 0.012228681705892086
- O 0 0.0633276104927063
Irish O 0 0.03469502925872803
migrants O 0 0.026093048974871635
. O 0 0.012523790821433067
. O 0 0.01761392503976822

Identification O 0 0.04969993233680725
of O 0 0.017756406217813492
constitutional O 0 0.05381032079458237
WT1 O 1 0.9962669014930725
mutations O 1 0.9965683221817017
, O 0 0.012931667268276215
in O 0 0.012920168228447437
patients O 1 0.9931320548057556
with O 0 0.023007085546851158
isolated O 1 0.9817041754722595
diffuse B-Disease 1 0.999198853969574
mesangial I-Disease 1 0.9996860027313232
sclerosis I-Disease 1 0.9997598528862
, O 0 0.012278610840439796
and O 0 0.00706734461709857
analysis O 0 0.022163016721606255
of O 0 0.012724839150905609
genotype O 1 0.9968016147613525
/ O 1 0.9597599506378174
phenotype O 1 0.997671902179718
correlations O 1 0.5557892322540283
by O 0 0.00901112426072359
use O 0 0.009089120663702488
of O 0 0.006378134712576866
a O 0 0.01711755432188511
computerized O 1 0.9514760971069336
mutation O 1 0.9969037175178528
database O 0 0.21386879682540894
. O 0 0.03396245837211609

Constitutional O 0 0.06270121037960052
mutations O 1 0.9610899090766907
of O 0 0.013673531822860241
the O 0 0.017358485609292984
WT1 O 1 0.9954286813735962
gene O 1 0.9877618551254272
, O 0 0.013224875554442406
encoding O 0 0.22903981804847717
a O 0 0.020067602396011353
zinc O 1 0.9733437299728394
- O 1 0.7232208251953125
finger O 1 0.9309978485107422
transcription O 1 0.9902462959289551
factor O 0 0.4288768768310547
involved O 0 0.022128358483314514
in O 0 0.014427362009882927
renal O 1 0.9994391798973083
and O 0 0.012493194080889225
gonadal O 1 0.9966503977775574
development O 0 0.01799735613167286
, O 0 0.0037349199410527945
are O 0 0.002673318376764655
found O 0 0.004935759585350752
in O 0 0.004605047404766083
most O 0 0.009269528090953827
patients O 1 0.9939568042755127
with O 0 0.033747218549251556
Denys B-Disease 1 0.9962144494056702
- I-Disease 1 0.9892789721488953
Drash I-Disease 1 0.9977633953094482
syndrome I-Disease 1 0.9998457431793213
( O 0 0.28705963492393494
DDS B-Disease 1 0.9913763403892517
) O 0 0.019172964617609978
, O 0 0.0120514165610075
or O 0 0.051589351147413254
diffuse B-Disease 1 0.9978697299957275
mesangial I-Disease 1 0.9995162487030029
sclerosis I-Disease 1 0.999841570854187
( O 0 0.40271270275115967
DMS B-Disease 1 0.992526650428772
) O 0 0.017842251807451248
associated O 0 0.019763629883527756
with O 0 0.0121395168825984
pseudohermaphroditism B-Disease 1 0.8429294228553772
and O 0 0.012986604124307632
/ O 1 0.7955950498580933
or O 0 0.24593062698841095
Wilms B-Disease 1 0.9991660118103027
tumor I-Disease 1 0.9991956353187561
( O 0 0.1170990914106369
WT B-Disease 1 0.981272280216217
) O 0 0.036390360444784164
. O 0 0.028285512700676918

Most O 0 0.03965665400028229
mutations O 1 0.994140088558197
in O 0 0.030758265405893326
DDS B-Disease 1 0.9954996705055237
patients O 1 0.9851067066192627
lie O 0 0.022208228707313538
in O 0 0.011465699411928654
exon O 1 0.785966157913208
8 O 0 0.018098272383213043
or O 0 0.013468605466187
exon O 1 0.6115402579307556
9 O 0 0.0164391677826643
, O 0 0.009136784821748734
encoding O 1 0.656594455242157
zinc O 1 0.9237952828407288
finger O 1 0.7168112397193909
2 O 0 0.016331255435943604
or O 0 0.013091091997921467
zinc O 1 0.9318203330039978
finger O 0 0.4893648326396942
3 O 0 0.011110424064099789
, O 0 0.004216444678604603
respectively O 0 0.0058744982816278934
, O 0 0.0032348129898309708
with O 0 0.003938439767807722
a O 0 0.006864580791443586
hot O 0 0.01764523983001709
spot O 0 0.018839756026864052
( O 0 0.017333142459392548
R394W O 1 0.6988406181335449
) O 0 0.013011190108954906
in O 0 0.011145143769681454
exon O 1 0.5692986249923706
9 O 0 0.028858397156000137
. O 0 0.023366335779428482

We O 0 0.012758346274495125
analyzed O 0 0.023106247186660767
a O 0 0.009257335215806961
series O 0 0.010424465872347355
of O 0 0.005666129756718874
24 O 0 0.015890290960669518
patients O 1 0.9582306742668152
, O 0 0.006157460156828165
10 O 0 0.007724050898104906
with O 0 0.0091318404302001
isolated B-Disease 1 0.8735767602920532
DMS I-Disease 1 0.9958595633506775
( O 0 0.05051908642053604
IDMS B-Disease 1 0.996088981628418
) O 0 0.01280382089316845
, O 0 0.005412146914750338
10 O 0 0.007341901771724224
with O 0 0.007720673456788063
DDS B-Disease 1 0.9772765636444092
, O 0 0.00538256298750639
and O 0 0.004705126862972975
4 O 0 0.010718989185988903
with O 0 0.012991217896342278
urogenital B-Disease 1 0.9974316954612732
abnormalities I-Disease 1 0.999152421951294
and O 0 0.01551822479814291
/ O 1 0.6675824522972107
or O 0 0.03117717057466507
WT B-Disease 1 0.9703907370567322
. O 0 0.03558971732854843

We O 0 0.02266673929989338
report O 0 0.03290445730090141
WT1 O 1 0.9921054840087891
heterozygous O 1 0.9925975799560547
mutations O 1 0.9957412481307983
in O 0 0.013161491602659225
16 O 0 0.022730303928256035
patients O 1 0.9839622974395752
, O 0 0.0063188630156219006
4 O 0 0.007523198612034321
of O 0 0.004593261517584324
whom O 0 0.00910896621644497
presented O 0 0.012809655629098415
with O 0 0.01988368108868599
IDMS B-Disease 1 0.9914211630821228
. O 0 0.030948078259825706

One O 0 0.023157844319939613
male O 0 0.045199207961559296
and O 0 0.010100855492055416
two O 0 0.013476653024554253
female O 1 0.7930353879928589
IDMS B-Disease 1 0.9980002045631409
patients O 1 0.9963917136192322
with O 0 0.22715263068675995
WT1 O 1 0.9985235333442688
mutations O 1 0.9986761212348938
underwent O 1 0.9889511466026306
normal O 1 0.8400898575782776
puberty O 1 0.9815165996551514
. O 0 0.04597156122326851

Two O 0 0.04224618151783943
mutations O 1 0.9952588677406311
associated O 0 0.04158403351902962
with O 0 0.0154753178358078
IDMS B-Disease 1 0.9858778715133667
are O 0 0.006167521234601736
different O 0 0.006746069993823767
from O 0 0.006979750003665686
those O 0 0.0069978851824998856
described O 0 0.020229876041412354
in O 0 0.02219792641699314
DDS B-Disease 1 0.9949641227722168
patients O 1 0.9927279949188232
. O 0 0.03889688104391098

No O 0 0.048935115337371826
WT1 O 1 0.9925251007080078
mutations O 1 0.9919981360435486
were O 0 0.01092403195798397
detected O 0 0.08407813310623169
in O 0 0.0060600400902330875
the O 0 0.005052364896982908
six O 0 0.01050303690135479
other O 0 0.016636185348033905
IDMS B-Disease 1 0.9989215135574341
patients O 1 0.9960843324661255
, O 0 0.011399961076676846
suggesting O 0 0.26528817415237427
genetic O 1 0.9963273406028748
heterogeneity O 1 0.9411530494689941
of O 0 0.01241566613316536
this O 0 0.020364489406347275
disease O 1 0.9982080459594727
. O 0 0.03522542119026184

We O 0 0.02474944107234478
analyzed O 0 0.18197816610336304
genotype O 1 0.991996705532074
/ O 1 0.9510565400123596
phenotype O 1 0.9979656934738159
correlations O 0 0.429497629404068
, O 0 0.00463816849514842
on O 0 0.0028909635730087757
the O 0 0.002519681118428707
basis O 0 0.003820637473836541
of O 0 0.0023125901352614164
the O 0 0.003374379361048341
constitution O 0 0.006071648560464382
of O 0 0.004466071259230375
a O 0 0.01505670789629221
WT1 O 1 0.9972713589668274
mutation O 1 0.9964597821235657
database O 0 0.040201976895332336
of O 0 0.008552396669983864
84 O 0 0.05846388265490532
germ O 1 0.9879921674728394
- O 0 0.3672722280025482
line O 0 0.03392781689763069
mutations O 1 0.9954432249069214
, O 0 0.004821693524718285
to O 0 0.0029837903566658497
compare O 0 0.0105878422036767
the O 0 0.0037811079528182745
distribution O 0 0.010779278352856636
and O 0 0.004258900415152311
type O 0 0.13563653826713562
of O 0 0.006001922767609358
mutations O 1 0.998586893081665
, O 0 0.0049674795009195805
according O 0 0.004812302533537149
to O 0 0.003688714699819684
the O 0 0.006249877158552408
different O 0 0.019320381805300713
symptoms O 1 0.9964969754219055
. O 0 0.03171874210238457

This O 0 0.01678679697215557
demonstrated O 0 0.025957904756069183
( O 0 0.011579900048673153
1 O 0 0.008912875317037106
) O 0 0.006882470566779375
the O 0 0.0046171508729457855
association O 0 0.01112435758113861
between O 0 0.01016111671924591
mutations O 1 0.997028648853302
in O 0 0.008203336037695408
exons O 1 0.6831556558609009
8 O 0 0.011214577592909336
and O 0 0.0046926564536988735
9 O 0 0.008992195129394531
and O 0 0.0065460833720862865
DMS B-Disease 1 0.9863030314445496
; O 0 0.013040900230407715
( O 0 0.009503408335149288
2 O 0 0.010143301449716091
) O 0 0.009694897569715977
among O 0 0.011687721125781536
patients O 1 0.9878155589103699
with O 0 0.011552822776138783
DMS B-Disease 1 0.9682743549346924
, O 0 0.006723969709128141
a O 0 0.007514626253396273
higher O 0 0.011864637024700642
frequency O 0 0.021805167198181152
of O 0 0.007814350537955761
exon O 1 0.8045754432678223
8 O 0 0.02600971795618534
mutations O 1 0.9940057992935181
among O 0 0.014077392406761646
46 O 0 0.025799013674259186
, O 0 0.014988057315349579
XY O 1 0.9965671300888062
patients O 1 0.99327552318573
with O 0 0.016078300774097443
female O 1 0.5436007976531982
phenotype O 1 0.9967944025993347
than O 0 0.009658153168857098
among O 0 0.010788626968860626
46 O 0 0.023511847481131554
, O 0 0.01221315935254097
XY O 1 0.9966220855712891
patients O 1 0.9866553544998169
with O 0 0.012036653235554695
sexual O 0 0.2692982256412506
ambiguity O 0 0.2564021050930023
or O 0 0.022637728601694107
male O 1 0.9478327631950378
phenotype O 1 0.9988710284233093
; O 0 0.012550167739391327
and O 0 0.004599698353558779
( O 0 0.0075798737816512585
3 O 0 0.007222335319966078
) O 0 0.005883070174604654
statistically O 0 0.013450426049530506
significant O 0 0.006592322140932083
evidence O 0 0.005800342652946711
that O 0 0.0053708842024207115
mutations O 1 0.9927593469619751
in O 0 0.008049067109823227
exons O 1 0.7554447650909424
8 O 0 0.011184852570295334
and O 0 0.005118272732943296
9 O 0 0.012618648819625378
preferentially O 0 0.34847235679626465
affect O 0 0.2101481407880783
amino O 1 0.9079992175102234
acids O 1 0.7440284490585327
with O 0 0.007344547193497419
different O 0 0.007815537974238396
functions O 0 0.0149959372356534
. O 0 0.010219830088317394
. O 0 0.016045400872826576

The O 0 0.04585252329707146
185delAG O 1 0.9697210788726807
BRCA1 O 1 0.9990735054016113
mutation O 1 0.9962882995605469
originated O 0 0.044945888221263885
before O 0 0.008342418819665909
the O 0 0.005700099281966686
dispersion O 0 0.09630096703767776
of O 0 0.004240535665303469
Jews O 0 0.006002867128700018
in O 0 0.0035479392390698195
the O 0 0.0037334279622882605
diaspora O 0 0.015442651696503162
and O 0 0.003154279198497534
is O 0 0.004030004143714905
not O 0 0.003901140298694372
limited O 0 0.009312070906162262
to O 0 0.009817457757890224
Ashkenazim O 1 0.624759316444397
. O 0 0.024960080161690712

The O 0 0.035050779581069946
185delAG O 1 0.9403039813041687
mutation O 1 0.9950640797615051
in O 0 0.029461901634931564
BRCA1 O 1 0.9984009861946106
is O 0 0.01496523804962635
detected O 0 0.3735473155975342
in O 0 0.008295527659356594
Ashkenazi O 0 0.37339484691619873
Jews O 0 0.010642173700034618
both O 0 0.007673611398786306
in O 0 0.02404654771089554
familial B-Disease 1 0.9997294545173645
breast I-Disease 1 0.9998836517333984
and I-Disease 1 0.7284519076347351
ovarian I-Disease 1 0.9999674558639526
cancer I-Disease 1 0.9997909665107727
and O 0 0.008200244978070259
in O 0 0.0057520619593560696
the O 0 0.005185682326555252
general O 0 0.009962253272533417
population O 0 0.018633730709552765
. O 0 0.021064074710011482

All O 0 0.027337128296494484
tested O 0 0.4605026841163635
Ashkenazi O 1 0.9725038409233093
mutation O 1 0.996311366558075
carriers O 0 0.25150737166404724
share O 0 0.013846097514033318
the O 0 0.00784322526305914
same O 0 0.012487964704632759
allelic O 1 0.9620896577835083
pattern O 0 0.3055163621902466
at O 0 0.013594311662018299
the O 0 0.01886461116373539
BRCA1 O 1 0.9989913105964661
locus O 1 0.983906626701355
. O 0 0.04286860674619675

Our O 0 0.018877333030104637
previous O 0 0.014046870172023773
study O 0 0.016091620549559593
showed O 0 0.011606262065470219
that O 0 0.004834885708987713
this O 0 0.0077754720114171505
Ashkenazi O 1 0.9635747075080872
mutation O 1 0.997817873954773
also O 0 0.007914177142083645
occurs O 0 0.08869574218988419
in O 0 0.00569907808676362
Iraqi O 0 0.009355816058814526
Jews O 0 0.007687821984291077
with O 0 0.005893900524824858
a O 0 0.011005434207618237
similar O 0 0.028451990336179733
allelic O 1 0.9792712330818176
pattern O 1 0.5842233896255493
. O 0 0.029435565695166588

We O 0 0.012891879305243492
extended O 0 0.01388711016625166
our O 0 0.007185499649494886
analysis O 0 0.01118425652384758
to O 0 0.0036271698772907257
other O 0 0.005273083690553904
non O 0 0.017370453104376793
- O 0 0.13318848609924316
Ashkenazi O 1 0.6965667605400085
subsets O 0 0.07518527656793594
354 O 0 0.03316142037510872
of O 0 0.008334115147590637
Moroccan O 0 0.02630796656012535
origin O 0 0.015070815570652485
, O 0 0.006954486016184092
200 O 0 0.012598727829754353
Yemenites O 0 0.3011402487754822
and O 0 0.0079739885404706
150 O 0 0.01605840027332306
Iranian O 0 0.01887907274067402
Jews O 0 0.021209100261330605
. O 0 0.020871514454483986

Heteroduplex O 0 0.39418789744377136
analysis O 0 0.04483846575021744
complemented O 0 0.04554795101284981
by O 0 0.014605625532567501
direct O 0 0.026048561558127403
DNA O 1 0.8233635425567627
sequencing O 0 0.4438769221305847
of O 0 0.01561764720827341
abnormally O 1 0.9740539193153381
migrating O 0 0.332550585269928
bands O 0 0.02876412495970726
were O 0 0.01089173462241888
employed O 0 0.028644075617194176
. O 0 0.02390710450708866

Four O 0 0.015933668240904808
of O 0 0.008939231745898724
Moroccan O 0 0.032523270696401596
origin O 0 0.017641685903072357
( O 0 0.00968764815479517
1 O 0 0.006578207481652498
. O 0 0.0038730832748115063
1 O 0 0.005650924984365702
% O 0 0.006416045129299164
) O 0 0.004486983176320791
and O 0 0.002342902822420001
none O 0 0.004006969276815653
of O 0 0.0026095514185726643
the O 0 0.00362925766967237
Yemenites O 1 0.5242051482200623
or O 0 0.007400201167911291
Iranians O 0 0.008929620496928692
was O 0 0.00417476799339056
a O 0 0.007729248609393835
carrier O 0 0.02513810805976391
of O 0 0.007072224747389555
the O 0 0.012703520245850086
185delAG O 1 0.9680203795433044
mutation O 1 0.9966505169868469
. O 0 0.037264157086610794

BRCA1 O 1 0.9962179064750671
allelic O 1 0.9646540880203247
patterns O 0 0.08954910188913345
were O 0 0.006419559940695763
determined O 0 0.008857584558427334
for O 0 0.0031674690544605255
four O 0 0.0031090928241610527
of O 0 0.002419796772301197
these O 0 0.002974518807604909
individuals O 0 0.005238441750407219
and O 0 0.0024982981849461794
for O 0 0.003259713761508465
12 O 0 0.0067862155847251415
additional O 0 0.00911919865757227
non O 0 0.023569975048303604
- O 1 0.5800767540931702
Ashkenazi O 1 0.9782826900482178
185delAG O 1 0.9889400601387024
mutation O 1 0.9981495141983032
carriers O 1 0.8034221529960632
who O 0 0.02382502146065235
had O 0 0.16830585896968842
breast B-Disease 1 0.9997684359550476
/ I-Disease 1 0.9982255101203918
ovarian I-Disease 1 0.9999189376831055
cancer I-Disease 1 0.9995343685150146
. O 0 0.05850118026137352

Six O 0 0.037657614797353745
non O 0 0.04418429359793663
- O 0 0.22013384103775024
Ashkenazi O 1 0.6512615084648132
individuals O 0 0.016437441110610962
shared O 0 0.01109058503061533
the O 0 0.006961424835026264
common O 0 0.17680777609348297
Ashkenazi O 1 0.9817713499069214
haplotype O 1 0.9939894676208496
, O 0 0.0057778870686888695
four O 0 0.005108227487653494
had O 0 0.00470562232658267
a O 0 0.007149146404117346
closely O 0 0.01279620360583067
related O 0 0.047954753041267395
pattern O 0 0.16142205893993378
, O 0 0.003908239305019379
and O 0 0.002656928263604641
the O 0 0.003987673670053482
rest O 0 0.009112376719713211
( O 0 0.011107584461569786
n O 0 0.043148770928382874
= O 0 0.05744309350848198
6 O 0 0.01190254371613264
) O 0 0.007750870659947395
displayed O 0 0.010608027689158916
a O 0 0.01691761054098606
distinct O 0 0.4793102443218231
BRCA1 O 1 0.9986340403556824
allelic O 1 0.9885737895965576
pattern O 1 0.785315752029419
. O 0 0.03628120943903923

We O 0 0.013921734876930714
conclude O 0 0.022251877933740616
that O 0 0.007550266571342945
the O 0 0.012308871373534203
185delAG O 1 0.9916111826896667
BRCA1 O 1 0.999722421169281
mutation O 1 0.9989845156669617
occurs O 0 0.3312590718269348
in O 0 0.00738605996593833
some O 0 0.006982783786952496
non O 0 0.033125247806310654
- O 0 0.4083561301231384
Ashkenazi O 1 0.9167949557304382
populations O 0 0.3813197612762451
at O 0 0.010443814098834991
rates O 0 0.025934459641575813
comparable O 0 0.020805003121495247
with O 0 0.006698911543935537
that O 0 0.006534183397889137
of O 0 0.01081753522157669
Ashkenazim O 1 0.6840338110923767
. O 0 0.02765878289937973

The O 0 0.015339910984039307
majority O 0 0.01649305410683155
of O 0 0.00864646676927805
Jewish O 0 0.03215468302369118
185delAG O 1 0.9788782596588135
mutation O 1 0.9983373880386353
carriers O 0 0.3444596529006958
have O 0 0.0062586166895926
a O 0 0.008862811140716076
common O 0 0.0825035572052002
allelic O 1 0.9871384501457214
pattern O 0 0.3384544551372528
, O 0 0.005215694662183523
supporting O 0 0.009208600036799908
the O 0 0.005098918452858925
founder O 0 0.02538776956498623
effect O 0 0.026751535013318062
notion O 0 0.013116566464304924
, O 0 0.0041020638309419155
but O 0 0.003905782476067543
dating O 0 0.011743980459868908
the O 0 0.005614746827632189
mutations O 1 0.9977832436561584
origin O 0 0.0097995949909091
to O 0 0.003427287330850959
an O 0 0.0036487977486103773
earlier O 0 0.006087819579988718
date O 0 0.007321665529161692
than O 0 0.005410575773566961
currently O 0 0.007900658063590527
estimated O 0 0.019094865769147873
. O 0 0.017844466492533684

However O 0 0.017469432204961777
, O 0 0.0076388404704630375
the O 0 0.0055142296478152275
different O 0 0.00944366492331028
allelic O 1 0.9615657329559326
pattern O 0 0.17833946645259857
at O 0 0.009815122000873089
the O 0 0.013186679221689701
BRCA1 O 1 0.9994043111801147
locus O 1 0.983647882938385
even O 0 0.00943034514784813
in O 0 0.004757475573569536
some O 0 0.005442495457828045
Jewish O 0 0.054132990539073944
mutation O 1 0.9990696310997009
carriers O 1 0.681611955165863
, O 0 0.006005920469760895
might O 0 0.008547862060368061
suggest O 0 0.009620681405067444
that O 0 0.004241883754730225
the O 0 0.007724258583039045
mutation O 1 0.9980723857879639
arose O 0 0.10805030167102814
independently O 0 0.0239538736641407
. O 0 0.011462532915174961
. O 0 0.01835900917649269

Crystal O 0 0.06893102079629898
structure O 0 0.02816491201519966
of O 0 0.009483441710472107
the O 0 0.01819276250898838
hemochromatosis B-Disease 1 0.9989805817604065
protein O 1 0.9951618313789368
HFE O 1 0.9873572587966919
and O 0 0.0096993213519454
characterization O 0 0.03063041903078556
of O 0 0.005236032418906689
its O 0 0.008317139931023121
interaction O 0 0.09882090985774994
with O 0 0.018601704388856888
transferrin O 1 0.9892776012420654
receptor O 1 0.9871984124183655
. O 0 0.03671343997120857

HFE O 1 0.9621410965919495
is O 0 0.02185063064098358
an O 0 0.021564748138189316
MHC O 1 0.9909645318984985
- O 0 0.46868303418159485
related O 0 0.12183630466461182
protein O 1 0.9015879034996033
that O 0 0.0071756248362362385
is O 0 0.008532790467143059
mutated O 1 0.9765613079071045
in O 0 0.008610978722572327
the O 0 0.01042084489017725
iron B-Disease 1 0.8785322308540344
- I-Disease 1 0.991872251033783
overload I-Disease 1 0.9990654587745667
disease I-Disease 1 0.9998089671134949
hereditary B-Disease 1 0.9988530874252319
hemochromatosis I-Disease 1 0.9986066222190857
. O 0 0.08202537149190903

HFE O 1 0.9424965977668762
binds O 1 0.6474427580833435
to O 0 0.02440420351922512
transferrin O 1 0.9865378141403198
receptor O 1 0.9925547242164612
( O 0 0.03337659686803818
TfR O 1 0.9776298999786377
) O 0 0.011814316734671593
and O 0 0.0057032485492527485
reduces O 0 0.13289284706115723
its O 0 0.006889873184263706
affinity O 0 0.15030589699745178
for O 0 0.008467553183436394
iron O 0 0.0774584487080574
- O 0 0.09025917947292328
loaded O 0 0.035129278898239136
transferrin O 1 0.9630604386329651
, O 0 0.017087582498788834
implicating O 1 0.888613760471344
HFE O 1 0.9845967888832092
in O 0 0.023676173761487007
iron O 0 0.39134836196899414
metabolism O 1 0.9853295683860779
. O 0 0.0377759113907814

The O 0 0.034539926797151566
2 O 0 0.04426847770810127
. O 0 0.034084830433130264

6 O 0 0.03480180725455284
A O 0 0.02435620315372944
crystal O 0 0.04549378529191017
structure O 0 0.02173137106001377
of O 0 0.01009049080312252
HFE O 1 0.9841212034225464
reveals O 0 0.028648952022194862
the O 0 0.006496816873550415
locations O 0 0.01270222757011652
of O 0 0.01233037281781435
hemochromatosis B-Disease 1 0.9995309114456177
mutations O 1 0.9983059167861938
and O 0 0.008114639669656754
a O 0 0.011866683140397072
patch O 1 0.8344016075134277
of O 0 0.006671467795968056
histidines O 0 0.47112908959388733
that O 0 0.004511402919888496
could O 0 0.005311011336743832
be O 0 0.0038144937716424465
involved O 0 0.012217514216899872
in O 0 0.011313976719975471
pH O 1 0.9910824298858643
- O 0 0.42801007628440857
dependent O 0 0.22397461533546448
interactions O 0 0.4461665451526642
. O 0 0.03084833174943924

We O 0 0.013286796398460865
also O 0 0.0077328491024672985
demonstrate O 0 0.015557386912405491
that O 0 0.009293903596699238
soluble O 1 0.9762256145477295
TfR O 1 0.9774608612060547
and O 0 0.014323385432362556
HFE O 1 0.9939830899238586
bind O 1 0.7524150609970093
tightly O 0 0.024070294573903084
at O 0 0.005243557970970869
the O 0 0.0038096336647868156
basic O 0 0.010063991881906986
pH O 1 0.8096591234207153
of O 0 0.0040358686819672585
the O 0 0.005452798213809729
cell O 1 0.9653787016868591
surface O 0 0.016606518998742104
, O 0 0.00386787299066782
but O 0 0.0027242323849350214
not O 0 0.0027215611189603806
at O 0 0.004410195164382458
the O 0 0.0070145511999726295
acidic O 1 0.9788716435432434
pH O 1 0.9811263680458069
of O 0 0.0195202324539423
intracellular O 1 0.9830139875411987
vesicles O 1 0.9703237414360046
. O 0 0.03791990131139755

TfR O 1 0.952553391456604
HFE O 1 0.972076952457428
stoichiometry O 1 0.8112318515777588
( O 0 0.02953573502600193
2 O 0 0.017356103286147118
1 O 0 0.01365155540406704
) O 0 0.011538858525454998
differs O 0 0.02800113335251808
from O 0 0.01221670862287283
TfR O 1 0.9836863875389099
transferrin O 1 0.989762008190155
stoichiometry O 1 0.9601864218711853
( O 0 0.012102916836738586
2 O 0 0.009754234924912453
2 O 0 0.009334206581115723
) O 0 0.0060327365063130856
, O 0 0.0036702766083180904
implying O 0 0.01303273905068636
a O 0 0.005522625055164099
different O 0 0.004652662202715874
mode O 0 0.013383918441832066
of O 0 0.004094965755939484
binding O 0 0.036208879202604294
for O 0 0.007248802110552788
HFE O 1 0.9901751279830933
and O 0 0.00855250284075737
transferrin O 1 0.9341338872909546
to O 0 0.00948131550103426
TfR O 1 0.9602810144424438
, O 0 0.006695701740682125
consistent O 0 0.010710366070270538
with O 0 0.004988095257431269
our O 0 0.00622332701459527
demonstration O 0 0.01611904241144657
that O 0 0.009233596734702587
HFE O 1 0.9872708320617676
, O 0 0.012266277335584164
transferrin O 1 0.8658544421195984
, O 0 0.008264751173555851
and O 0 0.0077865538187325
TfR O 1 0.9521751403808594
form O 0 0.025184592232108116
a O 0 0.021114401519298553
ternary O 1 0.7529504895210266
complex O 0 0.05609279125928879
. O 0 0.02602458745241165

Identification O 0 0.035738810896873474
of O 0 0.00923322606831789
three O 0 0.010836266912519932
novel O 0 0.13263313472270966
mutations O 1 0.9933664202690125
and O 0 0.005848258268088102
a O 0 0.007753188256174326
high O 0 0.008267191238701344
frequency O 0 0.017228037118911743
of O 0 0.00477558933198452
the O 0 0.007802026811987162
Arg778Leu O 1 0.9844918847084045
mutation O 1 0.9984012246131897
in O 0 0.014379997737705708
Korean O 0 0.3247257173061371
patients O 1 0.992517352104187
with O 0 0.03667933866381645
Wilson B-Disease 1 0.9406264424324036
disease I-Disease 1 0.9986467957496643
. O 0 0.0384768471121788

Four O 0 0.05185369402170181
mutations O 1 0.9949222207069397
- O 1 0.5579568147659302
- O 0 0.4040277600288391
R778L O 1 0.6399598717689514
, O 0 0.01454835757613182
A874V O 0 0.40872976183891296
, O 0 0.01058740820735693
L1083F O 0 0.24887968599796295
, O 0 0.007116042543202639
and O 0 0.006439371965825558
2304delC O 1 0.830665647983551
- O 0 0.19269201159477234
- O 0 0.030189000070095062
in O 0 0.005695371422916651
the O 0 0.006433590315282345
copper O 0 0.045144326984882355
- O 0 0.10799038410186768
transporting O 0 0.10257530212402344
enzyme O 1 0.9831978678703308
, O 0 0.01497409027069807
P O 1 0.5971137285232544
- O 1 0.6214514970779419
type O 1 0.8808121085166931
ATPase O 1 0.9926472902297974
( O 0 0.02266746200621128
ATP7B O 1 0.7490214705467224
) O 0 0.008955852128565311
, O 0 0.0033008186146616936
were O 0 0.0030110832303762436
identified O 0 0.01142113283276558
in O 0 0.007686279714107513
Korean O 0 0.24352693557739258
Patients O 1 0.9954994320869446
with O 0 0.029845105484128
Wilson B-Disease 1 0.944788932800293
disease I-Disease 1 0.998866081237793
. O 0 0.04146162047982216

Arg778Leu O 0 0.3449189066886902
, O 0 0.010022247210144997
the O 0 0.005969618912786245
most O 0 0.005982830189168453
frequently O 0 0.012393458746373653
reported O 0 0.022049512714147568
mutation O 1 0.9940356016159058
of O 0 0.004859893582761288
this O 0 0.0059590633027255535
enzyme O 1 0.9728091359138489
, O 0 0.004497034940868616
was O 0 0.00327605614438653
found O 0 0.004582467954605818
in O 0 0.0031465922947973013
six O 0 0.004706455860286951
of O 0 0.0039240350015461445
eight O 0 0.010526776313781738
unrelated O 1 0.9504709839820862
patients O 1 0.9948969483375549
studied O 0 0.017090868204832077
, O 0 0.005893889348953962
an O 0 0.009398111142218113
allele O 1 0.9820358157157898
frequency O 0 0.04511723294854164
of O 0 0.010732458904385567
37 O 0 0.028189077973365784
. O 0 0.02173496223986149

5 O 0 0.030078889802098274
% O 0 0.015527941286563873
, O 0 0.005554179660975933
which O 0 0.004122061654925346
is O 0 0.0048201968893408775
considerably O 0 0.016631847247481346
higher O 0 0.006983134895563126
than O 0 0.003543086117133498
those O 0 0.0038630221970379353
in O 0 0.004290040582418442
other O 0 0.006236434914171696
Asian O 0 0.09980887919664383
populations O 1 0.6723939180374146
. O 0 0.023823769763112068

The O 0 0.019151899963617325
novel O 0 0.04160764068365097
single O 0 0.0335804745554924
nucleotide O 1 0.9608314037322998
deletion O 1 0.9790959358215332
, O 0 0.013021690770983696
2304delC O 0 0.4885123372077942
, O 0 0.006058750674128532
was O 0 0.004733912646770477
found O 0 0.007806003093719482
in O 0 0.0067428103648126125
one O 0 0.01213072519749403
patient O 1 0.9516010880470276
. O 0 0.024862341582775116

Since O 0 0.035531576722860336
a O 0 0.027061905711889267
mutation O 1 0.988029420375824
at O 0 0.02292398177087307
cDNA O 1 0.9289425015449524
nucleotide O 1 0.983400285243988
2302 O 1 0.9896658658981323
( O 0 0.024729831144213676
2302insC O 1 0.6568009853363037
) O 0 0.008423812687397003
had O 0 0.004011893179267645
been O 0 0.0036495050881057978
previously O 0 0.005190059542655945
described O 0 0.007249175570905209
, O 0 0.003086447948589921
this O 0 0.002310111653059721
region O 0 0.004945199470967054
of O 0 0.003223308129236102
the O 0 0.006728188134729862
ATP7B O 1 0.9928998947143555
gene O 1 0.9971677660942078
may O 0 0.014303752221167088
be O 0 0.007131176069378853
susceptible O 1 0.9844498038291931
to O 0 0.01802038587629795
gene O 1 0.9974380731582642
rearrangements O 1 0.9935522079467773
causing O 1 0.9889608025550842
Wilson B-Disease 1 0.9690183997154236
disease I-Disease 1 0.9984980821609497
. O 0 0.04444563388824463

Disruption O 0 0.18623687326908112
of O 0 0.024370281025767326
splicing O 1 0.8343705534934998
regulated O 0 0.05771013721823692
by O 0 0.01772911474108696
a O 0 0.022499695420265198
CUG O 1 0.9104206562042236
- O 1 0.5736014246940613
binding O 1 0.723667323589325
protein O 1 0.9817501306533813
in O 0 0.10182013362646103
myotonic B-Disease 1 0.998601496219635
dystrophy I-Disease 1 0.999167799949646
. O 0 0.06107303872704506

Myotonic B-Disease 1 0.9975812435150146
dystrophy I-Disease 1 0.9991249442100525
( O 0 0.28541868925094604
DM B-Disease 1 0.9951393604278564
) O 0 0.01817116141319275
is O 0 0.007835526950657368
caused O 0 0.03224194422364235
by O 0 0.006632618606090546
a O 0 0.010510904714465141
CTG O 1 0.6713144779205322
expansion O 0 0.016175461933016777
in O 0 0.00516738323494792
the O 0 0.0051463935524225235
3 O 0 0.011915240436792374
untranslated O 0 0.32032325863838196
region O 0 0.012670477852225304
of O 0 0.007374064531177282
the O 0 0.01616654358804226
DM B-Disease 1 0.9959503412246704
gene O 1 0.9911008477210999
. O 0 0.04419548436999321

One O 0 0.022181540727615356
model O 0 0.03153327852487564
of O 0 0.0195618886500597
DM B-Disease 1 0.9974226951599121
pathogenesis O 1 0.9960656762123108
suggests O 0 0.09347650408744812
that O 0 0.009970014914870262
RNAs O 0 0.40148231387138367
from O 0 0.0063737486489117146
the O 0 0.004830166231840849
expanded O 0 0.012710710056126118
allele O 1 0.9660499691963196
create O 0 0.017279062420129776
a O 0 0.008297324180603027
gain O 0 0.014505473896861076
- O 0 0.054774075746536255
of O 0 0.006502279546111822
- O 1 0.525028645992279
function O 1 0.684843897819519
mutation O 1 0.9958856701850891
by O 0 0.006221112795174122
the O 0 0.005587026011198759
inappropriate O 0 0.0460972860455513
binding O 0 0.03283534571528435
of O 0 0.006661893334239721
proteins O 0 0.41614893078804016
to O 0 0.0072241537272930145
the O 0 0.011914785951375961
CUG O 1 0.9138842225074768
repeats O 1 0.5224603414535522
. O 0 0.026452146470546722

Data O 0 0.019631536677479744
presented O 0 0.01098114624619484
here O 0 0.005189063027501106
indicate O 0 0.008569695055484772
that O 0 0.0038658450357615948
the O 0 0.006090803537517786
conserved O 0 0.3093447983264923
heterogeneous O 1 0.8115034103393555
nuclear O 0 0.03902608901262283
ribonucleoprotein O 1 0.9625275135040283
, O 0 0.013108939863741398
CUG O 1 0.9151832461357117
- O 0 0.4103769361972809
binding O 1 0.5912267565727234
protein O 1 0.9740962386131287
( O 0 0.024949414655566216
CUG O 1 0.9447173476219177
- O 0 0.32092946767807007
BP O 0 0.28672879934310913
) O 0 0.010732646100223064
, O 0 0.0057123140431940556
may O 0 0.008860728703439236
mediate O 0 0.09066768735647202
the O 0 0.009480965323746204
trans O 1 0.9497861266136169
- O 0 0.24123384058475494
dominant O 0 0.1468276083469391
effect O 0 0.021232759580016136
of O 0 0.007247268222272396
the O 0 0.011516179889440536
RNA O 1 0.9472046494483948
. O 0 0.026367364451289177

CUG O 1 0.886500358581543
- O 0 0.08555811643600464
BP O 0 0.05976351723074913
was O 0 0.00966211874037981
found O 0 0.008845482021570206
to O 0 0.005628079175949097
bind O 0 0.05930730327963829
to O 0 0.005684090778231621
the O 0 0.009349867701530457
human O 1 0.7785804271697998
cardiac O 1 0.9994547963142395
troponin O 1 0.9978041052818298
T O 1 0.9902774095535278
( O 0 0.03170108422636986
cTNT O 1 0.6848827004432678
) O 0 0.018023626878857613
pre O 0 0.09056176245212555
- O 0 0.28635793924331665
messenger O 1 0.7406708598136902
RNA O 1 0.9227203130722046
and O 0 0.00981691014021635
regulate O 0 0.07116946578025818
its O 0 0.016385255381464958
alternative O 0 0.05656410753726959
splicing O 1 0.9640238881111145
. O 0 0.03208845108747482

Splicing O 1 0.6212344169616699
of O 0 0.02237892895936966
cTNT O 0 0.35609278082847595
was O 0 0.01761554926633835
disrupted O 0 0.29845762252807617
in O 0 0.026869511231780052
DM B-Disease 1 0.9977914094924927
striated O 1 0.9971139430999756
muscle O 1 0.9943100214004517
and O 0 0.0109235979616642
in O 0 0.010289208963513374
normal O 1 0.6985966563224792
cells O 1 0.9900512099266052
expressing O 0 0.04150250554084778
transcripts O 0 0.029345814138650894
that O 0 0.010646712966263294
contain O 0 0.042645517736673355
CUG O 1 0.8621693849563599
repeats O 0 0.35506537556648254
. O 0 0.032561734318733215

Altered O 0 0.10743961483240128
expression O 0 0.05262608826160431
of O 0 0.015573190525174141
genes O 1 0.9822580218315125
regulated O 0 0.44174909591674805
posttranscriptionally O 1 0.6772011518478394
by O 0 0.019981732591986656
CUG O 1 0.9261471033096313
- O 0 0.2513067126274109
BP O 0 0.16611959040164948
therefore O 0 0.016066674143075943
may O 0 0.014287694357335567
contribute O 0 0.03208380565047264
to O 0 0.016574310138821602
DM B-Disease 1 0.997916042804718
pathogenesis O 1 0.9957061409950256
. O 0 0.023745212703943253
. O 0 0.023858238011598587

Identification O 0 0.040597911924123764
of O 0 0.009542537853121758
a O 0 0.013374514877796173
novel O 0 0.041124336421489716
nonsense O 0 0.3447587192058563
mutation O 1 0.9927485585212708
and O 0 0.007279240991920233
a O 0 0.012835935689508915
missense O 1 0.9700366258621216
substitution O 0 0.06913940608501434
in O 0 0.00767712015658617
the O 0 0.009465000592172146
vasopressin O 1 0.9912392497062683
- O 1 0.6646347641944885
neurophysin O 1 0.9640774130821228
II O 0 0.26384615898132324
gene O 1 0.9750664830207825
in O 0 0.009011205285787582
two O 0 0.00808658730238676
Spanish O 0 0.031029703095555305
kindreds O 1 0.9809565544128418
with O 0 0.12060447782278061
familial B-Disease 1 0.9992628693580627
neurohypophyseal I-Disease 1 0.9968100190162659
diabetes I-Disease 1 0.9997188448905945
insipidus I-Disease 1 0.9959841966629028
. O 0 0.06448730826377869

Familial B-Disease 1 0.9961183071136475
neurohypophyseal I-Disease 1 0.9911593794822693
diabetes I-Disease 1 0.9996877908706665
insipidus I-Disease 1 0.9981369972229004
( O 0 0.11421476304531097
FNDI B-Disease 1 0.9743243455886841
) O 0 0.017900513485074043
is O 0 0.010351525619626045
an O 0 0.028009049594402313
autosomal B-Disease 1 0.999864935874939
dominant I-Disease 1 0.9969384670257568
disease I-Disease 1 0.9997503161430359
caused O 1 0.9594019651412964
by O 0 0.05085383728146553
deficiency O 1 0.9992278814315796
in O 0 0.016002681106328964
the O 0 0.020857399329543114
antidiuretic O 1 0.9967723488807678
hormone O 1 0.9971278309822083
arginine O 1 0.9848949313163757
vasopressin O 1 0.9802528619766235
( O 0 0.031694382429122925
AVP O 1 0.843600332736969
) O 0 0.016637947410345078
encoded O 0 0.03180381655693054
by O 0 0.007808607071638107
the O 0 0.009445185773074627
AVP O 1 0.9725496172904968
- O 1 0.5629015564918518
neurophysin O 1 0.9083510041236877
II O 0 0.19543270766735077
( O 0 0.03371024876832962
AVP O 1 0.9711611270904541
- O 1 0.7027406096458435
NPII O 1 0.9443604946136475
) O 0 0.03306717053055763
gene O 1 0.9775901436805725
on O 0 0.020735986530780792
chromosome O 1 0.9917028546333313
20p13 O 1 0.891287088394165
. O 0 0.03987947106361389

In O 0 0.011299478821456432
this O 0 0.007242089603096247
study O 0 0.010586218908429146
, O 0 0.0038213380612432957
we O 0 0.0028040450997650623
analyzed O 0 0.009939496405422688
two O 0 0.004262411966919899
families O 0 0.008013706654310226
with O 0 0.007290837820619345
FNDI B-Disease 1 0.8227337598800659
using O 0 0.013775152154266834
direct O 0 0.01615360751748085
automated O 0 0.04514129459857941
fluorescent O 1 0.5005847811698914
, O 0 0.00708617502823472
solid O 0 0.015746818855404854
phase O 0 0.042618054896593094
, O 0 0.0057944064028561115
single O 0 0.012650283053517342
- O 0 0.11465730518102646
stranded O 0 0.3670865595340729
DNA O 1 0.932069718837738
sequencing O 1 0.640977144241333
of O 0 0.016340909525752068
PCR O 1 0.974390983581543
- O 1 0.6402665972709656
amplified O 1 0.8958209753036499
AVP O 1 0.9789721965789795
- O 1 0.7870617508888245
NPII O 1 0.9636587500572205
DNA O 1 0.9283549785614014
. O 0 0.03881164267659187

In O 0 0.011313209310173988
one O 0 0.005256626754999161
of O 0 0.003534422954544425
the O 0 0.003886412363499403
families O 0 0.008880005218088627
, O 0 0.004899260122328997
affected O 0 0.03484267368912697
individuals O 0 0.009183809161186218
presented O 0 0.008435473777353764
a O 0 0.010033727623522282
novel O 0 0.09635000675916672
nonsense O 1 0.6280026435852051
mutation O 1 0.9976404905319214
in O 0 0.00914344098418951
exon O 0 0.48662981390953064
3 O 0 0.00999489240348339
of O 0 0.0044777910225093365
the O 0 0.005978057160973549
gene O 1 0.9875271916389465
, O 0 0.004416916985064745
consisting O 0 0.00772720854729414
in O 0 0.004874739795923233
a O 0 0.008152191527187824
G O 1 0.551202118396759
to O 0 0.00788106769323349
T O 1 0.8803863525390625
transition O 0 0.036992721259593964
at O 0 0.013457762077450752
nucleotide O 1 0.9323650598526001
2101 O 1 0.8650614619255066
, O 0 0.00800437293946743
which O 0 0.006237616762518883
produces O 0 0.02223118580877781
a O 0 0.00960486102849245
stop O 0 0.013763445429503918
signal O 0 0.02645714581012726
in O 0 0.012039721943438053
codon O 1 0.6764446496963501
82 O 0 0.0414302684366703
( O 0 0.024256350472569466
Glu O 1 0.9773542284965515
) O 0 0.01900220662355423
of O 0 0.013436596840620041
NPII O 1 0.7814281582832336
. O 0 0.03190358355641365

The O 0 0.029854729771614075
premature O 1 0.9492269158363342
termination O 1 0.8016103506088257
eliminates O 0 0.13263888657093048
part O 0 0.009369528852403164
of O 0 0.005215818993747234
the O 0 0.006582499016076326
C O 0 0.4926488995552063
- O 0 0.21501898765563965
terminal O 0 0.299608051776886
domain O 0 0.031207358464598656
of O 0 0.005935579538345337
NPII O 1 0.5981119871139526
, O 0 0.004590415395796299
including O 0 0.005055269226431847
a O 0 0.007689954247325659
cysteine O 1 0.6458470821380615
residue O 0 0.10577408224344254
in O 0 0.005090130493044853
position O 0 0.004453615751117468
85 O 0 0.009037849493324757
, O 0 0.003075521904975176
which O 0 0.0023965162690728903
could O 0 0.0029890506993979216
be O 0 0.002191839274019003
involved O 0 0.004954807925969362
in O 0 0.0027330946177244186
the O 0 0.004145527258515358
correct O 0 0.0372530035674572
folding O 0 0.17924174666404724
of O 0 0.00952735636383295
the O 0 0.015467815101146698
prohormone O 1 0.9717925786972046
. O 0 0.0385250523686409

In O 0 0.014137285761535168
the O 0 0.00785729382187128
second O 0 0.010564854368567467
family O 0 0.014776921831071377
, O 0 0.006256979890167713
a O 0 0.009572473354637623
G279A O 0 0.4219900667667389
substitution O 0 0.08877576887607574
at O 0 0.006968403235077858
position O 0 0.007620283402502537
- O 0 0.015136846341192722
1 O 0 0.005897556431591511
of O 0 0.002985115395858884
the O 0 0.0048497384414076805
signal O 0 0.04868070036172867
peptide O 1 0.9536168575286865
was O 0 0.005900377407670021
observed O 0 0.013632358983159065
in O 0 0.004676217678934336
all O 0 0.004834234714508057
affected O 0 0.1210482120513916
individuals O 0 0.02814982831478119
. O 0 0.018969586119055748

This O 0 0.03814554214477539
missense O 1 0.9773732423782349
mutation O 1 0.9881370663642883
, O 0 0.015017722733318806
which O 0 0.010614464990794659
replaces O 0 0.19493472576141357
Ala O 1 0.7107996940612793
with O 0 0.016921138390898705
Thr O 1 0.9907916784286499
, O 0 0.008360086008906364
is O 0 0.007095262873917818
frequent O 0 0.040324870496988297
among O 0 0.017865480855107307
FNDI B-Disease 1 0.9948180317878723
patients O 1 0.991152822971344
and O 0 0.0051791430450975895
is O 0 0.00460345484316349
thought O 0 0.007057146169245243
to O 0 0.003692214610055089
reduce O 0 0.01454761903733015
the O 0 0.0049217818304896355
efficiency O 0 0.018275773152709007
of O 0 0.008454956114292145
cleavage O 1 0.9753501415252686
by O 0 0.014785587787628174
signal O 0 0.11582139879465103
peptidases O 1 0.7624818086624146
. O 0 0.01471356488764286
. O 0 0.01891241781413555

Genetic O 1 0.9738280177116394
heterogeneity O 1 0.7456785440444946
of O 0 0.02663148008286953
Saethre B-Disease 1 0.9775471687316895
- I-Disease 1 0.969046950340271
Chotzen I-Disease 1 0.9954667091369629
syndrome I-Disease 1 0.9996634721755981
, O 0 0.01123768649995327
due O 0 0.013154828920960426
to O 0 0.009597107768058777
TWIST O 0 0.3926224112510681
and O 0 0.017015334218740463
FGFR O 1 0.9765852093696594
mutations O 1 0.9958494901657104
. O 0 0.038726501166820526

Thirty O 0 0.05558885261416435
- O 0 0.05197107046842575
two O 0 0.014997943304479122
unrelated O 1 0.7658392786979675
patients O 1 0.9487935304641724
with O 0 0.009329626336693764
features O 0 0.011154602281749249
of O 0 0.009196942672133446
Saethre B-Disease 1 0.9929227828979492
- I-Disease 1 0.9819690585136414
Chotzen I-Disease 1 0.9976232647895813
syndrome I-Disease 1 0.9997561573982239
, O 0 0.011337042786180973
a O 0 0.01934713125228882
common O 1 0.8229845762252808
autosomal B-Disease 1 0.9997944235801697
dominant I-Disease 1 0.915326714515686
condition I-Disease 1 0.763994038105011
of O 0 0.01216221135109663
craniosynostosis B-Disease 1 0.9987022876739502
and O 0 0.019842427223920822
limb B-Disease 1 0.9986547231674194
anomalies I-Disease 1 0.9631011486053467
, O 0 0.006397977005690336
were O 0 0.004168646410107613
screened O 0 0.02787141315639019
for O 0 0.008650106377899647
mutations O 1 0.9979729056358337
in O 0 0.011379419825971127
TWIST O 1 0.6069632768630981
, O 0 0.010853703133761883
FGFR2 O 1 0.7436230778694153
, O 0 0.010227974504232407
and O 0 0.011425462551414967
FGFR3 O 1 0.710659384727478
. O 0 0.031749166548252106

Nine O 0 0.03015805035829544
novel O 0 0.02942962758243084
and O 0 0.008581938222050667
three O 0 0.011691565625369549
recurrent O 1 0.9942270517349243
TWIST O 1 0.9566942453384399
mutations O 1 0.9965323209762573
were O 0 0.007083471864461899
found O 0 0.010667144320905209
in O 0 0.007616408169269562
12 O 0 0.014110852032899857
families O 0 0.023750929161906242
. O 0 0.020905504003167152

Seven O 0 0.022449664771556854
families O 0 0.015165927819907665
were O 0 0.004527273587882519
found O 0 0.005645920056849718
to O 0 0.003512936644256115
have O 0 0.004374870099127293
the O 0 0.0069231996312737465
FGFR3 O 1 0.9855986833572388
P250R O 1 0.990369975566864
mutation O 1 0.9978188276290894
, O 0 0.005988856311887503
and O 0 0.0033829661551862955
one O 0 0.0032747203949838877
individual O 0 0.0068435342982411385
was O 0 0.0034519792534410954
found O 0 0.005080933216959238
to O 0 0.003140901681035757
have O 0 0.004369277507066727
an O 0 0.008192826062440872
FGFR2 O 1 0.9664313793182373
VV269 O 1 0.9615565538406372
- O 0 0.46620848774909973
270 O 0 0.16565704345703125
deletion O 1 0.9584010243415833
. O 0 0.03753731772303581

To O 0 0.012699100188910961
date O 0 0.01170438900589943
, O 0 0.00587783008813858
our O 0 0.007079923525452614
detection O 0 0.20976878702640533
rate O 0 0.013745655305683613
for O 0 0.006905321963131428
TWIST O 0 0.43616628646850586
or O 0 0.01946965605020523
FGFR O 1 0.9860070943832397
mutations O 1 0.997200608253479
is O 0 0.008192340843379498
68 O 0 0.01396231260150671
% O 0 0.00943793822079897
in O 0 0.0060508595779538155
our O 0 0.011359148658812046
Saethre B-Disease 1 0.9896581768989563
- I-Disease 1 0.9926239252090454
Chotzen I-Disease 1 0.999016523361206
syndrome I-Disease 1 0.9999489784240723
patients O 1 0.9967947602272034
, O 0 0.00754019757732749
including O 0 0.0065716467797756195
our O 0 0.007002956233918667
five O 0 0.011575496755540371
patients O 1 0.9904700517654419
elsewhere O 0 0.01958424411714077
reported O 0 0.01917574740946293
with O 0 0.014170520007610321
TWIST O 1 0.9306195378303528
mutations O 1 0.996109664440155
. O 0 0.03355613350868225

More O 0 0.016572367399930954
than O 0 0.011948127299547195
35 O 0 0.015252782963216305
different O 0 0.011832524091005325
TWIST O 1 0.8591921925544739
mutations O 1 0.9968371391296387
are O 0 0.004707762971520424
now O 0 0.004855428822338581
known O 0 0.0070943222381174564
in O 0 0.004181378521025181
the O 0 0.005682443734258413
literature O 0 0.019091514870524406
. O 0 0.01764068752527237

The O 0 0.012968248687684536
most O 0 0.009343668818473816
common O 0 0.02225496433675289
phenotypic O 1 0.8690924644470215
features O 0 0.010959943756461143
, O 0 0.0038811014965176582
present O 0 0.0036570222582668066
in O 0 0.0024737827479839325
more O 0 0.0025675296783447266
than O 0 0.00302374130114913
a O 0 0.004650545306503773
third O 0 0.005021889228373766
of O 0 0.003899487666785717
our O 0 0.008904874324798584
patients O 1 0.9897332787513733
with O 0 0.014881128445267677
TWIST O 1 0.9534121155738831
mutations O 1 0.9976971745491028
, O 0 0.010532444342970848
are O 0 0.007992325350642204
coronal B-Disease 1 0.9289589524269104
synostosis I-Disease 1 0.8577747941017151
, O 0 0.013078179210424423
brachycephaly B-Disease 1 0.6912643313407898
, O 0 0.015115160495042801
low B-Disease 0 0.3411555886268616
frontal I-Disease 1 0.9964773058891296
hairline I-Disease 1 0.9983108043670654
, O 0 0.04202146455645561
facial B-Disease 1 0.9972419738769531
asymmetry I-Disease 1 0.9929667711257935
, O 0 0.040923453867435455
ptosis B-Disease 1 0.9983914494514465
, O 0 0.017414908856153488
hypertelorism B-Disease 1 0.9798611402511597
, O 0 0.01122151780873537
broad B-Disease 0 0.027347682043910027
great I-Disease 0 0.01597735285758972
toes I-Disease 1 0.5660039186477661
, O 0 0.010883395560085773
and O 0 0.011808388866484165
clinodactyly B-Disease 1 0.7762281894683838
. O 0 0.03171699866652489

Significant O 0 0.0490415096282959
intra O 0 0.4231908619403839
- O 0 0.07380514591932297
and O 0 0.014387344941496849
interfamilial O 1 0.9274365305900574
phenotypic O 1 0.9849615097045898
variability O 1 0.9218745827674866
is O 0 0.008035729639232159
present O 0 0.008191868662834167
for O 0 0.007740458939224482
either O 0 0.016097821295261383
TWIST O 1 0.9404013752937317
mutations O 1 0.9978073239326477
or O 0 0.07655677944421768
FGFR O 1 0.9838324189186096
mutations O 1 0.9953354001045227
. O 0 0.04004862159490585

The O 0 0.016147183254361153
overlap O 0 0.05870494991540909
in O 0 0.009780291467905045
clinical O 1 0.9154978394508362
features O 0 0.008659076876938343
and O 0 0.0028325431048870087
the O 0 0.0032598674297332764
presence O 0 0.00812884047627449
, O 0 0.0029718177393078804
in O 0 0.0028293821960687637
the O 0 0.003000717144459486
same O 0 0.0068549420684576035
genes O 1 0.984940230846405
, O 0 0.005111115053296089
of O 0 0.00564935989677906
mutations O 1 0.9967323541641235
for O 0 0.004460049327462912
more O 0 0.0034893418196588755
than O 0 0.003959523513913155
one O 0 0.0061260005459189415
craniosynostotic B-Disease 1 0.976205050945282
condition I-Disease 1 0.8634395599365234
- O 0 0.07214395701885223
such O 0 0.00919365044683218
as O 0 0.010129828006029129
Saethre B-Disease 1 0.9679467678070068
- I-Disease 1 0.568549633026123
Chotzen I-Disease 1 0.9171371459960938
, I-Disease 0 0.011842909269034863
Crouzon I-Disease 1 0.6485741138458252
, I-Disease 0 0.00966144260019064
and I-Disease 0 0.012517175637185574
Pfeiffer I-Disease 1 0.9979546070098877
syndromes I-Disease 1 0.9995152950286865
- O 0 0.14297226071357727
support O 0 0.009607645682990551
the O 0 0.005995343439280987
hypothesis O 0 0.0709734633564949
that O 0 0.006223144009709358
TWIST O 0 0.08513005077838898
and O 0 0.005214557982981205
FGFRs O 0 0.2287357747554779
are O 0 0.0036232308484613895
components O 0 0.007547587156295776
of O 0 0.002696954645216465
the O 0 0.002970080589875579
same O 0 0.006985404063016176
molecular O 1 0.9821731448173523
pathway O 1 0.9849948287010193
involved O 0 0.011113724671304226
in O 0 0.004522901959717274
the O 0 0.0063586789183318615
modulation O 1 0.8972147703170776
of O 0 0.01041660737246275
craniofacial O 1 0.9979713559150696
and O 0 0.015434223227202892
limb O 1 0.9971338510513306
development O 0 0.028278926387429237
in O 0 0.01310607697814703
humans O 1 0.7323043346405029
. O 0 0.015557066537439823
. O 0 0.021176695823669434

Mutation O 1 0.9819785952568054
analysis O 0 0.06531201303005219
of O 0 0.027812106534838676
UBE3A O 1 0.9864382743835449
in O 1 0.5602059364318848
Angelman B-Disease 1 0.9995757937431335
syndrome I-Disease 1 0.999816358089447
patients O 1 0.9949341416358948
. O 0 0.05818498134613037

Angelman B-Disease 1 0.9991617202758789
syndrome I-Disease 1 0.9996009469032288
( O 0 0.03059299848973751
AS B-Disease 0 0.012454630807042122
) O 0 0.009693917818367481
is O 0 0.006259717512875795
caused O 0 0.13719557225704193
by O 0 0.014789339154958725
chromosome O 1 0.9970076680183411
15q11 O 1 0.9765269756317139
- O 1 0.5791669487953186
q13 O 1 0.9307756423950195
deletions O 1 0.8671258091926575
of O 0 0.01101488433778286
maternal O 1 0.8772796988487244
origin O 0 0.020783308893442154
, O 0 0.009410464204847813
by O 0 0.01459619402885437
paternal O 1 0.979907751083374
uniparental B-Disease 1 0.9967015385627747
disomy I-Disease 1 0.9755777716636658
( O 0 0.050698716193437576
UPD B-Disease 1 0.9893025755882263
) O 0 0.016526952385902405
15 O 0 0.011760872788727283
, O 0 0.00708418944850564
by O 0 0.011489352211356163
imprinting O 1 0.9949405193328857
defects O 1 0.9960482716560364
, O 0 0.008375481702387333
and O 0 0.005878164432942867
by O 0 0.009743384085595608
mutations O 1 0.995144248008728
in O 0 0.011977688409388065
the O 0 0.01839432679116726
UBE3A O 1 0.9919409155845642
gene O 1 0.9888551831245422
. O 0 0.04040225222706795

UBE3A O 1 0.9274507164955139
encodes O 0 0.48812738060951233
a O 0 0.0450606569647789
ubiquitin O 1 0.9452282786369324
- O 1 0.5782917141914368
protein O 1 0.9684514403343201
ligase O 0 0.27315548062324524
and O 0 0.012723611667752266
shows O 0 0.032238539308309555
brain O 1 0.9966939687728882
- O 1 0.5233433842658997
specific O 0 0.0735604465007782
imprinting O 1 0.9807027578353882
. O 0 0.036065585911273956

Here O 0 0.02256154455244541
we O 0 0.013725528493523598
describe O 0 0.052643921226263046
UBE3A O 1 0.9859161972999573
coding O 1 0.979141891002655
- O 1 0.5386135578155518
region O 0 0.12712761759757996
mutations O 1 0.9983202815055847
detected O 1 0.6639395356178284
by O 0 0.0148354172706604
SSCP O 1 0.8259199261665344
analysis O 0 0.019600683823227882
in O 0 0.005651415791362524
13 O 0 0.008300366811454296
AS B-Disease 0 0.007243920583277941
individuals O 0 0.01389590185135603
or O 0 0.013552609831094742
families O 0 0.026725538074970245
. O 0 0.02249351516366005

Two O 0 0.029469871893525124
identical O 0 0.05424497276544571
de O 0 0.049104463309049606
novo O 0 0.24284851551055908
5 O 0 0.02633322961628437
- O 0 0.051148951053619385
bp O 0 0.10414189100265503
duplications O 1 0.6978176236152649
in O 0 0.015543765388429165
exon O 0 0.43538475036621094
16 O 0 0.01494110468775034
were O 0 0.006755267269909382
found O 0 0.017637869343161583
. O 0 0.018923087045550346

Among O 0 0.017572393640875816
the O 0 0.0074660335667431355
other O 0 0.006484597455710173
11 O 0 0.012152411974966526
unique O 0 0.020232606679201126
mutations O 1 0.9945740103721619
, O 0 0.006463346071541309
8 O 0 0.006894533522427082
were O 0 0.0032963664270937443
small O 0 0.008926177397370338
deletions O 1 0.7260239124298096
or O 0 0.012218303978443146
insertions O 1 0.7454485893249512
predicted O 0 0.02055489830672741
to O 0 0.0075178854167461395
cause O 1 0.8002943992614746
frameshifts O 1 0.7258943319320679
, O 0 0.005999919958412647
1 O 0 0.007171315606683493
was O 0 0.004624092020094395
a O 0 0.009009268134832382
mutation O 1 0.9914421439170837
to O 0 0.005523211322724819
a O 0 0.009027672000229359
stop O 0 0.015357364900410175
codon O 0 0.49389493465423584
, O 0 0.005380894523113966
1 O 0 0.006524689495563507
was O 0 0.004432106856256723
a O 0 0.010038664564490318
missense O 1 0.9958015084266663
mutation O 1 0.9982032775878906
, O 0 0.005636013112962246
and O 0 0.0035414628218859434
1 O 0 0.0051285517401993275
was O 0 0.0032357079908251762
predicted O 0 0.010243862867355347
to O 0 0.004461423493921757
cause O 0 0.46289804577827454
insertion O 0 0.3829953670501709
of O 0 0.00504085561260581
an O 0 0.006464913487434387
isoleucine O 0 0.4994117021560669
in O 0 0.005698721390217543
the O 0 0.006261419504880905
hect O 0 0.4203264117240906
domain O 0 0.0221755001693964
of O 0 0.005769730545580387
the O 0 0.009933107532560825
UBE3A O 1 0.9898457527160645
protein O 1 0.9470137357711792
, O 0 0.006619059480726719
which O 0 0.004843758884817362
functions O 0 0.012097450904548168
in O 0 0.008888200856745243
E2 O 1 0.9162702560424805
binding O 0 0.12640653550624847
and O 0 0.012023630551993847
ubiquitin O 1 0.6728848814964294
transfer O 0 0.03176560625433922
. O 0 0.022749697789549828

Eight O 0 0.01484918873757124
of O 0 0.005688533186912537
the O 0 0.005869145970791578
cases O 0 0.0177668035030365
were O 0 0.005983216688036919
familial O 1 0.99687659740448
, O 0 0.005441370420157909
and O 0 0.004025834146887064
five O 0 0.006874672137200832
were O 0 0.006992856971919537
sporadic O 0 0.19161604344844818
. O 0 0.026094283908605576

In O 0 0.01943400874733925
two O 0 0.017502062022686005
familial O 1 0.9952658414840698
cases O 0 0.03732558712363243
and O 0 0.005511056166142225
one O 0 0.007055134512484074
sporadic O 0 0.14891502261161804
case O 0 0.015620375983417034
, O 0 0.010562836192548275
mosaicism O 1 0.9878938794136047
for O 0 0.017943885177373886
UBE3A O 1 0.9963016510009766
mutations O 1 0.997055172920227
was O 0 0.011271555908024311
detected O 0 0.17159661650657654
in O 0 0.004825136158615351
the O 0 0.003929816652089357
mother O 0 0.01018951553851366
of O 0 0.0032730211969465017
three O 0 0.003994692582637072
AS B-Disease 0 0.005941868759691715
sons O 0 0.019415199756622314
, O 0 0.0033292558509856462
in O 0 0.0031100811902433634
the O 0 0.004131287336349487
maternal O 1 0.9433116316795349
grandfather O 0 0.020848890766501427
of O 0 0.0036422298289835453
two O 0 0.003564142854884267
AS B-Disease 0 0.00465916795656085
first O 0 0.004813261795789003
cousins O 0 0.13271696865558624
, O 0 0.0032666123006492853
and O 0 0.0023641404695808887
in O 0 0.00274671264924109
the O 0 0.003708419157192111
mother O 0 0.012770702131092548
of O 0 0.00411553680896759
an O 0 0.005888228304684162
AS B-Disease 0 0.013640671037137508
daughter O 0 0.19158849120140076
. O 0 0.02187460847198963

The O 0 0.015551135875284672
frequencies O 0 0.02452058345079422
with O 0 0.006992078851908445
which O 0 0.004445998463779688
we O 0 0.0051077743992209435
detected O 1 0.6687308549880981
mutations O 1 0.9919573068618774
were O 0 0.004703952465206385
5 O 0 0.008494996465742588
( O 0 0.006980474106967449
14 O 0 0.006420733407139778
% O 0 0.006360775791108608
) O 0 0.004267101641744375
of O 0 0.002730746055021882
35 O 0 0.006721091456711292
in O 0 0.004157773219048977
sporadic O 0 0.19994574785232544
cases O 0 0.01393995713442564
and O 0 0.0035903563257306814
8 O 0 0.007481604348868132
( O 0 0.006514349952340126
80 O 0 0.00756164500489831
% O 0 0.007134833373129368
) O 0 0.004737477283924818
of O 0 0.0033861477859318256
10 O 0 0.006192990578711033
in O 0 0.008888650685548782
familial O 1 0.9982436895370483
cases O 0 0.17964963614940643
. O 0 0.013543311506509781
. O 0 0.01878543198108673

The O 0 0.050576869398355484
hemochromatosis B-Disease 1 0.9955446124076843
845 O 1 0.9566104412078857
G O 1 0.950878381729126
- O 1 0.529211163520813
- O 0 0.33876535296440125
> O 1 0.6017051339149475
A O 0 0.020137785002589226
and O 0 0.011132795363664627
187 O 0 0.07245033979415894
C O 1 0.6501539945602417
- O 1 0.6153759956359863
- O 1 0.8449530601501465
> O 1 0.9875842928886414
G O 1 0.9882329106330872
mutations O 1 0.9979798197746277
: O 0 0.02815583162009716
prevalence O 1 0.9842252731323242
in O 0 0.011573282070457935
non O 0 0.06909175962209702
- O 1 0.6366849541664124
Caucasian O 1 0.974472165107727
populations O 1 0.6575713157653809
. O 0 0.03052569553256035

Hemochromatosis B-Disease 1 0.9932050704956055
, O 0 0.021815018728375435
the O 0 0.01807725988328457
inherited B-Disease 1 0.9971876740455627
disorder I-Disease 1 0.9988718628883362
of I-Disease 0 0.01099852379411459
iron I-Disease 1 0.6791525483131409
metabolism I-Disease 1 0.9957526922225952
, O 0 0.00874896440654993
leads O 0 0.05339836701750755
, O 0 0.005929472390562296
if O 0 0.00868759211152792
untreated O 1 0.9822826981544495
, O 0 0.006679822225123644
to O 0 0.006834866479039192
progressive O 0 0.4482840597629547
iron B-Disease 1 0.6624836921691895
overload I-Disease 1 0.9848610162734985
and O 0 0.018744125962257385
premature B-Disease 1 0.9813542366027832
death I-Disease 0 0.17557761073112488
. O 0 0.03539268672466278

The O 0 0.0579206645488739
hemochromatosis B-Disease 1 0.9981916546821594
gene O 1 0.9923039078712463
, O 0 0.022756407037377357
HFE O 1 0.9880788922309875
, O 0 0.008415061980485916
recently O 0 0.01016184687614441
has O 0 0.00432828301563859
been O 0 0.00391499325633049
identified O 0 0.007765090558677912
, O 0 0.003013113746419549
and O 0 0.0027228426188230515
characterization O 0 0.019927479326725006
of O 0 0.0032518128864467144
this O 0 0.004819812718778849
gene O 1 0.9863885045051575
has O 0 0.004461991135030985
shown O 0 0.0051312255673110485
that O 0 0.0023974275682121515
it O 0 0.0022651925683021545
contains O 0 0.0054346234537661076
two O 0 0.005787559784948826
mutations O 1 0.9963303208351135
that O 0 0.004728205967694521
result O 0 0.010763618163764477
in O 0 0.00801319070160389
amino O 1 0.8579378128051758
acid O 1 0.9780183434486389
substitutions O 0 0.2758638262748718
- O 0 0.3321938216686249
cDNA O 1 0.9316985011100769
nucleotides O 1 0.9609431624412537
845 O 1 0.9533975124359131
G O 1 0.9538659453392029
- O 1 0.5098658800125122
- O 0 0.40885213017463684
> O 1 0.6948193311691284
A O 0 0.02036217786371708
( O 0 0.01585404761135578
C282Y O 0 0.23322035372257233
) O 0 0.01200192142277956
and O 0 0.008198076859116554
187 O 0 0.062310587614774704
C O 1 0.599036455154419
- O 1 0.5157750248908997
- O 1 0.7531343698501587
> O 1 0.9719685912132263
G O 1 0.9228375554084778
( O 0 0.03217032551765442
H63D O 1 0.7534134387969971
) O 0 0.025255020707845688
. O 0 0.019115246832370758

Although O 0 0.0600162148475647
hemochromatosis B-Disease 1 0.996151864528656
is O 0 0.014712340198457241
common O 0 0.021949129179120064
in O 0 0.009239666163921356
Caucasians O 1 0.8942973017692566
, O 0 0.011963881552219391
affecting O 1 0.8118149638175964
> O 1 0.9625471234321594
= O 0 0.25325798988342285
1 O 0 0.013307817280292511
/ O 0 0.043681636452674866
300 O 0 0.008166824467480183
individuals O 0 0.006035307422280312
of O 0 0.0031338988337665796
northern O 0 0.004780024755746126
European O 0 0.005146955605596304
origin O 0 0.0069217500276863575
, O 0 0.002737064380198717
it O 0 0.0021221088245511055
has O 0 0.002507937140762806
not O 0 0.002408355940133333
been O 0 0.0030399311799556017
recognized O 0 0.008087688125669956
in O 0 0.005161140579730272
other O 0 0.008285942487418652
populations O 0 0.33434316515922546
. O 0 0.021673737093806267

The O 0 0.01619444414973259
present O 0 0.012843925505876541
study O 0 0.01708390936255455
used O 0 0.011071733199059963
PCR O 1 0.7171221971511841
and O 0 0.008875934407114983
restriction O 0 0.20101900398731232
- O 1 0.6754453182220459
enzyme O 1 0.9932149648666382
digestion O 1 0.9379248023033142
to O 0 0.006510952953249216
analyze O 0 0.01633119396865368
the O 0 0.005426593124866486
frequency O 0 0.017237341031432152
of O 0 0.005403259769082069
the O 0 0.009144473820924759
845 O 1 0.9523138403892517
G O 1 0.9728618264198303
- O 1 0.7040470242500305
- O 0 0.4893917441368103
> O 1 0.7326640486717224
A O 0 0.012594752945005894
and O 0 0.007364185992628336
187 O 0 0.06965748965740204
C O 1 0.6332273483276367
- O 1 0.6461628079414368
- O 1 0.7718967795372009
> O 1 0.9858280420303345
G O 1 0.9886460304260254
mutations O 1 0.9981537461280823
in O 0 0.02338705211877823
HLA O 1 0.9969563484191895
- O 0 0.25861111283302307
typed O 0 0.1072022095322609
samples O 0 0.029939576983451843
from O 0 0.010427328757941723
non O 0 0.028103169053792953
- O 0 0.426410436630249
Caucasian O 1 0.9670011401176453
populations O 0 0.32302388548851013
, O 0 0.0060168905183672905
comprising O 0 0.009324241429567337
Australian O 0 0.0111925033852458
Aboriginal O 0 0.021606087684631348
, O 0 0.004491040483117104
Chinese O 0 0.008031405508518219
, O 0 0.005593637470155954
and O 0 0.00699048675596714
Pacific O 0 0.02447347156703472
Islanders O 0 0.06385909020900726
. O 0 0.02049212157726288

Results O 0 0.03399553522467613
showed O 0 0.01922767050564289
that O 0 0.007387556601315737
the O 0 0.010950282216072083
845 O 1 0.9411981105804443
G O 1 0.9628205895423889
- O 1 0.6564891338348389
- O 1 0.6995546221733093
> O 1 0.9214004874229431
A O 0 0.027587609365582466
mutation O 1 0.992088258266449
was O 0 0.005364840384572744
present O 0 0.005870056338608265
in O 0 0.003693565260618925
these O 0 0.005099859554320574
populations O 0 0.4004392921924591
( O 0 0.01856468990445137
allele O 1 0.9921597838401794
frequency O 0 0.11579909920692444
0 O 0 0.012520479038357735
. O 0 0.004037905018776655
32 O 0 0.007983689196407795
% O 0 0.007368057034909725
) O 0 0.004813307896256447
, O 0 0.0024241001810878515
and O 0 0.0023382885847240686
, O 0 0.00260106916539371
furthermore O 0 0.008410806767642498
, O 0 0.0029144054278731346
it O 0 0.0021893272642046213
was O 0 0.0025017596781253815
always O 0 0.003846753155812621
seen O 0 0.005589975044131279
in O 0 0.004958213306963444
conjunction O 0 0.06436334550380707
with O 0 0.018001040443778038
HLA O 1 0.9984857439994812
haplotypes O 1 0.9948764443397522
common O 0 0.05192103981971741
in O 0 0.009756362065672874
Caucasians O 1 0.8322476744651794
, O 0 0.009217736311256886
suggesting O 0 0.022595683112740517
that O 0 0.009481270797550678
845 O 1 0.9493682384490967
G O 1 0.9692696332931519
- O 1 0.684316098690033
- O 1 0.6756518483161926
> O 1 0.8844738006591797
A O 0 0.011737673543393612
may O 0 0.007182850502431393
have O 0 0.0029985413420945406
been O 0 0.003407707903534174
introduced O 0 0.006847055163234472
into O 0 0.006154272239655256
these O 0 0.007998437620699406
populations O 0 0.21707168221473694
by O 0 0.01944975182414055
Caucasian O 1 0.9786838889122009
admixture O 1 0.9854643940925598
. O 0 0.04135403782129288

187 O 0 0.15688209235668182
C O 1 0.5827460885047913
- O 1 0.528813362121582
- O 1 0.5995718836784363
> O 1 0.8876824378967285
G O 0 0.2854844033718109
was O 0 0.008511745370924473
present O 0 0.009293056093156338
at O 0 0.007778658531606197
an O 0 0.00867396779358387
allele O 1 0.9749665260314941
frequency O 0 0.03993029147386551
of O 0 0.010820825584232807
2 O 0 0.020299872383475304
. O 0 0.01833052560687065

68 O 0 0.04209822043776512
% O 0 0.016990086063742638
in O 0 0.007040591910481453
the O 0 0.005419314838945866
two O 0 0.007387242279946804
populations O 0 0.17739973962306976
analyzed O 0 0.027732927352190018
( O 0 0.010723581537604332
Australian O 0 0.011592770926654339
Aboriginal O 0 0.022133491933345795
and O 0 0.00650792196393013
Chinese O 0 0.014921565540134907
) O 0 0.015946224331855774
. O 0 0.016878729686141014

In O 0 0.013502226211130619
the O 0 0.00873738806694746
Australian O 0 0.015398489311337471
Aboriginal O 0 0.031833477318286896
samples O 0 0.04024248942732811
, O 0 0.012264174409210682
187 O 0 0.10789823532104492
C O 1 0.6107624173164368
- O 1 0.5634734034538269
- O 1 0.7075856328010559
> O 1 0.9637026190757751
G O 1 0.5722984671592712
was O 0 0.005071926396340132
found O 0 0.004811990074813366
to O 0 0.0027842908166348934
be O 0 0.003153454512357712
associated O 0 0.01506065484136343
with O 0 0.012346656061708927
HLA O 1 0.999215841293335
haplotypes O 1 0.9974638223648071
common O 0 0.09787686169147491
in O 0 0.008221613243222237
Caucasians O 1 0.8670212030410767
, O 0 0.0064931646920740604
suggesting O 0 0.01712428592145443
that O 0 0.0037368100602179766
it O 0 0.0030484218150377274
was O 0 0.004282649140805006
introduced O 0 0.010013561695814133
by O 0 0.009433659724891186
recent O 0 0.02986808866262436
admixture O 1 0.9820165038108826
. O 0 0.0332963727414608

In O 0 0.014996514655649662
the O 0 0.00850469060242176
Chinese O 0 0.01263209618628025
samples O 0 0.03164738044142723
analyzed O 0 0.03290403634309769
, O 0 0.010923327878117561
187 O 0 0.057021964341402054
C O 1 0.7008671760559082
- O 1 0.6639091968536377
- O 1 0.739673912525177
> O 1 0.9596434235572815
G O 0 0.33160021901130676
was O 0 0.005714459344744682
present O 0 0.005649639293551445
in O 0 0.003757283790037036
association O 0 0.007550613489001989
with O 0 0.004078186582773924
a O 0 0.005100873298943043
wide O 0 0.01089248526841402
variety O 0 0.010115064680576324
of O 0 0.00826025940477848
HLA O 1 0.9986579418182373
haplotypes O 1 0.9959408044815063
, O 0 0.007075088564306498
showing O 0 0.010136457160115242
this O 0 0.005784212611615658
mutation O 1 0.9940106272697449
to O 0 0.0038207301404327154
be O 0 0.0031449354719370604
widespread O 0 0.010814132168889046
and O 0 0.0031870838720351458
likely O 0 0.007159997709095478
to O 0 0.003377889981493354
predate O 0 0.15702694654464722
the O 0 0.0047517623752355576
more O 0 0.007165346294641495
genetically O 1 0.9709477424621582
restricted O 0 0.16496223211288452
845 O 1 0.9712371230125427
G O 1 0.9744768142700195
- O 1 0.8012089729309082
- O 1 0.6551500558853149
> O 1 0.9276936650276184
A O 0 0.05494699627161026
mutation O 1 0.9931973218917847
. O 0 0.03398440405726433

Genotype O 1 0.9854723811149597
- O 1 0.9050326943397522
phenotype O 1 0.9922484159469604
correlations O 1 0.9474191069602966
in O 0 0.114017054438591
attenuated B-Disease 1 0.9977335929870605
adenomatous I-Disease 1 0.9993565678596497
polyposis I-Disease 1 0.9991938471794128
coli I-Disease 1 0.9966637492179871
. O 0 0.07549235224723816

Germ O 1 0.9366746544837952
- O 0 0.10503653436899185
line O 0 0.034485261887311935
mutations O 1 0.9892898201942444
of O 0 0.011460209265351295
the O 0 0.0230253916233778
tumor B-Disease 1 0.9996089339256287
suppressor O 1 0.9980816841125488
APC O 1 0.9827098846435547
are O 0 0.01672907918691635
implicated O 1 0.9312735795974731
in O 0 0.07225882261991501
attenuated B-Disease 1 0.9988666772842407
adenomatous I-Disease 1 0.9997547268867493
polyposis I-Disease 1 0.9997115731239319
coli I-Disease 1 0.9991279244422913
( O 0 0.22133766114711761
AAPC B-Disease 1 0.9820713400840759
) O 0 0.02125251293182373
, O 0 0.01035891380161047
a O 0 0.01755235530436039
variant O 1 0.9654863476753235
of O 0 0.05835013464093208
familial B-Disease 1 0.9995830655097961
adenomatous I-Disease 1 0.9995949864387512
polyposis I-Disease 1 0.999632716178894
( O 1 0.5035511255264282
FAP B-Disease 1 0.9889391660690308
) O 0 0.039983488619327545
. O 0 0.031834401190280914

AAPC B-Disease 1 0.9539185166358948
is O 0 0.017121680080890656
recognized O 0 0.017224492505192757
by O 0 0.007477667648345232
the O 0 0.006226294673979282
occurrence O 0 0.09714673459529877
of O 0 0.009134048596024513
< O 1 0.8044238686561584
100 O 0 0.019654523581266403
colonic B-Disease 1 0.9954373240470886
adenomas I-Disease 1 0.9944263696670532
and O 0 0.008091227151453495
a O 0 0.010990922339260578
later O 0 0.016458870843052864
onset O 1 0.998358428478241
of O 0 0.4212215840816498
colorectal B-Disease 1 0.9999626874923706
cancer I-Disease 1 0.9997592568397522
( O 0 0.04535704106092453
age O 0 0.05638127401471138
> O 1 0.7519580125808716
40 O 0 0.018504522740840912
years O 0 0.014630443416535854
) O 0 0.017724033445119858
. O 0 0.017661234363913536

The O 0 0.014504616148769855
aim O 0 0.01770818419754505
of O 0 0.005873601883649826
this O 0 0.004757317248731852
study O 0 0.009490844793617725
was O 0 0.0050378479063510895
to O 0 0.006836129818111658
assess O 0 0.44580408930778503
genotype O 1 0.996783971786499
- O 1 0.96288001537323
phenotype O 1 0.9979846477508545
correlations O 1 0.9530870318412781
in O 0 0.02578885480761528
AAPC B-Disease 1 0.985597550868988
families O 0 0.05030251666903496
. O 0 0.030599331483244896

By O 0 0.04183780029416084
protein O 1 0.9569265842437744
- O 0 0.30672627687454224
truncation O 1 0.8195083737373352
test O 0 0.03818826004862785
( O 0 0.018081944435834885
PTT O 0 0.09608059376478195
) O 0 0.014839530922472477
assay O 0 0.10827870666980743
, O 0 0.005261643324047327
the O 0 0.004844540264457464
entire O 0 0.013477806933224201
coding O 1 0.6318008303642273
region O 0 0.009823916479945183
of O 0 0.004429839085787535
the O 0 0.00790218822658062
APC B-Disease 1 0.9948365688323975
gene O 1 0.9950035214424133
was O 0 0.009108518250286579
screened O 0 0.02804672345519066
in O 0 0.006864852737635374
affected O 0 0.03194088116288185
individuals O 0 0.012676659040153027
from O 0 0.010109517723321915
11 O 0 0.023099301382899284
AAPC B-Disease 1 0.9938024282455444
kindreds O 1 0.9637655019760132
, O 0 0.007287014275789261
and O 0 0.004975716583430767
their O 0 0.00800487119704485
phenotypic O 1 0.891497790813446
differences O 0 0.03275999426841736
were O 0 0.010619984939694405
examined O 0 0.07307082414627075
. O 0 0.024055464193224907

Five O 0 0.032248202711343765
novel O 0 0.15349987149238586
germ O 1 0.9779908657073975
- O 0 0.2622920274734497
line O 0 0.04105130955576897
APC B-Disease 1 0.9883431792259216
mutations O 1 0.9929258823394775
were O 0 0.008749845437705517
identified O 0 0.017018094658851624
in O 0 0.009085535071790218
seven O 0 0.021498823538422585
kindreds O 1 0.92118901014328
. O 0 0.035641033202409744

Mutations O 1 0.9708996415138245
were O 0 0.008970346301794052
located O 0 0.008250756189227104
in O 0 0.004092432092875242
three O 0 0.003961777314543724
different O 0 0.0046566566452383995
regions O 0 0.009197925217449665
of O 0 0.004263508599251509
the O 0 0.009331812150776386
APC B-Disease 1 0.9960501790046692
gene O 1 0.9969030022621155
( O 0 0.014546526595950127
1 O 0 0.007987299002707005
) O 0 0.0058183977380394936
at O 0 0.0035591591149568558
the O 0 0.0031903909984976053
5 O 0 0.006922196596860886
end O 0 0.007988810539245605
spanning O 0 0.02306939661502838
exons O 1 0.7635161876678467
4 O 0 0.010614645667374134
and O 0 0.004127529915422201
5 O 0 0.008025424554944038
, O 0 0.004483016207814217
( O 0 0.006899929139763117
2 O 0 0.007237777579575777
) O 0 0.005594032350927591
within O 0 0.005789804272353649
exon O 0 0.4835972487926483
9 O 0 0.009006372652947903
, O 0 0.003518574871122837
and O 0 0.0029835905879735947
( O 0 0.0061011468060314655
3 O 0 0.007176718674600124
) O 0 0.005000907927751541
at O 0 0.003475117962807417
the O 0 0.003934293054044247
3 O 0 0.011730036698281765
distal O 1 0.9448497891426086
end O 0 0.01162260863929987
of O 0 0.007149752229452133
the O 0 0.01457937154918909
gene O 1 0.9858320951461792
. O 0 0.029952596873044968

Variability O 0 0.29021376371383667
in O 0 0.01097633596509695
the O 0 0.00670561334118247
number O 0 0.008289928548038006
of O 0 0.015758773311972618
colorectal B-Disease 1 0.9998691082000732
adenomas I-Disease 1 0.9986250400543213
was O 0 0.00990925170481205
most O 0 0.00741845415905118
apparent O 0 0.04742860794067383
in O 0 0.0053529758006334305
individuals O 0 0.010734650306403637
with O 0 0.009164074435830116
mutations O 1 0.9983006119728088
in O 0 0.005760147701948881
region O 0 0.008607219904661179
1 O 0 0.006308550946414471
, O 0 0.00412466935813427
and O 0 0.0048559196293354034
upper O 1 0.6212177276611328
- O 1 0.9794830083847046
gastrointestinal O 1 0.9995480179786682
manifestations O 1 0.7569259405136108
were O 0 0.007055375725030899
more O 0 0.010786165483295918
severe O 1 0.8322257995605469
in O 0 0.010147135704755783
them O 0 0.011510883457958698
. O 0 0.020015686750411987

In O 0 0.01761859841644764
individuals O 0 0.019444260746240616
with O 0 0.01179199106991291
mutations O 1 0.9956095814704895
in O 0 0.005902176257222891
either O 0 0.006823230069130659
region O 0 0.007815289311110973
2 O 0 0.007467326708137989
or O 0 0.005794741213321686
region O 0 0.007020785007625818
3 O 0 0.005248432978987694
, O 0 0.002777372719720006
the O 0 0.0027553883846849203
average O 0 0.006035544443875551
number O 0 0.004251660779118538
of O 0 0.005140713416039944
adenomas B-Disease 1 0.9967747330665588
tended O 0 0.018090231344103813
to O 0 0.003474814584478736
be O 0 0.0031457727309316397
lower O 0 0.006810413673520088
than O 0 0.003597972448915243
those O 0 0.003383461618795991
in O 0 0.004130437970161438
individuals O 0 0.009652596898376942
with O 0 0.008650594390928745
mutations O 1 0.9974942207336426
in O 0 0.006118897348642349
region O 0 0.008274090476334095
1 O 0 0.006131643429398537
, O 0 0.0034314850345253944
although O 0 0.005283495876938105
age O 0 0.010128393769264221
at O 0 0.009713888168334961
diagnosis O 1 0.9976069927215576
was O 0 0.010458973236382008
similar O 0 0.023018697276711464
. O 0 0.0204008799046278

In O 0 0.02456403151154518
all O 0 0.019091080874204636
AAPC B-Disease 1 0.9756031036376953
kindreds O 1 0.8835681080818176
, O 0 0.010344307869672775
a O 0 0.013171856291592121
predominance O 0 0.3529137670993805
of O 0 0.011233528144657612
right O 0 0.0408979207277298
- O 1 0.9444946646690369
sided O 1 0.9910092353820801
colorectal B-Disease 1 0.9998401403427124
adenomas I-Disease 1 0.9986649751663208
and O 0 0.13462290167808533
rectal B-Disease 1 0.9985344409942627
polyp I-Disease 1 0.9978194236755371
sparing O 1 0.927093505859375
was O 0 0.023275624960660934
observed O 0 0.04992186650633812
. O 0 0.02766048163175583

No O 0 0.044585488736629486
desmoid B-Disease 1 0.9600437879562378
tumors I-Disease 1 0.9960280656814575
were O 0 0.009722257032990456
found O 0 0.01181025430560112
in O 0 0.008559483103454113
these O 0 0.014934339560568333
kindreds O 1 0.9382652044296265
. O 0 0.031362228095531464

Our O 0 0.020019590854644775
data O 0 0.014192192815244198
suggest O 0 0.012908023782074451
that O 0 0.0041208830662071705
, O 0 0.004666411783546209
in O 0 0.006954083684831858
AAPC B-Disease 1 0.9888142943382263
families O 0 0.010462715290486813
, O 0 0.0035180365666747093
the O 0 0.0031763131264597178
location O 0 0.006107482593506575
of O 0 0.004031922202557325
the O 0 0.009380108676850796
APC B-Disease 1 0.9959229230880737
mutation O 1 0.9990872144699097
may O 0 0.06466502696275711
partially O 0 0.21383951604366302
predict O 0 0.09361866861581802
specific O 0 0.03265770897269249
phenotypic O 1 0.9631913900375366
expression O 0 0.3625846803188324
. O 0 0.028739389032125473

This O 0 0.011977090500295162
should O 0 0.007247165776789188
help O 0 0.009383544325828552
in O 0 0.004062394145876169
the O 0 0.0037705989088863134
design O 0 0.00922306813299656
of O 0 0.0063184769824147224
tailored O 1 0.9277622103691101
clinical O 1 0.9961483478546143
- O 1 0.6436716318130493
management O 0 0.08105049282312393
protocols O 0 0.07904531806707382
in O 0 0.0053801205940544605
this O 0 0.005633752793073654
subset O 0 0.4353191554546356
of O 0 0.014428134076297283
FAP B-Disease 1 0.9985864162445068
patients O 1 0.9914835095405579
. O 0 0.017874250188469887
. O 0 0.020998433232307434

Wilms B-Disease 1 0.9880650639533997
' I-Disease 0 0.36440756916999817
tumor I-Disease 1 0.9949108958244324
1 O 0 0.023015284910798073
and O 0 0.009994595311582088
Dax O 0 0.14846490323543549
- O 0 0.07713203877210617
1 O 0 0.018659399822354317
modulate O 1 0.8407948613166809
the O 0 0.014821125194430351
orphan O 1 0.9741591215133667
nuclear O 0 0.20012444257736206
receptor O 1 0.9926317930221558
SF O 1 0.9668935537338257
- O 0 0.08414065837860107
1 O 0 0.013969744555652142
in O 0 0.00886485818773508
sex O 0 0.1797083616256714
- O 0 0.2932380139827728
specific O 0 0.08966988325119019
gene O 1 0.9921116828918457
expression O 0 0.3004014790058136
. O 0 0.028423717245459557

Products O 0 0.05400471389293671
of O 0 0.020784204825758934
steroidogenic O 1 0.9862313866615295
factor O 0 0.2419506311416626
1 O 0 0.023887695744633675
( O 0 0.022216377779841423
SF O 1 0.9452772736549377
- O 0 0.10232454538345337
1 O 0 0.015728013589978218
) O 0 0.01454936247318983
and O 0 0.015065549872815609
Wilms B-Disease 1 0.9990779161453247
tumor I-Disease 1 0.9990296363830566
1 O 0 0.025937514379620552
( O 0 0.03339937701821327
WT1 O 1 0.9964451193809509
) O 0 0.018506767228245735
genes O 1 0.9138355255126953
are O 0 0.005774639081209898
essential O 0 0.012987037189304829
for O 0 0.009888040833175182
mammalian O 1 0.9801815152168274
gonadogenesis O 1 0.804651141166687
prior O 0 0.020888876169919968
to O 0 0.0116410618647933
sexual O 0 0.30071067810058594
differentiation O 1 0.9573757648468018
. O 0 0.029573725536465645

In O 0 0.024975506588816643
males O 0 0.12004309892654419
, O 0 0.014318861998617649
SF O 1 0.929172694683075
- O 0 0.08549149334430695
1 O 0 0.015462979674339294
participates O 0 0.04125600680708885
in O 0 0.00732848234474659
sexual O 0 0.039027657359838486
development O 0 0.011044844053685665
by O 0 0.008275067433714867
regulating O 0 0.16634659469127655
expression O 0 0.030228590592741966
of O 0 0.00839630700647831
the O 0 0.015735730528831482
polypeptide O 1 0.9959259033203125
hormone O 1 0.9984286427497864
Mullerian O 1 0.9976115226745605
inhibiting O 1 0.9965481162071228
substance O 1 0.9727035164833069
( O 0 0.1138930544257164
MIS O 1 0.9884678721427917
) O 0 0.03488222137093544
. O 0 0.026863519102334976

Here O 0 0.01563156768679619
, O 0 0.00789244007319212
we O 0 0.005288202781230211
show O 0 0.01124291680753231
that O 0 0.012495705857872963
WT1 O 1 0.994411051273346
- O 1 0.833712637424469
KTS O 1 0.9899653196334839
isoforms O 1 0.8805539608001709
associate O 0 0.03631627559661865
and O 0 0.012899010442197323
synergize O 1 0.9299147129058838
with O 0 0.022292230278253555
SF O 1 0.9394370317459106
- O 0 0.056363143026828766
1 O 0 0.014665859751403332
to O 0 0.010314076207578182
promote O 0 0.040015533566474915
MIS O 1 0.9856767654418945
expression O 0 0.2851454019546509
. O 0 0.03213091567158699

In O 0 0.03199438750743866
contrast O 0 0.04330062493681908
, O 0 0.02458682842552662
WT1 O 1 0.9957745671272278
missense O 1 0.9958460927009583
mutations O 1 0.9973912239074707
, O 0 0.014108738861978054
associated O 0 0.018870988860726357
with O 0 0.010691801086068153
male B-Disease 1 0.6118156313896179
pseudohermaphroditism I-Disease 1 0.9614962935447693
in O 0 0.0246339812874794
Denys B-Disease 1 0.994867205619812
- I-Disease 1 0.9793395400047302
Drash I-Disease 1 0.9969024062156677
syndrome I-Disease 1 0.999681830406189
, O 0 0.016989577561616898
fail O 0 0.055381882935762405
to O 0 0.01299787312746048
synergize O 1 0.959912896156311
with O 0 0.02250073477625847
SF O 1 0.9629942178726196
- O 0 0.1667104959487915
1 O 0 0.030320383608341217
. O 0 0.027995267882943153

Additionally O 0 0.039752449840307236
, O 0 0.010772588662803173
the O 0 0.011321928352117538
X O 0 0.3248489797115326
- O 0 0.21705757081508636
linked O 0 0.31134456396102905
, O 0 0.009579736739397049
candidate O 0 0.027590034529566765
dosage O 1 0.9747287034988403
- O 0 0.3808896839618683
sensitive O 0 0.11515707522630692
sex O 0 0.4098149240016937
- O 1 0.5439479947090149
reversal O 1 0.9290674924850464
gene O 1 0.9942471981048584
, O 0 0.015311988070607185
Dax O 0 0.1383458822965622
- O 0 0.06425595283508301
1 O 0 0.016290629282593727
, O 0 0.011890592984855175
antagonizes O 1 0.88552325963974
synergy O 1 0.7656577825546265
between O 0 0.021624747663736343
SF O 1 0.9635851383209229
- O 0 0.11312371492385864
1 O 0 0.013644124381244183
and O 0 0.008037661202251911
WT1 O 1 0.9872509241104126
, O 0 0.006033697165548801
most O 0 0.004416987765580416
likely O 0 0.006736006122082472
through O 0 0.00570731982588768
a O 0 0.007847560569643974
direct O 0 0.017539646476507187
interaction O 0 0.142824187874794
with O 0 0.01727205142378807
SF O 1 0.9771779775619507
- O 0 0.17792153358459473
1 O 0 0.024926237761974335
. O 0 0.023657023906707764

We O 0 0.019159292802214622
propose O 0 0.03803475946187973
that O 0 0.014066431671380997
WT1 O 1 0.9579857587814331
and O 0 0.01167233008891344
Dax O 0 0.18190732598304749
- O 0 0.09756501764059067
1 O 0 0.015684107318520546
functionally O 0 0.37523332238197327
oppose O 0 0.014196129515767097
each O 0 0.005388299934566021
other O 0 0.005059060174971819
in O 0 0.0077885729260742664
testis O 1 0.9886918067932129
development O 0 0.022673707455396652
by O 0 0.019730178639292717
modulating O 1 0.9946079254150391
SF O 1 0.9904083013534546
- O 0 0.4840782880783081
1 O 0 0.03202607482671738
- O 1 0.5190055966377258
mediated O 1 0.9706581234931946
transactivation O 1 0.9625838994979858
. O 0 0.023532550781965256
. O 0 0.025422492995858192

A O 0 0.05345112457871437
mouse O 1 0.9059697985649109
model O 0 0.06397958844900131
for O 0 0.03617404028773308
Prader B-Disease 1 0.9975640773773193
- I-Disease 1 0.9927996397018433
Willi I-Disease 1 0.9988566637039185
syndrome I-Disease 1 0.9997450709342957
imprinting O 1 0.994684636592865
- O 1 0.7999041676521301
centre O 0 0.24621346592903137
mutations O 1 0.9947080612182617
. O 0 0.0364651083946228

Imprinting O 1 0.8394871354103088
in O 0 0.017300615087151527
the O 0 0.014243559911847115
15q11 O 1 0.7608118653297424
- O 0 0.18693263828754425
q13 O 1 0.6825006604194641
region O 0 0.01831877790391445
involves O 0 0.047538578510284424
an O 0 0.012840324081480503
imprinting O 1 0.9866684675216675
centre O 0 0.034313615411520004
( O 0 0.017469506710767746
IC O 1 0.8177835941314697
) O 0 0.010007951408624649
, O 0 0.005033337976783514
mapping O 0 0.014868097379803658
in O 0 0.004212640225887299
part O 0 0.004791343584656715
to O 0 0.003395019331946969
the O 0 0.005124720744788647
promoter O 0 0.17588463425636292
and O 0 0.0066191223450005054
first O 0 0.011341715231537819
exon O 1 0.7054620385169983
of O 0 0.016913700848817825
SNRPN O 1 0.9112527966499329
. O 0 0.03097463957965374

Deletion O 1 0.5401434302330017
of O 0 0.017576437443494797
this O 0 0.01554526761174202
IC O 1 0.7413250207901001
abolishes O 1 0.8071681261062622
local O 0 0.02570074051618576
paternally O 1 0.9519968628883362
derived O 0 0.33319807052612305
gene O 1 0.9929295182228088
expression O 0 0.12427375465631485
and O 0 0.008591510355472565
results O 0 0.027061520144343376
in O 0 0.02835177630186081
Prader B-Disease 1 0.9988552331924438
- I-Disease 1 0.9957630634307861
Willi I-Disease 1 0.9991568326950073
syndrome I-Disease 1 0.9997819066047668
( O 0 0.47609052062034607
PWS B-Disease 1 0.990975558757782
) O 0 0.04590702801942825
. O 0 0.028440231457352638

We O 0 0.012111219577491283
have O 0 0.008266894146800041
created O 0 0.015022444538772106
two O 0 0.013455926440656185
deletion O 1 0.9954839944839478
mutations O 1 0.9985664486885071
in O 0 0.015486183576285839
mice O 1 0.9939250349998474
to O 0 0.007856364361941814
understand O 0 0.027562281116843224
PWS B-Disease 1 0.9898091554641724
and O 0 0.006260693538933992
the O 0 0.0058167544193565845
mechanism O 0 0.06498934328556061
of O 0 0.007063597906380892
this O 0 0.010221024975180626
IC O 1 0.8428007960319519
. O 0 0.02388986386358738

Mice O 1 0.982094943523407
harbouring O 1 0.6545227766036987
an O 0 0.025585344061255455
intragenic O 1 0.7734860777854919
deletion O 1 0.9444507956504822
in O 0 0.01681392267346382
Snrpn O 1 0.6265403032302856
are O 0 0.00936584360897541
phenotypically O 1 0.9775206446647644
normal O 0 0.11112234741449356
, O 0 0.007090544328093529
suggesting O 0 0.02110019326210022
that O 0 0.008345267735421658
mutations O 1 0.9954596161842346
of O 0 0.0067956517450511456
SNRPN O 1 0.6947228908538818
are O 0 0.004678263794630766
not O 0 0.004998517222702503
sufficient O 0 0.012482814490795135
to O 0 0.011395185254514217
induce O 1 0.98014897108078
PWS B-Disease 1 0.9907113909721375
. O 0 0.04303395375609398

Mice O 1 0.971444308757782
with O 0 0.015063653700053692
a O 0 0.015440586023032665
larger O 0 0.02286161296069622
deletion O 1 0.9445993304252625
involving O 0 0.03208933770656586
both O 0 0.00944314245134592
Snrpn O 0 0.23546621203422546
and O 0 0.006803237833082676
the O 0 0.010223036631941795
putative O 1 0.9890115261077881
PWS O 1 0.9974963068962097
- O 1 0.7632521390914917
IC O 1 0.8221139311790466
lack O 0 0.023233456537127495
expression O 0 0.02532266452908516
of O 0 0.006161182653158903
the O 0 0.00936749018728733
imprinted O 1 0.9846754670143127
genes O 1 0.9963386058807373
Zfp127 O 1 0.9717229008674622
( O 0 0.03450247645378113
mouse O 1 0.9825563430786133
homologue O 1 0.9625943899154663
of O 0 0.013033939525485039
ZNF127 O 1 0.8252000212669373
) O 0 0.015506858006119728
, O 0 0.00971963256597519
Ndn O 1 0.8886256814002991
and O 0 0.008382407017052174
Ipw O 1 0.5460180044174194
, O 0 0.006863085087388754
and O 0 0.006251630838960409
manifest O 0 0.044204287230968475
several O 0 0.012607128359377384
phenotypes O 1 0.9917405843734741
common O 0 0.11119623482227325
to O 0 0.022705448791384697
PWS B-Disease 1 0.9967297315597534
infants O 1 0.9915443658828735
. O 0 0.040785450488328934

These O 0 0.013038701377809048
data O 0 0.00972921121865511
demonstrate O 0 0.009341780096292496
that O 0 0.0033722021616995335
both O 0 0.0027251187711954117
the O 0 0.0025103408843278885
position O 0 0.0030838402453809977
of O 0 0.0024230070412158966
the O 0 0.0037669739685952663
IC O 0 0.3833405375480652
and O 0 0.003375633619725704
its O 0 0.0036785020492970943
role O 0 0.006455150432884693
in O 0 0.0030232754070311785
the O 0 0.003637163434177637
coordinate O 0 0.017501799389719963
expression O 0 0.029830412939190865
of O 0 0.005768004339188337
genes O 1 0.9883977770805359
is O 0 0.00713107455521822
conserved O 0 0.2741115987300873
between O 0 0.010691186413168907
mouse O 1 0.9690218567848206
and O 0 0.005016425624489784
human O 0 0.017112934961915016
, O 0 0.0034791198559105396
and O 0 0.002551697427406907
indicate O 0 0.006643188651651144
that O 0 0.002848193049430847
the O 0 0.004135933704674244
mouse O 1 0.9162533283233643
is O 0 0.004409072920680046
a O 0 0.006160744931548834
suitable O 0 0.016639407724142075
model O 0 0.012498412281274796
system O 0 0.008712850511074066
in O 0 0.0029726149514317513
which O 0 0.0024992418475449085
to O 0 0.002467413665726781
investigate O 0 0.009037668816745281
the O 0 0.005815348122268915
molecular O 1 0.9072169661521912
mechanisms O 0 0.4501422643661499
of O 0 0.0073046074248850346
imprinting O 1 0.9732880592346191
in O 0 0.005786390509456396
this O 0 0.0042595877312123775
region O 0 0.007448076736181974
of O 0 0.0047074235044419765
the O 0 0.009082973003387451
genome O 1 0.9530477523803711
. O 0 0.015480367466807365
. O 0 0.020705142989754677

Mutations O 1 0.9648874402046204
of O 0 0.013073147274553776
the O 0 0.014184067957103252
ATM O 1 0.907201886177063
gene O 1 0.993510901927948
detected O 0 0.4821489751338959
in O 0 0.013883596286177635
Japanese O 0 0.18755295872688293
ataxia B-Disease 1 0.9996457099914551
- I-Disease 1 0.9943377375602722
telangiectasia I-Disease 1 0.999386191368103
patients O 1 0.9955270886421204
: O 0 0.014825665391981602
possible O 0 0.014221115037798882
preponderance O 0 0.08177604526281357
of O 0 0.0052010840736329556
the O 0 0.005804617423564196
two O 0 0.008874768391251564
founder O 0 0.28942593932151794
mutations O 1 0.997450053691864
4612del165 O 1 0.8363087773323059
and O 0 0.018402524292469025
7883del5 O 1 0.6934323906898499
. O 0 0.030891770496964455

The O 0 0.023808348923921585
ATM O 0 0.12771913409233093
( O 0 0.022174309939146042
A O 0 0.030949078500270844
- O 1 0.6360791325569153
T O 1 0.984600841999054
, O 0 0.01830686628818512
mutated O 1 0.994023859500885
) O 0 0.028899161145091057
gene O 1 0.97881680727005
on O 0 0.01493401825428009
human O 0 0.3229444622993469
chromosome O 1 0.9938921928405762
11q22 O 1 0.8622704744338989
. O 0 0.04056032374501228

3 O 0 0.02550116367638111
has O 0 0.00912563782185316
recently O 0 0.010137260891497135
been O 0 0.004103659186512232
identified O 0 0.008971885778009892
as O 0 0.004159736447036266
the O 0 0.005514898803085089
gene O 1 0.9917348623275757
responsible O 0 0.016673536971211433
for O 0 0.006984788924455643
the O 0 0.012105550616979599
human O 1 0.9885724782943726
recessive B-Disease 1 0.9999474287033081
disease I-Disease 1 0.999933123588562
ataxia B-Disease 1 0.9998158812522888
- I-Disease 1 0.9942031502723694
telangiectasia I-Disease 1 0.998136043548584
( O 0 0.04328049719333649
A B-Disease 0 0.06523893773555756
- I-Disease 1 0.8329857587814331
T I-Disease 1 0.9890347719192505
) O 0 0.029111213982105255
. O 0 0.02437080815434456

In O 0 0.014511051587760448
order O 0 0.010111026465892792
to O 0 0.004969676490873098
define O 0 0.013568107970058918
the O 0 0.0059598395600914955
types O 0 0.08300834894180298
of O 0 0.017169635742902756
disease O 1 0.9996700286865234
- O 1 0.9323943853378296
causing O 1 0.9804620742797852
ATM O 1 0.979955792427063
mutations O 1 0.9963135123252869
in O 0 0.009505904279649258
Japanese O 0 0.01352766901254654
A B-Disease 0 0.11139680445194244
- I-Disease 1 0.9702529311180115
T I-Disease 1 0.9979555606842041
patients O 1 0.9886869192123413
as O 0 0.0048298523761332035
well O 0 0.003338518552482128
as O 0 0.0025809749495238066
to O 0 0.002931437222287059
look O 0 0.00716765271499753
for O 0 0.004599340260028839
possible O 0 0.02256447821855545
mutational O 1 0.9947545528411865
hotspots O 1 0.8552069067955017
, O 0 0.010335124097764492
reverse O 0 0.4323797821998596
- O 0 0.4860389828681946
transcribed O 1 0.9250407218933105
RNA O 1 0.9767270088195801
derived O 0 0.030306728556752205
from O 0 0.008874445222318172
ten O 0 0.012482073158025742
patients O 1 0.9741060733795166
belonging O 0 0.012741024605929852
to O 0 0.004616340156644583
eight O 0 0.008249320089817047
unrelated O 0 0.21358609199523926
Japanese O 0 0.014211272820830345
A B-Disease 0 0.032720718532800674
- I-Disease 1 0.7511237859725952
T I-Disease 1 0.9844484329223633
families O 0 0.016202712431550026
was O 0 0.006799972150474787
analyzed O 0 0.020457973703742027
for O 0 0.009747190400958061
mutations O 1 0.9885057210922241
by O 0 0.011492418125271797
the O 0 0.012305844575166702
restriction O 0 0.23370040953159332
endonuclease O 1 0.9553980827331543
fingerprinting O 0 0.3285014033317566
method O 0 0.07071156799793243
. O 0 0.03563973680138588

As O 0 0.013894281350076199
has O 0 0.007877891883254051
been O 0 0.006704119965434074
reported O 0 0.01064701471477747
by O 0 0.006331969052553177
others O 0 0.008119138889014721
, O 0 0.008149093016982079
mutations O 1 0.9947602152824402
that O 0 0.00636251550167799
lead O 0 0.014951839111745358
to O 0 0.008114608936011791
exon O 1 0.8602157235145569
skipping O 1 0.534723699092865
or O 0 0.026792306452989578
premature O 1 0.9916515946388245
protein O 1 0.9891602396965027
truncation O 1 0.7716997861862183
were O 0 0.005537118297070265
also O 0 0.005855698604136705
predominant O 0 0.027176542207598686
in O 0 0.0069940718822181225
our O 0 0.013674226589500904
mutants O 1 0.6194553971290588
. O 0 0.027278246358036995

Six O 0 0.027164507657289505
different O 0 0.020228533074259758
mutations O 1 0.9716792702674866
were O 0 0.005572653841227293
identified O 0 0.010091639123857021
on O 0 0.003912344574928284
12 O 0 0.00662829028442502
of O 0 0.0045547643676400185
the O 0 0.007217638660222292
16 O 0 0.025822848081588745
alleles O 1 0.9916766881942749
examined O 0 0.2755550146102905
. O 0 0.032423365861177444

Four O 0 0.01984706148505211
were O 0 0.009656306356191635
deletions O 0 0.46928414702415466
involving O 0 0.024777153506875038
a O 0 0.011153049767017365
loss O 0 0.016059575602412224
of O 0 0.004873661790043116
a O 0 0.008964919485151768
single O 0 0.02138102985918522
exon O 1 0.9316245317459106
exon O 1 0.8009145259857178
7 O 0 0.020420122891664505
, O 0 0.009260210208594799
exon O 0 0.4255285859107971
16 O 0 0.01638002134859562
, O 0 0.010579229332506657
exon O 1 0.5396355986595154
33 O 0 0.02692517638206482
or O 0 0.019311975687742233
exon O 1 0.6079899668693542
35 O 0 0.04174276068806648
. O 0 0.02657986618578434

The O 0 0.015309243462979794
others O 0 0.012614336796104908
were O 0 0.006572781130671501
minute O 0 0.02104312554001808
deletions O 1 0.5814552307128906
, O 0 0.011099332012236118
4649delA O 0 0.2672324478626251
in O 0 0.012894032523036003
exon O 0 0.4547533094882965
33 O 0 0.023857614025473595
and O 0 0.01144656166434288
7883del5 O 0 0.21102218329906464
in O 0 0.019182972609996796
exon O 1 0.6674186587333679
55 O 0 0.04919429123401642
. O 0 0.03114343248307705

The O 0 0.03824581578373909
mutations O 1 0.9904829263687134
4612del165 O 1 0.576622724533081
and O 0 0.009675209410488605
7883del5 O 0 0.12892715632915497
were O 0 0.004226575139909983
found O 0 0.006097382865846157
in O 0 0.0030707356054335833
more O 0 0.0034600645303726196
than O 0 0.0037908018566668034
two O 0 0.004826688207685947
unrelated O 0 0.29082947969436646
families O 0 0.01228945329785347
; O 0 0.007374574895948172
44 O 0 0.008608439937233925
% O 0 0.007441572844982147
( O 0 0.0065955547615885735
7 O 0 0.005436919629573822
of O 0 0.0028892015106976032
16 O 0 0.006145890336483717
) O 0 0.004685007501393557
of O 0 0.0029243435710668564
the O 0 0.005409100092947483
mutant O 1 0.9902328252792358
alleles O 1 0.9938217401504517
had O 0 0.005973610561341047
one O 0 0.0035133373457938433
of O 0 0.003419098211452365
the O 0 0.006071522366255522
two O 0 0.012592167593538761
mutations O 1 0.996912956237793
. O 0 0.026837075129151344

The O 0 0.027595415711402893
4612del165 O 1 0.843666136264801
mutations O 1 0.9899062514305115
in O 0 0.008559451438486576
three O 0 0.005414110142737627
different O 0 0.005204822868108749
families O 0 0.005710129160434008
were O 0 0.0024837458040565252
all O 0 0.002883671084418893
ascribed O 0 0.01786467619240284
to O 0 0.004241012968122959
the O 0 0.005382123868912458
same O 0 0.014311924576759338
T O 1 0.9922419786453247
- O 1 0.6650374531745911
- O 1 0.5551990270614624
> O 1 0.7607718110084534
A O 0 0.01565716601908207
substitution O 0 0.0534234344959259
at O 0 0.008111094124615192
the O 0 0.008811825886368752
splice O 1 0.9709742665290833
donor O 1 0.8625282049179077
site O 0 0.018477246165275574
in O 0 0.015419483184814453
intron O 1 0.9680842757225037
33 O 0 0.04204510152339935
. O 0 0.026263227686285973

Microsatellite O 1 0.9617947340011597
genotyping O 1 0.702769935131073
around O 0 0.01873074099421501
the O 0 0.011097480542957783
ATM O 0 0.4855819046497345
locus O 1 0.9150140285491943
also O 0 0.006088509224355221
indicated O 0 0.010202272795140743
that O 0 0.004226286895573139
a O 0 0.00731657026335597
common O 0 0.05714323744177818
haplotype O 1 0.9863216876983643
was O 0 0.005308825522661209
shared O 0 0.007647845894098282
by O 0 0.005793082527816296
the O 0 0.0076013901270926
mutant O 1 0.9931528568267822
alleles O 1 0.9944393634796143
in O 0 0.01439206674695015
both O 0 0.02084246464073658
mutations O 1 0.9954621195793152
. O 0 0.03206915408372879

This O 0 0.016065694391727448
suggests O 0 0.02010464109480381
that O 0 0.0048363544046878815
these O 0 0.004942207131534815
two O 0 0.0068262298591434956
founder O 0 0.28231382369995117
mutations O 1 0.9979548454284668
may O 0 0.013767301104962826
be O 0 0.005479329265654087
predominant O 0 0.0312998928129673
among O 0 0.011690787971019745
Japanese O 0 0.02230752445757389
ATM O 1 0.9040752649307251
mutant O 1 0.9891730546951294
alleles O 1 0.9909817576408386
. O 0 0.04401565343141556

W474C O 1 0.7477660179138184
amino O 1 0.8667786121368408
acid O 1 0.9533798098564148
substitution O 1 0.7145282030105591
affects O 1 0.8035423755645752
early O 0 0.013568880967795849
processing O 0 0.013017621822655201
of O 0 0.004767763894051313
the O 0 0.006595714949071407
alpha O 0 0.23884974420070648
- O 0 0.24244175851345062
subunit O 1 0.6672759056091309
of O 0 0.011152438819408417
beta O 1 0.8283288478851318
- O 0 0.2666575014591217
hexosaminidase O 0 0.4728877544403076
A O 0 0.011468424461781979
and O 0 0.005412556696683168
is O 0 0.0065073114819824696
associated O 0 0.02225632406771183
with O 0 0.01792892813682556
subacute O 1 0.9980218410491943
G B-Disease 1 0.9806031584739685
( I-Disease 0 0.03705233335494995
M2 I-Disease 1 0.9215593934059143
) I-Disease 0 0.025595972314476967
gangliosidosis I-Disease 1 0.5557388663291931
. O 0 0.023974116891622543

Mutations O 1 0.9690064191818237
in O 0 0.022006845101714134
the O 0 0.022176213562488556
HEXA O 1 0.9931342601776123
gene O 1 0.9794012308120728
, O 0 0.01437431387603283
encoding O 0 0.07711528986692429
the O 0 0.010254843160510063
alpha O 0 0.12137430906295776
- O 0 0.1397632211446762
subunit O 0 0.465285986661911
of O 0 0.010269575752317905
beta O 1 0.734792172908783
- O 0 0.1719892919063568
hexosaminidase O 1 0.6148743629455566
A O 0 0.014866617508232594
( O 0 0.013026396743953228
Hex O 0 0.06902223825454712
A O 0 0.012424305081367493
) O 0 0.007819048129022121
, O 0 0.004688037093728781
that O 0 0.005348186939954758
abolish O 0 0.03354484587907791
Hex O 0 0.1293358951807022
A O 0 0.027306871488690376
enzyme O 1 0.9924537539482117
activity O 1 0.7193771600723267
cause O 1 0.9943021535873413
Tay B-Disease 1 0.9993283748626709
- I-Disease 1 0.9948716163635254
Sachs I-Disease 1 0.9986365437507629
disease I-Disease 1 0.9995492100715637
( O 0 0.12192602455615997
TSD B-Disease 1 0.995201826095581
) O 0 0.013900607824325562
, O 0 0.006361022591590881
the O 0 0.01093435101211071
fatal O 1 0.9970775842666626
infantile B-Disease 1 0.9984074234962463
form I-Disease 0 0.06138715520501137
of I-Disease 0 0.011186297982931137
G I-Disease 1 0.9296784996986389
( I-Disease 0 0.028840599581599236
M2 I-Disease 1 0.880305290222168
) I-Disease 0 0.018764028325676918
gangliosidosis I-Disease 1 0.5293564796447754
, I-Disease 0 0.011507238261401653
Type I-Disease 0 0.08546577394008636
1 I-Disease 0 0.021235544234514236
. O 0 0.020170334726572037

Less O 0 0.05362381786108017
severe O 1 0.9569860696792603
, O 0 0.029312441125512123
subacute O 1 0.9950622916221619
( O 0 0.1838923841714859
juvenile O 1 0.9953536987304688
- O 1 0.9744099974632263
onset O 1 0.9988518953323364
) O 0 0.02994483895599842
and O 0 0.01426856778562069
chronic O 1 0.9992377758026123
( O 0 0.10421612113714218
adult O 1 0.9692364931106567
- O 1 0.9751699566841125
onset O 1 0.9989218711853027
) O 0 0.02183506451547146
variants O 0 0.44424155354499817
are O 0 0.0053225052542984486
characterized O 0 0.187464639544487
by O 0 0.005298546049743891
a O 0 0.008490444160997868
broad O 0 0.025746122002601624
spectrum O 0 0.12633450329303741
of O 0 0.007759434636682272
clinical O 1 0.9899813532829285
manifestations O 1 0.5802980065345764
and O 0 0.004257773514837027
are O 0 0.0037273140624165535
associated O 0 0.013333608396351337
with O 0 0.006205493118613958
residual O 0 0.49140024185180664
levels O 0 0.02044551819562912
of O 0 0.007622907869517803
Hex O 0 0.13588127493858337
A O 0 0.028608324006199837
enzyme O 1 0.9852808117866516
activity O 0 0.052386604249477386
. O 0 0.024922432377934456

We O 0 0.018867619335651398
identified O 0 0.027677692472934723
a O 0 0.022613251581788063
1422 O 1 0.9752326607704163
G O 1 0.9397934079170227
- O 1 0.675586462020874
- O 1 0.6283334493637085
> O 1 0.9539560675621033
C O 0 0.26530492305755615
( O 0 0.021096812561154366
amino O 1 0.8610971570014954
acid O 1 0.9844149351119995
W474C O 1 0.7320150136947632
) O 0 0.011228381656110287
substitution O 0 0.026429634541273117
in O 0 0.0036820198874920607
the O 0 0.002849770011380315
first O 0 0.003384106559678912
position O 0 0.005132170394062996
of O 0 0.004494125954806805
exon O 0 0.3974550664424896
13 O 0 0.011732431128621101
of O 0 0.008188792504370213
HEXA O 1 0.9814488291740417
of O 0 0.008016117848455906
a O 0 0.01037118025124073
non O 0 0.02239508368074894
- O 0 0.11046939343214035
Jewish O 0 0.023882471024990082
proband O 0 0.45641157031059265
who O 0 0.013976290822029114
manifested O 1 0.6588174700737
a O 0 0.033191341906785965
subacute O 1 0.9968235492706299
variant O 1 0.9708219170570374
of O 0 0.016474779695272446
G B-Disease 1 0.9090648889541626
( I-Disease 0 0.026574667543172836
M2 I-Disease 1 0.9015403985977173
) I-Disease 0 0.024335265159606934
gangliosidosis I-Disease 0 0.4453117549419403
. O 0 0.025167642161250114

On O 0 0.014611740596592426
the O 0 0.01098742987960577
second O 0 0.020923707634210587
maternally O 1 0.9861388802528381
inherited O 1 0.9925278425216675
allele O 1 0.9917749166488647
, O 0 0.007241019979119301
we O 0 0.00466622319072485
identified O 0 0.011831732466816902
the O 0 0.008878662250936031
common O 1 0.9160720109939575
infantile O 1 0.9997243285179138
disease O 1 0.999813973903656
- O 1 0.9400536417961121
causing O 1 0.8977447748184204
4 O 0 0.030930818989872932
- O 0 0.3232675790786743
bp O 0 0.3122732639312744
insertion O 1 0.8756182193756104
, O 0 0.018138444051146507
+ O 1 0.8450174927711487
TATC O 1 0.9282847046852112
1278 O 1 0.833734393119812
, O 0 0.016239633783698082
in O 0 0.013996201567351818
exon O 1 0.6082091331481934
11 O 0 0.03292057290673256
. O 0 0.025388285517692566

Pulse O 1 0.7321747541427612
- O 0 0.20610842108726501
chase O 0 0.15298281610012054
analysis O 0 0.034928541630506516
using O 0 0.025672918185591698
proband O 1 0.9139018058776855
fibroblasts O 1 0.9710490107536316
revealed O 0 0.02471001073718071
that O 0 0.007699442096054554
the O 0 0.008277369663119316
W474C O 1 0.6168308854103088
- O 0 0.0767093300819397
containing O 0 0.031349390745162964
alpha O 0 0.29099592566490173
- O 0 0.394829124212265
subunit O 1 0.8864418864250183
precursor O 1 0.6155217289924622
was O 0 0.008718915283679962
normally O 0 0.01328324619680643
synthesized O 0 0.26350826025009155
, O 0 0.004468980245292187
but O 0 0.003483541775494814
not O 0 0.004156251437962055
phosphorylated O 0 0.4100295603275299
or O 0 0.011237183585762978
secreted O 1 0.7411500215530396
, O 0 0.005577264353632927
and O 0 0.0039183772169053555
the O 0 0.007342788390815258
mature O 1 0.9509521126747131
lysosomal O 1 0.9964007139205933
alpha O 1 0.6938207745552063
- O 0 0.4844592809677124
subunit O 1 0.8101202249526978
was O 0 0.011697368696331978
not O 0 0.010613484308123589
detected O 0 0.42495793104171753
. O 0 0.022908629849553108

When O 0 0.02242571860551834
the O 0 0.014319305308163166
W474C O 0 0.41328004002571106
- O 0 0.08518491685390472
containing O 0 0.029619570821523666
alpha O 0 0.24075275659561157
- O 0 0.25597694516181946
subunit O 1 0.814292848110199
was O 0 0.0129921305924654
transiently O 1 0.8943074941635132
co O 0 0.10958171635866165
- O 0 0.02683916501700878
expressed O 0 0.010325033217668533
with O 0 0.005718728061765432
the O 0 0.006852523889392614
beta O 1 0.7226111888885498
- O 0 0.1640511006116867
subunit O 0 0.4845348596572876
to O 0 0.006390905939042568
produce O 0 0.015245342627167702
Hex O 0 0.08200012147426605
A O 0 0.01681423746049404
( O 0 0.014864549972116947
alphabeta O 0 0.49086230993270874
) O 0 0.011872980743646622
in O 0 0.008674952201545238
COS O 1 0.9553666114807129
- O 0 0.20954376459121704
7 O 0 0.01794668473303318
cells O 1 0.9391307830810547
, O 0 0.0063980440609157085
the O 0 0.006295096129179001
mature O 1 0.6226043701171875
alpha O 0 0.36020058393478394
- O 0 0.26808834075927734
subunit O 1 0.6619590520858765
was O 0 0.005279615521430969
present O 0 0.004828848410397768
, O 0 0.0027403985150158405
but O 0 0.0024384171701967716
its O 0 0.0027958413120359182
level O 0 0.005401809699833393
was O 0 0.003254792420193553
much O 0 0.004080572631210089
lower O 0 0.006913770921528339
than O 0 0.0038326564244925976
that O 0 0.003074305597692728
from O 0 0.005980290472507477
normal O 0 0.22444304823875427
alpha O 1 0.540656328201294
- O 1 0.6039016246795654
subunit O 1 0.9555944204330444
transfections O 1 0.6640661954879761
, O 0 0.005152923054993153
although O 0 0.0053949737921357155
higher O 0 0.007023245561867952
than O 0 0.004449059721082449
in O 0 0.004650538321584463
those O 0 0.007676008623093367
cells O 1 0.995157778263092
transfected O 1 0.992283046245575
with O 0 0.010258425027132034
an O 0 0.009097293019294739
alpha O 0 0.39409583806991577
- O 1 0.5845449566841125
subunit O 1 0.9562077522277832
associated O 0 0.08007098734378815
with O 0 0.03365356847643852
infantile O 1 0.996112048625946
TSD B-Disease 1 0.9858831763267517
. O 0 0.04278611019253731

Furthermore O 0 0.042599156498909
, O 0 0.009684557095170021
the O 0 0.007491191849112511
precursor O 0 0.07666725665330887
level O 0 0.008956369012594223
of O 0 0.004721384029835463
the O 0 0.007065384183079004
W474C O 1 0.7348517179489136
alpha O 1 0.5557769536972046
- O 0 0.302734911441803
subunit O 1 0.6948979496955872
was O 0 0.006498328875750303
found O 0 0.007301004603505135
to O 0 0.005095252301543951
accumulate O 0 0.26537901163101196
in O 0 0.004711958114057779
comparison O 0 0.00941510684788227
to O 0 0.003704731585457921
the O 0 0.005598322954028845
normal O 0 0.17418667674064636
alpha O 1 0.5182596445083618
- O 1 0.6096763610839844
subunit O 1 0.955880880355835
precursor O 1 0.9185907244682312
levels O 0 0.1032993420958519
. O 0 0.027779676020145416

We O 0 0.01544114574790001
conclude O 0 0.025155916810035706
that O 0 0.007935727015137672
the O 0 0.010879257693886757
1422 O 1 0.9782747030258179
G O 1 0.9624003767967224
- O 1 0.8345479965209961
- O 1 0.8789252042770386
> O 1 0.987775444984436
C O 1 0.9309656023979187
mutation O 1 0.9954463839530945
is O 0 0.007176089566200972
the O 0 0.005663908086717129
cause O 0 0.0741659551858902
of O 0 0.007178870029747486
Hex B-Disease 0 0.4161722958087921
A I-Disease 0 0.2353939414024353
enzyme I-Disease 1 0.9990763664245605
deficiency I-Disease 1 0.9996837377548218
in O 0 0.01303466409444809
the O 0 0.01467969547957182
proband O 1 0.7053191065788269
. O 0 0.030477410182356834

The O 0 0.027979955077171326
resulting O 0 0.1080215573310852
W474C O 0 0.3096875846385956
substitution O 0 0.0837169960141182
clearly O 0 0.02628152258694172
interferes O 0 0.4734499156475067
with O 0 0.01514873094856739
alpha O 0 0.48805710673332214
- O 0 0.30815452337265015
subunit O 1 0.8552634119987488
processing O 0 0.01916394755244255
, O 0 0.004668088164180517
but O 0 0.003707407508045435
because O 0 0.00477204192429781
the O 0 0.0036027077585458755
base O 0 0.008357311598956585
substitution O 0 0.07950672507286072
falls O 0 0.014155054464936256
at O 0 0.005004430655390024
the O 0 0.0031006678473204374
first O 0 0.0034292354248464108
position O 0 0.004373245872557163
of O 0 0.00517870532348752
exon O 1 0.7495108842849731
13 O 0 0.013524385169148445
, O 0 0.00909948069602251
aberrant O 1 0.9837110638618469
splicing O 1 0.980543315410614
may O 0 0.01260219793766737
also O 0 0.005201986525207758
contribute O 0 0.012204631231725216
to O 0 0.006005707196891308
Hex B-Disease 0 0.35332340002059937
A I-Disease 0 0.13940933346748352
deficiency I-Disease 1 0.9994150400161743
in O 0 0.010359538719058037
this O 0 0.009231857024133205
proband O 1 0.657799243927002
. O 0 0.014119287021458149
. O 0 0.019227584823966026

Two O 0 0.04399299621582031
frequent O 0 0.4646744132041931
missense O 1 0.9871270656585693
mutations O 1 0.9949901700019836
in O 0 0.07874196022748947
Pendred B-Disease 1 0.9933719635009766
syndrome I-Disease 1 0.998969316482544
. O 0 0.06540099531412125

Pendred B-Disease 1 0.993218719959259
syndrome I-Disease 1 0.9995179176330566
is O 0 0.06280999630689621
an O 1 0.5142208337783813
autosomal B-Disease 1 0.9999204874038696
recessive I-Disease 1 0.9999158382415771
disorder I-Disease 1 0.9997970461845398
characterized O 1 0.9554583430290222
by O 0 0.023996060714125633
early O 0 0.07426510751247406
childhood O 1 0.9908768534660339
deafness B-Disease 1 0.99910968542099
and O 0 0.05293471738696098
goiter B-Disease 1 0.9958006739616394
. O 0 0.04863734915852547

A O 0 0.026986178010702133
century O 0 0.013319442979991436
after O 0 0.009552882052958012
its O 0 0.006876521743834019
recognition O 0 0.016770709306001663
as O 0 0.008389675989747047
a O 0 0.027398915961384773
syndrome O 1 0.9993276596069336
by O 0 0.01708611100912094
Vaughan O 0 0.25574982166290283
Pendred O 1 0.8098958730697632
, O 0 0.01074571069329977
the O 0 0.021677585318684578
disease O 1 0.9997169375419617
gene O 1 0.9981887936592102
( O 0 0.043674178421497345
PDS O 1 0.9657047986984253
) O 0 0.012287839315831661
was O 0 0.007614177651703358
mapped O 0 0.02720451168715954
to O 0 0.01490849256515503
chromosome O 1 0.9959828853607178
7q22 O 1 0.9503688216209412
- O 0 0.47197067737579346
q31 O 1 0.7639868855476379
. O 0 0.03790966793894768

1 O 0 0.025088341906666756
and O 0 0.008227245882153511
, O 0 0.006368888076394796
recently O 0 0.010281641036272049
, O 0 0.005115238483995199
found O 0 0.00820218026638031
to O 0 0.007052001543343067
encode O 0 0.07077846676111221
a O 0 0.027830589562654495
putative O 1 0.9719432592391968
sulfate O 1 0.9893115162849426
transporter O 1 0.951369047164917
. O 0 0.04498039186000824

We O 0 0.01864633522927761
performed O 0 0.03128361701965332
mutation O 1 0.9918510317802429
analysis O 0 0.01748804561793804
of O 0 0.005540661513805389
the O 0 0.008654670789837837
PDS B-Disease 1 0.9909494519233704
gene O 1 0.9963719844818115
in O 0 0.013581824488937855
patients O 1 0.9814977645874023
from O 0 0.010673346929252148
14 O 0 0.014737500809133053
Pendred B-Disease 1 0.7612835764884949
families O 0 0.015498955734074116
originating O 0 0.022454343736171722
from O 0 0.00524552259594202
seven O 0 0.005614278372377157
countries O 0 0.004743160214275122
and O 0 0.004597619641572237
identified O 0 0.016995567828416824
all O 0 0.009221159853041172
mutations O 1 0.995980978012085
. O 0 0.03197561949491501

The O 0 0.02591007761657238
mutations O 1 0.9825542569160461
include O 0 0.017924554646015167
three O 0 0.009552385658025742
single O 0 0.013433095999062061
base O 0 0.015841567888855934
deletions O 0 0.27162668108940125
, O 0 0.008085973560810089
one O 0 0.010140467435121536
splice O 1 0.9410524368286133
site O 0 0.02730230987071991
mutation O 1 0.9931445121765137
and O 0 0.012191914953291416
10 O 0 0.025199085474014282
missense O 1 0.9916239380836487
mutations O 1 0.9956014156341553
. O 0 0.03899012878537178

One O 0 0.04989505559206009
missense O 1 0.9839127659797668
mutation O 1 0.9946936964988708
( O 0 0.032633859664201736
L236P O 1 0.6337898373603821
) O 0 0.010099110193550587
was O 0 0.004977294243872166
found O 0 0.00583611661568284
in O 0 0.00454135425388813
a O 0 0.008137846365571022
homozygous O 1 0.8588061332702637
state O 0 0.0064922203309834
in O 0 0.005089741665869951
two O 0 0.006981977727264166
consanguineous O 1 0.9393115043640137
families O 0 0.012805496342480183
and O 0 0.004367312416434288
in O 0 0.004246857017278671
a O 0 0.0073753357864916325
heterozygous O 1 0.883816659450531
state O 0 0.006246460601687431
in O 0 0.004410994704812765
five O 0 0.0066634719260036945
additional O 0 0.011370898224413395
non O 0 0.030543368309736252
- O 0 0.4934632182121277
consanguineous O 1 0.9794919490814209
families O 0 0.04132652282714844
. O 0 0.02754143625497818

Another O 0 0.07400885224342346
missense O 1 0.9893340468406677
mutation O 1 0.9966772794723511
( O 0 0.029868585988879204
T416P O 1 0.6777188181877136
) O 0 0.010163918137550354
was O 0 0.004693462513387203
found O 0 0.006615285761654377
in O 0 0.004568123258650303
a O 0 0.008367490023374557
homozygous O 1 0.932848334312439
state O 0 0.006049812771379948
in O 0 0.004267374984920025
one O 0 0.0043991669081151485
family O 0 0.008705152198672295
and O 0 0.0035842990037053823
in O 0 0.0046036383137106895
a O 0 0.009168647229671478
heterozygous O 1 0.787710964679718
state O 0 0.007725241594016552
in O 0 0.006192666944116354
four O 0 0.009503088891506195
families O 0 0.022267891094088554
. O 0 0.02071390673518181

Pendred B-Disease 1 0.94460529088974
patients O 1 0.9121409058570862
in O 0 0.01092604175209999
three O 0 0.01114067155867815
non O 0 0.029977811500430107
- O 0 0.3869766891002655
consanguineous O 1 0.9505048990249634
families O 0 0.014059376902878284
were O 0 0.003941482864320278
shown O 0 0.00814597774296999
to O 0 0.004169165156781673
be O 0 0.005126661621034145
compound O 0 0.043860770761966705
heterozygotes O 1 0.9047176241874695
for O 0 0.013655216433107853
L236P O 1 0.5159600377082825
and O 0 0.015226026996970177
T416P O 1 0.5152493715286255
. O 0 0.03379947319626808

In O 0 0.012853645719587803
total O 0 0.008812349289655685
, O 0 0.004231925122439861
one O 0 0.0034490691032260656
or O 0 0.003955380991101265
both O 0 0.0029029380530118942
of O 0 0.0027912771329283714
these O 0 0.004839126951992512
mutations O 1 0.9948291182518005
were O 0 0.003029274521395564
found O 0 0.00510750338435173
in O 0 0.0027859886176884174
nine O 0 0.004433586727827787
of O 0 0.003211737610399723
the O 0 0.004965802188962698
14 O 0 0.012067301198840141
families O 0 0.021467890590429306
analyzed O 0 0.06530430167913437
. O 0 0.022702887654304504

The O 0 0.015783270820975304
identification O 0 0.018496576696634293
of O 0 0.00640112766996026
two O 0 0.009197655133903027
frequent O 0 0.3263566493988037
PDS B-Disease 1 0.9883636236190796
mutations O 1 0.9972291588783264
will O 0 0.007553500588983297
facilitate O 0 0.02538803219795227
the O 0 0.012307414785027504
molecular O 1 0.9929754734039307
diagnosis O 1 0.9975565671920776
of O 0 0.04128127172589302
Pendred B-Disease 1 0.9969706535339355
syndrome I-Disease 1 0.9996498823165894
. O 0 0.05665626376867294

Insertional O 1 0.9248896837234497
mutation O 1 0.9842610359191895
by O 0 0.0279052946716547
transposable O 1 0.889394223690033
element O 0 0.03823124244809151
, O 0 0.01144300028681755
L1 O 1 0.7522929906845093
, O 0 0.006964603438973427
in O 0 0.007798786740750074
the O 0 0.01405219454318285
DMD B-Disease 1 0.9992877840995789
gene O 1 0.9957283139228821
results O 0 0.0664466917514801
in O 0 0.014214137569069862
X B-Disease 1 0.8319892883300781
- I-Disease 1 0.9010089039802551
linked I-Disease 1 0.9770286679267883
dilated I-Disease 1 0.997093677520752
cardiomyopathy I-Disease 1 0.9987603425979614
. O 0 0.05718732625246048

X B-Disease 1 0.6165685057640076
- I-Disease 1 0.8278905153274536
linked I-Disease 1 0.9775844216346741
dilated I-Disease 1 0.9969839453697205
cardiomyopathy I-Disease 1 0.9994353652000427
( O 0 0.09029644727706909
XLDCM B-Disease 1 0.9407712817192078
) O 0 0.012473495677113533
is O 0 0.00745348259806633
a O 0 0.015266790054738522
clinical O 1 0.9898754954338074
phenotype O 1 0.9964759945869446
of O 0 0.010253091342747211
dystrophinopathy B-Disease 1 0.7154444456100464
which O 0 0.007092357613146305
is O 0 0.006769266445189714
characterized O 0 0.250833660364151
by O 0 0.01325396541506052
preferential O 1 0.8990518450737
myocardial B-Disease 1 0.9990329742431641
involvement I-Disease 0 0.2127837836742401
without O 0 0.01393195055425167
any O 0 0.011605032719671726
overt O 1 0.7176058888435364
clinical O 1 0.974963903427124
signs O 0 0.13757683336734772
of O 0 0.026167886331677437
skeletal B-Disease 1 0.9977791905403137
myopathy I-Disease 1 0.9977704286575317
. O 0 0.05500592663884163

To O 0 0.014359207823872566
date O 0 0.013402215205132961
, O 0 0.007273808121681213
several O 0 0.010146960616111755
mutations O 1 0.9944097399711609
in O 0 0.013581670820713043
the O 0 0.03308477997779846
Duchenne B-Disease 1 0.9995235204696655
muscular I-Disease 1 0.9997298121452332
dystrophy I-Disease 1 0.9998685121536255
gene O 1 0.9986577033996582
, O 0 0.038935430347919464
DMD O 1 0.9981789588928223
, O 0 0.007922958582639694
have O 0 0.004488862119615078
been O 0 0.004843846429139376
identified O 0 0.013312752358615398
in O 0 0.007151332683861256
patients O 1 0.9876707792282104
with O 0 0.00894422922283411
XLDCM B-Disease 1 0.8295910358428955
, O 0 0.005248228088021278
but O 0 0.004979565739631653
a O 0 0.009946650825440884
pathogenic O 1 0.9850345253944397
correlation O 0 0.40960046648979187
of O 0 0.006946790497750044
these O 0 0.010997808538377285
cardiospecific O 1 0.9872884750366211
mutations O 1 0.9985688924789429
in O 0 0.020091356709599495
DMD O 1 0.9978356957435608
with O 0 0.013057038187980652
the O 0 0.011157925240695477
XLDCM B-Disease 1 0.9865882992744446
phenotype O 1 0.996638298034668
has O 0 0.010382991284132004
remained O 0 0.008330128155648708
to O 0 0.006078921724110842
be O 0 0.00873082410544157
elucidated O 1 0.6762759685516357
. O 0 0.022283874452114105

We O 0 0.011494357138872147
report O 0 0.008959620259702206
here O 0 0.004008371848613024
the O 0 0.003601297503337264
identification O 0 0.009007670916616917
of O 0 0.0034029358066618443
a O 0 0.0076338318176567554
unique O 0 0.014831982553005219
de O 0 0.048605140298604965
novo O 1 0.8122869729995728
L1 O 1 0.9721671938896179
insertion O 1 0.6652877926826477
in O 0 0.009363312274217606
the O 0 0.011339113116264343
muscle O 1 0.9954610466957092
exon O 1 0.9585041403770447
1 O 0 0.019620323553681374
in O 0 0.013577223755419254
DMD O 1 0.99688321352005
in O 0 0.01067623682320118
three O 0 0.012629972770810127
XLDCM B-Disease 1 0.9895492792129517
patients O 1 0.9835811853408813
from O 0 0.009617946110665798
two O 0 0.009746738709509373
unrelated O 0 0.21899956464767456
Japanese O 0 0.02268902026116848
families O 0 0.030872266739606857
. O 0 0.021776648238301277

The O 0 0.020004065707325935
insertion O 0 0.1870633363723755
was O 0 0.010834780521690845
a O 0 0.012530126608908176
5 O 0 0.015360365621745586
- O 0 0.039351414889097214
truncated O 0 0.16898305714130402
form O 0 0.014264913275837898
of O 0 0.007535438984632492
human O 0 0.12795470654964447
L1 O 1 0.9706375598907471
inversely O 0 0.4836995303630829
integrated O 0 0.027651077136397362
in O 0 0.006192931439727545
the O 0 0.005198745522648096
5 O 0 0.012814189307391644
- O 0 0.08978195488452911
untranslated O 1 0.5459489822387695
region O 0 0.012510906904935837
in O 0 0.006694873794913292
the O 0 0.00853730458766222
muscle O 1 0.9966417551040649
exon O 1 0.943091869354248
1 O 0 0.010398898273706436
, O 0 0.004334769211709499
which O 0 0.003278520191088319
affected O 0 0.013492397964000702
the O 0 0.004831140395253897
transcription O 1 0.9430774450302124
or O 0 0.0051126498728990555
the O 0 0.002949861343950033
stability O 0 0.007659710478037596
of O 0 0.0030328095890581608
the O 0 0.005499735940247774
muscle O 1 0.9924827218055725
form O 0 0.019270803779363632
of O 0 0.006874762941151857
dystrophin O 1 0.9968273043632507
transcripts O 0 0.0407114215195179
but O 0 0.004409248474985361
not O 0 0.002362713683396578
that O 0 0.0019519496709108353
of O 0 0.0024248724803328514
the O 0 0.005756506230682135
brain O 1 0.9985106587409973
or O 0 0.1174304187297821
Purkinje O 1 0.9989639520645142
cell O 1 0.9931877851486206
form O 0 0.02338321879506111
, O 0 0.0051142191514372826
probably O 0 0.005834836047142744
due O 0 0.005366375204175711
to O 0 0.0026141428388655186
its O 0 0.003958162385970354
unique O 0 0.007630805019289255
site O 0 0.008150387555360794
of O 0 0.006581087131053209
integration O 0 0.041314925998449326
. O 0 0.022037556394934654

We O 0 0.015008388087153435
speculate O 0 0.023410119116306305
that O 0 0.005250127520412207
this O 0 0.004454579669982195
insertion O 0 0.09037880599498749
of O 0 0.005448134616017342
an O 0 0.008447607979178429
L1 O 1 0.9762524366378784
sequence O 0 0.36586514115333557
in O 0 0.013035977259278297
DMD O 1 0.9988232254981995
is O 0 0.007387577556073666
responsible O 0 0.009228616952896118
for O 0 0.0032304557971656322
some O 0 0.002507643774151802
of O 0 0.0022371707018464804
the O 0 0.003102413611486554
population O 0 0.006098142359405756
of O 0 0.004877896048128605
Japanese O 0 0.023521343246102333
patients O 1 0.9944291114807129
with O 0 0.015522444620728493
XLDCM B-Disease 1 0.9482540488243103
. O 0 0.0159095861017704
. O 0 0.019908536225557327

Severe O 1 0.968897819519043
early O 0 0.1360117346048355
- O 1 0.9856993556022644
onset O 1 0.9990835189819336
obesity B-Disease 1 0.999453604221344
, O 0 0.1854197084903717
adrenal B-Disease 1 0.9991955161094666
insufficiency I-Disease 1 0.996813952922821
and O 0 0.023353630676865578
red O 1 0.6918866038322449
hair O 1 0.9951123595237732
pigmentation O 1 0.9986401200294495
caused O 1 0.90317302942276
by O 0 0.054111167788505554
POMC O 1 0.9964872598648071
mutations O 1 0.9962804913520813
in O 0 0.030340421944856644
humans O 1 0.7202268242835999
. O 0 0.0304038655012846

Sequential O 0 0.3027952313423157
cleavage O 1 0.5944837927818298
of O 0 0.011739586479961872
the O 0 0.01188900787383318
precursor O 1 0.8691428899765015
protein O 1 0.9654467105865479
pre O 0 0.25958457589149475
- O 0 0.2721872329711914
pro O 0 0.05661347135901451
- O 1 0.5244393348693848
opiomelanocortin O 1 0.9016107320785522
( O 0 0.03452209383249283
POMC O 1 0.9853000044822693
) O 0 0.02097337879240513
generates O 0 0.03320666775107384
the O 0 0.01669294387102127
melanocortin O 1 0.9721826314926147
peptides O 1 0.9705457091331482
adrenocorticotrophin O 1 0.9452207088470459
( O 0 0.03455669805407524
ACTH O 1 0.9813547730445862
) O 0 0.01883053220808506
, O 0 0.015323181636631489
melanocyte O 1 0.994698166847229
- O 1 0.8663712739944458
stimulating O 1 0.9882616400718689
hormones O 1 0.99549400806427
( O 0 0.13901400566101074
MSH O 1 0.9937792420387268
) O 0 0.021266818046569824
alpha O 0 0.060286883264780045
, O 0 0.00835537537932396
beta O 0 0.17831365764141083
and O 0 0.0063321553170681
gamma O 0 0.1573462337255478
as O 0 0.00546984001994133
well O 0 0.005053235217928886
as O 0 0.005737012717872858
the O 0 0.010831284336745739
opioid O 1 0.991870641708374
- O 1 0.9345991611480713
receptor O 1 0.9938886165618896
ligand O 1 0.9810980558395386
beta O 1 0.9587148427963257
- O 1 0.752289354801178
endorphin O 1 0.9709895849227905
. O 0 0.04578270763158798

While O 0 0.016475429758429527
a O 0 0.011950564570724964
few O 0 0.009028996340930462
cases O 0 0.015181334689259529
of O 0 0.008838260546326637
isolated O 1 0.979640543460846
ACTH B-Disease 1 0.9990886449813843
deficiency I-Disease 1 0.9996709823608398
have O 0 0.009730469435453415
been O 0 0.008260836824774742
reported O 0 0.023332364857196808
( O 0 0.027574189007282257
OMIM O 1 0.9946976900100708
201400 O 1 0.8791282176971436
) O 0 0.013502252288162708
, O 0 0.0062926956452429295
an O 0 0.010865814052522182
inherited O 1 0.9959063529968262
POMC O 1 0.9988806843757629
defect O 1 0.992845356464386
has O 0 0.00788586400449276
not O 0 0.004279013257473707
been O 0 0.004997893236577511
described O 0 0.011984936892986298
so O 0 0.00875011831521988
far O 0 0.012420111335814
. O 0 0.01673663966357708

Recent O 0 0.04246174171566963
studies O 0 0.03315924108028412
in O 0 0.011591808870434761
animal O 0 0.05075134336948395
models O 0 0.03338165581226349
elucidated O 1 0.5726109147071838
a O 0 0.010578216053545475
central O 0 0.007892267778515816
role O 0 0.010677042417228222
of O 0 0.006524949800223112
alpha O 1 0.5746883749961853
- O 1 0.5545046329498291
MSH O 1 0.9886276125907898
in O 0 0.006720175035297871
the O 0 0.0048718261532485485
regulation O 0 0.01843990571796894
of O 0 0.005374772474169731
food O 0 0.018673619255423546
intake O 1 0.5576478242874146
by O 0 0.01045137271285057
activation O 1 0.7324161529541016
of O 0 0.006923782639205456
the O 0 0.010817560367286205
brain O 1 0.9979419112205505
melanocortin O 1 0.9943148493766785
- O 0 0.3996374011039734
4 O 0 0.031950462609529495
- O 1 0.7664191722869873
receptor O 1 0.9922069907188416
( O 0 0.05936891958117485
MC4 O 1 0.9930738210678101
- O 1 0.5910314917564392
R O 0 0.49370890855789185
; O 0 0.016675015911459923
refs O 0 0.2177201509475708
3 O 0 0.016046056523919106
- O 0 0.03115820698440075
5 O 0 0.01023257989436388
) O 0 0.0056180269457399845
and O 0 0.002662590006366372
the O 0 0.004047746770083904
linkage O 0 0.34007880091667175
of O 0 0.006793634034693241
human O 1 0.5544998049736023
obesity B-Disease 1 0.9992496371269226
to O 0 0.009957747533917427
chromosome O 1 0.9960850477218628
2 O 0 0.009061392396688461
in O 0 0.004372249357402325
close O 0 0.006922333501279354
proximity O 0 0.01444080751389265
to O 0 0.004105016589164734
the O 0 0.008225993253290653
POMC O 1 0.9957439303398132
locus O 1 0.9773757457733154
, O 0 0.005810776259750128
led O 0 0.006059236824512482
to O 0 0.0028254620265215635
the O 0 0.002938119461759925
proposal O 0 0.0068449475802481174
of O 0 0.0033983897883445024
an O 0 0.005402701441198587
association O 0 0.013641349971294403
of O 0 0.009550265967845917
POMC O 1 0.9934533834457397
with O 0 0.025647031143307686
human O 1 0.78822922706604
obesity B-Disease 1 0.9981426000595093
. O 0 0.040097925812006

The O 0 0.018099546432495117
dual O 0 0.033132199198007584
role O 0 0.01668158359825611
of O 0 0.009251757524907589
alpha O 0 0.47195976972579956
- O 1 0.6641076803207397
MSH O 1 0.9906356930732727
in O 0 0.015804708003997803
regulating O 0 0.4151434004306793
food O 0 0.039114437997341156
intake O 1 0.6125192642211914
and O 0 0.011347010731697083
influencing O 1 0.7773371338844299
hair O 1 0.9948315024375916
pigmentation O 1 0.9982175230979919
predicts O 0 0.3544880449771881
that O 0 0.008068835362792015
the O 0 0.009597343392670155
phenotype O 1 0.9986032843589783
associated O 0 0.02846650779247284
with O 0 0.007741608656942844
a O 0 0.013962024822831154
defect O 1 0.9890151619911194
in O 0 0.01606931909918785
POMC O 1 0.9970894455909729
function O 0 0.2175876498222351
would O 0 0.007651994004845619
include O 0 0.04141658917069435
obesity B-Disease 1 0.9992552399635315
, O 0 0.011743570677936077
alteration O 1 0.9024261832237244
in O 0 0.02529613859951496
pigmentation O 1 0.9987922310829163
and O 0 0.07828383892774582
ACTH B-Disease 1 0.9982505440711975
deficiency I-Disease 1 0.9991878867149353
. O 0 0.04984761402010918

The O 0 0.016076356172561646
observation O 0 0.02462058514356613
of O 0 0.007326075807213783
these O 0 0.009870427660644054
symptoms O 1 0.9926683902740479
in O 0 0.007291147485375404
two O 0 0.007823191583156586
probands O 1 0.581027090549469
prompted O 0 0.0227443166077137
us O 0 0.008038254454731941
to O 0 0.0043706139549613
search O 0 0.010717058554291725
for O 0 0.008490609005093575
mutations O 1 0.990570068359375
within O 0 0.015136142261326313
their O 0 0.018629031255841255
POMC O 1 0.993341863155365
genes O 1 0.9863948822021484
. O 0 0.03609442710876465

Patient O 1 0.8373310565948486
1 O 0 0.018842941150069237
was O 0 0.006672865245491266
found O 0 0.006134157069027424
to O 0 0.0030374769121408463
be O 0 0.003058413742110133
a O 0 0.005933558102697134
compound O 0 0.03304561227560043
heterozygote O 1 0.9180319905281067
for O 0 0.007253432180732489
two O 0 0.007772114593535662
mutations O 1 0.9963338375091553
in O 0 0.010566560551524162
exon O 1 0.9047076106071472
3 O 0 0.01815822906792164
( O 0 0.013582476414740086
G7013T O 1 0.5047563314437866
, O 0 0.008586687035858631
C7133delta O 1 0.566582202911377
) O 0 0.009672691114246845
which O 0 0.005853821523487568
interfere O 0 0.025086235255002975
with O 0 0.006991102360188961
appropriate O 0 0.015718817710876465
synthesis O 0 0.44503098726272583
of O 0 0.011770563200116158
ACTH O 1 0.9798808693885803
and O 0 0.01525986660271883
alpha O 1 0.6287347674369812
- O 1 0.8042916059494019
MSH O 1 0.9846150279045105
. O 0 0.0468798466026783

Patient O 1 0.8350521922111511
2 O 0 0.022816671058535576
was O 0 0.010624394752085209
homozygous O 1 0.799466609954834
for O 0 0.008937566541135311
a O 0 0.01516488753259182
mutation O 1 0.9954094290733337
in O 0 0.014020089991390705
exon O 1 0.8381729125976562
2 O 0 0.02177620679140091
( O 0 0.017648523673415184
C3804A O 1 0.5199938416481018
) O 0 0.01515353936702013
which O 0 0.012829212471842766
abolishes O 1 0.962280809879303
POMC O 1 0.9857223033905029
translation O 0 0.06248868256807327
. O 0 0.03098975121974945

These O 0 0.015253404155373573
findings O 0 0.016216734424233437
represent O 0 0.007139840628951788
the O 0 0.003654981032013893
first O 0 0.00437246123328805
examples O 0 0.008270076476037502
of O 0 0.00512651028111577
a O 0 0.01785643771290779
genetic B-Disease 1 0.9986156225204468
defect I-Disease 1 0.9877150058746338
within O 0 0.013299217447638512
the O 0 0.01423186156898737
POMC O 1 0.9972795844078064
gene O 1 0.990760326385498
and O 0 0.008497604168951511
define O 0 0.021669989451766014
a O 0 0.014822489582002163
new O 0 0.03501439839601517
monogenic B-Disease 1 0.9987908005714417
endocrine I-Disease 1 0.9997833371162415
disorder I-Disease 1 0.999450147151947
resulting O 1 0.6004072427749634
in O 0 0.01271341647952795
early O 0 0.08782745152711868
- O 1 0.9887097477912903
onset O 1 0.9996331930160522
obesity B-Disease 1 0.9996477365493774
, O 0 0.21084685623645782
adrenal B-Disease 1 0.9991359114646912
insufficiency I-Disease 1 0.9981587529182434
and O 0 0.020303688943386078
red O 1 0.7772836089134216
hair O 1 0.9954328536987305
pigmentation O 1 0.9976897239685059
. O 0 0.023639647290110588
. O 0 0.024799296632409096

A O 0 0.03783997893333435
European O 0 0.03231928125023842
multicenter O 1 0.933207094669342
study O 0 0.03959022834897041
of O 0 0.020029954612255096
phenylalanine B-Disease 1 0.9902503490447998
hydroxylase I-Disease 1 0.9966339468955994
deficiency I-Disease 1 0.9994993209838867
: O 0 0.020706763491034508
classification O 0 0.047189678996801376
of O 0 0.007551682181656361
105 O 0 0.02656598575413227
mutations O 1 0.9934365749359131
and O 0 0.006018684245646
a O 0 0.007147281430661678
general O 0 0.006770841311663389
system O 0 0.014800619333982468
for O 0 0.010807259008288383
genotype O 1 0.9959046244621277
- O 0 0.279435396194458
based O 0 0.017493002116680145
prediction O 0 0.3658633530139923
of O 0 0.023640809580683708
metabolic O 1 0.9985853433609009
phenotype O 1 0.9967809915542603
. O 0 0.041568487882614136

Phenylketonuria B-Disease 1 0.9901896119117737
( O 0 0.13311852514743805
PKU B-Disease 1 0.9940145611763
) O 0 0.027406588196754456
and O 0 0.015024340711534023
mild B-Disease 1 0.9740748405456543
hyperphenylalaninemia I-Disease 1 0.9826235175132751
( O 0 0.09571179002523422
MHP B-Disease 1 0.9934913516044617
) O 0 0.01984420046210289
are O 0 0.01370097417384386
allelic B-Disease 1 0.9965081810951233
disorders I-Disease 1 0.9994049072265625
caused O 1 0.8913983106613159
by O 0 0.020119084045290947
mutations O 1 0.9969325065612793
in O 0 0.011814885772764683
the O 0 0.017641356214880943
gene O 1 0.9943429231643677
encoding O 1 0.9661003947257996
phenylalanine O 1 0.9837318658828735
hydroxylase O 1 0.9815951585769653
( O 0 0.12744946777820587
PAH O 1 0.9913357496261597
) O 0 0.04464418813586235
. O 0 0.032526638358831406

Previous O 0 0.03377711772918701
studies O 0 0.024825965985655785
have O 0 0.007224071770906448
suggested O 0 0.011258215643465519
that O 0 0.0049539594911038876
the O 0 0.006689421832561493
highly O 0 0.07644400000572205
variable O 1 0.9609820246696472
metabolic O 1 0.9984859824180603
phenotypes O 1 0.9939636588096619
of O 0 0.2015594094991684
PAH B-Disease 1 0.9994375109672546
deficiency I-Disease 1 0.9995965361595154
correlate O 1 0.9793857336044312
with O 0 0.15479552745819092
PAH O 1 0.9971573352813721
genotypes O 1 0.982390284538269
. O 0 0.055480603128671646

We O 0 0.01903695799410343
identified O 0 0.02889321558177471
both O 0 0.01663484238088131
causative O 1 0.9941182136535645
mutations O 1 0.99750816822052
in O 0 0.02026255615055561
686 O 1 0.9800431728363037
patients O 1 0.9824641346931458
from O 0 0.011780994944274426
seven O 0 0.01339043490588665
European O 0 0.022340944036841393
centers O 0 0.04496864229440689
. O 0 0.022973129525780678

On O 0 0.009410766884684563
the O 0 0.005713877268135548
basis O 0 0.006726110354065895
of O 0 0.003770686686038971
the O 0 0.0054946341551840305
phenotypic O 1 0.8952321410179138
characteristics O 0 0.0656900480389595
of O 0 0.009642199613153934
297 O 1 0.841912567615509
functionally O 1 0.9912155866622925
hemizygous O 1 0.99098140001297
patients O 1 0.9932222366333008
, O 0 0.006039252504706383
105 O 0 0.01013785507529974
of O 0 0.003609416540712118
the O 0 0.005179521162062883
mutations O 1 0.987687885761261
were O 0 0.0037319527473300695
assigned O 0 0.006140867713838816
to O 0 0.0029085723217576742
one O 0 0.003017069771885872
of O 0 0.0033848960883915424
four O 0 0.007616302464157343
arbitrary O 0 0.04278881102800369
phenotype O 1 0.995901882648468
categories O 0 0.046373527497053146
. O 0 0.02561400830745697

We O 0 0.012702886015176773
proposed O 0 0.016009388491511345
and O 0 0.00543565209954977
tested O 0 0.02132975310087204
a O 0 0.007178152445703745
simple O 0 0.011366069316864014
model O 0 0.012933121994137764
for O 0 0.006931006442755461
correlation O 0 0.467388778924942
between O 0 0.01722625456750393
genotype O 1 0.986568808555603
and O 0 0.014083211310207844
phenotypic O 1 0.9491437077522278
outcome O 0 0.05872241407632828
. O 0 0.026183931156992912

The O 0 0.025559376925230026
observed O 0 0.09290289878845215
phenotype O 1 0.9938849806785583
matched O 0 0.08121205121278763
the O 0 0.01072423905134201
predicted O 0 0.09928563237190247
phenotype O 1 0.9964321851730347
in O 0 0.007614108733832836
79 O 0 0.015777362510561943
% O 0 0.006444913800805807
of O 0 0.00299670547246933
the O 0 0.0034000796731561422
cases O 0 0.015098139643669128
, O 0 0.0028178202919662
and O 0 0.002211290644481778
in O 0 0.002565201837569475
only O 0 0.0030045541934669018
5 O 0 0.005941265728324652
of O 0 0.00494737783446908
184 O 0 0.18862909078598022
patients O 1 0.9763062596321106
was O 0 0.00584510387852788
the O 0 0.005326856393367052
observed O 0 0.16872453689575195
phenotype O 1 0.9966542720794678
more O 0 0.004740324802696705
than O 0 0.003867983352392912
one O 0 0.003613063134253025
category O 0 0.010097566060721874
away O 0 0.0071166022680699825
from O 0 0.005749068688601255
that O 0 0.005426979158073664
expected O 0 0.012127821333706379
. O 0 0.01765429973602295

Among O 0 0.015743115916848183
the O 0 0.006846379954367876
seven O 0 0.007682709489017725
contributing O 0 0.017968935891985893
centers O 0 0.013924210332334042
, O 0 0.0039003947749733925
the O 0 0.003456261707469821
proportion O 0 0.016678830608725548
of O 0 0.005646939855068922
patients O 1 0.984991729259491
for O 0 0.005619205068796873
whom O 0 0.008352009579539299
the O 0 0.006067872047424316
observed O 0 0.14135707914829254
phenotype O 1 0.9975212216377258
did O 0 0.0072549874894320965
not O 0 0.003759325947612524
match O 0 0.006364885251969099
the O 0 0.005955154541879892
predicted O 0 0.18011139333248138
phenotype O 1 0.9968132376670837
was O 0 0.007857011631131172
4 O 0 0.011539914645254612
% O 0 0.013652827590703964
- O 0 0.031142765656113625
23 O 0 0.013791536912322044
% O 0 0.014688573777675629
( O 0 0.018128463998436928
P O 1 0.5788335204124451
< O 1 0.8398005366325378
. O 0 0.012974617071449757
0001 O 1 0.9496738910675049
) O 0 0.00821768306195736
, O 0 0.004064781591296196
suggesting O 0 0.00942318607121706
that O 0 0.0029504867270588875
differences O 0 0.00898559857159853
in O 0 0.0040854415856301785
methods O 0 0.009356911294162273
used O 0 0.007215691264718771
for O 0 0.009996331296861172
mutation O 1 0.999091386795044
detection O 1 0.9645007252693176
or O 0 0.08393462747335434
phenotype O 1 0.9987509250640869
classification O 1 0.5101721286773682
may O 0 0.01093309372663498
account O 0 0.009199603460729122
for O 0 0.005588806699961424
a O 0 0.008207534439861774
considerable O 0 0.014967234805226326
proportion O 0 0.03269633650779724
of O 0 0.018420837819576263
genotype O 1 0.9949597120285034
- O 1 0.946625292301178
phenotype O 1 0.9948959946632385
inconsistencies O 0 0.49686139822006226
. O 0 0.03700444474816322

Our O 0 0.021004557609558105
data O 0 0.01700044423341751
indicate O 0 0.01912461221218109
that O 0 0.00799450371414423
the O 0 0.015104252845048904
PAH O 1 0.9988529682159424
- O 1 0.9817450642585754
mutation O 1 0.9989227652549744
genotype O 1 0.9909136295318604
is O 0 0.0072549874894320965
the O 0 0.0052742138504981995
main O 0 0.010522561147809029
determinant O 1 0.7639085650444031
of O 0 0.01855732873082161
metabolic O 1 0.9994383454322815
phenotype O 1 0.9986227750778198
in O 0 0.015494829043745995
most O 0 0.020822802558541298
patients O 1 0.9966515898704529
with O 0 0.44103169441223145
PAH B-Disease 1 0.9995408058166504
deficiency I-Disease 1 0.9993886947631836
. O 0 0.05953623354434967

In O 0 0.013320667669177055
the O 0 0.007328545209020376
present O 0 0.0076220035552978516
study O 0 0.010364928282797337
, O 0 0.004089815076440573
the O 0 0.00465264031663537
classification O 0 0.04621041566133499
of O 0 0.008487476967275143
105 O 0 0.4132506549358368
PAH O 1 0.9994173049926758
mutations O 1 0.9986206293106079
may O 0 0.012961170636117458
allow O 0 0.008591936901211739
the O 0 0.00471162935718894
prediction O 0 0.019995370879769325
of O 0 0.005201066378504038
the O 0 0.008305765688419342
biochemical O 1 0.9940949082374573
phenotype O 1 0.9985546469688416
in O 0 0.013716867193579674
> O 1 0.7101436257362366
10 O 0 0.009571226313710213
, O 0 0.005616381298750639
000 O 0 0.023965241387486458
genotypes O 1 0.9839150905609131
, O 0 0.004509211052209139
which O 0 0.0029729343950748444
may O 0 0.004654725547879934
be O 0 0.0025814587716013193
useful O 0 0.0065949056297540665
for O 0 0.0033227847889065742
the O 0 0.004922183696180582
management O 0 0.015302171930670738
of O 0 0.008521762676537037
hyperphenylalaninemia B-Disease 1 0.942961573600769
in O 0 0.023395931348204613
newborns O 1 0.9905125498771667
. O 0 0.03602726012468338

Somatic O 1 0.9519498944282532
instability O 0 0.19592790305614471
of O 0 0.010594564490020275
the O 0 0.01098455861210823
CTG O 1 0.8390730619430542
repeat O 0 0.2340787947177887
in O 0 0.016433943063020706
mice O 1 0.996098518371582
transgenic O 1 0.9710635542869568
for O 0 0.013809856958687305
the O 0 0.023639999330043793
myotonic B-Disease 1 0.9996899366378784
dystrophy I-Disease 1 0.9997102618217468
region O 0 0.04705066978931427
is O 0 0.009283025749027729
age O 0 0.013427408412098885
dependent O 0 0.01998022198677063
but O 0 0.004302172921597958
not O 0 0.0041051991283893585
correlated O 0 0.16044048964977264
to O 0 0.004238106310367584
the O 0 0.005764874629676342
relative O 0 0.05186755210161209
intertissue O 1 0.964478075504303
transcription O 1 0.9837676286697388
levels O 0 0.15093183517456055
and O 0 0.016179196536540985
proliferative O 1 0.9955059289932251
capacities O 0 0.10974420607089996
. O 0 0.02945283055305481

A O 0 0.04456300660967827
( O 0 0.03505469858646393
CTG O 1 0.7863638401031494
) O 0 0.0201322752982378
nexpansion O 0 0.11665774136781693
in O 0 0.00806199200451374
the O 0 0.006912468001246452
3 O 0 0.015143979340791702
- O 0 0.09808101505041122
untranslated O 1 0.6862730979919434
region O 0 0.02086273767054081
( O 0 0.01835811138153076
UTR O 1 0.6892607808113098
) O 0 0.010361739434301853
of O 0 0.005109553690999746
the O 0 0.01131916418671608
DM O 1 0.9985652565956116
protein O 1 0.9973269701004028
kinase O 1 0.9977503418922424
gene O 1 0.9965353012084961
( O 0 0.03674745187163353
DMPK O 1 0.8995490670204163
) O 0 0.013707910664379597
is O 0 0.008363588713109493
responsible O 0 0.02013321779668331
for O 0 0.01930907927453518
causing O 1 0.9914925694465637
myotonic B-Disease 1 0.9995954632759094
dystrophy I-Disease 1 0.9997498393058777
( O 1 0.5803084969520569
DM B-Disease 1 0.9947457313537598
) O 0 0.04144733026623726
. O 0 0.027841245755553246

Major O 0 0.047726575285196304
instability O 0 0.30646997690200806
, O 0 0.008598954416811466
with O 0 0.005926252342760563
very O 0 0.0060773203149437904
large O 0 0.007328357547521591
expansions O 0 0.026048369705677032
between O 0 0.008026422932744026
generations O 0 0.01336850505322218
and O 0 0.004002086818218231
high O 0 0.008599767461419106
levels O 0 0.018854189664125443
of O 0 0.008399046957492828
somatic O 1 0.9953818917274475
mosaicism O 1 0.9958472847938538
, O 0 0.009809646755456924
is O 0 0.008699295111000538
observed O 0 0.027652880176901817
in O 0 0.013750853016972542
patients O 1 0.9905995726585388
. O 0 0.025857532396912575

There O 0 0.01249214168637991
is O 0 0.007469068747013807
a O 0 0.00807784404605627
good O 0 0.009290949441492558
correlation O 0 0.15699368715286255
between O 0 0.010689258575439453
repeat O 0 0.21700438857078552
size O 0 0.0145283667370677
( O 0 0.007657384499907494
at O 0 0.004580124747008085
least O 0 0.006326104048639536
in O 0 0.006841706577688456
leucocytes O 1 0.9387519955635071
) O 0 0.012061436660587788
, O 0 0.00931596476584673
clinical O 1 0.9867651462554932
severity O 1 0.844702959060669
and O 0 0.0075744157657027245
age O 0 0.0222010500729084
of O 0 0.01464874017983675
onset O 1 0.9960600733757019
. O 0 0.03188116103410721

The O 0 0.03310010954737663
trinucleotide O 1 0.9682173728942871
repeat O 1 0.7046874165534973
instability O 1 0.9088792204856873
mechanisms O 1 0.5891037583351135
involved O 0 0.02061246708035469
in O 0 0.010380944237112999
DM B-Disease 1 0.9944057464599609
and O 0 0.008350146003067493
other O 0 0.009915041737258434
human O 1 0.9377533793449402
genetic B-Disease 1 0.9996315240859985
diseases I-Disease 1 0.999422550201416
are O 0 0.013581152074038982
unknown O 0 0.04623059555888176
. O 0 0.02197962999343872

We O 0 0.01993865892291069
studied O 0 0.03961057588458061
somatic O 1 0.9689782857894897
instability O 0 0.4528544843196869
by O 0 0.012560997158288956
measuring O 0 0.025698771700263023
the O 0 0.010088104754686356
CTG O 1 0.9128119945526123
repeat O 0 0.13754531741142273
length O 0 0.016070518642663956
at O 0 0.006038245279341936
several O 0 0.006259544752538204
ages O 0 0.013385586440563202
in O 0 0.0052270786836743355
various O 0 0.008019228465855122
tissues O 1 0.9657226800918579
of O 0 0.01110938098281622
transgenic O 1 0.9931038022041321
mice O 1 0.9949040412902832
carrying O 0 0.02011786587536335
a O 0 0.016525061801075935
( O 0 0.018176965415477753
CTG O 1 0.9388604164123535
) O 0 0.014070914126932621
55expansion O 0 0.20989581942558289
surrounded O 0 0.017761804163455963
by O 0 0.007531416602432728
45 O 0 0.010289262048900127
kb O 0 0.03119099885225296
of O 0 0.005175590980798006
the O 0 0.007378194946795702
human O 0 0.3613681495189667
DM B-Disease 1 0.9966378211975098
region O 0 0.018294911831617355
, O 0 0.006091369315981865
using O 0 0.012282446026802063
small O 0 0.016450336202979088
- O 0 0.1557033509016037
pool O 0 0.1696367710828781
PCR O 1 0.9374539852142334
. O 0 0.030230361968278885

These O 0 0.024964209645986557
mice O 1 0.9670589566230774
have O 0 0.008275975473225117
been O 0 0.005845935083925724
shown O 0 0.008838444948196411
to O 0 0.0050816903822124004
reproduce O 0 0.10355766117572784
the O 0 0.007073172368109226
intergenerational O 1 0.9411312937736511
and O 0 0.008718576282262802
somatic O 1 0.9898321628570557
instability O 0 0.3570442795753479
of O 0 0.006116693839430809
the O 0 0.005976895801723003
55 O 0 0.021883253008127213
CTG O 1 0.9685714840888977
repeat O 0 0.22317074239253998
suggesting O 0 0.019772924482822418
that O 0 0.004732911009341478
surrounding O 0 0.012053404003381729
sequences O 0 0.0305178165435791
and O 0 0.0048883575946092606
the O 0 0.006333496421575546
chromatin O 1 0.9200239181518555
environment O 0 0.017097724601626396
are O 0 0.00546925887465477
involved O 0 0.013687970116734505
in O 0 0.011538689956068993
instability O 1 0.9038891196250916
mechanisms O 1 0.7558214068412781
. O 0 0.028164567425847054

As O 0 0.01397193968296051
observed O 0 0.016598429530858994
in O 0 0.004496586974710226
some O 0 0.003043726785108447
of O 0 0.002973946277052164
the O 0 0.006470330525189638
tissues O 1 0.9921562671661377
of O 0 0.02699895203113556
DM B-Disease 1 0.9996730089187622
patients O 1 0.9976678490638733
, O 0 0.005829773843288422
there O 0 0.0034009863156825304
is O 0 0.0031955179292708635
a O 0 0.005262873601168394
tendency O 0 0.04165051877498627
for O 0 0.005615840665996075
repeat O 0 0.14974108338356018
length O 0 0.017883209511637688
and O 0 0.0070981248281896114
somatic O 1 0.9942693710327148
mosaicism O 1 0.9899022579193115
to O 0 0.0063883657567203045
increase O 0 0.008528204634785652
with O 0 0.00411773007363081
the O 0 0.0035285467747598886
age O 0 0.007662915159016848
of O 0 0.0054309130646288395
the O 0 0.010721022263169289
mouse O 1 0.9819170832633972
. O 0 0.027391817420721054

Furthermore O 0 0.03504731506109238
, O 0 0.00914954673498869
we O 0 0.005116808693856001
observed O 0 0.013607899658381939
no O 0 0.007622915785759687
correlation O 0 0.0956077054142952
between O 0 0.008481512777507305
the O 0 0.009034322574734688
somatic O 1 0.9973829388618469
mutation O 1 0.9983736276626587
rate O 0 0.08840392529964447
and O 0 0.014734883792698383
tissue O 1 0.9963129162788391
proliferation O 1 0.8736276626586914
capacity O 0 0.027870817109942436
. O 0 0.022013386711478233

The O 0 0.03534011170268059
somatic O 1 0.9891353845596313
mutation O 1 0.9962303042411804
rates O 0 0.036393556743860245
in O 0 0.006506516598165035
different O 0 0.00746167404577136
tissues O 1 0.9514306783676147
were O 0 0.00290652341209352
also O 0 0.0027553937397897243
not O 0 0.00285286083817482
correlated O 0 0.11689087748527527
to O 0 0.0036500580608844757
the O 0 0.004350109025835991
relative O 0 0.022610602900385857
inter O 0 0.26717618107795715
- O 1 0.7100996375083923
tissue O 1 0.9943720102310181
difference O 0 0.019230077043175697
in O 0 0.007636627648025751
transcriptional O 1 0.8485235571861267
levels O 0 0.017415152862668037
of O 0 0.0040400149300694466
the O 0 0.004802151117473841
three O 0 0.009054835885763168
genes O 1 0.9935169219970703
( O 0 0.02263704501092434
DMAHP O 1 0.8920871019363403
, O 0 0.010965605266392231
DMPK O 1 0.6722361445426941
and O 0 0.006264761555939913
59 O 0 0.018939971923828125
) O 0 0.00927654653787613
surrounding O 0 0.013470295816659927
the O 0 0.009416738525032997
repeat O 0 0.10660380125045776
. O 0 0.01410328596830368
. O 0 0.01902746967971325

A O 0 0.052418023347854614
novel O 0 0.33930617570877075
missense O 1 0.989351212978363
mutation O 1 0.9965038299560547
in O 0 0.022905532270669937
patients O 1 0.9783554077148438
from O 0 0.014738790690898895
a O 0 0.026744810864329338
retinoblastoma B-Disease 1 0.9955242872238159
pedigree O 1 0.8657492399215698
showing O 0 0.022086072713136673
only O 0 0.009841307997703552
mild O 1 0.8515515327453613
expression O 0 0.06358520686626434
of O 0 0.011007188819348812
the O 0 0.029570112004876137
tumor B-Disease 1 0.9995635151863098
phenotype O 1 0.9978348612785339
. O 0 0.04267686977982521

We O 0 0.010669530369341373
have O 0 0.005981418304145336
used O 0 0.008215139620006084
single O 0 0.0181391853839159
strand O 1 0.8514155149459839
conformation O 1 0.9309805035591125
polymorphism O 1 0.9225049614906311
analysis O 0 0.019152255728840828
to O 0 0.004953677766025066
study O 0 0.009165503084659576
the O 0 0.004837694112211466
27 O 0 0.012008041143417358
exons O 0 0.39656010270118713
of O 0 0.006925501860678196
the O 0 0.011006047949194908
RB1 O 1 0.9983075857162476
gene O 1 0.9897117614746094
in O 0 0.00835117232054472
individuals O 0 0.010078908875584602
from O 0 0.006333979777991772
a O 0 0.008700150065124035
family O 0 0.022789152339100838
showing O 0 0.04270985722541809
mild O 1 0.9036408066749573
expression O 0 0.1306743621826172
of O 0 0.009932123124599457
the O 0 0.020825693383812904
retinoblastoma B-Disease 1 0.9974186420440674
phenotype O 1 0.9965384006500244
. O 0 0.044104717671871185

In O 0 0.01534289214760065
this O 0 0.010735872201621532
family O 0 0.022972317412495613
affected O 0 0.09658040851354599
individuals O 0 0.028185855597257614
developed O 0 0.2865646481513977
unilateral B-Disease 1 0.9135379791259766
tumors I-Disease 1 0.9989942908287048
and O 0 0.005353478714823723
, O 0 0.003853256581351161
as O 0 0.003346605459228158
a O 0 0.005416588392108679
result O 0 0.009807552210986614
of O 0 0.005916799418628216
linkage O 1 0.9603467583656311
analysis O 0 0.05428162217140198
, O 0 0.010086920112371445
unaffected O 1 0.9828333258628845
mutation O 1 0.9988293051719666
carriers O 0 0.23676644265651703
were O 0 0.004245598800480366
also O 0 0.004357391968369484
identified O 0 0.010802019387483597
within O 0 0.008395127952098846
the O 0 0.009903711266815662
pedigree O 1 0.685302734375
. O 0 0.022218206897377968

A O 0 0.03276173025369644
single O 0 0.025142140686511993
band O 0 0.025396214798092842
shift O 0 0.029703157022595406
using O 0 0.021840300410985947
SSCP O 1 0.5944867134094238
was O 0 0.008172604255378246
identified O 0 0.013423208147287369
in O 0 0.007444094866514206
exon O 1 0.6728373765945435
21 O 0 0.011788098141551018
which O 0 0.005300205200910568
resulted O 0 0.014948698692023754
in O 0 0.0068284738808870316
a O 0 0.0159163661301136
missense O 1 0.9912599921226501
mutation O 1 0.9946743249893188
converting O 0 0.05649804323911667
a O 0 0.031247228384017944
cys O 1 0.9904583692550659
- O 1 0.8025920391082764
- O 1 0.7866588830947876
> O 1 0.9722278118133545
arg O 1 0.9079803228378296
at O 0 0.016458485275506973
nucleotide O 0 0.40837621688842773
position O 0 0.012559778988361359
28 O 0 0.013160983100533485
in O 0 0.007709868252277374
the O 0 0.012554516084492207
exon O 1 0.6948989629745483
. O 0 0.029197029769420624

The O 0 0.0347059890627861
mutation O 1 0.973455548286438
destroyed O 0 0.04498592019081116
an O 0 0.019982360303401947
NdeI O 1 0.7952111959457397
restriction O 0 0.29925039410591125
enzyme O 1 0.959283709526062
site O 0 0.03754676133394241
. O 0 0.02858085185289383

Analysis O 0 0.028839316219091415
of O 0 0.00547045236453414
all O 0 0.004339550156146288
family O 0 0.009141232818365097
members O 0 0.005221205297857523
demonstrated O 0 0.011362838558852673
that O 0 0.004524875432252884
the O 0 0.009171226061880589
missense O 1 0.9964602589607239
mutation O 1 0.9990807771682739
co O 1 0.8026410341262817
- O 0 0.46179983019828796
segregated O 1 0.6071786880493164
with O 0 0.02233509160578251
patients O 1 0.9972962737083435
with O 0 0.08869585394859314
tumors B-Disease 1 0.9996324777603149
or O 0 0.010714991949498653
who O 0 0.004390362650156021
, O 0 0.0031070213299244642
as O 0 0.002753026084974408
a O 0 0.004854274448007345
result O 0 0.008778013288974762
of O 0 0.0051343622617423534
linkage O 1 0.8315255641937256
analysis O 0 0.019031265750527382
had O 0 0.005906696897000074
been O 0 0.004920026753097773
predicted O 0 0.010711094364523888
to O 0 0.004338567610830069
carry O 0 0.012008334510028362
the O 0 0.0137440524995327
predisposing O 1 0.9960057139396667
mutation O 1 0.9966176152229309
. O 0 0.04320888593792915

These O 0 0.015226583927869797
observations O 0 0.018193183466792107
point O 0 0.007623410318046808
to O 0 0.004135000519454479
another O 0 0.007106548175215721
region O 0 0.007226079702377319
of O 0 0.004982061218470335
the O 0 0.010574697516858578
RB1 O 1 0.997445821762085
gene O 1 0.993108868598938
where O 0 0.013400298543274403
mutations O 1 0.9897674918174744
only O 0 0.006172159221023321
modify O 0 0.044100046157836914
the O 0 0.004627129528671503
function O 0 0.012650891207158566
of O 0 0.003441575448960066
the O 0 0.005423593334853649
gene O 1 0.9893640279769897
and O 0 0.00479143438860774
raise O 0 0.010038028471171856
important O 0 0.004966664128005505
questions O 0 0.007476567290723324
for O 0 0.006030941382050514
genetic O 1 0.9971874356269836
counseling O 1 0.7734938859939575
in O 0 0.005783554632216692
families O 0 0.010373114608228207
with O 0 0.00661648903042078
these O 0 0.008108539506793022
distinctive O 1 0.6358872652053833
phenotypes O 1 0.993312418460846
. O 0 0.017207082360982895
. O 0 0.02105037309229374

Maternal B-Disease 1 0.9415680766105652
disomy I-Disease 1 0.8334183096885681
and O 0 0.04226859286427498
Prader B-Disease 1 0.9969491362571716
- I-Disease 1 0.9884090423583984
Willi I-Disease 1 0.9982663989067078
syndrome I-Disease 1 0.9995927214622498
consistent O 0 0.15147770941257477
with O 0 0.020843008533120155
gamete O 1 0.9921351671218872
complementation O 1 0.985885500907898
in O 0 0.009377088397741318
a O 0 0.009909547865390778
case O 0 0.011058029718697071
of O 0 0.010187062434852123
familial O 1 0.9991463422775269
translocation O 1 0.9972423315048218
( O 0 0.01848069578409195
3 O 0 0.013911525718867779
; O 0 0.010168841108679771
15 O 0 0.010827458463609219
) O 0 0.011037253774702549
( O 0 0.016909094527363777
p25 O 1 0.9543717503547668
; O 0 0.019004013389348984
q11 O 0 0.2666577994823456
. O 0 0.010941822081804276
2 O 0 0.016868699342012405
) O 0 0.015982044860720634
. O 0 0.017737170681357384

Maternal B-Disease 1 0.9666866660118103
uniparental I-Disease 1 0.9825226068496704
disomy I-Disease 1 0.900277853012085
( I-Disease 0 0.05350072309374809
UPD I-Disease 1 0.9799998998641968
) I-Disease 0 0.018693286925554276
for I-Disease 0 0.010570883750915527
chromosome I-Disease 1 0.9870800375938416
15 I-Disease 0 0.009266848675906658
is O 0 0.004385741893202066
responsible O 0 0.007210364565253258
for O 0 0.0028358986601233482
an O 0 0.003039964474737644
estimated O 0 0.007581768091768026
30 O 0 0.007085353136062622
% O 0 0.00664215674623847
of O 0 0.005166914779692888
cases O 0 0.04004167765378952
of O 0 0.018400555476546288
Prader B-Disease 1 0.9991434812545776
- I-Disease 1 0.9962936043739319
Willi I-Disease 1 0.9994383454322815
syndrome I-Disease 1 0.9998001456260681
( O 0 0.4273110032081604
PWS B-Disease 1 0.9950779676437378
) O 0 0.038995686918497086
. O 0 0.03250397369265556

We O 0 0.011182817630469799
report O 0 0.009268214926123619
on O 0 0.004720008932054043
an O 0 0.0056899734772741795
unusual O 0 0.01222893688827753
case O 0 0.011672143824398518
of O 0 0.008102635852992535
maternal B-Disease 1 0.9717414975166321
disomy I-Disease 1 0.8741862177848816
15 I-Disease 0 0.01527581736445427
in O 0 0.01060582511126995
PWS B-Disease 1 0.9926329255104065
that O 0 0.00504771014675498
is O 0 0.004126005806028843
most O 0 0.0035119084641337395
consistent O 0 0.009185397066175938
with O 0 0.005186479538679123
adjacent O 0 0.01448325626552105
- O 0 0.027151985093951225
1 O 0 0.008286776952445507
segregation O 0 0.03308221325278282
of O 0 0.004683556035161018
a O 0 0.01234272588044405
paternal O 1 0.9711632132530212
t O 1 0.9578673839569092
( O 0 0.014519822783768177
3 O 0 0.01077660359442234
; O 0 0.008415769785642624
15 O 0 0.008317115716636181
) O 0 0.008592789992690086
( O 0 0.012392336502671242
p25 O 1 0.9621679186820984
; O 0 0.012595097534358501
q11 O 0 0.31753063201904297
. O 0 0.007514492142945528
2 O 0 0.009552864357829094
) O 0 0.007926395162940025
with O 0 0.00797325000166893
simultaneous O 0 0.15251898765563965
maternal O 1 0.9869129657745361
meiotic O 1 0.9936716556549072
nondisjunction O 1 0.9173492193222046
for O 0 0.027048839256167412
chromosome O 1 0.9879705309867859
15 O 0 0.035159505903720856
. O 0 0.02327227033674717

The O 0 0.029298705980181694
patient O 1 0.9562554955482483
( O 0 0.03187372162938118
J O 1 0.9668110013008118
. O 0 0.009401663206517696
B O 0 0.19371071457862854
. O 0 0.005388184916228056
) O 0 0.005971322767436504
, O 0 0.00339343398809433
a O 0 0.006232735235244036
17 O 0 0.011862216517329216
- O 0 0.04917192459106445
year O 0 0.008799415081739426
- O 0 0.059093914926052094
old O 0 0.0175070371478796
white O 0 0.05186283588409424
male O 0 0.38277682662010193
with O 0 0.013355650939047337
PWS B-Disease 1 0.9960197806358337
, O 0 0.005503957159817219
was O 0 0.003951237071305513
found O 0 0.005440684035420418
to O 0 0.0033899652771651745
have O 0 0.0039441888220608234
47 O 0 0.013917730189859867
chromosomes O 1 0.8669334650039673
with O 0 0.007637112867087126
a O 0 0.010135691612958908
supernumerary O 1 0.9170154333114624
, O 0 0.010316957719624043
paternal O 1 0.9239872097969055
der O 0 0.25105127692222595
( O 0 0.01062801480293274
15 O 0 0.007698072120547295
) O 0 0.005831882357597351
consisting O 0 0.005915038287639618
of O 0 0.0027791536413133144
the O 0 0.0037702859845012426
short O 0 0.011450722813606262
arm O 0 0.06668835133314133
and O 0 0.0038303136825561523
the O 0 0.006635943427681923
proximal O 1 0.9916104674339294
long O 0 0.08090560883283615
arm O 0 0.29013973474502563
of O 0 0.011185232549905777
chromosome O 1 0.9950528740882874
15 O 0 0.01572599820792675
, O 0 0.009360059164464474
and O 0 0.012264647521078587
distal O 1 0.9959903359413147
chromosome O 1 0.99755859375
arm O 1 0.836002767086029
3p O 1 0.895024299621582
. O 0 0.03945867344737053

The O 0 0.02824508398771286
t O 1 0.8403969407081604
( O 0 0.01615184172987938
3 O 0 0.011728152632713318
; O 0 0.007489869371056557
15 O 0 0.0062756892293691635
) O 0 0.004389272071421146
was O 0 0.0025808352511376143
present O 0 0.0035675072576850653
in O 0 0.0028559486381709576
the O 0 0.0030171561520546675
balanced O 0 0.012614278122782707
state O 0 0.004496313631534576
in O 0 0.004383244086056948
the O 0 0.006793122738599777
patients O 1 0.9872127175331116
father O 0 0.015346558764576912
and O 0 0.007108442950993776
a O 0 0.017175870016217232
sister O 0 0.06483302265405655
. O 0 0.023161662742495537

Fluorescent O 0 0.48038017749786377
in O 0 0.028627917170524597
situ O 1 0.744194746017456
hybridization O 1 0.6979720592498779
analysis O 0 0.030482474714517593
demonstrated O 0 0.01981857419013977
that O 0 0.00572234345600009
the O 0 0.008669950999319553
PWS B-Disease 1 0.9941585063934326
critical O 0 0.026676032692193985
region O 0 0.012098105624318123
resided O 0 0.016080370172858238
on O 0 0.004977123811841011
the O 0 0.007220919709652662
derivative O 1 0.9550822973251343
chromosome O 1 0.9972339272499084
3 O 0 0.00896550714969635
and O 0 0.002956886077299714
that O 0 0.0022779537830501795
there O 0 0.00242756400257349
was O 0 0.002582281595095992
no O 0 0.0042030285112559795
deletion O 1 0.5811075568199158
of O 0 0.004344538785517216
the O 0 0.007114257663488388
PWS B-Disease 1 0.99642413854599
region O 0 0.010539154522120953
on O 0 0.003933573607355356
the O 0 0.004465194884687662
normal O 0 0.025345390662550926
pair O 0 0.015596129931509495
of O 0 0.006752382963895798
15s O 1 0.5801618099212646
present O 0 0.01639147475361824
in O 0 0.016192331910133362
J O 1 0.9419605731964111
. O 0 0.029999976977705956

B O 0 0.22032447159290314
. O 0 0.05458126217126846

Methylation O 1 0.7381807565689087
analysis O 0 0.04014085978269577
at O 0 0.01449243351817131
exon O 0 0.2946518659591675
alpha O 0 0.03162892535328865
of O 0 0.005553892347961664
the O 0 0.006484692450612783
small O 0 0.014128662645816803
nuclear O 0 0.03255405277013779
ribonucleoprotein O 1 0.974968671798706
- O 0 0.3574334383010864
associated O 0 0.20328716933727264
polypeptide O 1 0.9839856028556824
N O 0 0.3058592677116394
( O 0 0.025337733328342438
SNRPN O 1 0.8769736289978027
) O 0 0.020805008709430695
gene O 1 0.9782431125640869
showed O 0 0.014901518821716309
a O 0 0.010929969139397144
pattern O 0 0.2054365873336792
characteristic O 0 0.03731551021337509
of O 0 0.004204585216939449
only O 0 0.00465294998139143
the O 0 0.007848548702895641
maternal O 1 0.9910934567451477
chromosome O 1 0.9976166486740112
15 O 0 0.026011614128947258
in O 0 0.019781218841671944
J O 1 0.9569599032402039
. O 0 0.02803044021129608

B O 0 0.26136910915374756
. O 0 0.05991240590810776

Maternal B-Disease 1 0.9303745627403259
disomy I-Disease 0 0.38981249928474426
was O 0 0.018569793552160263
confirmed O 0 0.02519521862268448
by O 0 0.018673868849873543
polymerase O 1 0.9703304767608643
chain O 1 0.5622830986976624
reaction O 0 0.10105392336845398
analysis O 0 0.02296561747789383
of O 0 0.010362207889556885
microsatellite O 1 0.974942147731781
repeats O 0 0.060593850910663605
at O 0 0.010143229737877846
the O 0 0.010666168294847012
gamma O 1 0.9057967066764832
- O 1 0.6719028949737549
aminobutyric O 1 0.9767032265663147
acid O 1 0.9929595589637756
receptor O 1 0.9931932091712952
beta3 O 1 0.9621150493621826
subunit O 1 0.9452264904975891
( O 0 0.038946375250816345
GABRB3 O 1 0.8746356964111328
) O 0 0.03609124943614006
locus O 1 0.9606063365936279
. O 0 0.029650170356035233

A O 0 0.04927115514874458
niece O 1 0.5852400064468384
( O 0 0.027078408747911453
B O 0 0.2899758219718933
. O 0 0.00958569347858429
B O 0 0.09325624257326126
. O 0 0.004915830213576555
) O 0 0.005846655927598476
with O 0 0.004302007611840963
45 O 0 0.00871505867689848
chromosomes O 1 0.6028721332550049
and O 0 0.004177373833954334
the O 0 0.005107022821903229
derivative O 0 0.261583149433136
3 O 0 0.00857640616595745
but O 0 0.0037983220536261797
without O 0 0.005140535067766905
the O 0 0.004658062476664782
der O 0 0.06018202379345894
( O 0 0.008920573629438877
15 O 0 0.008389401249587536
) O 0 0.007105660624802113
demonstrated O 0 0.013176511973142624
a O 0 0.011726454831659794
phenotype O 1 0.9977795481681824
consistent O 0 0.01697922684252262
with O 0 0.004927628207951784
that O 0 0.004271897487342358
reported O 0 0.009483643807470798
for O 0 0.006853657308965921
haploinsufficiency O 0 0.43323570489883423
of O 0 0.012078812345862389
distal O 1 0.9850316047668457
3 O 0 0.03764177858829498
p O 0 0.24364283680915833
. O 0 0.026529010385274887

Uniparental B-Disease 1 0.985191822052002
disomy I-Disease 1 0.9097225666046143
associated O 0 0.052258335053920746
with O 0 0.01603490300476551
unbalanced O 0 0.24511681497097015
segregation O 0 0.054719265550374985
of O 0 0.00936398096382618
non O 0 0.04110686853528023
- O 0 0.469264417886734
Robertsonian O 1 0.9622118473052979
translocations O 1 0.9871915578842163
has O 0 0.008201233111321926
been O 0 0.005265478044748306
reported O 0 0.008495640009641647
previously O 0 0.0050160544924438
but O 0 0.0028566669207066298
has O 0 0.0026187344919890165
not O 0 0.001977028790861368
, O 0 0.0018558378797024488
to O 0 0.0020601272117346525
our O 0 0.0037349604535847902
knowledge O 0 0.0058237845078110695
, O 0 0.003257577773183584
been O 0 0.004182517994195223
observed O 0 0.009759854525327682
in O 0 0.00463224807754159
a O 0 0.008098643273115158
case O 0 0.015184469521045685
of O 0 0.012807642109692097
PWS B-Disease 1 0.9883772730827332
. O 0 0.03502561151981354

Furthermore O 0 0.040305014699697495
, O 0 0.00965429563075304
our O 0 0.007479897700250149
findings O 0 0.012860054150223732
are O 0 0.0041903541423380375
best O 0 0.006730667315423489
interpreted O 0 0.011983581818640232
as O 0 0.007367164362221956
true O 0 0.025072043761610985
gamete O 1 0.9916327595710754
complementation O 1 0.9958289265632629
resulting O 1 0.6051992774009705
in O 0 0.02091248147189617
maternal B-Disease 1 0.9876819252967834
UPD I-Disease 1 0.9863794445991516
15 I-Disease 0 0.04153984785079956
and O 0 0.030645735561847687
PWS B-Disease 1 0.9792085886001587

Schwartz B-Disease 1 0.8374295234680176
- I-Disease 1 0.8949461579322815
Jampel I-Disease 1 0.9896321296691895
syndrome I-Disease 1 0.9992581009864807
type I-Disease 0 0.4369954466819763
2 I-Disease 0 0.023279212415218353
and O 0 0.015168783254921436
Stuve B-Disease 1 0.9811846613883972
- I-Disease 1 0.9867026805877686
Wiedemann I-Disease 1 0.9986716508865356
syndrome I-Disease 1 0.9997202754020691
: O 0 0.01662266254425049
a O 0 0.010051011107861996
case O 0 0.012148577719926834
for O 0 0.007552360650151968
" O 0 0.012623081915080547
lumping O 0 0.18242719769477844
" O 0 0.021381285041570663
. O 0 0.022894926369190216

Recent O 0 0.034351203590631485
studies O 0 0.025838801637291908
demonstrated O 0 0.016927476972341537
the O 0 0.005053829867392778
existence O 0 0.009569517336785793
of O 0 0.004618222359567881
a O 0 0.010358748026192188
genetically O 1 0.9452040791511536
distinct O 0 0.09418541193008423
, O 0 0.00641685351729393
usually O 0 0.010430147871375084
lethal O 1 0.5751715302467346
form O 0 0.014428257010877132
of O 0 0.005673449020832777
the O 0 0.009999909438192844
Schwartz B-Disease 1 0.9483329653739929
- I-Disease 1 0.9787741303443909
Jampel I-Disease 1 0.9973606467247009
syndrome I-Disease 1 0.9998249411582947
( O 1 0.52180016040802
SJS B-Disease 1 0.9976798892021179
) O 0 0.017201615497469902
of O 0 0.011706274002790451
myotonia B-Disease 1 0.997642457485199
and O 0 0.02212570235133171
skeletal B-Disease 1 0.9989849925041199
dysplasia I-Disease 1 0.9994329810142517
, O 0 0.009772209450602531
which O 0 0.006034949794411659
we O 0 0.006290512625128031
called O 0 0.040936265140771866
SJS B-Disease 1 0.9976128339767456
type I-Disease 0 0.4323740005493164
2 I-Disease 0 0.02425154112279415
. O 0 0.020929725840687752

This O 0 0.03312956914305687
disorder O 1 0.9948154091835022
is O 0 0.01170266605913639
reminiscent O 0 0.03266196697950363
of O 0 0.006480890791863203
another O 0 0.01292230375111103
rare O 0 0.2229158878326416
condition O 0 0.291170597076416
, O 0 0.00708829564973712
the O 0 0.010837722569704056
Stuve B-Disease 1 0.9924851059913635
- I-Disease 1 0.9934043288230896
Wiedemann I-Disease 1 0.9986942410469055
syndrome I-Disease 1 0.9998121857643127
( O 0 0.12169788777828217
SWS B-Disease 1 0.9890972375869751
) O 0 0.012696238234639168
, O 0 0.0051915813237428665
which O 0 0.004627778194844723
comprises O 0 0.011500752530992031
campomelia B-Disease 0 0.4265044331550598
at O 0 0.01164642721414566
birth O 1 0.613829493522644
with O 0 0.04487915709614754
skeletal B-Disease 1 0.9990517497062683
dysplasia I-Disease 1 0.9996719360351562
, O 0 0.021196115761995316
contractures B-Disease 1 0.9931782484054565
, O 0 0.008593818172812462
and O 0 0.006763735320419073
early B-Disease 0 0.0162536408752203
death I-Disease 0 0.04397236928343773
. O 0 0.022601479664444923

To O 0 0.012334665283560753
test O 0 0.01901744119822979
for O 0 0.008069155737757683
possible O 0 0.0165668036788702
nosologic O 1 0.6163524389266968
identity O 0 0.026217520236968994
between O 0 0.009191843681037426
these O 0 0.010049896314740181
disorders O 1 0.9988613128662109
, O 0 0.004880489315837622
we O 0 0.0027492858935147524
reviewed O 0 0.006038142368197441
the O 0 0.0026250588707625866
literature O 0 0.006172175519168377
and O 0 0.002669939072802663
obtained O 0 0.005672389641404152
a O 0 0.005185214336961508
follow O 0 0.007749590557068586
- O 0 0.011481004767119884
up O 0 0.003231695154681802
of O 0 0.002142582554370165
the O 0 0.0025280816480517387
only O 0 0.0027530088555067778
two O 0 0.004957679659128189
surviving O 1 0.6319519281387329
patients O 1 0.9891799688339233
, O 0 0.00526970811188221
one O 0 0.005269413348287344
with O 0 0.014649619348347187
SJS B-Disease 1 0.9986910223960876
type I-Disease 0 0.38035398721694946
2 I-Disease 0 0.009787831455469131
at O 0 0.004936066921800375
age O 0 0.007956701330840588
10 O 0 0.0058906106278300285
years O 0 0.004663530737161636
and O 0 0.003367161378264427
another O 0 0.007591686677187681
with O 0 0.01040402241051197
SWS B-Disease 1 0.9903462529182434
at O 0 0.010414112359285355
age O 0 0.016512451693415642
7 O 0 0.016117073595523834
years O 0 0.015548473224043846
. O 0 0.018293030560016632

Patients O 1 0.9664258360862732
reported O 0 0.02853013202548027
as O 0 0.011084855534136295
having O 0 0.01776682212948799
either O 0 0.09729133546352386
neonatal O 1 0.9993993043899536
SJS B-Disease 1 0.9979045391082764
or O 0 0.03370833769440651
SWS B-Disease 1 0.9730254411697388
presented O 0 0.013180078938603401
a O 0 0.009918692521750927
combination O 0 0.06185946613550186
of O 0 0.00593239301815629
a O 0 0.01747528463602066
severe O 1 0.9922608733177185
, O 0 0.07299110293388367
prenatal O 1 0.9994710087776184
- O 1 0.9966675639152527
onset O 1 0.9997653365135193
neuromuscular B-Disease 1 0.9998594522476196
disorder I-Disease 1 0.9996248483657837
( O 0 0.14783602952957153
with O 0 0.27768754959106445
congenital B-Disease 1 0.9998959302902222
joint I-Disease 1 0.9715904593467712
contractures I-Disease 1 0.9987186193466187
, O 0 0.05839904397726059
respiratory O 1 0.9994586110115051
and O 0 0.010662597604095936
feeding O 1 0.7726506590843201
difficulties O 0 0.10883256047964096
, O 0 0.007475010585039854
tendency O 0 0.42606619000434875
to O 0 0.009080380201339722
hyperthermia B-Disease 1 0.9971977472305298
, O 0 0.007819699123501778
and O 0 0.005778955761343241
frequent O 0 0.11026468127965927
death O 0 0.05391695722937584
in O 0 0.01026107743382454
infancy O 1 0.9099382758140564
) O 0 0.01214994490146637
with O 0 0.007345912978053093
a O 0 0.011865627020597458
distinct O 0 0.285859078168869
campomelic B-Disease 1 0.9738204479217529
- I-Disease 1 0.936338484287262
metaphyseal I-Disease 1 0.9870622754096985
skeletal I-Disease 1 0.997713565826416
dysplasia I-Disease 1 0.998798131942749
. O 0 0.05798257142305374

The O 0 0.0161159485578537
similarity O 0 0.03127632662653923
of O 0 0.00675821490585804
the O 0 0.007877206429839134
clinical O 1 0.935543417930603
and O 0 0.008145562373101711
radiographic O 1 0.9559897184371948
findings O 0 0.0225184578448534
is O 0 0.005531535483896732
so O 0 0.005474305711686611
extensive O 0 0.012358242645859718
that O 0 0.004826569464057684
these O 0 0.00955247599631548
disorders O 1 0.9990629553794861
appear O 0 0.010734347626566887
to O 0 0.003981186542659998
be O 0 0.003590329084545374
a O 0 0.0075577739626169205
single O 0 0.01622765325009823
entity O 0 0.06943084299564362
. O 0 0.02330198511481285

The O 0 0.017422154545783997
follow O 0 0.0200683381408453
- O 0 0.02228083647787571
up O 0 0.0074703386053442955
observation O 0 0.012638235464692116
of O 0 0.00374859431758523
an O 0 0.004530209582298994
identical O 0 0.016765844076871872
and O 0 0.004504529293626547
unique O 0 0.011470760218799114
pattern O 0 0.21029357612133026
of O 0 0.009933599270880222
progressive O 1 0.990760087966919
bone B-Disease 1 0.9997197985649109
dysplasia I-Disease 1 0.999626636505127
in O 0 0.008050857111811638
the O 0 0.0061021409928798676
two O 0 0.009098824113607407
patients O 1 0.9936228394508362
( O 0 0.010710412636399269
one O 0 0.006728926673531532
with O 0 0.020648280158638954
SJS B-Disease 1 0.9990655779838562
type I-Disease 0 0.3876642882823944
2 I-Disease 0 0.009265097789466381
, O 0 0.0039435443468391895
one O 0 0.004276788793504238
with O 0 0.008733308874070644
SWS B-Disease 1 0.9912227392196655
) O 0 0.012930875644087791
surviving O 0 0.043354254215955734
beyond O 0 0.016398200765252113
infancy O 1 0.7461429834365845
adds O 0 0.020234743133187294
to O 0 0.003517368109896779
the O 0 0.00330720329657197
evidence O 0 0.006175838876515627
in O 0 0.004192591179162264
favor O 0 0.009950162842869759
of O 0 0.006181197706609964
identity O 0 0.04033556953072548
. O 0 0.020869307219982147

The O 0 0.026473086327314377
hypothesis O 0 0.1518680453300476
that O 0 0.01895321160554886
SWS B-Disease 1 0.9737034440040588
and O 0 0.020845230668783188
SJS B-Disease 1 0.9967473745346069
type I-Disease 0 0.10831212997436523
2 I-Disease 0 0.009502330794930458
are O 0 0.003691730322316289
the O 0 0.004960023332387209
same O 0 0.011913729831576347
disorder O 1 0.998769223690033
should O 0 0.005436309613287449
be O 0 0.004244007170200348
testable O 0 0.13301236927509308
by O 0 0.011047388426959515
molecular O 1 0.8758105635643005
methods O 0 0.029123904183506966
. O 0 0.01205237116664648
. O 0 0.015254923142492771

A O 0 0.054472725838422775
mouse O 1 0.8669052720069885
model O 0 0.04695815220475197
of O 0 0.02349700964987278
severe O 1 0.996894121170044
von B-Disease 1 0.9978271126747131
Willebrand I-Disease 1 0.999785840511322
disease I-Disease 1 0.999721348285675
: O 0 0.26170191168785095
defects O 1 0.9977306723594666
in O 0 0.03598317131400108
hemostasis O 1 0.9966625571250916
and O 0 0.05559944361448288
thrombosis B-Disease 1 0.9982635378837585
. O 0 0.049217112362384796

von B-Disease 1 0.9543201923370361
Willebrand I-Disease 1 0.9962639212608337
factor I-Disease 1 0.8889636993408203
( I-Disease 0 0.17589257657527924
vWf I-Disease 1 0.9956722259521484
) I-Disease 1 0.7594525218009949
deficiency I-Disease 1 0.9997937083244324
causes O 1 0.9981899857521057
severe O 1 0.9977732300758362
von B-Disease 1 0.997114896774292
Willebrand I-Disease 1 0.9996975660324097
disease I-Disease 1 0.9995748400688171
in O 0 0.039229195564985275
humans O 1 0.9477422833442688
. O 0 0.03417739272117615

We O 0 0.015721451491117477
generated O 0 0.02288125641644001
a O 0 0.01635804958641529
mouse O 1 0.9225146174430847
model O 0 0.0217131320387125
for O 0 0.008170927874743938
this O 0 0.010622821748256683
disease O 1 0.9984514713287354
by O 0 0.014269714243710041
using O 0 0.0354401096701622
gene O 1 0.9869388341903687
targeting O 0 0.11452853679656982
. O 0 0.029571183025836945

vWf B-Disease 1 0.9768280982971191
- I-Disease 1 0.9030988812446594
deficient I-Disease 1 0.9883525967597961
mice O 1 0.9901915788650513
appeared O 0 0.03106449358165264
normal O 0 0.0726398229598999
at O 0 0.01253979466855526
birth O 0 0.3602035939693451
; O 0 0.007707264274358749
they O 0 0.0032870450522750616
were O 0 0.004091120790690184
viable O 0 0.053045809268951416
and O 0 0.009769759140908718
fertile O 0 0.31443098187446594
. O 0 0.02828766405582428

Neither O 0 0.1046229749917984
vWf O 1 0.9329048991203308
nor O 0 0.08512473106384277
vWf O 1 0.9568246603012085
propolypeptide O 1 0.8768444657325745
( O 0 0.0635695680975914
von B-Disease 1 0.9660342931747437
Willebrand I-Disease 1 0.9991891980171204
antigen O 1 0.9983065128326416
II O 0 0.15819476544857025
) O 0 0.010533935390412807
were O 0 0.004990715999156237
detectable O 1 0.7206330299377441
in O 0 0.008955552242696285
plasma O 1 0.917733371257782
, O 0 0.012041865848004818
platelets O 1 0.9960079193115234
, O 0 0.010106931440532207
or O 0 0.04064088314771652
endothelial O 1 0.9987218976020813
cells O 1 0.9787039756774902
of O 0 0.010749075561761856
the O 0 0.01836637407541275
homozygous O 1 0.9933218359947205
mutant O 1 0.9922611117362976
mice O 1 0.9916456341743469
. O 0 0.046538375318050385

The O 0 0.039844810962677
mutant O 1 0.9771329164505005
mice O 1 0.9901592135429382
exhibited O 0 0.3424324691295624
defects O 1 0.99454665184021
in O 0 0.018101928755640984
hemostasis O 1 0.9920141100883484
with O 0 0.012060719542205334
a O 0 0.01583133637905121
highly O 0 0.2447790652513504
prolonged O 1 0.9919719696044922
bleeding O 1 0.9972387552261353
time O 0 0.012865557335317135
and O 0 0.009285643696784973
spontaneous O 1 0.9643138647079468
bleeding O 1 0.99594646692276
events O 0 0.01507614552974701
in O 0 0.00755234993994236
approximately O 0 0.010255510918796062
10 O 0 0.009113364852964878
% O 0 0.012503745965659618
of O 0 0.011670272797346115
neonates O 1 0.9789141416549683
. O 0 0.029713084921240807

As O 0 0.011474025435745716
in O 0 0.007521956693381071
the O 0 0.007687073200941086
human O 1 0.6572834849357605
disease O 1 0.9991284012794495
, O 0 0.0067947120405733585
the O 0 0.006064657587558031
factor O 1 0.5269113779067993
VIII O 1 0.7188771963119507
level O 0 0.009645952843129635
in O 0 0.004741361364722252
these O 0 0.006264512427151203
mice O 1 0.9937166571617126
was O 0 0.0058206492103636265
reduced O 0 0.015321827493607998
strongly O 0 0.0070262192748487
as O 0 0.003453116398304701
a O 0 0.005299478769302368
result O 0 0.007354524452239275
of O 0 0.00311862351372838
the O 0 0.003433236852288246
lack O 0 0.008724670857191086
of O 0 0.004656060133129358
protection O 0 0.01966574601829052
provided O 0 0.013717384077608585
by O 0 0.018248310312628746
vWf O 1 0.9704294800758362
. O 0 0.030159471556544304

Defective O 1 0.9848768711090088
thrombosis B-Disease 1 0.997124969959259
in O 0 0.035134296864271164
mutant O 1 0.9907249808311462
mice O 1 0.9939733147621155
was O 0 0.009904785081744194
also O 0 0.005552633665502071
evident O 0 0.01122252643108368
in O 0 0.004190479405224323
an O 0 0.005119482055306435
in O 0 0.00699013564735651
vivo O 1 0.985934317111969
model O 0 0.07140322774648666
of O 0 0.022231578826904297
vascular B-Disease 1 0.9996287822723389
injury I-Disease 1 0.9845943450927734
. O 0 0.03300671651959419

In O 0 0.013903887942433357
this O 0 0.0071532693691551685
model O 0 0.013359534554183483
, O 0 0.006040272768586874
the O 0 0.008211021311581135
exteriorized O 1 0.8229432106018066
mesentery O 1 0.9694828987121582
was O 0 0.014388791285455227
superfused O 1 0.6463298797607422
with O 0 0.015646498650312424
ferric O 1 0.9846028089523315
chloride O 1 0.8883302211761475
and O 0 0.006974358577281237
the O 0 0.0073512461967766285
accumulation O 0 0.44464433193206787
of O 0 0.011909830383956432
fluorescently O 1 0.9672330021858215
labeled O 1 0.7028592824935913
platelets O 1 0.9913193583488464
was O 0 0.01494902279227972
observed O 0 0.028167538344860077
by O 0 0.015968957915902138
intravital O 1 0.7456678748130798
microscopy O 0 0.3461194634437561
. O 0 0.03362664580345154

We O 0 0.01376969926059246
conclude O 0 0.021652765572071075
that O 0 0.006518888287246227
these O 0 0.00830117892473936
mice O 1 0.9896016716957092
very O 0 0.016395747661590576
closely O 0 0.06685937941074371
mimic O 1 0.9941808581352234
severe O 1 0.995597779750824
human O 1 0.981181800365448
von B-Disease 1 0.9981372356414795
Willebrand I-Disease 1 0.999817430973053
disease I-Disease 1 0.9995105266571045
and O 0 0.006818275898694992
will O 0 0.003375908127054572
be O 0 0.002702057361602783
very O 0 0.0040094745345413685
useful O 0 0.00684523256495595
for O 0 0.0032259051222354174
investigating O 0 0.007702160160988569
the O 0 0.004448282532393932
role O 0 0.010377378202974796
of O 0 0.0072262343019247055
vWf O 1 0.9872094392776489
in O 0 0.010606875643134117
normal O 1 0.5749667286872864
physiology O 1 0.9645717740058899
and O 0 0.008132736198604107
in O 0 0.01749504543840885
disease O 1 0.9992232322692871
models O 0 0.12046609818935394
. O 0 0.014812528155744076
. O 0 0.01999785751104355

Oral O 1 0.8110999464988708
contraceptives O 1 0.80245041847229
and O 0 0.009612375870347023
the O 0 0.010880767367780209
risk O 1 0.9580693244934082
of O 0 0.04966402426362038
hereditary B-Disease 1 0.9996389150619507
ovarian I-Disease 1 0.999937891960144
cancer I-Disease 1 0.9996410608291626
. O 0 0.05841168016195297

Hereditary B-Disease 1 0.9982548356056213
Ovarian I-Disease 1 0.9998062252998352
Cancer I-Disease 1 0.9995601773262024
Clinical O 1 0.9928804039955139
Study O 0 0.17309944331645966
Group O 0 0.038259197026491165
. O 0 0.026788990944623947

BACKGROUND O 0 0.054933156818151474
Women O 0 0.023930823430418968
with O 0 0.0157264843583107
mutations O 1 0.9937350153923035
in O 0 0.008014843799173832
either O 0 0.009704846888780594
the O 0 0.010576245374977589
BRCA1 O 1 0.9985536932945251
or O 0 0.02049727737903595
the O 0 0.017120227217674255
BRCA2 O 1 0.9995396137237549
gene O 1 0.9934172630310059
have O 0 0.00872048083692789
a O 0 0.011741436086595058
high O 0 0.020512990653514862
lifetime O 1 0.6303929686546326
risk O 1 0.98237544298172
of O 0 0.16706039011478424
ovarian B-Disease 1 0.9998828172683716
cancer I-Disease 1 0.9994423985481262
. O 0 0.06748615205287933

Oral O 1 0.9063723087310791
contraceptives O 1 0.9601317644119263
protect O 0 0.39645010232925415
against O 0 0.46463313698768616
ovarian B-Disease 1 0.9999394416809082
cancer I-Disease 1 0.999823272228241
in O 0 0.008931274525821209
general O 0 0.006129999179393053
, O 0 0.003515974385663867
but O 0 0.00253501464612782
it O 0 0.0022287205792963505
is O 0 0.0026055697817355394
not O 0 0.0024474370293319225
known O 0 0.005079497583210468
whether O 0 0.003904847428202629
they O 0 0.0025571074802428484
also O 0 0.0034098010510206223
protect O 0 0.014812965877354145
against O 0 0.012420597486197948
hereditary B-Disease 1 0.9899253845214844
forms I-Disease 0 0.41597193479537964
of I-Disease 0 0.31747889518737793
ovarian I-Disease 1 0.9999135732650757
cancer I-Disease 1 0.9995262622833252
. O 0 0.06297101825475693

METHODS O 0 0.045101579278707504
We O 0 0.01424721535295248
enrolled O 0 0.03397855535149574
207 O 0 0.15475532412528992
women O 0 0.032408442348241806
with O 0 0.15278270840644836
hereditary B-Disease 1 0.9995145797729492
ovarian I-Disease 1 0.9999620914459229
cancer I-Disease 1 0.9997424483299255
and O 0 0.008031200617551804
161 O 0 0.01894453540444374
of O 0 0.004118715412914753
their O 0 0.00444797845557332
sisters O 0 0.015888098627328873
as O 0 0.0044852434657514095
controls O 0 0.013678162358701229
in O 0 0.00450090691447258
a O 0 0.008348818868398666
case O 0 0.017414556816220284
- O 0 0.14127753674983978
control O 0 0.04499895125627518
study O 0 0.03565400093793869
. O 0 0.020200058817863464

All O 0 0.012638818472623825
the O 0 0.01222451962530613
patients O 1 0.870530903339386
carried O 0 0.014785269275307655
a O 0 0.023248620331287384
pathogenic O 1 0.9970101118087769
mutation O 1 0.997543215751648
in O 0 0.014189151115715504
either O 0 0.04722817614674568
BRCA1 O 1 0.9988253712654114
( O 0 0.025278709828853607
179 O 0 0.058983687311410904
women O 0 0.02589036524295807
) O 0 0.017713509500026703
or O 0 0.03017338179051876
BRCA2 O 1 0.9987311959266663
( O 0 0.022124649956822395
28 O 0 0.018660610541701317
women O 0 0.022377874702215195
) O 0 0.017796853557229042
. O 0 0.017632830888032913

The O 0 0.014633500948548317
control O 0 0.01992860995233059
women O 0 0.010517650283873081
were O 0 0.00426498893648386
enrolled O 0 0.015250210650265217
regardless O 0 0.00897374376654625
of O 0 0.0034593017771840096
whether O 0 0.004847327712923288
or O 0 0.004546486772596836
not O 0 0.003324733814224601
they O 0 0.003305107355117798
had O 0 0.006824296899139881
either O 0 0.018993554636836052
mutation O 1 0.9952172040939331
. O 0 0.027251355350017548

Lifetime O 0 0.08878237009048462
histories O 0 0.058157093822956085
of O 0 0.013285083696246147
oral O 1 0.783765435218811
- O 1 0.6646029949188232
contraceptive O 1 0.9905489087104797
use O 0 0.009969930164515972
were O 0 0.003903954057022929
obtained O 0 0.006811404600739479
by O 0 0.004666096530854702
interview O 0 0.008038436993956566
or O 0 0.004661140963435173
by O 0 0.003957519773393869
written O 0 0.0051270462572574615
questionnaire O 0 0.02043025754392147
and O 0 0.0031421026214957237
were O 0 0.0023469228763133287
compared O 0 0.010166273452341557
between O 0 0.01072537899017334
patients O 1 0.9881659746170044
and O 0 0.004400587175041437
control O 0 0.018566524609923363
women O 0 0.010294245555996895
, O 0 0.004356431774795055
after O 0 0.006995833944529295
adjustment O 0 0.02496263012290001
for O 0 0.004462944809347391
year O 0 0.005741717293858528
of O 0 0.0052696228958666325
birth O 0 0.3805607557296753
and O 0 0.009731819853186607
parity O 0 0.24577991664409637
. O 0 0.022352194413542747

RESULTS O 0 0.04378504678606987
The O 0 0.015508606098592281
adjusted O 0 0.03488717973232269
odds O 0 0.08345690369606018
ratio O 0 0.48570355772972107
for O 0 0.32443952560424805
ovarian B-Disease 1 0.9999539852142334
cancer I-Disease 1 0.9998568296432495
associated O 0 0.09043180197477341
with O 0 0.0068519460037350655
any O 0 0.005028679035604
past O 0 0.006251914892345667
use O 0 0.008040224201977253
of O 0 0.007186945993453264
oral O 1 0.8641377091407776
contraceptives O 1 0.9615411162376404
was O 0 0.013314650394022465
0 O 0 0.033691421151161194
. O 0 0.02417096309363842

5 O 0 0.0379021055996418
( O 0 0.019222985953092575
95 O 0 0.018024923279881477
percent O 0 0.013302108272910118
confidence O 0 0.01554639171808958
interval O 0 0.028897369280457497
, O 0 0.0059258765541017056
0 O 0 0.011765106581151485
. O 0 0.00526838842779398
3 O 0 0.007133812643587589
to O 0 0.004074158612638712
0 O 0 0.013187503442168236
. O 0 0.0074671790935099125
8 O 0 0.013414799235761166
) O 0 0.01605326123535633
. O 0 0.015749426558613777

The O 0 0.027436506003141403
risk O 1 0.8260075449943542
decreased O 0 0.08112980425357819
with O 0 0.008702186867594719
increasing O 0 0.01713641732931137
duration O 0 0.021039871498942375
of O 0 0.004702670965343714
use O 0 0.008258703164756298
( O 0 0.010257515124976635
P O 0 0.08304475247859955
for O 0 0.0067891343496739864
trend O 0 0.02958545833826065
, O 0 0.008290653117001057
< O 1 0.810005247592926
0 O 0 0.017905887216329575
. O 0 0.0079032676294446
001 O 1 0.5529794096946716
) O 0 0.007518226746469736
; O 0 0.004848811775445938
use O 0 0.0044569955207407475
for O 0 0.003071042476221919
six O 0 0.004348822869360447
or O 0 0.004076908342540264
more O 0 0.0034949767868965864
years O 0 0.004161534830927849
was O 0 0.003571055131033063
associated O 0 0.008972249925136566
with O 0 0.004113789647817612
a O 0 0.005414377432316542
60 O 0 0.009002547711133957
percent O 0 0.013285459019243717
reduction O 0 0.2396995723247528
in O 0 0.014334320090711117
risk O 1 0.8529012799263
. O 0 0.02540046162903309

Oral O 1 0.8649756908416748
- O 1 0.62721848487854
contraceptive O 1 0.9824414849281311
use O 0 0.024228524416685104
protected O 0 0.10073675960302353
against O 0 0.2917305827140808
ovarian B-Disease 1 0.9999363422393799
cancer I-Disease 1 0.9996905326843262
both O 0 0.009256172925233841
for O 0 0.006538862362504005
carriers O 0 0.09062688797712326
of O 0 0.0070342146791517735
the O 0 0.016049768775701523
BRCA1 O 1 0.9997735619544983
mutation O 1 0.9990066885948181
( O 0 0.024701068177819252
odds O 0 0.18327763676643372
ratio O 0 0.09822648018598557
, O 0 0.0067595080472528934
0 O 0 0.012039953842759132
. O 0 0.004801946226507425
5 O 0 0.007795657962560654
; O 0 0.005570096429437399
95 O 0 0.008055504411458969
percent O 0 0.00907669123262167
confidence O 0 0.013196677900850773
interval O 0 0.03794414550065994
, O 0 0.005514522548764944
0 O 0 0.010364977642893791
. O 0 0.0041123987175524235
3 O 0 0.0057834722101688385
to O 0 0.0033916363026946783
0 O 0 0.009406028315424919
. O 0 0.00390663044527173
9 O 0 0.006507758516818285
) O 0 0.004340584389865398
and O 0 0.00268212310038507
for O 0 0.0037102443166077137
carriers O 0 0.027633221819996834
of O 0 0.0054936460219323635
the O 0 0.013606056571006775
BRCA2 O 1 0.9997381567955017
mutation O 1 0.9991732239723206
( O 0 0.02371121756732464
odds O 0 0.14659249782562256
ratio O 0 0.07413008064031601
, O 0 0.005335901398211718
0 O 0 0.012062343768775463
. O 0 0.005014408379793167
4 O 0 0.008027037605643272
; O 0 0.006233358755707741
95 O 0 0.009113693609833717
percent O 0 0.00803769938647747
confidence O 0 0.011468878015875816
interval O 0 0.03255981206893921
, O 0 0.004997257608920336
0 O 0 0.009063191711902618
. O 0 0.003406618721783161
2 O 0 0.0044335247948765755
to O 0 0.0031690325122326612
1 O 0 0.006556318141520023
. O 0 0.005336235277354717
1 O 0 0.010669384151697159
) O 0 0.012264948338270187
. O 0 0.014486502856016159

CONCLUSIONS O 0 0.08225376904010773
Oral O 1 0.789466917514801
- O 1 0.6972105503082275
contraceptive O 1 0.9919165968894958
use O 0 0.017008747905492783
may O 0 0.014728600159287453
reduce O 0 0.039609044790267944
the O 0 0.008558835834264755
risk O 1 0.983205258846283
of O 0 0.16084052622318268
ovarian B-Disease 1 0.9999685287475586
cancer I-Disease 1 0.9998094439506531
in O 0 0.012431744486093521
women O 0 0.038202498108148575
with O 0 0.03621239215135574
pathogenic O 1 0.9981252551078796
mutations O 1 0.9978590607643127
in O 0 0.015954172238707542
the O 0 0.021156875416636467
BRCA1 O 1 0.999187171459198
or O 1 0.7026126384735107
BRCA2 O 1 0.9988722205162048
gene O 1 0.9927046895027161

A O 0 0.040325891226530075
Japanese O 0 0.027583157643675804
family O 0 0.03179032355546951
with O 0 0.01947414129972458
adrenoleukodystrophy B-Disease 1 0.9936524629592896
with O 0 0.014675192534923553
a O 0 0.018811024725437164
codon O 1 0.8762069940567017
291 O 1 0.541483998298645
deletion O 1 0.9694002270698547
: O 0 0.016280438750982285
a O 0 0.015747763216495514
clinical O 1 0.9625220894813538
, O 0 0.009671851061284542
biochemical O 1 0.9655854105949402
, O 0 0.009535690769553185
pathological O 1 0.942158043384552
, O 0 0.008422601968050003
and O 0 0.008694830350577831
genetic O 1 0.9889344573020935
report O 0 0.020744947716593742
. O 0 0.02123628929257393

We O 0 0.013221141882240772
report O 0 0.011637483723461628
a O 0 0.010481472127139568
Japanese O 0 0.013712023384869099
family O 0 0.02516762539744377
with O 0 0.029067277908325195
adrenoleukodystrophy B-Disease 1 0.9990853071212769
( O 0 0.435966432094574
ALD B-Disease 1 0.9988464117050171
) O 0 0.012160910293459892
with O 0 0.005580798257142305
a O 0 0.007490957621484995
three O 0 0.006319566164165735
base O 0 0.011043637059628963
pair O 0 0.029347022995352745
deletion O 1 0.9827828407287598
( O 0 0.02290448173880577
delGAG O 1 0.6914881467819214
291 O 0 0.17498838901519775
) O 0 0.015266811475157738
in O 0 0.011017128825187683
the O 0 0.0208058413118124
ALD B-Disease 1 0.9987804293632507
gene O 1 0.9931501746177673
. O 0 0.036310672760009766

A O 0 0.029398411512374878
variety O 0 0.022808587178587914
of O 0 0.01051629614084959
phenotypes O 1 0.9369986653327942
were O 0 0.007293833419680595
observed O 0 0.01812571845948696
within O 0 0.008646044880151749
this O 0 0.007232332136482
family O 0 0.023423394188284874
. O 0 0.02014954574406147

While O 0 0.019844017922878265
the O 0 0.01398027129471302
proband O 1 0.7693338394165039
( O 0 0.026244258508086205
patient O 1 0.9580091834068298
1 O 0 0.011789465323090553
) O 0 0.0065426514483988285
was O 0 0.003774335840716958
classified O 0 0.008904420770704746
as O 0 0.0035263914614915848
having O 0 0.006083910819143057
a O 0 0.008274558931589127
rare O 0 0.058658696711063385
intermediate O 0 0.1353054791688919
type O 0 0.07639241218566895
of O 0 0.009016858413815498
adult O 1 0.8192060589790344
cerebral O 1 0.9973313808441162
and O 0 0.01915251463651657
cerebello O 1 0.9910633563995361
- O 1 0.985535740852356
brain O 1 0.9990277290344238
stem O 1 0.9913043975830078
forms O 0 0.03172867372632027
, O 0 0.005391837563365698
his O 0 0.006583319511264563
younger O 0 0.23725685477256775
brother O 0 0.13322697579860687
( O 0 0.030150769278407097
patient O 1 0.9464700818061829
2 O 0 0.01244417205452919
) O 0 0.009158005937933922
and O 0 0.0058188061229884624
nephew O 0 0.4348762035369873
( O 0 0.026244880631566048
patient O 1 0.9446471929550171
3 O 0 0.013696703128516674
) O 0 0.009141846559941769
had O 0 0.008197370916604996
a O 0 0.018459854647517204
childhood O 1 0.9826996326446533
ALD B-Disease 1 0.9982855916023254
type O 1 0.7656452059745789
. O 0 0.03602727875113487

Another O 0 0.045333538204431534
nephew O 0 0.39677923917770386
( O 0 0.030559122562408447
patient O 1 0.883211076259613
4 O 0 0.01606782153248787
) O 0 0.009697050787508488
of O 0 0.005406463984400034
patient O 1 0.8638426065444946
1 O 0 0.008779947645962238
was O 0 0.005190993659198284
classified O 0 0.013074660673737526
as O 0 0.0054800440557301044
having O 0 0.009847786277532578
an O 0 0.010246657766401768
adolescent O 1 0.9778347015380859
form O 0 0.06812302023172379
. O 0 0.02502419427037239

The O 0 0.022708507254719734
tau O 0 0.22749920189380646
level O 0 0.01407229620963335
in O 0 0.008837592788040638
the O 0 0.011738303117454052
cerebrospinal O 1 0.9982397556304932
fluid O 1 0.9908983111381531
( O 0 0.08366353064775467
CSF O 1 0.9956380724906921
) O 0 0.013396177440881729
in O 0 0.008053941652178764
patient O 1 0.916118860244751
1 O 0 0.007828978821635246
was O 0 0.0035395524464547634
as O 0 0.0032148470636457205
high O 0 0.004907109308987856
as O 0 0.0034379337448626757
that O 0 0.003797776997089386
of O 0 0.0074335746467113495
patients O 1 0.9973467588424683
with O 1 0.7293793559074402
Alzheimers B-Disease 1 0.9999059438705444
disease I-Disease 1 0.9997777342796326
( O 0 0.08722426742315292
AD B-Disease 0 0.28828099370002747
) O 0 0.024784620851278305
. O 0 0.02173835039138794

His O 0 0.05467326566576958
brain O 1 0.9850671291351318
magnetic O 0 0.16843028366565704
resonance O 1 0.5721076130867004
image O 0 0.15406465530395508
( O 0 0.02909213677048683
MRI O 1 0.9414696097373962
) O 0 0.014875159598886967
showed O 0 0.021491805091500282
abnormalities B-Disease 1 0.9962926506996155
in I-Disease 0 0.007442699279636145
the I-Disease 0 0.008534681983292103
bilateral I-Disease 0 0.1329268366098404
cerebellar I-Disease 1 0.9972844123840332
hemispheres I-Disease 1 0.9527515769004822
and O 0 0.03564562276005745
brain O 1 0.9993166923522949
stem O 1 0.987604022026062
, O 0 0.0054513015784323215
but O 0 0.0037360857240855694
not O 0 0.002839028835296631
in O 0 0.003701107809320092
the O 0 0.006450112909078598
cerebral O 1 0.9984561204910278
white O 0 0.06859346479177475
matter O 0 0.007955733686685562
, O 0 0.003859474789351225
where O 0 0.0034103617072105408
marked O 0 0.009426195174455643
reductions O 0 0.016616739332675934
of O 0 0.004832454491406679
the O 0 0.009915153495967388
cerebral O 1 0.9990119934082031
blood O 1 0.992728590965271
flow O 0 0.30371367931365967
and O 0 0.010581830516457558
oxygen O 1 0.966913640499115
metabolism O 1 0.9713577628135681
were O 0 0.005787933245301247
clearly O 0 0.010008221492171288
demonstrated O 0 0.018590303137898445
by O 0 0.014181667938828468
positron O 1 0.991407573223114
emission O 1 0.9233506917953491
tomography O 1 0.9823881983757019
( O 0 0.0373234786093235
PET O 1 0.8036301136016846
) O 0 0.028556806966662407
. O 0 0.02490568533539772

In O 0 0.031373053789138794
patients O 1 0.9571698904037476
2 O 0 0.012463923543691635
and O 0 0.0048626018688082695
3 O 0 0.007335972506552935
, O 0 0.003509421367198229
the O 0 0.004499255213886499
autopsy O 0 0.2871341407299042
findings O 0 0.022500062361359596
showed O 0 0.017975322902202606
massive O 0 0.3502576947212219
demyelination B-Disease 1 0.9947918057441711
of I-Disease 0 0.00750148668885231
the I-Disease 0 0.010500113479793072
cerebral I-Disease 1 0.9981679916381836
white I-Disease 0 0.044549256563186646
matter I-Disease 0 0.008245576173067093
with O 0 0.00518772890791297
sparing O 0 0.10722977668046951
of O 0 0.004444297403097153
the O 0 0.006365566980093718
U O 1 0.5340735912322998
- O 1 0.6935632824897766
fibers O 1 0.9644254446029663
, O 0 0.007061116863042116
compatible O 0 0.02944725565612316
with O 0 0.005563951097428799
the O 0 0.005724262446165085
findings O 0 0.018554043024778366
of O 0 0.014505523256957531
childhood O 1 0.9828729033470154
ALD B-Disease 1 0.9967731833457947
. O 0 0.04815687611699104

Oleic O 1 0.8703497648239136
and O 0 0.03634236380457878
erucic O 1 0.9649211764335632
acids O 1 0.8508455753326416
( O 0 0.023213256150484085
Lorenzos O 0 0.44578996300697327
Oil O 0 0.016245385631918907
) O 0 0.007643490098416805
were O 0 0.003524417756125331
administered O 0 0.018646011129021645
to O 0 0.005147165153175592
patients O 1 0.9846432209014893
1 O 0 0.007499619387090206
and O 0 0.003518364392220974
4 O 0 0.00595077546313405
, O 0 0.003663616022095084
but O 0 0.0036844974383711815
sufficient O 0 0.011491497978568077
effectiveness O 0 0.04927712306380272
was O 0 0.006319650448858738
not O 0 0.006248396821320057
obtained O 0 0.01516253687441349
. O 0 0.018052656203508377

The O 0 0.016484534367918968
findings O 0 0.02111184410750866
in O 0 0.006309214048087597
this O 0 0.004918397404253483
family O 0 0.011961854062974453
suggest O 0 0.012478829361498356
that O 0 0.005288467742502689
delGAG291 O 0 0.295132577419281
is O 0 0.004283288028091192
part O 0 0.003911860752850771
of O 0 0.0032017570920288563
the O 0 0.004348088055849075
cause O 0 0.21244001388549805
of O 0 0.007940261624753475
Japanese O 0 0.04226737841963768
ALD B-Disease 1 0.9979623556137085
with O 0 0.02664218097925186
phenotypic O 1 0.9560104012489319
variations O 0 0.2478259950876236
. O 0 0.029015779495239258

Moreover O 0 0.036547817289829254
, O 0 0.006960027851164341
although O 0 0.005716548766940832
the O 0 0.003314778208732605
scale O 0 0.008727098815143108
of O 0 0.0028849930968135595
the O 0 0.003208056092262268
study O 0 0.009770672768354416
is O 0 0.0036623443011194468
limited O 0 0.005416953936219215
, O 0 0.002452434040606022
there O 0 0.0022104301024228334
is O 0 0.002715734299272299
a O 0 0.004435764625668526
possibility O 0 0.010147735476493835
that O 0 0.004448793828487396
PET O 1 0.7632354497909546
can O 0 0.010198738425970078
detect O 1 0.7460809946060181
an O 0 0.012714875862002373
insidious B-Disease 1 0.994851291179657
lesion I-Disease 1 0.9986347556114197
which O 0 0.006995539180934429
is O 0 0.008919700980186462
undetectable O 1 0.9674369692802429
by O 0 0.011249015107750893
computed O 1 0.5371597409248352
tomogram O 1 0.9726182818412781
( O 0 0.05840591341257095
CT O 1 0.9938005805015564
) O 0 0.015033475123345852
or O 0 0.01259149145334959
MRI O 1 0.9319503307342529
analysis O 0 0.014786518178880215
, O 0 0.002660458441823721
and O 0 0.001858461182564497
that O 0 0.0020709035452455282
the O 0 0.002719220472499728
higher O 0 0.006461536046117544
level O 0 0.006138880271464586
of O 0 0.004507122095674276
tau O 0 0.46890389919281006
reflects O 0 0.013560337945818901
the O 0 0.00548156164586544
process O 0 0.013950291089713573
of O 0 0.013257072307169437
neuronal B-Disease 1 0.9981824159622192
degeneration I-Disease 1 0.9992307424545288
in O 0 0.16759759187698364
ALD B-Disease 1 0.9968626499176025
. O 0 0.05349075794219971

Lorenzos O 0 0.42100971937179565
Oil O 0 0.022574298083782196
should O 0 0.006493041757494211
be O 0 0.0035702763125300407
given O 0 0.004525081254541874
in O 0 0.003921683877706528
the O 0 0.004523860290646553
early O 0 0.011259977705776691
stage O 0 0.037499845027923584
. O 0 0.01259929034858942
. O 0 0.01884022355079651

Nonsense O 0 0.3711061477661133
mutation O 1 0.9735011458396912
in O 0 0.018754106014966965
exon O 0 0.22649548947811127
4 O 0 0.01630553789436817
of O 0 0.008691283874213696
human O 0 0.09453237056732178
complement O 1 0.8322451710700989
C9 O 1 0.9968607425689697
gene O 1 0.9927655458450317
is O 0 0.007630595937371254
the O 0 0.00527459941804409
major O 0 0.011830237694084644
cause O 0 0.1710633635520935
of O 0 0.007857710123062134
Japanese O 0 0.02492467872798443
complement B-Disease 1 0.8809468150138855
C9 I-Disease 1 0.9976853132247925
deficiency I-Disease 1 0.9991807341575623
. O 0 0.04190355911850929

Deficiency B-Disease 1 0.9956444501876831
of I-Disease 0 0.010965756140649319
the I-Disease 0 0.00836396124213934
ninth I-Disease 0 0.020537929609417915
component I-Disease 0 0.025833070278167725
of I-Disease 0 0.005898534785956144
human I-Disease 0 0.035078417509794235
complement I-Disease 0 0.167129248380661
( O 0 0.020837634801864624
C9 O 1 0.9884215593338013
) O 0 0.008762120269238949
is O 0 0.0034808609634637833
the O 0 0.0030857829842716455
most O 0 0.005168177653104067
common O 0 0.31060266494750977
complement B-Disease 1 0.9872424602508545
deficiency I-Disease 1 0.9998615980148315
in O 0 0.0064460807479918
Japan O 0 0.006139195058494806
but O 0 0.0041770837269723415
is O 0 0.003986768424510956
rare O 0 0.015029196627438068
in O 0 0.004487898666411638
other O 0 0.005176975857466459
countries O 0 0.008581483736634254
. O 0 0.01597302034497261

We O 0 0.013109865598380566
studied O 0 0.014191646128892899
the O 0 0.007197943981736898
molecular O 0 0.3320072889328003
basis O 0 0.011085670441389084
of O 0 0.011402986012399197
C9 B-Disease 1 0.9978399276733398
deficiency I-Disease 1 0.9995015859603882
in O 0 0.012287457473576069
four O 0 0.011426830664277077
Japanese O 0 0.061484985053539276
C9 B-Disease 1 0.9983976483345032
- I-Disease 1 0.9896562099456787
deficient I-Disease 1 0.9978814721107483
patients O 1 0.9935609102249146
who O 0 0.01634323224425316
had O 0 0.015300138853490353
suffered O 1 0.899465024471283
from O 0 0.27529656887054443
meningococcal B-Disease 1 0.9996564388275146
meningitis I-Disease 1 0.9990963935852051
. O 0 0.06003618612885475

Direct O 0 0.059266962110996246
sequencing O 0 0.11198247224092484
of O 0 0.0229188222438097
amplified O 0 0.43433451652526855
C9 O 1 0.9740170836448669
cDNA O 1 0.5736375451087952
and O 0 0.01566380262374878
DNA O 1 0.5868839621543884
revealed O 0 0.0229522492736578
a O 0 0.014512716792523861
nonsense O 0 0.07367169857025146
substitution O 0 0.3202262222766876
( O 0 0.025161582976579666
CGA O 0 0.45838645100593567
- O 1 0.6218734979629517
- O 1 0.7500722408294678
> O 1 0.9806545376777649
TGA O 1 0.9812761545181274
) O 0 0.015868352726101875
at O 0 0.008987980894744396
codon O 0 0.2455352395772934
95 O 0 0.01677229069173336
in O 0 0.008902544155716896
exon O 0 0.25874805450439453
4 O 0 0.012520218268036842
in O 0 0.006109254434704781
the O 0 0.006370071321725845
four O 0 0.015050133690237999
C9 B-Disease 1 0.9940953254699707
- I-Disease 1 0.8636137247085571
deficient I-Disease 1 0.9778144955635071
individuals O 0 0.05079694092273712
. O 0 0.02957833930850029

An O 0 0.038922347128391266
allele O 1 0.9789484143257141
- O 0 0.1830708235502243
specific O 0 0.04752592742443085
polymerase O 1 0.9783721566200256
chain O 0 0.47338998317718506
reaction O 0 0.11900391429662704
system O 0 0.014267676509916782
designed O 0 0.010723005048930645
to O 0 0.004950379021465778
detect O 0 0.08551031351089478
exclusively O 0 0.007085812743753195
only O 0 0.0023237948771566153
one O 0 0.0023770062252879143
of O 0 0.002433035522699356
the O 0 0.0035083326511085033
normal O 0 0.03538922965526581
and O 0 0.006186736281961203
mutant O 1 0.9946381449699402
alleles O 1 0.9984367489814758
indicated O 0 0.01459434162825346
that O 0 0.002745317993685603
all O 0 0.00208623637445271
the O 0 0.0031664185225963593
four O 0 0.006627373397350311
patients O 1 0.9763737916946411
were O 0 0.0055116466246545315
homozygous O 1 0.9508686661720276
for O 0 0.005915175192058086
the O 0 0.007161161862313747
mutation O 1 0.9976565837860107
in O 0 0.008529474027454853
exon O 1 0.7146023511886597
4 O 0 0.008545502088963985
and O 0 0.003083722898736596
that O 0 0.002890045056119561
the O 0 0.0038215669337660074
parents O 0 0.013347886502742767
of O 0 0.006467324215918779
patient O 1 0.8983688354492188
2 O 0 0.015052762813866138
were O 0 0.009300338104367256
heterozygous O 1 0.9672867059707642
. O 0 0.02778449095785618

The O 0 0.021460719406604767
common O 0 0.07016924023628235
mutation O 1 0.9877604246139526
at O 0 0.016104407608509064
codon O 0 0.44362324476242065
95 O 0 0.019105877727270126
in O 0 0.010409359820187092
exon O 1 0.659113883972168
4 O 0 0.010356303304433823
might O 0 0.007347530219703913
be O 0 0.003564276732504368
responsible O 0 0.008090434595942497
for O 0 0.004546502139419317
most O 0 0.007596146780997515
Japanese O 0 0.040343038737773895
C9 B-Disease 1 0.997490644454956
deficiency I-Disease 1 0.9995013475418091
. O 0 0.025310374796390533
. O 0 0.03061215952038765

BRCA1 O 1 0.9853962063789368
required O 0 0.0379762165248394
for O 0 0.020218612626194954
transcription O 1 0.9431983232498169
- O 0 0.2840938866138458
coupled O 0 0.2700191140174866
repair O 1 0.5869338512420654
of O 0 0.019741985946893692
oxidative O 1 0.9965667724609375
DNA O 1 0.9887346625328064
damage O 1 0.7183361649513245
. O 0 0.03362264856696129

The O 0 0.05871158838272095
breast B-Disease 1 0.9985264539718628
and I-Disease 1 0.6952182650566101
ovarian I-Disease 1 0.9999427795410156
cancer I-Disease 1 0.9999014139175415
susceptibility O 1 0.9994840621948242
gene O 1 0.9987598657608032
BRCA1 O 1 0.9988340735435486
encodes O 1 0.943263053894043
a O 0 0.03247709572315216
zinc O 1 0.9569684863090515
finger O 1 0.8933459520339966
protein O 1 0.9170886278152466
of O 0 0.01118291262537241
unknown O 0 0.03540518879890442
function O 0 0.08707501739263535
. O 0 0.020911511033773422

Association O 0 0.02713138423860073
of O 0 0.009078527800738811
the O 0 0.013736684806644917
BRCA1 O 1 0.9988201260566711
protein O 1 0.9528555870056152
with O 0 0.009654046967625618
the O 0 0.009466029703617096
DNA O 1 0.9866377115249634
repair O 1 0.9657014608383179
protein O 1 0.9922072291374207
Rad51 O 1 0.9893993139266968
and O 0 0.006664627231657505
changes O 0 0.010244843550026417
in O 0 0.004331646021455526
the O 0 0.005253620911389589
phosphorylation O 0 0.19058525562286377
and O 0 0.006938861683011055
cellular O 1 0.7796317934989929
localization O 0 0.14029131829738617
of O 0 0.004639956168830395
the O 0 0.006505196914076805
protein O 1 0.9558423161506653
after O 0 0.014385086484253407
exposure O 1 0.9008249640464783
to O 0 0.00865195319056511
DNA O 1 0.9853179454803467
- O 0 0.3153107464313507
damaging O 0 0.4173174202442169
agents O 0 0.014237569645047188
are O 0 0.003650772850960493
consistent O 0 0.009692196734249592
with O 0 0.005426809191703796
a O 0 0.0070310612209141254
role O 0 0.014937033876776695
for O 0 0.012681124731898308
BRCA1 O 1 0.9989118576049805
in O 0 0.027309725061058998
DNA O 1 0.9817734360694885
repair O 1 0.8009097576141357
. O 0 0.030360227450728416

Here O 0 0.01400370616465807
, O 0 0.006832870189100504
it O 0 0.004426026716828346
is O 0 0.005672655999660492
shown O 0 0.010762841440737247
that O 0 0.00838722474873066
mouse O 1 0.9947326183319092
embryonic O 1 0.9982176423072815
stem O 1 0.9980214834213257
cells O 1 0.9985880255699158
deficient B-Disease 1 0.9953994154930115
in I-Disease 0 0.017049312591552734
BRCA1 I-Disease 1 0.9990643858909607
are O 0 0.0087816771119833
defective O 1 0.9503189325332642
in O 0 0.00518894474953413
the O 0 0.0038267821073532104
ability O 0 0.009557701647281647
to O 0 0.003994305618107319
carry O 0 0.0086010517552495
out O 0 0.008462498895823956
transcription O 1 0.9861198663711548
- O 0 0.3888951241970062
coupled O 1 0.6034365296363831
repair O 1 0.7497391700744629
of O 0 0.013577965088188648
oxidative O 1 0.9983525276184082
DNA O 1 0.9905760288238525
damage O 0 0.3045339286327362
, O 0 0.00596207519993186
and O 0 0.004730510525405407
are O 0 0.005086639896035194
hypersensitive O 1 0.823591411113739
to O 0 0.010410633869469166
ionizing O 1 0.9887867569923401
radiation O 1 0.9537346959114075
and O 0 0.013789578340947628
hydrogen O 1 0.7372685074806213
peroxide O 1 0.9688855409622192
. O 0 0.03652023524045944

These O 0 0.015301411040127277
results O 0 0.020170720294117928
suggest O 0 0.020544394850730896
that O 0 0.011873310431838036
BRCA1 O 1 0.9990578293800354
participates O 0 0.26924121379852295
, O 0 0.006770019885152578
directly O 0 0.007163913920521736
or O 0 0.007364260032773018
indirectly O 0 0.021809197962284088
, O 0 0.0068721589632332325
in O 0 0.009483303874731064
transcription O 1 0.9877064824104309
- O 0 0.3953505754470825
coupled O 0 0.4167981445789337
repair O 1 0.647432267665863
of O 0 0.015691235661506653
oxidative O 1 0.9972568154335022
DNA O 1 0.9906120896339417
damage O 1 0.548717737197876
. O 0 0.01926480419933796
. O 0 0.02515706792473793

Truncation O 1 0.9416422843933105
mutations O 1 0.9818612337112427
in O 0 0.013335045427083969
the O 0 0.011034495197236538
transactivation O 1 0.9211268424987793
region O 0 0.01906561851501465
of O 0 0.01011283602565527
PAX6 O 1 0.9893665909767151
result O 0 0.0282455962151289
in O 0 0.010901001282036304
dominant O 1 0.5133361220359802
- O 0 0.4167538583278656
negative O 0 0.43218281865119934
mutants O 1 0.88662189245224
. O 0 0.033566877245903015

PAX6 O 1 0.9472588300704956
is O 0 0.01920023374259472
a O 0 0.017624514177441597
transcription O 1 0.8339529633522034
factor O 0 0.03851492330431938
with O 0 0.007577169686555862
two O 0 0.00909580010920763
DNA O 1 0.9526756405830383
- O 0 0.21113014221191406
binding O 0 0.2961409389972687
domains O 0 0.4444597661495209
( O 0 0.016024747863411903
paired O 0 0.31708016991615295
box O 0 0.02813621237874031
and O 0 0.010123035870492458
homeobox O 1 0.9954653382301331
) O 0 0.011493685655295849
and O 0 0.006186369806528091
a O 0 0.014358088374137878
proline O 1 0.9394477605819702
- O 0 0.40506160259246826
serine O 1 0.9164223074913025
- O 1 0.5452992916107178
threonine O 1 0.8906784057617188
( O 0 0.03542099520564079
PST O 1 0.7746459245681763
) O 0 0.024225423112511635
- O 0 0.09336157143115997
rich O 0 0.06428943574428558
transactivation O 1 0.9716300368309021
domain O 0 0.13888606429100037
. O 0 0.03008958511054516

PAX6 O 1 0.9854943752288818
regulates O 1 0.9390236139297485
eye O 1 0.7237853407859802
development O 0 0.021592462435364723
in O 0 0.008944009430706501
animals O 0 0.03958335891366005
ranging O 0 0.018731726333498955
from O 0 0.010952744632959366
jellyfish O 1 0.8447408676147461
to O 0 0.01221456378698349
Drosophila O 1 0.8337674140930176
to O 0 0.015158927999436855
humans O 1 0.614677906036377
. O 0 0.02611643821001053

Heterozygous O 1 0.974239706993103
mutations O 1 0.9819138646125793
in O 0 0.014945955015718937
the O 0 0.012353355064988136
human O 0 0.4248104989528656
PAX6 O 1 0.9973512887954712
gene O 1 0.9937716126441956
result O 0 0.02335331402719021
in O 0 0.007281469646841288
various O 0 0.010223432444036007
phenotypes O 1 0.987405002117157
, O 0 0.0085136778652668
including O 0 0.011922950856387615
aniridia B-Disease 1 0.9641017913818359
, O 0 0.015231217257678509
Peters B-Disease 1 0.842522382736206
anomaly I-Disease 1 0.9893682599067688
, O 0 0.08887838572263718
autosomal B-Disease 1 0.9997692704200745
dominant I-Disease 1 0.9829869270324707
keratitis I-Disease 1 0.997832715511322
, O 0 0.021252557635307312
and O 0 0.021258480846881866
familial B-Disease 1 0.9979618787765503
foveal I-Disease 1 0.9906629323959351
dysplasia I-Disease 1 0.9987425208091736
. O 0 0.054357804358005524

It O 0 0.01188676618039608
is O 0 0.007427230477333069
believed O 0 0.008990084752440453
that O 0 0.0048772129230201244
the O 0 0.00832426454871893
mutated O 1 0.9944631457328796
allele O 1 0.9889801740646362
of O 0 0.013768902979791164
PAX6 O 1 0.9929152727127075
produces O 0 0.1951911896467209
an O 0 0.011495066806674004
inactive O 0 0.49568429589271545
protein O 1 0.9295130372047424
and O 0 0.009927771985530853
aniridia B-Disease 1 0.9462506771087646
is O 0 0.01207057572901249
caused O 0 0.3350255489349365
due O 0 0.015968095511198044
to O 0 0.011316388845443726
genetic O 1 0.9956896901130676
haploinsufficiency O 1 0.9468259215354919
. O 0 0.029621025547385216

However O 0 0.01862139068543911
, O 0 0.007816798985004425
several O 0 0.010393187403678894
truncation O 1 0.9683042764663696
mutations O 1 0.9958297610282898
have O 0 0.0053743342868983746
been O 0 0.003987230360507965
found O 0 0.005578682292252779
to O 0 0.003480243030935526
occur O 0 0.029951544478535652
in O 0 0.004081437364220619
the O 0 0.00592360133305192
C O 0 0.3731176555156708
- O 0 0.16396817564964294
terminal O 0 0.1013946384191513
half O 0 0.01068032719194889
of O 0 0.008492748253047466
PAX6 O 1 0.9926355481147766
in O 0 0.013026624917984009
patients O 1 0.9866324067115784
with O 0 0.012791662476956844
Aniridia B-Disease 1 0.9580439329147339
resulting O 0 0.29826629161834717
in O 0 0.009862024337053299
mutant O 1 0.9850999712944031
proteins O 1 0.8608588576316833
that O 0 0.0064271800220012665
retain O 0 0.015041131526231766
the O 0 0.007833361625671387
DNA O 1 0.9697595238685608
- O 0 0.22222334146499634
binding O 0 0.19952985644340515
domains O 0 0.15474019944667816
but O 0 0.00442152377218008
have O 0 0.003661801340058446
lost O 0 0.005487772636115551
most O 0 0.0038948820438236
of O 0 0.0044105215929448605
the O 0 0.009477365761995316
transactivation O 1 0.9785056710243225
domain O 0 0.19114768505096436
. O 0 0.025757521390914917

It O 0 0.010837918147444725
is O 0 0.0068471780978143215
not O 0 0.0037767281755805016
clear O 0 0.006304245442152023
whether O 0 0.0055586290545761585
such O 0 0.006035137921571732
mutants O 1 0.6483957171440125
really O 0 0.01247638463973999
behave O 0 0.04761398583650589
as O 0 0.007638521492481232
loss O 0 0.1303607076406479
- O 0 0.052489228546619415
of O 0 0.00720294751226902
- O 0 0.22894982993602753
function O 0 0.3174147605895996
mutants O 1 0.6918194890022278
as O 0 0.00962701253592968
predicted O 0 0.030678963288664818
by O 0 0.017502782866358757
haploinsufficiency O 1 0.7144671678543091
. O 0 0.030256425961852074

Contrary O 0 0.02695181779563427
to O 0 0.006433666218072176
this O 0 0.004424956627190113
theory O 0 0.009510773234069347
, O 0 0.003240857506170869
our O 0 0.0035873213782906532
data O 0 0.004724172875285149
showed O 0 0.005719937849789858
that O 0 0.0027352659963071346
these O 0 0.0038255047984421253
mutants O 0 0.3668079078197479
are O 0 0.005411168560385704
dominant O 0 0.3661624491214752
- O 0 0.18659070134162903
negative O 0 0.11339318007230759
in O 0 0.011509602889418602
transient O 1 0.9938200116157532
transfection O 1 0.9957096576690674
assays O 1 0.713300883769989
when O 0 0.008421303704380989
they O 0 0.003991563338786364
are O 0 0.004690184723585844
coexpressed O 0 0.27311766147613525
with O 0 0.01187148131430149
wild O 0 0.258568674325943
- O 1 0.7347507476806641
type O 1 0.876361072063446
PAX6 O 1 0.9884462356567383
. O 0 0.03890640661120415

We O 0 0.010938168503344059
found O 0 0.008872647769749165
that O 0 0.004057307727634907
the O 0 0.005337141919881105
dominant O 0 0.2875518500804901
- O 0 0.2952159345149994
negative O 0 0.29180726408958435
effects O 1 0.7288801074028015
result O 0 0.013113146647810936
from O 0 0.00553005700930953
the O 0 0.0056837452575564384
enhanced O 0 0.4251193702220917
DNA O 1 0.9635657668113708
binding O 0 0.1187892034649849
ability O 0 0.016133569180965424
of O 0 0.0067994603887200356
these O 0 0.010598442517220974
mutants O 1 0.6360607147216797
. O 0 0.02550630085170269

Kinetic O 0 0.07215365767478943
studies O 0 0.02288198098540306
of O 0 0.006509660743176937
binding O 0 0.027825336903333664
and O 0 0.006825828924775124
dissociation O 1 0.8018132448196411
revealed O 0 0.014217926189303398
that O 0 0.004822791088372469
various O 0 0.007596406154334545
truncation O 1 0.8959460854530334
mutants O 1 0.6267563104629517
have O 0 0.006868430413305759
3 O 0 0.012816453352570534
- O 0 0.04722650349140167
5 O 0 0.012826308608055115
- O 0 0.03249210864305496
fold O 0 0.038954123854637146
higher O 0 0.011913180351257324
affinity O 0 0.076131671667099
to O 0 0.004395241849124432
various O 0 0.007901458069682121
DNA O 1 0.918630063533783
- O 0 0.10913625359535217
binding O 0 0.052954886108636856
sites O 0 0.008494908921420574
when O 0 0.005596985574811697
compared O 0 0.009677854366600513
with O 0 0.005862119607627392
the O 0 0.006942056119441986
wild O 0 0.2649571895599365
- O 1 0.7314500212669373
type O 1 0.9016534090042114
PAX6 O 1 0.9866188168525696
. O 0 0.04198865965008736

These O 0 0.0169285349547863
results O 0 0.017591530457139015
provide O 0 0.010090943425893784
a O 0 0.008278192020952702
new O 0 0.006492617540061474
insight O 0 0.01830451563000679
into O 0 0.006125274114310741
the O 0 0.0056206947192549706
role O 0 0.013144828379154205
of O 0 0.010395302437245846
mutant O 1 0.9893430471420288
PAX6 O 1 0.9934430122375488
in O 0 0.021861344575881958
causing O 1 0.9319130778312683
aniridia B-Disease 1 0.9458299875259399
. O 0 0.02111821249127388
. O 0 0.023981546983122826

Reversal O 0 0.42562156915664673
of O 0 0.03846905007958412
severe O 1 0.9941802024841309
hypertrophic B-Disease 1 0.9993288516998291
cardiomyopathy I-Disease 1 0.9988749623298645
and O 0 0.015019810758531094
excellent O 0 0.026952125132083893
neuropsychologic O 1 0.6089079976081848
outcome O 0 0.02302272990345955
in O 0 0.007845941931009293
very B-Disease 0 0.011892340146005154
- I-Disease 0 0.18765728175640106
long I-Disease 0 0.04711153730750084
- I-Disease 1 0.6051831841468811
chain I-Disease 1 0.9244019985198975
acyl I-Disease 1 0.9938640594482422
- I-Disease 1 0.9134460687637329
coenzyme I-Disease 1 0.9907878041267395
A I-Disease 1 0.6038329601287842
dehydrogenase I-Disease 1 0.9986454844474792
deficiency I-Disease 1 0.9990585446357727
. O 0 0.04903976991772652

Very B-Disease 0 0.04322781413793564
- I-Disease 0 0.07176586985588074
long I-Disease 0 0.0421309657394886
- I-Disease 0 0.3961847424507141
chain I-Disease 1 0.8138301372528076
acyl I-Disease 1 0.9839651584625244
- I-Disease 1 0.689801037311554
coenzyme I-Disease 1 0.9828698039054871
A I-Disease 0 0.11584485322237015
dehydrogenase I-Disease 1 0.9961773157119751
( I-Disease 0 0.05509293079376221
VLCAD I-Disease 1 0.9797565340995789
) I-Disease 0 0.14095239341259003
deficiency I-Disease 1 0.9994070529937744
is O 0 0.010230711661279202
a O 0 0.01841527223587036
disorder O 1 0.9973118305206299
of O 0 0.013631102629005909
fatty O 1 0.996926486492157
acid O 1 0.9956297874450684
beta O 1 0.9746295213699341
oxidation O 1 0.9079530239105225
that O 0 0.006687223445624113
reportedly O 0 0.01057847123593092
has O 0 0.005012683570384979
high O 0 0.009029192849993706
rates O 0 0.02012377604842186
of O 0 0.010550574399530888
morbidity O 1 0.9946659803390503
and O 0 0.01877007447183132
mortality O 1 0.9822898507118225
. O 0 0.03247752785682678

We O 0 0.013302027247846127
describe O 0 0.018879126757383347
the O 0 0.0055589983239769936
outcome O 0 0.012020334601402283
of O 0 0.004697888158261776
a O 0 0.008097310550510883
5 O 0 0.011405561119318008
- O 0 0.06407749652862549
year O 0 0.009705616161227226
- O 0 0.06306140124797821
old O 0 0.02201942726969719
girl O 0 0.26381975412368774
with O 0 0.039048533886671066
VLCAD B-Disease 1 0.9986541271209717
deficiency I-Disease 1 0.9997908473014832
who O 0 0.008220446296036243
was O 0 0.004060982260853052
first O 0 0.004403186496347189
seen O 0 0.007145853713154793
at O 0 0.005374446045607328
5 O 0 0.007321880664676428
months O 0 0.007197595667093992
of O 0 0.005248206201940775
age O 0 0.02765357680618763
with O 0 0.0691644549369812
severe O 1 0.9985748529434204
hypertrophic B-Disease 1 0.999704897403717
cardiomyopathy I-Disease 1 0.9996440410614014
, O 0 0.1546262800693512
hepatomegaly B-Disease 1 0.9968588352203369
, O 0 0.05000218749046326
encephalopathy B-Disease 1 0.9986975193023682
, O 0 0.02148185856640339
and O 0 0.01882113143801689
hypotonia B-Disease 1 0.9849258065223694
. O 0 0.03423541039228439

Biochemical O 1 0.941336989402771
studies O 0 0.23334671556949615
indicated O 0 0.4283161461353302
VLCAD B-Disease 1 0.996268093585968
deficiency I-Disease 1 0.9997096657752991
caused O 0 0.42596930265426636
by O 0 0.014663833193480968
a O 0 0.01625010371208191
stable O 0 0.23810774087905884
yet O 0 0.021903332322835922
inactive O 1 0.570263147354126
enzyme O 1 0.979691207408905
. O 0 0.030139965936541557

Molecular O 1 0.9571371078491211
genetic O 1 0.9524959325790405
analysis O 0 0.030501490458846092
of O 0 0.010726243257522583
her O 0 0.022870346903800964
VLCAD O 1 0.9655589461326599
gene O 1 0.9876540303230286
revealed O 0 0.036046743392944336
a O 0 0.019431229680776596
T1372C O 1 0.6847188472747803
( O 0 0.023058263584971428
F458L O 1 0.801847517490387
) O 0 0.031007520854473114
missense O 1 0.9923537969589233
mutation O 1 0.99524986743927
and O 0 0.010662747547030449
a O 0 0.023113271221518517
1668 O 1 0.953839898109436
ACAG O 1 0.9555618762969971
1669 O 1 0.9253808856010437
splice O 1 0.9634935855865479
site O 0 0.06749390810728073
mutation O 1 0.9908841252326965
. O 0 0.040887631475925446

After O 0 0.03594258800148964
initial O 0 0.040622908622026443
treatment O 1 0.736998975276947
with O 0 0.017487995326519012
intravenous O 1 0.9969421029090881
glucose O 1 0.9954791069030762
and O 0 0.013236315920948982
carnitine O 1 0.9939792156219482
, O 0 0.008254564367234707
the O 0 0.006917313672602177
patient O 1 0.9154404997825623
has O 0 0.006334291771054268
thrived O 0 0.023549919947981834
on O 0 0.004614123143255711
a O 0 0.00950088631361723
low O 0 0.06322503089904785
- O 0 0.3884175717830658
fat O 1 0.938994824886322
diet O 1 0.845123827457428
supplemented O 0 0.0460360161960125
with O 0 0.011130517348647118
medium O 0 0.05176486819982529
- O 0 0.39275822043418884
chain O 1 0.6661367416381836
triglyceride O 1 0.9676215052604675
oil O 0 0.022775918245315552
and O 0 0.012104535475373268
carnitine O 1 0.9838981032371521
and O 0 0.013670523650944233
avoidance O 1 0.732839047908783
of O 0 0.01525204349309206
fasting O 0 0.4093242883682251
. O 0 0.028777988627552986

Her O 0 0.19948309659957886
ventricular O 1 0.9947084188461304
hypertrophy O 1 0.9956892132759094
resolved O 0 0.05941588059067726
significantly O 0 0.038226235657930374
over O 0 0.007531567011028528
1 O 0 0.007453602273017168
year O 0 0.006086204666644335
, O 0 0.004236150532960892
and O 0 0.004951369948685169
cognitively O 1 0.797266960144043
, O 0 0.005035884212702513
she O 0 0.003946149256080389
is O 0 0.003107399446889758
in O 0 0.0031494805589318275
the O 0 0.0041458457708358765
superior O 0 0.014399033971130848
range O 0 0.010277635417878628
for O 0 0.007541275583207607
age O 0 0.024327099323272705
. O 0 0.02117280848324299

Clinical O 1 0.8754898905754089
recognition O 0 0.04227812960743904
of O 0 0.018151555210351944
VLCAD B-Disease 1 0.9977352619171143
deficiency I-Disease 1 0.9997990727424622
is O 0 0.008613251149654388
important O 0 0.005129551514983177
because O 0 0.00488057266920805
it O 0 0.0024044595193117857
is O 0 0.0022554071620106697
one O 0 0.002187667414546013
of O 0 0.0022060382179915905
the O 0 0.0032405543606728315
few O 0 0.007078422699123621
directly O 0 0.056105997413396835
treatable O 1 0.9996128678321838
causes O 1 0.994648277759552
of O 0 0.01744743622839451
cardiomyopathy B-Disease 1 0.9994131326675415
in O 0 0.014188431203365326
children O 0 0.03892723098397255
. O 0 0.01438672374933958
. O 0 0.02069850265979767

Cloning O 0 0.24211269617080688
of O 0 0.010931061580777168
a O 0 0.012240179814398289
novel O 0 0.018000656738877296
member O 0 0.00756929162889719
of O 0 0.005002364981919527
the O 0 0.007385085336863995
low O 0 0.06986705958843231
- O 1 0.6091556549072266
density O 1 0.8894685506820679
lipoprotein O 1 0.9977872371673584
receptor O 1 0.9912988543510437
family O 0 0.11533750593662262
. O 0 0.03472331911325455

A O 0 0.06016121804714203
gene O 1 0.9506783485412598
encoding O 0 0.2070745825767517
a O 0 0.02188764698803425
novel O 0 0.08560168743133545
transmembrane O 1 0.9608379006385803
protein O 1 0.9416289329528809
was O 0 0.008156673051416874
identified O 0 0.012553157284855843
by O 0 0.008057882077991962
DNA O 1 0.7629972100257874
sequence O 0 0.05296947807073593
analysis O 0 0.018477989360690117
within O 0 0.00843639113008976
the O 0 0.012959335930645466
insulin B-Disease 1 0.9988507032394409
- I-Disease 1 0.9831094145774841
dependent I-Disease 1 0.99367755651474
diabetes I-Disease 1 0.9999148845672607
mellitus I-Disease 1 0.9991242289543152
( O 0 0.13085414469242096
IDDM B-Disease 1 0.956617534160614
) O 0 0.03868720307946205
locus O 1 0.9627992510795593
IDDM4 O 1 0.8186730742454529
on O 0 0.02834489941596985
chromosome O 1 0.9899292588233948
11q13 O 1 0.7716425061225891
. O 0 0.03753596171736717

Based O 0 0.019792189821600914
on O 0 0.007689116522669792
its O 0 0.010444751009345055
chromosomal O 1 0.98859041929245
position O 0 0.009538022801280022
, O 0 0.005528633017092943
this O 0 0.006168919149786234
gene O 1 0.9747326970100403
is O 0 0.006017566192895174
a O 0 0.008537482470273972
candidate O 0 0.01352414395660162
for O 0 0.011825856752693653
conferring O 1 0.7696452736854553
susceptibility O 1 0.9979085922241211
to O 0 0.05046282336115837
diabetes B-Disease 1 0.9992061257362366
. O 0 0.04738352820277214

The O 0 0.0324588418006897
gene O 1 0.9521315097808838
, O 0 0.01628616824746132
termed O 0 0.14247049391269684
low O 0 0.09903202205896378
- O 0 0.4752103090286255
density O 1 0.7928891181945801
lipoprotein O 1 0.9972668886184692
receptor O 1 0.9945119619369507
related O 0 0.307753324508667
protein O 1 0.9482085108757019
5 O 0 0.020621128380298615
( O 0 0.016507478430867195
LRP5 O 1 0.6758559942245483
) O 0 0.009966693818569183
, O 0 0.00563403544947505
encodes O 0 0.16699594259262085
a O 0 0.011670845560729504
protein O 1 0.6789390444755554
of O 0 0.00856026541441679
1615 O 1 0.6453721523284912
amino O 1 0.8394237160682678
acids O 1 0.5885496735572815
that O 0 0.004688888788223267
contains O 0 0.008785630576312542
conserved O 0 0.05748898535966873
modules O 0 0.016832297667860985
which O 0 0.0037509577814489603
are O 0 0.003052760614082217
characteristic O 0 0.013390619307756424
of O 0 0.004151772242039442
the O 0 0.006434095092117786
low O 0 0.13719338178634644
- O 1 0.6522501111030579
density O 1 0.8439289331436157
lipoprotein O 1 0.9983999133110046
( O 0 0.4226008355617523
LDL O 1 0.9985849857330322
) O 0 0.09356681257486343
receptor O 1 0.986515998840332
family O 0 0.049950599670410156
. O 0 0.02533990517258644

These O 0 0.017180386930704117
modules O 0 0.03137936815619469
include O 0 0.014797699637711048
a O 0 0.014328865334391594
putative O 1 0.7606019973754883
signal O 0 0.09090809524059296
peptide O 1 0.9317407011985779
for O 0 0.008467518724501133
protein O 1 0.8962928056716919
export O 0 0.01342079695314169
, O 0 0.0062627787701785564
four O 0 0.01097849477082491
epidermal O 1 0.996107280254364
growth O 1 0.5523501038551331
factor O 1 0.608245313167572
( O 0 0.03056499920785427
EGF O 1 0.9924206137657166
) O 0 0.014726289547979832
repeats O 0 0.06483683735132217
with O 0 0.010066062211990356
associated O 0 0.03178534656763077
spacer O 1 0.9748902320861816
domains O 0 0.30227041244506836
, O 0 0.008249960839748383
three O 0 0.015300310216844082
LDL O 1 0.9989456534385681
- O 1 0.9509422779083252
receptor O 1 0.9939990043640137
( O 0 0.03019336797297001
LDLR O 1 0.888174831867218
) O 0 0.015079615637660027
repeats O 0 0.056151166558265686
, O 0 0.005618362687528133
a O 0 0.007931024767458439
single O 0 0.014895444735884666
transmembrane O 1 0.7675157785415649
spanning O 0 0.04262614995241165
domain O 0 0.02742176502943039
, O 0 0.006402318831533194
and O 0 0.005442173220217228
a O 0 0.013020220212638378
cytoplasmic O 1 0.964103102684021
domain O 0 0.1590789258480072
. O 0 0.027002748101949692

The O 0 0.019010821357369423
encoded O 0 0.07059559226036072
protein O 1 0.6495815515518188
has O 0 0.007166817784309387
a O 0 0.007734897080808878
unique O 0 0.008869866840541363
organization O 0 0.009484502486884594
of O 0 0.006887482013553381
EGF O 1 0.9914001226425171
and O 0 0.01140904612839222
LDLR O 1 0.9589124321937561
repeats O 1 0.5611888766288757
; O 0 0.01070973090827465
therefore O 0 0.00931052677333355
, O 0 0.006898948457092047
LRP5 O 1 0.5813575983047485
likely O 0 0.011644748039543629
represents O 0 0.009834219701588154
a O 0 0.005710097029805183
new O 0 0.00529751880094409
category O 0 0.010354886762797832
of O 0 0.005235897842794657
the O 0 0.008876153267920017
LDLR O 1 0.919251561164856
family O 0 0.045547932386398315
. O 0 0.024676252156496048

Both O 0 0.022364290431141853
human O 0 0.031161144375801086
and O 0 0.013956242240965366
mouse O 1 0.9860116839408875
LRP5 O 1 0.966009795665741
cDNAs O 1 0.6785547137260437
have O 0 0.006775168236345053
been O 0 0.005598392337560654
isolated O 0 0.01837329752743244
and O 0 0.004083971492946148
the O 0 0.005063838325440884
encoded O 0 0.38070014119148254
mature O 1 0.8300708532333374
proteins O 1 0.5951720476150513
are O 0 0.00426543690264225
95 O 0 0.008746223524212837
% O 0 0.007585995830595493
identical O 0 0.014758717268705368
, O 0 0.00416463753208518
indicating O 0 0.013074475340545177
a O 0 0.007064704783260822
high O 0 0.008200302720069885
degree O 0 0.010818331502377987
of O 0 0.005656383000314236
evolutionary O 1 0.5981578230857849
conservation O 0 0.028493620455265045
. O 0 0.011348385363817215
. O 0 0.017532695084810257

The O 0 0.03500331565737724
APC B-Disease 1 0.8908846974372864
variants O 1 0.6251752972602844
I1307K O 1 0.5149646401405334
and O 0 0.01304952334612608
E1317Q O 0 0.37828660011291504
are O 0 0.009364675730466843
associated O 0 0.119657963514328
with O 0 0.3786156177520752
colorectal B-Disease 1 0.9999674558639526
tumors I-Disease 1 0.9998137354850769
, O 0 0.008637642487883568
but O 0 0.004415633622556925
not O 0 0.0032231889199465513
always O 0 0.0043607731349766254
with O 0 0.005349534563720226
a O 0 0.009254459291696548
family O 0 0.016562968492507935
history O 0 0.016984328627586365
. O 0 0.021892886608839035

Classical O 1 0.6791126728057861
familial B-Disease 1 0.9979717135429382
adenomatous I-Disease 1 0.999125063419342
polyposis I-Disease 1 0.9989068508148193
( O 0 0.2340756058692932
FAP B-Disease 1 0.9897180795669556
) O 0 0.01756076142191887
is O 0 0.007485330104827881
a O 0 0.012557313777506351
high O 0 0.026727717369794846
- O 1 0.9307244420051575
penetrance O 1 0.999015212059021
autosomal B-Disease 1 0.9998817443847656
dominant I-Disease 1 0.9929989576339722
disease I-Disease 1 0.9994465708732605
that O 0 0.011070050299167633
predisposes O 1 0.9834384322166443
to O 0 0.005892367102205753
hundreds O 0 0.010967560112476349
or O 0 0.008802601136267185
thousands O 0 0.014865122735500336
of O 0 0.02909751795232296
colorectal B-Disease 1 0.9999061822891235
adenomas I-Disease 1 0.9993645548820496
and I-Disease 0 0.042425353080034256
carcinoma I-Disease 1 0.9997194409370422
and O 0 0.0070390463806688786
that O 0 0.0059143370017409325
results O 0 0.0175654087215662
from O 0 0.013573586009442806
truncating O 1 0.9893116354942322
mutations O 1 0.9973258972167969
in O 0 0.013007700443267822
the O 0 0.01914781704545021
APC B-Disease 1 0.9915751814842224
gene O 1 0.9932689070701599
. O 0 0.035653892904520035

A O 0 0.05638868734240532
variant O 1 0.8535069227218628
of O 0 0.02420920319855213
FAP B-Disease 1 0.9944618344306946
is O 0 0.22734335064888
attenuated B-Disease 1 0.9986748695373535
adenomatous I-Disease 1 0.9998251795768738
polyposis I-Disease 1 0.999738872051239
coli I-Disease 1 0.9989029169082642
, O 0 0.01121760718524456
which O 0 0.006508076563477516
results O 0 0.016846656799316406
from O 0 0.013161404989659786
germ O 1 0.9912003874778748
- O 0 0.369064599275589
line O 0 0.026108065620064735
mutations O 1 0.9967519044876099
in O 0 0.004670089576393366
the O 0 0.003360048169270158
5 O 0 0.005683302413672209
and O 0 0.0031626340933144093
3 O 0 0.0068443831987679005
regions O 0 0.009120654314756393
of O 0 0.005300058983266354
the O 0 0.011257503181695938
APC B-Disease 1 0.9887378215789795
gene O 1 0.9887839555740356
. O 0 0.03063417226076126

Attenuated B-Disease 1 0.9954555034637451
adenomatous I-Disease 1 0.9993190765380859
polyposis I-Disease 1 0.9995569586753845
coli I-Disease 1 0.9990873336791992
patients O 1 0.984064519405365
have O 0 0.014634236693382263
" O 0 0.015713602304458618
multiple O 0 0.3910766839981079
" O 0 0.18887150287628174
colorectal B-Disease 1 0.9998681545257568
adenomas I-Disease 1 0.9987657070159912
( O 0 0.022580992430448532
typically O 0 0.014165985397994518
fewer O 0 0.012283267453312874
than O 0 0.005087054334580898
100 O 0 0.0076142349280416965
) O 0 0.007619373966008425
without O 0 0.007921376265585423
the O 0 0.009522265754640102
florid O 1 0.9772201180458069
phenotype O 1 0.996377170085907
of O 0 0.014810949563980103
classical O 0 0.08018789440393448
FAP B-Disease 1 0.9888725876808167
. O 0 0.036888204514980316

Another O 0 0.025319764390587807
group O 0 0.017499634996056557
of O 0 0.01037128921598196
patients O 1 0.9845506548881531
with O 0 0.012424545362591743
multiple O 1 0.7378240823745728
adenomas B-Disease 1 0.9973356127738953
has O 0 0.008150719106197357
no O 0 0.008370490744709969
mutations O 1 0.9959631562232971
in O 0 0.006198527757078409
the O 0 0.008320058695971966
APC B-Disease 1 0.9966212511062622
gene O 1 0.9951743483543396
, O 0 0.005547885317355394
and O 0 0.0037461521569639444
their O 0 0.007145880721509457
phenotype O 1 0.9979738593101501
probably O 0 0.012247134931385517
results O 0 0.012328037992119789
from O 0 0.006770382635295391
variation O 0 0.07229330390691757
at O 0 0.007416249718517065
a O 0 0.01146642304956913
locus O 1 0.9837524890899658
, O 0 0.007476083002984524
or O 0 0.012498948723077774
loci O 1 0.9803783297538757
, O 0 0.007863772101700306
elsewhere O 0 0.009145138785243034
in O 0 0.005621776916086674
the O 0 0.010045964270830154
genome O 1 0.9560458064079285
. O 0 0.024087728932499886

Recently O 0 0.0362149216234684
, O 0 0.010409492999315262
however O 0 0.008169092237949371
, O 0 0.006756052374839783
a O 0 0.014156832359731197
missense O 1 0.9855479598045349
variant O 1 0.9400930404663086
of O 0 0.013130336999893188
APC B-Disease 1 0.9856894016265869
( O 0 0.020815731957554817
I1307K O 1 0.7227333188056946
) O 0 0.009240500628948212
was O 0 0.004242282826453447
described O 0 0.008934136480093002
that O 0 0.004464237485080957
confers O 0 0.3358159363269806
an O 0 0.007989388890564442
increased O 0 0.09702358394861221
risk O 1 0.987663209438324
of O 0 0.13699592649936676
colorectal B-Disease 1 0.9999538660049438
tumors I-Disease 1 0.9997411370277405
, O 0 0.016580475494265556
including O 0 0.0172840915620327
multiple O 1 0.7641215920448303
adenomas B-Disease 1 0.9955459833145142
, O 0 0.01463492400944233
in O 0 0.01645846851170063
Ashkenazim O 1 0.7704325318336487
. O 0 0.026677696034312248

We O 0 0.00975015852600336
have O 0 0.005894252564758062
studied O 0 0.008981005288660526
a O 0 0.005775680299848318
set O 0 0.0051833451725542545
of O 0 0.005561244674026966
164 O 0 0.2176331728696823
patients O 1 0.9939460158348083
with O 0 0.029777612537145615
multiple O 1 0.9919497966766357
colorectal B-Disease 1 0.9999388456344604
adenomas I-Disease 1 0.9991235136985779
and I-Disease 0 0.02026604861021042
/ I-Disease 1 0.836778461933136
or I-Disease 0 0.08862132579088211
carcinoma I-Disease 1 0.9993665814399719
and O 0 0.01600777357816696
analyzed O 0 0.19842272996902466
codons O 1 0.9403297305107117
1263 O 1 0.9498734474182129
- O 1 0.5322571396827698
1377 O 1 0.9149767160415649
( O 0 0.0372050404548645
exon O 1 0.8526330590248108
15G O 1 0.7924307584762573
) O 0 0.013323466293513775
of O 0 0.005555583164095879
the O 0 0.008812209591269493
APC B-Disease 1 0.9885693192481995
gene O 1 0.9948078989982605
for O 0 0.018210049718618393
germ O 1 0.9846720099449158
- O 0 0.21828219294548035
line O 0 0.03140760213136673
variants O 1 0.5393214225769043
. O 0 0.028202448040246964

Three O 0 0.03241962566971779
patients O 1 0.8637242913246155
with O 0 0.011447187513113022
the O 0 0.010899484157562256
I1307K O 1 0.9331026673316956
allele O 1 0.9874958992004395
were O 0 0.007825604639947414
detected O 0 0.2479850947856903
, O 0 0.0058469828218221664
each O 0 0.0064684730023145676
of O 0 0.008207003585994244
Ashkenazi O 1 0.6886517405509949
descent O 0 0.13219968974590302
. O 0 0.028874114155769348

Four O 0 0.03618478402495384
patients O 1 0.8729022145271301
had O 0 0.01256009191274643
a O 0 0.019349779933691025
germ O 1 0.9778910875320435
- O 0 0.15686951577663422
line O 0 0.03044380061328411
E1317Q O 1 0.9655004739761353
missense O 1 0.9915931224822998
variant O 1 0.9258265495300293
of O 0 0.009253138676285744
APC O 1 0.9369295835494995
that O 0 0.004341446328908205
was O 0 0.0030468555632978678
not O 0 0.002464336110278964
present O 0 0.003950060345232487
in O 0 0.0035562647972255945
controls O 0 0.013848414644598961
; O 0 0.004319385625422001
one O 0 0.0025332404766231775
of O 0 0.0021397818345576525
these O 0 0.002979486947879195
individuals O 0 0.006569795776158571
had O 0 0.0033389627933502197
an O 0 0.0035755594726651907
unusually O 0 0.019601793959736824
large O 0 0.006571355275809765
number O 0 0.004920815117657185
of O 0 0.007042813114821911
metaplastic B-Disease 1 0.9800967574119568
polyps I-Disease 1 0.9964877367019653
of I-Disease 0 0.009331521578133106
the I-Disease 0 0.012806051410734653
colorectum I-Disease 1 0.8310127258300781
. O 0 0.029591022059321404

There O 0 0.013705570250749588
is O 0 0.007394262123852968
increasing O 0 0.012784662656486034
evidence O 0 0.0070281620137393475
that O 0 0.003747867653146386
there O 0 0.004193369764834642
exist O 0 0.012818420305848122
germ O 1 0.9852042198181152
- O 0 0.0656404197216034
line O 0 0.012181377038359642
variants O 0 0.16331978142261505
of O 0 0.00466898363083601
the O 0 0.007899275049567223
APC B-Disease 1 0.9930784106254578
gene O 1 0.995114803314209
that O 0 0.0077748908661305904
predispose O 1 0.9483094811439514
to O 0 0.004552797414362431
the O 0 0.004451793618500233
development O 0 0.010037148371338844
of O 0 0.008552518673241138
multiple O 1 0.9928608536720276
colorectal B-Disease 1 0.9999580383300781
adenomas I-Disease 1 0.9996824264526367
and I-Disease 0 0.11390082538127899
carcinoma I-Disease 1 0.9997854828834534
, O 0 0.008549802005290985
but O 0 0.005327099468559027
without O 0 0.006603945977985859
the O 0 0.007082968018949032
florid O 1 0.9787768721580505
phenotype O 1 0.9970255494117737
of O 0 0.008539259433746338
classical O 0 0.02934199944138527
FAP B-Disease 1 0.9922739863395691
, O 0 0.006953057367354631
and O 0 0.004360541235655546
possibly O 0 0.011269909329712391
with O 0 0.006497115362435579
importance O 0 0.016934461891651154
for O 0 0.22650839388370514
colorectal B-Disease 1 0.9999778270721436
cancer I-Disease 1 0.9999237060546875
risk O 1 0.984671413898468
in O 0 0.0062113418243825436
the O 0 0.00505785970017314
general O 0 0.007176446262747049
population O 0 0.011676809750497341
. O 0 0.009618323296308517
. O 0 0.016094740480184555

Genomic O 1 0.901925802230835
structure O 0 0.035123735666275024
of O 0 0.011642761528491974
the O 0 0.01683909446001053
human O 1 0.9645854234695435
congenital B-Disease 1 0.9998403787612915
chloride I-Disease 1 0.9985972046852112
diarrhea I-Disease 1 0.9994978904724121
( O 0 0.4945519268512726
CLD B-Disease 1 0.9951413869857788
) O 0 0.10109391063451767
gene O 1 0.9858846068382263
. O 0 0.044161174446344376

Congenital B-Disease 1 0.9994893074035645
chloride I-Disease 1 0.9978278279304504
diarrhea I-Disease 1 0.9995816349983215
( O 0 0.29932093620300293
CLD B-Disease 1 0.9954800605773926
) O 0 0.016975630074739456
is O 0 0.00755426986142993
caused O 0 0.1547718197107315
by O 0 0.01087226253002882
mutations O 1 0.996248185634613
in O 0 0.007454954087734222
a O 0 0.014399858191609383
gene O 1 0.9914742708206177
which O 0 0.013633564114570618
encodes O 1 0.8755757212638855
an O 0 0.03576072305440903
intestinal O 1 0.9984207153320312
anion O 1 0.9844278693199158
transporter O 1 0.9611268043518066
. O 0 0.043395932763814926

We O 0 0.01083536259829998
report O 0 0.007462882436811924
here O 0 0.003657917259261012
the O 0 0.003806719556450844
complete O 0 0.011397047899663448
genomic O 1 0.9459580183029175
organization O 0 0.011160125955939293
of O 0 0.00478790421038866
the O 0 0.007093159947544336
human O 1 0.5620065927505493
CLD B-Disease 1 0.9973600506782532
gene O 1 0.989941418170929
which O 0 0.010541643016040325
spans O 0 0.029841484501957893
approximately O 0 0.015047787688672543
39kb O 0 0.2919398546218872
, O 0 0.006013147067278624
and O 0 0.00538213923573494
comprises O 0 0.013993977569043636
21 O 0 0.022433262318372726
exons O 1 0.7641085982322693
. O 0 0.027735766023397446

All O 0 0.03427867218852043
exon O 1 0.865469753742218
/ O 0 0.34443584084510803
intron O 1 0.8307244181632996
boundaries O 0 0.019195662811398506
conform O 0 0.0240922961384058
to O 0 0.007899085059762001
the O 0 0.011093995533883572
GT O 1 0.9628916382789612
/ O 1 0.7943010926246643
AG O 1 0.9508206844329834
rule O 0 0.03976422920823097
. O 0 0.02701176330447197

An O 0 0.01608113944530487
analysis O 0 0.01820927858352661
of O 0 0.006506245117634535
the O 0 0.008570238016545773
putative O 1 0.9250814318656921
promoter O 1 0.6048278212547302
region O 0 0.017101939767599106
sequence O 0 0.032907236367464066
shows O 0 0.014369180426001549
a O 0 0.014309939928352833
putative O 1 0.9211633205413818
TATA O 1 0.75328528881073
box O 0 0.0328071229159832
and O 0 0.009735644795000553
predicts O 0 0.3165896534919739
multiple O 0 0.4260514974594116
transcription O 1 0.9840158224105835
factor O 0 0.2970428764820099
binding O 0 0.07385420054197311
sites O 0 0.025441136211156845
. O 0 0.022468598559498787

The O 0 0.024151930585503578
genomic O 1 0.8940954208374023
structure O 0 0.02395245060324669
was O 0 0.006712724920362234
determined O 0 0.010604704730212688
using O 0 0.011035141535103321
DNA O 0 0.44453075528144836
from O 0 0.005387597251683474
several O 0 0.00445661460980773
sources O 0 0.006908834911882877
including O 0 0.007313788868486881
multiple O 0 0.0323261134326458
large O 0 0.014577507972717285
- O 0 0.19658881425857544
insert O 1 0.8362716436386108
libaries O 1 0.8621663451194763
and O 0 0.012758761644363403
genomic O 1 0.9935854077339172
DNA O 1 0.9377111196517944
from O 0 0.01637575961649418
Finnish O 1 0.5855909585952759
CLD B-Disease 1 0.9970308542251587
patients O 1 0.9903236627578735
and O 0 0.0151651157066226
controls O 0 0.058398596942424774
. O 0 0.029118048027157784

Exon O 1 0.8942444920539856
- O 0 0.11014965921640396
specific O 0 0.027978844940662384
primers O 1 0.5785499215126038
developed O 0 0.020074404776096344
in O 0 0.004274028353393078
this O 0 0.003393251448869705
study O 0 0.008737492375075817
will O 0 0.004746109712868929
facilitate O 0 0.3736584484577179
mutation O 1 0.9990552067756653
screening O 1 0.8425213694572449
studies O 0 0.0377245768904686
of O 0 0.008905772119760513
patients O 1 0.9902873039245605
with O 0 0.011803889647126198
the O 0 0.018291203305125237
disease O 1 0.998748779296875
. O 0 0.03272468224167824

Genomic O 1 0.8844016194343567
sequencing O 0 0.13972508907318115
of O 0 0.016601474955677986
a O 0 0.02799559198319912
BAC O 1 0.9876399636268616
clone O 1 0.9916900396347046
H O 1 0.9485645890235901
_ O 0 0.026134705170989037
RG364P16 O 1 0.5345028638839722
revealed O 0 0.01251038908958435
the O 0 0.004239841364324093
presence O 0 0.008213172666728497
of O 0 0.0031831779051572084
another O 0 0.00622991006821394
, O 0 0.005949771497398615
highly O 0 0.07081146538257599
homologous O 1 0.9951723217964172
gene O 1 0.9872635006904602
3 O 0 0.010922723449766636
of O 0 0.004455938003957272
the O 0 0.008083566091954708
CLD B-Disease 1 0.9979382157325745
gene O 1 0.9937360286712646
, O 0 0.005580237600952387
with O 0 0.0043048555962741375
a O 0 0.00695386016741395
similar O 0 0.018052013590931892
genomic O 1 0.9888530969619751
structure O 0 0.025422830134630203
, O 0 0.005965246353298426
recently O 0 0.01070387102663517
identified O 0 0.011906176805496216
as O 0 0.0071008941158652306
the O 0 0.016913915053009987
Pendred B-Disease 1 0.9988154172897339
syndrome I-Disease 1 0.9999436140060425
gene O 1 0.998608410358429
( O 0 0.10321109741926193
PDS B-Disease 1 0.9737938642501831
) O 0 0.01998322643339634
. O 0 0.014432976022362709
. O 0 0.020079147070646286

The O 0 0.03573010116815567
APCI1307K O 1 0.9721154570579529
allele O 1 0.9950492978096008
and O 0 0.039179880172014236
cancer B-Disease 1 0.9994335770606995
risk O 1 0.9080214500427246
in O 0 0.0076616681180894375
a O 0 0.009933345951139927
community O 0 0.011922873556613922
- O 0 0.0694873183965683
based O 0 0.010985937900841236
study O 0 0.013727630488574505
of O 0 0.009273063391447067
Ashkenazi O 1 0.6847434043884277
Jews O 0 0.027670135721564293
. O 0 0.02334384247660637

Mutations O 1 0.9828376770019531
in O 0 0.02813037298619747
APC O 1 0.8310516476631165
are O 0 0.014814004302024841
classically O 1 0.8848007917404175
associated O 0 0.185109481215477
with O 0 0.1798030585050583
familial B-Disease 1 0.9996968507766724
adenomatous I-Disease 1 0.9998555183410645
polyposis I-Disease 1 0.9997648596763611
( O 0 0.30107390880584717
FAP B-Disease 1 0.9919195175170898
) O 0 0.019519837573170662
, O 0 0.008756870403885841
a O 0 0.017086902633309364
highly O 0 0.40272173285484314
penetrant O 1 0.9989700317382812
autosomal B-Disease 1 0.9998224377632141
dominant I-Disease 1 0.994895875453949
disorder I-Disease 1 0.999698281288147
characterized O 1 0.9631360769271851
by O 0 0.03255171701312065
multiple O 1 0.985893964767456
intestinal O 1 0.9998059868812561
polyps B-Disease 1 0.9989132881164551
and O 0 0.00901817437261343
, O 0 0.007059184368699789
without O 0 0.01317124255001545
surgical O 1 0.9707848429679871
intervention O 0 0.13847076892852783
, O 0 0.00496599730104208
the O 0 0.005616610404103994
development O 0 0.027446115389466286
of O 0 0.12943966686725616
colorectal B-Disease 1 0.9999580383300781
cancer I-Disease 1 0.999816358089447
( O 0 0.17966575920581818
CRC B-Disease 1 0.9706225991249084
) O 0 0.036016665399074554
. O 0 0.026238346472382545

APC B-Disease 1 0.8134196996688843
is O 0 0.03045203909277916
a O 0 0.053019993007183075
tumour O 1 0.9984437823295593
- O 1 0.9821374416351318
suppressor O 1 0.9984073042869568
gene O 1 0.9929665327072144
, O 0 0.012900546193122864
and O 0 0.009832125157117844
somatic O 1 0.9927152991294861
loss O 0 0.4908204972743988
occurs O 1 0.7930564284324646
in O 0 0.023466525599360466
tumours B-Disease 1 0.997713565826416
. O 0 0.03708794713020325

The O 0 0.04899156093597412
germline O 1 0.992950439453125
T O 1 0.9772608876228333
- O 0 0.08061770349740982
to O 0 0.010152947157621384
- O 0 0.04339282587170601
A O 0 0.018248949199914932
transversion O 0 0.4277319312095642
responsible O 0 0.018222970888018608
for O 0 0.007778456900268793
the O 0 0.009031360037624836
APC O 1 0.979296863079071
I1307K O 1 0.9525070786476135
allele O 1 0.9798178672790527
converts O 0 0.04363109916448593
the O 0 0.009296129457652569
wild O 0 0.06235526502132416
- O 0 0.14453089237213135
type O 0 0.07412199676036835
sequence O 0 0.026583073660731316
to O 0 0.006584816612303257
a O 0 0.013385605067014694
homopolymer O 1 0.9788080453872681
tract O 1 0.9962892532348633
( O 0 0.024157997220754623
A8 O 1 0.9699349999427795
) O 0 0.010536987334489822
that O 0 0.005083166062831879
is O 0 0.007407191209495068
genetically O 1 0.9682563543319702
unstable O 1 0.7805240154266357
and O 0 0.010607616975903511
prone O 1 0.7029123306274414
to O 0 0.017774460837244987
somatic O 1 0.9966675639152527
mutation O 1 0.9976479411125183
. O 0 0.0397021658718586

The O 0 0.03364329785108566
I1307K O 1 0.8128505349159241
allele O 1 0.9518500566482544
was O 0 0.01502529438585043
found O 0 0.015349190682172775
in O 0 0.011985309422016144
6 O 0 0.02595396712422371
. O 0 0.023541154339909554

1 O 0 0.024895530194044113
% O 0 0.01704907976090908
of O 0 0.01037854328751564
unselected O 1 0.6530507802963257
Ashkenazi O 0 0.27064019441604614
Jews O 0 0.012123429216444492
and O 0 0.005945537239313126
higher O 0 0.01236993633210659
proportions O 0 0.17998211085796356
of O 0 0.008199384436011314
Ashkenazim O 1 0.620918869972229
with O 0 0.008256149478256702
family O 0 0.016713228076696396
or O 0 0.009454639628529549
personal O 0 0.01466431561857462
histories O 0 0.13317373394966125
of O 0 0.010811775922775269
CRC B-Disease 1 0.9852504134178162
( O 0 0.024905234575271606
ref O 1 0.7272710204124451
. O 0 0.010028978809714317
2 O 0 0.016037631779909134
) O 0 0.017052358016371727
. O 0 0.02051956206560135

To O 0 0.01605995185673237
evaluate O 0 0.026773300021886826
the O 0 0.007828048430383205
role O 0 0.012602429836988449
of O 0 0.007085805758833885
I1307K O 1 0.820640504360199
in O 0 0.018246149644255638
cancer B-Disease 1 0.99866783618927
, O 0 0.010297239758074284
we O 0 0.00793532095849514
genotyped O 0 0.22588789463043213
5 O 0 0.0179456677287817
, O 0 0.011773071251809597
081 O 1 0.8720749020576477
Ashkenazi O 1 0.5689261555671692
volunteers O 0 0.026944400742650032
in O 0 0.008535311557352543
a O 0 0.012365927919745445
community O 0 0.019533319398760796
survey O 0 0.025474250316619873
. O 0 0.02305254153907299

Risk O 1 0.8129062652587891
of O 0 0.017817694693803787
developing O 1 0.9717386960983276
colorectal B-Disease 1 0.9997891783714294
, I-Disease 0 0.04850700497627258
breast I-Disease 1 0.9992063641548157
and I-Disease 0 0.008223067969083786
other I-Disease 0 0.010815274901688099
cancers I-Disease 1 0.998945415019989
were O 0 0.005673266481608152
compared O 0 0.015207990072667599
between O 0 0.01274797786027193
genotyped O 1 0.9570218920707703
I1307K O 1 0.9123319983482361
carriers O 0 0.42630600929260254
and O 0 0.0064017134718596935
non O 0 0.02672521583735943
- O 0 0.15854433178901672
carriers O 0 0.17485974729061127
and O 0 0.005171581171452999
their O 0 0.005431863479316235
first O 0 0.007972558960318565
- O 0 0.10765881836414337
degree O 0 0.026399891823530197
relatives O 0 0.04039384424686432
. O 0 0.022436771541833878

Sperm O 1 0.9586650729179382
DNA O 1 0.8406721353530884
analysis O 0 0.03990047052502632
in O 0 0.014550586231052876
a O 0 0.033808961510658264
Friedreich B-Disease 1 0.9957701563835144
ataxia I-Disease 1 0.9983474016189575
premutation O 1 0.9676117897033691
carrier O 0 0.35692349076271057
suggests O 0 0.033695392310619354
both O 0 0.013079730793833733
meiotic O 1 0.9784553647041321
and O 0 0.01036312710493803
mitotic O 1 0.8830181360244751
expansion O 0 0.02184992842376232
in O 0 0.00850978959351778
the O 0 0.011793920770287514
FRDA B-Disease 1 0.9748821258544922
gene O 1 0.9908101558685303
. O 0 0.03362933546304703

Friedreich B-Disease 1 0.9894248247146606
ataxia I-Disease 1 0.9965207576751709
is O 0 0.01907084323465824
usually O 0 0.016285603865981102
caused O 0 0.06347343325614929
by O 0 0.007430074270814657
an O 0 0.005625261925160885
expansion O 0 0.013411865569651127
of O 0 0.005960678681731224
a O 0 0.014358919113874435
GAA O 0 0.20666562020778656
trinucleotide O 1 0.9818121790885925
repeat O 0 0.3636065125465393
in O 0 0.015960725024342537
intron O 1 0.9767802357673645
1 O 0 0.013755496591329575
of O 0 0.008475396782159805
the O 0 0.01635073870420456
FRDA B-Disease 1 0.9758778810501099
gene O 1 0.9863762259483337
. O 0 0.03705302253365517

Occasionally O 0 0.033818319439888
, O 0 0.008107305504381657
a O 0 0.009729413315653801
fully O 0 0.01126399077475071
expanded O 0 0.015240545384585857
allele O 1 0.9422390460968018
has O 0 0.005783055443316698
been O 0 0.004327423870563507
found O 0 0.005800755228847265
to O 0 0.004241263028234243
arise O 0 0.03127948194742203
from O 0 0.005922719836235046
a O 0 0.008793510496616364
premutation O 0 0.2201133668422699
of O 0 0.005618768278509378
100 O 0 0.009149913676083088
or O 0 0.012097193859517574
less O 0 0.021504394710063934
triplet O 1 0.9735316634178162
repeats O 1 0.6030895709991455
. O 0 0.032372456043958664

We O 0 0.01352979987859726
have O 0 0.00928033422678709
examined O 0 0.022561779245734215
the O 0 0.01051025465130806
sperm O 1 0.9596462845802307
DNA O 1 0.5926002264022827
of O 0 0.01037311926484108
a O 0 0.020209603011608124
premutation O 1 0.8373819589614868
carrier O 0 0.25950613617897034
. O 0 0.03243016079068184

This O 0 0.02214091457426548
mans O 0 0.12825602293014526
leucocyte O 1 0.871219277381897
DNA O 1 0.751559853553772
showed O 0 0.01782718487083912
one O 0 0.01103400718420744
normal O 0 0.13173188269138336
allele O 1 0.9587349891662598
and O 0 0.007338965777307749
one O 0 0.008385400287806988
allele O 1 0.7925789952278137
of O 0 0.007802323438227177
approximately O 0 0.013847801834344864
100 O 0 0.018010295927524567
repeats O 0 0.08711381256580353
. O 0 0.02378530241549015

His O 0 0.031322866678237915
sperm O 1 0.5577290058135986
showed O 0 0.0194625873118639
an O 0 0.009647737257182598
expanded O 0 0.017426099628210068
allele O 1 0.9411935806274414
in O 0 0.007018372416496277
a O 0 0.008758998475968838
tight O 0 0.016943760216236115
range O 0 0.010797638446092606
centering O 0 0.020855683833360672
on O 0 0.004686994012445211
a O 0 0.006621731910854578
size O 0 0.011029407382011414
of O 0 0.00616510258987546
approximately O 0 0.020420121029019356
320 O 0 0.15570010244846344
trinucleotide O 1 0.9783782362937927
repeats O 1 0.5033255219459534
. O 0 0.03768175095319748

His O 0 0.03368965908885002
affected O 0 0.07719383388757706
son O 0 0.038853537291288376
has O 0 0.013622243888676167
repeat O 0 0.05924468860030174
sizes O 0 0.025916770100593567
of O 0 0.01255884487181902
1040 O 1 0.7600518465042114
and O 0 0.017219094559550285
540 O 0 0.10780689865350723
. O 0 0.03005516156554222

These O 0 0.01524819154292345
data O 0 0.013751765713095665
suggest O 0 0.013383439742028713
that O 0 0.005137978121638298
expansion O 0 0.014376489445567131
occurs O 0 0.03298494219779968
in O 0 0.004169913940131664
two O 0 0.00481631001457572
stages O 0 0.028467033058404922
, O 0 0.004082879517227411
the O 0 0.0034942824859172106
first O 0 0.004861143883317709
during O 0 0.010613013058900833
meiosis O 1 0.9433445334434509
followed O 0 0.012880106456577778
by O 0 0.00694634672254324
a O 0 0.010139677673578262
second O 0 0.014553711749613285
mitotic O 1 0.8847368955612183
expansion O 0 0.056083858013153076
. O 0 0.03194437175989151

We O 0 0.011016275733709335
also O 0 0.005441499408334494
show O 0 0.006417497526854277
that O 0 0.00310831842944026
in O 0 0.0033424682915210724
all O 0 0.0036820548120886087
informative O 0 0.034248992800712585
carrier O 0 0.07217032462358475
father O 0 0.011360476724803448
to O 0 0.005553142167627811
affected O 0 0.13736751675605774
child O 0 0.28284958004951477
transmissions O 0 0.3357749879360199
, O 0 0.004826257470995188
with O 0 0.0036673571448773146
the O 0 0.003122808411717415
notable O 0 0.005615438800305128
exception O 0 0.007262915838509798
of O 0 0.003302834928035736
the O 0 0.005731039680540562
premutation O 1 0.8847578763961792
carrier O 0 0.09130734205245972
, O 0 0.005087141878902912
the O 0 0.005284859798848629
expansion O 0 0.017389852553606033
size O 0 0.02200951986014843
decreases O 0 0.4401104748249054
. O 0 0.015179936774075031
. O 0 0.02142607979476452

The O 0 0.03673529624938965
R496H O 1 0.8583965301513672
mutation O 1 0.9807326197624207
of O 0 0.016689570620656013
arylsulfatase O 1 0.5159317851066589
A O 0 0.021715616807341576
does O 0 0.017784753814339638
not O 0 0.015295435674488544
cause O 1 0.936415433883667
metachromatic B-Disease 1 0.984995424747467
leukodystrophy I-Disease 1 0.992064893245697
. O 0 0.057165537029504776

Deficiency B-Disease 1 0.995912492275238
of I-Disease 0 0.02173934131860733
arylsulfatase I-Disease 1 0.6464705467224121
A I-Disease 0 0.030066221952438354
( O 0 0.03636237233877182
ARSA O 1 0.9895943403244019
) O 0 0.037395499646663666
enzyme O 1 0.9869810938835144
activity O 0 0.4979478716850281
causes O 1 0.9902742505073547
metachromatic B-Disease 1 0.9912433624267578
leukodystrophy I-Disease 1 0.9981464147567749
( O 0 0.11864318698644638
MLD B-Disease 1 0.9778503179550171
) O 0 0.040034640580415726
. O 0 0.02577362209558487

A O 0 0.030101116746664047
number O 0 0.015624772757291794
of O 0 0.018509764224290848
ARSA O 1 0.9914378523826599
gene O 1 0.9978335499763489
mutations O 1 0.9971656203269958
responsible O 0 0.03609137609601021
for O 0 0.01307726837694645
MLD B-Disease 1 0.9824616312980652
have O 0 0.010074804536998272
been O 0 0.011007481254637241
identified O 0 0.025652753189206123
. O 0 0.0192911084741354

Recently O 0 0.03728674724698067
, O 0 0.011388499289751053
the O 0 0.011514085344970226
R496H O 1 0.858655571937561
mutation O 1 0.9960516095161438
of O 0 0.013082735240459442
ARSA O 1 0.9749129414558411
was O 0 0.007592495530843735
proposed O 0 0.010003885254263878
to O 0 0.003895521629601717
be O 0 0.0036572653334587812
a O 0 0.007702633738517761
cause O 0 0.38890576362609863
of O 0 0.010354387573897839
MLD B-Disease 1 0.9931017160415649
( O 0 0.03183874115347862
Draghia O 1 0.9177345037460327
et O 0 0.37157535552978516
al O 0 0.027061354368925095
. O 0 0.008920273743569851
, O 0 0.007906288839876652
1997 O 0 0.020851295441389084
) O 0 0.01850922219455242
. O 0 0.018921300768852234

We O 0 0.01043250598013401
have O 0 0.0070831966586411
investigated O 0 0.01742485910654068
the O 0 0.009531502611935139
R496H O 1 0.9258496761322021
mutation O 1 0.9973468780517578
and O 0 0.006857588421553373
found O 0 0.00835819635540247
this O 0 0.006582356058061123
mutation O 1 0.9957311749458313
at O 0 0.00710562989115715
a O 0 0.006879938300698996
relatively O 0 0.012078778818249702
high O 0 0.008574452251195908
frequency O 0 0.02185998298227787
in O 0 0.004386937245726585
an O 0 0.004376949276775122
African O 0 0.014664508402347565
American O 0 0.010711342096328735
population O 0 0.012936074286699295
( O 0 0.013935619033873081
f O 0 0.09599047899246216
= O 0 0.13963206112384796
0 O 0 0.015870170667767525
. O 0 0.006542139686644077
09 O 0 0.027630198746919632
, O 0 0.009092153050005436
n O 0 0.03185522183775902
= O 0 0.05239144712686539
61 O 0 0.02689996361732483
subjects O 0 0.024354595690965652
) O 0 0.018156075850129128
. O 0 0.018340352922677994

The O 0 0.037255316972732544
ARSA O 1 0.9846487641334534
enzyme O 1 0.9796141982078552
activity O 0 0.02377486042678356
in O 0 0.006063352804630995
subjects O 0 0.010325511917471886
with O 0 0.00424915412440896
and O 0 0.003345416160300374
without O 0 0.005953365005552769
the O 0 0.0063871280290186405
R496H O 1 0.9780262112617493
mutation O 1 0.9979408383369446
was O 0 0.006820878479629755
determined O 0 0.00820472463965416
and O 0 0.0036302783992141485
found O 0 0.0059822178445756435
to O 0 0.004245371092110872
be O 0 0.005947520956397057
normal O 0 0.056548845022916794
. O 0 0.021722322329878807

It O 0 0.01341225579380989
is O 0 0.00838867574930191
therefore O 0 0.008303087204694748
concluded O 0 0.010842325165867805
that O 0 0.0042128786444664
the O 0 0.006185883190482855
R496H O 1 0.9658204317092896
mutation O 1 0.9978016018867493
of O 0 0.012212520465254784
ARSA O 1 0.9908395409584045
does O 0 0.011212415061891079
not O 0 0.004593950696289539
negatively O 0 0.022099412977695465
influence O 0 0.009918748401105404
the O 0 0.004712702706456184
activity O 0 0.013747116550803185
of O 0 0.007138218265026808
ARSA O 1 0.9835071563720703
and O 0 0.005597479175776243
is O 0 0.004708544351160526
not O 0 0.004286621697247028
a O 0 0.011304656974971294
cause O 0 0.40544235706329346
of O 0 0.01856623776257038
MLD B-Disease 1 0.9816696643829346

Down O 0 0.051936984062194824
- O 0 0.06048273295164108
regulation O 0 0.04505467787384987
of O 0 0.017273234203457832
transmembrane O 1 0.9646973609924316
carbonic O 1 0.9907538890838623
anhydrases O 1 0.9730176329612732
in O 0 0.22622424364089966
renal B-Disease 1 0.9997896552085876
cell I-Disease 1 0.999143123626709
carcinoma I-Disease 1 0.9998737573623657
cell O 1 0.9830000400543213
lines O 0 0.0371430329978466
by O 0 0.013780095614492893
wild O 0 0.14958499372005463
- O 1 0.6997417211532593
type O 1 0.8778883814811707
von B-Disease 1 0.9652396440505981
Hippel I-Disease 1 0.9926694631576538
- I-Disease 1 0.9434919953346252
Lindau I-Disease 1 0.9816064834594727
transgenes O 1 0.9404537081718445
. O 0 0.05576092377305031

To O 0 0.02618367038667202
discover O 0 0.14910177886486053
genes O 1 0.9062987565994263
involved O 0 0.027527544647455215
in O 0 0.016552578657865524
von B-Disease 1 0.9109687805175781
Hippel I-Disease 1 0.9946593642234802
- I-Disease 1 0.9638136625289917
Lindau I-Disease 1 0.9950605034828186
( O 0 0.17565098404884338
VHL B-Disease 1 0.9970598816871643
) O 0 0.04005010053515434
- O 1 0.7048085927963257
mediated O 1 0.9905068874359131
carcinogenesis O 1 0.9922210574150085
, O 0 0.00965194869786501
we O 0 0.007883402518928051
used O 0 0.04225281998515129
renal B-Disease 1 0.9997300505638123
cell I-Disease 1 0.9983949065208435
carcinoma I-Disease 1 0.9997263550758362
cell O 1 0.9881882071495056
lines O 0 0.1773299276828766
stably O 1 0.9510629177093506
transfected O 1 0.9807682633399963
with O 0 0.022753393277525902
wild O 0 0.3324853181838989
- O 1 0.8242956399917603
type O 1 0.9629796147346497
VHL O 1 0.9973164200782776
- O 1 0.6165354251861572
expressing O 0 0.1356535106897354
transgenes O 1 0.9280425310134888
. O 0 0.038570158183574677

Large O 0 0.044207897037267685
- O 0 0.06175743043422699
scale O 0 0.06181146577000618
RNA O 1 0.9420788288116455
differential O 0 0.12953799962997437
display O 0 0.012846007011830807
technology O 0 0.012793300673365593
applied O 0 0.009341091848909855
to O 0 0.004027497489005327
these O 0 0.006468497682362795
cell O 1 0.8121140599250793
lines O 0 0.01790503039956093
identified O 0 0.016627324745059013
several O 0 0.009312150999903679
differentially O 1 0.6619254946708679
expressed O 0 0.01858476549386978
genes O 1 0.9751786589622498
, O 0 0.006649854127317667
including O 0 0.007136089727282524
an O 0 0.009873067028820515
alpha O 1 0.7593445181846619
carbonic O 1 0.992879331111908
anhydrase O 1 0.9929814338684082
gene O 1 0.9920023679733276
, O 0 0.027493758127093315
termed O 0 0.3650037944316864
CA12 O 1 0.8524462580680847
. O 0 0.04001142829656601

The O 0 0.021125467494130135
deduced O 0 0.07126777619123459
protein O 1 0.8080949783325195
sequence O 0 0.034855686128139496
was O 0 0.006573198363184929
classified O 0 0.011936687864363194
as O 0 0.00456602917984128
a O 0 0.006218156311661005
one O 0 0.005529248621314764
- O 0 0.03313301131129265
pass O 0 0.02276534028351307
transmembrane O 1 0.9270003437995911
CA O 0 0.021432099863886833
possessing O 0 0.017092596739530563
an O 0 0.006440475583076477
apparently O 0 0.016136012971401215
intact O 0 0.0856509655714035
catalytic O 1 0.8980473279953003
domain O 0 0.02945569157600403
in O 0 0.00694048497825861
the O 0 0.009413007646799088
extracellular O 1 0.8650769591331482
CA O 0 0.05984707176685333
module O 0 0.07354698330163956
. O 0 0.02435094676911831

Reintroduced O 0 0.2828088402748108
wild O 0 0.1751808226108551
- O 0 0.49108248949050903
type O 1 0.7799976468086243
VHL B-Disease 1 0.9940139651298523
strongly O 0 0.03612401708960533
inhibited O 1 0.7190999388694763
the O 0 0.011921726167201996
overexpression O 1 0.8746211528778076
of O 0 0.007261402439326048
the O 0 0.009770635515451431
CA12 O 1 0.9785479307174683
gene O 1 0.9918721318244934
in O 0 0.011658169329166412
the O 0 0.01853610761463642
parental O 1 0.9972860813140869
renal B-Disease 1 0.9998630285263062
cell I-Disease 1 0.9991399049758911
carcinoma I-Disease 1 0.9998284578323364
cell O 1 0.9841384291648865
lines O 0 0.0717054232954979
. O 0 0.03440851345658302

Similar O 0 0.0367015041410923
results O 0 0.019440757110714912
were O 0 0.006302151363343
obtained O 0 0.012326309457421303
with O 0 0.011535922065377235
CA9 O 1 0.9691293239593506
, O 0 0.011029907502233982
encoding O 0 0.147647887468338
another O 0 0.016614988446235657
transmembrane O 1 0.8619726300239563
CA O 0 0.02352006733417511
with O 0 0.00812069047242403
an O 0 0.009148232638835907
intact O 0 0.09888699650764465
catalytic O 1 0.8894838094711304
domain O 0 0.10937818139791489
. O 0 0.02848017029464245

Although O 0 0.020187484100461006
both O 0 0.00872805155813694
domains O 0 0.026147862896323204
of O 0 0.006046561524271965
the O 0 0.010038787499070168
VHL B-Disease 1 0.997502863407135
protein O 1 0.9819137454032898
contribute O 0 0.029824204742908478
to O 0 0.007971454411745071
regulation O 0 0.024823958054184914
of O 0 0.0067317895591259
CA12 O 1 0.7184788584709167
expression O 0 0.039107292890548706
, O 0 0.005838585551828146
the O 0 0.006144643295556307
elongin O 1 0.6325621604919434
binding O 0 0.25838029384613037
domain O 0 0.04435896873474121
alone O 0 0.016069713979959488
could O 0 0.01292995736002922
effectively O 0 0.050776220858097076
regulate O 1 0.8258066177368164
CA9 O 1 0.9761992692947388
expression O 0 0.22058922052383423
. O 0 0.0328904464840889

We O 0 0.03013000264763832
mapped O 0 0.06948382407426834
CA12 O 1 0.5701616406440735
and O 0 0.027707796543836594
CA9 O 1 0.9550583362579346
loci O 1 0.9484166502952576
to O 0 0.02746664546430111
chromosome O 1 0.9867364764213562
bands O 0 0.05329202488064766
15q22 O 0 0.36054402589797974
and O 0 0.021609675139188766
17q21 O 0 0.4518231451511383
. O 0 0.03850056603550911

2 O 0 0.028452886268496513
respectively O 0 0.018708381801843643
, O 0 0.00983665231615305
regions O 0 0.021105876192450523
prone O 0 0.3268209397792816
to O 0 0.00881117582321167
amplification O 1 0.7856858372688293
in O 0 0.0073697553016245365
some O 0 0.010897397994995117
human O 1 0.6628449559211731
cancers B-Disease 1 0.9988447427749634
. O 0 0.03558202087879181

Additional O 0 0.028304029256105423
experiments O 0 0.026527520269155502
are O 0 0.004538785200566053
needed O 0 0.007230723742395639
to O 0 0.0027927348855882883
define O 0 0.008421550504863262
the O 0 0.003322129137814045
role O 0 0.0077653187327086926
of O 0 0.005062065552920103
CA O 0 0.03562316671013832
IX O 1 0.6294333338737488
and O 0 0.006588273216038942
CA O 0 0.04921416565775871
XII O 1 0.6520189046859741
enzymes O 1 0.7874085307121277
in O 0 0.0052223000675439835
the O 0 0.004994383081793785
regulation O 0 0.02286519855260849
of O 0 0.005782430525869131
pH O 1 0.9309617877006531
in O 0 0.005897181574255228
the O 0 0.006636961828917265
extracellular O 1 0.9624976515769958
microenvironment O 1 0.9847280979156494
and O 0 0.0061120460741221905
its O 0 0.0071672736667096615
potential O 0 0.034304387867450714
impact O 0 0.05014888197183609
on O 0 0.015990199521183968
cancer B-Disease 1 0.999691367149353
cell O 1 0.9906170964241028
growth O 0 0.3165721297264099
. O 0 0.030401768162846565

A O 0 0.06167927384376526
gene O 1 0.9726291298866272
encoding O 0 0.3346828520298004
a O 0 0.028563939034938812
transmembrane O 1 0.956759512424469
protein O 1 0.963620126247406
is O 0 0.015966948121786118
mutated O 1 0.9960441589355469
in O 0 0.05015889182686806
patients O 1 0.9982823133468628
with O 1 0.8422383666038513
diabetes B-Disease 1 0.999934196472168
mellitus I-Disease 1 0.9993782043457031
and O 0 0.2736995816230774
optic B-Disease 1 0.9986874461174011
atrophy I-Disease 1 0.9986880421638489
( O 1 0.8239856362342834
Wolfram B-Disease 1 0.9973198771476746
syndrome I-Disease 1 0.9995009899139404
) O 0 0.05085422843694687
. O 0 0.035188667476177216

Wolfram B-Disease 1 0.9875739216804504
syndrome I-Disease 1 0.9987797141075134
( O 0 0.21209834516048431
WFS B-Disease 1 0.9764590263366699
; O 0 0.06995324045419693
OMIM O 1 0.9872647523880005
222300 O 1 0.8052844405174255
) O 0 0.024877458810806274
is O 0 0.015456964261829853
an O 0 0.09747837483882904
autosomal B-Disease 1 0.9998968839645386
recessive I-Disease 1 0.9999293088912964
neurodegenerative I-Disease 1 0.9999092817306519
disorder I-Disease 1 0.9995244741439819
defined O 0 0.06656154245138168
by O 0 0.01535985991358757
young O 0 0.25861307978630066
- O 1 0.968212902545929
onset O 1 0.9990755319595337
non O 1 0.8655750155448914
- O 1 0.9941330552101135
immune O 1 0.9997552037239075
insulin B-Disease 1 0.9993158578872681
- I-Disease 1 0.9923397302627563
dependent I-Disease 1 0.9937149882316589
diabetes I-Disease 1 0.9998925924301147
mellitus I-Disease 1 0.9989173412322998
and O 0 0.05590761825442314
progressive O 1 0.978325605392456
optic B-Disease 1 0.9973673224449158
atrophy I-Disease 1 0.9954476952552795
. O 0 0.06119248643517494

Linkage O 0 0.25177738070487976
to O 0 0.01718851551413536
markers O 0 0.07509462535381317
on O 0 0.01639142632484436
chromosome O 1 0.9967015385627747
4p O 1 0.9264214038848877
was O 0 0.009894326329231262
confirmed O 0 0.01606742851436138
in O 0 0.006669815629720688
five O 0 0.010912199504673481
families O 0 0.02409628964960575
. O 0 0.0203256756067276

On O 0 0.0104893883690238
the O 0 0.006484151817858219
basis O 0 0.0101761594414711
of O 0 0.010414721444249153
meiotic O 1 0.9924764037132263
recombinants O 1 0.9815638065338135
and O 0 0.05302921310067177
disease O 1 0.9995549321174622
- O 1 0.8677756786346436
associated O 0 0.3777907192707062
haplotypes O 1 0.9892035126686096
, O 0 0.010278075002133846
the O 0 0.012014728970825672
WFS B-Disease 1 0.9930661916732788
gene O 1 0.9914242625236511
was O 0 0.011314083822071552
localized O 1 0.7594894170761108
to O 0 0.00865425169467926
a O 0 0.019219432026147842
BAC O 1 0.9875727891921997
/ O 1 0.7502642869949341
P1 O 1 0.8702635765075684
contig O 0 0.2740947902202606
of O 0 0.007897971197962761
less O 0 0.01065327599644661
than O 0 0.0101314727216959
250 O 0 0.02698839083313942
kb O 0 0.2843974530696869
. O 0 0.027609840035438538

Mutations O 1 0.9798097610473633
in O 0 0.015774251893162727
a O 0 0.019089968875050545
novel O 0 0.3226866126060486
gene O 1 0.9940968751907349
( O 0 0.02654757723212242
WFS1 O 1 0.8323370814323425
) O 0 0.013904619961977005
encoding O 0 0.15573856234550476
a O 0 0.0140707828104496
putative O 1 0.973869264125824
transmembrane O 1 0.9724950194358826
protein O 1 0.7835225462913513
were O 0 0.004004247020930052
found O 0 0.005640052258968353
in O 0 0.0032954076305031776
all O 0 0.0030903839506208897
affected O 0 0.018640266731381416
individuals O 0 0.009164387360215187
in O 0 0.005413915496319532
six O 0 0.011582033708691597
WFS B-Disease 1 0.9887890219688416
families O 0 0.011243436485528946
, O 0 0.004362425766885281
and O 0 0.0035513918846845627
these O 0 0.005550343077629805
mutations O 1 0.9971888661384583
were O 0 0.0045114196836948395
associated O 0 0.019967349246144295
with O 0 0.009778924286365509
the O 0 0.04581586644053459
disease O 1 0.9997425675392151
phenotype O 1 0.9986376166343689
. O 0 0.044715236872434616

WFS1 O 1 0.6823710799217224
appears O 0 0.031430020928382874
to O 0 0.008489308878779411
function O 0 0.02225401997566223
in O 0 0.008531236089766026
survival O 0 0.27269789576530457
of O 0 0.012020197696983814
islet O 1 0.983790934085846
beta O 1 0.9730100035667419
- O 1 0.9207763671875
cells O 1 0.9920582175254822
and O 0 0.01517423428595066
neurons O 1 0.939038872718811
. O 0 0.016962330788373947
. O 0 0.01954025775194168

Stable O 0 0.12146557867527008
interaction O 0 0.03531660884618759
between O 0 0.007959697395563126
the O 0 0.004939445294439793
products O 0 0.012243201024830341
of O 0 0.006255826912820339
the O 0 0.012055152095854282
BRCA1 O 1 0.9993688464164734
and O 0 0.15603862702846527
BRCA2 O 1 0.9997790455818176
tumor B-Disease 1 0.9997438788414001
suppressor O 1 0.9975935816764832
genes O 1 0.9889113903045654
in O 0 0.019051969051361084
mitotic O 1 0.9614818692207336
and O 0 0.026425475254654884
meiotic O 1 0.9921736717224121
cells O 1 0.9887569546699524
. O 0 0.03812938928604126

BRCA1 O 1 0.9936536550521851
and O 0 0.029543377459049225
BRCA2 O 1 0.9954415559768677
account O 0 0.015047293156385422
for O 0 0.006202779710292816
most O 0 0.006511983461678028
cases O 0 0.01834920234978199
of O 0 0.0089574558660388
familial O 1 0.9986163377761841
, O 0 0.012170916423201561
early O 0 0.23108841478824615
onset O 1 0.9996439218521118
breast B-Disease 1 0.9995691180229187
and I-Disease 0 0.02530982345342636
/ I-Disease 1 0.9750403165817261
or I-Disease 1 0.7747948169708252
ovarian I-Disease 1 0.9999536275863647
cancer I-Disease 1 0.999769389629364
and O 0 0.010007588192820549
encode O 0 0.2970736026763916
products O 0 0.01975061371922493
that O 0 0.006048487965017557
each O 0 0.0073050460778176785
interact O 0 0.07387273013591766
with O 0 0.015154208987951279
hRAD51 O 1 0.7206895351409912
. O 0 0.025267954915761948

Results O 0 0.03482711687684059
presented O 0 0.01665046624839306
here O 0 0.006979862228035927
show O 0 0.011083705350756645
that O 0 0.010066342540085316
BRCA1 O 1 0.9985812902450562
and O 0 0.018140077590942383
BRCA2 O 1 0.9990761280059814
coexist O 0 0.479104608297348
in O 0 0.007592690177261829
a O 0 0.011826314963400364
biochemical O 1 0.8938288688659668
complex O 0 0.02252272143959999
and O 0 0.006381991785019636
colocalize O 1 0.5091637969017029
in O 0 0.011088347062468529
subnuclear O 1 0.9202518463134766
foci O 1 0.9705784916877747
in O 0 0.017467966303229332
somatic O 1 0.99760901927948
cells O 1 0.9782533049583435
and O 0 0.004836581647396088
on O 0 0.0036054851952940226
the O 0 0.004487873055040836
axial O 0 0.2488948255777359
elements O 0 0.01454626489430666
of O 0 0.009609987027943134
developing O 0 0.40060895681381226
synaptonemal O 1 0.9248701930046082
complexes O 1 0.5270251035690308
. O 0 0.03138090297579765

Like O 0 0.08316180855035782
BRCA1 O 1 0.9904028177261353
and O 0 0.03537141531705856
RAD51 O 1 0.9777896404266357
, O 0 0.03633934259414673
BRCA2 O 1 0.9959678649902344
relocates O 1 0.7710667848587036
to O 0 0.021476266905665398
PCNA O 1 0.9874518513679504
+ O 1 0.9125882387161255
replication O 1 0.9621834754943848
sites O 0 0.015813447535037994
following O 0 0.013992938213050365
exposure O 1 0.5074689388275146
of O 0 0.010017349384725094
S O 0 0.38225889205932617
phase O 1 0.6110976934432983
cells O 1 0.9885411262512207
to O 0 0.017979169264435768
hydroxyurea O 1 0.9899947643280029
or O 0 0.0745358094573021
UV O 1 0.9889602661132812
irradiation O 1 0.8928391933441162
. O 0 0.04226269572973251

Thus O 0 0.039960410445928574
, O 0 0.023762665688991547
BRCA1 O 1 0.9957660436630249
and O 0 0.01992027275264263
BRCA2 O 1 0.9974740147590637
participate O 0 0.015227763913571835
, O 0 0.005559620913118124
together O 0 0.005794636905193329
, O 0 0.003998842556029558
in O 0 0.004932742100208998
a O 0 0.00951395370066166
pathway O 1 0.9789360761642456
( O 0 0.013911735266447067
s O 0 0.0581032820045948
) O 0 0.00802129041403532
associated O 0 0.009606322273612022
with O 0 0.004490622319281101
the O 0 0.00477772019803524
activation O 1 0.704999566078186
of O 0 0.00588188273832202
double O 0 0.09790074080228806
- O 1 0.524882435798645
strand O 1 0.9415988326072693
break O 0 0.058316297829151154
repair O 1 0.6376071572303772
and O 0 0.010923382826149464
/ O 0 0.44489237666130066
or O 0 0.030864739790558815
homologous O 1 0.9897476434707642
recombination O 1 0.9815284013748169
. O 0 0.042805567383766174

Dysfunction O 1 0.9887909889221191
of O 0 0.011979201808571815
this O 0 0.00999786052852869
pathway O 1 0.8981153964996338
may O 0 0.00944247841835022
be O 0 0.003255804069340229
a O 0 0.005182224325835705
general O 0 0.00529105681926012
phenomenon O 0 0.043278325349092484
in O 0 0.0032008353155106306
the O 0 0.003061621682718396
majority O 0 0.005804542917758226
of O 0 0.0039949263446033
cases O 0 0.023306168615818024
of O 0 0.010246329009532928
hereditary B-Disease 1 0.9991208910942078
breast I-Disease 1 0.999760091304779
and I-Disease 0 0.03692255914211273
/ I-Disease 1 0.9885634183883667
or I-Disease 1 0.9293464422225952
ovarian I-Disease 1 0.9999555349349976
cancer I-Disease 1 0.9997020363807678
. O 0 0.02577592059969902
. O 0 0.027186717838048935

A O 0 0.04892558977007866
novel O 0 0.08641091734170914
Arg362Ser O 1 0.9278205037117004
mutation O 1 0.9862602353096008
in O 0 0.014477130956947803
the O 0 0.014555223286151886
sterol O 1 0.9647414088249207
27 O 0 0.04958522319793701
- O 1 0.8154140710830688
hydroxylase O 1 0.9932397603988647
gene O 1 0.9944050312042236
( O 0 0.030819443985819817
CYP27 O 1 0.7761937975883484
) O 0 0.01144365780055523
: O 0 0.00784039031714201
its O 0 0.006343614310026169
effects O 0 0.07165590673685074
on O 0 0.007032565772533417
pre O 0 0.08804158121347427
- O 0 0.3059951364994049
mRNA O 1 0.9325647950172424
splicing O 1 0.9715793132781982
and O 0 0.017157994210720062
enzyme O 1 0.9688639044761658
activity O 0 0.0545552596449852
. O 0 0.026549741625785828

A O 0 0.04064101353287697
novel O 0 0.04435551166534424
C O 0 0.04149506613612175
to O 0 0.008619661442935467
A O 0 0.01651962846517563
mutation O 1 0.9872034192085266
in O 0 0.009175406768918037
the O 0 0.010950959287583828
sterol O 1 0.9786706566810608
27 O 0 0.053587429225444794
- O 1 0.8396468758583069
hydroxylase O 1 0.9935716390609741
gene O 1 0.9958180785179138
( O 0 0.0267571322619915
CYP27 O 1 0.8025359511375427
) O 0 0.012136314064264297
was O 0 0.0065699853003025055
identified O 0 0.013301445171236992
by O 0 0.011711284518241882
sequencing O 1 0.8323251605033875
amplified O 1 0.8637266159057617
CYP27 O 1 0.9824684262275696
gene O 1 0.9925693869590759
products O 0 0.03164175897836685
from O 0 0.00998246856033802
a O 0 0.01830950379371643
patient O 1 0.9261289238929749
with O 0 0.024015478789806366
cerebrotendinous B-Disease 1 0.9799441695213318
xanthomatosis I-Disease 1 0.9762758016586304
( O 0 0.06635802239179611
CTX B-Disease 1 0.9789127707481384
) O 0 0.03327178210020065
. O 0 0.025521190837025642

The O 0 0.0363461971282959
mutation O 1 0.9769220352172852
changed O 0 0.028718147426843643
the O 0 0.013547479175031185
adrenodoxin O 1 0.6559377312660217
cofactor O 1 0.8320453763008118
binding O 0 0.29699525237083435
residue O 0 0.48439541459083557
362Arg O 0 0.4553763270378113
to O 0 0.016521619632840157
362Ser O 1 0.6619214415550232
( O 0 0.030694279819726944
CGT O 1 0.5246745944023132
362Arg O 1 0.7840204238891602
to O 0 0.01748529262840748
AGT O 1 0.9939523339271545
362Ser O 1 0.8825682997703552
) O 0 0.01143078412860632
, O 0 0.004788683727383614
and O 0 0.0030763319227844477
was O 0 0.004428335931152105
responsible O 0 0.012760383076965809
for O 0 0.008999000303447247
deficiency O 1 0.999284565448761
in O 0 0.008462214842438698
the O 0 0.008436411619186401
sterol O 1 0.9899839162826538
27 O 0 0.040378790348768234
- O 1 0.6819178462028503
hydroxylase O 1 0.9839032888412476
activity O 0 0.02486417628824711
, O 0 0.00579165481030941
as O 0 0.004762629978358746
confirmed O 0 0.009701225906610489
by O 0 0.006443991791456938
expression O 0 0.027705255895853043
of O 0 0.010103192180395126
mutant O 1 0.9722129106521606
cDNA O 1 0.8837752938270569
into O 0 0.02735809236764908
COS O 1 0.9690406322479248
- O 0 0.3674062192440033
1 O 0 0.037704989314079285
cells O 1 0.9723629355430603
. O 0 0.026631250977516174

Quantitative O 0 0.09125560522079468
analysis O 0 0.024601653218269348
showed O 0 0.01040256954729557
that O 0 0.004099362995475531
the O 0 0.004208810161799192
expression O 0 0.023218147456645966
of O 0 0.008613275364041328
CYP27 O 1 0.9907591342926025
gene O 1 0.9970526695251465
mRNA O 1 0.8071314692497253
in O 0 0.009954147972166538
the O 0 0.009361269883811474
patient O 1 0.7920770049095154
represented O 0 0.017464637756347656
52 O 0 0.03639007359743118
. O 0 0.023249324411153793

5 O 0 0.021907711401581764
% O 0 0.012367826886475086
of O 0 0.005854260642081499
the O 0 0.00785189401358366
normal O 0 0.03623804450035095
level O 0 0.021025024354457855
. O 0 0.019822245463728905

As O 0 0.01741264946758747
the O 0 0.013882175087928772
mutation O 1 0.9878036975860596
occurred O 0 0.023079898208379745
at O 0 0.007280462887138128
the O 0 0.0075389910489320755
penultimate O 0 0.36545395851135254
nucleotide O 1 0.7924285531044006
of O 0 0.01069489773362875
exon O 1 0.7591173648834229
6 O 0 0.0195865910500288
( O 0 0.012691647745668888
- O 0 0.020507287234067917
2 O 0 0.008752194233238697
position O 0 0.006476286798715591
of O 0 0.006773621775209904
exon O 1 0.7090801000595093
6 O 0 0.02485024183988571
- O 0 0.3221178352832794
intron O 1 0.9865617156028748
6 O 0 0.02342524379491806
splice O 1 0.9257270693778992
site O 0 0.011709778569638729
) O 0 0.0059235310181975365
of O 0 0.0034972894936800003
the O 0 0.005287620238959789
gene O 1 0.979005753993988
, O 0 0.004838679451495409
we O 0 0.003707488998770714
hypothesized O 0 0.18264804780483246
that O 0 0.004044810775667429
the O 0 0.006468013860285282
mutation O 1 0.9983880519866943
may O 0 0.014475070871412754
partially O 0 0.04673240706324577
affect O 0 0.019326450303196907
the O 0 0.005307218991219997
normal O 0 0.11293734610080719
splicing O 1 0.975888192653656
efficiency O 0 0.03825627639889717
in O 0 0.009792666882276535
exon O 1 0.6970039010047913
6 O 0 0.013085704296827316
and O 0 0.006829944904893637
cause O 1 0.539287269115448
alternative O 0 0.06313757598400116
splicing O 1 0.9610385894775391
elsewhere O 0 0.012022105976939201
, O 0 0.004285679664462805
which O 0 0.0040029557421803474
resulted O 0 0.01490912213921547
in O 0 0.006590087432414293
decreased O 0 0.4720526933670044
transcript O 0 0.2873710095882416
in O 0 0.007720257621258497
the O 0 0.010693580843508244
patient O 1 0.9643431305885315
. O 0 0.024945087730884552

Transfection O 1 0.8505259156227112
of O 0 0.01616046018898487
constructed O 0 0.022926095873117447
minigenes O 0 0.40872400999069214
, O 0 0.007517912890762091
with O 0 0.005465488415211439
or O 0 0.005884875077754259
without O 0 0.0052969129756093025
the O 0 0.005556863732635975
mutation O 1 0.9966044425964355
, O 0 0.006549092009663582
into O 0 0.01024298183619976
COS O 1 0.9739900231361389
- O 0 0.27434220910072327
1 O 0 0.018591180443763733
cells O 1 0.9826447367668152
confirmed O 0 0.010711479000747204
that O 0 0.0035361377522349358
the O 0 0.005801816936582327
mutant O 1 0.9757739901542664
minigene O 1 0.5000405311584473
was O 0 0.00772459851577878
responsible O 0 0.010455135256052017
for O 0 0.005457056686282158
a O 0 0.012576098553836346
mRNA O 1 0.7829422354698181
species O 0 0.07207740098237991
alternatively O 0 0.24586434662342072
spliced O 1 0.8631733655929565
at O 0 0.010575906373560429
an O 0 0.00971108116209507
activated O 1 0.5119054317474365
cryptic O 1 0.6022380590438843
5 O 0 0.02021140791475773
splice O 1 0.6036149263381958
site O 0 0.016017163172364235
88 O 0 0.022152189165353775
bp O 0 0.036083295941352844
upstream O 0 0.023512260988354683
from O 0 0.006601521745324135
the O 0 0.004991942550987005
3 O 0 0.0088011734187603
end O 0 0.008781258016824722
of O 0 0.0090555464848876
exon O 1 0.7278172373771667
6 O 0 0.03145819529891014
. O 0 0.023779485374689102

Our O 0 0.020632676780223846
data O 0 0.014505610801279545
suggest O 0 0.0144053278490901
that O 0 0.004703970160335302
the O 0 0.005330210085958242
C O 0 0.02328144758939743
to O 0 0.005351376719772816
A O 0 0.01306306105107069
mutation O 1 0.9927667379379272
at O 0 0.006806193385273218
the O 0 0.005766276735812426
penultimate O 0 0.4927331805229187
nucleotide O 1 0.8558627963066101
of O 0 0.008729669265449047
exon O 0 0.3981548249721527
6 O 0 0.010168596170842648
of O 0 0.003949896898120642
the O 0 0.006646513007581234
CYP27 O 1 0.9780400991439819
gene O 1 0.9926350712776184
not O 0 0.0062024821527302265
only O 0 0.005829955451190472
causes O 1 0.8958202600479126
the O 0 0.01154276542365551
deficiency B-Disease 1 0.999321460723877
in I-Disease 0 0.0108486982062459
the I-Disease 0 0.011972482316195965
sterol I-Disease 1 0.986182689666748
27 I-Disease 0 0.05204452946782112
- I-Disease 1 0.6459127068519592
hydroxylase I-Disease 1 0.982883632183075
activity I-Disease 0 0.02345169335603714
, O 0 0.005096083972603083
but O 0 0.00401685805991292
also O 0 0.004141439218074083
partially O 0 0.020774921402335167
leads O 0 0.01588095724582672
to O 0 0.006069318391382694
alternative O 0 0.023245183750987053
pre O 0 0.16082258522510529
- O 0 0.28086572885513306
mRNA O 1 0.7838888168334961
splicing O 1 0.8410292267799377
of O 0 0.009744263254106045
the O 0 0.013633103109896183
gene O 1 0.9868687987327576
. O 0 0.02726389840245247

To O 0 0.00986967422068119
our O 0 0.007776730693876743
knowledge O 0 0.009529773145914078
, O 0 0.0033866018056869507
this O 0 0.00252413097769022
is O 0 0.0024372076150029898
the O 0 0.00236228434368968
first O 0 0.002946973778307438
report O 0 0.004464398603886366
regarding O 0 0.008285452611744404
effects O 0 0.08359746634960175
on O 0 0.005172430071979761
pre O 0 0.08689246326684952
- O 0 0.30745118856430054
mRNA O 1 0.8752013444900513
splicing O 1 0.8432573676109314
of O 0 0.007973984815180302
a O 0 0.015411622822284698
mutation O 1 0.993587851524353
at O 0 0.007648468017578125
the O 0 0.005116121377795935
- O 0 0.018514450639486313
2 O 0 0.0074965390376746655
position O 0 0.005160176195204258
of O 0 0.004319475498050451
a O 0 0.010590285062789917
5 O 0 0.016883589327335358
splice O 1 0.833703339099884
site O 0 0.031971175223588943
. O 0 0.023770909756422043

ATM O 1 0.9249776005744934
germline O 1 0.9928478002548218
mutations O 1 0.9926183819770813
in O 0 0.028159042820334435
classical O 1 0.543202817440033
ataxia B-Disease 1 0.9996457099914551
- I-Disease 1 0.9952281713485718
telangiectasia I-Disease 1 0.9994353652000427
patients O 1 0.9936739206314087
in O 0 0.010728146880865097
the O 0 0.008671246469020844
Dutch O 0 0.027302246540784836
population O 0 0.025606002658605576
. O 0 0.02302883006632328

Germline O 1 0.9905900955200195
mutations O 1 0.9849653244018555
in O 0 0.014801308512687683
the O 0 0.011641522869467735
ATM O 1 0.7313414216041565
gene O 1 0.9714170694351196
are O 0 0.007729958277195692
responsible O 0 0.01726951077580452
for O 0 0.01075639110058546
the O 0 0.2596921920776367
autosomal B-Disease 1 0.9999570846557617
recessive I-Disease 1 0.999971866607666
disorder I-Disease 1 0.9999589920043945
ataxia B-Disease 1 0.9997994303703308
- I-Disease 1 0.993638813495636
telangiectasia I-Disease 1 0.998856782913208
( O 0 0.07487346976995468
A B-Disease 0 0.16278411448001862
- I-Disease 1 0.8318442702293396
T I-Disease 1 0.9846999645233154
) O 0 0.0274993646889925
. O 0 0.021266110241413116

In O 0 0.014833926223218441
our O 0 0.009690220467746258
study O 0 0.011614138260483742
, O 0 0.004058352671563625
we O 0 0.0027303588576614857
have O 0 0.0028613191097974777
determined O 0 0.007054125890135765
the O 0 0.005505617707967758
ATM O 1 0.883883535861969
mutation O 1 0.9974474906921387
spectrum O 0 0.103664830327034
in O 0 0.005856925155967474
19 O 0 0.01026242971420288
classical O 0 0.018769921734929085
A B-Disease 0 0.08090893179178238
- I-Disease 1 0.9534597992897034
T I-Disease 1 0.9984700083732605
patients O 1 0.9949718713760376
, O 0 0.006212695501744747
including O 0 0.004799535498023033
some O 0 0.0050140367820858955
immigrant O 0 0.08932938426733017
populations O 0 0.21496820449829102
, O 0 0.0037949727848172188
as O 0 0.0029558250680565834
well O 0 0.0032995750661939383
as O 0 0.0033148510847240686
12 O 0 0.006068328395485878
of O 0 0.004294332582503557
Dutch O 0 0.015649788081645966
ethnic O 0 0.016229871660470963
origin O 0 0.027797214686870575
. O 0 0.022665970027446747

Both O 0 0.01910129375755787
the O 0 0.014445407316088676
protein O 1 0.9281884431838989
truncation O 1 0.8256711959838867
test O 0 0.0354304201900959
( O 0 0.01587301678955555
PTT O 0 0.06872805207967758
) O 0 0.010255374945700169
and O 0 0.005127989687025547
the O 0 0.007281056605279446
restriction O 0 0.1506575047969818
endonuclease O 1 0.9834936857223511
fingerprinting O 1 0.6298006772994995
( O 0 0.021993480622768402
REF O 1 0.7132474184036255
) O 0 0.009011306799948215
method O 0 0.010142391547560692
were O 0 0.0023424301762133837
used O 0 0.003532133065164089
and O 0 0.0027348732110112906
compared O 0 0.007300057914108038
for O 0 0.003665352240204811
their O 0 0.005674600601196289
detection O 1 0.5232658982276917
efficiency O 0 0.025876440107822418
, O 0 0.006328481249511242
identifying O 0 0.06252562254667282
76 O 0 0.018932579085230827
% O 0 0.008398852311074734
and O 0 0.0037060712929815054
60 O 0 0.007148703094571829
% O 0 0.006706540938466787
of O 0 0.004384717438369989
the O 0 0.007683352567255497
mutations O 1 0.9952034950256348
, O 0 0.010857329703867435
respectively O 0 0.018358025699853897
. O 0 0.018500464037060738

Most O 0 0.02935062162578106
patients O 1 0.8617417812347412
were O 0 0.005707254633307457
found O 0 0.008470156230032444
to O 0 0.0058040008880198
be O 0 0.007116538006812334
compound O 0 0.12639273703098297
heterozygote O 1 0.9642319679260254
. O 0 0.02675517089664936

Seventeen O 0 0.06313662230968475
mutations O 1 0.9726169109344482
were O 0 0.008694254793226719
distinct O 0 0.020002277567982674
, O 0 0.00439279293641448
of O 0 0.002986618783324957
which O 0 0.0029675879050046206
10 O 0 0.004329976625740528
were O 0 0.0029934279154986143
not O 0 0.004879064857959747
reported O 0 0.013897091150283813
previously O 0 0.016126742586493492
. O 0 0.018138770014047623

Mutations O 1 0.9784994125366211
are O 0 0.01485238503664732
small O 0 0.022800786420702934
deletions O 1 0.7154584527015686
or O 0 0.017616374418139458
point O 0 0.018868692219257355
mutations O 1 0.9955974221229553
frequently O 0 0.03721662983298302
affecting O 1 0.6012187600135803
splice O 1 0.9446092247962952
sites O 0 0.03894057869911194
. O 0 0.028255034238100052

Moreover O 0 0.05483093112707138
, O 0 0.01437088381499052
a O 0 0.015939986333251
16 O 0 0.026257701218128204
. O 0 0.025598695501685143

7 O 0 0.05880594626069069
- O 0 0.11263036727905273
kb O 1 0.577623188495636
genomic O 1 0.973170816898346
deletion O 1 0.5642470121383667
of O 0 0.005964008159935474
the O 0 0.004929906222969294
3 O 0 0.007053771987557411
end O 0 0.004904297646135092
of O 0 0.003141493070870638
the O 0 0.005180027335882187
gene O 1 0.991292417049408
, O 0 0.004418367985635996
most O 0 0.0037669376470148563
likely O 0 0.006457799579948187
a O 0 0.004895360674709082
result O 0 0.008047212846577168
of O 0 0.0049538519233465195
recombination O 1 0.9578410387039185
between O 0 0.007237175479531288
two O 0 0.005129599943757057
LINE O 0 0.009881777688860893
elements O 0 0.011607948690652847
, O 0 0.005581838544458151
was O 0 0.007333895191550255
identified O 0 0.02306108921766281
. O 0 0.02008512243628502

The O 0 0.01427300926297903
most O 0 0.009696398861706257
frequently O 0 0.014283234253525734
found O 0 0.021455543115735054
mutation O 1 0.9975929856300354
, O 0 0.006731763947755098
identified O 0 0.009797652252018452
in O 0 0.0045262291096150875
three O 0 0.006479846779257059
unrelated O 0 0.2041040062904358
Turkish O 0 0.022141000255942345
A B-Disease 0 0.047164011746644974
- I-Disease 1 0.7816361784934998
T I-Disease 1 0.9912759065628052
individuals O 0 0.012967615388333797
, O 0 0.004070736933499575
was O 0 0.0037067600060254335
previously O 0 0.004873448982834816
described O 0 0.006184082943946123
to O 0 0.002871698932722211
be O 0 0.0032481022644788027
a O 0 0.007521967403590679
Turkish O 0 0.016855774447321892
A B-Disease 0 0.03485114872455597
- I-Disease 1 0.8027489185333252
T I-Disease 1 0.9928044676780701
founder O 1 0.5874407291412354
mutation O 1 0.9918913841247559
. O 0 0.03780593350529671

The O 0 0.014808458276093006
presence O 0 0.017425822094082832
of O 0 0.00629218528047204
a O 0 0.012226570397615433
founder O 0 0.1519920378923416
mutation O 1 0.9959347248077393
among O 0 0.010678796097636223
relatively O 0 0.01323339156806469
small O 0 0.00812184251844883
ethnic O 0 0.008602166548371315
population O 0 0.006726696155965328
groups O 0 0.005428513046354055
in O 0 0.003705055685713887
Western O 0 0.007373454514890909
Europe O 0 0.007097852881997824
could O 0 0.004848362412303686
indicate O 0 0.009385228157043457
a O 0 0.007305477745831013
high O 0 0.011558301746845245
carrier O 0 0.15504370629787445
frequency O 0 0.027917586266994476
in O 0 0.006329701282083988
such O 0 0.008770772255957127
communities O 0 0.025310631841421127
. O 0 0.01862736977636814

In O 0 0.022419357672333717
patients O 1 0.8559068441390991
of O 0 0.006903478875756264
Dutch O 0 0.016638977453112602
ethnic O 0 0.011725411750376225
origin O 0 0.010619735345244408
, O 0 0.00426520174369216
however O 0 0.0038250214420259
, O 0 0.003380218520760536
no O 0 0.004203966353088617
significant O 0 0.008992267772555351
founder O 0 0.028666453436017036
effect O 0 0.020728476345539093
could O 0 0.006478527095168829
be O 0 0.005408356431871653
identified O 0 0.021164964884519577
. O 0 0.016912223771214485

The O 0 0.022708095610141754
observed O 0 0.057037584483623505
genetic O 1 0.9858341813087463
heterogeneity O 1 0.5759379863739014
including O 0 0.00888269953429699
the O 0 0.00581110967323184
relative O 0 0.014771931804716587
high O 0 0.011200525797903538
percentage O 0 0.01466426718980074
of O 0 0.007814350537955761
splice O 1 0.9832434058189392
- O 0 0.36676666140556335
site O 0 0.02487865462899208
mutations O 1 0.9949370622634888
had O 0 0.008062450215220451
no O 0 0.006361767649650574
reflection O 0 0.017584098502993584
on O 0 0.006697481032460928
the O 0 0.013664595782756805
phenotype O 1 0.9960881471633911
. O 0 0.02750767022371292

All O 0 0.027330994606018066
patients O 1 0.965825617313385
manifested O 1 0.5433114171028137
classical O 0 0.029764609411358833
A B-Disease 0 0.033747971057891846
- I-Disease 1 0.5540528297424316
T I-Disease 1 0.9699742794036865
and O 0 0.011005539447069168
increased O 0 0.03787940740585327
cellular O 1 0.9550811052322388
radioresistant O 1 0.9508820176124573
DNA O 1 0.9663950800895691
synthesis O 1 0.775596022605896
. O 0 0.03349732980132103

Determination O 0 0.029190314933657646
of O 0 0.0075640566647052765
the O 0 0.009018464013934135
genomic O 1 0.9376247525215149
structure O 0 0.01629437319934368
of O 0 0.005388542544096708
the O 0 0.0074934326112270355
COL4A4 O 1 0.9703540802001953
gene O 1 0.9839150905609131
and O 0 0.00789768435060978
of O 0 0.009868227876722813
novel O 1 0.8628387451171875
mutations O 1 0.999514102935791
causing O 1 0.9982807636260986
autosomal B-Disease 1 0.9998922348022461
recessive I-Disease 1 0.9998125433921814
Alport I-Disease 1 0.9992720484733582
syndrome I-Disease 1 0.9994062185287476
. O 0 0.06932853162288666

Autosomal B-Disease 1 0.9994316697120667
recessive I-Disease 1 0.9996522665023804
Alport I-Disease 1 0.9992221593856812
syndrome I-Disease 1 0.9994046688079834
is O 0 0.023749472573399544
a O 0 0.026441367343068123
progressive O 1 0.7083053588867188
hematuric B-Disease 1 0.9820592999458313
glomerulonephritis I-Disease 1 0.9970302581787109
characterized O 1 0.8317073583602905
by O 0 0.03158845379948616
glomerular B-Disease 1 0.9967594742774963
basement I-Disease 1 0.8784767389297485
membrane I-Disease 1 0.9937458038330078
abnormalities I-Disease 1 0.9982326030731201
and O 0 0.00834855530411005
associated O 0 0.022089378908276558
with O 0 0.008755107410252094
mutations O 1 0.9973446726799011
in O 0 0.005460704211145639
either O 0 0.0073324451223015785
the O 0 0.005951283499598503
COL4A3 O 1 0.7039872407913208
or O 0 0.009427913464605808
the O 0 0.008725782856345177
COL4A4 O 1 0.9766374826431274
gene O 1 0.989276647567749
, O 0 0.007126346230506897
which O 0 0.005378393922001123
encode O 0 0.0329580195248127
the O 0 0.008882783353328705
alpha3 O 1 0.5828472375869751
and O 0 0.013179252855479717
alpha4 O 1 0.9433316588401794
type O 1 0.9035132527351379
IV O 1 0.9825897216796875
collagen O 1 0.9968248605728149
chains O 0 0.4292057156562805
, O 0 0.014467998407781124
respectively O 0 0.023587683215737343
. O 0 0.02347155287861824

To O 0 0.013660233467817307
date O 0 0.014759701676666737
, O 0 0.011849094182252884
mutation O 1 0.995618999004364
screening O 0 0.14455559849739075
in O 0 0.005042501725256443
the O 0 0.0040403143502771854
two O 0 0.005912839900702238
genes O 1 0.9848482012748718
has O 0 0.0062019298784434795
been O 0 0.005224450957030058
hampered O 0 0.11655628681182861
by O 0 0.005366005934774876
the O 0 0.004333332646638155
lack O 0 0.011351557448506355
of O 0 0.007801672909408808
genomic O 1 0.9880852699279785
structure O 0 0.03680500015616417
information O 0 0.01596250757575035
. O 0 0.017974169924855232

We O 0 0.010393359698355198
report O 0 0.008071782998740673
here O 0 0.0043950919061899185
the O 0 0.00393341388553381
complete O 0 0.007655601482838392
characterization O 0 0.018228940665721893
of O 0 0.003618940245360136
the O 0 0.004382182378321886
48 O 0 0.013872000388801098
exons O 0 0.3381218910217285
of O 0 0.005497928708791733
the O 0 0.008053027093410492
COL4A4 O 1 0.9748835563659668
gene O 1 0.9907419085502625
, O 0 0.008120882324874401
a O 0 0.010324526578187943
comprehensive O 0 0.3208823502063751
gene O 1 0.9929667711257935
screen O 0 0.024086087942123413
, O 0 0.004220086149871349
and O 0 0.003085168544203043
the O 0 0.00369859766215086
subsequent O 0 0.020694797858595848
detection O 0 0.25706225633621216
of O 0 0.005361238028854132
10 O 0 0.011568667367100716
novel O 0 0.36397644877433777
mutations O 1 0.9974697828292847
in O 0 0.01613324135541916
eight O 0 0.16018572449684143
patients O 1 0.9993498921394348
diagnosed O 1 0.999631404876709
with O 1 0.9484501481056213
autosomal B-Disease 1 0.9999208450317383
recessive I-Disease 1 0.9998704195022583
Alport I-Disease 1 0.9993976354598999
syndrome I-Disease 1 0.9995032548904419
. O 0 0.06407985091209412

Furthermore O 0 0.049489740282297134
, O 0 0.011100850999355316
we O 0 0.006315597333014011
identified O 0 0.014084681868553162
a O 0 0.011632735840976238
glycine O 0 0.11010897904634476
to O 0 0.009468953125178814
alanine O 1 0.567630410194397
substitution O 0 0.05471149459481239
in O 0 0.0065467469394207
the O 0 0.008048652671277523
collagenous O 1 0.9858273267745972
domain O 0 0.04273754730820656
that O 0 0.005221052095293999
is O 0 0.006127173081040382
apparently O 0 0.015651889145374298
silent O 0 0.02285257913172245
in O 0 0.0065488871186971664
the O 0 0.008213678374886513
heterozygous O 1 0.9895327091217041
carriers O 0 0.3502858877182007
, O 0 0.0083021754398942
in O 0 0.008997268974781036
11 O 0 0.01921103522181511
. O 0 0.021467329934239388

5 O 0 0.02337765507400036
% O 0 0.012512538582086563
of O 0 0.0047576287761330605
all O 0 0.0040276083163917065
control O 0 0.012173839844763279
individuals O 0 0.007737079635262489
, O 0 0.0028161699883639812
and O 0 0.0023527853190898895
in O 0 0.0029592912178486586
one O 0 0.004240287933498621
control O 0 0.016652384772896767
individual O 0 0.016046982258558273
homozygous O 1 0.9644343852996826
for O 0 0.008588448166847229
this O 0 0.009034049697220325
glycine O 1 0.5947028994560242
substitution O 0 0.32061105966567993
. O 0 0.02694074623286724

There O 0 0.011332517489790916
has O 0 0.006623977795243263
been O 0 0.004163301549851894
no O 0 0.003903742413967848
previous O 0 0.00590519281104207
finding O 0 0.008153441362082958
of O 0 0.0035238517448306084
a O 0 0.008206137455999851
glycine O 1 0.6196927428245544
substitution O 0 0.2503966689109802
that O 0 0.004444225691258907
is O 0 0.0037710131146013737
not O 0 0.0033399180974811316
associated O 0 0.008237936533987522
with O 0 0.004139366094022989
any O 0 0.006528156343847513
obvious O 0 0.30152803659439087
phenotype O 1 0.997865617275238
in O 0 0.02027222141623497
homozygous O 1 0.9872776865959167
individuals O 0 0.05838475376367569
. O 0 0.02859317697584629

Founder O 1 0.665560781955719
BRCA1 O 1 0.99671870470047
and O 0 0.039132311940193176
BRCA2 O 1 0.9987249970436096
mutations O 1 0.9967087507247925
in O 0 0.017458312213420868
French O 0 0.07128331065177917
Canadian O 1 0.6799662113189697
breast B-Disease 1 0.9996296167373657
and I-Disease 1 0.6222591400146484
ovarian I-Disease 1 0.9999315738677979
cancer I-Disease 1 0.9996209144592285
families O 0 0.16914202272891998
. O 0 0.03411385416984558

We O 0 0.011158693581819534
have O 0 0.00639443751424551
identified O 0 0.01281221117824316
four O 0 0.007710379548370838
mutations O 1 0.9959442019462585
in O 0 0.005012859124690294
each O 0 0.004686865024268627
of O 0 0.005892973393201828
the O 0 0.0442768819630146
breast B-Disease 1 0.9999053478240967
cancer I-Disease 1 0.9998979568481445
- O 1 0.9939019680023193
susceptibility O 1 0.9993991851806641
genes O 1 0.9975823163986206
, O 0 0.029961861670017242
BRCA1 O 1 0.999025821685791
and O 0 0.01739112287759781
BRCA2 O 1 0.9988499879837036
, O 0 0.010194224305450916
in O 0 0.009220375679433346
French O 0 0.14487247169017792
Canadian O 1 0.9362539649009705
breast B-Disease 1 0.9999154806137085
cancer I-Disease 1 0.999871015548706
and O 1 0.801474928855896
breast B-Disease 1 0.9999197721481323
/ I-Disease 1 0.9991100430488586
ovarian I-Disease 1 0.9999607801437378
cancer I-Disease 1 0.9997742772102356
families O 0 0.05364207923412323
from O 0 0.02190839871764183
Quebec O 0 0.0788220465183258
. O 0 0.0324445478618145

To O 0 0.01953434757888317
identify O 0 0.037427663803100586
founder O 0 0.049490343779325485
effects O 0 0.32724329829216003
, O 0 0.007334104739129543
we O 0 0.00464584631845355
examined O 0 0.021345878019928932
independently O 0 0.01657288148999214
ascertained O 0 0.08121173828840256
French O 0 0.030657753348350525
Canadian O 0 0.20418721437454224
cancer B-Disease 1 0.9991075396537781
families O 0 0.012615608051419258
for O 0 0.004695587791502476
the O 0 0.004146109335124493
distribution O 0 0.010083943605422974
of O 0 0.004247208125889301
these O 0 0.006040340289473534
eight O 0 0.01946973241865635
mutations O 1 0.9964776635169983
. O 0 0.02708064764738083

Mutations O 1 0.983336329460144
were O 0 0.01032465323805809
found O 0 0.011716805398464203
in O 0 0.0073186787776649
41 O 0 0.016610026359558105
of O 0 0.009280052967369556
97 O 0 0.032554253935813904
families O 0 0.026786038652062416
. O 0 0.02123180776834488

Six O 0 0.021540142595767975
of O 0 0.009025544859468937
eight O 0 0.017032843083143234
mutations O 1 0.991020143032074
were O 0 0.007207406219094992
observed O 0 0.017274482175707817
at O 0 0.0072936126962304115
least O 0 0.011751620098948479
twice O 0 0.02209402434527874
. O 0 0.018592115491628647

The O 0 0.045822370797395706
BRCA1 O 1 0.9972265362739563
C4446T O 1 0.9785136580467224
mutation O 1 0.9941062927246094
was O 0 0.008027630858123302
the O 0 0.005443272180855274
most O 0 0.007128167897462845
common O 0 0.2801292836666107
mutation O 1 0.9981727600097656
found O 0 0.013055157847702503
, O 0 0.006249942351132631
followed O 0 0.01036980003118515
by O 0 0.00996687076985836
the O 0 0.017508622258901596
BRCA2 O 1 0.9989566802978516
8765delAG O 1 0.9876664876937866
mutation O 1 0.9953646659851074
. O 0 0.046632684767246246

Together O 0 0.019502980634570122
, O 0 0.007305657956749201
these O 0 0.007341974880546331
mutations O 1 0.9892149567604065
were O 0 0.004098747856914997
found O 0 0.005955756176263094
in O 0 0.003580237738788128
28 O 0 0.006115059368312359
of O 0 0.0037703108973801136
41 O 0 0.012282487004995346
families O 0 0.010738251730799675
identified O 0 0.011214086785912514
to O 0 0.004540929105132818
have O 0 0.0065120793879032135
a O 0 0.01740284450352192
mutation O 1 0.9952491521835327
. O 0 0.03108258731663227

The O 0 0.014484304003417492
odds O 0 0.02640417590737343
of O 0 0.00634983042255044
detection O 0 0.051676906645298004
of O 0 0.004054883029311895
any O 0 0.0038236931432038546
of O 0 0.003478085156530142
the O 0 0.00710509205237031
four O 0 0.021342765539884567
BRCA1 O 1 0.9995200634002686
mutations O 1 0.9969475865364075
was O 0 0.016435867175459862
18 O 0 0.022433387115597725
. O 0 0.02198474481701851

7x O 1 0.8752281665802002
greater O 0 0.022728050127625465
if O 0 0.008997189812362194
one O 0 0.004770461469888687
or O 0 0.006634987890720367
more O 0 0.006015770602971315
cases O 0 0.1037621721625328
of O 0 0.07841823995113373
ovarian B-Disease 1 0.9999703168869019
cancer I-Disease 1 0.9997853636741638
were O 0 0.00569798331707716
also O 0 0.004374425392597914
present O 0 0.005919615272432566
in O 0 0.004970157518982887
the O 0 0.007676822133362293
family O 0 0.026872161775827408
. O 0 0.021091638132929802

The O 0 0.014257720671594143
odds O 0 0.026965931057929993
of O 0 0.007117477711290121
detection O 0 0.04061266779899597
of O 0 0.0034411358647048473
any O 0 0.0036722368095070124
of O 0 0.0032054211478680372
the O 0 0.005927758291363716
four O 0 0.01891372539103031
BRCA2 O 1 0.9996229410171509
mutations O 1 0.9978107810020447
was O 0 0.016415361315011978
5 O 0 0.02378004975616932
. O 0 0.020879196003079414

3x O 0 0.2682393789291382
greater O 0 0.019865544512867928
if O 0 0.006502051837742329
there O 0 0.0030761915259063244
were O 0 0.002312915865331888
at O 0 0.00353671470656991
least O 0 0.004927300848066807
five O 0 0.00614527240395546
cases O 0 0.1345984935760498
of O 0 0.053586773574352264
breast B-Disease 1 0.9999319314956665
cancer I-Disease 1 0.9996346235275269
in O 0 0.009424779564142227
the O 0 0.009543602354824543
family O 0 0.038881342858076096
. O 0 0.021140480414032936

Interestingly O 0 0.054243188351392746
, O 0 0.007387969642877579
the O 0 0.005318956915289164
presence O 0 0.011940169148147106
of O 0 0.007000357378274202
a O 0 0.27956023812294006
breast B-Disease 1 0.9999043941497803
cancer I-Disease 1 0.9997503161430359
case O 0 0.16188064217567444
< O 1 0.8402116298675537
36 O 0 0.014011225663125515
years O 0 0.006046063266694546
of O 0 0.0037112636491656303
age O 0 0.008685218170285225
was O 0 0.004570274613797665
strongly O 0 0.008747384883463383
predictive O 1 0.5917078852653503
of O 0 0.0037404720205813646
the O 0 0.0034202421084046364
presence O 0 0.007131902035325766
of O 0 0.002926485612988472
any O 0 0.0030524474568665028
of O 0 0.0031045645009726286
the O 0 0.005511014256626368
eight O 0 0.017043529078364372
mutations O 1 0.9979107975959778
screened O 0 0.31898725032806396
. O 0 0.029680587351322174

Carriers O 0 0.057037342339754105
of O 0 0.007395134307444096
the O 0 0.006361638195812702
same O 0 0.010357114486396313
mutation O 1 0.9974455833435059
, O 0 0.0046908254735171795
from O 0 0.0044608390890061855
different O 0 0.004764398094266653
families O 0 0.00813095923513174
, O 0 0.0046762400306761265
shared O 0 0.010026297532022
similar O 0 0.02111448347568512
haplotypes O 1 0.989161491394043
, O 0 0.006438968703150749
indicating O 0 0.013779214583337307
that O 0 0.0036945445463061333
the O 0 0.005691343918442726
mutant O 1 0.987978458404541
alleles O 1 0.9942438006401062
were O 0 0.004448126535862684
likely O 0 0.005783845204859972
to O 0 0.002351951552554965
be O 0 0.0024191918782889843
identical O 0 0.01029919646680355
by O 0 0.005114437080919743
descent O 0 0.01840447261929512
for O 0 0.005145707633346319
a O 0 0.011297592893242836
mutation O 1 0.9943276047706604
in O 0 0.007342926226556301
the O 0 0.007890155538916588
founder O 0 0.034621138125658035
population O 0 0.024779170751571655
. O 0 0.0224902406334877

The O 0 0.017293773591518402
identification O 0 0.02513423003256321
of O 0 0.011091568507254124
common O 0 0.20831362903118134
BRCA1 O 1 0.9985803365707397
and O 0 0.03800680488348007
BRCA2 O 1 0.9993610978126526
mutations O 1 0.9961561560630798
will O 0 0.011732076294720173
facilitate O 0 0.08617760986089706
carrier O 0 0.34092000126838684
detection O 0 0.4908156991004944
in O 0 0.00958741270005703
French O 0 0.10021207481622696
Canadian O 1 0.9124348163604736
breast B-Disease 1 0.9998835325241089
cancer I-Disease 1 0.9998526573181152
and O 1 0.7574017643928528
breast B-Disease 1 0.99989914894104
/ I-Disease 1 0.9985163807868958
ovarian I-Disease 1 0.9999251365661621
cancer I-Disease 1 0.9995551705360413
families O 0 0.13768519461154938
. O 0 0.03898994252085686

Are O 0 0.0264133270829916
Dp71 O 0 0.30164724588394165
and O 0 0.025880850851535797
Dp140 O 1 0.9773463606834412
brain O 1 0.9973527193069458
dystrophin O 1 0.9950320720672607
isoforms O 1 0.9493004083633423
related O 0 0.09353175759315491
to O 0 0.021607154980301857
cognitive B-Disease 1 0.9877777695655823
impairment I-Disease 1 0.9955874681472778
in O 0 0.2963387370109558
Duchenne B-Disease 1 0.9988394379615784
muscular I-Disease 1 0.9988031387329102
dystrophy I-Disease 1 0.9989314675331116
? O 1 0.5816561579704285

Molecular O 1 0.7707469463348389
study O 0 0.034051235765218735
and O 0 0.011025969870388508
neuropsychological O 1 0.8371620178222656
analysis O 0 0.018119025975465775
were O 0 0.004688361659646034
performed O 0 0.010762542486190796
concurrently O 0 0.012730521149933338
on O 0 0.008329395204782486
49 O 0 0.11251071095466614
patients O 1 0.9959190487861633
with O 0 0.27454742789268494
Duchenne B-Disease 1 0.9997105002403259
muscular I-Disease 1 0.9997183680534363
dystrophy I-Disease 1 0.999839186668396
( O 1 0.6775901317596436
DMD B-Disease 1 0.9990594983100891
) O 0 0.012832299806177616
in O 0 0.004734209273010492
order O 0 0.00454085785895586
to O 0 0.0032397874165326357
find O 0 0.006292751524597406
a O 0 0.007563985418528318
molecular O 1 0.7796784043312073
explanation O 0 0.013518953695893288
for O 0 0.005891190841794014
the O 0 0.00788695178925991
cognitive B-Disease 1 0.9930508136749268
impairment I-Disease 1 0.9959620833396912
observed O 0 0.127793088555336
in O 0 0.012494752183556557
most O 0 0.04645984247326851
DMD B-Disease 1 0.9992904663085938
patients O 1 0.993817150592804
. O 0 0.03544319421052933

Complete O 0 0.03292541205883026
analysis O 0 0.022553496062755585
of O 0 0.0073729767464101315
the O 0 0.011053390800952911
dystrophin O 1 0.9966734647750854
gene O 1 0.9900248050689697
was O 0 0.007961061783134937
performed O 0 0.009459039196372032
to O 0 0.0037201845552772284
define O 0 0.010406075976788998
the O 0 0.004834632854908705
localization O 0 0.11931152641773224
of O 0 0.007483686786144972
deletions O 1 0.7326788902282715
and O 0 0.007821941748261452
duplications O 1 0.6463121175765991
in O 0 0.006272615399211645
relation O 0 0.014490526169538498
to O 0 0.005350821185857058
the O 0 0.00810993555933237
different O 0 0.022783612832427025
DMD B-Disease 1 0.9970201849937439
promoters O 1 0.575087308883667
. O 0 0.03634091094136238

Qualitative O 0 0.0589105598628521
analysis O 0 0.021663732826709747
of O 0 0.006852731574326754
the O 0 0.00785540509968996
Dp71 O 1 0.7863124012947083
transcript O 0 0.09801334887742996
and O 0 0.005508155561983585
testing O 0 0.018875161185860634
for O 0 0.003649357706308365
the O 0 0.003918618895113468
specific O 0 0.00892694666981697
first O 0 0.006608740426599979
exon O 0 0.4241131544113159
of O 0 0.006962143816053867
Dp140 O 0 0.19633366167545319
were O 0 0.004801859613507986
also O 0 0.0056516434997320175
carried O 0 0.010716420598328114
out O 0 0.011807627975940704
. O 0 0.018875783309340477

Neuropsychological O 1 0.9192245602607727
analysis O 0 0.056106749922037125
assessed O 0 0.04465125501155853
verbal O 0 0.04871699586510658
and O 0 0.014324474148452282
visuospatial O 1 0.9590245485305786
intelligence O 0 0.027827518060803413
, O 0 0.009625335223972797
verbal O 0 0.05059428885579109
memory O 0 0.029248738661408424
, O 0 0.006415935233235359
and O 0 0.005899096839129925
reading O 0 0.016623660922050476
skills O 0 0.031069761142134666
. O 0 0.024604741483926773

Comparison O 0 0.03534417226910591
of O 0 0.011846867389976978
molecular O 0 0.47116076946258545
and O 0 0.010014345869421959
psychometric O 1 0.6620935797691345
findings O 0 0.01993144303560257
demonstrated O 0 0.01627117209136486
that O 0 0.006498211529105902
deletions O 0 0.47052276134490967
and O 0 0.005192020442336798
duplications O 1 0.5791923403739929
that O 0 0.004732282366603613
were O 0 0.00409439392387867
localized O 1 0.8317552804946899
in O 0 0.00505372928455472
the O 0 0.005351838655769825
distal O 1 0.9601091146469116
part O 0 0.0067425742745399475
of O 0 0.004079211037606001
the O 0 0.006754809990525246
gene O 1 0.989245593547821
seemed O 0 0.01365341804921627
to O 0 0.004766021389514208
be O 0 0.0057139527052640915
preferentially O 0 0.3639541566371918
associated O 0 0.03280206769704819
with O 0 0.015657702460885048
cognitive B-Disease 1 0.9863640666007996
impairment I-Disease 1 0.9916797280311584
. O 0 0.03815639019012451

Two O 0 0.028279511258006096
altered O 0 0.14712227880954742
Dp71 O 0 0.3184259831905365
transcripts O 0 0.02842096798121929
and O 0 0.006903700530529022
two O 0 0.00834034476429224
deleted O 0 0.10745453834533691
Dp140 O 1 0.822193443775177
DNA O 1 0.903032660484314
sequences O 0 0.05582333728671074
were O 0 0.004607170354574919
found O 0 0.007702911738306284
in O 0 0.005751240998506546
four O 0 0.01256546936929226
patients O 1 0.9963964819908142
with O 0 0.22847667336463928
severe O 1 0.998508632183075
cerebral B-Disease 1 0.9993494153022766
dysfunction I-Disease 1 0.9989064931869507
. O 0 0.061274852603673935

These O 0 0.016460075974464417
findings O 0 0.020482441410422325
suggest O 0 0.013588188216090202
that O 0 0.004648568108677864
some O 0 0.004432678688317537
sequences O 0 0.023485053330659866
located O 0 0.005280282348394394
in O 0 0.0037218518555164337
the O 0 0.004298449028283358
distal O 1 0.9646142721176147
part O 0 0.006170883774757385
of O 0 0.00357424165122211
the O 0 0.005342505406588316
gene O 1 0.9941954016685486
and O 0 0.0037540150806307793
, O 0 0.003504084190353751
in O 0 0.0032878266647458076
particular O 0 0.007049458101391792
, O 0 0.00464585330337286
some O 0 0.008352556265890598
DMD B-Disease 1 0.998508870601654
isoforms O 1 0.8421891331672668
expressed O 0 0.012223277240991592
in O 0 0.006175178103148937
the O 0 0.00863014068454504
brain O 1 0.9975324869155884
may O 0 0.010488149709999561
be O 0 0.004006329458206892
related O 0 0.010909915901720524
to O 0 0.0047303419560194016
the O 0 0.008832773193717003
cognitive B-Disease 1 0.9928638935089111
impairment I-Disease 1 0.9961821436882019
associated O 0 0.28566834330558777
with O 0 0.031497444957494736
DMD B-Disease 1 0.9975681900978088
. O 0 0.02003832347691059
. O 0 0.02422725036740303

I1307K O 1 0.67713862657547
APC O 1 0.7595541477203369
and O 0 0.024960918352007866
hMLH1 O 1 0.845284640789032
mutations O 1 0.9850308299064636
in O 0 0.012107888236641884
a O 0 0.013362852856516838
non O 0 0.021532896906137466
- O 0 0.06936071813106537
Jewish O 0 0.017388582229614258
family O 0 0.023892926052212715
with O 0 0.018280573189258575
hereditary B-Disease 1 0.996483564376831
non I-Disease 1 0.9622161388397217
- I-Disease 1 0.9966386556625366
polyposis I-Disease 1 0.9998632669448853
colorectal I-Disease 1 0.9999061822891235
cancer I-Disease 1 0.9992881417274475
. O 0 0.06899789720773697

We O 0 0.01474962942302227
describe O 0 0.026696348562836647
a O 0 0.016435010358691216
French O 0 0.02643216773867607
Canadian O 0 0.06519600749015808
hereditary B-Disease 1 0.9939835667610168
non I-Disease 1 0.9248722791671753
- I-Disease 1 0.9970500469207764
polyposis I-Disease 1 0.9998936653137207
colorectal I-Disease 1 0.9999572038650513
cancer I-Disease 1 0.9998267292976379
( O 1 0.589146077632904
HNPCC B-Disease 1 0.9979985356330872
) O 0 0.02825457602739334
kindred O 1 0.7091512680053711
which O 0 0.009548073634505272
carries O 0 0.020586047321558
a O 0 0.01602315530180931
novel O 0 0.1926160752773285
truncating O 1 0.9860783815383911
mutation O 1 0.995945394039154
in O 0 0.026273326948285103
hMLH1 O 1 0.7161362767219543
. O 0 0.0381857194006443

Interestingly O 0 0.07491948455572128
, O 0 0.01267644576728344
the O 0 0.012110313400626183
I1307K O 1 0.924067497253418
APC O 1 0.9892401695251465
polymorphism O 1 0.9563525319099426
, O 0 0.008258375339210033
associated O 0 0.011491768062114716
with O 0 0.004753575660288334
an O 0 0.005536358803510666
increased O 0 0.09679298847913742
risk O 1 0.9907974004745483
of O 0 0.26835504174232483
colorectal B-Disease 1 0.9999767541885376
cancer I-Disease 1 0.999869704246521
, O 0 0.00841443333774805
is O 0 0.0049844905734062195
also O 0 0.0035021782387048006
present O 0 0.005048203282058239
in O 0 0.004379532765597105
this O 0 0.005446461495012045
family O 0 0.022999582812190056
. O 0 0.01792936399579048

The O 0 0.02812449261546135
I1307K O 1 0.6674870252609253
polymorphism O 1 0.7476250529289246
has O 0 0.008231916464865208
previously O 0 0.006346109788864851
only O 0 0.002940630540251732
been O 0 0.0033044051378965378
identified O 0 0.007261588238179684
in O 0 0.003798362100496888
individuals O 0 0.009140653535723686
of O 0 0.006139566656202078
self O 0 0.07244251668453217
- O 0 0.30530810356140137
reported O 0 0.04696386307477951
Ashkenazi O 1 0.7880710363388062
Jewish O 0 0.03594671189785004
origins O 0 0.07177566736936569
. O 0 0.02638772316277027

In O 0 0.014921719208359718
addition O 0 0.011590165086090565
, O 0 0.0042225997895002365
in O 0 0.0031334145460277796
this O 0 0.0027803971897810698
family O 0 0.007136123720556498
, O 0 0.0031310252379626036
there O 0 0.0026908768340945244
appears O 0 0.00656575383618474
to O 0 0.0025192643515765667
be O 0 0.0023969486355781555
no O 0 0.003746999194845557
relationship O 0 0.012336854822933674
between O 0 0.005576930940151215
the O 0 0.006601093802601099
I1307K O 1 0.8916003704071045
polymorphism O 1 0.9131339192390442
and O 0 0.00474081514403224
the O 0 0.004862476605921984
presence O 0 0.015747299417853355
or O 0 0.00960568618029356
absence O 0 0.05824825167655945
of O 0 0.01445364486426115
cancer B-Disease 1 0.9990793466567993
. O 0 0.018332289531826973
. O 0 0.023372745141386986

Identification O 0 0.03258392959833145
of O 0 0.007774647790938616
a O 0 0.01132992748171091
novel O 0 0.06600546091794968
mutation O 1 0.9899181723594666
of O 0 0.007095614913851023
the O 0 0.00845842994749546
CPO O 1 0.7578550577163696
gene O 1 0.9869935512542725
in O 0 0.009633492678403854
a O 0 0.0131264952942729
Japanese O 0 0.024616625159978867
hereditary B-Disease 1 0.9853522181510925
coproporphyria I-Disease 1 0.9536782503128052
family O 0 0.07198363542556763
. O 0 0.030335931107401848

Hereditary B-Disease 1 0.9763935208320618
coproporphyria I-Disease 1 0.9195418357849121
( O 0 0.05836474895477295
HCP B-Disease 1 0.9872180819511414
) O 0 0.017269963398575783
is O 0 0.008800117298960686
an O 0 0.017227012664079666
autosomal B-Disease 1 0.9998118281364441
dominant I-Disease 1 0.9943934679031372
disease I-Disease 1 0.999734103679657
characterized O 1 0.8581879734992981
by O 0 0.012217767536640167
a O 0 0.03951844945549965
deficiency B-Disease 1 0.9993184804916382
of I-Disease 0 0.015298249199986458
coproporphyrinogen I-Disease 1 0.9863392114639282
oxidase I-Disease 1 0.9965993762016296
( O 0 0.028977112844586372
CPO O 0 0.4204021692276001
) O 0 0.011885550804436207
caused O 0 0.05837555229663849
by O 0 0.007399945054203272
a O 0 0.01259028259664774
mutation O 1 0.9961025714874268
in O 0 0.010868816636502743
the O 0 0.0128775117918849
CPO O 1 0.8323978185653687
gene O 1 0.9875649809837341
. O 0 0.03342906013131142

Only O 0 0.019132474437355995
11 O 0 0.026016056537628174
mutations O 1 0.9698551893234253
of O 0 0.007822295650839806
the O 0 0.00846833921968937
gene O 1 0.9840673208236694
have O 0 0.0066641285084187984
been O 0 0.007951432839035988
reported O 0 0.019227851182222366
in O 0 0.019276583567261696
HCP B-Disease 1 0.9955447316169739
patients O 1 0.9930510520935059
. O 0 0.03319030627608299

We O 0 0.013756519183516502
report O 0 0.014777658507227898
another O 0 0.016711125150322914
mutation O 1 0.9916822910308838
in O 0 0.008857161737978458
a O 0 0.012935910373926163
Japanese O 0 0.017589353024959564
family O 0 0.028487175703048706
. O 0 0.021889369934797287

Polymerase O 1 0.9380199313163757
chain O 0 0.37257176637649536
reaction O 0 0.18375913798809052
- O 0 0.06661173701286316
single O 0 0.030612386763095856
strand O 1 0.9215334057807922
conformational O 1 0.9604904055595398
polymorphism O 1 0.9157072305679321
and O 0 0.007860193960368633
direct O 0 0.015601513907313347
sequence O 0 0.03595767542719841
analyses O 0 0.023547938093543053
demonstrated O 0 0.016430765390396118
a O 0 0.010742506943643093
C O 0 0.07167703658342361
to O 0 0.007982736453413963
T O 1 0.8980292677879333
substitution O 0 0.15404364466667175
in O 0 0.00839056447148323
exon O 0 0.4512638449668884
1 O 0 0.007258756086230278
of O 0 0.0036690453998744488
the O 0 0.006512829102575779
CPO O 1 0.6754693984985352
gene O 1 0.9896801114082336
at O 0 0.01124530378729105
nucleotide O 1 0.6903400421142578
position O 0 0.00805571023374796
85 O 0 0.011990313418209553
, O 0 0.004070719704031944
which O 0 0.0034512756392359734
lies O 0 0.006089166272431612
in O 0 0.004035535268485546
the O 0 0.0070544034242630005
putative O 1 0.9272791147232056
presequence O 1 0.6267978549003601
for O 0 0.01053638570010662
targeting O 0 0.03754865750670433
to O 0 0.013575398363173008
mitochondria O 1 0.9358765482902527
. O 0 0.029181409627199173

This O 0 0.024409925565123558
mutation O 1 0.9787960648536682
changes O 0 0.022851623594760895
the O 0 0.010246366262435913
codon O 0 0.25116440653800964
for O 0 0.0097995949909091
glutamine O 0 0.42559969425201416
to O 0 0.007193815428763628
a O 0 0.01590246707201004
termination O 1 0.7924155592918396
codon O 1 0.6980405449867249
at O 0 0.018771519884467125
amino O 1 0.8308571577072144
acid O 1 0.9168773293495178
position O 0 0.018571604043245316
29 O 0 0.03292837366461754
. O 0 0.0238246638327837

MaeI O 1 0.5295916199684143
restriction O 0 0.06664979457855225
analysis O 0 0.0281386636197567
showed O 0 0.012270783074200153
two O 0 0.006233036983758211
other O 0 0.006024470087140799
carriers O 0 0.0860995426774025
in O 0 0.006790079642087221
the O 0 0.008789638057351112
family O 0 0.030961520969867706
. O 0 0.020693929865956306

The O 0 0.03765789046883583
C O 1 0.6496089696884155
- O 1 0.8770599961280823
T O 1 0.9921196699142456
mutation O 1 0.9953867793083191
is O 0 0.00836714543402195
located O 0 0.0071381209418177605
within O 0 0.006433748174458742
a O 0 0.007221842650324106
recently O 0 0.012074989266693592
proposed O 0 0.014915607869625092
putative O 1 0.5590726733207703
alternative O 0 0.03147304803133011
translation O 0 0.034851279109716415
initiation O 1 0.8260691165924072
codon O 1 0.9543520212173462
( O 0 0.06113956496119499
TIC O 1 0.991245687007904
- O 0 0.12093780189752579
1 O 0 0.010617630556225777
) O 0 0.007383742835372686
, O 0 0.004174072295427322
supporting O 0 0.009163934737443924
that O 0 0.0070979236625134945
TIC O 1 0.973290205001831
- O 0 0.05849985033273697
1 O 0 0.007971842773258686
is O 0 0.004328934010118246
the O 0 0.004678071476519108
real O 0 0.015372556634247303
TIC O 1 0.9392465353012085
rather O 0 0.014910627156496048
than O 0 0.015108431689441204
TIC O 1 0.9870883822441101
- O 0 0.18019241094589233
2 O 0 0.02150474116206169
. O 0 0.014103498309850693
. O 0 0.02083742618560791

Human B-Disease 0 0.10261179506778717
complement I-Disease 0 0.3867591321468353
factor I-Disease 1 0.9377426505088806
H I-Disease 1 0.9924495220184326
deficiency I-Disease 1 0.999488115310669
associated O 1 0.8743635416030884
with O 1 0.8616969585418701
hemolytic B-Disease 1 0.9999206066131592
uremic I-Disease 1 0.9998366832733154
syndrome I-Disease 1 0.9996064305305481
. O 0 0.06973259896039963

This O 0 0.013917898759245872
study O 0 0.016421698033809662
reports O 0 0.009110549464821815
on O 0 0.004256816115230322
six O 0 0.006970686838030815
cases O 0 0.01502015721052885
of O 0 0.008392801508307457
deficiency B-Disease 1 0.9994860887527466
in I-Disease 0 0.006969967857003212
the I-Disease 0 0.006389828398823738
human I-Disease 0 0.07481521368026733
complement I-Disease 0 0.47935205698013306
regulatory I-Disease 1 0.9250149130821228
protein I-Disease 1 0.9926954507827759
Factor I-Disease 1 0.9008648991584778
H I-Disease 1 0.9699352383613586
( O 0 0.0334918349981308
FH O 1 0.989161491394043
) O 0 0.009330431930720806
in O 0 0.004314048681408167
the O 0 0.003683975897729397
context O 0 0.012121127918362617
of O 0 0.008800195530056953
an O 0 0.23085331916809082
acute B-Disease 1 0.9997939467430115
renal I-Disease 1 0.9999573230743408
disease I-Disease 1 0.9997074007987976
. O 0 0.08668792247772217

Five O 0 0.014498796314001083
of O 0 0.006030978634953499
the O 0 0.005370998755097389
cases O 0 0.012518880888819695
were O 0 0.0039185332134366035
observed O 0 0.011929064989089966
in O 0 0.007073557935655117
children O 0 0.055960722267627716
presenting O 0 0.3626641035079956
with O 1 0.6842002868652344
idiopathic O 1 0.9998838901519775
hemolytic B-Disease 1 0.9999632835388184
uremic I-Disease 1 0.9999570846557617
syndrome I-Disease 1 0.9998906850814819
( O 1 0.6077588796615601
HUS B-Disease 1 0.9955769777297974
) O 0 0.04204897955060005
. O 0 0.02785584144294262

Two O 0 0.01281513087451458
of O 0 0.005995761603116989
the O 0 0.006239722017198801
children O 0 0.018440235406160355
exhibited O 0 0.04540305584669113
a O 0 0.06045323982834816
homozygous O 1 0.9988204836845398
deficiency O 1 0.9997709393501282
characterized O 1 0.7203696370124817
by O 0 0.00761543121188879
the O 0 0.004797001834958792
absence O 0 0.012102175503969193
of O 0 0.003803814295679331
the O 0 0.004965073429048061
150 O 0 0.012746736407279968
- O 0 0.30654993653297424
kD O 1 0.947724461555481
form O 0 0.017515268176794052
of O 0 0.006010496988892555
Factor O 1 0.673830509185791
H O 1 0.6136879324913025
and O 0 0.0034216842614114285
the O 0 0.0032617412507534027
presence O 0 0.009393632411956787
, O 0 0.003941729664802551
upon O 0 0.006895767524838448
immunoblotting O 0 0.27162930369377136
, O 0 0.004419289063662291
of O 0 0.00351615808904171
the O 0 0.006165598519146442
42 O 0 0.024883786216378212
- O 0 0.45251989364624023
kD O 1 0.9778839349746704
Factor O 1 0.793287456035614
H O 1 0.9056360721588135
- O 0 0.13697101175785065
like O 0 0.021899770945310593
protein O 1 0.951954185962677
1 O 0 0.019323233515024185
( O 0 0.020305640995502472
FHL O 1 0.9823725819587708
- O 0 0.0681922435760498
1 O 0 0.011020059697329998
) O 0 0.007829026319086552
and O 0 0.005097143352031708
other O 0 0.010471348650753498
FH O 1 0.9949437975883484
- O 1 0.7665513753890991
related O 0 0.4434455931186676
protein O 1 0.985236644744873
( O 0 0.030009621754288673
FHR O 1 0.8706861138343811
) O 0 0.01812092401087284
bands O 0 0.030932530760765076
. O 0 0.02393941581249237

Southern O 0 0.052415989339351654
blot O 0 0.26825129985809326
and O 0 0.015221270732581615
PCR O 1 0.7239936590194702
analysis O 0 0.019689911976456642
of O 0 0.006514115259051323
DNA O 0 0.4473939538002014
of O 0 0.00539414444938302
one O 0 0.008020501583814621
patient O 1 0.9873286485671997
with O 0 0.050912100821733475
homozygous O 1 0.9990808963775635
deficiency O 1 0.9997512698173523
ruled O 0 0.022994106635451317
out O 0 0.005825162399560213
the O 0 0.004131036810576916
presence O 0 0.00767581956461072
of O 0 0.003009157022461295
a O 0 0.0059596276842057705
large O 0 0.008693540468811989
deletion O 1 0.8703523278236389
of O 0 0.005033037159591913
the O 0 0.008265748620033264
FH O 1 0.9976547956466675
gene O 1 0.9932742118835449
as O 0 0.007436762563884258
the O 0 0.007279333658516407
underlying O 1 0.7241994738578796
defect O 1 0.9859827160835266
for O 0 0.01228237058967352
the O 0 0.022578442469239235
deficiency O 1 0.9989970326423645
. O 0 0.03455368056893349

The O 0 0.013708418235182762
other O 0 0.007860318757593632
four O 0 0.007490390446037054
children O 0 0.01471923477947712
presented O 0 0.012574724853038788
with O 0 0.015186565928161144
heterozygous O 1 0.9983353018760681
deficiency O 1 0.9997109770774841
and O 0 0.008665804751217365
exhibited O 0 0.018467601388692856
a O 0 0.010446594096720219
normal O 0 0.18836793303489685
immunoblotting O 1 0.8068521618843079
pattern O 0 0.1664457768201828
of O 0 0.00784915778785944
proteins O 1 0.6514124870300293
of O 0 0.0070602805353701115
the O 0 0.01243671029806137
FH O 1 0.9918797612190247
family O 0 0.0644996240735054
. O 0 0.025112004950642586

Factor B-Disease 1 0.8963568806648254
H I-Disease 1 0.9833774566650391
deficiency I-Disease 1 0.9984723925590515
is O 0 0.011768566444516182
the O 0 0.007434446830302477
only O 0 0.01083051785826683
complement B-Disease 1 0.9748372435569763
deficiency I-Disease 1 0.9996535778045654
associated O 0 0.2522599399089813
with O 0 0.027168577536940575
HUS B-Disease 1 0.9899120926856995
. O 0 0.039005231112241745

These O 0 0.015119221992790699
observations O 0 0.017844926565885544
suggest O 0 0.015019777230918407
a O 0 0.009246906265616417
role O 0 0.01320586632937193
for O 0 0.009655422531068325
FH O 1 0.9881032109260559
and O 0 0.010112982243299484
/ O 0 0.4701855182647705
or O 0 0.02758697047829628
FH O 1 0.9939879179000854
receptors O 1 0.9400560259819031
in O 0 0.010597762651741505
the O 0 0.013235669583082199
pathogenesis O 1 0.9963311553001404
of O 0 0.03563224896788597
idiopathic O 1 0.9993376135826111
HUS B-Disease 1 0.9969933032989502
. O 0 0.022929375991225243
. O 0 0.02355627343058586

Further O 0 0.0204960685223341
evidence O 0 0.013082791119813919
for O 0 0.006839108187705278
a O 0 0.009627954103052616
major O 0 0.016139745712280273
ancient O 0 0.037466298788785934
mutation O 1 0.9990311861038208
underlying O 1 0.993073046207428
myotonic B-Disease 1 0.9995038509368896
dystrophy I-Disease 1 0.9994338154792786
from O 0 0.04180721938610077
linkage O 1 0.9872924089431763
disequilibrium O 1 0.9901579022407532
studies O 0 0.034541238099336624
in O 0 0.007615006063133478
the O 0 0.007518347818404436
Japanese O 0 0.014840199612081051
population O 0 0.021539956331253052
. O 0 0.019747436046600342

The O 0 0.08336272835731506
myotonic B-Disease 1 0.9982062578201294
dystrophy I-Disease 1 0.9994601607322693
( O 0 0.46127763390541077
DM B-Disease 1 0.9967041611671448
) O 0 0.0678345188498497
mutation O 1 0.9956119060516357
is O 0 0.009593581780791283
an O 0 0.009647815488278866
unstable O 1 0.842859148979187
( O 0 0.020286081358790398
CTG O 1 0.9368810653686523
) O 0 0.012947233393788338
n O 0 0.026203932240605354
repeat O 0 0.035268135368824005
, O 0 0.003624384757131338
present O 0 0.004163396079093218
at O 0 0.003493246855214238
a O 0 0.004653639160096645
copy O 0 0.009313554503023624
number O 0 0.004085090942680836
of O 0 0.003937211353331804
5 O 0 0.010183793492615223
- O 0 0.032519396394491196
37 O 0 0.016154227778315544
repeats O 0 0.04597627744078636
on O 0 0.0059101274237036705
normal O 0 0.1024889126420021
chromosomes O 1 0.8971332907676697
but O 0 0.007351357489824295
amplified O 0 0.04393380135297775
to O 0 0.006056474056094885
50 O 0 0.012363314628601074
- O 0 0.03952242434024811
3000 O 0 0.08219461143016815
copies O 0 0.020903032273054123
on O 0 0.0158530380576849
DM B-Disease 1 0.9942800998687744
chromosomes O 1 0.9743527173995972
. O 0 0.03375743702054024

Previous O 0 0.03545564413070679
findings O 0 0.032984569668769836
in O 0 0.01685624197125435
Caucasian O 1 0.800334095954895
populations O 0 0.08181744068861008
of O 0 0.009802529588341713
a O 0 0.02654382772743702
DM B-Disease 1 0.9962239265441895
founder O 1 0.6512385010719299
chromosome O 1 0.9957162737846375
raise O 0 0.02013605833053589
a O 0 0.0084229726344347
question O 0 0.006601725704967976
about O 0 0.003897683694958687
the O 0 0.004867400974035263
molecular O 1 0.7156297564506531
events O 0 0.010983864776790142
involved O 0 0.010235232301056385
in O 0 0.005579036194831133
the O 0 0.008221388794481754
expansion O 0 0.09419655054807663
mutation O 1 0.996672511100769
. O 0 0.02795340120792389

To O 0 0.015186866745352745
investigate O 0 0.023468006402254105
whether O 0 0.011061212047934532
a O 0 0.013523240573704243
founder O 0 0.09050329029560089
chromosome O 1 0.9919176697731018
for O 0 0.009510385803878307
the O 0 0.013124647550284863
DM B-Disease 1 0.9992213249206543
mutation O 1 0.9990873336791992
exists O 0 0.025501366704702377
in O 0 0.003907289355993271
the O 0 0.003836047602817416
Japanese O 0 0.006615010090172291
population O 0 0.007292124908417463
, O 0 0.004297852981835604
we O 0 0.004550446756184101
genotyped O 0 0.23460710048675537
families O 0 0.015391125343739986
using O 0 0.020164284855127335
polymorphic O 1 0.9865607619285583
markers O 0 0.21076735854148865
near O 0 0.015246201306581497
the O 0 0.008252305909991264
( O 0 0.016155395656824112
CTG O 1 0.9329850077629089
) O 0 0.01763971894979477
n O 0 0.03259129077196121
repeat O 0 0.05898117274045944
region O 0 0.013973135501146317
and O 0 0.008020886220037937
constructed O 0 0.02589275874197483
haplotypes O 1 0.9801069498062134
. O 0 0.03245393559336662

Six O 0 0.024943755939602852
different O 0 0.016604246571660042
haplotypes O 1 0.9083803296089172
were O 0 0.006295728497207165
found O 0 0.012238473631441593
and O 0 0.011186303570866585
DM B-Disease 1 0.9963353872299194
alleles O 1 0.9905896186828613
were O 0 0.010194099508225918
always O 0 0.019300242885947227
haplotype O 1 0.9844232201576233
A O 0 0.030874554067850113
. O 0 0.026484135538339615

To O 0 0.011218941770493984
find O 0 0.011640973389148712
an O 0 0.005423294380307198
origin O 0 0.008561046794056892
of O 0 0.0037174078170210123
the O 0 0.005303706042468548
( O 0 0.013425620272755623
CTG O 1 0.9427037835121155
) O 0 0.013505745679140091
n O 0 0.07936014235019684
repeat O 1 0.704533576965332
mutation O 1 0.9940395355224609
and O 0 0.004565093200653791
to O 0 0.0035195883829146624
investigate O 0 0.008924776688218117
the O 0 0.00374962342903018
mechanism O 0 0.02133326791226864
of O 0 0.0031639873050153255
the O 0 0.004498764406889677
expansion O 0 0.042861420661211014
mutation O 1 0.9968234300613403
in O 0 0.005144607275724411
the O 0 0.0039045026060193777
Japanese O 0 0.006278462242335081
population O 0 0.006380703765898943
we O 0 0.0033360410016030073
have O 0 0.0036976668052375317
studied O 0 0.009909533895552158
90 O 0 0.012581270188093185
Japanese O 0 0.01869702897965908
DM B-Disease 1 0.9912300109863281
families O 0 0.022646794095635414
comprising O 0 0.02002820558845997
190 O 0 0.029359139502048492
affected O 0 0.0397106371819973
and O 0 0.009935724548995495
130 O 0 0.03047606162726879
unaffected O 0 0.26713550090789795
members O 0 0.024418113753199577
. O 0 0.024771030992269516

The O 0 0.015455299988389015
results O 0 0.016331609338521957
suggest O 0 0.012406064197421074
that O 0 0.004312652163207531
a O 0 0.00557476282119751
few O 0 0.006476421840488911
common O 0 0.04953315109014511
ancestral O 1 0.9033107757568359
mutations O 1 0.9979557991027832
in O 0 0.006110351532697678
both O 0 0.005705874878913164
Caucasian O 1 0.6440110206604004
and O 0 0.004835438448935747
Japanese O 0 0.008883580565452576
populations O 0 0.05275470390915871
have O 0 0.004604249726980925
originated O 0 0.013169297017157078
by O 0 0.004273031838238239
expansion O 0 0.008411450311541557
of O 0 0.003367398399859667
an O 0 0.005477378144860268
ancestral O 0 0.16747181117534637
n O 0 0.08608131855726242
= O 0 0.06342270225286484
5 O 0 0.013232345692813396
repeat O 0 0.03152405843138695
to O 0 0.006723734084516764
n O 0 0.039990104734897614
= O 0 0.0891919806599617
19 O 0 0.017142819240689278
- O 0 0.03338053822517395
37 O 0 0.025907345116138458
copies O 0 0.0245103370398283
. O 0 0.019621513783931732

These O 0 0.015460393391549587
data O 0 0.014909695833921432
support O 0 0.01266950648277998
multistep O 0 0.33906230330467224
models O 0 0.022856827825307846
of O 0 0.010089343413710594
triplet O 1 0.9860225915908813
repeat O 0 0.3620925843715668
expansion O 0 0.016059711575508118
that O 0 0.004181592725217342
have O 0 0.0033518692944198847
been O 0 0.004019491840153933
proposed O 0 0.008602850139141083
for O 0 0.005840722471475601
both O 0 0.011742142960429192
DM B-Disease 1 0.9952630996704102
and O 0 0.02595009282231331
Friedreichs B-Disease 1 0.9880232810974121
ataxia I-Disease 1 0.9967924952507019
. O 0 0.025324879214167595
. O 0 0.026355400681495667

The O 0 0.02051623910665512
molecular O 0 0.31303760409355164
basis O 0 0.017765481024980545
of O 0 0.015433142893016338
C6 B-Disease 1 0.9984539747238159
deficiency I-Disease 1 0.9994837045669556
in O 0 0.010666017420589924
the O 0 0.007689553312957287
western O 0 0.012319670058786869
Cape O 0 0.025440426543354988
, O 0 0.0081131961196661
South O 0 0.01310765091329813
Africa O 0 0.026472223922610283
. O 0 0.02374328300356865

Deficiency B-Disease 1 0.996121346950531
of I-Disease 0 0.00920594111084938
the I-Disease 0 0.007026897743344307
sixth I-Disease 0 0.015178724192082882
component I-Disease 0 0.02003415860235691
of I-Disease 0 0.005757808219641447
human I-Disease 0 0.04550791531801224
complement I-Disease 0 0.3173050880432129
( O 0 0.029937030747532845
C6 O 1 0.992743730545044
) O 0 0.007661787327378988
has O 0 0.003596321679651737
been O 0 0.0028761441353708506
reported O 0 0.005199071019887924
in O 0 0.002672165632247925
a O 0 0.0035417424514889717
number O 0 0.0028319719713181257
of O 0 0.002605253364890814
families O 0 0.005762262269854546
from O 0 0.004162498749792576
the O 0 0.003835013136267662
western O 0 0.008133875206112862
Cape O 0 0.023988619446754456
, O 0 0.006987772881984711
South O 0 0.010657134465873241
Africa O 0 0.023809583857655525
. O 0 0.019122954457998276

Meningococcal B-Disease 1 0.9988272786140442
disease I-Disease 1 0.9985231757164001
is O 0 0.018552232533693314
endemic O 0 0.45238104462623596
in O 0 0.006485060788691044
the O 0 0.0046386392787098885
Cape O 0 0.013884341344237328
and O 0 0.003710424294695258
almost O 0 0.004636187572032213
all O 0 0.0036123711615800858
pedigrees O 0 0.11543877422809601
of O 0 0.007862439379096031
total O 0 0.035039640963077545
C6 B-Disease 1 0.999083399772644
deficiency I-Disease 1 0.9997679591178894
( O 0 0.05063673481345177
C6Q0 O 1 0.8798665404319763
) O 0 0.011104880832135677
have O 0 0.004788501653820276
been O 0 0.005877562332898378
ascertained O 0 0.08234710991382599
because O 0 0.01286093145608902
of O 0 0.01367243193089962
recurrent O 1 0.9979683756828308
disease O 1 0.9991932511329651
. O 0 0.0441494919359684

We O 0 0.013094943948090076
have O 0 0.008286858908832073
sequenced O 0 0.049122948199510574
the O 0 0.007821725681424141
expressed O 0 0.011377723887562752
exons O 0 0.30163517594337463
of O 0 0.006694885902106762
the O 0 0.010558496229350567
C6 O 1 0.9953448176383972
gene O 1 0.9895070195198059
from O 0 0.007467093877494335
selected O 0 0.007657485548406839
cases O 0 0.011485053226351738
and O 0 0.002655331278219819
have O 0 0.0029003415256738663
found O 0 0.00602589501067996
three O 0 0.007752994075417519
molecular O 1 0.9923393726348877
defects O 1 0.9971537590026855
leading O 0 0.016583548858761787
to O 0 0.007174571510404348
total O 0 0.02526610717177391
deficiency O 1 0.9998160004615784
879delG O 1 0.9109318852424622
, O 0 0.005423480179160833
which O 0 0.003031971864402294
is O 0 0.003029218642041087
the O 0 0.0038055642507970333
common O 0 0.06037462130188942
defect O 1 0.958034336566925
in O 0 0.005097738467156887
the O 0 0.004624675959348679
Cape O 0 0.016358381137251854
and O 0 0.004748391918838024
hitherto O 0 0.10752473026514053
unreported O 0 0.14125178754329681
, O 0 0.0057396371848881245
and O 0 0.004516579210758209
1195delC O 1 0.5893514156341553
and O 0 0.005614709109067917
1936delG O 1 0.7641744613647461
, O 0 0.00380699266679585
which O 0 0.002451955806463957
have O 0 0.002478786511346698
been O 0 0.0031134437303990126
previously O 0 0.00587433110922575
reported O 0 0.010486171580851078
in O 0 0.006428782362490892
African O 0 0.05622478947043419
- O 0 0.14065143465995789
Americans O 0 0.03533579409122467
. O 0 0.0241085197776556

We O 0 0.010182322934269905
also O 0 0.00628353375941515
show O 0 0.007176399230957031
that O 0 0.004184415098279715
the O 0 0.006086342502385378
879delG O 1 0.517916738986969
and O 0 0.010157790035009384
1195delC O 1 0.9799982905387878
defects O 1 0.9949780106544495
are O 0 0.007920020259916782
associated O 0 0.02190009318292141
with O 0 0.011896454729139805
characteristic O 1 0.8391129374504089
C6 O 1 0.9959064722061157
/ O 1 0.9346661567687988
C7 O 1 0.9890961050987244
region O 0 0.038962122052907944
DNA O 1 0.971341609954834
marker O 1 0.6621909737586975
haplotypes O 1 0.9911439418792725
, O 0 0.008788666687905788
although O 0 0.008590479381382465
small O 0 0.00995918083935976
variations O 0 0.023876693099737167
were O 0 0.007820031605660915
observed O 0 0.030851535499095917
. O 0 0.02340731956064701

The O 0 0.02918381057679653
1936delG O 1 0.9144579172134399
defect O 1 0.9517276287078857
was O 0 0.010535426437854767
observed O 0 0.01451901812106371
only O 0 0.0037244714330881834
once O 0 0.005300632677972317
in O 0 0.003494455711916089
the O 0 0.004169811028987169
Cape O 0 0.018101481720805168
, O 0 0.004647431429475546
but O 0 0.0035636667162179947
its O 0 0.005298616364598274
associated O 0 0.09098764508962631
haplotype O 1 0.9907506108283997
could O 0 0.010137734934687614
be O 0 0.0076662153005599976
deduced O 0 0.05072372779250145
. O 0 0.020411882549524307

The O 0 0.011008471250534058
data O 0 0.010745406150817871
from O 0 0.006513782311230898
the O 0 0.006295268889516592
haplotypes O 1 0.9824584126472473
indicate O 0 0.011865771375596523
that O 0 0.0038057630881667137
these O 0 0.004084830638021231
three O 0 0.00637061195448041
molecular O 1 0.9929799437522888
defects O 1 0.9955828785896301
account O 0 0.009943964891135693
for O 0 0.004891145974397659
the O 0 0.006044470705091953
defects O 1 0.9868583679199219
in O 0 0.005082669667899609
all O 0 0.0034499478060752153
the O 0 0.005090605933219194
38 O 0 0.020939042791724205
unrelated O 1 0.6825881004333496
C6Q0 O 1 0.862281858921051
individuals O 0 0.012349599041044712
we O 0 0.0039375857450068
have O 0 0.003708824049681425
studied O 0 0.008196147158741951
from O 0 0.007023361045867205
the O 0 0.008521207608282566
Cape O 0 0.045293841511011124
. O 0 0.024017533287405968

We O 0 0.010504038073122501
have O 0 0.006520234514027834
also O 0 0.0054467604495584965
observed O 0 0.014066958799958229
the O 0 0.007436614949256182
879delG O 1 0.8852239847183228
defect O 1 0.9671608805656433
in O 0 0.009034783579409122
two O 0 0.012015997432172298
Dutch O 0 0.23133133351802826
C6 B-Disease 1 0.997042715549469
- I-Disease 1 0.9479817748069763
deficient I-Disease 1 0.996187150478363
kindreds O 1 0.9473155736923218
, O 0 0.0074290866032242775
but O 0 0.0049403076991438866
the O 0 0.006474667228758335
879delG O 1 0.8832734823226929
defect O 1 0.972179114818573
in O 0 0.007423237897455692
the O 0 0.005996829830110073
Cape O 0 0.027522344142198563
probably O 0 0.008124904707074165
did O 0 0.004984261002391577
not O 0 0.002965489635244012
come O 0 0.004487566649913788
from O 0 0.004751207772642374
The O 0 0.0057480791583657265
Netherlands O 0 0.014064141549170017
. O 0 0.00999575573951006
. O 0 0.016039980575442314

Complement B-Disease 1 0.896746039390564
C7 I-Disease 1 0.9951902627944946
deficiency I-Disease 1 0.9987422823905945
: O 0 0.021095413714647293
seven O 0 0.01432918943464756
further O 0 0.0179128460586071
molecular O 1 0.9865820407867432
defects O 1 0.9953542947769165
and O 0 0.00843566469848156
their O 0 0.010340574197471142
associated O 0 0.07876630127429962
marker O 1 0.7631241679191589
haplotypes O 1 0.9843016266822815
. O 0 0.03589624911546707

Seven O 0 0.030002936720848083
further O 0 0.023335207253694534
molecular O 0 0.4279734790325165
bases O 0 0.02839285135269165
of O 0 0.02267869934439659
C7 B-Disease 1 0.9981387853622437
deficiency I-Disease 1 0.9994547963142395
are O 0 0.017200391739606857
described O 0 0.04206836223602295
. O 0 0.026897398754954338

All O 0 0.011794031597673893
these O 0 0.009092358872294426
new O 0 0.01337922178208828
molecular O 1 0.9785782098770142
defects O 1 0.9949042797088623
involve O 0 0.09879098832607269
single O 0 0.022623756900429726
- O 0 0.22696048021316528
nucleotide O 1 0.8365902900695801
events O 0 0.014769474044442177
, O 0 0.006676994264125824
deletions O 0 0.3342664837837219
and O 0 0.004935919307172298
substitutions O 0 0.019018571823835373
, O 0 0.00398366991430521
some O 0 0.00332266790792346
of O 0 0.003726768773049116
which O 0 0.005678988061845303
alter O 0 0.35831111669540405
splice O 1 0.9149157404899597
sites O 0 0.012720311991870403
, O 0 0.0067171803675591946
and O 0 0.007455878891050816
others O 0 0.017081793397665024
codons O 1 0.7207458019256592
. O 0 0.025423916056752205

They O 0 0.011945904232561588
are O 0 0.006139031611382961
distributed O 0 0.012366347946226597
along O 0 0.009302104823291302
the O 0 0.010261799208819866
C7 O 1 0.9970658421516418
gene O 1 0.9927213788032532
, O 0 0.007462705951184034
but O 0 0.004738826770335436
predominantly O 0 0.008750672452151775
towards O 0 0.007448217365890741
the O 0 0.006123982835561037
3 O 0 0.013704190962016582
end O 0 0.016093986108899117
. O 0 0.016934707760810852

All O 0 0.010799442417919636
were O 0 0.007017501629889011
found O 0 0.011509907431900501
in O 0 0.011022274382412434
compound O 0 0.12324225157499313
heterozygous O 1 0.9633152484893799
individuals O 0 0.04839508980512619
. O 0 0.029377976432442665

The O 0 0.048644278198480606
C6 O 1 0.9775609374046326
/ O 1 0.8280459642410278
C7 O 1 0.9842193722724915
marker O 1 0.8225798010826111
haplotypes O 1 0.9853852391242981
associated O 0 0.03204893693327904
with O 0 0.011451289057731628
most O 0 0.015147527679800987
C7 B-Disease 1 0.9962013363838196
defects I-Disease 1 0.994628369808197
are O 0 0.010055528953671455
tabulated O 0 0.023792129009962082
. O 0 0.013789234682917595
. O 0 0.01878189854323864

A O 0 0.05439063161611557
genome O 1 0.9448458552360535
- O 0 0.05310818552970886
wide O 0 0.02357490174472332
search O 0 0.019082248210906982
for O 0 0.014481744728982449
chromosomal O 1 0.9987218976020813
loci O 1 0.9954922199249268
linked O 1 0.7480898499488831
to O 0 0.013393113389611244
mental O 1 0.9893977642059326
health O 1 0.9460558295249939
wellness O 1 0.8590835332870483
in O 0 0.0097129438072443
relatives O 0 0.022013112902641296
at O 0 0.009901540353894234
high O 0 0.03124949149787426
risk O 1 0.9852864742279053
for O 0 0.12413588166236877
bipolar B-Disease 1 0.9998152852058411
affective I-Disease 1 0.9992357492446899
disorder I-Disease 1 0.9992314577102661
among O 0 0.015246930532157421
the O 0 0.008991408161818981
Old O 0 0.022126268595457077
Order O 0 0.02047833614051342
Amish O 0 0.12683941423892975
. O 0 0.025458455085754395

Bipolar B-Disease 1 0.9983941912651062
affective I-Disease 1 0.9979197382926941
disorder I-Disease 1 0.9987406134605408
( O 0 0.21140997111797333
BPAD B-Disease 1 0.9924393892288208
; O 0 0.49284887313842773
manic B-Disease 1 0.9989290833473206
- I-Disease 1 0.9957302212715149
depressive I-Disease 1 0.9997249245643616
illness I-Disease 1 0.9987537860870361
) O 0 0.01971699297428131
is O 0 0.008791790343821049
characterized O 0 0.136825829744339
by O 0 0.008577493019402027
episodes O 0 0.020753288641572
of O 0 0.010010337457060814
mania B-Disease 1 0.9930209517478943
and O 0 0.011408239603042603
/ O 1 0.5928578972816467
or O 0 0.030164914205670357
hypomania B-Disease 1 0.9949217438697815
interspersed O 0 0.2708302140235901
with O 0 0.013540839776396751
periods O 0 0.030563203617930412
of O 0 0.01521369069814682
depression B-Disease 1 0.9851680994033813
. O 0 0.03320670127868652

Compelling O 0 0.04735932871699333
evidence O 0 0.019608570262789726
supports O 0 0.01973148249089718
a O 0 0.011331059038639069
significant O 0 0.020301366224884987
genetic O 1 0.9913668036460876
component O 0 0.047299861907958984
in O 0 0.006810184568166733
the O 0 0.00925782136619091
susceptibility O 1 0.9927741289138794
to O 0 0.013559751212596893
develop O 1 0.7395333647727966
BPAD B-Disease 1 0.9697529077529907
. O 0 0.03013007342815399

To O 0 0.011815297417342663
date O 0 0.011194687336683273
, O 0 0.006026729010045528
however O 0 0.005639228038489819
, O 0 0.0056062256917357445
linkage O 1 0.6684073209762573
studies O 0 0.012878724373877048
have O 0 0.003389080986380577
attempted O 0 0.007762875407934189
only O 0 0.0030258435290306807
to O 0 0.004248845856636763
identify O 0 0.27854123711586
chromosomal O 1 0.9990881681442261
loci O 1 0.9935529232025146
that O 0 0.008858149871230125
cause O 1 0.7370924949645996
or O 0 0.008274029940366745
increase O 0 0.0113298948854208
the O 0 0.007520422339439392
risk O 1 0.8777307271957397
of O 0 0.010972972959280014
developing O 1 0.6111080646514893
BPAD B-Disease 1 0.9679160714149475
. O 0 0.031092306599020958

To O 0 0.012704470194876194
determine O 0 0.0130902249366045
whether O 0 0.007511739619076252
there O 0 0.003990704659372568
could O 0 0.005383490119129419
be O 0 0.005421351175755262
protective O 1 0.6999996304512024
alleles O 1 0.9935397505760193
that O 0 0.007642144337296486
prevent O 0 0.20416387915611267
or O 0 0.00896658655256033
reduce O 0 0.04083376005291939
the O 0 0.006159693468362093
risk O 1 0.7095444798469543
of O 0 0.0059666880406439304
developing O 0 0.4706488847732544
BPAD B-Disease 1 0.9410264492034912
, O 0 0.005498922895640135
similar O 0 0.006371169816702604
to O 0 0.0027891979552805424
what O 0 0.004052923060953617
is O 0 0.003782804124057293
observed O 0 0.011441349983215332
in O 0 0.005706491880118847
other O 0 0.021407682448625565
genetic B-Disease 1 0.999823272228241
disorders I-Disease 1 0.9998182654380798
, O 0 0.007318270392715931
we O 0 0.005236642900854349
used O 0 0.012067869305610657
mental O 1 0.9917559623718262
health O 1 0.9628968238830566
wellness O 1 0.9854918122291565
( O 0 0.014791952446103096
absence O 0 0.01833709515631199
of O 0 0.005650898441672325
any O 0 0.026095056906342506
psychiatric B-Disease 1 0.9989023208618164
disorder I-Disease 1 0.9995118379592896
) O 0 0.010865905322134495
as O 0 0.005108356010168791
the O 0 0.0066590989008545876
phenotype O 1 0.9968307614326477
in O 0 0.007464203517884016
our O 0 0.010300902649760246
genome O 1 0.9872578978538513
- O 0 0.1603703796863556
wide O 0 0.027340393513441086
linkage O 1 0.8971666693687439
scan O 0 0.19326908886432648
of O 0 0.006012406200170517
several O 0 0.007228225003927946
large O 0 0.012283348478376865
multigeneration O 0 0.49554577469825745
Old O 0 0.02354070357978344
Order O 0 0.017809700220823288
Amish O 0 0.21015101671218872
pedigrees O 1 0.7309533953666687
exhibiting O 0 0.12902304530143738
an O 0 0.01284068450331688
extremely O 0 0.0319330133497715
high O 0 0.028030656278133392
incidence O 1 0.9836245775222778
of O 0 0.02023898810148239
BPAD B-Disease 1 0.9580305218696594
. O 0 0.0379890576004982

We O 0 0.011901498772203922
have O 0 0.006575723644345999
found O 0 0.008781581185758114
strong O 0 0.008452030830085278
evidence O 0 0.006462828256189823
for O 0 0.005131812300533056
a O 0 0.010975414887070656
locus O 1 0.9606868624687195
on O 0 0.014775837771594524
chromosome O 1 0.9961453676223755
4p O 1 0.9365988969802856
at O 0 0.017766479402780533
D4S2949 O 0 0.4640803039073944
( O 0 0.01964842900633812
maximum O 0 0.025195349007844925
GENEHUNTER O 1 0.8094063997268677
- O 0 0.07020143419504166
PLUS O 0 0.03026774153113365
nonparametric O 1 0.7421038150787354
linkage O 1 0.5937981009483337
score O 0 0.017168806865811348
= O 0 0.04126230999827385
4 O 0 0.011997472494840622
. O 0 0.006558213382959366
05 O 0 0.02963106520473957
, O 0 0.00820198655128479
P O 0 0.1933189034461975
= O 0 0.049352016299963
5 O 0 0.00980482529848814
. O 0 0.0051285638473927975
22 O 0 0.007978025823831558
x O 0 0.022001875564455986
10 O 0 0.009166399016976357
( O 0 0.01132102683186531
- O 0 0.03555610403418541
4 O 0 0.013512698002159595
) O 0 0.011026422493159771
; O 0 0.011441715992987156
SIBPAL O 1 0.7479916214942932
Pempirical O 1 0.588385820388794
value O 0 0.015443798154592514
< O 1 0.6079686284065247
3 O 0 0.014358609914779663
x O 0 0.029898153617978096
10 O 0 0.009574404917657375
( O 0 0.011620109900832176
- O 0 0.02775566093623638
5 O 0 0.010049786418676376
) O 0 0.007095491047948599
) O 0 0.006246824283152819
and O 0 0.004325452260673046
suggestive O 0 0.14886118471622467
evidence O 0 0.007591863628476858
for O 0 0.0050713131204247475
a O 0 0.01088261604309082
locus O 1 0.9648933410644531
on O 0 0.014864479191601276
chromosome O 1 0.9966410398483276
4q O 1 0.976482629776001
at O 0 0.019765496253967285
D4S397 O 1 0.717216432094574
( O 0 0.01708308421075344
maximum O 0 0.02577461302280426
GENEHUNTER O 1 0.8294527530670166
- O 0 0.06200237572193146
PLUS O 0 0.034108057618141174
nonparametric O 1 0.6551046371459961
linkage O 1 0.5690375566482544
score O 0 0.018916867673397064
= O 0 0.04164237529039383
3 O 0 0.011150563135743141
. O 0 0.005832902621477842
29 O 0 0.010576553642749786
, O 0 0.006072431802749634
P O 0 0.08794859796762466
= O 0 0.03089023195207119
2 O 0 0.009590438567101955
. O 0 0.005741521250456572
57 O 0 0.013507288880646229
x O 0 0.02331884577870369
10 O 0 0.009491422213613987
( O 0 0.011786257848143578
- O 0 0.03669477254152298
3 O 0 0.01407737284898758
) O 0 0.011331219226121902
; O 0 0.013871237635612488
SIBPAL O 1 0.712425708770752
Pempirical O 1 0.6065932512283325
value O 0 0.015234407968819141
< O 1 0.5423867106437683
1 O 0 0.012135971337556839
x O 0 0.027510017156600952
10 O 0 0.01062687672674656
( O 0 0.01203034445643425
- O 0 0.04721121862530708
3 O 0 0.009396295063197613
) O 0 0.007149788551032543
) O 0 0.005244704894721508
that O 0 0.003204634878784418
are O 0 0.004229285754263401
linked O 0 0.09791602939367294
to O 0 0.011913933791220188
mental O 1 0.9847835898399353
health O 1 0.9380331039428711
wellness O 1 0.9674650430679321
. O 0 0.035797636955976486

These O 0 0.013717526569962502
findings O 0 0.015410617925226688
are O 0 0.004159523174166679
consistent O 0 0.00972081534564495
with O 0 0.005020277574658394
the O 0 0.004361146129667759
hypothesis O 0 0.08322975039482117
that O 0 0.0053021893836557865
certain O 0 0.014493850991129875
alleles O 1 0.995375394821167
could O 0 0.010681797750294209
prevent O 0 0.2741487920284271
or O 0 0.009208638221025467
modify O 0 0.14915449917316437
the O 0 0.008264563977718353
clinical O 1 0.9767959117889404
manifestations O 0 0.47845521569252014
of O 0 0.0084894560277462
BPAD B-Disease 1 0.9733821153640747
and O 0 0.008038589730858803
perhaps O 0 0.01562831737101078
other O 0 0.011644616723060608
related O 1 0.8306090235710144
affective B-Disease 1 0.9984523057937622
disorders I-Disease 1 0.9992467164993286
. O 0 0.046487126499414444

Segregation O 1 0.5533314347267151
distortion O 1 0.773055374622345
in O 0 0.11233499646186829
myotonic B-Disease 1 0.9972047209739685
dystrophy I-Disease 1 0.9983215928077698
. O 0 0.0736585259437561

Myotonic B-Disease 1 0.9968373775482178
dystrophy I-Disease 1 0.9990481734275818
( O 0 0.32990527153015137
DM B-Disease 1 0.9947100877761841
) O 0 0.022678978741168976
is O 0 0.010280035436153412
an O 0 0.026084762066602707
autosomal B-Disease 1 0.9998722076416016
dominant I-Disease 1 0.9948528409004211
disease I-Disease 1 0.9995477795600891
which O 0 0.005489927716553211
, O 0 0.0036049026530236006
in O 0 0.003345490898936987
the O 0 0.00402234448119998
typical O 0 0.09873609989881516
pedigree O 1 0.6144574880599976
, O 0 0.005229219328612089
shows O 0 0.007530319970101118
a O 0 0.007208896800875664
three O 0 0.009121955372393131
generation O 0 0.045980457216501236
anticipation O 0 0.08779864758253098
cascade O 1 0.9067001938819885
. O 0 0.031678296625614166

This O 0 0.019558031111955643
results O 0 0.03869963809847832
in O 0 0.030007898807525635
infertility B-Disease 1 0.9988952279090881
and O 0 0.48589634895324707
congenital B-Disease 1 0.9998800754547119
myotonic I-Disease 1 0.9995855689048767
dystrophy I-Disease 1 0.999574601650238
( O 0 0.19517304003238678
CDM B-Disease 1 0.9748433828353882
) O 0 0.014055351726710796
with O 0 0.007325035985559225
the O 0 0.006159591488540173
disappearance O 0 0.05798204615712166
of O 0 0.009716290980577469
DM B-Disease 1 0.9947513937950134
in O 0 0.012225959450006485
that O 0 0.012347713112831116
pedigree O 1 0.6683484315872192
. O 0 0.027906004339456558

The O 0 0.013960657641291618
concept O 0 0.01845283806324005
of O 0 0.0076921661384403706
segregation O 0 0.16960957646369934
distortion O 0 0.21039116382598877
, O 0 0.005525149870663881
where O 0 0.00414573960006237
there O 0 0.0031656825449317694
is O 0 0.004270814824849367
preferential O 0 0.08944623172283173
transmission O 0 0.2009386420249939
of O 0 0.004026472568511963
the O 0 0.005285403225570917
larger O 0 0.02042657695710659
allele O 1 0.9888958930969238
at O 0 0.008481862023472786
the O 0 0.01048809103667736
DM B-Disease 1 0.9989786148071289
locus O 1 0.9831257462501526
, O 0 0.006184766534715891
has O 0 0.004270158242434263
been O 0 0.0037370496429502964
put O 0 0.00615512952208519
forward O 0 0.005296942312270403
to O 0 0.003375913016498089
explain O 0 0.010627763345837593
partially O 0 0.019528375938534737
the O 0 0.005221621599048376
maintenance O 0 0.02482951059937477
of O 0 0.00876451563090086
DM B-Disease 1 0.9902833700180054
in O 0 0.009840080514550209
the O 0 0.008704600855708122
population O 0 0.01998637616634369
. O 0 0.022587595507502556

In O 0 0.017745232209563255
a O 0 0.014477211982011795
survey O 0 0.015902593731880188
of O 0 0.009797564707696438
DM B-Disease 1 0.9886254072189331
in O 0 0.009677663445472717
Northern O 0 0.014213770627975464
Ireland O 0 0.014334105886518955
, O 0 0.008739839307963848
59 O 0 0.023504946380853653
pedigrees O 0 0.2219579964876175
were O 0 0.013337121345102787
ascertained O 0 0.1412954479455948
. O 0 0.028008807450532913

Sibships O 0 0.21284174919128418
where O 0 0.009720017202198505
the O 0 0.005636144429445267
status O 0 0.006743021309375763
of O 0 0.00249222619459033
all O 0 0.002114702947437763
the O 0 0.002367793582379818
members O 0 0.003322973847389221
had O 0 0.0033583876211196184
been O 0 0.003317167516797781
identified O 0 0.006838389206677675
were O 0 0.0021459595300257206
examined O 0 0.009313936345279217
to O 0 0.0028226531576365232
determine O 0 0.00651445472612977
the O 0 0.0042346385307610035
transmission O 0 0.19172509014606476
of O 0 0.004566683433949947
the O 0 0.0077011981047689915
DM B-Disease 1 0.9962259531021118
expansion O 0 0.025172825902700424
from O 0 0.008826789446175098
affected O 0 0.057971421629190445
parents O 0 0.01394361536949873
to O 0 0.005806428380310535
their O 0 0.010466932319104671
offspring O 1 0.9178992509841919
. O 0 0.027337780222296715

Where O 0 0.01831115037202835
the O 0 0.014398641884326935
transmitting O 1 0.5331732034683228
parent O 0 0.25935909152030945
was O 0 0.0113994674757123
male O 0 0.07646281272172928
, O 0 0.011457978747785091
58 O 0 0.03312446549534798
. O 0 0.023113584145903587

3 O 0 0.02218099683523178
% O 0 0.010965542867779732
of O 0 0.005421746522188187
the O 0 0.005524636711925268
offspring O 1 0.6209841966629028
were O 0 0.004341652616858482
affected O 0 0.02637578174471855
, O 0 0.0034981933422386646
and O 0 0.002425207057967782
in O 0 0.002925666281953454
the O 0 0.0030020782724022865
case O 0 0.005916905589401722
of O 0 0.00424176687374711
a O 0 0.010789451189339161
female O 0 0.26412537693977356
transmitting O 1 0.9523646831512451
parent O 1 0.647383451461792
, O 0 0.014186469838023186
68 O 0 0.04010756313800812
. O 0 0.024116361513733864

7 O 0 0.0400485135614872
% O 0 0.02367868833243847
were O 0 0.011624460108578205
affected O 0 0.048321980983018875
. O 0 0.028539437800645828

Studies O 0 0.04880369454622269
on O 0 0.01656116545200348
meiotic O 1 0.921495258808136
drive O 0 0.034550778567790985
in O 0 0.013708915561437607
DM B-Disease 1 0.9825810790061951
have O 0 0.008442872203886509
shown O 0 0.013415235094726086
increased O 0 0.016071876510977745
transmission O 0 0.4825798273086548
of O 0 0.004960215650498867
the O 0 0.005745377391576767
larger O 0 0.019131353124976158
allele O 1 0.9802005290985107
at O 0 0.010036814957857132
the O 0 0.012604678981006145
DM B-Disease 1 0.9975700974464417
locus O 1 0.982944905757904
in O 0 0.015567729249596596
non O 0 0.14681941270828247
- O 1 0.8928710222244263
DM O 1 0.9964805245399475
heterozygotes O 1 0.9769957065582275
for O 0 0.028771141543984413
CTGn O 1 0.6713130474090576
. O 0 0.0370531901717186

This O 0 0.013185307383537292
study O 0 0.01637757197022438
provides O 0 0.012420403771102428
further O 0 0.0066574616357684135
evidence O 0 0.0066131120547652245
that O 0 0.004494866356253624
the O 0 0.006828305311501026
DM B-Disease 1 0.9935593605041504
expansion O 0 0.0316101536154747
tends O 0 0.02814115397632122
to O 0 0.007156843319535255
be O 0 0.009929487481713295
transmitted O 1 0.8263522982597351
preferentially O 1 0.5531653761863708
. O 0 0.027480028569698334

Diagnosis O 1 0.9807952046394348
of O 0 0.054745908826589584
hemochromatosis B-Disease 1 0.9920587539672852
. O 0 0.05933532491326332

If O 0 0.038012903183698654
untreated O 1 0.9834344983100891
, O 0 0.03226934000849724
hemochromatosis B-Disease 1 0.9992014765739441
can O 0 0.08479633182287216
cause O 1 0.9750255346298218
serious O 1 0.9369200468063354
illness O 1 0.9957202076911926
and O 0 0.0074783433228731155
early B-Disease 0 0.010897376574575901
death I-Disease 0 0.04287625104188919
, O 0 0.004826730117201805
but O 0 0.004637098405510187
the O 0 0.007756322156637907
disease O 1 0.9991499185562134
is O 0 0.007061805110424757
still O 0 0.007737488951534033
substantially O 0 0.19893546402454376
under O 0 0.01704685389995575
- O 1 0.9522406458854675
diagnosed O 1 0.9985905289649963
. O 0 0.03654081001877785

The O 0 0.01615641824901104
cornerstone O 0 0.03482552990317345
of O 0 0.008479717187583447
screening O 0 0.164090096950531
and O 0 0.005928958300501108
case O 0 0.012369981035590172
detection O 0 0.33993959426879883
is O 0 0.004653337877243757
the O 0 0.005331054329872131
measurement O 0 0.027780113741755486
of O 0 0.009524887427687645
serum O 1 0.9903692603111267
transferrin O 1 0.9807301759719849
saturation O 0 0.45453473925590515
and O 0 0.009846885688602924
the O 0 0.014894820749759674
serum O 1 0.9860931038856506
ferritin O 1 0.965255618095398
level O 0 0.03693512827157974
. O 0 0.02640782855451107

Once O 0 0.025086428970098495
the O 0 0.01639322005212307
diagnosis O 1 0.9947615265846252
is O 0 0.011675212532281876
suspected O 0 0.039186783134937286
, O 0 0.00805933028459549
physicians O 0 0.0948982685804367
must O 0 0.007052075583487749
use O 0 0.01476364117115736
serum O 1 0.9881916642189026
ferritin O 1 0.9759010076522827
levels O 0 0.11969342082738876
and O 0 0.013613295741379261
hepatic O 1 0.9987744688987732
iron O 0 0.20502518117427826
stores O 0 0.024937383830547333
on O 0 0.01841088756918907
liver O 1 0.9997439980506897
biopsy O 1 0.998009979724884
specimens O 0 0.25567561388015747
to O 0 0.007502701133489609
assess O 0 0.3415694832801819
patients O 1 0.972748339176178
for O 0 0.005250740796327591
the O 0 0.004885704722255468
presence O 0 0.014754509553313255
of O 0 0.00902037788182497
iron B-Disease 0 0.46703919768333435
overload I-Disease 1 0.9728408455848694
. O 0 0.03464913368225098

Liver O 1 0.9989761114120483
biopsy O 1 0.984036386013031
is O 0 0.010860915295779705
also O 0 0.005487135611474514
used O 0 0.004856338258832693
to O 0 0.0031506724189966917
establish O 0 0.007534240372478962
the O 0 0.003785491455346346
presence O 0 0.0111702224239707
or O 0 0.006658215541392565
absence O 0 0.029646098613739014
of O 0 0.0071191429160535336
cirrhosis B-Disease 1 0.9993773102760315
, O 0 0.006523806601762772
which O 0 0.005446467082947493
can O 0 0.011418317444622517
affect O 1 0.7216991782188416
prognosis O 1 0.9923225045204163
and O 0 0.014565937221050262
management O 0 0.057940855622291565
. O 0 0.022437570616602898

A O 0 0.048377662897109985
DNA O 1 0.8644708395004272
- O 0 0.05006623640656471
based O 0 0.012314838357269764
test O 0 0.015076124109327793
for O 0 0.00651672063395381
the O 0 0.010006553493440151
HFE O 1 0.997107207775116
gene O 1 0.9923923015594482
is O 0 0.008355039171874523
commercially O 0 0.013659127987921238
available O 0 0.004565822891891003
, O 0 0.0025616346392780542
but O 0 0.0020321656484156847
its O 0 0.0024447727482765913
place O 0 0.002932430012151599
in O 0 0.003440751461312175
the O 0 0.005742467939853668
diagnosis O 1 0.9979392886161804
of O 0 0.013644431717693806
hemochromatosis B-Disease 1 0.9993131160736084
is O 0 0.010609318502247334
still O 0 0.009488177485764027
being O 0 0.010722873732447624
evaluated O 0 0.07756780087947845
. O 0 0.02206660807132721

Currently O 0 0.016524318605661392
, O 0 0.005777602083981037
the O 0 0.004193279892206192
most O 0 0.004567035008221865
useful O 0 0.009149140678346157
role O 0 0.0076782894320786
for O 0 0.003261379897594452
this O 0 0.003102552378550172
test O 0 0.007782450877130032
is O 0 0.003343860385939479
in O 0 0.00298760156147182
the O 0 0.00359084433875978
detection O 1 0.6278181076049805
of O 0 0.008028056472539902
hemochromatosis B-Disease 1 0.9992239475250244
in O 0 0.005468063056468964
the O 0 0.004256720654666424
family O 0 0.009672020561993122
members O 0 0.004899353254586458
of O 0 0.00505497120320797
patients O 1 0.985983669757843
with O 0 0.006362789310514927
a O 0 0.008662991225719452
proven O 0 0.05597425252199173
case O 0 0.010432525537908077
of O 0 0.006716731935739517
the O 0 0.016911378130316734
disease O 1 0.9982750415802002
. O 0 0.03346387296915054

It O 0 0.01656341925263405
is O 0 0.013485316187143326
crucial O 0 0.028895823284983635
to O 0 0.023401979357004166
diagnose O 1 0.9979727864265442
hemochromatosis B-Disease 1 0.9990723133087158
before O 1 0.6683362126350403
hepatic B-Disease 1 0.9996651411056519
cirrhosis I-Disease 1 0.9996129870414734
develops O 1 0.9889814853668213
because O 0 0.20285628736019135
phlebotomy O 1 0.9952985644340515
therapy O 1 0.9947699904441833
can O 0 0.10621766746044159
avert O 1 0.9943705201148987
serious O 1 0.995686411857605
chronic O 1 0.9999017715454102
disease O 1 0.9996457099914551
and O 0 0.00708761066198349
can O 0 0.00619012676179409
even O 0 0.006041108630597591
lead O 0 0.011522901244461536
to O 0 0.00557331508025527
normal O 0 0.18931342661380768
life O 0 0.023069480434060097
expectancy O 1 0.6406717300415039
. O 0 0.01627005636692047
. O 0 0.01975729689002037

Prevalence O 1 0.8690400123596191
of O 0 0.014609172940254211
the O 0 0.01591375097632408
I1307K O 1 0.9531962275505066
APC B-Disease 1 0.9942827224731445
gene O 1 0.9972473978996277
variant O 1 0.9272353053092957
in O 0 0.007603339850902557
Israeli O 0 0.010100341401994228
Jews O 0 0.006762245669960976
of O 0 0.0041779265739023685
differing O 0 0.014754523523151875
ethnic O 0 0.01258871890604496
origin O 0 0.016828715801239014
and O 0 0.009959760122001171
risk O 1 0.9903379678726196
for O 0 0.46151474118232727
colorectal B-Disease 1 0.9999352693557739
cancer I-Disease 1 0.9995481371879578
. O 0 0.05820847675204277

BACKGROUND O 0 0.06663210690021515
& O 0 0.041926730424165726
AIMS O 0 0.02724294923245907
Israeli O 0 0.01163637638092041
Jews O 0 0.00722107058390975
of O 0 0.004145302809774876
European O 0 0.009278089739382267
birth O 0 0.32742545008659363
, O 0 0.004746961407363415
i O 0 0.004537722561508417
. O 0 0.004099658690392971
e O 0 0.020562734454870224
. O 0 0.004174074158072472
, O 0 0.0044783647172153
Ashkenazim O 0 0.2709311842918396
, O 0 0.004771871957927942
have O 0 0.0038461959920823574
the O 0 0.007056047208607197
highest O 1 0.7163696885108948
colorectal B-Disease 1 0.999972939491272
cancer I-Disease 1 0.9999256134033203
incidence O 1 0.9967837333679199
of O 0 0.007788697723299265
any O 0 0.008495873771607876
Israeli O 0 0.012769618071615696
ethnic O 0 0.020892715081572533
group O 0 0.021912097930908203
. O 0 0.019710460677742958

The O 0 0.04384545981884003
I1307K O 1 0.9382798075675964
APC B-Disease 1 0.9877325296401978
gene O 1 0.9942381381988525
variant O 1 0.956463098526001
was O 0 0.013710669241845608
found O 0 0.015270905569195747
in O 0 0.011310730129480362
6 O 0 0.023985108360648155
. O 0 0.02117101103067398

1 O 0 0.02046247199177742
% O 0 0.01244161743670702
of O 0 0.005451696924865246
American O 0 0.007853410206735134
Jews O 0 0.006412295158952475
, O 0 0.00395537493750453
28 O 0 0.0075680105946958065
% O 0 0.007039105985313654
of O 0 0.005456701852381229
their O 0 0.05842217057943344
familial O 1 0.9998983144760132
colorectal B-Disease 1 0.9999798536300659
cancer I-Disease 1 0.9999068975448608
cases O 0 0.3084767758846283
, O 0 0.006460345350205898
but O 0 0.004173788707703352
not O 0 0.0037897322326898575
in O 0 0.005610765423625708
non O 0 0.020190944895148277
- O 0 0.04167846962809563
Jews O 0 0.021340129896998405
. O 0 0.018298257142305374

We O 0 0.017434027045965195
assessed O 0 0.030433334410190582
the O 0 0.012150523252785206
I1307K O 1 0.8279387950897217
prevalence O 1 0.9830365777015686
in O 0 0.007928830571472645
Israeli O 0 0.008525164797902107
Jews O 0 0.006119761615991592
of O 0 0.003982192371040583
differing O 0 0.014807685278356075
ethnic O 0 0.012258653528988361
origin O 0 0.016859347000718117
and O 0 0.011297550052404404
risk O 1 0.9907568097114563
for O 0 0.40833207964897156
colorectal B-Disease 1 0.9999263286590576
cancer I-Disease 1 0.9995272159576416
. O 0 0.0589582584798336

METHODS O 0 0.0643175020813942
DNA O 0 0.4695046544075012
samples O 0 0.028548911213874817
from O 0 0.009727933444082737
500 O 0 0.013715718872845173
unrelated O 0 0.03126139938831329
Jews O 0 0.006786109879612923
of O 0 0.003922355826944113
European O 0 0.007030791603028774
or O 0 0.006487501319497824
non O 0 0.017161967232823372
- O 0 0.030503174290060997
European O 0 0.007515640463680029
origin O 0 0.007896584458649158
, O 0 0.003245204919949174
with O 0 0.00319181801751256
or O 0 0.004290146753191948
without O 0 0.004993448965251446
a O 0 0.005043004173785448
personal O 0 0.008553690277040005
and O 0 0.004656095523387194
/ O 0 0.2306712120771408
or O 0 0.007137579377740622
family O 0 0.010461116209626198
history O 0 0.006847489159554243
of O 0 0.00583752291277051
neoplasia B-Disease 1 0.9961754083633423
, O 0 0.005709728226065636
were O 0 0.0033235170412808657
examined O 0 0.014920072630047798
for O 0 0.004944097250699997
the O 0 0.007235778030008078
I1307K O 1 0.8439997434616089
variant O 1 0.884398877620697
by O 0 0.010356537997722626
the O 0 0.009069008752703667
allele O 1 0.9946374297142029
- O 0 0.40223002433776855
specific O 0 0.06982974708080292
oligonucleotide O 1 0.9752276539802551
( O 0 0.030308928340673447
ASO O 1 0.5983496308326721
) O 0 0.022600948810577393
method O 0 0.04193134605884552
. O 0 0.0239663515239954

RESULTS O 0 0.0423586405813694
In O 0 0.01023785024881363
persons O 0 0.016260305419564247
at O 0 0.010436484590172768
average O 0 0.03486908972263336
risk O 1 0.9849933385848999
for O 0 0.29926130175590515
colorectal B-Disease 1 0.9999643564224243
cancer I-Disease 1 0.9998043179512024
, O 0 0.016573714092373848
I1307K O 1 0.6490879654884338
was O 0 0.008160052821040154
found O 0 0.010210201144218445
in O 0 0.008190869353711605
5 O 0 0.017985442653298378
. O 0 0.01840628683567047

0 O 0 0.03849809244275093
% O 0 0.01545906811952591
of O 0 0.00633638771250844
120 O 0 0.011749139055609703
European O 0 0.010625268332660198
and O 0 0.007225494831800461
1 O 0 0.015252329409122467
. O 0 0.01781507395207882

6 O 0 0.030399251729249954
% O 0 0.018143633380532265
of O 0 0.008876681327819824
188 O 0 0.028589818626642227
non O 0 0.023577449843287468
- O 0 0.030305257067084312
European O 0 0.012042086571455002
Jews O 0 0.013337021693587303
( O 0 0.018403369933366776
P O 0 0.4152100384235382
= O 0 0.08277348428964615
0 O 0 0.02117573283612728
. O 0 0.009547780267894268
08 O 0 0.04599323123693466
) O 0 0.01842341013252735
. O 0 0.019018223509192467

It O 0 0.022917168214917183
occurred O 0 0.03287392854690552
in O 0 0.013393089175224304
15 O 0 0.026366282254457474
. O 0 0.024506837129592896

4 O 0 0.0329783596098423
% O 0 0.020232681185007095
of O 0 0.010147320106625557
52 O 0 0.03073488362133503
Ashkenazi O 0 0.47050103545188904
Israelis O 0 0.03746861591935158
with O 0 0.04564641788601875
familial O 1 0.9995505213737488
cancer B-Disease 1 0.9995601773262024
( O 0 0.05202493444085121
P O 1 0.7321893572807312
= O 0 0.15194891393184662
0 O 0 0.02157595008611679
. O 0 0.008231675252318382
02 O 0 0.2345159947872162
) O 0 0.007757775951176882
and O 0 0.0032058092765510082
was O 0 0.0033187726512551308
not O 0 0.00395955191925168
detected O 0 0.07156601548194885
in O 0 0.005628169514238834
51 O 0 0.014584126882255077
non O 0 0.014793523587286472
- O 0 0.023694511502981186
European O 0 0.010638570412993431
Jews O 0 0.01229933276772499
at O 0 0.012721690349280834
increased O 1 0.5742172598838806
cancer B-Disease 1 0.999407172203064
risk O 1 0.975121796131134
. O 0 0.030751632526516914

Colorectal B-Disease 1 0.9985048770904541
neoplasia I-Disease 1 0.9935831427574158
occurred O 0 0.06242354214191437
personally O 0 0.025285519659519196
or O 0 0.008636408485472202
in O 0 0.004466921556740999
the O 0 0.0035582983400672674
families O 0 0.006536260712891817
of O 0 0.003577995114028454
13 O 0 0.006679182406514883
of O 0 0.005335076246410608
20 O 0 0.011325804516673088
Ashkenazi O 1 0.9077956080436707
I1307K O 1 0.9528542757034302
carriers O 1 0.5128326416015625
, O 0 0.004821352194994688
8 O 0 0.005467646289616823
of O 0 0.0030251212883740664
whom O 0 0.0050658853724598885
also O 0 0.0025205942802131176
had O 0 0.0032149036414921284
a O 0 0.005416344851255417
personal O 0 0.009275108575820923
or O 0 0.00810334924608469
family O 0 0.01248521264642477
history O 0 0.010943081229925156
of O 0 0.01145440898835659
noncolonic O 1 0.9811392426490784
neoplasia B-Disease 1 0.9938545227050781
. O 0 0.0398559607565403

CONCLUSIONS O 0 0.05949060618877411
The O 0 0.02482319250702858
I1307K O 1 0.8570231795310974
APC O 1 0.9744283556938171
variant O 1 0.9616198539733887
may O 0 0.017148558050394058
represent O 0 0.011516602709889412
a O 0 0.02732531540095806
susceptibility O 1 0.9991692304611206
gene O 1 0.9984704852104187
for O 0 0.03754110634326935
colorectal B-Disease 1 0.9996975660324097
, I-Disease 0 0.007143819704651833
or I-Disease 0 0.00796507392078638
other I-Disease 0 0.0058414526283741
, I-Disease 0 0.009548370726406574
cancers I-Disease 1 0.9992721676826477
in O 0 0.009980960749089718
Ashkenazi O 1 0.6835665702819824
Jews O 0 0.008934677578508854
, O 0 0.004949904512614012
and O 0 0.004509608261287212
partially O 0 0.07382585853338242
explains O 0 0.021502507850527763
the O 0 0.006089798640459776
higher O 0 0.05060946196317673
incidence O 1 0.9983341097831726
of O 0 0.32177603244781494
colorectal B-Disease 1 0.9999566078186035
cancer I-Disease 1 0.9996781349182129
in O 0 0.019516609609127045
European O 0 0.025339117273688316
Israelis O 0 0.03960640728473663
. O 0 0.024508319795131683

Systematic O 0 0.09046518802642822
analysis O 0 0.04065970331430435
of O 0 0.01763307861983776
coproporphyrinogen O 1 0.9780013561248779
oxidase O 1 0.9982767105102539
gene O 1 0.9978771209716797
defects O 1 0.9962295889854431
in O 0 0.02827855572104454
hereditary B-Disease 1 0.9927287101745605
coproporphyria I-Disease 1 0.958737850189209
and O 0 0.025032781064510345
mutation O 1 0.9963775277137756
update O 1 0.6059373617172241
. O 0 0.03938974812626839

Hereditary B-Disease 1 0.9709442853927612
coproporphyria I-Disease 1 0.8607906699180603
( O 0 0.042720843106508255
HC B-Disease 1 0.6120308637619019
) O 0 0.01723617874085903
is O 0 0.012107295915484428
an O 0 0.023986242711544037
acute O 1 0.9990862607955933
hepatic B-Disease 1 0.9997965693473816
porphyria I-Disease 1 0.9991804957389832
with O 0 0.28963881731033325
autosomal O 1 0.9996458292007446
dominant O 1 0.9405915141105652
inheritance O 1 0.9831468462944031
caused O 1 0.7921273708343506
by O 0 0.01990235224366188
deficient B-Disease 1 0.982806921005249
activity I-Disease 0 0.03139762207865715
of I-Disease 0 0.014685564674437046
coproporphyrinogen I-Disease 1 0.9775519371032715
III I-Disease 1 0.9576582908630371
oxidase I-Disease 1 0.9926438927650452
( O 0 0.04094765707850456
CPO O 0 0.4226486086845398
) O 0 0.029797056689858437
. O 0 0.025318393483757973

Clinical O 1 0.9606220722198486
manifestations O 0 0.1957962065935135
of O 0 0.009795724414288998
the O 0 0.013181999325752258
disease O 1 0.9991450309753418
are O 0 0.010334416292607784
characterized O 1 0.8458424806594849
by O 0 0.019094647839665413
acute O 1 0.997410237789154
attacks O 0 0.23826199769973755
of O 0 0.03136904910206795
neurological B-Disease 1 0.9997424483299255
dysfunction I-Disease 1 0.999276340007782
often O 0 0.06452664732933044
precipitated O 1 0.9808432459831238
by O 0 0.018349546939134598
drugs O 1 0.9111685156822205
, O 0 0.01256239227950573
fasting O 1 0.6653387546539307
, O 0 0.017541512846946716
cyclical O 1 0.9924675822257996
hormonal O 1 0.9981630444526672
changes O 0 0.11286711692810059
, O 0 0.01684524491429329
or O 0 0.31848397850990295
infectious B-Disease 1 0.9991424083709717
diseases I-Disease 1 0.9988355040550232
. O 0 0.045232143253088

Skin O 1 0.9963276982307434
photosensitivity O 1 0.9905183911323547
may O 0 0.024203792214393616
also O 0 0.007638652343302965
be O 0 0.007125381380319595
present O 0 0.014296239241957664
. O 0 0.01921861059963703

The O 0 0.01905672252178192
seven O 0 0.017920684069395065
exons O 0 0.3741629719734192
, O 0 0.010335338301956654
the O 0 0.009524059481918812
exon O 1 0.9292613863945007
/ O 1 0.6559841632843018
intron O 1 0.957761287689209
boundaries O 0 0.011567272245883942
and O 0 0.004039826802909374
part O 0 0.005683298222720623
of O 0 0.0041020577773451805
3 O 0 0.013318317010998726
noncoding O 1 0.9460259675979614
sequence O 0 0.028915926814079285
of O 0 0.004957086872309446
the O 0 0.0064505040645599365
CPO O 1 0.5131610035896301
gene O 1 0.9793938398361206
were O 0 0.007460868917405605
systematically O 0 0.022433584555983543
analyzed O 0 0.021297434344887733
by O 0 0.007476804777979851
an O 0 0.009097886271774769
exon O 1 0.9301836490631104
- O 0 0.11333832144737244
by O 0 0.017760738730430603
- O 0 0.36626484990119934
exon O 1 0.9626908302307129
denaturing O 1 0.9778342247009277
gradient O 1 0.9633359313011169
gel O 1 0.9924113750457764
electrophoresis O 1 0.9884424805641174
( O 0 0.03628449887037277
DGGE O 1 0.8385582566261292
) O 0 0.014534800313413143
strategy O 0 0.01750480756163597
followed O 0 0.009731576777994633
by O 0 0.006407277658581734
direct O 0 0.014081165194511414
sequencing O 0 0.20939874649047852
in O 0 0.008081997744739056
seven O 0 0.013662450946867466
unrelated O 1 0.8936205506324768
heterozygous O 1 0.9954916834831238
HC B-Disease 1 0.9884352684020996
patients O 1 0.9853585958480835
from O 0 0.011381339281797409
France O 0 0.014694304205477238
, O 0 0.007000708021223545
Holland O 0 0.021096237003803253
, O 0 0.005712468642741442
and O 0 0.006051327101886272
Czech O 0 0.019562017172574997
Republic O 0 0.01682852767407894
. O 0 0.019979894161224365

Seven O 0 0.03847866132855415
novel O 0 0.1494196057319641
mutations O 1 0.9886564016342163
and O 0 0.008745545521378517
two O 0 0.008909094147384167
new O 0 0.014119080267846584
polymorphisms O 1 0.9749137163162231
were O 0 0.012444401159882545
detected O 1 0.5372645258903503
. O 0 0.02454412914812565

Among O 0 0.026270469650626183
these O 0 0.016890525817871094
mutations O 1 0.9807605743408203
two O 0 0.01018314529210329
are O 0 0.009798110462725163
missense O 1 0.9841194748878479
( O 0 0.022579027339816093
G197W O 1 0.5377094149589539
, O 0 0.010599417611956596
W427R O 1 0.5052257180213928
) O 0 0.008448934182524681
, O 0 0.0038083563558757305
two O 0 0.0034091623965650797
are O 0 0.0038368827663362026
nonsense O 0 0.05111193656921387
( O 0 0.012556929141283035
Q306X O 1 0.5855293273925781
, O 0 0.007846291176974773
Q385X O 1 0.517458975315094
) O 0 0.007626141421496868
, O 0 0.0037667162250727415
two O 0 0.0036163553595542908
are O 0 0.003910785540938377
small O 0 0.011472511105239391
deletions O 1 0.8940739631652832
( O 0 0.018766453489661217
662de14bp O 1 0.686780571937561
; O 0 0.016064682975411415
1168del3bp O 0 0.3049066960811615
removing O 0 0.03494136407971382
a O 0 0.01360397133976221
glycine O 0 0.20988334715366364
at O 0 0.008565879426896572
position O 0 0.0082110445946455
390 O 0 0.03504433110356331
) O 0 0.007274324540048838
, O 0 0.00311853620223701
and O 0 0.0023325157817453146
one O 0 0.0036812324542552233
is O 0 0.004950707778334618
a O 0 0.014055020175874233
splicing O 1 0.9940769672393799
mutation O 1 0.9988334774971008
( O 0 0.06647074967622757
IVS1 O 1 0.9808909893035889
- O 1 0.7768572568893433
15c O 1 0.98248690366745
- O 1 0.8055337071418762
- O 1 0.7758591771125793
> O 1 0.9549526572227478
g O 0 0.4029073417186737
) O 0 0.010057100094854832
which O 0 0.00542839989066124
creates O 0 0.0236786101013422
a O 0 0.01141118723899126
new O 0 0.016583221033215523
acceptor O 1 0.9118566513061523
splice O 1 0.9400656223297119
site O 0 0.036818474531173706
. O 0 0.027455158531665802

The O 0 0.02272033505141735
pathological O 0 0.2791079580783844
significance O 0 0.01695851795375347
of O 0 0.005518299527466297
the O 0 0.006696928758174181
point O 0 0.012736598961055279
mutations O 1 0.9981695413589478
G197W O 1 0.8790814876556396
, O 0 0.009340466000139713
W427R O 0 0.1972460001707077
, O 0 0.004662265069782734
and O 0 0.00320760952308774
the O 0 0.003990245517343283
in O 0 0.005853238981217146
- O 0 0.17552785575389862
frame O 0 0.20286600291728973
deletion O 1 0.9859304428100586
390delGly O 1 0.5816652178764343
were O 0 0.005169940181076527
assessed O 0 0.012513522990047932
by O 0 0.004593719728291035
their O 0 0.0043328553438186646
respective O 0 0.011362512595951557
expression O 0 0.032877642661333084
in O 0 0.005204810760915279
a O 0 0.008469363674521446
prokaryotic O 1 0.7630243897438049
system O 0 0.016050776466727257
using O 0 0.012945380993187428
site O 0 0.017233196645975113
- O 0 0.0717347264289856
directed O 0 0.03340195491909981
mutagenesis O 1 0.8397212624549866
. O 0 0.03286787495017052

These O 0 0.028791826218366623
mutations O 1 0.988950788974762
resulted O 0 0.030779046937823296
in O 0 0.006775329355150461
the O 0 0.005699291359633207
absence O 0 0.01630084216594696
or O 0 0.0070735071785748005
a O 0 0.00904123205691576
dramatic O 0 0.02885398641228676
decrease O 0 0.12176796048879623
of O 0 0.010912513360381126
CPO O 0 0.428536593914032
activity O 0 0.04800523445010185
. O 0 0.02750450000166893

The O 0 0.018893342465162277
two O 0 0.015232154168188572
polymorphisms O 1 0.9372131824493408
were O 0 0.009282763116061687
localized O 1 0.7952046394348145
in O 0 0.009651091881096363
noncoding O 1 0.9305422902107239
part O 0 0.008239639922976494
of O 0 0.005011487286537886
the O 0 0.008127499371767044
gene O 1 0.9906512498855591
1 O 0 0.011995726265013218
) O 0 0.008855818770825863
a O 0 0.01168440468609333
C O 1 0.5531307458877563
/ O 1 0.5146385431289673
G O 1 0.7567934989929199
polymorphism O 1 0.8079959154129028
in O 0 0.008169733919203281
the O 0 0.008571396581828594
promotor O 1 0.86713707447052
region O 0 0.015282548032701015
, O 0 0.008445913903415203
142 O 0 0.026211339980363846
bp O 0 0.043856024742126465
upstream O 0 0.02902575209736824
from O 0 0.009087883867323399
the O 0 0.009616971015930176
transcriptional O 1 0.930577278137207
initiation O 1 0.6600359082221985
site O 0 0.018540753051638603
( O 0 0.0199244674295187
- O 0 0.4553427994251251
142C O 1 0.9652093052864075
/ O 1 0.7481575012207031
G O 1 0.7699865698814392
) O 0 0.008109758608043194
, O 0 0.003897080197930336
and O 0 0.0035361547488719225
2 O 0 0.007578689604997635
) O 0 0.006869197357445955
a O 0 0.007413750514388084
6 O 0 0.012436042539775372
bp O 0 0.08277178555727005
deletion O 1 0.976628839969635
polymorphism O 1 0.7663136124610901
in O 0 0.0067098005674779415
the O 0 0.005098385736346245
3 O 0 0.012242785654962063
noncoding O 1 0.8774219155311584
part O 0 0.007924697361886501
of O 0 0.004937734454870224
the O 0 0.007266247179359198
CPO O 1 0.7150579690933228
gene O 1 0.9913743138313293
, O 0 0.011302920058369637
574 O 0 0.1992693841457367
bp O 0 0.03928573429584503
downstream O 0 0.02678445167839527
of O 0 0.004925104323774576
the O 0 0.003938247449696064
last O 0 0.005277246702462435
base O 0 0.005566004663705826
of O 0 0.003916817717254162
the O 0 0.0068209171295166016
normal O 0 0.3119479715824127
termination O 1 0.9443288445472717
codon O 1 0.9577789306640625
( O 0 0.03316168487071991
+ O 1 0.772028386592865
574 O 1 0.66154944896698
delATTCTT O 1 0.7468918561935425
) O 0 0.03090304136276245
. O 0 0.022738706320524216

Five O 0 0.037846993654966354
intragenic O 1 0.6579120755195618
dimorphisms O 0 0.3188638389110565
are O 0 0.007423750590533018
now O 0 0.005971028935164213
well O 0 0.004978225100785494
characterized O 0 0.03099498711526394
and O 0 0.0029683951288461685
the O 0 0.0031242561526596546
high O 0 0.00762128597125411
degree O 0 0.01087992638349533
of O 0 0.005900632124394178
allelic O 1 0.9891118407249451
heterogeneity O 1 0.9689788818359375
in O 0 0.009813440032303333
HC B-Disease 1 0.6820457577705383
is O 0 0.005579629447311163
demonstrated O 0 0.00902520027011633
with O 0 0.004374317359179258
seven O 0 0.005278363358229399
new O 0 0.0050896331667900085
different O 0 0.007539669051766396
mutations O 1 0.9917173981666565
making O 0 0.007572502829134464
a O 0 0.006179750431329012
total O 0 0.005278999451547861
of O 0 0.006525339558720589
nineteen O 0 0.08163072913885117
CPO O 1 0.9768123030662537
gene B-Disease 1 0.9988614320755005
defects I-Disease 1 0.9973117113113403
reported O 0 0.0265419352799654
so O 0 0.009555128403007984
far O 0 0.009611826390028
. O 0 0.011302175000309944
. O 0 0.017214423045516014

Coincidence O 0 0.05537756159901619
of O 0 0.011470143683254719
two O 0 0.01166727114468813
novel O 0 0.05236636847257614
arylsulfatase O 1 0.6704104542732239
A O 0 0.030574681237339973
alleles O 1 0.9919273853302002
and O 0 0.021778790280222893
mutation O 1 0.9959771037101746
459 O 1 0.954235315322876
+ O 1 0.9503026008605957
1G O 1 0.9734528064727783
> O 1 0.5953442454338074
A O 0 0.01601160317659378
within O 0 0.009113792330026627
a O 0 0.009542897343635559
family O 0 0.017337702214717865
with O 0 0.015227807685732841
metachromatic B-Disease 1 0.9874895215034485
leukodystrophy I-Disease 1 0.9980833530426025
: O 0 0.02398563362658024
molecular O 1 0.6589239835739136
basis O 0 0.014471732079982758
of O 0 0.011097410693764687
phenotypic O 1 0.9725684523582458
heterogeneity O 1 0.9125778079032898
. O 0 0.03658647835254669

In O 0 0.016163690015673637
a O 0 0.013791056349873543
family O 0 0.015918293967843056
with O 0 0.007046625483781099
three O 0 0.007592071779072285
siblings O 0 0.13210923969745636
, O 0 0.0060248663648962975
one O 0 0.007038372103124857
developed O 0 0.0268606785684824
classical O 0 0.02904718555510044
late O 0 0.05031488835811615
infantile O 1 0.9980359673500061
metachromatic B-Disease 1 0.9952093958854675
leukodystrophy I-Disease 1 0.9980720281600952
( O 0 0.14061060547828674
MLD B-Disease 1 0.9911125302314758
) O 0 0.019426362589001656
, O 0 0.009687832556664944
fatal O 1 0.9719627499580383
at O 0 0.007937689311802387
age O 0 0.0116033423691988
5 O 0 0.00894468929618597
years O 0 0.006663193926215172
, O 0 0.0053731463849544525
with O 0 0.009108527563512325
deficient O 1 0.9900344014167786
arylsulfatase O 1 0.8250226378440857
A O 0 0.022386832162737846
( O 0 0.02640238218009472
ARSA O 1 0.9797306060791016
) O 0 0.01416047289967537
activity O 0 0.01512897852808237
and O 0 0.006737326737493277
increased O 0 0.02437201514840126
galactosylsulfatide O 1 0.8097925782203674
( O 0 0.036530740559101105
GS O 1 0.9878088235855103
) O 0 0.03680660203099251
excretion O 1 0.9738520979881287
. O 0 0.03171071782708168

The O 0 0.012340947054326534
two O 0 0.008868701756000519
other O 0 0.0069174254313111305
siblings O 0 0.11874405294656754
, O 0 0.006435355171561241
apparently O 0 0.013962442986667156
healthy O 0 0.2749413847923279
at O 0 0.006120910402387381
12 O 0 0.009024739265441895
( O 0 0.00843492429703474
1 O 0 0.008691194467246532
/ O 0 0.0759182795882225
2 O 0 0.007074357941746712
) O 0 0.004412699956446886
and O 0 0.0024904075544327497
15 O 0 0.004377422854304314
years O 0 0.004168961197137833
, O 0 0.0026881347876042128
respectively O 0 0.004110759124159813
, O 0 0.0024586617946624756
and O 0 0.0020524675492197275
their O 0 0.0031227904837578535
father O 0 0.008693782612681389
, O 0 0.004355170298367739
apparently O 0 0.011316005140542984
healthy O 0 0.4465204179286957
as O 0 0.0041699339635670185
well O 0 0.004684676416218281
, O 0 0.0049421475268900394
presented O 0 0.011404708959162235
ARSA O 1 0.9802955985069275
and O 0 0.008620403707027435
GS O 1 0.9396453499794006
values O 0 0.01126010436564684
within O 0 0.0068483357317745686
the O 0 0.005863497965037823
range O 0 0.015510207042098045
of O 0 0.0146619388833642
MLD B-Disease 1 0.9941917061805725
patients O 1 0.99029141664505
. O 0 0.03744477033615112

Mutation O 1 0.9909582138061523
screening O 0 0.25500795245170593
and O 0 0.01142458338290453
sequence O 0 0.036646924912929535
analysis O 0 0.019204799085855484
disclosed O 0 0.01704363152384758
the O 0 0.0044136797077953815
involvement O 0 0.013813242316246033
of O 0 0.004805091768503189
three O 0 0.0069565800949931145
different O 0 0.014139113016426563
ARSA O 1 0.9953000545501709
mutations O 1 0.996207594871521
being O 0 0.009318557567894459
the O 0 0.008313722908496857
molecular O 1 0.5806722044944763
basis O 0 0.014503293670713902
of O 0 0.013391450978815556
intrafamilial O 1 0.8977131843566895
phenotypic O 1 0.9696053862571716
heterogeneity O 1 0.9426888227462769
. O 0 0.04461001232266426

The O 0 0.03035668469965458
late O 0 0.0720498263835907
infantile O 1 0.999099612236023
patient O 1 0.9944524168968201
inherited O 1 0.9469008445739746
from O 0 0.01073162816464901
his O 0 0.009314529597759247
mother O 0 0.023832587525248528
the O 0 0.008864125236868858
frequent O 0 0.16634637117385864
0 O 0 0.08117056638002396
- O 1 0.6096421480178833
type O 1 0.8812501430511475
mutation O 1 0.9981151819229126
459 O 1 0.9646914005279541
+ O 1 0.9776673913002014
1G O 1 0.9884732365608215
> O 1 0.8069491982460022
A O 0 0.012235797941684723
, O 0 0.004689588211476803
and O 0 0.0030467254109680653
from O 0 0.003988785203546286
his O 0 0.004544104915112257
father O 0 0.010049919597804546
a O 0 0.008619707077741623
novel O 0 0.02174787037074566
, O 0 0.0063184406608343124
single O 0 0.014143799431622028
basepair O 1 0.6350901126861572
microdeletion O 0 0.3171573579311371
of O 0 0.009471073746681213
guanine O 1 0.5134099125862122
at O 0 0.011979262344539165
nucleotide O 1 0.6277607679367065
7 O 0 0.016410257667303085
in O 0 0.011559494771063328
exon O 1 0.7561632990837097
1 O 0 0.021977055817842484
( O 0 0.023781633004546165
7delG O 1 0.6304765939712524
) O 0 0.026398027315735817
. O 0 0.025557566434144974

The O 0 0.019883204251527786
two O 0 0.01990363933146
clinically O 1 0.9193967580795288
unaffected O 1 0.760174572467804
siblings O 0 0.15373557806015015
carried O 0 0.020681537687778473
the O 0 0.016681034117937088
maternal O 1 0.9881145358085632
mutation O 1 0.9978184700012207
459 O 1 0.9619634747505188
+ O 1 0.9703848361968994
1G O 1 0.9848113059997559
> O 1 0.8461101651191711
A O 0 0.012558880262076855
and O 0 0.004611856769770384
, O 0 0.004023181274533272
on O 0 0.003430656623095274
their O 0 0.006534712389111519
paternal O 1 0.950954794883728
allele O 1 0.9898903369903564
, O 0 0.007693528197705746
a O 0 0.008937008678913116
novel O 0 0.03805459290742874
cytosine O 1 0.6507082581520081
to O 0 0.013731931336224079
thymidine O 1 0.9242597222328186
transition O 0 0.03793928772211075
at O 0 0.01798708550632
nucleotide O 1 0.930237352848053
2435 O 1 0.9595513343811035
in O 0 0.01720074564218521
exon O 1 0.6301977038383484
8 O 0 0.015052863396704197
, O 0 0.007913166657090187
resulting O 0 0.0270964615046978
in O 0 0.008472767658531666
substitution O 0 0.06255585700273514
of O 0 0.01297588087618351
alanine O 1 0.9314241409301758
464 O 1 0.6289392709732056
by O 0 0.021711457520723343
valine O 1 0.9341464638710022
( O 0 0.03425770625472069
A464V O 1 0.7600113749504089
) O 0 0.027889220044016838
. O 0 0.022559363394975662

The O 0 0.03189031407237053
fathers O 0 0.13186541199684143
genotype O 1 0.9700896739959717
thus O 0 0.030065519735217094
was O 0 0.019112352281808853
7delG O 1 0.8068891763687134
/ O 1 0.5227470993995667
A464V O 1 0.6388691067695618
. O 0 0.038700852543115616

Mutation O 1 0.9905553460121155
A464V O 0 0.44682925939559937
was O 0 0.013019994832575321
not O 0 0.007074904628098011
found O 0 0.01113157719373703
in O 0 0.00935344211757183
18 O 0 0.021305836737155914
unrelated O 1 0.9517298936843872
MLD B-Disease 1 0.9968915581703186
patients O 1 0.9864309430122375
and O 0 0.01085593644529581
50 O 0 0.017533887177705765
controls O 0 0.04982489347457886
. O 0 0.023673443123698235

A464V O 0 0.27103710174560547
, O 0 0.01634850725531578
although O 0 0.014862272888422012
clearly O 0 0.02022506669163704
modifying O 1 0.7363609075546265
ARSA O 1 0.9789373278617859
and O 0 0.015017688274383545
GS O 1 0.9903581738471985
levels O 0 0.07294636964797974
, O 0 0.007646600715816021
apparently O 0 0.014245421625673771
bears O 0 0.014392578974366188
little O 0 0.010606885887682438
significance O 0 0.011798249557614326
for O 0 0.008096115663647652
clinical O 1 0.9603419303894043
manifestation O 1 0.5125466585159302
of O 0 0.014642063528299332
MLD B-Disease 1 0.9856061339378357
, O 0 0.015965143218636513
mimicking O 0 0.4869862198829651
the O 0 0.019546525552868843
frequent O 1 0.5826191902160645
ARSA O 1 0.9918177127838135
pseudodeficiency O 1 0.9747372269630432
allele O 1 0.9808443784713745
. O 0 0.0430750735104084

Our O 0 0.018034985288977623
results O 0 0.0168874841183424
demonstrate O 0 0.012335971929132938
that O 0 0.005001639015972614
in O 0 0.005910099484026432
certain O 0 0.016107844188809395
genetic O 1 0.9967678785324097
conditions O 1 0.5123999118804932
MLD B-Disease 1 0.9954323768615723
- O 0 0.35649481415748596
like O 0 0.02799353003501892
ARSA O 1 0.982994556427002
and O 0 0.010493447072803974
GS O 1 0.9527461528778076
values O 0 0.010986746288836002
need O 0 0.006602551322430372
not O 0 0.0031054001301527023
be O 0 0.0035075710620731115
paralleled O 0 0.32300838828086853
by O 0 0.02525654435157776
clinical O 1 0.9989455342292786
disease O 1 0.9996283054351807
, O 0 0.0066430759616196156
a O 0 0.007623962126672268
finding O 0 0.013996504247188568
with O 0 0.009590656496584415
serious O 1 0.6790724396705627
diagnostic O 1 0.9765164256095886
and O 0 0.016966823488473892
prognostic O 1 0.9930775165557861
implications O 1 0.7671352028846741
. O 0 0.03272784501314163

Moreover O 0 0.0556497648358345
, O 0 0.019366195425391197
further O 0 0.03189711272716522
ARSA O 1 0.9868353605270386
alleles O 1 0.9960122108459473
functionally O 1 0.8988704681396484
similar O 0 0.019192121922969818
to O 0 0.007573505863547325
A464V O 0 0.3443481922149658
might O 0 0.01102898083627224
exist O 0 0.007932385429739952
which O 0 0.0032939608208835125
, O 0 0.0031214782502502203
together O 0 0.004750747699290514
with O 0 0.006800468545407057
0 O 0 0.061061613261699677
- O 1 0.706853985786438
type O 1 0.9290432333946228
mutations O 1 0.9984961748123169
, O 0 0.01099943183362484
may O 0 0.027567746117711067
cause O 1 0.9358164072036743
pathological O 1 0.9932621121406555
ARSA O 1 0.9934327602386475
and O 0 0.014148261398077011
GS O 1 0.9947332143783569
levels O 0 0.08280407637357712
, O 0 0.005914779845625162
but O 0 0.005406438373029232
not O 0 0.007190403528511524
clinical O 1 0.9928840398788452
outbreak O 1 0.993504524230957
of O 0 0.008780071511864662
the O 0 0.015496567822992802
disease O 1 0.9989703893661499
. O 0 0.020024601370096207
. O 0 0.024056553840637207

Human O 1 0.8298653364181519
MLH1 O 1 0.9905996918678284
deficiency O 1 0.9991021156311035
predisposes O 1 0.9862076044082642
to O 0 0.04846955090761185
hematological B-Disease 1 0.9970012307167053
malignancy I-Disease 1 0.9978345036506653
and O 0 0.03938927873969078
neurofibromatosis B-Disease 1 0.9980402588844299
type I-Disease 1 0.5781499147415161
1 I-Disease 0 0.0304050724953413
. O 0 0.026041241362690926

Heterozygous O 1 0.9593877196311951
germ O 1 0.9583562016487122
- O 0 0.15233004093170166
line O 0 0.03293799236416817
mutations O 1 0.9889495372772217
in O 0 0.010222399607300758
the O 0 0.01291599776595831
DNA O 1 0.9850956797599792
mismatch O 1 0.9912903308868408
repair O 1 0.9629515409469604
genes O 1 0.9867672324180603
lead O 0 0.12304858863353729
to O 0 0.020176177844405174
hereditary B-Disease 1 0.9972508549690247
nonpolyposis I-Disease 1 0.9977431297302246
colorectal I-Disease 1 0.9998536109924316
cancer I-Disease 1 0.9993113279342651
. O 0 0.061079733073711395

The O 0 0.0639740526676178
disease O 1 0.9990682005882263
susceptibility O 1 0.9933111667633057
of O 0 0.009158170782029629
individuals O 0 0.01611774042248726
who O 0 0.007830738089978695
constitutionally O 0 0.033240143209695816
lack O 0 0.015609758906066418
both O 0 0.008782926946878433
wild O 0 0.1979052573442459
- O 1 0.7809986472129822
type O 1 0.928015410900116
alleles O 1 0.9954642653465271
is O 0 0.015534572303295135
unknown O 0 0.03766417130827904
. O 0 0.020163005217909813

We O 0 0.010632919147610664
have O 0 0.006520086899399757
identified O 0 0.012739956378936768
three O 0 0.007321537937968969
offspring O 1 0.6190162897109985
in O 0 0.008726979605853558
a O 0 0.05908737704157829
hereditary B-Disease 1 0.9987101554870605
nonpolyposis I-Disease 1 0.9989514350891113
colorectal I-Disease 1 0.999962329864502
cancer I-Disease 1 0.9998502731323242
family O 0 0.22101984918117523
who O 0 0.017033400014042854
developed O 1 0.8668538331985474
hematological B-Disease 1 0.999242901802063
malignancy I-Disease 1 0.9984941482543945
at O 0 0.008836807683110237
a O 0 0.007532963994890451
very O 0 0.005778341554105282
early O 0 0.0063933017663657665
age O 0 0.006717686541378498
, O 0 0.002605853136628866
and O 0 0.0022162620443850756
at O 0 0.002602296182885766
least O 0 0.003116337116807699
two O 0 0.002337630372494459
of O 0 0.0022983362432569265
them O 0 0.00307780341245234
displayed O 0 0.007318814285099506
signs O 0 0.03613843396306038
of O 0 0.013074943795800209
neurofibromatosis B-Disease 1 0.9985508322715759
type I-Disease 1 0.6652985215187073
1 I-Disease 0 0.024327360093593597
( O 0 0.030733926221728325
NF1 B-Disease 1 0.9864218235015869
) O 0 0.02899068221449852
. O 0 0.02136405184864998

DNA O 1 0.5804372429847717
sequence O 0 0.059504229575395584
analysis O 0 0.03200370445847511
and O 0 0.01228606142103672
allele O 1 0.9878394603729248
- O 0 0.20309750735759735
specific O 0 0.024016041308641434
amplification O 1 0.7674996256828308
in O 0 0.007262526545673609
two O 0 0.008267410099506378
siblings O 0 0.3502461016178131
revealed O 0 0.03354976326227188
a O 0 0.023788772523403168
homozygous O 1 0.9953022003173828
MLH1 O 1 0.9969878792762756
mutation O 1 0.9985159039497375
( O 0 0.05291007086634636
C676T O 1 0.9708847999572754
- O 1 0.8010131120681763
- O 1 0.859470546245575
> O 1 0.9762470722198486
Arg226Stop O 1 0.9465587139129639
) O 0 0.03168715164065361
. O 0 0.023688755929470062

Thus O 0 0.03573860973119736
, O 0 0.01586010679602623
a O 0 0.023608140647411346
homozygous O 1 0.9886151552200317
germ O 1 0.9885508418083191
- O 0 0.39405062794685364
line O 0 0.05363292247056961
MLH1 O 1 0.9937142729759216
mutation O 1 0.9959081411361694
and O 0 0.020782440900802612
consequent O 1 0.9793137907981873
mismatch O 1 0.9969893097877502
repair O 1 0.9951894283294678
deficiency O 1 0.9996395111083984
results O 0 0.06147867068648338
in O 0 0.011805368587374687
a O 0 0.03376203775405884
mutator O 1 0.9978193044662476
phenotype O 1 0.9989205598831177
characterized O 1 0.9654622673988342
by O 0 0.10059843212366104
leukemia B-Disease 1 0.9997755885124207
and O 0 0.019453462213277817
/ O 1 0.9605152606964111
or O 1 0.5449886918067932
lymphoma B-Disease 1 0.9998985528945923
associated O 1 0.5000051259994507
with O 0 0.057897116988897324
neurofibromatosis B-Disease 1 0.99913090467453
type I-Disease 1 0.7055918574333191
1 I-Disease 0 0.019542938098311424
. O 0 0.012228596955537796
. O 0 0.019132615998387337

Missense O 1 0.9791358113288879
mutations O 1 0.9812104105949402
in O 0 0.010624971240758896
the O 0 0.00537897041067481
most O 0 0.005059352610260248
ancient O 0 0.009723052382469177
residues O 0 0.04807547479867935
of O 0 0.006470361724495888
the O 0 0.010466466657817364
PAX6 O 1 0.9935378432273865
paired O 1 0.605499267578125
domain O 0 0.2793920338153839
underlie O 1 0.7949057817459106
a O 0 0.018640300258994102
spectrum O 0 0.12662094831466675
of O 0 0.016271475702524185
human O 1 0.9740577936172485
congenital B-Disease 1 0.9998675584793091
eye I-Disease 1 0.996117115020752
malformations I-Disease 1 0.9979568719863892
. O 0 0.047873176634311676

Mutations O 1 0.9462618231773376
of O 0 0.016138065606355667
the O 0 0.01640467718243599
human O 0 0.3039686381816864
PAX6 O 1 0.9952771663665771
gene O 1 0.9966225624084473
underlie O 1 0.9909226298332214
aniridia B-Disease 1 0.9925092458724976
( O 0 0.39570391178131104
congenital B-Disease 1 0.9996116757392883
absence I-Disease 0 0.05188880115747452
of I-Disease 0 0.006783130578696728
the I-Disease 0 0.008425222709774971
iris I-Disease 1 0.9798966646194458
) O 0 0.01127578690648079
, O 0 0.00551216397434473
a O 0 0.010299026034772396
rare O 0 0.19967760145664215
dominant O 1 0.8438324332237244
malformation B-Disease 1 0.9954074025154114
of I-Disease 0 0.010610760189592838
the I-Disease 0 0.014255482703447342
eye I-Disease 1 0.9245228171348572
. O 0 0.03166589513421059

The O 0 0.024981090798974037
spectrum O 0 0.05950760468840599
of O 0 0.01924976333975792
PAX6 O 1 0.9950010180473328
mutations O 1 0.9969835877418518
in O 0 0.025475362315773964
aniridia B-Disease 1 0.9936503767967224
patients O 1 0.9950760006904602
is O 0 0.009854907169938087
highly O 0 0.015596432611346245
biased O 0 0.018470732495188713
, O 0 0.0046224589459598064
with O 0 0.0051374295726418495
92 O 0 0.012220974080264568
% O 0 0.006546654272824526
of O 0 0.003181045176461339
all O 0 0.004204613156616688
reported O 0 0.023030593991279602
mutations O 1 0.9958226680755615
leading O 0 0.015420440584421158
to O 0 0.007243440020829439
premature O 1 0.8773432970046997
truncation O 1 0.5021215677261353
of O 0 0.006681523751467466
the O 0 0.008144965395331383
protein O 1 0.9671232104301453
( O 0 0.012920661829411983
nonsense O 0 0.043184794485569
, O 0 0.00852266140282154
splicing O 1 0.9564286470413208
, O 0 0.008141730912029743
insertions O 1 0.7061315178871155
and O 0 0.005986960604786873
deletions O 1 0.7257820963859558
) O 0 0.007136765401810408
and O 0 0.0028146945405751467
just O 0 0.0038466397672891617
2 O 0 0.0055426559410989285
% O 0 0.006023918278515339
leading O 0 0.0060792043805122375
to O 0 0.003627295605838299
substitution O 0 0.020807256922125816
of O 0 0.004453714471310377
one O 0 0.006956135854125023
amino O 1 0.8173356056213379
acid O 1 0.9349277019500732
by O 0 0.011414937674999237
another O 0 0.017471371218562126
( O 0 0.02588084526360035
missense O 1 0.9817628860473633
) O 0 0.027853064239025116
. O 0 0.02228545770049095

The O 0 0.019331585615873337
extraordinary O 0 0.02547539584338665
conservation O 0 0.021104218438267708
of O 0 0.006736659910529852
the O 0 0.010484429076313972
PAX6 O 1 0.9903242588043213
protein O 1 0.7880187630653381
at O 0 0.009703636169433594
the O 0 0.008005902171134949
amino O 1 0.7614420056343079
acid O 1 0.914242148399353
level O 0 0.01416607853025198
amongst O 0 0.018182968720793724
vertebrates O 1 0.6664333343505859
predicts O 0 0.4113546311855316
that O 0 0.010696805082261562
pathological O 1 0.9933979511260986
missense O 1 0.9980841875076294
mutations O 1 0.998050332069397
should O 0 0.006542797200381756
in O 0 0.004156884737312794
fact O 0 0.005569597706198692
be O 0 0.0030679828487336636
common O 0 0.00941811315715313
even O 0 0.003916054964065552
though O 0 0.003989029675722122
they O 0 0.002141582779586315
are O 0 0.0026624505408108234
hardly O 0 0.00831897184252739
ever O 0 0.006141694262623787
seen O 0 0.011036098003387451
in O 0 0.01382055226713419
aniridia B-Disease 1 0.9916695356369019
patients O 1 0.9936168193817139
. O 0 0.02771071158349514

This O 0 0.013827584683895111
indicates O 0 0.017743544653058052
that O 0 0.00409325398504734
there O 0 0.0032573940698057413
is O 0 0.003658528672531247
a O 0 0.006795545574277639
heavy O 0 0.021455343812704086
ascertainment O 1 0.967708945274353
bias O 0 0.0858655720949173
in O 0 0.005260986741632223
the O 0 0.00443635880947113
selection O 0 0.010399354621767998
of O 0 0.007130321580916643
patients O 1 0.990362823009491
for O 0 0.01930253580212593
PAX6 O 1 0.9987804293632507
mutation O 1 0.9989950060844421
analysis O 0 0.025420833379030228
and O 0 0.004296253435313702
that O 0 0.004458146635442972
the O 0 0.00805032067000866
missing O 0 0.06131425127387047
PAX6 O 1 0.9940762519836426
missense O 1 0.9945928454399109
mutations O 1 0.9970229268074036
frequently O 0 0.04889295622706413
may O 0 0.03622312843799591
underlie O 1 0.9837604761123657
phenotypes O 1 0.9931620359420776
distinct O 0 0.21567653119564056
from O 0 0.02301507443189621
textbook O 0 0.429534912109375
aniridia B-Disease 1 0.9123737812042236
. O 0 0.03714098036289215

Here O 0 0.014637607149779797
we O 0 0.006291064899414778
present O 0 0.008891713805496693
four O 0 0.011092709377408028
novel O 0 0.31556370854377747
PAX6 O 1 0.9963423609733582
missense O 1 0.9962906837463379
mutations O 1 0.9966502785682678
, O 0 0.007426709868013859
two O 0 0.00530695216730237
in O 0 0.006266043987125158
association O 0 0.015087799169123173
with O 0 0.014490172266960144
atypical O 1 0.9971891045570374
phenotypes O 1 0.9976835250854492
ectopia B-Disease 1 0.9837270975112915
pupillae I-Disease 1 0.9623344540596008
( O 0 0.02212062105536461
displaced B-Disease 0 0.07158087193965912
pupils I-Disease 0 0.04738684371113777
) O 0 0.019034605473279953
and O 0 0.019520888105034828
congenital B-Disease 1 0.9998059868812561
nystagmus I-Disease 1 0.9970518350601196
( O 0 0.021352877840399742
searching B-Disease 0 0.025722239166498184
gaze I-Disease 0 0.16847218573093414
) O 0 0.007517215795814991
, O 0 0.002949698595330119
and O 0 0.0024330781307071447
two O 0 0.0030816434882581234
in O 0 0.0035205178428441286
association O 0 0.009365742094814777
with O 0 0.007291154935956001
more O 0 0.009983023628592491
recognizable O 1 0.6665940880775452
aniridia B-Disease 1 0.9805651307106018
phenotypes O 1 0.989189863204956
. O 0 0.046053506433963776

Strikingly O 0 0.06683332473039627
, O 0 0.008974658325314522
all O 0 0.005535471718758345
four O 0 0.008263513445854187
mutations O 1 0.9873407483100891
are O 0 0.0038824104703962803
located O 0 0.005503479391336441
within O 0 0.006159346085041761
the O 0 0.007284380029886961
PAX6 O 1 0.9884623885154724
paired O 0 0.3309271037578583
domain O 0 0.03639352694153786
and O 0 0.007352978922426701
affect O 0 0.17257775366306305
amino O 1 0.9083694219589233
acids O 1 0.8377916216850281
which O 0 0.004466131795197725
are O 0 0.003976957406848669
highly O 0 0.012301161885261536
conserved O 0 0.04507159814238548
in O 0 0.004499012138694525
all O 0 0.004164119716733694
known O 0 0.012941446155309677
paired O 0 0.4084327518939972
domain O 0 0.33723458647727966
proteins O 1 0.9099059104919434
. O 0 0.02923075295984745

Our O 0 0.018224870786070824
results O 0 0.01646466925740242
support O 0 0.007004985585808754
the O 0 0.0043160440400242805
hypothesis O 0 0.03823691979050636
that O 0 0.003436390310525894
the O 0 0.0034280268009752035
under O 0 0.004496078472584486
- O 0 0.0159288439899683
representation O 0 0.009946716018021107
of O 0 0.008082724176347256
missense O 1 0.9969491362571716
mutations O 1 0.9982389211654663
is O 0 0.012415152974426746
caused O 0 0.17189818620681763
by O 0 0.013118844479322433
ascertainment O 1 0.9716475009918213
bias O 0 0.24607227742671967
and O 0 0.00562850059941411
suggest O 0 0.01007227972149849
that O 0 0.0038426551036536694
a O 0 0.0068100146017968655
substantial O 0 0.013554278761148453
burden O 0 0.08626783639192581
of O 0 0.012014254927635193
PAX6 B-Disease 1 0.9987661838531494
- I-Disease 1 0.9727477431297302
related I-Disease 1 0.9455064535140991
disease I-Disease 1 0.9993951320648193
remains O 0 0.01473830547183752
to O 0 0.006040753331035376
be O 0 0.006276881787925959
uncovered O 0 0.02622431144118309
. O 0 0.012733031995594501
. O 0 0.01886371150612831

The O 0 0.02364572137594223
chromosomal O 1 0.9787893891334534
order O 0 0.014864319935441017
of O 0 0.00962498877197504
genes O 1 0.9825865626335144
controlling O 0 0.2849387228488922
the O 0 0.010243785567581654
major O 0 0.02848232164978981
histocompatibility O 1 0.993552565574646
complex O 0 0.05997004359960556
, O 0 0.011214287020266056
properdin O 1 0.9360581040382385
factor O 1 0.7057374119758606
B O 0 0.3667018711566925
, O 0 0.007072931155562401
and O 0 0.006896166130900383
deficiency B-Disease 1 0.9989722967147827
of I-Disease 0 0.004506148863583803
the I-Disease 0 0.003972338046878576
second I-Disease 0 0.0069441539235413074
component I-Disease 0 0.02726009488105774
of I-Disease 0 0.009117070585489273
complement I-Disease 0 0.07245476543903351
. O 0 0.021592190489172935

The O 0 0.01753179170191288
relationship O 0 0.02490980364382267
of O 0 0.00739970663562417
the O 0 0.009472067467868328
genes O 1 0.9924690127372742
coding O 1 0.9704543948173523
for O 0 0.013234361074864864
HLA O 1 0.9887964725494385
to O 0 0.006642697844654322
those O 0 0.007860940881073475
coding O 1 0.852743923664093
for O 0 0.010470419190824032
properdin O 1 0.9362096786499023
Factor O 1 0.8133070468902588
B O 1 0.7119588851928711
allotypes O 0 0.49005767703056335
and O 0 0.006135431583970785
for O 0 0.009002462960779667
deficiency B-Disease 1 0.998887836933136
of I-Disease 0 0.0050648474134504795
the I-Disease 0 0.003974279388785362
second I-Disease 0 0.006272235419601202
component I-Disease 0 0.019689295440912247
of I-Disease 0 0.006081745959818363
complement I-Disease 0 0.16781380772590637
( O 0 0.019021473824977875
C2 O 1 0.9934857487678528
) O 0 0.01038980484008789
was O 0 0.005024460144340992
studied O 0 0.008060089312493801
in O 0 0.004773903638124466
families O 0 0.009762841276824474
of O 0 0.010150269605219364
patients O 1 0.9972519278526306
with O 0 0.3471654951572418
connective O 1 0.9996167421340942
tissue O 1 0.999413251876831
disorders O 1 0.9992148876190186
. O 0 0.047542180866003036

Patients O 1 0.8906856179237366
were O 0 0.00760238291695714
selected O 0 0.009544393979012966
because O 0 0.007843381725251675
they O 0 0.004252793733030558
were O 0 0.006324464455246925
heterozygous O 1 0.9604081511497498
or O 0 0.026444263756275177
homozygous O 1 0.9876178503036499
for O 0 0.07618922740221024
C2 B-Disease 1 0.9986637830734253
deficiency I-Disease 1 0.999504804611206
. O 0 0.0479227714240551

12 O 0 0.03366094082593918
families O 0 0.024232380092144012
with O 0 0.013738714158535004
15 O 0 0.018576255068182945
matings O 1 0.8410210609436035
informative O 0 0.10340145230293274
for O 0 0.02569092996418476
C2 B-Disease 1 0.998759388923645
deficiency I-Disease 1 0.9992913007736206
were O 0 0.013325662352144718
found O 0 0.024342689663171768
. O 0 0.023836279287934303

Of O 0 0.02056579850614071
57 O 0 0.03445778414607048
informative O 0 0.04600291699171066
meioses O 0 0.11787097156047821
, O 0 0.0076224044896662235
two O 0 0.006150283385068178
crossovers O 0 0.02467481978237629
were O 0 0.004275481682270765
noted O 0 0.007710795383900404
between O 0 0.00917323213070631
the O 0 0.013661948963999748
C2 B-Disease 1 0.9994090795516968
deficiency I-Disease 1 0.9998958110809326
gene O 1 0.9960629343986511
and O 0 0.009423035196959972
the O 0 0.014699826948344707
HLA O 1 0.9991289973258972
- O 1 0.9625049829483032
B O 1 0.9768268465995789
gene O 1 0.9923239946365356
, O 0 0.0073508210480213165
with O 0 0.007100326474756002
a O 0 0.012880190275609493
recombinant O 1 0.9713425040245056
fraction O 0 0.030176717787981033
of O 0 0.011607455089688301
0 O 0 0.03396245092153549
. O 0 0.02265387587249279

035 O 1 0.8109980821609497
. O 0 0.09032464027404785

A O 0 0.03807048872113228
lod O 0 0.07508262991905212
score O 0 0.011280934326350689
of O 0 0.005217407830059528
13 O 0 0.008502486161887646
was O 0 0.004715845920145512
calculated O 0 0.011907916516065598
for O 0 0.007911504246294498
linkage O 1 0.917372465133667
between O 0 0.14206019043922424
C2 B-Disease 1 0.9995519518852234
deficiency I-Disease 1 0.9998859167098999
and O 0 0.042045339941978455
HLA O 1 0.9987432360649109
- O 1 0.7051787972450256
B O 0 0.27429401874542236
at O 0 0.006800835020840168
a O 0 0.007278375327587128
maximum O 0 0.011045542545616627
likelihood O 0 0.02824975736439228
value O 0 0.006402495317161083
of O 0 0.0045639704912900925
the O 0 0.007398447021842003
recombinant O 1 0.9683721661567688
fraction O 0 0.03477533534169197
of O 0 0.010627804324030876
0 O 0 0.030078528448939323
. O 0 0.019048990681767464

04 O 0 0.2078634798526764
. O 0 0.06679225713014603

18 O 0 0.02933979220688343
families O 0 0.021122895181179047
with O 0 0.01000820193439722
21 O 0 0.014360795728862286
informative O 0 0.039595652371644974
matings O 1 0.6091089844703674
for O 0 0.007451334502547979
both O 0 0.008998830802738667
properdin O 1 0.9392334818840027
Factor O 1 0.846983015537262
B O 1 0.8412624597549438
allotype O 1 0.8964973092079163
and O 0 0.01801639050245285
HLA O 1 0.9985698461532593
- O 1 0.6532382965087891
B O 0 0.27028340101242065
were O 0 0.007956638000905514
found O 0 0.017235167324543
. O 0 0.01933295838534832

Of O 0 0.020227136090397835
72 O 0 0.03957029804587364
informative O 0 0.05166774243116379
meioses O 0 0.21954844892024994
, O 0 0.009094963781535625
three O 0 0.008064149878919125
recombinants O 0 0.12960106134414673
were O 0 0.004443122539669275
found O 0 0.006945676635950804
, O 0 0.004753814544528723
giving O 0 0.010147841647267342
a O 0 0.011495929211378098
recombinant O 1 0.9684467315673828
fraction O 0 0.031141703948378563
of O 0 0.010317892767488956
0 O 0 0.032080039381980896
. O 0 0.01996546983718872

042 O 0 0.42313551902770996
. O 0 0.08357023447751999

A O 0 0.043506085872650146
lod O 0 0.07677889615297318
score O 0 0.012761530466377735
of O 0 0.007746797986328602
16 O 0 0.01440364308655262
between O 0 0.019786259159445763
HLA O 1 0.9981617331504822
- O 1 0.7376211881637573
B O 1 0.6197991967201233
and O 0 0.0076780361123383045
Factor O 0 0.43761953711509705
B O 1 0.6337787508964539
allotypes O 1 0.5142021179199219
was O 0 0.006456918083131313
calculated O 0 0.011477443389594555
at O 0 0.0050361137837171555
a O 0 0.0069521283730864525
maximum O 0 0.011221284046769142
likelihood O 0 0.032271645963191986
value O 0 0.006393220275640488
of O 0 0.004667762666940689
the O 0 0.0075391619466245174
recombinant O 1 0.9765198230743408
fraction O 0 0.037705376744270325
of O 0 0.012898155488073826
0 O 0 0.03500809147953987
. O 0 0.020376071333885193

04 O 0 0.21524839103221893
. O 0 0.0697343721985817

A O 0 0.031181707978248596
crossover O 0 0.04196428880095482
was O 0 0.007857367396354675
shown O 0 0.008269877173006535
to O 0 0.003530549118295312
have O 0 0.003932941239327192
occurred O 0 0.011726870201528072
between O 0 0.008993534371256828
genes O 1 0.9674994349479675
for O 0 0.008999936282634735
Factor O 1 0.7057086825370789
B O 1 0.6897972226142883
and O 0 0.012434367090463638
HLA O 1 0.9985419511795044
- O 1 0.8430176377296448
D O 1 0.6562679409980774
, O 0 0.006300664506852627
in O 0 0.006327437702566385
which O 0 0.010536560788750648
HLA O 1 0.9977868795394897
- O 1 0.8686473369598389
D O 1 0.9491344690322876
segregared O 1 0.9430409073829651
with O 0 0.02822820656001568
HLA O 1 0.9967886209487915
- O 0 0.2937929332256317
A O 0 0.020638229325413704
and O 0 0.011842709966003895
B O 0 0.27614760398864746
. O 0 0.02401992678642273

These O 0 0.01940704509615898
studies O 0 0.02100464515388012
suggest O 0 0.013157193548977375
that O 0 0.0051232087425887585
the O 0 0.0066831824369728565
genes O 1 0.9653815627098083
for O 0 0.009617865085601807
Factor O 1 0.5808990597724915
B O 1 0.7754346132278442
and O 0 0.0174392182379961
C2 B-Disease 1 0.9994668364524841
deficiency I-Disease 1 0.9997194409370422
are O 0 0.0060735540464520454
located O 0 0.005679914262145758
outside O 0 0.005163148976862431
those O 0 0.004494747146964073
for O 0 0.005690610036253929
HLA O 1 0.9894296526908875
, O 0 0.004660747479647398
that O 0 0.002988894237205386
the O 0 0.0031195057090371847
order O 0 0.005655836313962936
of O 0 0.005144626833498478
genese O 1 0.8013783097267151
is O 0 0.014339307323098183
HLA O 1 0.9966500401496887
- O 0 0.26103562116622925
A O 0 0.01802998222410679
, O 0 0.010765284299850464
- O 0 0.3513355851173401
B O 1 0.6503745913505554
, O 0 0.011112016625702381
- O 0 0.3723604381084442
D O 1 0.5735886096954346
, O 0 0.01227747742086649
Factor O 1 0.7133069038391113
B O 1 0.8306023478507996
allotype O 1 0.9424038529396057
, O 0 0.02797483094036579
C2 B-Disease 1 0.9988911747932434
deficiency I-Disease 1 0.9996939897537231
, O 0 0.008791266940534115
that O 0 0.0057955654338002205
the O 0 0.008739719167351723
genes O 1 0.9924272894859314
coding O 1 0.9881072044372559
for O 0 0.06288934499025345
C2 B-Disease 1 0.9990566372871399
deficiency I-Disease 1 0.9996777772903442
and O 0 0.016362307593226433
Factor O 1 0.6551454663276672
B O 1 0.5721356868743896
allotypes O 0 0.4150232672691345
are O 0 0.006313174031674862
approximately O 0 0.010721296072006226
3 O 0 0.013043059967458248
- O 0 0.06754108518362045
- O 0 0.045521944761276245
5 O 0 0.014180682599544525
centimorgans O 0 0.2675071358680725
from O 0 0.0073753525502979755
the O 0 0.009283200837671757
HLA O 1 0.9972406625747681
- O 0 0.3039669692516327
A O 0 0.019517546519637108
and O 0 0.014574329368770123
HLA O 1 0.9982603192329407
- O 1 0.9241739511489868
B O 1 0.9247170090675354
loci O 1 0.9850931763648987
, O 0 0.005910446867346764
and O 0 0.0029151923954486847
that O 0 0.0023481359239667654
the O 0 0.0032784659415483475
apparent O 0 0.024596309289336205
lack O 0 0.010098548606038094
of O 0 0.005135911516845226
recombinants O 0 0.4405433237552643
between O 0 0.008464295417070389
the O 0 0.007505897432565689
Factor O 1 0.8901057839393616
B O 1 0.9815884828567505
gene O 1 0.9984685778617859
and O 0 0.08808235079050064
C2 B-Disease 1 0.9997743964195251
deficiency I-Disease 1 0.9999537467956543
gene O 1 0.9986261129379272
suggests O 0 0.05449444428086281
that O 0 0.00397857092320919
these O 0 0.0035554238129407167
two O 0 0.005854313261806965
genes O 1 0.9782698154449463
lie O 0 0.012301034294068813
in O 0 0.005668265745043755
close O 0 0.008303872309625149
proximity O 0 0.016938474029302597
to O 0 0.004787962883710861
one O 0 0.005871641915291548
another O 0 0.01482048537582159
. O 0 0.016670791432261467

Distribution O 0 0.04357466101646423
of O 0 0.015231058932840824
emerin O 0 0.28832489252090454
and O 0 0.01121776644140482
lamins O 1 0.6239597797393799
in O 0 0.009179427288472652
the O 0 0.009176205843687057
heart O 1 0.738791823387146
and O 0 0.009765870869159698
implications O 0 0.30141398310661316
for O 0 0.018894262611865997
Emery B-Disease 1 0.9591580033302307
- I-Disease 1 0.9690171480178833
Dreifuss I-Disease 1 0.994830310344696
muscular I-Disease 1 0.9984525442123413
dystrophy I-Disease 1 0.9982345104217529
. O 0 0.07668207585811615

Emerin O 0 0.20528271794319153
is O 0 0.018070194870233536
a O 0 0.016510482877492905
nuclear O 0 0.026886984705924988
membrane O 1 0.8031160831451416
protein O 1 0.8698760271072388
which O 0 0.00642556045204401
is O 0 0.006253805477172136
missing O 0 0.014967923052608967
or O 0 0.013205287978053093
defective O 1 0.9788087010383606
in O 0 0.015689505264163017
Emery B-Disease 1 0.9740774631500244
- I-Disease 1 0.9710088968276978
Dreifuss I-Disease 1 0.9967382550239563
muscular I-Disease 1 0.9991117119789124
dystrophy I-Disease 1 0.9995837807655334
( O 0 0.2524670362472534
EDMD B-Disease 1 0.9831349849700928
) O 0 0.032194335013628006
. O 0 0.024940045550465584

It O 0 0.01080702431499958
is O 0 0.005767000839114189
one O 0 0.0040702903643250465
member O 0 0.005286787636578083
of O 0 0.0036741201765835285
a O 0 0.007179511711001396
family O 0 0.013093958608806133
of O 0 0.00885014794766903
lamina O 1 0.9919589757919312
- O 1 0.637152373790741
associated O 0 0.0905953124165535
proteins O 1 0.6967765688896179
which O 0 0.008278175257146358
includes O 0 0.013822780922055244
LAP1 O 1 0.7929291129112244
, O 0 0.012266797013580799
LAP2 O 1 0.771636426448822
and O 0 0.016152381896972656
lamin O 1 0.9886765480041504
B O 1 0.9582674503326416
receptor O 1 0.989421010017395
( O 0 0.050038743764162064
LBR O 1 0.9610052108764648
) O 0 0.03323929384350777
. O 0 0.024563441053032875

A O 0 0.029877832159399986
panel O 0 0.026508966460824013
of O 0 0.0111696757376194
16 O 0 0.027342811226844788
monoclonal O 1 0.9970822930335999
antibodies O 1 0.9975236058235168
( O 0 0.048291780054569244
mAbs O 1 0.9756701588630676
) O 0 0.008837501518428326
has O 0 0.004178160801529884
been O 0 0.0035297556314617395
mapped O 0 0.009295172058045864
to O 0 0.0030868775211274624
six O 0 0.00474921939894557
specific O 0 0.007439275737851858
sites O 0 0.006179955322295427
throughout O 0 0.006566519383341074
the O 0 0.006894826889038086
emerin O 1 0.8125231266021729
molecule O 1 0.8751845359802246
using O 0 0.032603368163108826
phage O 1 0.9915571212768555
- O 0 0.1280175745487213
displayed O 0 0.02338981069624424
peptide O 1 0.9595053791999817
libraries O 0 0.017643999308347702
and O 0 0.004344229120761156
has O 0 0.003984886687248945
been O 0 0.003701593028381467
used O 0 0.005670798011124134
to O 0 0.006408667657524347
localize O 1 0.8819137215614319
emerin O 1 0.7057526111602783
in O 0 0.012279433198273182
human O 0 0.057837337255477905
and O 0 0.015476721338927746
rabbit O 1 0.9916969537734985
heart O 1 0.981801450252533
. O 0 0.03182157874107361

Several O 0 0.03602821007370949
mAbs O 1 0.5897027850151062
against O 0 0.016489574685692787
different O 0 0.017178768292069435
emerin O 1 0.8028712272644043
epitopes O 1 0.8573654890060425
did O 0 0.009042506106197834
not O 0 0.005831376649439335
recognize O 0 0.025295205414295197
intercalated O 1 0.6539704203605652
discs O 0 0.022817112505435944
in O 0 0.005045981612056494
the O 0 0.005453605204820633
heart O 1 0.80991131067276
, O 0 0.004510914441198111
though O 0 0.004944153130054474
they O 0 0.003436050610616803
recognized O 0 0.011829100549221039
cardiomyocyte O 1 0.8299187421798706
nuclei O 0 0.48390790820121765
strongly O 0 0.008268074132502079
, O 0 0.003279461758211255
both O 0 0.0028746549505740404
at O 0 0.0035498228389769793
the O 0 0.003980052191764116
rim O 0 0.030692443251609802
and O 0 0.004878463223576546
in O 0 0.006924038752913475
intranuclear O 1 0.8253657221794128
spots O 0 0.05181620270013809
or O 0 0.016241172328591347
channels O 0 0.043086327612400055
. O 0 0.027799952775239944

A O 0 0.08288418501615524
polyclonal O 1 0.9659889936447144
rabbit O 1 0.9662438035011292
antiserum O 1 0.9101054668426514
against O 0 0.022349633276462555
emerin O 0 0.2520101070404053
did O 0 0.011245394125580788
recognize O 0 0.016412466764450073
both O 0 0.0067083220928907394
nuclear O 0 0.01698344759643078
membrane O 0 0.36562487483024597
and O 0 0.008249706588685513
intercalated O 1 0.7591693997383118
discs O 0 0.025506988167762756
but O 0 0.005060979630798101
, O 0 0.004440943710505962
after O 0 0.00786963663995266
affinity O 0 0.25486522912979126
purification O 0 0.1383882761001587
against O 0 0.007782354950904846
a O 0 0.009270282462239265
pure O 0 0.04824197292327881
- O 0 0.1671440452337265
emerin O 1 0.5915254950523376
band O 0 0.013502887450158596
on O 0 0.00483448151499033
a O 0 0.007097231224179268
western O 0 0.010745740495622158
blot O 0 0.412727028131485
, O 0 0.006449373904615641
it O 0 0.005997202359139919
stained O 0 0.19048559665679932
only O 0 0.006078212987631559
the O 0 0.007654189132153988
nuclear O 0 0.024694830179214478
membrane O 1 0.6741338968276978
. O 0 0.022412700578570366

These O 0 0.013378703966736794
results O 0 0.014173905365169048
would O 0 0.00435651233419776
not O 0 0.002978813834488392
be O 0 0.002622010884806514
expected O 0 0.0052092247642576694
if O 0 0.005432803183794022
immunostaining O 0 0.3741817772388458
at O 0 0.008215650916099548
intercalated O 1 0.7205661535263062
discs O 0 0.017188649624586105
were O 0 0.00265760556794703
due O 0 0.005228282883763313
to O 0 0.002606051741167903
a O 0 0.004241774789988995
product O 0 0.007501401472836733
of O 0 0.003633809043094516
the O 0 0.006003630347549915
emerin O 1 0.9817313551902771
gene O 1 0.9941366910934448
and O 0 0.00544133922085166
, O 0 0.003817938268184662
therefore O 0 0.004720340482890606
, O 0 0.002867203438654542
cast O 0 0.00444414559751749
some O 0 0.003006851999089122
doubt O 0 0.006044719833880663
upon O 0 0.004281974397599697
the O 0 0.004652614239603281
hypothesis O 1 0.8116185665130615
that O 0 0.025187388062477112
cardiac B-Disease 1 0.9997690320014954
defects I-Disease 1 0.9987285733222961
in O 0 0.01485343836247921
EDMD B-Disease 1 0.9729464650154114
are O 0 0.007831204682588577
caused O 0 0.14390785992145538
by O 0 0.008184418082237244
absence O 0 0.019475558772683144
of O 0 0.007742433343082666
emerin O 1 0.6506907939910889
from O 0 0.017596622928977013
intercalated O 1 0.9504718780517578
discs O 0 0.14857885241508484
. O 0 0.028259316459298134

Although O 0 0.031183667480945587
emerin O 0 0.15732741355895996
was O 0 0.008511286228895187
abundant O 0 0.01366625539958477
in O 0 0.004948645364493132
the O 0 0.006238352507352829
membranes O 1 0.8591300845146179
of O 0 0.007941299118101597
cardiomyocyte O 1 0.8849000930786133
nuclei O 0 0.36769920587539673
, O 0 0.005053134635090828
it O 0 0.003440932836383581
was O 0 0.0037867489736527205
absent O 0 0.012705253437161446
from O 0 0.005067553836852312
many O 0 0.006167153362184763
non O 0 0.09339281916618347
- O 1 0.8525511622428894
myocyte O 1 0.9970877766609192
cells O 1 0.9912530779838562
in O 0 0.01251665223389864
the O 0 0.013333200477063656
heart O 1 0.9477612376213074
. O 0 0.028310224413871765

This O 0 0.01452791690826416
distribution O 0 0.019709249958395958
of O 0 0.007203316316008568
emerin O 0 0.24133282899856567
was O 0 0.005475703161209822
similar O 0 0.007770029827952385
to O 0 0.002963392063975334
that O 0 0.003261827863752842
of O 0 0.004701530560851097
lamin O 1 0.9566540718078613
A O 0 0.010093020275235176
, O 0 0.004635853227227926
a O 0 0.00765098026022315
candidate O 0 0.024777526035904884
gene O 1 0.9880567789077759
for O 0 0.007648160215467215
an O 0 0.012628409080207348
autosomal O 1 0.9991772770881653
form O 0 0.04801756143569946
of O 0 0.014465746469795704
EDMD B-Disease 1 0.9581703543663025
. O 0 0.03094048611819744

In O 0 0.026064200326800346
contrast O 0 0.039609525352716446
, O 0 0.022609317675232887
lamin O 1 0.9827696084976196
B1 O 1 0.9652106165885925
was O 0 0.01279474701732397
absent O 0 0.034355588257312775
from O 0 0.012633237987756729
cardiomyocyte O 1 0.7623457312583923
nuclei O 0 0.48961853981018066
, O 0 0.006863241083920002
showing O 0 0.013134188950061798
that O 0 0.009438126347959042
lamin O 1 0.9944936633110046
B1 O 1 0.9903169870376587
is O 0 0.006917756050825119
not O 0 0.004248254932463169
essential O 0 0.00781345646828413
for O 0 0.005193362478166819
localization O 0 0.08455798029899597
of O 0 0.006256505381315947
emerin O 0 0.25305718183517456
to O 0 0.006278764922171831
the O 0 0.008922947570681572
nuclear O 0 0.0358264334499836
lamina O 1 0.9483336806297302
. O 0 0.028374549001455307

Lamin O 1 0.969810962677002
B1 O 1 0.928678572177887
is O 0 0.01565050147473812
also O 0 0.008657991886138916
almost O 0 0.011149995028972626
completely O 0 0.018667012453079224
absent O 0 0.08509330451488495
from O 0 0.022517433390021324
skeletal O 1 0.996006190776825
muscle O 1 0.9954051971435547
nuclei O 1 0.8347015380859375
. O 0 0.039301663637161255

In O 0 0.024609841406345367
EDMD B-Disease 1 0.5224572420120239
, O 0 0.007951331324875355
the O 0 0.005170673597604036
additional O 0 0.009982320480048656
absence O 0 0.01939469389617443
of O 0 0.010275374166667461
lamin O 1 0.9946022629737854
B1 O 1 0.9912393689155579
from O 0 0.01822962798178196
heart O 1 0.9609326720237732
and O 0 0.014981081709265709
skeletal O 1 0.9975950121879578
muscle O 1 0.9981552958488464
nuclei O 1 0.7074317932128906
which O 0 0.006836932618170977
already O 0 0.01008707657456398
lack O 0 0.01885034143924713
emerin O 1 0.6678131222724915
may O 0 0.00848427228629589
offer O 0 0.006986329797655344
an O 0 0.0041798753663897514
alternative O 0 0.012343492358922958
explanation O 0 0.01039346307516098
of O 0 0.00424273731186986
why O 0 0.008532891049981117
these O 0 0.0066396938636898994
tissues O 1 0.9768115878105164
are O 0 0.0072777410969138145
particularly O 0 0.019692638888955116
affected O 0 0.058581214398145676
. O 0 0.013186994008719921
. O 0 0.0190040934830904

Genetic O 1 0.9390516877174377
mapping O 0 0.04731149598956108
of O 0 0.00990602932870388
the O 0 0.011861841194331646
copper B-Disease 0 0.24270397424697876
toxicosis I-Disease 1 0.9895612597465515
locus O 1 0.9761318564414978
in O 0 0.02637118473649025
Bedlington O 1 0.9697924852371216
terriers O 1 0.9218312501907349
to O 0 0.01712271384894848
dog O 1 0.7663851380348206
chromosome O 1 0.9877941608428955
10 O 0 0.010823388583958149
, O 0 0.004761414602398872
in O 0 0.004081788007169962
a O 0 0.0070364754647016525
region O 0 0.01301255077123642
syntenic O 0 0.44691839814186096
to O 0 0.00993152242153883
human O 0 0.27238231897354126
chromosome O 1 0.9968135952949524
region O 0 0.06458079814910889
2p13 O 1 0.9619778990745544
- O 1 0.7811520099639893
p16 O 1 0.9759726524353027
. O 0 0.04390426725149155

Abnormal O 1 0.9919983744621277
hepatic B-Disease 1 0.9967371821403503
copper I-Disease 0 0.41707924008369446
accumulation I-Disease 1 0.6554403901100159
is O 0 0.010760948993265629
recognized O 0 0.014698585495352745
as O 0 0.007263850886374712
an O 0 0.016808390617370605
inherited B-Disease 1 0.9988259673118591
disorder I-Disease 1 0.9996447563171387
in O 0 0.01105607021600008
man O 0 0.025248844176530838
, O 0 0.012185095809400082
mouse O 1 0.987074613571167
, O 0 0.014106468297541142
rat O 1 0.9736714363098145
and O 0 0.015748806297779083
dog O 0 0.4557756781578064
. O 0 0.030684281140565872

The O 0 0.01920427568256855
major O 0 0.026407858356833458
cause O 0 0.3897666037082672
of O 0 0.01633950136601925
hepatic B-Disease 1 0.9990280866622925
copper I-Disease 1 0.6152035593986511
accumulation I-Disease 1 0.8494494557380676
in O 0 0.00979391485452652
man O 0 0.014470132067799568
is O 0 0.008632169105112553
a O 0 0.01810605823993683
dysfunctional O 1 0.9914217591285706
ATP7B O 1 0.9900104403495789
gene O 1 0.9952229857444763
, O 0 0.024712970480322838
causing O 1 0.9806531667709351
Wilson B-Disease 1 0.9797619581222534
disease I-Disease 1 0.9995043277740479
( O 0 0.3152925670146942
WD B-Disease 1 0.995876669883728
) O 0 0.028342684730887413
. O 0 0.02359853684902191

Mutations O 1 0.9801319241523743
in O 0 0.014800536446273327
the O 0 0.012071964330971241
ATP7B O 1 0.9754947423934937
genes O 1 0.9584704637527466
have O 0 0.006666496396064758
also O 0 0.004554950166493654
been O 0 0.005237986799329519
demonstrated O 0 0.015325656160712242
in O 0 0.010509639047086239
mouse O 1 0.9746274948120117
and O 0 0.01718677394092083
rat O 1 0.9671512842178345
. O 0 0.03655368834733963

The O 0 0.037418466061353683
ATP7B O 1 0.9431585669517517
gene O 1 0.9788401126861572
has O 0 0.009166698902845383
been O 0 0.006187645252794027
excluded O 0 0.013252094388008118
in O 0 0.004787893034517765
the O 0 0.005424604285508394
much O 0 0.009908274747431278
rarer O 1 0.9631942510604858
human O 1 0.5751160383224487
copper B-Disease 1 0.9360528588294983
overload I-Disease 1 0.9982806444168091
disease O 1 0.9994327425956726
non B-Disease 0 0.31836116313934326
- I-Disease 1 0.5662177801132202
Indian I-Disease 0 0.07751081138849258
childhood I-Disease 1 0.9928244352340698
cirrhosis I-Disease 1 0.9994516968727112
, O 0 0.01907235197722912
indicating O 0 0.46114400029182434
genetic O 1 0.9956657290458679
heterogeneity O 1 0.9683800935745239
. O 0 0.036637865006923676

By O 0 0.02603803761303425
investigating O 0 0.032044265419244766
the O 0 0.018028976395726204
common O 1 0.8472357988357544
autosomal O 1 0.999736487865448
recessive O 1 0.9996205568313599
copper B-Disease 1 0.9570872783660889
toxicosis I-Disease 1 0.9961578249931335
( O 0 0.09328926354646683
CT B-Disease 1 0.9896658658981323
) O 0 0.017669888213276863
in O 0 0.011590422131121159
Bedlington O 1 0.9865458011627197
terriers O 1 0.8937242031097412
, O 0 0.005907556042075157
we O 0 0.00309836957603693
have O 0 0.003439831081777811
identified O 0 0.008849329315125942
a O 0 0.008148105815052986
new O 0 0.011224601417779922
locus O 1 0.9875554442405701
involved O 0 0.056205932050943375
in O 0 0.03168293461203575
progressive O 1 0.9962161183357239
liver B-Disease 1 0.9998903274536133
disease I-Disease 1 0.9996101260185242
. O 0 0.05581368878483772

We O 0 0.0163455568253994
examined O 0 0.03279557824134827
whether O 0 0.01513349823653698
the O 0 0.016686629503965378
WD B-Disease 1 0.9975402355194092
gene O 1 0.9950002431869507
ATP7B O 1 0.8077929019927979
was O 0 0.01042551826685667
also O 0 0.00953815970569849
causative O 1 0.9683623313903809
for O 0 0.012633654288947582
CT B-Disease 1 0.9802992343902588
by O 0 0.00980436708778143
investigating O 0 0.0221602451056242
the O 0 0.012795547023415565
chromosomal O 1 0.9975706934928894
co O 1 0.5926442742347717
- O 0 0.17936724424362183
localization O 0 0.22228306531906128
of O 0 0.009859086945652962
ATP7B O 1 0.5078945159912109
and O 0 0.009490023367106915
C04107 O 0 0.31041419506073
, O 0 0.00868900865316391
using O 0 0.015667743980884552
fluorescence O 1 0.7746788263320923
in O 0 0.016132235527038574
situ O 1 0.9369729161262512
hybridization O 1 0.9213765263557434
( O 0 0.024595150724053383
FISH O 0 0.042049385607242584
) O 0 0.020172549411654472
. O 0 0.020563321188092232

C04107 O 0 0.44389843940734863
is O 0 0.016291867941617966
an O 0 0.015296713449060917
anonymous O 0 0.17055369913578033
microsatellite O 1 0.9792453050613403
marker O 0 0.33578407764434814
closely O 0 0.0315776951611042
linked O 0 0.34667372703552246
to O 0 0.020438464358448982
CT B-Disease 1 0.9706658720970154
. O 0 0.0355871245265007

However O 0 0.030207421630620956
, O 0 0.019889703020453453
BAC O 1 0.9658362865447998
clones O 1 0.9347764253616333
containing O 0 0.038426633924245834
ATP7B O 1 0.7210823893547058
and O 0 0.010788261890411377
C04107 O 0 0.2727850377559662
mapped O 0 0.025052927434444427
to O 0 0.0075601134449243546
the O 0 0.012058925814926624
canine O 1 0.9963892698287964
chromosome O 1 0.9980155229568481
regions O 0 0.14958326518535614
CFA22q11 O 1 0.8687449097633362
and O 0 0.009053945541381836
CFA10q26 O 1 0.7282606959342957
, O 0 0.006407796870917082
respectively O 0 0.0071805790066719055
, O 0 0.004709966015070677
demonstrating O 0 0.015515509061515331
that O 0 0.007859093137085438
WD B-Disease 1 0.9927777647972107
cannot O 0 0.012153981253504753
be O 0 0.007625181693583727
homologous O 1 0.9416205883026123
to O 0 0.017513347789645195
CT B-Disease 1 0.9752864837646484
. O 0 0.03043678030371666

The O 0 0.021731583401560783
copper O 0 0.05557085946202278
transport O 0 0.06073237955570221
genes O 1 0.9875719547271729
CTR1 O 1 0.859056293964386
and O 0 0.01013197097927332
CTR2 O 0 0.18583960831165314
were O 0 0.004377945326268673
also O 0 0.0042393882758915424
excluded O 0 0.012995780445635319
as O 0 0.005718955770134926
candidate O 0 0.01753281243145466
genes O 1 0.9846446514129639
for O 0 0.010150935500860214
CT B-Disease 1 0.9774878025054932
since O 0 0.007881821133196354
they O 0 0.0035746011417359114
both O 0 0.005358386319130659
mapped O 0 0.02395995892584324
to O 0 0.01198549009859562
canine O 1 0.9954521059989929
chromosome O 1 0.9959896206855774
region O 0 0.06231066957116127
CFA11q22 O 1 0.8222597241401672
. O 0 0.03870193287730217

2 O 0 0.06030411273241043
- O 0 0.06949599832296371
22 O 0 0.04234365001320839
. O 0 0.03350668400526047

5 O 0 0.0702255517244339
. O 0 0.046346817165613174

A O 0 0.042423851788043976
transcribed O 0 0.10647541284561157
sequence O 0 0.04711132124066353
identified O 0 0.016603123396635056
from O 0 0.0072265067137777805
the O 0 0.0067529683001339436
C04107 O 1 0.8181881904602051
- O 0 0.17269475758075714
containing O 0 0.031100211665034294
BAC O 1 0.9269205927848816
was O 0 0.006982249207794666
found O 0 0.006802046671509743
to O 0 0.0037302332930266857
be O 0 0.004662050399929285
homologous O 1 0.8504711985588074
to O 0 0.005775937344878912
a O 0 0.011610662564635277
gene O 1 0.9790658950805664
expressed O 0 0.011402498930692673
from O 0 0.010953334160149097
human O 1 0.5663884878158569
chromosome O 1 0.9987315535545349
2p13 O 1 0.9752146005630493
- O 1 0.754548192024231
p16 O 1 0.986339807510376
, O 0 0.008454912342131138
a O 0 0.01042231172323227
region O 0 0.01156778447329998
devoid O 0 0.022307349368929863
of O 0 0.006179738789796829
any O 0 0.00998284388333559
positional O 1 0.5030662417411804
candidate O 0 0.05028850585222244
genes O 1 0.9859291911125183
. O 0 0.028784973546862602

Molecular O 1 0.5999587178230286
analysis O 0 0.031101645901799202
of O 0 0.008832994848489761
the O 0 0.013250038959085941
APC B-Disease 1 0.9791060090065002
gene O 1 0.9796745181083679
in O 0 0.012273442931473255
205 O 0 0.03904755413532257
families O 0 0.018206153064966202
: O 0 0.01628582552075386
extended O 0 0.03652193024754524
genotype O 1 0.9960916638374329
- O 1 0.9600957632064819
phenotype O 1 0.9987409710884094
correlations O 1 0.9560348987579346
in O 0 0.013287495821714401
FAP B-Disease 1 0.9900200366973877
and O 0 0.0057776798494160175
evidence O 0 0.006816203240305185
for O 0 0.003916754387319088
the O 0 0.004312828648835421
role O 0 0.012200912460684776
of O 0 0.00802078377455473
APC B-Disease 1 0.9894968271255493
amino O 1 0.9807687401771545
acid O 1 0.9904325604438782
changes O 0 0.38300642371177673
in O 1 0.5534141063690186
colorectal B-Disease 1 0.9999395608901978
cancer I-Disease 1 0.9998409748077393
predisposition O 1 0.996316134929657
. O 0 0.05454224720597267

BACKGROUND O 0 0.07766088843345642
/ O 0 0.062059029936790466
AIMS O 0 0.029221350327134132
The O 0 0.010248040780425072
development O 0 0.02151677757501602
of O 0 0.04604843258857727
colorectal B-Disease 1 0.9999309778213501
cancer I-Disease 1 0.9997153878211975
and O 0 0.009787012822926044
a O 0 0.012662308290600777
variable O 0 0.18265622854232788
range O 0 0.013315878808498383
of O 0 0.00873829796910286
extracolonic O 1 0.9098832011222839
manifestations O 1 0.8905211687088013
in O 0 0.21676336228847504
familial B-Disease 1 0.9996738433837891
adenomatous I-Disease 1 0.9998601675033569
polyposis I-Disease 1 0.9997286200523376
( O 0 0.33357447385787964
FAP B-Disease 1 0.9943806529045105
) O 0 0.011641663499176502
is O 0 0.004595346283167601
the O 0 0.0035353247076272964
result O 0 0.00687679136171937
of O 0 0.0035100621171295643
the O 0 0.006398710887879133
dominant O 1 0.5885462760925293
inheritance O 1 0.9797414541244507
of O 0 0.39544737339019775
adenomatous B-Disease 1 0.9998953342437744
polyposis I-Disease 1 0.9998325109481812
coli I-Disease 1 0.9993351101875305
( O 0 0.22596830129623413
APC B-Disease 1 0.9863349199295044
) O 0 0.18239393830299377
gene O 1 0.9942265748977661
mutations O 1 0.9950516819953918
. O 0 0.04145350679755211

In O 0 0.012788628228008747
this O 0 0.007281469646841288
study O 0 0.011371482163667679
, O 0 0.005576925817877054
direct O 0 0.018858645111322403
mutation O 1 0.9956645369529724
analysis O 0 0.01510138064622879
of O 0 0.004732879344373941
the O 0 0.007145535666495562
APC B-Disease 1 0.993595540523529
gene O 1 0.9922347068786621
was O 0 0.007547301705926657
performed O 0 0.010710205882787704
to O 0 0.006846828386187553
determine O 0 0.054689232259988785
genotype O 1 0.9970788955688477
- O 1 0.9445092678070068
phenotype O 1 0.9983248114585876
correlations O 1 0.7234432101249695
for O 0 0.007840665057301521
nine O 0 0.012332748621702194
extracolonic O 1 0.7894049882888794
manifestations O 0 0.17332689464092255
and O 0 0.004940917249768972
to O 0 0.003953883890062571
investigate O 0 0.011714950203895569
the O 0 0.007230429444462061
incidence O 1 0.9884384274482727
of O 0 0.013557530008256435
APC B-Disease 1 0.9946677684783936
mutations O 1 0.997546374797821
in O 0 0.021896885707974434
non O 1 0.6109021902084351
- O 1 0.991064190864563
FAP O 1 0.9994206428527832
colorectal B-Disease 1 0.9998779296875
cancer I-Disease 1 0.999224066734314
. O 0 0.06624706834554672

METHODS O 0 0.06373604387044907
The O 0 0.02477015182375908
APC B-Disease 1 0.9725974202156067
gene O 1 0.9788395762443542
was O 0 0.012341387569904327
analysed O 0 0.03810260817408562
in O 0 0.011524748057126999
190 O 0 0.036280594766139984
unrelated O 1 0.5858210921287537
FAP B-Disease 1 0.9754685163497925
and O 0 0.012256366200745106
15 O 0 0.02124073915183544
non O 0 0.49301645159721375
- O 1 0.9937614798545837
FAP O 1 0.9996371269226074
colorectal B-Disease 1 0.9999603033065796
cancer I-Disease 1 0.9998428821563721
patients O 1 0.9950043559074402
using O 0 0.09129102528095245
denaturing O 1 0.9866099953651428
gradient O 1 0.9771949648857117
gel O 1 0.9919780492782593
electrophoresis O 1 0.9626203775405884
, O 0 0.011850211769342422
the O 0 0.01193075068295002
protein O 1 0.967492401599884
truncation O 1 0.8605073690414429
test O 0 0.023375248536467552
, O 0 0.007875241339206696
and O 0 0.0073880525305867195
direct O 0 0.022695381194353104
sequencing O 1 0.5182002186775208
. O 0 0.027801990509033203

RESULTS O 0 0.07802634686231613
Chain O 0 0.2801830470561981
terminating O 0 0.1623358577489853
signals O 0 0.02048121578991413
were O 0 0.003769075032323599
only O 0 0.0038924815598875284
identified O 0 0.01122021023184061
in O 0 0.0063275839202106
patients O 1 0.9822141528129578
belonging O 0 0.01464957743883133
to O 0 0.005756558384746313
the O 0 0.009150541387498379
FAP B-Disease 1 0.9927520751953125
group O 0 0.03012908436357975
( O 0 0.023395420983433723
105 O 0 0.1035010814666748
patients O 1 0.9888591766357422
) O 0 0.023106789216399193
. O 0 0.02162393182516098

Amino O 1 0.8272911906242371
acid O 1 0.8618687987327576
changes O 0 0.01719295233488083
were O 0 0.004793949890881777
identified O 0 0.009768565185368061
in O 0 0.0049916659481823444
four O 0 0.006734481081366539
patients O 1 0.9522150754928589
, O 0 0.004254728090018034
three O 0 0.0034278815146535635
of O 0 0.002902662381529808
whom O 0 0.006213151849806309
belonged O 0 0.007297650445252657
to O 0 0.0033759484067559242
the O 0 0.00515542458742857
non O 0 0.06891247630119324
- O 1 0.8434882760047913
FAP O 1 0.9968857169151306
group O 0 0.16125303506851196
of O 0 0.2803281545639038
colorectal B-Disease 1 0.999943733215332
cancer I-Disease 1 0.9998477697372437
patients O 1 0.9959104061126709
. O 0 0.055087823420763016

Genotype O 1 0.9917483329772949
- O 1 0.9359923005104065
phenotype O 1 0.9960598349571228
correlations O 1 0.9067938923835754
identified O 0 0.028232628479599953
significant O 0 0.013819869607686996
differences O 0 0.012180694378912449
in O 0 0.0038893762975931168
the O 0 0.0035774288699030876
nature O 0 0.007498519960790873
of O 0 0.004535347688943148
certain O 0 0.012715120799839497
extracolonic O 1 0.9218319654464722
manifestations O 1 0.8441952466964722
in O 0 0.026093333959579468
FAP B-Disease 1 0.9980766773223877
patients O 1 0.9861940741539001
belonging O 0 0.02423340640962124
to O 0 0.008660960011184216
three O 0 0.01774546317756176
mutation O 1 0.997527539730072
subgroups O 1 0.8434151411056519
. O 0 0.03356875479221344

CONCLUSIONS O 0 0.08338502794504166
Extended O 0 0.07315922528505325
genotype O 1 0.9892219305038452
- O 1 0.8860583901405334
phenotype O 1 0.9974042773246765
correlations O 1 0.5545481443405151
made O 0 0.006297142244875431
in O 0 0.0043352339416742325
this O 0 0.0032612064387649298
study O 0 0.008178792893886566
may O 0 0.0047658998519182205
have O 0 0.0024445911403745413
the O 0 0.0025573652237653732
potential O 0 0.009040539152920246
to O 0 0.0026644619647413492
determine O 0 0.00533079169690609
the O 0 0.003027341328561306
most O 0 0.004320899490267038
appropriate O 0 0.014891902916133404
surveillance O 0 0.08088546991348267
and O 0 0.009469463489949703
prophylactic O 1 0.9919918179512024
treatment O 1 0.9893795847892761
regimens O 1 0.9914484620094299
for O 0 0.010194022208452225
those O 0 0.013162557035684586
patients O 1 0.9958587288856506
with O 0 0.03812948614358902
mutations O 1 0.9990185499191284
associated O 0 0.09681414812803268
with O 0 0.012732707895338535
life O 0 0.03526296466588974
threatening O 1 0.8638577461242676
conditions O 0 0.10986962914466858
. O 0 0.028631150722503662

This O 0 0.013695389963686466
study O 0 0.016785459592938423
also O 0 0.004987167660146952
provided O 0 0.006107633002102375
evidence O 0 0.005303448997437954
for O 0 0.003626613412052393
the O 0 0.004860871471464634
pathological O 1 0.5923234820365906
nature O 0 0.013026141561567783
of O 0 0.006339889019727707
amino O 1 0.9403598308563232
acid O 1 0.9808804392814636
changes O 0 0.02265714295208454
in O 0 0.008921421132981777
APC O 1 0.9845699667930603
associated O 0 0.02680341526865959
with O 0 0.007201144006103277
both O 0 0.010059944353997707
FAP B-Disease 1 0.9917144179344177
and O 0 0.01338019035756588
non O 1 0.7328421473503113
- O 1 0.995159924030304
FAP O 1 0.9997363686561584
colorectal B-Disease 1 0.9999680519104004
cancer I-Disease 1 0.999920129776001
patients O 1 0.9968208074569702
. O 0 0.023880871012806892
. O 0 0.024600820615887642

Inherited B-Disease 1 0.9944750666618347
colorectal I-Disease 1 0.9996603727340698
polyposis I-Disease 1 0.9991880059242249
and O 0 0.11976473778486252
cancer B-Disease 1 0.999200165271759
risk O 1 0.8585107326507568
of O 0 0.011438255198299885
the O 0 0.018258539959788322
APC O 1 0.9770553112030029
I1307K O 1 0.9429337382316589
polymorphism O 1 0.9470531940460205
. O 0 0.041942037642002106

Germ O 1 0.9562968015670776
- O 0 0.06539495289325714
line O 0 0.023453475907444954
and O 0 0.013043870218098164
somatic O 1 0.9882043600082397
truncating O 1 0.9848830103874207
mutations O 1 0.9924893379211426
of O 0 0.008500033989548683
the O 0 0.01033139880746603
APC B-Disease 1 0.9893028140068054
gene O 1 0.9887752532958984
are O 0 0.008194154128432274
thought O 0 0.015929529443383217
to O 0 0.011807382106781006
initiate O 1 0.9870840907096863
colorectal B-Disease 1 0.9998764991760254
tumor I-Disease 1 0.9995561242103577
formation O 1 0.9589195251464844
in O 0 0.44166675209999084
familial B-Disease 1 0.9997771382331848
adenomatous I-Disease 1 0.9998823404312134
polyposis I-Disease 1 0.9998965263366699
syndrome I-Disease 1 0.9997634291648865
and O 0 0.0925932377576828
sporadic O 1 0.9907721281051636
colorectal O 1 0.9997138381004333
carcinogenesis O 1 0.9948983788490295
, O 0 0.021556086838245392
respectively O 0 0.027010666206479073
. O 0 0.026081060990691185

Recently O 0 0.04679270088672638
, O 0 0.014015165157616138
an O 0 0.015610282309353352
isoleucine O 1 0.9031158685684204
- O 1 0.5223165154457092
- O 1 0.67335045337677
> O 1 0.959665834903717
lysine O 1 0.9501035809516907
polymorphism O 1 0.8822986483573914
at O 0 0.025397274643182755
codon O 1 0.9203069806098938
1307 O 1 0.8923227787017822
( O 0 0.022198950871825218
I1307K O 0 0.3550529181957245
) O 0 0.010393834672868252
of O 0 0.00503840297460556
the O 0 0.008574687875807285
APC B-Disease 1 0.9914161562919617
gene O 1 0.9942954182624817
has O 0 0.006445207167416811
been O 0 0.005680480040609837
identified O 0 0.01011325977742672
in O 0 0.004397358279675245
6 O 0 0.008391580544412136
% O 0 0.010101733729243279
- O 0 0.021337240934371948
7 O 0 0.008815906941890717
% O 0 0.006703532766550779
of O 0 0.004277466796338558
the O 0 0.007128816097974777
Ashkenazi O 1 0.6111825108528137
Jewish O 0 0.025178994983434677
population O 0 0.02167435735464096
. O 0 0.020999986678361893

To O 0 0.013515761122107506
assess O 0 0.026179131120443344
the O 0 0.007653080392628908
risk O 0 0.25878259539604187
of O 0 0.004656917415559292
this O 0 0.006187106017023325
common O 0 0.14739447832107544
APC B-Disease 1 0.9925024509429932
allelic O 1 0.9953362345695496
variant O 1 0.9934597015380859
in O 0 0.12573033571243286
colorectal O 1 0.999800980091095
carcinogenesis O 1 0.9965806603431702
, O 0 0.00836825743317604
we O 0 0.0034356864634901285
have O 0 0.003692382713779807
analyzed O 0 0.013083388097584248
a O 0 0.008503339253365993
large O 0 0.011118432506918907
cohort O 0 0.3579346537590027
of O 0 0.01004093885421753
unselected O 1 0.8343631029129028
Ashkenazi O 1 0.6938368082046509
Jewish O 0 0.02615276910364628
subjects O 0 0.034408148378133774
with O 0 0.07533266395330429
adenomatous B-Disease 1 0.9996451139450073
polyps I-Disease 1 0.9986061453819275
and O 0 0.01268924679607153
. O 0 0.015119859017431736
or O 1 0.6465766429901123
colorectal B-Disease 1 0.9999334812164307
cancer I-Disease 1 0.9996224641799927
, I-Disease 0 0.011262674815952778
for O 0 0.00954915676265955
the O 0 0.01595657505095005
APC O 1 0.9754523038864136
I1307K O 1 0.9537185430526733
polymorphism O 1 0.9391042590141296
. O 0 0.04698155075311661

The O 0 0.038311637938022614
APC O 1 0.9642518162727356
I1307K O 1 0.9434735178947449
allele O 1 0.975964367389679
was O 0 0.01316490862518549
identified O 0 0.015299426391720772
in O 0 0.006848232354968786
48 O 0 0.013223842717707157
( O 0 0.008504464291036129
10 O 0 0.005789656192064285
. O 0 0.004490281455218792
1 O 0 0.006852692924439907
% O 0 0.009323197416961193
) O 0 0.009113091044127941
of O 0 0.009272576309740543
476 O 1 0.824783205986023
patients O 1 0.9867708683013916
. O 0 0.03024779073894024

Compared O 0 0.031440574675798416
with O 0 0.009527258574962616
the O 0 0.006285944953560829
frequency O 0 0.017366774380207062
in O 0 0.0043060970492661
two O 0 0.003980857785791159
separate O 0 0.007598972879350185
population O 0 0.00802744459360838
control O 0 0.012835562229156494
groups O 0 0.007410628255456686
, O 0 0.005053017288446426
the O 0 0.007328981999307871
APC O 1 0.9892320036888123
I1307K O 1 0.9844338297843933
allele O 1 0.9939348101615906
is O 0 0.009356486611068249
associated O 0 0.012639804743230343
with O 0 0.004608150105923414
an O 0 0.005323469638824463
estimated O 0 0.012021172791719437
relative O 0 0.02545052394270897
risk O 1 0.5048163533210754
of O 0 0.008894439786672592
1 O 0 0.018080202862620354
. O 0 0.019914411008358

5 O 0 0.06432260572910309
- O 0 0.06341972947120667
1 O 0 0.034213922917842865
. O 0 0.032454121857881546

7 O 0 0.06333652138710022
for O 0 0.045069415122270584
colorectal B-Disease 1 0.9993841648101807
neoplasia I-Disease 1 0.9961585402488708
( O 0 0.02911738120019436
both O 0 0.015381105244159698
P O 0 0.3846582770347595
= O 0 0.1957477331161499
. O 0 0.014662717469036579
01 O 1 0.6533187031745911
) O 0 0.024363478645682335
. O 0 0.021856125444173813

Furthermore O 0 0.05367523059248924
, O 0 0.012424293905496597
compared O 0 0.019674524664878845
with O 0 0.01281452365219593
noncarriers O 1 0.5699068307876587
, O 0 0.014198719523847103
APC O 1 0.9746963381767273
I1307K O 1 0.8541576266288757
carriers O 0 0.20696453750133514
had O 0 0.007896017283201218
increased O 0 0.011522706598043442
numbers O 0 0.009942912496626377
of O 0 0.009443374350667
adenomas B-Disease 1 0.9989008903503418
and O 0 0.25901666283607483
colorectal B-Disease 1 0.9999387264251709
cancers I-Disease 1 0.9997816681861877
per O 0 0.10686306655406952
patient O 1 0.9927863478660583
( O 0 0.03164803981781006
P O 1 0.6778079271316528
= O 0 0.15233942866325378
. O 0 0.008612273260951042
03 O 0 0.3366648852825165
) O 0 0.007492439355701208
, O 0 0.003403277136385441
as O 0 0.003218284109607339
well O 0 0.0038089114241302013
as O 0 0.004448362626135349
a O 0 0.008646833710372448
younger O 0 0.04899052530527115
age O 0 0.027278350666165352
at O 0 0.02222439832985401
diagnosis O 1 0.9945532083511353
. O 0 0.030346188694238663

We O 0 0.013567661866545677
conclude O 0 0.01942228153347969
that O 0 0.00597238726913929
the O 0 0.007574513088911772
APC O 1 0.9547415971755981
I1307K O 1 0.9274709224700928
variant O 1 0.9552022218704224
leads O 0 0.04252270981669426
to O 0 0.008029879070818424
increased O 0 0.24722404778003693
adenoma B-Disease 1 0.9989418387413025
formation O 0 0.13514015078544617
and O 0 0.00439112912863493
directly O 0 0.00837962981313467
contributes O 0 0.02783743478357792
to O 0 0.004296147730201483
3 O 0 0.007629129569977522
% O 0 0.009893756359815598
- O 0 0.021582286804914474
4 O 0 0.009058190509676933
% O 0 0.007135292515158653
of O 0 0.0039435140788555145
all O 0 0.006886108312755823
Ashkenazi O 1 0.9774304032325745
Jewish O 1 0.9027155637741089
colorectal B-Disease 1 0.9998914003372192
cancer I-Disease 1 0.9994812607765198
. O 0 0.05392715707421303

The O 0 0.016559915617108345
estimated O 0 0.02514655329287052
relative O 0 0.0343727171421051
risk O 1 0.6757779717445374
for O 0 0.009542213752865791
carriers O 0 0.3130875825881958
may O 0 0.011607397347688675
justify O 0 0.026672566309571266
specific O 0 0.030418172478675842
clinical O 1 0.9886912107467651
screening O 0 0.21923021972179413
for O 0 0.004677253775298595
the O 0 0.004491820931434631
360 O 0 0.013317437842488289
, O 0 0.004289165139198303
000 O 0 0.011377541348338127
Americans O 0 0.007054492831230164
expected O 0 0.004195191897451878
to O 0 0.0036063275765627623
harbor O 0 0.010074685327708721
this O 0 0.005740094929933548
allele O 1 0.9823284149169922
, O 0 0.005236767698079348
and O 0 0.005477648228406906
genetic O 1 0.9958767890930176
testing O 0 0.037370726466178894
in O 0 0.0039559402503073215
the O 0 0.003163794754073024
setting O 0 0.007716503459960222
of O 0 0.004532365128397942
long O 0 0.02314728870987892
- O 0 0.22211582958698273
term O 0 0.05021388456225395
- O 0 0.15064607560634613
outcome O 0 0.0432976633310318
studies O 0 0.065765880048275
may O 0 0.01430424489080906
impact O 0 0.08638767898082733
significantly O 1 0.7780618667602539
on O 0 0.1899809092283249
colorectal B-Disease 1 0.9999762773513794
cancer I-Disease 1 0.9999265670776367
prevention O 1 0.9927472472190857
in O 0 0.012016789987683296
this O 0 0.009620485827326775
population O 0 0.0227561853826046
. O 0 0.022737180814146996

Localization O 0 0.1499432921409607
of O 0 0.0164365004748106
human O 0 0.1880197823047638
BRCA1 O 1 0.9975392818450928
and O 0 0.009031505323946476
its O 0 0.00762147968634963
loss O 0 0.0255027636885643
in O 0 0.007488511968404055
high O 0 0.015922140330076218
- O 0 0.15974687039852142
grade O 0 0.08079543709754944
, O 0 0.011314650997519493
non B-Disease 0 0.26002785563468933
- I-Disease 1 0.9748837947845459
inherited I-Disease 1 0.9980144500732422
breast I-Disease 1 0.9996486902236938
carcinomas I-Disease 1 0.998383641242981
. O 0 0.050306037068367004

Although O 0 0.022931139916181564
the O 0 0.01085368450731039
link O 0 0.03358892351388931
between O 0 0.017952196300029755
the O 0 0.028615862131118774
BRCA1 O 1 0.9996598958969116
tumour B-Disease 1 0.9996145963668823
- O 1 0.989378035068512
suppressor O 1 0.9985105395317078
gene O 1 0.9971309900283813
and O 0 0.06386113166809082
hereditary B-Disease 1 0.9989259839057922
breast I-Disease 1 0.9998490810394287
and I-Disease 1 0.7596727013587952
ovarian I-Disease 1 0.9999803304672241
cancer I-Disease 1 0.9998552799224854
is O 0 0.008729868568480015
established O 0 0.007326838560402393
, O 0 0.0033318884670734406
the O 0 0.003111212747171521
role O 0 0.007579636760056019
, O 0 0.0032092349138110876
if O 0 0.00333941332064569
any O 0 0.003065698314458132
, O 0 0.0034926861990243196
of O 0 0.005994769744575024
BRCA1 O 1 0.9994103908538818
in O 0 0.013332334347069263
non B-Disease 0 0.44447582960128784
- I-Disease 1 0.9870644807815552
familial I-Disease 1 0.9995110034942627
cancers I-Disease 1 0.9995571970939636
is O 0 0.020861824974417686
unclear O 0 0.036194682121276855
. O 0 0.021721577271819115

BRCA1 O 1 0.9980493783950806
mutations O 1 0.9931226372718811
are O 0 0.015486138872802258
rare O 0 0.066068634390831
in O 0 0.014186123386025429
sporadic B-Disease 1 0.9724521040916443
cancers I-Disease 1 0.999466598033905
, O 0 0.009814867749810219
but O 0 0.006555237807333469
loss O 0 0.03418702259659767
of O 0 0.010001958347856998
BRCA1 O 1 0.9992716908454895
resulting O 0 0.35354575514793396
from O 0 0.009732278995215893
reduced O 0 0.028196725994348526
expression O 0 0.11460062116384506
or O 0 0.011693504638969898
incorrect O 0 0.087361179292202
subcellular O 1 0.8872833847999573
localization O 1 0.5914585590362549
is O 0 0.006951082032173872
postulated O 0 0.053350549191236496
to O 0 0.0036210070829838514
be O 0 0.0028213474433869123
important O 0 0.00491053843870759
in O 0 0.007057440001517534
non B-Disease 0 0.43459179997444153
- I-Disease 1 0.9917575716972351
familial I-Disease 1 0.9996798038482666
breast I-Disease 1 0.9997416138648987
and I-Disease 1 0.7181680202484131
ovarian I-Disease 1 0.9998955726623535
cancers I-Disease 1 0.9994834661483765
. O 0 0.07133474946022034

Epigenetic O 1 0.9797408580780029
loss O 0 0.081609807908535
, O 0 0.008101769722998142
however O 0 0.005672368220984936
, O 0 0.003631530562415719
has O 0 0.003505112137645483
not O 0 0.002440711483359337
received O 0 0.004819007124751806
general O 0 0.004837593995034695
acceptance O 0 0.019972380250692368
due O 0 0.007482524961233139
to O 0 0.004029694013297558
controversy O 0 0.01383103895932436
regarding O 0 0.009613155387341976
the O 0 0.006425383500754833
subcellular O 1 0.6731293797492981
localization O 1 0.5643243193626404
of O 0 0.015835177153348923
BRCA1 O 1 0.9996324777603149
proteins O 1 0.9643992781639099
, O 0 0.004992108326405287
reports O 0 0.005032946355640888
of O 0 0.0027743682730942965
which O 0 0.0029641941655427217
have O 0 0.003514875192195177
ranged O 0 0.011349878273904324
from O 0 0.005046234931796789
exclusively O 0 0.008923743851482868
nuclear O 0 0.010106807574629784
, O 0 0.003647449193522334
to O 0 0.0031807851046323776
conditionally O 0 0.024225175380706787
nuclear O 0 0.011079431511461735
, O 0 0.003974581602960825
to O 0 0.0036560893058776855
the O 0 0.0070937746204435825
ER O 1 0.9866929650306702
/ O 1 0.6734380125999451
golgi O 1 0.9599626660346985
, O 0 0.008891831152141094
to O 0 0.008619255386292934
cytoplasmic O 1 0.9443196654319763
invaginations O 0 0.319414347410202
into O 0 0.013262612745165825
the O 0 0.012411855161190033
nucleus O 0 0.42730218172073364
. O 0 0.025404782965779305

In O 0 0.013409405015408993
an O 0 0.007358381990343332
attempt O 0 0.011915145441889763
to O 0 0.004450217355042696
resolve O 0 0.013209812343120575
this O 0 0.003423348069190979
issue O 0 0.005040731746703386
, O 0 0.0027364930137991905
we O 0 0.0028765418101102114
have O 0 0.004381563048809767
comprehensively O 0 0.08810972422361374
characterized O 1 0.5518340468406677
19 O 0 0.033325813710689545
anti O 1 0.5044798851013184
- O 1 0.9793893694877625
BRCA1 O 1 0.9993383288383484
antibodies O 1 0.9956681728363037
. O 0 0.04404980316758156

These O 0 0.030858678743243217
reagents O 0 0.3592556118965149
detect O 0 0.15502187609672546
a O 0 0.021231213584542274
220 O 0 0.04335356503725052
- O 0 0.46064335107803345
kD O 1 0.9786298871040344
protein O 1 0.9825049042701721
localized O 1 0.9022687077522278
in O 0 0.012627813965082169
discrete O 0 0.08177242428064346
nuclear O 0 0.02498197928071022
foci O 0 0.4962189495563507
in O 0 0.007013482041656971
all O 0 0.007449842989444733
epithelial O 1 0.9980766773223877
cell O 1 0.94633948802948
lines O 0 0.017581231892108917
, O 0 0.00523248640820384
including O 0 0.006355341989547014
those O 0 0.00778405973687768
derived O 0 0.18043600022792816
from O 0 0.04882387816905975
breast B-Disease 1 0.9993446469306946
malignancies I-Disease 1 0.9963294863700867
. O 0 0.0465938076376915

Immunohistochemical O 1 0.9391174912452698
staining O 1 0.8052318096160889
of O 0 0.02448718063533306
human O 1 0.7731403112411499
breast O 1 0.9987115859985352
specimens O 0 0.2871732711791992
also O 0 0.014002125710248947
revealed O 0 0.32009926438331604
BRCA1 O 1 0.9991399049758911
nuclear O 0 0.20139582455158234
foci O 1 0.9706416130065918
in O 0 0.03188779950141907
benign O 1 0.9983888864517212
breast O 1 0.9994592070579529
, O 0 0.1976364254951477
invasive B-Disease 1 0.9988455772399902
lobular I-Disease 1 0.9994638562202454
cancers I-Disease 1 0.9992260932922363
and O 0 0.021592291072010994
low B-Disease 0 0.3018973767757416
- I-Disease 1 0.872639536857605
grade I-Disease 1 0.968220591545105
ductal I-Disease 1 0.9987964630126953
carcinomas I-Disease 1 0.9977744221687317
. O 0 0.054161686450242996

Conversely O 0 0.26800474524497986
, O 0 0.029244281351566315
BRCA1 O 1 0.9970487952232361
expression O 0 0.07271265983581543
was O 0 0.009012661874294281
reduced O 0 0.023190360516309738
or O 0 0.012748309411108494
undetectable O 1 0.9412248134613037
in O 0 0.0053524356335401535
the O 0 0.00399416359141469
majority O 0 0.0062317312695086
of O 0 0.003954752814024687
high O 0 0.013178447261452675
- O 0 0.3610604703426361
grade O 0 0.38915959000587463
, O 0 0.02268061228096485
ductal B-Disease 1 0.9995445609092712
carcinomas I-Disease 1 0.9988048076629639
, O 0 0.008440804667770863
suggesting O 0 0.016727816313505173
that O 0 0.0050679962150752544
absence O 0 0.01796748675405979
of O 0 0.009899101220071316
BRCA1 O 1 0.999559223651886
may O 0 0.01790602132678032
contribute O 0 0.017312079668045044
to O 0 0.004464898724108934
the O 0 0.005933957174420357
pathogenesis O 1 0.9900926947593689
of O 0 0.004959086421877146
a O 0 0.007369913160800934
significant O 0 0.009240574203431606
percentage O 0 0.015107637271285057
of O 0 0.010765619575977325
sporadic B-Disease 1 0.9930694699287415
breast I-Disease 1 0.9998315572738647
cancers I-Disease 1 0.9996088147163391
. O 0 0.02592579275369644
. O 0 0.024021906778216362

